Citrus Sinensis ID: 005400
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 698 | 2.2.26 [Sep-21-2011] | |||||||
| O81833 | 815 | G-type lectin S-receptor- | yes | no | 0.957 | 0.819 | 0.554 | 0.0 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.928 | 0.827 | 0.517 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.965 | 0.792 | 0.484 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.954 | 0.790 | 0.479 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.961 | 0.805 | 0.469 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.964 | 0.794 | 0.472 | 1e-180 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.951 | 0.774 | 0.457 | 1e-177 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.967 | 0.791 | 0.467 | 1e-177 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.959 | 0.792 | 0.454 | 1e-173 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.967 | 0.795 | 0.452 | 1e-168 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 719 bits (1856), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/694 (55%), Positives = 489/694 (70%), Gaps = 26/694 (3%)
Query: 21 ITPSQSIRDGETLVSVNGTFELGFFSPGTSAK---RYLGIWYKRVSPRTVAWVANRETPL 77
ITP + ++DG+TL S + F+LGFFS + R+LG+WY + P V WVANR PL
Sbjct: 28 ITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWVANRNNPL 85
Query: 78 TDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITM-----KNPVVQLMDSGNLVLTDGNYN 131
SG LN++S G + L DG + WSS++S T NP++++ SGNL+ +DG
Sbjct: 86 YGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLISSDGE-E 144
Query: 132 SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVL 191
++LWQSFD+P +T+L GMKLG+NFKT M+ LSSWK++ DP+PG+F+L +DT G PQL+L
Sbjct: 145 AVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLIL 204
Query: 192 RKG--SVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAVSRLWV 249
RK S YR GSWNGL FTG P + L DYKF + EV Y + VSRL +
Sbjct: 205 RKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHRIVSRLVL 264
Query: 250 NQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNS--SRRCDCLEGFVPK 307
N +G + R I S+Q+ W LA AP D CD YS+CGA A C NS + C CL+GF PK
Sbjct: 265 NNTGKLHRFI-QSKQNQWILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPK 323
Query: 308 SPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNA--SMNLKECSELCS 360
S W + GCV E C D F K+ LKLPDTS SW++A M L++C CS
Sbjct: 324 SGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCS 383
Query: 361 KNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTKKQVGII 420
NCSCTAYAN+D+ GG GCLLWFGDL+DM+EY+ GQD+YIR+ + ++ VG++
Sbjct: 384 SNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMV 443
Query: 421 IASVLLMAMFIVASLFCIWRKKLKKQGLTKMSH--MKEDMELWEFDFASIAKATDNFASY 478
+ SV+ +A+ +V C +K +K+ +ED++L FD +I+ ATD+F+
Sbjct: 444 VGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDRKTISIATDDFSYV 503
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
N LG GGFGPVYKG L +GQEIAVKRLS SGQG+EEFKNEV LIA+LQHRNLV+LLGCC
Sbjct: 504 NFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCC 563
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
IQ +E MLIYEYMPNKSLDFFIFD+ R+T LDW+KR++I+ G+ARGILYLHQDSR+RIIH
Sbjct: 564 IQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIH 623
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKS 658
RDLKA NVLLDNDMNPKISDFG+A+ FGGD+ +++T++VVGTYGYM PEYA +G FSVKS
Sbjct: 624 RDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKS 683
Query: 659 DVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
DVFSFGVLVLEI++GK N F H DHD NLLGHV
Sbjct: 684 DVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHV 717
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/692 (51%), Positives = 480/692 (69%), Gaps = 44/692 (6%)
Query: 15 SAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRE 74
+ A D + +Q+++DG+T+VS G+FE+GFFSPG S RYLGIWYK++S +TV WVANR+
Sbjct: 21 AQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRD 80
Query: 75 TPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNT-----SITMKNPVVQLMDSGNLVLTD- 127
+PL D SG L V+ G + L + R+ I WSS++ +++NP+VQ++D+GNLV+ +
Sbjct: 81 SPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVRNS 140
Query: 128 GNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFP 187
G+ +WQS D+P D LPGMK G NF TG++R L+SW++I+DP+ G ++ +D +G P
Sbjct: 141 GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVP 200
Query: 188 QLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SR 246
Q L+K SV+ +R G WNGL FTG P LK N P+ Y++V E EVYY + P+V +R
Sbjct: 201 QFFLKKNSVVVFRTGPWNGLRFTGMPNLKPN-PIYRYEYVFTEEEVYYTYKLENPSVLTR 259
Query: 247 LWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVP 306
+ +N +G + R W W A +D CD Y++CG+ C N S C CL+GFV
Sbjct: 260 MQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVA 319
Query: 307 KSPN-----NWSEGCVRERELKCRNG-DEFPKYVKLKLPDTSSSWFNASMNLKECSELCS 360
K+P +WSEGCVR +L C G D F K KLKLPDT +SW++ +M+L EC ++C
Sbjct: 320 KTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCL 379
Query: 361 KNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTKKQVGII 420
+NC+C+AY+ D+ GG GC+LWFGDL+D++EYN+ GQDLY+R+AS ++ ++
Sbjct: 380 RNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESS--- 436
Query: 421 IASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNK 480
R +KQ +ED+EL D ++++AT F++ NK
Sbjct: 437 -------------------RVSSRKQ-------EEEDLELPFLDLDTVSEATSGFSAGNK 470
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
LG+GGFGPVYKGTL GQE+AVKRLS+ S QG+EEFKNE+ LIA+LQHRNLVK+LG C+
Sbjct: 471 LGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVD 530
Query: 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
+E MLIYEY PNKSLD FIFD+ R LDW KR+ I+ GIARG+LYLH+DSR+RIIHRD
Sbjct: 531 EEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRD 590
Query: 601 LKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDV 660
LKASNVLLD+DMN KISDFG+AR GGDE + NT +VVGTYGYMSPEY +G FS+KSDV
Sbjct: 591 LKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDV 650
Query: 661 FSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
FSFGVLVLEIVSG++N F + +H NLLGH
Sbjct: 651 FSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHA 682
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/720 (48%), Positives = 470/720 (65%), Gaps = 46/720 (6%)
Query: 15 SAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRE 74
SA + + S +I T+VS FELGFF PG ++ YLGIWYK +S RT WVANR+
Sbjct: 28 SANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRD 87
Query: 75 TPLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLVLTDGNYNS 132
TPL+ G L ++ +V+LD D WS+N T +++P+V +L+D+GN VL D ++
Sbjct: 88 TPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSA 147
Query: 133 ---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQL 189
+LWQSFD P DTLLP MKLG + KTG +R + SWKS +DP+ G+FS ++T GFP++
Sbjct: 148 PDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEI 207
Query: 190 VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECD-AKGPAVSRLW 248
L YR+G WNG+ F+G P ++ + + F ++ EV Y K SRL
Sbjct: 208 FLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMV-FNFTTSKEEVTYSFRITKSDVYSRLS 266
Query: 249 VNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
++ SGL+ R W W +YAP D+CD Y CG C +N+S C+C++GF P++
Sbjct: 267 ISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRN 326
Query: 309 PNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNC 363
P W S+GCVR+ L C GD F + K+KLPDT+++ + + +KEC + C ++C
Sbjct: 327 PQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDC 386
Query: 364 SCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTKKQVGII 420
+CTA+AN+D+ GSGC+ W G+L D++ Y GGQDLY+R+A+ E R+ + K +G
Sbjct: 387 NCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSS 446
Query: 421 I-ASVLLMAMFIVASLFCIWRKKLKKQGLTKM---------------------------S 452
I SVLL+ FI+ F +W++K K+ L +
Sbjct: 447 IGVSVLLLLSFII---FFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRE 503
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+ +D+EL +F +A AT+NF++ NKLG+GGFG VYKG L++GQE+AVKRLSK S QG
Sbjct: 504 NNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQG 563
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+EFKNEV LIARLQH NLV+LL CC+ A E MLIYEY+ N SLD +FD++R + L+WQ
Sbjct: 564 TDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQ 623
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
R I+ GIARG+LYLHQDSR RIIHRDLKASN+LLD M PKISDFGMARIFG DE +
Sbjct: 624 MRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEA 683
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
NT KVVGTYGYMSPEYA +G+FS+KSDVFSFGVL+LEI+S K+N F + D D NLLG V
Sbjct: 684 NTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCV 743
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/709 (47%), Positives = 460/709 (64%), Gaps = 43/709 (6%)
Query: 22 TPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQS 81
T S +I +T++S + FELGFF+P +S++ YLGIWYK + RT WVANR+ PL+ +
Sbjct: 33 TESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSN 92
Query: 82 GLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLVLTDGNYNSLLWQSFD 139
G L ++ +V+ D DR WS+N T +++PV +L+D+GN +L D N N LLWQSFD
Sbjct: 93 GTLKISGNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSN-NRLLWQSFD 151
Query: 140 HPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQY 199
P DTLL MKLG + KTG +R L SWK+ +DP+ GEFS ++T FP+ + + Y
Sbjct: 152 FPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILY 211
Query: 200 RAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA-KGPAVSRLWVNQSGLVLRS 258
R+G WNG+ F+ P + V Y F ++ EV Y K SRL++N +GL+ R
Sbjct: 212 RSGPWNGMRFSSVPGTIQ-VDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQRL 270
Query: 259 IWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKSPNNW-----S 313
W W +Y+P D CD Y VCG C +NS C C++GF P + W S
Sbjct: 271 TWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQAWDLRDGS 330
Query: 314 EGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDV 373
GC+R+ L C D F + ++KLPDT+++ + + LK C E C ++C+CTA+AN+D+
Sbjct: 331 AGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADI 390
Query: 374 ERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTKKQVGIII-ASVLLMAM 429
GGSGC++W +++DM+ Y GGQDLY+R+A+ E R +K +G I S+LL+
Sbjct: 391 RNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNEKIIGSSIGVSILLLLS 450
Query: 430 FIVASLFCIWRKKLKK--------------------------QGLTKMSHMKEDMELWEF 463
F++ F W++K K+ +G T E +EL
Sbjct: 451 FVI---FHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLL 507
Query: 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLI 523
+ ++A AT+NF++ NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +EF NEV LI
Sbjct: 508 ELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLI 567
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
A+LQH NLV+LLGCC+ E MLIYEY+ N SLD +FDQ R++ L+WQKR I+ GIAR
Sbjct: 568 AKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIAR 627
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
G+LYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMARIFG +E + NT +VVGTYGY
Sbjct: 628 GLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGY 687
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
MSPEYA +G+FS+KSDVFSFGVL+LEI+SGK+N F + + D NLLG V
Sbjct: 688 MSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFV 736
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 640 bits (1650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/714 (46%), Positives = 452/714 (63%), Gaps = 43/714 (6%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
D I QS+RDGE ++S F GFFS G S RY+GIWY ++S +T+ WVANR+ P+
Sbjct: 20 DTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHPIN 79
Query: 79 DQSGLLNVTSKG---IVLLDGRDRIFWSSNTSITMKNP--VVQLMDSGNLVLTDGNYNSL 133
D SG++ +++G + D + WS+N S +M P V L D GNLVL D
Sbjct: 80 DTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTGRS 139
Query: 134 LWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRK 193
W+SFDHP DT LP M+LG K G+DR L+SWKS DP G+ L ++ GFPQL+L K
Sbjct: 140 FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYK 199
Query: 194 GSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SRLWVNQS 252
G +R GSW G ++G P + + + FV NE+EV + +V +R VN++
Sbjct: 200 GVTPWWRMGSWTGHRWSGVPEMPIGY-IFNNSFVNNEDEVSFTYGVTDASVITRTMVNET 258
Query: 253 GLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSR--RCDCLEGFVPKSPN 310
G + R W ++ W + P ++CD Y+ CG N C + SS+ C CL GF PK P
Sbjct: 259 GTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPR 318
Query: 311 NW-----SEGCVRERELK-CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCS 364
+W S GC +++ C D F K ++K+PDTS + + ++ LKEC + C KNCS
Sbjct: 319 HWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCS 378
Query: 365 CTAYANS--DVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASE------RGRSVTKKQ 416
C AYA++ + +RG GCL W G ++D + Y + GQD YIR+ E R K++
Sbjct: 379 CVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRR 438
Query: 417 VGIIIASVLLMAMFIVASLFCIWRKKLKK------------------QGLTKMSHMKEDM 458
V +I+ S++ M + LFC+ R++ K + +
Sbjct: 439 VLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNR 498
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
EL FD +I AT+NF+S NKLG GGFGPVYKG L EIAVKRLS+ SGQGMEEFKN
Sbjct: 499 ELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKN 558
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
EV LI++LQHRNLV++LGCC++ +E ML+YEY+PNKSLD+FIF + + LDW KR+ IV
Sbjct: 559 EVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIV 618
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
GIARGILYLHQDSR+RIIHRDLKASN+LLD++M PKISDFGMARIFGG++++ T +VV
Sbjct: 619 RGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVV 678
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
GT+GYM+PEYA EG FS+KSDV+SFGVL+LEI++GKKN F + NL+GH+
Sbjct: 679 GTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLVGHI 730
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 632 bits (1631), Expect = e-180, Method: Compositional matrix adjust.
Identities = 339/718 (47%), Positives = 458/718 (63%), Gaps = 45/718 (6%)
Query: 16 AANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRET 75
A+N + T S +I +T++S + FELGFF+P +S++ YLGIWYK + RT WVANR+
Sbjct: 27 ASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDN 86
Query: 76 PLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLVLTDGNYNS- 132
PL+ +G L ++ +V+ D DR WS+N T +++PV +L+D GN VL D N
Sbjct: 87 PLSSSNGTLKISDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKP 146
Query: 133 --LLWQSFDHPCDTLLPGMKLGRNFKTG-MDRHLSSWKSINDPAPGEFSLWIDTHGFPQL 189
LWQSFD P DTLL MK+G + K+G +R L SWK+ +DP+ G+FS + T GFP+
Sbjct: 147 SGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEF 206
Query: 190 VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA-KGPAVSRLW 248
+ + YR+G W G F+ P +K V D F N +V Y K S L
Sbjct: 207 YIYNKESITYRSGPWLGNRFSSVPGMKP-VDYIDNSFTENNQQVVYSYRVNKTNIYSILS 265
Query: 249 VNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
++ +GL+ R W W +Y+P D CD Y CG C N+S C+C++GF P +
Sbjct: 266 LSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMN 325
Query: 309 PN----NWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCS 364
+ S GCVR+ +L C D F + K++LPDT+ + + + LKEC E C K C+
Sbjct: 326 EQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCN 385
Query: 365 CTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTKKQVGIII 421
CTA+AN+D+ GGSGC++W G L D++ Y GGQDLY+R+A+ E R +KK +G I
Sbjct: 386 CTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSI 445
Query: 422 A-SVLLMAMFIVASLFCIWRKKLKK--------------------------QGLTKMSHM 454
S+LL+ FI+ F W++K K+ + T +
Sbjct: 446 GVSILLLLSFII---FHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENK 502
Query: 455 KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME 514
+ +EL ++ ++A AT+NF++ NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +
Sbjct: 503 TDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTD 562
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
EF NEV LIA+LQH NLV+LLGCC+ E MLIYEY+ N SLD +FDQ R++ L+WQKR
Sbjct: 563 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 622
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
I+ GIARG+LYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMARIFG +E + NT
Sbjct: 623 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 682
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
+VVGTYGYMSPEYA +G+FS+KSDVFSFGVL+LEI+SGK+N F + + D NLLG V
Sbjct: 683 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFV 740
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 621 bits (1602), Expect = e-177, Method: Compositional matrix adjust.
Identities = 327/714 (45%), Positives = 464/714 (64%), Gaps = 50/714 (7%)
Query: 22 TPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQS 81
T S +I +TLVS FE+GFF T+++ YLG+WYK+VS RT WVANR+ PL++
Sbjct: 39 TESLTISSNKTLVSPGSIFEVGFFR--TNSRWYLGMWYKKVSDRTYVWVANRDNPLSNAI 96
Query: 82 GLLNVTSKGIVLLDGRDR-IFWSSNTSITMKNPVV-QLMDSGNLVLTDGNYN---SLLWQ 136
G L ++ +VLLD ++ ++W++ T ++PVV +L+ +GN V+ D + N LWQ
Sbjct: 97 GTLKISGNNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRDSSNNDASEYLWQ 156
Query: 137 SFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSV 196
SFD+P DTLLP MKLG N KTG++R L+SW+S +DP+ G FS ++T P+ L + +
Sbjct: 157 SFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENF 216
Query: 197 LQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SRLWVNQSGLV 255
+R+G WNG+ F+G P + + Y F+ N EV Y + SRL + G
Sbjct: 217 PMHRSGPWNGIRFSGIPE-DQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYF 275
Query: 256 LRSIWSSQQDVWFLAYYAPLD-RCDLYSVCGANARCTTNSSRRCDCLEGFVPKSPNNWSE 314
R W +W + +P+D +CD Y +CG A C N+S C+C++GF P++ W +
Sbjct: 276 QRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQ 335
Query: 315 -----GCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYA 369
GC+R +L C +GD F + K+KLP+T+ + + S+ +KEC + C +C+CTA+A
Sbjct: 336 RVWAGGCIRRTQLSC-SGDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFA 394
Query: 370 NSDVERGGSGCLLWFGDLMDMKEYNDG---GQDLYIRIASERGRSVTKKQ--VGIIIASV 424
N+D+ GGSGC++W L D++ Y GQDLY+R+A+ + KK+ G II+
Sbjct: 395 NADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAA---DIAKKRNASGKIISLT 451
Query: 425 LLMAMFIVASLFCIWRKKLKKQGLTKMS--------------------------HMKEDM 458
+ +++ ++ +FC+W++K K+ + +S + E++
Sbjct: 452 VGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEEL 511
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
EL + ++ KAT+NF+S NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +EF N
Sbjct: 512 ELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMN 571
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
EVTLIARLQH NLV++LGCCI+ DE MLIYEY+ N SLD ++F + R + L+W +R I
Sbjct: 572 EVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDIT 631
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
G+ARG+LYLHQDSR RIIHRDLK SN+LLD +M PKISDFGMARIF DE + NT KVV
Sbjct: 632 NGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVV 691
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
GTYGYMSPEYA G+FS KSDVFSFGV+VLEIVSGKKN F + D++++LL +V
Sbjct: 692 GTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYV 745
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 621 bits (1602), Expect = e-177, Method: Compositional matrix adjust.
Identities = 337/721 (46%), Positives = 451/721 (62%), Gaps = 46/721 (6%)
Query: 12 LGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVA 71
L S + T S +I +T+VS G FELGFF YLGIWYK++S RT WVA
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVA 86
Query: 72 NRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVV-QLMDSGNLVLTDGNY 130
NR+TPL++ G+L +++ +V+LD D WS+N + +++ VV +L+D+GN VL
Sbjct: 87 NRDTPLSNPIGILKISNANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKI 146
Query: 131 NS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFP 187
N LWQSFD P DTLLP MKLGR+ K G++R ++SWKS DP+ G F ++T G P
Sbjct: 147 NESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLP 206
Query: 188 QLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGP-AVSR 246
+ + YR+G W+GL F+G +++ + Y F N EV Y + SR
Sbjct: 207 EFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDII-YNFTENREEVAYTFRVTDHNSYSR 265
Query: 247 LWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVP 306
L +N G + +W Q W + ++ P D CDLY +CG A C ++S C+C++GF P
Sbjct: 266 LTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKGFQP 325
Query: 307 KSPNNWSEG-----CVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK 361
SP +W+ G C R+ +L C D F + + +K+P T+++ + + LKEC E C
Sbjct: 326 LSPQDWASGDVTGRCRRKTQLTC-GEDRFFRLMNMKIPATTAAIVDKRIGLKECEEKCKT 384
Query: 362 NCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS----ERGRSVTKKQV 417
+C+CTAYANSD+ GGSGC++W G+ D++ Y GQDL++R+A+ ER K
Sbjct: 385 HCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERRTIRGKIIG 444
Query: 418 GIIIASVLLMAMFIVASLFCIWRKKLKKQGLTK--MSHMKEDMEL--------------- 460
II S++L+ FI+ +C W+KK K+ T + + EL
Sbjct: 445 LIIGISLMLVLSFII---YCFWKKKQKRARATAAPIGYRDRIQELIITNGVVMSSGRRLL 501
Query: 461 --------WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+F ++ AT+NF+ N LG GGFG VYKG L++GQEIAVKRLS+ S QG
Sbjct: 502 GEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMSSQG 561
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARAT-FLDW 571
EFKNEV LIARLQH NLV+LL CCI ADE +LIYEY+ N SLD +F+ +++ L+W
Sbjct: 562 TNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNKLNW 621
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q R I+ GIARG+LYLHQDSR +IIHRDLKASNVLLD +M PKISDFGMARIF DE +
Sbjct: 622 QTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERDETE 681
Query: 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691
NT KVVGTYGYMSPEYA EG+FSVKSDVFSFGVLVLEIVSGK+N F + D+NLLG+
Sbjct: 682 ANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNNLLGY 741
Query: 692 V 692
Sbjct: 742 T 742
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 610 bits (1573), Expect = e-173, Method: Compositional matrix adjust.
Identities = 329/724 (45%), Positives = 468/724 (64%), Gaps = 54/724 (7%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
+++ I SQS++DG+ + S F GFFS G S RY+GIWY +VS +T+ WVANR+ P
Sbjct: 21 SDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHP 80
Query: 77 LTDQSGLLNVTSKGIVLL----DGRDRIFWSSNTSITMKNP--VVQLMDSGNLVLTDGNY 130
+ D SGL+ +++G + + +G + I WS++ ++ P V +L D GNLVL D
Sbjct: 81 INDTSGLIKFSTRGNLCVYASGNGTEPI-WSTDVIDMIQEPALVAKLSDLGNLVLLDPVT 139
Query: 131 NSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLV 190
W+SF+HP +TLLP MK G ++G+DR ++SW+S DP G + I+ GFPQ++
Sbjct: 140 GKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMM 199
Query: 191 LRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEV---YYECDAKGPAVSRL 247
+ KG L +R GSW G ++G P + N + + FV N +EV Y DA +R+
Sbjct: 200 MYKGLTLWWRTGSWTGQRWSGVPEMT-NKFIFNISFVNNPDEVSITYGVLDAS--VTTRM 256
Query: 248 WVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRR--CDCLEGFV 305
+N++G + R W+ + W + AP D+CD+Y+ CG N C + S+ + C CL G+
Sbjct: 257 VLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYE 316
Query: 306 PKSPNNW-----SEGCVRERELKCRNGDE-FPKYVKLKLPDTSSSWFNASMNLKECSELC 359
PK+P +W S+GC R + NG E F K ++K+P+TS+ + ++ LKEC + C
Sbjct: 317 PKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRC 376
Query: 360 SKNCSCTAYANS--DVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRI-ASERGR-----S 411
KNCSC AYA++ + + G GCL W G+++D + Y GQD Y+R+ SE R +
Sbjct: 377 LKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGA 436
Query: 412 VTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQG-----------------------L 448
KK++ +I+ S++ + M ++ S C RK+ ++ L
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 449 TKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG 508
++ EL F+ ++IA AT+NFA NKLG GGFGPVYKG L G EIAVKRLSK
Sbjct: 497 EELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKS 556
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF 568
SGQGMEEFKNEV LI++LQHRNLV++LGCC++ +E ML+YEY+PNKSLD+FIF + +
Sbjct: 557 SGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAE 616
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
LDW KR+ I+ GI RGILYLHQDSR+RIIHRDLKASNVLLDN+M PKI+DFG+ARIFGG+
Sbjct: 617 LDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGN 676
Query: 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
+I+ +T++VVGTYGYMSPEYA +G FS+KSDV+SFGVL+LEI++GK+N F + NL
Sbjct: 677 QIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFY--EESLNL 734
Query: 689 LGHV 692
+ H+
Sbjct: 735 VKHI 738
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 594 bits (1531), Expect = e-168, Method: Compositional matrix adjust.
Identities = 333/736 (45%), Positives = 445/736 (60%), Gaps = 61/736 (8%)
Query: 9 LFILGASAANDNITPSQSIRDG---ETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPR 65
F+ +S A + I +S+RDG + LVS TFELGFFSPG+S R+LGIWY + +
Sbjct: 17 FFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDK 76
Query: 66 TVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSN---TSITMKNPVVQLMDSG 121
V WVANR TP++DQSG+L +++ G +VLLDG++ WSSN ++ N VV + D+G
Sbjct: 77 AVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTG 136
Query: 122 NLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWI 181
N VL++ + + +W+SF+HP DT LP M++ N +TG + SW+S DP+PG +SL +
Sbjct: 137 NFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGV 196
Query: 182 DTHGFPQLVLRKGS-VLQYRAGSWNGLGFTGTP--PLKENVPLCDYKFVINENE---VYY 235
D G P++VL +G+ ++R+G WN FTG P L N L +K +E VY+
Sbjct: 197 DPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNY-LYGFKLSSPPDETGSVYF 255
Query: 236 ECDAKGPAVS-RLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNS 294
P+V R V +G W+ W P CD Y+ CG C
Sbjct: 256 TYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKG 315
Query: 295 SRR-CDCLEGFVPKSPNNWSEGCVRERELKCRNG-----DEFPKYVKLKLPDTSSSWFNA 348
S C C+ G+ S NWS GC R LKC DEF +KLPD N
Sbjct: 316 SNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNL 375
Query: 349 SMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASER 408
++ ++C E C +NCSC AY+ GG GC++W DL+D++++ GG L+IR+A
Sbjct: 376 -VDPEDCRERCLRNCSCNAYSLV----GGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSE 430
Query: 409 GRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQ-----------------GLTKM 451
K ++ +I+A VL+ + I +WR K KK LTK
Sbjct: 431 VGENRKTKIAVIVA-VLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKS 489
Query: 452 SHMKEDM----------------ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV 495
EL F +IA AT++F N+LG GGFGPVYKG L
Sbjct: 490 KETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE 549
Query: 496 EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555
+G+EIAVKRLS SGQG++EFKNE+ LIA+LQHRNLV+LLGCC + +E ML+YEYMPNKS
Sbjct: 550 DGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKS 609
Query: 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615
LDFF+FD+ + +DW+ R I+ GIARG+LYLH+DSR+RIIHRDLK SNVLLD +MNPK
Sbjct: 610 LDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPK 669
Query: 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
ISDFGMARIFGG++ + NT +VVGTYGYMSPEYA EGLFSVKSDV+SFGVL+LEIVSGK+
Sbjct: 670 ISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKR 729
Query: 676 NWRFSHPDHDHNLLGH 691
N +H +L+G+
Sbjct: 730 NTSLRSSEHG-SLIGY 744
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 698 | ||||||
| 255575986 | 1597 | ATP binding protein, putative [Ricinus c | 0.988 | 0.432 | 0.615 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.982 | 0.844 | 0.602 | 0.0 | |
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.979 | 0.823 | 0.601 | 0.0 | |
| 224122966 | 783 | predicted protein [Populus trichocarpa] | 0.938 | 0.836 | 0.600 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.972 | 0.826 | 0.573 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.984 | 0.839 | 0.568 | 0.0 | |
| 224122810 | 810 | predicted protein [Populus trichocarpa] | 0.978 | 0.843 | 0.571 | 0.0 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 0.430 | 0.569 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.944 | 0.840 | 0.586 | 0.0 | |
| 359493727 | 1767 | PREDICTED: uncharacterized protein LOC10 | 0.981 | 0.387 | 0.559 | 0.0 |
| >gi|255575986|ref|XP_002528889.1| ATP binding protein, putative [Ricinus communis] gi|223531688|gb|EEF33513.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2299), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/708 (61%), Positives = 533/708 (75%), Gaps = 18/708 (2%)
Query: 1 MLGAYSCLLFILGASAANDN-ITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWY 59
M+ Y LLF+ S + N I PSQS++DGETLVS +G FELGFF+P S RYLGIWY
Sbjct: 1 MVWVYLFLLFLSHTSVSGLNTINPSQSVKDGETLVSADGGFELGFFNPNNSENRYLGIWY 60
Query: 60 KRVSPRTVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLM 118
K VS V WVANRETPLT+ SG+L+ T +GI +LLDG++ WSS + +NP+VQL+
Sbjct: 61 KEVSAYAVVWVANRETPLTESSGVLSFTKEGILILLDGKNNTIWSSKKAKNSQNPLVQLL 120
Query: 119 DSGNLVLTDGNYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPG 175
DSGNLV+ DGN +S LWQSFD PCDT LPGMK+GRNF TG D ++SWKS ++P G
Sbjct: 121 DSGNLVVKDGNDSSSDNFLWQSFDSPCDTFLPGMKIGRNFLTGQDWFITSWKSADNPGKG 180
Query: 176 EFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYY 235
+FSLWID GFPQLVLR G+ YR GSWNGL FTGTP + ++ +F + +N VYY
Sbjct: 181 QFSLWIDPDGFPQLVLRNGTSKYYRLGSWNGLYFTGTPQVPQD--FLKLEFELTKNGVYY 238
Query: 236 ECDAKGPA--VSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTN 293
+ G + ++RL+VN+SG V R + W Y+APLD+CD Y VCGA +C N
Sbjct: 239 GYEVHGYSKLMTRLFVNRSGFVQRFARVDRTVGWRNIYFAPLDQCDKYDVCGAYMKCNIN 298
Query: 294 -SSRRCDCLEGFVPKSPNNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNL 352
+S C CLEGFV +SP NWS+GCVR+ L C GD F Y++LKLPDTS SW+N +M+L
Sbjct: 299 DNSPNCVCLEGFVFRSPKNWSDGCVRKTPLHCEKGDVFQTYIRLKLPDTSGSWYNTTMSL 358
Query: 353 KECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSV 412
EC ELCS NCSCTAYANS++ GGSGCLLWFG+L+D++EY +GGQ++YIR++S +
Sbjct: 359 SECKELCSTNCSCTAYANSNISNGGSGCLLWFGELVDIREYTEGGQEIYIRMSSSKPDQT 418
Query: 413 TKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHM--------KEDMELWEFD 464
K +G + + +L+ M +V SL I +K+ + QGLTK SH+ KE+MEL FD
Sbjct: 419 KNKLIGTTVGAAVLIGMLVVGSLVYIRKKEQRMQGLTKGSHINDYENNAGKEEMELPIFD 478
Query: 465 FASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIA 524
F +I KATDNF++ NKLG+GGFGPVYKG L +GQEIAVKRLSK SGQG+ EF+NEV LI+
Sbjct: 479 FTAIVKATDNFSNNNKLGQGGFGPVYKGILTDGQEIAVKRLSKSSGQGLTEFENEVILIS 538
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
+LQHRNLVKLLG CIQ DE MLIYE+MPNKSLDFF+FD+ R FLDW RIHI+ GIARG
Sbjct: 539 KLQHRNLVKLLGYCIQKDEKMLIYEFMPNKSLDFFVFDEMRCKFLDWDLRIHIIDGIARG 598
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+LYLHQDSR+RIIHRDLKASNVLLD DMNPKISDFGMARIFGGD+ + NT+KV GTYGYM
Sbjct: 599 LLYLHQDSRLRIIHRDLKASNVLLDKDMNPKISDFGMARIFGGDQTEANTNKVAGTYGYM 658
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
+PEYA +GLFS+KSDVFSFGVLVLEI+SGKKN F HPDH HNLLGH
Sbjct: 659 APEYAVDGLFSMKSDVFSFGVLVLEIISGKKNRGFFHPDHSHNLLGHA 706
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/707 (60%), Positives = 525/707 (74%), Gaps = 21/707 (2%)
Query: 4 AYSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVS 63
YS IL S+A D + +QS+RDGETLVS G+FELGFF+P S RYLG+WYK+ S
Sbjct: 9 VYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKK-S 67
Query: 64 PRTVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLMDSGN 122
P+TV WVANR P++++ G LNVTS+GI VLL+G + I WSSNTS T++NPV QL+DSGN
Sbjct: 68 PQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSGN 127
Query: 123 LVLTDGNYN---SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSL 179
LV+ DGN N + LWQSFD+PCDTLLPGMKLG N TG++ LSSWK +PAPG+F+L
Sbjct: 128 LVVRDGNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQFTL 187
Query: 180 WIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA 239
ID G+PQL+LRK + + YR GSWNG FTG P LK + P+ ++FV N NEVY++ +
Sbjct: 188 GIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPD-PIYTFEFVFNRNEVYFKFEL 246
Query: 240 KGPAV-SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRC 298
+ +V SRL V SGLV WS Q + W++ A +DRC+ Y++CGANARC +NSS C
Sbjct: 247 QNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNSSPVC 306
Query: 299 DCLEGFVPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLK 353
DCL+GF+ KSP NW+ GC+R L C + D F Y +KLPDTSSSW++ S +L
Sbjct: 307 DCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSFSLV 366
Query: 354 ECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-SERGRSV 412
EC LC +NCSC AYAN D GSGCL WFGDL+D + +GGQD+YIR+A S+ G +
Sbjct: 367 ECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEGGQDIYIRLAASQSGVTG 426
Query: 413 TKKQ-----VGIIIASVLL-MAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFA 466
KK+ G+I +V+L ++ I+ +FCI R+K +K G + +E+MEL D
Sbjct: 427 EKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFE-DRKEEEMELPMLDLT 485
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL 526
+I ATDNF+S KLGEGGFG VYKG L+EGQEIAVKRLSK SGQG+ EFKNEV LIA+L
Sbjct: 486 TIEHATDNFSSSKKLGEGGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKL 545
Query: 527 QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
QHRNLVKLLGCCI DE MLIYEYMPN+SLD FIFD R FLDW KR HI+ GIARG+L
Sbjct: 546 QHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLL 605
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YLHQDSR+RIIHRD+KASN+LLDN++NPKISDFG+AR+FGGD+ + NT +VVGTYGYMSP
Sbjct: 606 YLHQDSRLRIIHRDIKASNILLDNELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSP 665
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH-NLLGHV 692
EYA +G FSVKSDVFSFGVLVLEIVSGKKN F HPD++ NLLGH
Sbjct: 666 EYALDGHFSVKSDVFSFGVLVLEIVSGKKNRGFCHPDYNQKNLLGHA 712
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2150), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/710 (60%), Positives = 515/710 (72%), Gaps = 26/710 (3%)
Query: 8 LLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTV 67
L I A+ D +TP QSIRDG+ LVS +G+FELGFFSPG S RYLGIWY+++S TV
Sbjct: 16 FLLISAIRASTDTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRYLGIWYQKISAGTV 75
Query: 68 AWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLT 126
WVANRETPL D SG L VT +GI +LL+ WSSN S T +NPV++L+DSGNLV+
Sbjct: 76 VWVANRETPLNDSSGALIVTDQGILILLNSSKDAIWSSNASRTAQNPVMKLLDSGNLVVK 135
Query: 127 DGNYNS--LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTH 184
D N NS LWQSFD+P DTLLPGMK GRN TG+DR+LSSWKS NDPA GEF+ ID
Sbjct: 136 DINDNSENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLSSWKSSNDPAQGEFTFRIDPR 195
Query: 185 GFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV 244
G Q++L +G + YR G+WNG +TGTP L+ N+ L Y F+ E+YY+ D +V
Sbjct: 196 GNTQMLLMRGPKILYRTGTWNGYRWTGTPQLEPNM-LYTYGFISTATEMYYKFDLINSSV 254
Query: 245 -SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEG 303
SR+ +N SG R W ++ + W LD+CD Y++CGA C N C CLEG
Sbjct: 255 ASRIVMNSSGAAQRFTWITRTNSWARFSAVLLDQCDDYALCGAYGSCNVNKQPVCACLEG 314
Query: 304 FVPKSPNNWS-----EGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSEL 358
F+PKSP +WS +GCVR +L C GD F ++ +KLPD SW + S LKEC +L
Sbjct: 315 FIPKSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGGVKLPDMIKSWVDTSKGLKECKDL 374
Query: 359 CSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS------ERGRSV 412
C KNCSC AYANSD+ GGSGCLLWF +L+D +E GGQDLYIRIA+ E+ RS
Sbjct: 375 CLKNCSCVAYANSDIRGGGSGCLLWFDELIDTRELTTGGQDLYIRIAASELYNIEKNRSS 434
Query: 413 TKKQVGIIIASVLLMAM-FIVASLFCIWRKKLKKQGLTKMSHM---------KEDMELWE 462
KKQ+GII+ +++ + ++A + RKKLKKQ K SH+ KEDMEL
Sbjct: 435 DKKQLGIIVGTIITIVGVLVLAFILYARRKKLKKQANMKTSHLQNYEDEDQRKEDMELPT 494
Query: 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTL 522
FD ++IA ATDNF+S NKLGEGGFG VYKGTL+EGQE+AVKRLSK SGQG+ EFKNEV L
Sbjct: 495 FDLSTIANATDNFSSRNKLGEGGFGSVYKGTLIEGQEVAVKRLSKNSGQGLTEFKNEVIL 554
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA 582
IA+LQHRNLVKLLGCCI+ DE +LIYEYMPNKSLD+FIFD+ DW+ I+IVGGIA
Sbjct: 555 IAKLQHRNLVKLLGCCIEGDERILIYEYMPNKSLDYFIFDKKTRNSSDWRIWINIVGGIA 614
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
RG+LYLHQDSR+RIIHRDLKA+NVLLDN MNPKISDFG+AR FGGD+ + NT+K+VGTYG
Sbjct: 615 RGLLYLHQDSRLRIIHRDLKAANVLLDNGMNPKISDFGLARTFGGDQTEANTNKIVGTYG 674
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
YMSPEYA +G FSVKSDVFSFGVLVLEIVSGKKN F+HPDH HNLLGH
Sbjct: 675 YMSPEYAVDGFFSVKSDVFSFGVLVLEIVSGKKNRGFNHPDHHHNLLGHA 724
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122966|ref|XP_002330408.1| predicted protein [Populus trichocarpa] gi|222871793|gb|EEF08924.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 819 bits (2115), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/693 (60%), Positives = 505/693 (72%), Gaps = 38/693 (5%)
Query: 8 LLFILGASAANDNITPSQSIRDGET-LVSVNGTFELGFFSPGTSAKRYLGIWYKR--VSP 64
LLF+ A A DNIT ++SI+DGE+ LVS GTFELGFFSPG S R+LG+WYK +
Sbjct: 21 LLFLSLAFATQDNITSNESIKDGESPLVSAGGTFELGFFSPGNSMNRFLGVWYKNELSTH 80
Query: 65 RTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNL 123
+ V WVANRE PL D+SG LN T +G++LL +G + WSSN + +++PV+QL+DSGNL
Sbjct: 81 KEVIWVANREIPLKDRSGFLNFTQQGVLLLFNGNNERIWSSNKTTNVESPVMQLLDSGNL 140
Query: 124 VLTDGNYNS-LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWID 182
V+ DG N+ +LWQSF++PCDT LPGM +G N +TG+DR+L SWKS +DP PG+FS ID
Sbjct: 141 VVIDGKDNNFILWQSFEYPCDTFLPGMMIGGNSQTGVDRNLISWKSADDPGPGQFSFGID 200
Query: 183 THGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINEN--EVYYECDAK 240
GFPQLV+R G++ R GSWNG FTGTP L + L Y F++N+ + YE
Sbjct: 201 RQGFPQLVIRNGTLKHCRLGSWNGKRFTGTPDLPRDQFL-KYDFILNKTHADYSYEILRP 259
Query: 241 GPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARC-TTNSSRRCD 299
G ++RL VNQSG V R + Q + W Y AP D CD YSVCGA+ C + S C
Sbjct: 260 GALLTRLIVNQSGFVERFMRPIQNNNWTSIYSAPRDLCDNYSVCGAHMICKMVDQSHNCT 319
Query: 300 CLEGFVPKSPNNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELC 359
CLEGF PKS +WS GC R L C +G F + LKLPDTS SW++ SM+L EC ++C
Sbjct: 320 CLEGFEPKSHTDWSRGCARRSALNCTHG-IFQNFTGLKLPDTSLSWYDTSMSLVECKDMC 378
Query: 360 SKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTKKQVGI 419
KNCSCTAYANS++ SGC+LWFG+L+DM+E++ GGQDLYIR+ +T
Sbjct: 379 LKNCSCTAYANSNITGEASGCILWFGELVDMREFSTGGQDLYIRMPPPLKTGLT------ 432
Query: 420 IIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYN 479
F IWRKK +KQ ++EDMEL F A+I KATDNF+S N
Sbjct: 433 ----------------FYIWRKKQRKQ------EIEEDMELPSFHLATIVKATDNFSSNN 470
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG+GGFGPVYKGTL++GQEIAVKRLSK S QG+ EFKNEV LIA+LQHRNLVKLLGCCI
Sbjct: 471 KLGQGGFGPVYKGTLIDGQEIAVKRLSKSSRQGLTEFKNEVILIAKLQHRNLVKLLGCCI 530
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
Q DE MLIYE+MPNKSLD+FIFDQ R FLDWQ+R I+GGIARG+LYLHQDSR+RIIHR
Sbjct: 531 QGDEVMLIYEFMPNKSLDYFIFDQTRNKFLDWQRRNLIIGGIARGLLYLHQDSRLRIIHR 590
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DLKASN+LLD DMNPKISDFGMAR+FG D+I+ +T+KVVGTYGYMSPEYA +G FS+KSD
Sbjct: 591 DLKASNILLDKDMNPKISDFGMARLFGVDQIEADTNKVVGTYGYMSPEYAVDGRFSLKSD 650
Query: 660 VFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
VFSFGVLVLEI+SGKKN FSHPDH HNLLGH
Sbjct: 651 VFSFGVLVLEIISGKKNRGFSHPDHCHNLLGHA 683
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 811 bits (2095), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/725 (57%), Positives = 510/725 (70%), Gaps = 46/725 (6%)
Query: 11 ILGASAAN-DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAW 69
+L SAA + + P QS++DGETL+S +G FELGFFS G S RYLGIWYKR+ +TV W
Sbjct: 1 MLRVSAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVW 60
Query: 70 VANRETPLTDQSGLLNVTSKGIVLLDGRDR-IFWSSNTSITMKNPVVQLMDSGNLVLTDG 128
V NRE P D G+L V +G+++L + I WSSN+S T KNPV+QL+DSGNL++ DG
Sbjct: 61 VGNREVPSFDNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDG 120
Query: 129 NYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHG 185
N N+ ++WQSFD P +TLLP MKLG N G++R+L+SWKSI+DPA G FS ID G
Sbjct: 121 NGNNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRG 180
Query: 186 FPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV- 244
FPQL ++KG +Q R+G WNGL FTG+P L N P+ ++ FV N++E+YY + K +V
Sbjct: 181 FPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPN-PVFNFSFVSNKHEIYYSYELKNTSVV 239
Query: 245 SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGF 304
SRL V++ G + R W + W L + P D+CD Y +CGA A C NS C CLEGF
Sbjct: 240 SRLIVSEKGALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGF 299
Query: 305 VPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELC 359
VPKSP ++WS+GCVR EL C GD F K +KLPDTSSSW + SM+LKEC +C
Sbjct: 300 VPKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMC 359
Query: 360 SKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-SERGRSVTKKQVG 418
+NCSC AYANSD+ GSGCLLWF L+DM+++ +GGQDLYIRIA SE + + +
Sbjct: 360 LRNCSCLAYANSDIR--GSGCLLWFDHLIDMRKFTEGGQDLYIRIAASELAKGKSHGKRV 417
Query: 419 IIIASVLLMAMFIVASLFCIWRKKLKKQ-----------------------GLTKMSHM- 454
II S L++ M + A ++ +K K+ GL K +++
Sbjct: 418 AIIVSCLIIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKETYIE 477
Query: 455 -------KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSK 507
KED EL FD +I AT NF++YNKLGEGGFGPVYKGTL++GQEIAVKRLS+
Sbjct: 478 NYGDNGAKEDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKRLSE 537
Query: 508 GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARAT 567
SGQG +EFKNEV LIARLQHRNLVKLLGCCI DE MLIYEYMPNKSLD FIFD+ R+
Sbjct: 538 TSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKKRSM 597
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
LDW I+GGIARG+LYLHQDSR+RIIHRDLKASN+LLD DMNPKISDFG+AR FG
Sbjct: 598 LLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLARTFGK 657
Query: 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
D+ NT +VVGTYGYMSPEYA +GLFSVKSDVFSFGVLVLEIVSGK+N FSH DH N
Sbjct: 658 DQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLDHSLN 717
Query: 688 LLGHV 692
LLGH
Sbjct: 718 LLGHA 722
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2074), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/709 (56%), Positives = 522/709 (73%), Gaps = 22/709 (3%)
Query: 5 YSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSP 64
+S ++ IL S A D+IT +Q I+DGET++S G FELGF GTS +YLGIWYK+V+P
Sbjct: 11 FSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYKKVTP 70
Query: 65 RTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNL 123
RTV WVANRE P+TD SG L VT +G +V+L+G + + WSSN+S + +NP QL+DSGNL
Sbjct: 71 RTVVWVANRELPVTDSSGXLKVTDQGSLVILNGSNGLIWSSNSSRSARNPTAQLLDSGNL 130
Query: 124 VLTDGN---YNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLW 180
V+ GN ++ LWQSFD+P DTLLPGMK GRN TG+DR+LSSWKS +DP+ G+F+
Sbjct: 131 VIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYG 190
Query: 181 IDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAK 240
+D G PQL LR GS + +R+G WNG+ F G P L+ N P+ +Y FV NE E+Y+
Sbjct: 191 LDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPN-PVFNYSFVFNEKEMYFTYKLV 249
Query: 241 GPAV-SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
+V SRL +N +G V R IW + W + A D CD Y++CGA + C + S RC
Sbjct: 250 NSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCGAYSTCNIHRSPRCG 309
Query: 300 CLEGFVPKSPN-----NWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKE 354
C++GFVPK P +WS GCVR+ L C+ GD F KY +KLPDT +SWFN SMNLKE
Sbjct: 310 CMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNSWFNESMNLKE 369
Query: 355 CSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTK 414
C+ LC +NCSC+AY NSD++ GGSGCLLWFGDL+D+KE+ + GQD YIR+A+ +++K
Sbjct: 370 CASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTENGQDFYIRMAASELDAISK 429
Query: 415 --KQVGIIIASVLLMAMFIVASLFCIW--RKKLKKQGLTKMSH-------MKEDMELWEF 463
K+ +I+++V + M +++ + ++ +K+LK++G T++++ +ED+EL F
Sbjct: 430 VTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNEGAETNERQEDLELPLF 489
Query: 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLI 523
+I AT NF+ NKLGEGGFGPVYKG L +G+EIAVKRLSK S QG++EFKNEV I
Sbjct: 490 XLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYI 549
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
++LQHRNLVKLLGCCI +E MLIYEYMPNKSL+FFIFD ++ LDW KR I+ GIAR
Sbjct: 550 SKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIAR 609
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
G+LYLHQDSR+RIIHRDLKA NVLLDN+MNP+ISDFGMAR FGG+E T +VVGTYGY
Sbjct: 610 GLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETIARTKRVVGTYGY 669
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
MSPEYA +G++SVKSDVFSFGVL LEI+SGK+N F+HPDHD NLLGH
Sbjct: 670 MSPEYAIDGVYSVKSDVFSFGVLXLEIISGKRNRGFNHPDHDLNLLGHA 718
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122810|ref|XP_002330369.1| predicted protein [Populus trichocarpa] gi|222871754|gb|EEF08885.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/707 (57%), Positives = 501/707 (70%), Gaps = 24/707 (3%)
Query: 6 SCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPR 65
S + IL S A + I P QS+RDGETLVS +G+FELGFFSP S +YLG+W + SP+
Sbjct: 8 SFFISILTTSTALEIINPGQSLRDGETLVSSSGSFELGFFSPQGSTSKYLGLWLDK-SPQ 66
Query: 66 TVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSIT--MKNPVVQLMDSGN 122
TV WVANRE L+D G+LN+T++GI +LL+ + I WSSN+S + +NPV QL+DSGN
Sbjct: 67 TVLWVANRENSLSDNMGVLNITTQGILILLNSTNHIVWSSNSSASRNTQNPVAQLLDSGN 126
Query: 123 LVLTDGN-YN--SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSL 179
V+ +GN YN LWQSFDHPCDTLLPGM++G NF T +DR LSSWKS DPA GEF+
Sbjct: 127 FVVREGNDYNPAKFLWQSFDHPCDTLLPGMRIGVNFVTRIDRFLSSWKSPEDPARGEFTF 186
Query: 180 WIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTP-PLKENVPLCDYKFVINENEVYYECD 238
ID G+PQ++L+KG+ +R G W G+ FT P P+ + +FV+N EVY+E
Sbjct: 187 GIDPQGYPQVLLKKGNRTVFRGGPWTGIKFTSNPRPIPNQI--STNEFVLNNQEVYFEYR 244
Query: 239 AKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRC 298
+ S+L ++ GL W+ + W + D+C+ Y CG N RC + C
Sbjct: 245 IQSSVSSKLTLSPLGLAQSLTWNDRAQDWVIVENGQYDQCEEYEFCGPNTRCEITRTPIC 304
Query: 299 DCLEGFVPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLK 353
CL+GF P SP ++WS GC R L C + D F KY KLPDTS+S F+ S++LK
Sbjct: 305 VCLDGFTPMSPVDWNFSDWSGGCHRRTPLNCSDKDGFLKYTANKLPDTSTSSFDKSIDLK 364
Query: 354 ECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-SERGRSV 412
EC LC KNCSCTAY N D GGSGCL+WFGDL+DM+ GQD+Y+R+A SE G +
Sbjct: 365 ECERLCLKNCSCTAYTNLDFRAGGSGCLIWFGDLIDMRRSTGDGQDVYVRVAASELGANA 424
Query: 413 ------TKKQVGIII-ASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDF 465
TK + GII A+ L M M + +FC R+ L K + KED+EL D
Sbjct: 425 KKRNLSTKLKAGIIASAAALGMGMLLAGMMFCRRRRNLGKNDRLEEVR-KEDIELPIVDL 483
Query: 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
++IA ATDNF+S NKLGEGGFGPVYKG L+EGQEIAVK LSK S QGM+EFKNEV IA+
Sbjct: 484 STIAHATDNFSSSNKLGEGGFGPVYKGILIEGQEIAVKSLSKSSVQGMDEFKNEVKFIAK 543
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
LQHRNLVKLLG CIQ DE+MLIYEYMPNKSLDFFIFDQAR LDW KR++I+GGIARG+
Sbjct: 544 LQHRNLVKLLGYCIQEDENMLIYEYMPNKSLDFFIFDQARRKLLDWTKRMNIIGGIARGL 603
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
LYLHQDSR+R+IHRD+KASN+LLDN++NPKISDFG+AR+F GDE + NTH+V+GTYGYMS
Sbjct: 604 LYLHQDSRLRVIHRDIKASNILLDNELNPKISDFGLARMFRGDETEANTHRVIGTYGYMS 663
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
PEYA+ G FSVK+DVFSFGVL+LEIVSGKKN F HPD + NLLGH
Sbjct: 664 PEYASNGHFSVKTDVFSFGVLILEIVSGKKNRGFRHPDRNLNLLGHA 710
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2052), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/718 (56%), Positives = 512/718 (71%), Gaps = 28/718 (3%)
Query: 2 LGAYSCLLFILGA---SAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIW 58
+GA LL + S A D I +Q +RDGE L S G+FELGFFSP S +RYLGIW
Sbjct: 1 MGALPTLLLVFSIFRISIAVDTIALNQVVRDGEILTSAGGSFELGFFSPDDSNRRYLGIW 60
Query: 59 YKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRD-RIFWSSNTSITMKNPVVQ 116
YK+VS TV WVANRE PL D SG+L VT +G + +L+G + I WSSN+S + +NP Q
Sbjct: 61 YKKVSTMTVVWVANREIPLNDSSGVLKVTDQGTLAILNGSNTNILWSSNSSRSARNPTAQ 120
Query: 117 LMDSGNLVLTDGNYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPA 173
L+DSGNLV+ DGN ++ LWQSFD+PC+TLLPGMKLGRN TG+DR+LS+WKS++DP+
Sbjct: 121 LLDSGNLVMKDGNDDNPENFLWQSFDYPCNTLLPGMKLGRNTVTGLDRYLSAWKSVDDPS 180
Query: 174 PGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEV 233
G F+ +D G+PQL+LRKGS + +R+G WNGL F+G P L N P+ Y+FV NE E+
Sbjct: 181 KGNFTYRLDPSGYPQLILRKGSAVTFRSGPWNGLRFSGFPELGSN-PVYTYEFVFNEKEM 239
Query: 234 YYECD-AKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTT 292
Y+ + VSRL +N G R W + W L AP+D CD Y++CG C
Sbjct: 240 YFRYELVNSSVVSRLVLNPDGSKQRVNWIDRTHGWILYSSAPMDSCDSYALCGVYGSCNI 299
Query: 293 NSSRRCDCLEGFVPKSPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFN 347
N S +C+C+EGFVPK PN+W S GCVR L C+NG+ F K+ +KLPDT +SWFN
Sbjct: 300 NRSPKCECMEGFVPKFPNDWDMADWSNGCVRSTPLGCQNGEGFVKFSGVKLPDTRNSWFN 359
Query: 348 ASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASE 407
SM+LKEC+ +C NCSCTAY N D+ GGSGCLLWFGDL+D++E+N+ GQ+LY+R+A+
Sbjct: 360 RSMDLKECAAVCLSNCSCTAYTNLDIRDGGSGCLLWFGDLIDIREFNENGQELYVRMAAS 419
Query: 408 R-------GRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLK------KQGLTKMSHM 454
G KK+ +I+ SV + + ++ L ++ K K G
Sbjct: 420 ELGMHRRSGNFKGKKREWVIVGSVSSLGIILLCLLLTLYLLKKKKLRKKGTMGYNLEGGQ 479
Query: 455 KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME 514
KED+EL FDFA+++KAT++F+ +NKLGEGGFG VYKGTL E QEIAVKRLSK SGQG+
Sbjct: 480 KEDVELPLFDFATVSKATNHFSIHNKLGEGGFGLVYKGTLQEEQEIAVKRLSKNSGQGLN 539
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
EFKNEV I++LQHRNLV+LLG CI +E MLIYEYMPNKSLD FIFD+ R+ LDW KR
Sbjct: 540 EFKNEVIYISKLQHRNLVRLLGGCIHDEEKMLIYEYMPNKSLDSFIFDKTRSMELDWNKR 599
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
I+ GIARG+LYLHQDSR+RIIHRDLKA NVLLD +M PKISDFG+AR FGG+E + NT
Sbjct: 600 FLIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDEEMTPKISDFGIARSFGGNETEANT 659
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
+VVGTYGYMSPEYA +GL+S KSDVFSFGVLVLEIVSGK+N FSHPDH NLLGH
Sbjct: 660 KRVVGTYGYMSPEYAIDGLYSTKSDVFSFGVLVLEIVSGKRNRGFSHPDHSLNLLGHA 717
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 793 bits (2047), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/702 (58%), Positives = 498/702 (70%), Gaps = 43/702 (6%)
Query: 2 LGAYSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKR 61
L YS LL + S A D I+P Q I DG+T+VS FELGFFSPG+S +RYLGIWYK+
Sbjct: 15 LFVYSFLLSTIRVSNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSSTRRYLGIWYKK 74
Query: 62 VSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDS 120
S TV WVANRE P+ D SG+L T++G ++LL+G + WSSN + NPV QL++S
Sbjct: 75 FSTGTVVWVANRENPIFDHSGVLYFTNQGTLLLLNGTKDVVWSSNRTTPKNNPVAQLLES 134
Query: 121 GNLVLTDGNYN---SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEF 177
GNLV+ DGN + S LWQSFD+P DT LP MKLGRN TG+D +SSWKS++DPA GE+
Sbjct: 135 GNLVVKDGNDSNPESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSWKSLDDPARGEY 194
Query: 178 SLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYEC 237
SL ID G+ QLV +KG +Q+RAGSWNG+ FTG L+ N P+ Y+FV+N+ EVY+
Sbjct: 195 SLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPN-PVYRYEFVLNDKEVYFNF 253
Query: 238 DAKGPAV-SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSR 296
+ +V SR VN SG+V R W SQ W + D+CD YS CG+NA+C + S
Sbjct: 254 ELLNSSVASRFVVNASGVVERLTWISQMHRWTRYFAVGEDQCDAYSFCGSNAKCNIDKSP 313
Query: 297 RCDCLEGFVPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMN 351
C CL+GF PKS +WS GCVR L C G+ F K+ +KLPDTSSSW+N S++
Sbjct: 314 VCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGMKLPDTSSSWYNTSIS 373
Query: 352 LKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRS 411
LKEC ELC K CSC AYAN+DV GGSGCLLWFGDL+DM+E+ + GQDLYIR+A+ S
Sbjct: 374 LKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREFVNTGQDLYIRMAA----S 429
Query: 412 VTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSH-MKEDMELWEFDFASIAK 470
K I+ + SH KE++EL D ++IAK
Sbjct: 430 YLGKMKNIL--------------------------EMDYDSHSRKEELELPIIDLSTIAK 463
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
AT NF+S KLGEGGFG VYKGTL GQ+IAVKRLS SGQG+EEFKNEV LIA+LQHRN
Sbjct: 464 ATGNFSSNKKLGEGGFGLVYKGTLY-GQDIAVKRLSMYSGQGIEEFKNEVLLIAKLQHRN 522
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
LVKLLGCCI+ DE MLIYEYMPNKSLD+FIFDQ+R+ LDW RI I+ GIARG+LYLHQ
Sbjct: 523 LVKLLGCCIEGDERMLIYEYMPNKSLDYFIFDQSRSKLLDWPTRISIIDGIARGLLYLHQ 582
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
DSR+RIIHRDLKASNVLLD DMNPKISDFGMARIFGG++ + NT +VVGTYGYM+PEYA
Sbjct: 583 DSRLRIIHRDLKASNVLLDTDMNPKISDFGMARIFGGNQTEANTKRVVGTYGYMAPEYAV 642
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
EGLFSVKSD+FSFGVLVLEIVSG+KN F +H NL+GH
Sbjct: 643 EGLFSVKSDIFSFGVLVLEIVSGRKNRGFFSHNHHLNLVGHA 684
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493727|ref|XP_002280656.2| PREDICTED: uncharacterized protein LOC100243545 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2039), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/699 (55%), Positives = 501/699 (71%), Gaps = 14/699 (2%)
Query: 5 YSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSP 64
+S +L +L S A D I +Q+I DGET+ S G+FELGFFSPG S RYLGIWYK+ S
Sbjct: 11 FSYVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKASK 70
Query: 65 RTVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLMDSGNL 123
+ V WVANRE+P+TD SG+L VT GI VL++G + I W+S +S + ++P QL++SGNL
Sbjct: 71 KPVVWVANRESPITDSSGVLKVTQPGILVLVNGTNGILWNSTSSRSAQDPNAQLLESGNL 130
Query: 124 VLTDGN---YNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLW 180
V+ +GN + LWQSFD+PCDTLLPGMKLGRN G+DR+LSSWKS +DP+ G F+ W
Sbjct: 131 VMRNGNDRDPENFLWQSFDYPCDTLLPGMKLGRNRVAGLDRYLSSWKSADDPSKGNFTYW 190
Query: 181 IDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECD-A 239
ID GFPQL+LR G + +R G WNG+ F+G P L N P+ Y++V NE E+YY
Sbjct: 191 IDPSGFPQLLLRNGLAVAFRPGPWNGIRFSGIPQLTIN-PVYSYEYVSNEKEIYYIYSLV 249
Query: 240 KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
+ RL + G RSIW+ +++ W L A D+CD Y++CG N C + S C+
Sbjct: 250 NSSVIMRLVLTPDGAAQRSIWTDKKNEWTLYSTAQRDQCDNYAICGVNGICKIDQSPNCE 309
Query: 300 CLEGFVPKSPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKE 354
C++GF PK +NW S GCVR L C+ GD F KY +KLPDT SSWFN SMNLKE
Sbjct: 310 CMKGFRPKFQSNWDMEDWSNGCVRSTPLDCQKGDGFVKYSGVKLPDTRSSWFNESMNLKE 369
Query: 355 CSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTK 414
C+ LC NCSCTAYANSD+ GGSGCLLWFGDL+D++++ + GQ+ Y+R+A+ + +
Sbjct: 370 CASLCLSNCSCTAYANSDIRGGGSGCLLWFGDLIDIRDFTENGQEFYVRMAAADLETTKE 429
Query: 415 KQVGIIIASVLLMAMFIVASL-FCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATD 473
K++G + S+ + ++ + + L F + + K G + + +E +EL FD ++ AT+
Sbjct: 430 KRLGNRLNSIFVNSLILHSILHFAAYMEHNSKGG--ENNEGQEHLELPLFDLDTLLNATN 487
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
NF+S NKLGEGGFGPVYKG L EGQEIAVK +SK S QG++EFKNEV IA+LQHRNLVK
Sbjct: 488 NFSSDNKLGEGGFGPVYKGILQEGQEIAVKMMSKTSRQGLKEFKNEVESIAKLQHRNLVK 547
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLGCCI E +LIYE+MPNKSLD FIFDQ R LDW KR I+ GIA+G+LYLH+DSR
Sbjct: 548 LLGCCIHGRERLLIYEHMPNKSLDLFIFDQMRRRVLDWPKRFLIINGIAQGLLYLHRDSR 607
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
+RIIHRDLKA N+LLDN+M PKISDFG+ FGG+EI+TNT +V T GYMSPEYA EGL
Sbjct: 608 LRIIHRDLKAENILLDNEMIPKISDFGITGSFGGNEIETNTTRVARTLGYMSPEYAREGL 667
Query: 654 FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
+S KSDVFSFGVLVLEIVSGK+N F+HP HD +LLGH
Sbjct: 668 YSTKSDVFSFGVLVLEIVSGKRNKGFNHPYHDLSLLGHA 706
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 698 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.557 | 0.496 | 0.475 | 1.4e-194 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.911 | 0.780 | 0.549 | 5.8e-185 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.621 | 0.510 | 0.416 | 1.3e-180 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.618 | 0.512 | 0.409 | 8.3e-177 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.666 | 0.548 | 0.382 | 6e-172 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.332 | 0.273 | 0.678 | 1.1e-161 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.329 | 0.277 | 0.617 | 1.2e-149 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.964 | 0.839 | 0.451 | 1.8e-149 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.965 | 0.835 | 0.437 | 4.8e-149 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.962 | 0.834 | 0.429 | 7.1e-148 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 1.4e-194, Sum P(2) = 1.4e-194
Identities = 192/404 (47%), Positives = 277/404 (68%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
A D + +Q+++DG+T+VS G+FE+GFFSPG S RYLGIWYK++S +TV WVANR++P
Sbjct: 23 ATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSP 82
Query: 77 LTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTS-----ITMKNPVVQLMDSGNLVLTD-GN 129
L D SG L V+ G + L + R+ I WSS++S +++NP+VQ++D+GNLV+ + G+
Sbjct: 83 LYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVRNSGD 142
Query: 130 YNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQL 189
+WQS D+P D LPGMK G NF TG++R L+SW++I+DP+ G ++ +D +G PQ
Sbjct: 143 DQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQF 202
Query: 190 VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SRLW 248
L+K SV+ +R G WNGL FTG P LK N P+ Y++V E EVYY + P+V +R+
Sbjct: 203 FLKKNSVVVFRTGPWNGLRFTGMPNLKPN-PIYRYEYVFTEEEVYYTYKLENPSVLTRMQ 261
Query: 249 VNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
+N +G + R W W A +D CD Y++CG+ C N S C CL+GFV K+
Sbjct: 262 LNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKT 321
Query: 309 PN-----NWSEGCVRERELKCRNGDE-FPKYVKLKLPDTSSSWFNASMNLKECSELCSKN 362
P +WSEGCVR +L C G++ F K KLKLPDT +SW++ +M+L EC ++C +N
Sbjct: 322 PQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRN 381
Query: 363 CSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS 406
C+C+AY+ D+ GG GC+LWFGDL+D++EYN+ GQDLY+R+AS
Sbjct: 382 CTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLAS 425
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1794 (636.6 bits), Expect = 5.8e-185, P = 5.8e-185
Identities = 362/659 (54%), Positives = 458/659 (69%)
Query: 53 RYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITM-- 110
R+LG+WY N T L+ + L DG + WSS++S T
Sbjct: 63 RFLGLWYMEPFAVVWVANRNNPLYGTSGFLNLSSLGD-LQLFDGEHKALWSSSSSSTKAS 121
Query: 111 ---KNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWK 167
NP++++ SGNL+ +DG ++LWQSFD+P +T+L GMKLG+NFKT M+ LSSWK
Sbjct: 122 KTANNPLLKISCSGNLISSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWK 180
Query: 168 SINDPAPGEFSLWIDTHGFPQLVLRKG--SVLQYRAGSWNGLGFTGTPPLKENVPLCDYK 225
++ DP+PG+F+L +DT G PQL+LRK S YR GSWNGL FTG P + L DYK
Sbjct: 181 TLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYK 240
Query: 226 FVINENEVYYECDAKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCG 285
F + EV Y + VSRL +N +G + R I S+Q+ W LA AP D CD YS+CG
Sbjct: 241 FTSSAQEVNYSWTPRHRIVSRLVLNNTGKLHRFI-QSKQNQWILANTAPEDECDYYSICG 299
Query: 286 ANARCTTNSSRR--CDCLEGFVPKSPNNWS-----EGCVRERELKCRNGDEFPKYVKLKL 338
A A C NS C CL+GF PKS W+ GCV E C D F K+ LKL
Sbjct: 300 AYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKL 359
Query: 339 PDTSSSWFNAS--MNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDG 396
PDTS SW++A M L++C CS NCSCTAYAN+D+ GG GCLLWFGDL+DM+EY+
Sbjct: 360 PDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSF 419
Query: 397 GQDLYIRIASERGRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQ--GLT-KMSH 453
GQD+YIR+ + ++ VG+++ SV+ +A+ +V +F +RKK+ K+ G +
Sbjct: 420 GQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVV-VFACFRKKIMKRYRGENFRKGI 478
Query: 454 MKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM 513
+ED++L FD +I+ ATD+F+ N LG GGFGPVYKG L +GQEIAVKRLS SGQG+
Sbjct: 479 EEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGV 538
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573
EEFKNEV LIA+LQHRNLV+LLGCCIQ +E MLIYEYMPNKSLDFFIFD+ R+T LDW+K
Sbjct: 539 EEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKK 598
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
R++I+ G+ARGILYLHQDSR+RIIHRDLKA NVLLDNDMNPKISDFG+A+ FGGD+ +++
Sbjct: 599 RMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESS 658
Query: 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
T++VVGTYGYM PEYA +G FSVKSDVFSFGVLVLEI++GK N F H DHD NLLGHV
Sbjct: 659 TNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHV 717
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 1.3e-180, Sum P(2) = 1.3e-180
Identities = 189/454 (41%), Positives = 280/454 (61%)
Query: 8 LLFILGASAAND-NITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRT 66
+LF + +AN + + S +I T+VS FELGFF PG ++ YLGIWYK +S RT
Sbjct: 20 ILFPAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRT 79
Query: 67 VAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLV 124
WVANR+TPL+ G L ++ +V+LD D WS+N T +++P+V +L+D+GN V
Sbjct: 80 YVWVANRDTPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFV 139
Query: 125 LTDGNYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWI 181
L D ++ +LWQSFD P DTLLP MKLG + KTG +R + SWKS +DP+ G+FS +
Sbjct: 140 LRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKL 199
Query: 182 DTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECD-AK 240
+T GFP++ L YR+G WNG+ F+G P ++ + + F ++ EV Y K
Sbjct: 200 ETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMV-FNFTTSKEEVTYSFRITK 258
Query: 241 GPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDC 300
SRL ++ SGL+ R W W +YAP D+CD Y CG C +N+S C+C
Sbjct: 259 SDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNC 318
Query: 301 LEGFVPKSPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKEC 355
++GF P++P W S+GCVR+ L C GD F + K+KLPDT+++ + + +KEC
Sbjct: 319 IKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKEC 378
Query: 356 SELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSV 412
+ C ++C+CTA+AN+D+ GSGC+ W G+L D++ Y GGQDLY+R+A+ E R+
Sbjct: 379 EQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNR 438
Query: 413 TKKQVGIIIA-SVLLMAMFIVASLFCIWRKKLKK 445
+ K +G I SVLL+ FI+ F +W++K K+
Sbjct: 439 SAKIIGSSIGVSVLLLLSFII---FFLWKRKQKR 469
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 907 (324.3 bits), Expect = 8.3e-177, Sum P(2) = 8.3e-177
Identities = 185/452 (40%), Positives = 275/452 (60%)
Query: 8 LLFILGASAAND-NITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRT 66
+LF+ + + N + T S +I +T++S + FELGFF+P +S++ YLGIWYK + RT
Sbjct: 18 ILFLAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRT 77
Query: 67 VAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLV 124
WVANR+ PL+ +G L ++ +V+ D DR WS+N T +++PV +L+D+GN +
Sbjct: 78 YVWVANRDNPLSSSNGTLKISGNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFL 137
Query: 125 LTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTH 184
L D N N LLWQSFD P DTLL MKLG + KTG +R L SWK+ +DP+ GEFS ++T
Sbjct: 138 LRDSN-NRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETS 196
Query: 185 GFPQL-VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA-KGP 242
FP+ + K S+L YR+G WNG+ F+ P + V Y F ++ EV Y K
Sbjct: 197 EFPEFYICSKESIL-YRSGPWNGMRFSSVPGTIQ-VDYMVYNFTASKEEVTYSYRINKTN 254
Query: 243 AVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLE 302
SRL++N +GL+ R W W +Y+P D CD Y VCG C +NS C C++
Sbjct: 255 LYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIK 314
Query: 303 GFVPKSPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSE 357
GF P + W S GC+R+ L C D F + ++KLPDT+++ + + LK C E
Sbjct: 315 GFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKE 374
Query: 358 LCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTK 414
C ++C+CTA+AN+D+ GGSGC++W +++DM+ Y GGQDLY+R+A+ E R +
Sbjct: 375 RCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNE 434
Query: 415 KQVGIIIA-SVLLMAMFIVASLFCIWRKKLKK 445
K +G I S+LL+ F++ F W++K K+
Sbjct: 435 KIIGSSIGVSILLLLSFVI---FHFWKRKQKR 463
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 871 (311.7 bits), Expect = 6.0e-172, Sum P(2) = 6.0e-172
Identities = 186/486 (38%), Positives = 280/486 (57%)
Query: 8 LLFI-LGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRT 66
+LF+ A+N + T S +I +T++S + FELGFF+P +S++ YLGIWYK + RT
Sbjct: 18 ILFLAFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRT 77
Query: 67 VAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLV 124
WVANR+ PL+ +G L ++ +V+ D DR WS+N T +++PV +L+D GN V
Sbjct: 78 YVWVANRDNPLSSSNGTLKISDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFV 137
Query: 125 LTDGNYNS---LLWQSFDHPCDTLLPGMKLGRNFKTG-MDRHLSSWKSINDPAPGEFSLW 180
L D N LWQSFD P DTLL MK+G + K+G +R L SWK+ +DP+ G+FS
Sbjct: 138 LRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTK 197
Query: 181 IDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA- 239
+ T GFP+ + + YR+G W G F+ P +K V D F N +V Y
Sbjct: 198 LRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKP-VDYIDNSFTENNQQVVYSYRVN 256
Query: 240 KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
K S L ++ +GL+ R W W +Y+P D CD Y CG C N+S C+
Sbjct: 257 KTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICN 316
Query: 300 CLEGFVPKSPN----NWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKEC 355
C++GF P + + S GCVR+ +L C D F + K++LPDT+ + + + LKEC
Sbjct: 317 CIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKEC 376
Query: 356 SELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSV 412
E C K C+CTA+AN+D+ GGSGC++W G L D++ Y GGQDLY+R+A+ E R
Sbjct: 377 EERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIK 436
Query: 413 TKKQVGIIIA-SVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKA 471
+KK +G I S+LL+ FI+ F W++K +K+ +T + + + + + + KA
Sbjct: 437 SKKIIGSSIGVSILLLLSFII---FHFWKRK-QKRSITIQTPIVDLVRSQDSLMNELVKA 492
Query: 472 TDNFAS 477
+ ++ S
Sbjct: 493 SRSYTS 498
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 1.1e-161, Sum P(2) = 1.1e-161
Identities = 158/233 (67%), Positives = 193/233 (82%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
EL F +IA AT++F N+LG GGFGPVYKG L +G+EIAVKRLS SGQG++EFKN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E+ LIA+LQHRNLV+LLGCC + +E ML+YEYMPNKSLDFF+FD+ + +DW+ R I+
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
GIARG+LYLH+DSR+RIIHRDLK SNVLLD +MNPKISDFGMARIFGG++ + NT +VV
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691
GTYGYMSPEYA EGLFSVKSDV+SFGVL+LEIVSGK+N +H +L+G+
Sbjct: 693 GTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIGY 744
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 754 (270.5 bits), Expect = 1.2e-149, Sum P(2) = 1.2e-149
Identities = 142/230 (61%), Positives = 184/230 (80%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
EL F+F +A AT+NF+ NKLG+GGFG VYKG L EG +IAVKRLS+ SGQG+EEF N
Sbjct: 496 ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVN 555
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
EV +I++LQHRNLV+LLG CI+ +E ML+YE+MP LD ++FD + LDW+ R +I+
Sbjct: 556 EVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNII 615
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
GI RG++YLH+DSR++IIHRDLKASN+LLD ++NPKISDFG+ARIF G+E + +T +VV
Sbjct: 616 DGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVV 675
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
GTYGYM+PEYA GLFS KSDVFS GV++LEIVSG++N F + + NL
Sbjct: 676 GTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNL 725
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1459 (518.7 bits), Expect = 1.8e-149, P = 1.8e-149
Identities = 323/716 (45%), Positives = 439/716 (61%)
Query: 5 YSCLLF-ILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVS 63
++C LF L S + ITP+ + G+TL S NG FELGFFSP S Y+GIW+K +
Sbjct: 4 FACFLFSTLLLSFSYAAITPTSPLSIGQTLSSPNGIFELGFFSPNNSRNLYVGIWFKGII 63
Query: 64 PRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGN 122
PRTV WVANRE +TD + L ++S G +LL DG+ WS+ + +L DSGN
Sbjct: 64 PRTVVWVANRENSVTDATADLAISSNGSLLLFDGKHSTVWSTGETFASNGSSAELSDSGN 123
Query: 123 LVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWID 182
L++ D LWQSF+H DT+LP L N TG R LSSWKS DP PGEF +I
Sbjct: 124 LLVIDKVSGITLWQSFEHLGDTMLPYSSLMYNPGTGEKRVLSSWKSYTDPLPGEFVGYIT 183
Query: 183 THGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINEN---EVYYECDA 239
T PQ + +GS +R+G W FTG P E+ + F + ++ VY+
Sbjct: 184 TQVPPQGFIMRGSKPYWRSGPWAKTRFTGVPLTDESYT---HPFSVQQDANGSVYFSHLQ 240
Query: 240 KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
+ S L + G L+ + D W L P + CD Y VCG C + +C
Sbjct: 241 RNFKRSLLVLTSEGS-LKVTHHNGTD-WVLNIDVPANTCDFYGVCGPFGLCVMSIPPKCK 298
Query: 300 CLEGFVPK-----SPNNWSEGCVRERELKC------RNGDEFPKYVKLKLPDTSSSWFNA 348
C +GFVP+ NW+ GCVR EL C R+ + F +K PD F +
Sbjct: 299 CFKGFVPQFSEEWKRGNWTGGCVRRTELLCQGNSTGRHVNVFHPVANIKPPDFYE--FVS 356
Query: 349 SMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS-E 407
S + +EC + C NCSC A+A + G GCL+W +LMD+ +++ GG+ L IR+AS E
Sbjct: 357 SGSAEECYQSCLHNCSCLAFAYIN----GIGCLIWNQELMDVMQFSVGGELLSIRLASSE 412
Query: 408 RGRSVTKKQVGIIIASVLLMAMFIV--ASLFCIWRKKLKKQGL-TKMS-------HMK-E 456
G + KK IIAS++ +++F+ ++ F WR +LK + +K+S +K E
Sbjct: 413 MGGNQRKKT---IIASIVSISLFVTLASAAFGFWRYRLKHNAIVSKVSLQGAWRNDLKSE 469
Query: 457 DME-LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEE 515
D+ L+ F+ +I AT+NF+ NKLG+GGFGPVYKG L +G+EIAVKRLS SGQG EE
Sbjct: 470 DVSGLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEE 529
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F NE+ LI++LQH NLV++LGCCI+ +E +L+YE+M NKSLD FIFD + +DW KR
Sbjct: 530 FMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKRF 589
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
I+ GIARG+LYLH+DSR+RIIHRD+K SN+LLD+ MNPKISDFG+AR++ G + Q NT
Sbjct: 590 SIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTR 649
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691
++VGT GYMSPEYA G+FS KSD +SFGVL+LE++SG+K RFS+ NLL +
Sbjct: 650 RIVGTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKISRFSYDKERKNLLAY 705
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1455 (517.2 bits), Expect = 4.8e-149, P = 4.8e-149
Identities = 313/715 (43%), Positives = 432/715 (60%)
Query: 4 AYSCLL-FILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRV 62
AY L F + +S+A IT + G+TL S NG +ELGFF+ S +Y+GIW+K +
Sbjct: 10 AYLLLSSFFISSSSAG--ITKESPLPIGQTLSSSNGFYELGFFNFNNSQNQYVGIWFKGI 67
Query: 63 SPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSG 121
PR V WVANRE P+TD + L +++ G +LL +G+ + WSS ++ +L D+G
Sbjct: 68 IPRVVVWVANREKPVTDSTANLAISNNGSLLLFNGKHGVAWSSGEALVSNGSRAELSDTG 127
Query: 122 NLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWI 181
NL++ D LWQSFDH DT+LP L N TG + LSSWKS DP+ G+F L I
Sbjct: 128 NLIVIDNFSGRTLWQSFDHLGDTMLPSSTLKYNLATGEKQVLSSWKSYTDPSVGDFVLQI 187
Query: 182 DTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENV--PLCDYKFVINENEVYYECDA 239
Q+++ KGS YR+G W FTG P + + P+ + + Y
Sbjct: 188 TPQVPTQVLVTKGSTPYYRSGPWAKTRFTGIPLMDDTFTGPVSVQQDTNGSGSLTYL--N 245
Query: 240 KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
+ + R + G S W + D W L + AP CD Y VCG C + +C
Sbjct: 246 RNDRLQRTMLTSKGTQELS-WHNGTD-WVLNFVAPEHSCDYYGVCGPFGLCVKSVPPKCT 303
Query: 300 CLEGFVPK-----SPNNWSEGCVRERELKCRNGDEFPKYV-------KLKLPDTSSSWFN 347
C +GFVPK NW+ GCVR EL C+ G+ KY ++K PD F
Sbjct: 304 CFKGFVPKLIEEWKRGNWTGGCVRRTELYCQ-GNSTGKYANVFHPVARIKPPDFYE--FA 360
Query: 348 ASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-S 406
+ +N++EC + C NCSC A+A D G GCL+W DLMD ++++GG+ L IR+A S
Sbjct: 361 SFVNVEECQKSCLHNCSCLAFAYID----GIGCLMWNQDLMDAVQFSEGGELLSIRLARS 416
Query: 407 ERGRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQG--LTKMSHM--KEDMELWE 462
E G + KK + I S+ L+ + + FC WR ++K T S + + D++ +
Sbjct: 417 ELGGNKRKKAITASIVSLSLVVIIAFVA-FCFWRYRVKHNADITTDASQVSWRNDLKPQD 475
Query: 463 ------FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEF 516
FD +I AT+NF+ NKLG+GGFGPVYKG L +G+EIAVKRLS SGQG EEF
Sbjct: 476 VPGLDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEF 535
Query: 517 KNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIH 576
NE+ LI++LQH+NLV++LGCCI+ +E +LIYE+M N SLD F+FD + +DW KR+
Sbjct: 536 MNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKRLD 595
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I+ GIARGI YLH+DS +++IHRDLK SN+LLD MNPKISDFG+AR++ G E Q NT +
Sbjct: 596 IIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRR 655
Query: 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691
VVGT GYM+PEYA G+FS KSD++SFGVL+LEI+SG+K RFS+ + L+ +
Sbjct: 656 VVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKTLIAY 710
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1444 (513.4 bits), Expect = 7.1e-148, P = 7.1e-148
Identities = 307/714 (42%), Positives = 441/714 (61%)
Query: 5 YSCLLFIL-----GASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWY 59
++CLL ++ G +A N + +P SIR +TL S G +ELGFFSP + +Y+GIW+
Sbjct: 6 FACLLLLIIFPTCGYAAINTS-SPL-SIR--QTLSSPGGFYELGFFSPNNTQNQYVGIWF 61
Query: 60 KRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLM 118
K++ PR V WVANR+TP+T + L ++S G ++LLDG+ + WS+ + T +L+
Sbjct: 62 KKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLDGKQDVIWSTGKAFTSNKCHAELL 121
Query: 119 DSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFS 178
D+GN V+ D + LWQSF+H +T+LP L + G R L++WKS +DP+PGEFS
Sbjct: 122 DTGNFVVIDDVSGNKLWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSDPSPGEFS 181
Query: 179 LWIDTHGFP-QLVLRKGSVLQYRAGSWNGLGFTGTPPLKENV--PLCDYKFVINENEVYY 235
L I T P Q ++R+GSV +R G W F+G + + P + +
Sbjct: 182 LEI-TPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAAGTGSFS 240
Query: 236 ECDAKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSS 295
+ +S + + G ++ +W + W L P + CDLY CG C +
Sbjct: 241 YSTLRNYNLSYVTLTPEGK-MKILWDDGNN-WKLHLSLPENPCDLYGRCGPYGLCVRSDP 298
Query: 296 RRCDCLEGFVPKSPN-----NWSEGCVRERELKC----------RNGDEFPKYVKLKLPD 340
+C+CL+GFVPKS NW+ GCVR +L C ++ D F + +K PD
Sbjct: 299 PKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTDVKTPD 358
Query: 341 TSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDL 400
F + +N ++C + C NCSCTA+A G GCL+W G+L D ++ G+ L
Sbjct: 359 LHQ--FASFLNAEQCYQGCLGNCSCTAFAYIS----GIGCLVWNGELADTVQFLSSGEFL 412
Query: 401 YIRIASERGRSVTKKQVGIIIASVLLMAMFIVA--SLFCIWRKKLKKQGLTKMSHMKEDM 458
+IR+AS ++++ II+ + + +++F++ + +WR + K+ K ++D+
Sbjct: 413 FIRLASSELAGSSRRK--IIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGFERQDV 470
Query: 459 E-LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFK 517
+ F+ +I AT+NF+ NKLG+GGFGPVYKG LV+G+EI VKRL+ SGQG EEF
Sbjct: 471 SGVNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFM 530
Query: 518 NEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
NE+TLI++LQHRNLV+LLG CI +E +LIYE+M NKSLD FIFD LDW KR +I
Sbjct: 531 NEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNI 590
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ GIARG+LYLH+DSR+R+IHRDLK SN+LLD+ MNPKISDFG+AR+F G + Q NT +V
Sbjct: 591 IQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRV 650
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691
VGT GYMSPEYA GLFS KSD++SFGVL+LEI+SGK+ RF + D LL +
Sbjct: 651 VGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAY 704
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81833 | SD11_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5547 | 0.9570 | 0.8196 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_134000023 | hypothetical protein (812 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 698 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-42 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 4e-35 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-31 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 8e-31 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-29 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 1e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-28 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-27 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-26 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-24 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 6e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-20 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 7e-55
Identities = 81/200 (40%), Positives = 112/200 (56%), Gaps = 13/200 (6%)
Query: 480 KLGEGGFGPVYKGTL-----VEGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKGTL + E+AVK L + S Q +EEF E ++ +L H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLG C + + M++ EYMP L ++ R L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
IHRDL A N L+ ++ KISDFG++R ++ D + K+ +M+PE EG
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179
Query: 653 LFSVKSDVFSFGVLVLEIVS 672
F+ KSDV+SFGVL+ EI +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-54
Identities = 76/199 (38%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 480 KLGEGGFGPVYKGTLV-----EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKG L + E+AVK L + S Q +EEF E ++ +L H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLG C + + ++ EYM L ++ + L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
IHRDL A N L+ ++ KISDFG++R D+ + +M+PE EG
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGK 179
Query: 654 FSVKSDVFSFGVLVLEIVS 672
F+ KSDV+SFGVL+ EI +
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 3e-53
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 479 NKLGEGGFGPVYKGTLVEGQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKG L E+AVK L + S + ++F E ++ +L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGIARGILY 587
LLG C + + L+ EYM L ++ F + L + + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVGTYGYMSP 646
L + +HRDL A N L+ D+ KISDFG++R ++ D + T + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVS 672
E +G+F+ KSDV+SFGVL+ EI +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 2e-50
Identities = 74/200 (37%), Positives = 109/200 (54%), Gaps = 11/200 (5%)
Query: 480 KLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKGTL ++AVK L +G+ + EEF E +++ +L H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLG C Q + ++ EYMP L F+ + L + + + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
+HRDL A N L+ ++ KISDFG++R D+ +M+PE +G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 654 FSVKSDVFSFGVLVLEIVSG 673
F+ KSDV+SFGVL+ EI +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 70/194 (36%), Positives = 108/194 (55%), Gaps = 11/194 (5%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LGEGGFG VY + G+++A+K + K S +EE E+ ++ +L H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ L+ EY SL + + L + + I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 599 RDLKASNVLLDND-MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-YAAEGLFSV 656
RDLK N+LLD+D K++DFG++++ D+ T +VGT YM+PE +G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 657 KSDVFSFGVLVLEI 670
KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 69/200 (34%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 480 KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFK---NEVTLIARLQHRNLVKLL 535
KLG G FG VYK G+ +AVK L K + ++ + E+ ++ RL H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
D L+ EY L ++ +R L + I I RG+ YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-YAAEGLF 654
IIHRDLK N+LLD + KI+DFG+A+ ++ VGT YM+PE +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 655 SVKSDVFSFGVLVLEIVSGK 674
K DV+S GV++ E+++GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 7e-46
Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLG 536
KLGEG FG VY + G+ +A+K + K + E E+ ++ +L+H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
D+ L+ EY L + + R + + R + I + YLH I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHS---KGI 118
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSV 656
+HRDLK N+LLD D + K++DFG+AR E VGT YM+PE +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 657 KSDVFSFGVLVLEIVSGK 674
D++S GV++ E+++GK
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
LG G FG VY + G+ +AVK LS S + +E + E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 536 GCCIQADESML-IY-EYMPNKSLDFFIFDQARATFLDWQKRIHI------VGGIARGILY 587
G +++ L I+ EY+ SL ++ L ++ I G+ Y
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSL---------SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH I+HRD+K +N+L+D+D K++DFG A+ G E T V GT +M+PE
Sbjct: 117 LH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
+ +D++S G V+E+ +GK W + L
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPW-SELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 61/111 (54%), Positives = 69/111 (62%), Gaps = 3/111 (2%)
Query: 64 PRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGN 122
+TV WVANR PLTD S L + S G +VL DG R+ WSSNTS V L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 123 LVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPA 173
LVL D + +LWQSFDHP DTLLPG K G N G R L+SWKS DP+
Sbjct: 61 LVLYDNS-GKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 72/228 (31%), Positives = 111/228 (48%), Gaps = 31/228 (13%)
Query: 481 LGEGGFGPVYKGT---LVEGQE---IAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVK 533
LGEG FG V+ G L + +AVK L + + + F+ E L+ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQAR-ATFLDWQKR----------IHIVGGIA 582
G C + D ++++EYM + L+ F+ A FL + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT-- 640
G++YL + +HRDL N L+ D+ KI DFGM+R D T+ ++V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 641 --YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHD 685
+M PE F+ +SDV+SFGV++ EI + GK+ W + + +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
K+G+GGFG VYK G+E+A+K + S + E+ NE+ ++ + +H N+VK G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSRM 594
++ DE ++ E+ SL + T + Q + + + +L YLH
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQ-----IAYVCKELLKGLEYLHS---N 117
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
IIHRD+KA+N+LL +D K+ DFG++ D NT +VGT +M+PE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNT--MVGTPYWMAPEVINGKPY 174
Query: 655 SVKSDVFSFGVLVLEIVSGK 674
K+D++S G+ +E+ GK
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 71/199 (35%), Positives = 105/199 (52%), Gaps = 18/199 (9%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRNLVKLLGC 537
KLG G FG V+ GT ++AVK L G+ M E F E ++ +L+H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 538 CIQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
C + + ++ EYM SL DF + + L + + + IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE---SRNY 124
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT---YGYMSPEYAAEGL 653
IHRDL A N+L+ ++ KI+DFG+AR+ DE G + +PE A G
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGR 180
Query: 654 FSVKSDVFSFGVLVLEIVS 672
F++KSDV+SFG+L+ EIV+
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 73/213 (34%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 481 LGEGGFGPVYKGTLV------EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLVK 533
LGEG FG VYKG L +A+K L + + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIF-------------DQARATFLDWQKRIHIVGG 580
LLG C + + +++EY+ + L F+ D+ + LD +HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVG 639
IA G+ YL S +HRDL A N L+ + KISDFG++R I+ D + K +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV-QSKSLL 188
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M PE G F+ +SD++SFGV++ EI S
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 6/198 (3%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
F KLG G FG V++G +A+K L ++F+ EV + RL+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
C + +I E M SL F+ L I + +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
IHRDL A N+L+ D+ K++DFG+AR+ D ++ K+ Y + +PE A+ G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 655 SVKSDVFSFGVLVLEIVS 672
S KSDV+SFG+L+ E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 479 NKLGEGGFGPVYKGTLV-----EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLV 532
+LGEG FG V G+++AVK L+ G Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 533 KLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
K G C + LI EY+P+ SL ++ Q ++ ++ + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMSPEY 648
R IHRDL A N+L++++ KISDFG+A++ D + Y +PE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
FS SDV+SFGV + E+ F++ D
Sbjct: 184 LRTSKFSSASDVWSFGVTLYEL--------FTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVKRLS--KGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
+ +G G FG VYKG L G +A+K++S K + ++ E+ L+ L+H N+VK +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG------------IAR 583
G +D +I EY N SL ++ I G + +
Sbjct: 66 GSIETSDSLYIILEYAENGSL---------------RQIIKKFGPFPESLVAVYVYQVLQ 110
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
G+ YLH+ +IHRD+KA+N+L D K++DFG+A + VVGT +
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYW 165
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
M+PE S SD++S G V+E+++G
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 464 DFASIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTL 522
D S + + + K+GEG G VYK T G+E+A+K++ + Q E NE+ +
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILI 68
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL------DFFIFDQARATFLDWQKRIH 576
+ +H N+V + DE ++ EYM SL +F ++ + +
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------- 120
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
+ + +G+ YLH +IHRD+K+ N+LL D + K++DFG A + ++ +
Sbjct: 121 VCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNS 175
Query: 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
VVGT +M+PE + K D++S G++ +E+ G
Sbjct: 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 3e-31
Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 17/228 (7%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH-R 529
++ KLGEG FG VY + +A+K L+K + +E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+VKL L+ EY+ SL+ + R L + + I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 590 QDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGD----EIQTNTHKVVGTYGYM 644
IIHRD+K N+LLD + K+ DFG+A++ I VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 645 SPEYAAEGLF---SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
+PE S SD++S G+ + E+++G + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223
|
Length = 384 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-31
Identities = 56/119 (47%), Positives = 70/119 (58%), Gaps = 4/119 (3%)
Query: 24 SQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGL 83
S + G+TLVS FELGFF ++ Y I YK S RTV WVANR+ P S
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYK-GSSRTVVWVANRDNPSGS-SCT 58
Query: 84 LNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHP 141
L + S G +V+ DG + WSSNT+ N V+ L+D GNLVL D + N LWQSFD+P
Sbjct: 59 LTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNF-LWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 76/210 (36%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 481 LGEGGFGPVYKGTLV-------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLV 532
LG G FG VY+GT +AVK L KG+ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF----LDWQKRIHIVGGIARGILYL 588
KLLG C+ + +I E M L ++ D F L ++ + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 589 HQDSRMRIIHRDLKASNVLL-----DNDMNPKISDFGMAR-IFGGDEIQTNTHKVVGTYG 642
Q M IHRDL A N L+ D D KI DFG+AR I+ D + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE +G F+ +SDV+SFGVL+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 15/194 (7%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
+G+G FG V G GQ++AVK L K + F E +++ L+H NLV+LLG +Q
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
+ ++ EYM SL ++ + RA + +++ + G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 601 LKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY--GYMSPEYAAEGLFSVKS 658
L A NVL+ D+ K+SDFG+A+ + Q G + +PE E FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFSTKS 180
Query: 659 DVFSFGVLVLEIVS 672
DV+SFG+L+ EI S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEI-AVKR--LSKGSGQGMEEFKNEVTLIARLQHRN 530
+ ++G+G FG VY ++ +K LS S + E+ NEV ++ +L H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA-------TFLDW--QKRIHIVGGI 581
++K + + ++ EY L I Q + LDW Q +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--------L 112
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
+ YLH SR +I+HRD+K N+ L ++ K+ DFG++++ T VVGT
Sbjct: 113 CLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTP 167
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
Y+SPE ++ KSD++S G ++ E+ + K
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 21/206 (10%)
Query: 481 LGEGGFGPVYKGT-LVEGQ----EIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VYKG + EG+ +A+K L + + + +E +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARA----TFLDWQKRIHIVGGIARGILYLHQ 590
LG C+ + + LI + MP L ++ + L+W +I A+G+ YL +
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
R++HRDL A NVL+ + KI+DFG+A++ DE + + +M+ E
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 651 EGLFSVKSDVFSFGVLVLEIVS-GKK 675
+++ KSDV+S+GV V E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVK 533
LG+G FG V K T G+ A+K L K + +E E +++R+ H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 534 LLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILY 587
L Q +E + L+ EY P L + F + RA F I + Y
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--------YAAEIVLALEY 108
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH + II+RDLK N+LLD D + K++DFG+A+ + +TNT GT Y++PE
Sbjct: 109 LH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPE 163
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ D +S GVL+ E+++GK
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 14/199 (7%)
Query: 481 LGEGGFGPVYKGTLVEGQE----IAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVKLL 535
+G G FG V +G L + +A+K L GS +F E +++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G ++ M+I EYM N SLD F+ + + + ++ GIA G+ YL S M
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGG--DEIQTNTHKVVGTYGYMSPEYAAEGL 653
+HRDL A N+L+++++ K+SDFG++R T K+ + +PE A
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRK 184
Query: 654 FSVKSDVFSFGVLVLEIVS 672
F+ SDV+SFG+++ E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE D SI KLG G FG V++G +AVK L G+ ++F E
Sbjct: 1 WEIDRTSIQLL-------RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEA 52
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVG 579
++ +L+H L++L C + ++ E M SL ++ RA L + I +
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAA 110
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+A G+ YL IHRDL A NVL+ + K++DFG+AR+ D + G
Sbjct: 111 QVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----G 163
Query: 640 T---YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE A FS+KSDV+SFG+L+ EIV+
Sbjct: 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 72/194 (37%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ G ++A+K L +GS E F E L+ +LQH LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 540 QADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
Q + +I EYM N SL DF + L K I + IA G+ ++ R IH
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKS 658
RDL+A+N+L+ + KI+DFG+AR+ +E T + +PE G F++KS
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 659 DVFSFGVLVLEIVS 672
DV+SFG+L+ EIV+
Sbjct: 185 DVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 41/231 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-Q 527
D+F +GEG F V E +E A+K L K + ++ K E ++ RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 528 HRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGI 581
H ++KL Q +E++ + EY PN L +I D+ F I
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAAEI 111
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV---- 637
+ YLH IIHRDLK N+LLD DM+ KI+DFG A++ + +
Sbjct: 112 LLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 638 --------------VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
VGT Y+SPE E SD+++ G ++ ++++GK
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 57/118 (48%), Positives = 74/118 (62%), Gaps = 5/118 (4%)
Query: 24 SQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGL 83
S ++ G+TLVS N FELGFF+ Y I YK S RTV WVANR+ P++D S
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYK-SSSRTVVWVANRDNPVSD-SCT 57
Query: 84 LNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140
L + S G +VL DG R+ WSSNT+ N V+ L+D GNLV+ D + + LWQSFD+
Sbjct: 58 LTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD-SDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
LG+G G VYK G+ A+K++ G + ++ E+ + + +VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI----VGGIARGIL----YLH 589
+ E ++ EYM SL + +K I + IAR IL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL-----------KKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
IIHRD+K SN+L+++ KI+DFG++++ + + VGT YMSPE
Sbjct: 117 TKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERI 172
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGK 674
+S +D++S G+ +LE GK
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 479 NKLGEGGFGPVYKGTLVE--GQEI--AVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
+LG G FG V KG + G+E+ AVK L + G +EF E +++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
L+G C + + ML+ E P L ++ + D ++ H +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH---QVAMGMAYLES--- 113
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARI--FGGDEIQTNTHKVVGTY--GYMSPEYA 649
+HRDL A NVLL N KISDFGM+R G D + T G + + +PE
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYAPECI 170
Query: 650 AEGLFSVKSDVFSFGVLVLEIVS 672
G FS KSDV+S+GV + E S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 72/194 (37%), Positives = 102/194 (52%), Gaps = 8/194 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ G ++AVK L G+ ++ F E L+ LQH LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 540 QADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ + +I EYM SL DF D+ L K I IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKS 658
RDL+A+NVL+ + KI+DFG+AR+ +E T + +PE G F++KS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 659 DVFSFGVLVLEIVS 672
DV+SFG+L+ EIV+
Sbjct: 186 DVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 61/196 (31%), Positives = 105/196 (53%), Gaps = 7/196 (3%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
++G G FG V+ G +E +++A+K + +G+ E+F E ++ +L H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ L++E+M + L ++ +A+ + + + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL A N L+ + K+SDFGM R D+ T++ + SPE + +S KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 660 VFSFGVLVLEIVSGKK 675
V+SFGVL+ E+ S K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLGEG +G VYK GQ +A+K + + ++E E++++ + +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 539 IQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ + ++ EY S + D + L ++ I+ +G+ YLH +
Sbjct: 68 FKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKK 120
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSV 656
IHRD+KA N+LL+ + K++DFG++ + NT V+GT +M+PE E ++
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNN 178
Query: 657 KSDVFSFGVLVLEIVSGKKNWRFSHP 682
K+D++S G+ +E+ GK + HP
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 29/208 (13%)
Query: 481 LGEGGFG--------PVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
LG+G FG P+ T G+ +AVK+L + + + +F+ E+ ++ LQH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNT---GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 533 KLLGCCIQA--DESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
K G C A L+ EY+P SL D+ + R LD +K + I +G+ YL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL- 124
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG-----YM 644
R +HRDL N+L++++ KI DFG+ ++ D+ + V G +
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK----EYYKVREPGESPIFWY 178
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+PE E FSV SDV+SFGV++ E+ +
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 481 LGEGGFGPVYKGTLVEG----QEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LGEG FG V +G L + ++AVK +L + +EEF +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 535 LGCCIQADES------MLIYEYMPNKSLDFFIFDQARAT---FLDWQKRIHIVGGIARGI 585
+G C +A M+I +M + L F+ L Q + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEI-QTNTHKVVGTYGY 643
YL S IHRDL A N +L DM ++DFG+++ I+ GD Q K+ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
++ E A+ +++ KSDV++FGV + EI +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKLLGCC 538
K+G+G FG VYKG L E+AVK + +F E ++ + H N+VKL+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+Q ++ E +P F + + L +K + + A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGL 653
RDL A N L+ + KISDFGM+R E + + V + +PE G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 654 FSVKSDVFSFGVLVLEIVSG 673
++ +SDV+S+G+L+ E S
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-26
Identities = 36/67 (53%), Positives = 49/67 (73%), Gaps = 1/67 (1%)
Query: 324 CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLW 383
C GD F + +KLPDT+++ + S+ LKEC + C NCSCTAYA +D+ RGGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADI-RGGSGCLIW 59
Query: 384 FGDLMDM 390
G+L+DM
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEG-------QEIAVKRL-SKGSGQGMEEFKNEVTL 522
D+ LG G FG VY+G L G ++AVK L S Q +F E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEG-LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD----QARATFLDWQKRIHIV 578
+++ H+N+V+L+G + ++ E M L F+ + R + L + +
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMAR-IFGGDEIQTNT 634
+A+G YL ++ IHRD+ A N LL KI+DFGMAR I+ +
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + +M PE +G+F+ K+DV+SFGVL+ EI S
Sbjct: 180 -RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 66/193 (34%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ GT ++AVK L G+ E F E ++ +L+H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV-V 70
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ EYM SL F+ D L + + +A G+ Y+ RM IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL+++N+L+ + + KI+DFG+AR+ +E T + +PE A G F++KSD
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 660 VFSFGVLVLEIVS 672
V+SFG+L+ E+V+
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-26
Identities = 41/111 (36%), Positives = 60/111 (54%), Gaps = 2/111 (1%)
Query: 199 YRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYE-CDAKGPAVSRLWVNQSGLVLR 257
+R+G WNG+ F+G P +++ Y F N EVYY SRL ++ G + R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKL-SYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLER 59
Query: 258 SIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
W W L + AP D+CD+Y CG C N+S +C+C++GFVPK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 68/210 (32%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 480 KLGEGGFGPVYKGTLVEGQ----EIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVKL 534
KLG+G FG V +G +AVK L M++F E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG----IARGILYLHQ 590
G + M++ E P SL + A FL I + IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFL-----ISTLCDYAVQIANGMRYLES 115
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMSPEY 648
R IHRDL A N+LL +D KI DFG+ R D H V + + +PE
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPES 171
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVS-GKKNW 677
FS SDV+ FGV + E+ + G++ W
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 74/218 (33%), Positives = 113/218 (51%), Gaps = 33/218 (15%)
Query: 480 KLGEGGFGPVYKGTLV------EGQEIAVKRLS-KGSGQGMEEFKNEVTLIARLQHRNLV 532
+LGE FG VYKG L + Q +A+K L K G EEFK+E + +RLQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIF-------------DQARATFLDWQKRIHIVG 579
LLG + +I+ Y + L F+ D+ + L+ +HIV
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVV 638
IA G+ +L S ++H+DL NVL+ + +N KISD G+ R ++ D +K++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD-----YYKLM 183
Query: 639 GT----YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
G +MSPE G FS+ SD++S+GV++ E+ S
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 32/209 (15%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHRN 530
KLGEG +G VYK G+ +A+K++ ++ + E++L+ L+H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKELKHPN 59
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKLL + L++EY + L ++ + + K I+ + RG+ Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIK--SIMYQLLRGLAYCHS 116
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
RI+HRDLK N+L++ D K++DFG+AR F G ++T TH+VV T Y +PE
Sbjct: 117 ---HRILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEI-- 169
Query: 651 EGLFSVKS-----DVFSFGVLVLEIVSGK 674
L K D++S G + E+++GK
Sbjct: 170 --LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 30/221 (13%)
Query: 480 KLGEGGFGPVYKG---TLVEGQE---IAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
+LGEG FG V+ L+ Q+ +AVK L + S ++F+ E L+ LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF---------IFDQARATF---LDWQKRIHIVGGI 581
G C + ++++EYM + L+ F I L + + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG-- 639
A G++YL + + +HRDL N L+ + KI DFGM+R D T+ ++V G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 184
Query: 640 --TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNW 677
+M PE F+ +SD++SFGV++ EI + GK+ W
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 70/222 (31%), Positives = 111/222 (50%), Gaps = 22/222 (9%)
Query: 474 NFASYNKLGEGGFGPVYKG---TLVEGQE---IAVKRLSKGSGQGMEEFKNEVTLIARLQ 527
N +LGEG FG V+ L Q+ +AVK L S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQA----------RATFLDWQKRIHI 577
H ++VK G C++ D ++++EYM + L+ F+ R L + +HI
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHK 636
IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D + H
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNW 677
++ +M PE F+ +SDV+S GV++ EI + GK+ W
Sbjct: 183 MLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 68/215 (31%), Positives = 111/215 (51%), Gaps = 18/215 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNE 519
WE + I +KLG G +G VY+G + +AVK L K +EEF E
Sbjct: 1 WEMERTDITM-------KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKE 52
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R ++ +++
Sbjct: 53 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMAT 111
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
I+ + YL + + IHRDL A N L+ + K++DFG++R+ GD T T
Sbjct: 112 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGA 165
Query: 640 TY--GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + +PE A FS+KSDV++FGVL+ EI +
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 67/203 (33%), Positives = 118/203 (58%), Gaps = 21/203 (10%)
Query: 481 LGEGGFGPVYKGTL-VEGQE---IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G FG V++G L + G++ +A+K L G + + ++F +E +++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G + +M+I EYM N +LD ++ D F +Q + ++ GIA G+ YL S M
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQ-LVGMLRGIAAGMKYL---SDMN 127
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG------YMSPEYA 649
+HRDL A N+L+++++ K+SDFG++R+ D T T T G + +PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGGKIPIRWTAPEAI 182
Query: 650 AEGLFSVKSDVFSFGVLVLEIVS 672
A F+ SDV+SFG+++ E++S
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 63/193 (32%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG+G FG V+ GT +A+K L G+ E F E ++ +L+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ EYM SL F+ + +L + + + IA G+ Y+ RM +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL+A+N+L+ ++ K++DFG+AR+ +E T + +PE A G F++KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 660 VFSFGVLVLEIVS 672
V+SFG+L+ E+ +
Sbjct: 186 VWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHR 529
++GEG +G VYK G+ +A+K++ ME K E+ L+ +L+H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR------MENEKEGFPITAIREIKLLQKLRHP 58
Query: 530 NLVKLLGCCIQADES--MLIYEYMPNKSLDFF-IFDQARATFLDWQKRIHIVGGIARGIL 586
N+V+L + +++EYM + D + D F + Q + + + G+
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIK-CYMKQLLEGLQ 114
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YLH I+HRD+K SN+L++ND K++DFG+AR + T++V+ T Y P
Sbjct: 115 YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 647 E-------YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
E Y E D++S G ++ E+ GK
Sbjct: 171 ELLLGATRYGPE------VDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 25/219 (11%)
Query: 480 KLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
+LGEG FG V+ + +AVK L + ++F+ E L+ LQH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQA--RATFLDWQKR-----------IHIVGG 580
G C D ++++EYM + L+ F+ +D Q R +HI
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVG 639
IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D + H ++
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNW 677
+M PE F+ +SDV+SFGV++ EI + GK+ W
Sbjct: 189 IR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
LG G FG V+ G ++A+K + +G+ ++F E ++ +L H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
++ EYM N L ++ + R L + + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 601 LKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT---YGYMSPEYAAEGLFSVK 657
L A N L+ D K+SDFG+AR D+ ++ GT + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 658 SDVFSFGVLVLEIVSGKK 675
SDV+SFGVL+ E+ S K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 34/218 (15%)
Query: 481 LGEGGFGPVYKG-TLVEGQEIAVKR--LSKGSGQG-------MEEFKNEVTLIARLQHRN 530
+G G FG VY G G+ +AVK+ L S ++ E+ L+ LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------HIVGGIARG 584
+V+ LG + AD + EY+P S+ A L+ + V I +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118
Query: 585 ILYLHQDSRMR-IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT--NTHK--VVG 639
+ YLH R IIHRD+K +N+L+DN KISDFG+++ + + T N + + G
Sbjct: 119 LNYLH----NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ +M+PE + ++ K+D++S G LV+E+++GK +
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 474 NFASYNKLGEGGFGPVYKGTL-VEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRN 530
+F NK+G+G FG V+K + + A+K+ LSK + + EE +E ++A+L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD---WQKRIHIVGGIARGILY 587
+++ + + ++ EY N L + Q + W+ I I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH +I+HRD+K+ N+ LD N KI D G+A++ + NT +VGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ ++ KSDV++ GV++ E +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 23/208 (11%)
Query: 481 LGEGGFGPVY----KGTLVEGQE--IAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVK 533
LG G FG V+ KG EG E + VK L K + ++ EF+ E+ + +L H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGIARGILY 587
LLG C +A+ +I EY L F+ ++ + L ++++ + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG---YM 644
L S R +HRDL A N L+ + K+S +++ D + +K+ ++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALIPLRWL 185
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+PE E FS KSDV+SFGVL+ E+ +
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 70/194 (36%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ T + ++AVK + GS +E F E ++ LQH LVKL +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70
Query: 540 QADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ +I E+M SL DF D+ L K I IA G+ ++ Q + IH
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKS 658
RDL+A+N+L+ + KI+DFG+AR+ +E T + +PE G F++KS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 659 DVFSFGVLVLEIVS 672
DV+SFG+L++EIV+
Sbjct: 185 DVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 65/193 (33%), Positives = 108/193 (55%), Gaps = 7/193 (3%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG+G FG V+ GT ++A+K L G+ E F E ++ +L+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAV-V 70
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ E+M SL F+ + +L + + + IA G+ Y+ RM IHR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL+A+N+L+ +++ KI+DFG+AR+ +E T + +PE A G F++KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 660 VFSFGVLVLEIVS 672
V+SFG+L+ E+V+
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-24
Identities = 35/81 (43%), Positives = 51/81 (62%), Gaps = 5/81 (6%)
Query: 325 RNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWF 384
+ D F K +KLPD +S+ +++L+EC E C NCSCTAYA ++ G GCLLW
Sbjct: 9 GSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWN 63
Query: 385 GDLMDMKEYNDGGQDLYIRIA 405
G L +++ + GG LY+R+A
Sbjct: 64 GLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 25/210 (11%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKR-----LSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG VY V+ G+E+AVK+ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 535 LGCCIQADESMLIY-EYMPNKSLDFFIFDQARATFLDWQKRIHIVGG-----IARGILYL 588
GC ++ DE++ I+ EYMP S + DQ +A + V I G+ YL
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGS----VKDQLKA----YGALTETVTRKYTRQILEGVEYL 120
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE 647
H I+HRD+K +N+L D+ N K+ DFG + R+ T V GT +MSPE
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ + K+DV+S G V+E+++ K W
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPW 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 481 LGEGGFGPVYKGTL------VEGQEIAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVK 533
LG+G FG VY+G +A+K +++ + EF NE +++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIF----DQARATFLD---WQKRIHIVGGIARGIL 586
LLG ++++ E M L ++ + L QK I + IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT----YG 642
YL + +HRDL A N ++ D+ KI DFGM R D +T+ ++ G
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE +G+F+ KSDV+SFGV++ E+ +
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQHRNLVKLLG 536
K+GEG +G VYK + G+ +A+K++ E+ L+ L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ L++E+M D + + R L + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--YAAEGLF 654
+HRDLK N+L++ + K++DFG+AR FG + TH VV T Y +PE +G +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKG-Y 176
Query: 655 SVKSDVFSFGVLVLEIVSGK 674
S D++S G + E++S +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 68/202 (33%), Positives = 114/202 (56%), Gaps = 20/202 (9%)
Query: 481 LGEGGFGPVYKGTLV-EGQEI----AVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VYKG V EG+ + A+K L++ +G + EF +E ++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQ----ARATFLDWQKRIHIVGGIARGILYLHQ 590
LG C+ + L+ + MP+ L ++ + L+W +I A+G++YL +
Sbjct: 75 LGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
R++HRDL A NVL+ + + KI+DFG+AR+ GDE + N +M+ E
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 651 EGLFSVKSDVFSFGVLVLEIVS 672
F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+GGFG V G + +++ KRL K G+ M NE ++ ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFI-------FDQARATFLDWQKRIHIVGGIARGILY 587
D+ L+ M L + I F +ARA F Q I G+ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ--------IICGLEH 110
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LHQ RI++RDLK NVLLD+ N +ISD G+A G GT GYM+PE
Sbjct: 111 LHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPE 164
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
++ D F+ G + E+++G+ +R
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 75/207 (36%), Positives = 104/207 (50%), Gaps = 28/207 (13%)
Query: 481 LGEGGFG--------PVYKGTLVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNL 531
LGEG FG P GT G+ +AVK L + GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 532 VKLLGCCI-QADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
VK GCC Q + + LI EY+P SL ++ L+ + + I G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLH 124
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDE---IQTNTHKVVGTYGYMS 645
IHRDL A NVLLDND KI DFG+A+ + G E ++ + V Y +
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---A 178
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVS 672
E E FS SDV+SFGV + E+++
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 40/219 (18%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAV-KRLSKGSGQGMEEFK-----NEVTLIARLQHRNLV 532
+G+G FG V K +I V K + G+ M E + +EV ++ L+H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIV 62
Query: 533 KLLG---------------CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
+ C D + LI + + +++ + I
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK------------YIEEEFIWRI 110
Query: 578 VGGIARGILYLH--QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+ + + H D ++HRDLK +N+ LD + N K+ DFG+A+I G D T+
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
VGT YMSPE + KSD++S G L+ E+ +
Sbjct: 171 --VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVKL 534
+LG G G V K G+ +AVK + K E+ ++ + +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQ 590
G + + EYM SLD I + + + I+G IA +L YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPE-----RILGKIAVAVLKGLTYLH- 117
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ +IIHRD+K SN+L+++ K+ DFG++ +T VGT YM+PE
Sbjct: 118 -EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF----VGTSSYMAPERIQ 172
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+SVKSD++S G+ ++E+ +G RF +P +
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATG----RFPYPPEN 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 72/216 (33%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 480 KLGEGGFGPVYKGTLV-----EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLVK 533
+LGE FG +YKG L Q +A+K L + Q EF+ E +L+A L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIF--------------DQARATFLDWQKRIHIVG 579
LLG Q +++EY+ L F+ D + LD +HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD--EIQTNTHK 636
IA G+ YL S +H+DL A N+L+ ++ KISD G++R I+ D +Q +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +M PE G FS SD++SFGV++ EI S
Sbjct: 189 PI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 68/227 (29%), Positives = 113/227 (49%), Gaps = 30/227 (13%)
Query: 480 KLGEGGFGPVY-------------KGTLVEGQE--IAVKRL-SKGSGQGMEEFKNEVTLI 523
KLGEG FG V+ +GQ +AVK L + + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD-QARATF--------LDWQKR 574
+RL++ N+++LLG C+ D +I EYM N L+ F+ + +TF +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTN 633
+++ IA G+ YL + + +HRDL N L+ N KI+DFGM+R ++ GD +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680
V+ +M+ E G F+ SDV++FGV + E+ + K +S
Sbjct: 189 GRAVLPIR-WMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 481 LGEGGFGPVYKGT---LVEGQE---IAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVK 533
+G+G FG V++ L+ + +AVK L + + M+ +F+ E L+A H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-------------------LDWQKR 574
LLG C L++EYM L+ F+ ++ L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTN 633
+ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R I+ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + +M PE ++ +SDV+++GV++ EI S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 61/217 (28%), Positives = 111/217 (51%), Gaps = 10/217 (4%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
SI + Y K+G+G G V+ V GQE+A+K+++ E NE+ ++
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L++ N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH + ++IHRD+K+ NVLL D + K++DFG ++ + +T +VGT +M+
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
PE + K D++S G++ +E+V G+ + +P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 37/219 (16%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLS---------KGSGQGM-EEFKNEVTLIARLQHR 529
+G+G +G VY V G+ +AVK++ + M + ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARG 584
N+V+ LG + + EY+P S+ + F++ F Q + G
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEG 120
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR----IFGGDEIQTNTHKVVGT 640
+ YLH I+HRDLKA N+L+D D KISDFG+++ I+ D Q + + G+
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND--QNMSMQ--GS 173
Query: 641 YGYMSPE--YAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+M+PE ++ +S K D++S G +VLE+ +G++ W
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 481 LGEGGFGPVYKGTLVEGQ------EIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
LGEG FG V K T + +AVK L + + + + +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI---------------------FDQARATFLDWQ 572
L G C Q +LI EY SL F+ D L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
I I+RG+ YL + M+++HRDL A NVL+ KISDFG++R ++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K +M+ E + +++ +SDV+SFGVL+ EIV+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 481 LGEGGFGPVYKGTLVEGQ-EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G +G VY + Q IA+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ + E +P SL + + + Q I I G+ YLH + +I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHR 132
Query: 600 DLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL--FSV 656
D+K NVL++ KISDFG ++ G I T GT YM+PE +G +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 657 KSDVFSFGVLVLEIVSGK 674
+D++S G ++E+ +GK
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 36/236 (15%)
Query: 480 KLGEGGFGPVY-------KGTLVEGQEI----------AVKRLSKG-SGQGMEEFKNEVT 521
KLGEG FG V+ + + AVK L S E+F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--------FDQARATFLDWQK 573
+++RL N+ +LLG C +I EYM N L+ F+ + L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD--EI 630
+++ IA G+ YL + +HRDL N L+ + KI+DFGM+R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH-PDHD 685
Q +M+ E G F+ KSDV++FGV + EI++ + + H D
Sbjct: 189 QGR---APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 69/215 (32%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 481 LGEGGFGPVYKGTL-VEGQE---IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G FG V G L + G+ +A+K L G + + +F +E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVG---GIARGILYLHQD 591
G ++ M++ EYM N SLD F+ + T I +VG GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV------IQLVGMLRGIASGMKYL--- 122
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD-EIQTNTHKVVGTYGYMSPEYAA 650
S M +HRDL A N+L+++++ K+SDFG++R+ D E T + +PE A
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 651 EGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHPD 683
F+ SDV+S+G+++ E++S + W S+ D
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 18/209 (8%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRL---SKGSGQGMEEFKNEVTLIARLQHR 529
++ K+GEG +G VYKG GQ +A+K++ S+ G + E++L+ LQH
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59
Query: 530 NLVKLLGCCIQADESMLIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
N+V L +Q LI+E++ K LD Q ++D + + I +GIL
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQ----YMDAELVKSYLYQILQGIL 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
+ H R++HRDLK N+L+DN K++DFG+AR F G ++ TH+VV T Y +P
Sbjct: 116 FCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAP 170
Query: 647 E-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
E +S D++S G + E+ + K
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 7/193 (3%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G FG V+KGTL + +AVK + Q ++ +F +E ++ + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
Q ++ E +P DF F + + L ++ + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL A N L+ + KISDFGM+R ++ K + + +PE G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESD 176
Query: 660 VFSFGVLVLEIVS 672
V+S+G+L+ E S
Sbjct: 177 VWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
NK+G G FG VY L G+ +AVK R+ + ++E +E+ ++ L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI-VGGIARGILYLHQDSRM 594
G + ++ + EY +L + + + I + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMSPEYAAEG 652
I+HRD+K +N+ LD++ K+ DFG A + + GT YM+PE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 653 LFSVK---SDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
+D++S G +VLE+ +GK+ W S D++ ++ HV
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFHV 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 481 LGEGGFGPVYK------GTLVEGQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
LG G F Y+ GTL+ +++ R + + +E + E+ L+ARL H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI--VGGIARGILYLHQD 591
+LG + L E+M S+ + + +++ + I + RG+ YLH++
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 592 SRMRIIHRDLKASNVLLDND-MNPKISDFGMA-----RIFGGDEIQTNTHKVVGTYGYMS 645
+IIHRD+K +N+L+D+ +I+DFG A + G E Q +++GT +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
PE + DV+S G +++E+ + K W
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQ 527
NF K+G+G F VYK L++G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARGI 585
H N++K L I+ +E ++ E L I F + + + + V + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ-LCSAL 119
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
++H RI+HRD+K +NV + K+ D G+ R F T H +VGT YMS
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMS 174
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEI 670
PE E ++ KSD++S G L+ E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 70/216 (32%), Positives = 117/216 (54%), Gaps = 21/216 (9%)
Query: 481 LGEGGFGPVYKGTL-VEGQE---IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G FG V +G L + G+ +A+K L G + + +F +E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG---GIARGILYLHQDS 592
G ++ M+I E+M N +LD F+ Q F I +VG GIA G+ YL S
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL-RQNDGQF----TVIQLVGMLRGIAAGMKYL---S 123
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYG--YMSPEYA 649
M +HRDL A N+L+++++ K+SDFG++R D T T + G + +PE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 650 AEGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHPD 683
A F+ SDV+S+G+++ E++S + W S+ D
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 73/232 (31%), Positives = 112/232 (48%), Gaps = 37/232 (15%)
Query: 480 KLGEGGFGPVYKGTLVEGQE------------------IAVKRL-SKGSGQGMEEFKNEV 520
KLGEG FG V+ EG E +AVK L + +F E+
Sbjct: 12 KLGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--------FDQARATFLDWQ 572
+++RL+ N+++LL CI +D +I EYM N L+ F+ ++A + +
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD--E 629
I + IA G+ YL S + +HRDL N L+ + KI+DFGM+R ++ GD
Sbjct: 131 TLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187
Query: 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681
IQ + V +MS E G F+ SDV++FGV + EI++ K +S
Sbjct: 188 IQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
F ++G+G FG VYKG +E+ A+K + + +E+ + E+T++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 533 KLLGCCIQADESMLIYEYMPNKS-LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ G ++ + +I EY+ S LD T++ I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 120
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
R IHRD+KA+NVLL + K++DFG+A +I+ NT VGT +M+PE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ K+D++S G+ +E+ G+ HP
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 43/215 (20%)
Query: 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLS-KGSGQGMEEFK-NEVTLIARLQ---HRNLV 532
++GEG +G VYK L G+ +A+K++ S +G+ E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 533 KLLGCC--IQADESMLIYEYMPNKSLDFFIFDQARATFLD---------WQKRIHIVGGI 581
+LL C + D + + L F DQ AT+L + ++ +
Sbjct: 65 RLLDVCHGPRTDRELKLT-------LVFEHVDQDLATYLSKCPKPGLPPETIK-DLMRQL 116
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
RG+ +LH RI+HRDLK N+L+ +D KI+DFG+ARI+ + T+ VV T
Sbjct: 117 LRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS---VVVTL 170
Query: 642 GYMSPE------YAAEGLFSVKSDVFSFGVLVLEI 670
Y +PE YA V D++S G + E+
Sbjct: 171 WYRAPEVLLQSSYA----TPV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 28/210 (13%)
Query: 481 LGEGGFGPVYKG-TLVEGQEIAVKRLS-----KGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VY+G L +G AVK +S + + +++ + E+ L+++LQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 535 LGCCIQADESMLIY-EYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
LG + ++++ I+ E +P SL + F + Q I G+ YL
Sbjct: 68 LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ--------ILLGLEYL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H +HRD+K +N+L+D + K++DFGMA+ + G+ +M+PE
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEV 172
Query: 649 -AAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
A +G + + +D++S G VLE+ +GK W
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 61/193 (31%), Positives = 97/193 (50%), Gaps = 13/193 (6%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
+G+G FG V G G ++AVK + + + F E +++ +L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 541 ADESMLIY-EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ I EYM SL ++ + R + L + + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL A NVL+ D K+SDFG+ + E + + +PE E FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 660 VFSFGVLVLEIVS 672
V+SFG+L+ EI S
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 68/210 (32%), Positives = 111/210 (52%), Gaps = 25/210 (11%)
Query: 481 LGEGGFGPVYKGTLVEGQEI---AVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
LGEG FG V +G L + I AVK +++ + ME+F +E + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 536 GCCIQADES------MLIYEYMPNKSLDFFIF-----DQARATFLDWQKRIHIVGGIARG 584
G C+Q ES ++I +M + L F+ D +L Q + + IA G
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP--QYLPTQMLVKFMTDIASG 124
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEI-QTNTHKVVGTYG 642
+ YL S IHRDL A N +L+ +MN ++DFG++ +I+ GD Q K+
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVK 179
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+++ E A+ +++ KSDV+SFGV + EI +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRN 530
+ ++LGEG G V K L I A+K ++ ++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 531 LVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGIL 586
+VK G + S + EY SLD I+ + + RI ++G IA +L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKR----GGRIGEKVLGKIAESVL 115
Query: 587 ----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
YLH +IIHRD+K SN+LL K+ DFG++ G+ + + GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
YM+PE +S+ SDV+S G+ +LE+ RF P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQN----RFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 482 GEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVKL 534
G+G FG V V+ + A+K ++K +N E ++ L H LV L
Sbjct: 9 GKGAFGKVCI---VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
Q +E+M L+ + + L + + + F + Q + I I + YLH
Sbjct: 66 WYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYLHS--- 118
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
IIHRD+K N+LLD + I+DF +A D T T GT GYM+PE
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGYMAPEVLCRQG 175
Query: 654 FSVKSDVFSFGVLVLEIVSGKKNWRFS 680
+SV D +S GV E + GK+ +R
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGH 202
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 61/210 (29%), Positives = 110/210 (52%), Gaps = 11/210 (5%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
F ++G+G FG V+KG Q++ A+K + + +E+ + E+T++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
K G ++ + +I EY+ S D RA D + ++ I +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+ IHRD+KA+NVLL + K++DFG+A +I+ NT VGT +M+PE +
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ K+D++S G+ +E+ G+ HP
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 56/203 (27%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
++ K+GEG G V T G+++AVK++ Q E NEV ++ QH N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
++ + DE ++ E++ +L D T ++ ++ + + + + +LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ- 134
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGM-ARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
+IHRD+K+ ++LL +D K+SDFG A++ E+ +VGT +M+PE +
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEV-PRRKSLVGTPYWMAPEVISR 189
Query: 652 GLFSVKSDVFSFGVLVLEIVSGK 674
+ + D++S G++V+E+V G+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLS------KGSGQGMEEFKNEVTLIARLQHRNLV 532
LG+G +G VY G +GQ IAVK++ + + E+ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFI--FDQ-ARATFLDWQKRIHIVGGIARGILYLH 589
+ LG C+ + + E++P S+ + F F + K+I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDGVAYLH 119
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR---IFGGDEIQTNTHKVV-GTYGYMS 645
+ ++HRD+K +NV+L + K+ DFG AR G +N K + GT +M+
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
PE E + KSD++S G V E+ +GK
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 50/226 (22%)
Query: 481 LGEGGFGPVYKGTLV------EGQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHRNLV 532
LGEG FG V K V E +AVK L + + + + +E+ ++ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 533 KLLGCCIQADESMLIYEY----------------MPNKSLDFFIFDQARATFLD-----W 571
LLG C Q ++ EY S D + T D +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q +ARG+ +L + IHRDL A NVL+ D KI+DFG+AR +I
Sbjct: 140 Q--------VARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIH 183
Query: 632 TNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ T G +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 480 KLGEGGFGPVYKGTLVEGQE-----------------IAVKRL-SKGSGQGMEEFKNEVT 521
KLGEG FG V+ +V Q+ +AVK L + +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ----------------AR 565
+++RL+ N+++LLG C+ D +I EYM N L+ F+
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 566 ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-I 624
+ + +H+ IA G+ YL S + +HRDL N L+ ++ KI+DFGM+R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ GD + V+ +M+ E G F+ SDV++FGV + EI+
Sbjct: 189 YAGDYYRIQGRAVLPIR-WMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 67/204 (32%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 481 LGEGGFGPVYKGTLV--EGQEI--AVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLL 535
+G+G FG VY GTL+ +GQ+I AVK L++ + + +E+F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 536 GCCIQADES-MLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVG---GIARGILYLHQ 590
G C+ ++ S +++ YM + L FI + T D ++G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD------LIGFGLQVAKGMEYLAS 116
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVG-TYGYMSPEY 648
+ +HRDL A N +LD K++DFG+AR I+ + + H +M+ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVS 672
F+ KSDV+SFGVL+ E+++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGT---LVEGQ---EIAVKRL-SKGSGQGM 513
WEF +N + LG G FG V + T L + ++AVK L
Sbjct: 30 WEF-------PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER 82
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
E +E+ +++ L H N+V LLG C ++I EY L F+ + R +FL +
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLE 141
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+ +A+G+ +L + IHRDL A NVLL + KI DFG+AR D +
Sbjct: 142 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR----DIMND 194
Query: 633 NTHKVVGT----YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + V G +M+PE +++ +SDV+S+G+L+ EI S
Sbjct: 195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 481 LGEGGFGPVYKGTLVEG---QEIAVKRLSK-GSGQGMEEFKNEVTLIARL-QHRNLVKLL 535
+GEG FG V K + + + A+KR+ + S +F E+ ++ +L H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 536 GCCIQADESMLIYEYMPNKSL-DF------------FIFDQARATFLDWQKRIHIVGGIA 582
G C L EY P+ +L DF F + A+ L Q+ +H +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
RG+ YL Q + IHRDL A N+L+ + KI+DFG++R G E+ K +G
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK--KTMGRLP 186
Query: 643 --YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+ E +++ SDV+S+GVL+ EIVS
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-21
Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 13/193 (6%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+GEG FG V +G GQ++AVK + + F E ++ +L H+NLV+LLG I
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ E M +L F+ + RA + + + +A G+ YL +++HR
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL A N+L+ D K+SDFG+AR+ G + + V T +PE FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV-GSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 660 VFSFGVLVLEIVS 672
V+S+GVL+ E+ S
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+LG G FG V G ++A+K + +GS +EF E ++ +L H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ EYM N L ++ + + + + + + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT---YGYMSPEYAAEGLFSV 656
DL A N L+D+ K+SDFG++R DE ++ VG+ + PE FS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180
Query: 657 KSDVFSFGVLVLEIVS-GK 674
KSDV++FGVL+ E+ S GK
Sbjct: 181 KSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRNL 531
F +G+G FG VYK Q +A+K L + + +E+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
K G ++ + +I EY S D + LD I+ + G+ YLH++
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
IHRD+KA+N+LL + + K++DFG++ + NT VGT +M+PE +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172
Query: 652 GLFSVKSDVFSFGVLVLEIVSGK 674
+ K+D++S G+ +E+ G+
Sbjct: 173 SGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 10/209 (4%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY V GQE+A+K+++ E NE+ ++
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+H N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH + ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT +M+
Sbjct: 129 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + K D++S G++ +E+V G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+LG G FG V+ G ++A+K +++G+ E+F E ++ +L H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
Q ++ E+M N L ++ + R L + + + G+ YL ++S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL A N L+ + K+SDFGM R DE T++ + PE +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 660 VFSFGVLVLEIVSGKK 675
V+SFGVL+ E+ + K
Sbjct: 184 VWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
+G G FG V+ LV ++I V++++K + NE ++ L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
++ M++ EY P +L +I + + LD +H I + ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 595 RIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
I+HRDLK N+LLD + M KI DFG+++I ++ + VVGT Y+SPE
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKP 177
Query: 654 FSVKSDVFSFGVLVLEIVSGKK 675
++ KSD+++ G ++ E+ S K+
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 61/220 (27%), Positives = 112/220 (50%), Gaps = 21/220 (9%)
Query: 468 IAKATDNFASYNKLGEGGFGPVYKGTLVEG-----QEIAVKRLSKGSGQ-GMEEFKNEVT 521
IA + D + L EG FG ++ G L++ +E+ VK + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 522 LIARLQHRNLVKLLGCCIQ-ADESMLIYEYMPNKSLDFF-----IFDQARATFLDWQKRI 575
L+ L H+N++ +L CI+ + ++Y YM +L F + + L Q+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDE--IQT 632
H+ IA G+ YLH + +IH+D+ A N ++D ++ KI+D ++R +F D +
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
N ++ V +M+ E +S SDV+SFGVL+ E+++
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 57/209 (27%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 481 LGEGGFGP--VYK----GTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG +Y+ +LV +E+ + RLS+ + + NE+ +++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64
Query: 535 LGCCIQADESMLI-YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
+ D ++LI EY +L + + + + + + + I + Y+H+
Sbjct: 65 YNHFMD-DNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
I+HRD+K N+ L K+ DFG+++I G + T VVGT YMSPE
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVK 177
Query: 654 FSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
++ KSD+++ G ++ E+++ K+ + ++P
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 57/217 (26%), Positives = 110/217 (50%), Gaps = 10/217 (4%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY + GQE+A+K+++ E NE+ ++
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
++ N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH + ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT +M+
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
PE + K D++S G++ +E+V G+ + +P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 68/214 (31%), Positives = 111/214 (51%), Gaps = 31/214 (14%)
Query: 480 KLGEGGFGPVY----KGTLVEGQE--IAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG+G FG VY KG + + E +A+K +++ S + EF NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFD----------QARATFLDWQKRIHIVGGIA 582
+LLG Q +++I E M L ++ QA + +K I + G IA
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL---KKMIQMAGEIA 129
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT-- 640
G+ YL+ + + +HRDL A N ++ D KI DFGM R D +T+ ++ G
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 182
Query: 641 --YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+MSPE +G+F+ SDV+SFGV++ EI +
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + +++ KR+ K G+ M NE ++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R +V L D L+ M L F I+ A F + + + I G+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE 647
HQ+ RI++RDLK N+LLD+ + +ISD G+A + G I+ VGT GYM+PE
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPE 171
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ D ++ G L+ E+++G+
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 474 NFASYNKLGEGGFGPVYK-GTLVEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRN 530
+F KLG+G +G VYK L + Q A+K L S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 531 LVK-----LLGC--CIQADESMLIYEYMPNKSLDFFIFDQARA-----TFLDWQKRIHIV 578
++ L G CI + EY P L I + + W+ I ++
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
RG+ LH+ +I+HRDLK++N+LL + KI D G++++ + +T +
Sbjct: 114 ----RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT----QI 162
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT YM+PE +S KSD++S G L+ E+ +
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 7e-20
Identities = 55/217 (25%), Positives = 108/217 (49%), Gaps = 10/217 (4%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY + GQE+A+++++ E NE+ ++
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
++ N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH + ++IHRD+K+ N+LL D + K++DFG + Q+ +VGT +M+
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMA 184
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
PE + K D++S G++ +E++ G+ + +P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 37/214 (17%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-----EVTLIARLQHRNLV 532
KLGEG + VYK E G+ +A+K++ G + ++ N E+ L+ L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 533 KLLGCCIQADESMLIYEYMP--------NKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
LL L++E+M +KS+ + A RG
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLM--------TLRG 114
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG--GDEIQTNTHKVVGTYG 642
+ YLH + I+HRDLK +N+L+ +D K++DFG+AR FG ++ TH+VV T
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV-TRW 167
Query: 643 YMSPE--YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y +PE + A + V D++S G + E++
Sbjct: 168 YRAPELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 11/210 (5%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
F K+G+G FG V+KG Q++ A+K + + +E+ + E+T++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
K G ++ + +I EY+ S D LD + I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+ IHRD+KA+NVLL K++DFG+A +I+ N VGT +M+PE +
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQS 176
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ K+D++S G+ +E+ G+ HP
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-20
Identities = 67/215 (31%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 468 IAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEI----AVKRLSKG-SGQGMEEFKNEVT 521
I K T+ F LG G FG VYKG + EG+++ A+K L + S + +E +E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DFFIFDQARAT---FLDWQKRIHI 577
++A + + ++ +LLG C+ + LI + MP L D+ + L+W +I
Sbjct: 62 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
A+G+ YL + R++HRDL A NVL+ + KI+DFG+A++ G DE + +
Sbjct: 119 ----AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+ E +++ +SDV+S+GV V E+++
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 9e-20
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + + + KR+ K G+ M NE ++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
+ +V L D L+ M L F I++ F + ++ + I G+ L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-EEERALFYAAEILCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE 647
H+++ ++RDLK N+LLD+ + +ISD G+A +I G+ I+ VGT GYM+PE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPE 171
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
+++ D + G L+ E++ G+ +R
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-20
Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRN 530
NF K+GEG +G VYK + G+ +A+K RL + E++L+ L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 531 LVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
+VKLL I + + L++E++ ++ L F+ D + + + + + +G+ + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-Y 648
R++HRDLK N+L++ + K++DFG+AR F G ++T TH+VV T Y +PE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
+S D++S G + E+V+ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 13/206 (6%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFK-NEVTLIARLQHRNL 531
NF KLGEG + VYKG G+ +A+K + + +G E++L+ L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V+L ++ ML++EYM +K L ++ LD + +GI + H++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT--HKVVGTYGYMSPE-Y 648
R++HRDLK N+L++ K++DFG+AR FG I NT ++VV T Y +P+
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVL 172
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
+S D++S G ++ E+++G+
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHRN 530
K+GEG +G VYK + G+ +A+K++ +E E++L+ L H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKELNHPN 59
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIF-DQARATFLDWQKRIHIVGGIARGILYLH 589
+V+LL ++ L++E++ LD + D + T LD + + +GI Y H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
R++HRDLK N+L+D + K++DFG+AR F G ++T TH+VV T Y +PE
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 171
Query: 650 AEG-LFSVKSDVFSFGVLVLEIVSGK 674
+S D++S G + E+V+ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 60/212 (28%), Positives = 109/212 (51%), Gaps = 29/212 (13%)
Query: 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQH---R 529
+ +G G +G VY+G V G+ +A+K ++ + + + + EV L+++L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL--- 586
N+ K G ++ +I EY S+ + +A + +K I + I R +L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIA-EKYISV---IIREVLVAL 114
Query: 587 -YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK---VVGTYG 642
Y+H+ +IHRD+KA+N+L+ N N K+ DFG+A + N+ K VGT
Sbjct: 115 KYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGTPY 166
Query: 643 YMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSG 673
+M+PE EG + K+D++S G+ + E+ +G
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 56/176 (31%), Positives = 91/176 (51%), Gaps = 20/176 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRNLVKLL- 535
++GEG G V+K E G+ +A+K+ L + G + E+ + QH +VKLL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 536 ----GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
G +L+ EYMP+ L + D+ R K + + +G+ Y+H +
Sbjct: 67 VFPHGSGF-----VLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHAN 118
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
I+HRDLK +N+L+ D KI+DFG+AR+F +E + +H+ V T Y +PE
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 70/214 (32%), Positives = 110/214 (51%), Gaps = 26/214 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS-KGSGQGMEEFK-NEVTLIARLQHR 529
D + K+GEG +G VYK V + IA+K++ + +G+ E++L+ +QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 530 NLVKLLGCCIQADESMLIYEYMP-------NKSLDFFIFDQARATFLDWQKRIHIVGGIA 582
N+V+L L++EY+ + S DF + T+L +Q I
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL-YQ--------IL 112
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVVGTY 641
RGI Y H R++HRDLK N+L+D N K++DFG+AR F G ++T TH+VV T
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TL 167
Query: 642 GYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y +PE +S D++S G + E+V+ K
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + +++ KR+ K G+ M NE ++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R +V L D L+ M L F I++ F D ++ + I G+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF-DEERAVFYAAEITCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE 647
H R RI++RDLK N+LLD+ + +ISD G+A I G+ I+ VGT GYM+PE
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPE 171
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
++ D + G L+ E++ GK +R
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 69/214 (32%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+GGFG V G L +++ KRL K +G E E ++A++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFFI---------FDQARATFLDWQKRIHIVGGIARG 584
Q + L+ M L + I F + RA F Q I G
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ--------IISG 109
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LHQ RII+RDLK NVLLDND N +ISD G+A + Q+ T GT G+M
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFM 164
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
+PE + D F+ GV + E+++ + +R
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G FG VYK E G A K + S + +E+F E+ +++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
++ ++ E+ +LD I + + Q R + + + +LH ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH---SHKVIHR 127
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS---- 655
DLKA N+LL D + K++DFG++ +Q +GT +M+PE A F
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKR-DTFIGTPYWMAPEVVACETFKDNPY 185
Query: 656 -VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
K+D++S G+ ++E+ + P H+ N
Sbjct: 186 DYKADIWSLGITLIELAQMEP------PHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-19
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F ++G G FG VY V E+ A+K++S Q E++++ EV + R++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
++ GC ++ + L+ EY + D + L + I G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY-- 648
+ +IHRD+KA N+LL K++DFG A I + + VGT +M+PE
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 649 -AAEGLFSVKSDVFSFGVLVLEIVSGK 674
EG + K DV+S G+ +E+ K
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-IAVKR--LSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G VY + E +A+KR L K ++E + EV +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ DE L+ Y+ SL + LD ++ + +G+ YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGM-ARIF-GGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
IHRD+KA N+LL D + KI+DFG+ A + GGD + VGT +M+PE +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 654 -FSVKSDVFSFGVLVLEIVSGK 674
+ K+D++SFG+ +E+ +G
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 474 NFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHR 529
NF K+G G F VY+ T L++ + +A+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLD---WQKRIHIVGGIARG 584
N++K L I+ +E ++ E L I F + + + W+ + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
H SR R++HRD+K +NV + K+ D G+ R F T H +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYM 173
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
SPE E ++ KSD++S G L+ E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F+ ++G G FG VY V E+ A+K++S Q E++++ EV + +L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
++ GC ++ + L+ EY + D + L + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY-- 648
+ +IHRD+KA N+LL K+ DFG A I + VGT +M+PE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 649 -AAEGLFSVKSDVFSFGVLVLEIVSGK 674
EG + K DV+S G+ +E+ K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 481 LGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+GGFG V G + +++ KRL K SG+ M + E+ + ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
L+ M L + I++ L+ ++ IH I GIL+LH M
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS---M 114
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
I++RD+K NVLLD+ N ++SD G+A + G +T T + GT GYM+PE E
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR-AGTNGYMAPEILKEEP 170
Query: 654 FSVKSDVFSFGVLVLEIVSGKKNWR 678
+S D F+ G + E+V+G+ ++
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + +++ KR+ K G+ M NE ++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R +V L D L+ M L F I++ F D Q+ I + G+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYAAELCCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE 647
R RI++RDLK N+LLD+ + +ISD G+A +I G+ ++ VGT GYM+PE
Sbjct: 119 Q---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPE 171
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
++ D + G L+ E++ G+ +R
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 69/212 (32%), Positives = 109/212 (51%), Gaps = 28/212 (13%)
Query: 481 LGEGGFGPVYKGTLV-EGQEI--AVKRLSK-GSGQGMEEFKNEVTLIARL-QHRNLVKLL 535
+GEG FG V + + +G ++ A+K L + S +F E+ ++ +L H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 536 GCCIQADESMLIYEYMPNKSL-DF------------FIFDQARATFLDWQKRIHIVGGIA 582
G C + EY P +L DF F + A+ L Q+ + +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
G+ YL S + IHRDL A NVL+ ++ KI+DFG++R G+E+ K +G
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVK--KTMGRLP 181
Query: 643 --YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+ E +++ KSDV+SFGVL+ EIVS
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F +++G G FG VY T E+ AVK++S Q E++++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
++ GC ++ + L+ EY + D + L + I G +G+ YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY-- 648
+ +IHRD+KA N+LL K++DFG A + + VGT +M+PE
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVIL 190
Query: 649 -AAEGLFSVKSDVFSFGVLVLEIVSGK 674
EG + K DV+S G+ +E+ K
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 67/208 (32%), Positives = 111/208 (53%), Gaps = 19/208 (9%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-----SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG VY V+ G+E+A K++ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 535 LGCCI-QADESMLIY-EYMPNKSLDFFIFDQARA--TFLDWQKRIHIVGGIARGILYLHQ 590
GC +A++++ I+ EYMP S+ DQ +A + R + I G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKY-TRQILEGMSYLHS 124
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYGYMSPEYA 649
+ I+HRD+K +N+L D+ N K+ DFG ++ + T V GT +MSPE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ + K+DV+S G V+E+++ K W
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 63/215 (29%), Positives = 113/215 (52%), Gaps = 33/215 (15%)
Query: 480 KLGEGGFGPVYKGT---LVEGQ---EIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG+G FG VY+G +++G+ +AVK +++ S + EF NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD-----------WQKRIHIVGGI 581
+LLG + ++++ E M + L ++ R+ + Q+ I + I
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT- 640
A G+ YL+ + +HRDL A N ++ +D KI DFGM R D +T+ ++ G
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKG 181
Query: 641 ---YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE +G+F+ SD++SFGV++ EI S
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 474 NFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHR 529
NF K+G G F VY+ T L++G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLD---WQKRIHIVGGIARG 584
N++K I+ +E ++ E L I F + + + W+ + + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
H SR R++HRD+K +NV + K+ D G+ R F T H +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYM 173
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
SPE E ++ KSD++S G L+ E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
S+ K+GEG G V T G+++AVK++ Q E NEV ++ H N+V
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
+ + DE ++ E++ +L D T ++ ++ + + R + YLH
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG- 138
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
+IHRD+K+ ++LL +D K+SDFG + + + +VGT +M+PE +
Sbjct: 139 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLP 194
Query: 654 FSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ + D++S G++V+E++ G+ + F+ P
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPPY-FNEP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 64/198 (32%), Positives = 105/198 (53%), Gaps = 12/198 (6%)
Query: 481 LGEGGFGPVYKGTLV-EGQEI----AVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG V+KG + EG I A+K + SG Q +E + + + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
LG C A L+ + P SL + + LD Q+ ++ IA+G+ YL +
Sbjct: 75 LGICPGA-SLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
R++HR+L A N+LL +D +I+DFG+A + D+ + + +M+ E G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 655 SVKSDVFSFGVLVLEIVS 672
+ +SDV+S+GV V E++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 10/199 (5%)
Query: 477 SYNKLGEGGFGPV-YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
+Y K+GEG G V G+++AVK + Q E NEV ++ QH+N+V++
Sbjct: 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ +E ++ E++ +L I Q R L+ ++ + + + + YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTR---LNEEQIATVCESVLQALCYLHSQG--- 137
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
+IHRD+K+ ++LL D K+SDFG D + + +VGT +M+PE + +
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYG 195
Query: 656 VKSDVFSFGVLVLEIVSGK 674
+ D++S G++V+E+V G+
Sbjct: 196 TEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 27/212 (12%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-----SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VY + G+E+AVK++ S+ + + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 535 LGCCIQADESML--IYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQD 591
GC +E L EYMP S I DQ +A L I +G+ YLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ------TNTHKVVGTYGYMS 645
I+HRD+K +N+L D+ N K+ DFG ++ IQ T V GT +MS
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK-----RIQTICMSGTGIKSVTGTPYWMS 177
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
PE + + K+DV+S V+E+++ K W
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 480 KLGEGGFGPVY---KGTLVEGQEIAV-KRLSKGSGQGMEEFKN--EVTLIARLQHRNLVK 533
+LG+G FG VY V + + V K + G E + E L+++L H +VK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARGILYLHQD 591
++ D +I EY + LD + T + Q + G+ Y+HQ
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV-CEWFIQLLLGVHYMHQ- 124
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG--DEIQTNTHKVVGTYGYMSPEYA 649
RI+HRDLKA N+ L N++ KI DFG++R+ G D T T GT YMSPE
Sbjct: 125 --RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT----GTPYYMSPEAL 177
Query: 650 AEGLFSVKSDVFSFGVLVLEI 670
+ KSD++S G ++ E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 28/222 (12%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHR 529
T F +GEG +G VYK + ++ ++ EE K E ++ + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63
Query: 530 NLVKLLGCCIQ------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------HI 577
N+ G I+ D+ L+ E S + D + KR+ +I
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKGL-RKKGKRLKEEWIAYI 118
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ RG+ YLH++ ++IHRD+K N+LL + K+ DFG++ + NT
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--F 173
Query: 638 VGTYGYMSPE-----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+GT +M+PE + + +SDV+S G+ +E+ GK
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 61/212 (28%), Positives = 111/212 (52%), Gaps = 16/212 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
DNF K+GEG G V T+ G+ +AVK++ Q E NEV ++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V++ + DE ++ E++ +L D T ++ ++ + + + + LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGM-ARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+IHRD+K+ ++LL +D K+SDFG A++ E+ +VGT +M+PE +
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRK-SLVGTPYWMAPELIS 189
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ + D++S G++V+E+V G+ + F+ P
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPY-FNEP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLV 532
LG+G FG V KGT + AVK L K +E E ++A +H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGIL 586
+L C Q + + + EY+ L F I FD+ RA F I G+
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY--------AAEIVLGLQ 110
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYM 644
+LH+ II+RDLK NVLLD++ + KI+DFGM + I GG T+T GT Y+
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTST--FCGTPDYI 163
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+PE + + D ++ GVL+ E+++G+
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F ++G G FG VY V E+ A+K++S Q E++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR-------IHIVGGIAR 583
++ GC ++ + L+ EY + D L+ K+ I G +
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDI----------LEVHKKPLQEVEIAAICHGALQ 126
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
G+ YLH R IHRD+KA N+LL K++DFG A + + + VGT +
Sbjct: 127 GLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYW 177
Query: 644 MSPEY---AAEGLFSVKSDVFSFGVLVLEIVSGK 674
M+PE EG + K DV+S G+ +E+ K
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-----SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG VY + G+E+AVK++ S + + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 535 LGCCIQADESML--IYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQD 591
GC E L E+MP S I DQ ++ L I G+ YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYGYMSPEYAA 650
I+HRD+K +N+L D+ N K+ DFG ++ + T V GT +MSPE +
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ K+D++S G V+E+++ K W
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 45/116 (38%), Positives = 70/116 (60%), Gaps = 10/116 (8%)
Query: 574 RIHIVGGIA----RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ I+G IA G+ YL+ + RI+HRD+K SN+L+++ K+ DFG++ G+
Sbjct: 101 PVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GEL 154
Query: 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
I + VGT YMSPE G ++VKSDV+S G+ ++E+ GK + FS+ D D
Sbjct: 155 INSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 6e-18
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCI 539
+G G +G VYKG V+ ++A ++ +G EE K E+ ++ + HRN+ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 540 QA------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
+ D+ L+ E+ S+ I + L + +I I RG+ +LHQ
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA--- 650
++IHRD+K NVLL + K+ DFG++ D + +GT +M+PE A
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 651 --EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ + KSD++S G+ +E+ G HP
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG V + L Q++AVK L S +EEF E + H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 535 LGCCIQADES------MLIYEYMPNKSLDFFIFDQ---ARATFLDWQKRIHIVGGIARGI 585
+G +++ M+I +M + L F+ L Q + + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEI-QTNTHKVVGTYGY 643
YL S IHRDL A N +L+ +M ++DFG+++ I+ GD Q K+ +
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVKW 181
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
++ E A+ +++ SDV++FGV + EI++
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 68/246 (27%), Positives = 119/246 (48%), Gaps = 40/246 (16%)
Query: 453 HMKEDM---ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG 508
H++ D+ E+WE +LG+G FG VYK E G A K +
Sbjct: 3 HVRRDLDPNEVWEI--------------IGELGDGAFGKVYKAKNKETGALAAAKVIETK 48
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF 568
S + +E++ E+ ++A H +VKLLG + ++ E+ P ++D + + R
Sbjct: 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-L 107
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
+ Q ++ I + + YLH M+IIHRDLKA NVLL D + K++DFG++
Sbjct: 108 TEPQIQV-ICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS----AK 159
Query: 629 EIQTNTHK--VVGTYGYMSPEYA-----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681
++T + +GT +M+PE + + K+D++S G+ ++E+ +
Sbjct: 160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA------QIEP 213
Query: 682 PDHDHN 687
P H+ N
Sbjct: 214 PHHELN 219
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 71/236 (30%), Positives = 111/236 (47%), Gaps = 33/236 (13%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYK----GTLVEGQE----IAVKRLS-KGSG 510
WEF D LGEG FG V + G + +AVK L +
Sbjct: 6 KWEF-------PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD 58
Query: 511 QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--------- 560
+ + + +E+ L+ + +H+N++ LLG C Q +I EY +L F+
Sbjct: 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 561 --FDQARAT--FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616
FD + L ++ + +ARG+ YL +SR R IHRDL A NVL+ D KI
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKI 175
Query: 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+DFG+AR + T +M+PE + +++ +SDV+SFG+L+ EI +
Sbjct: 176 ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 481 LGEGGFGPVYKGTLVEG---QEIAVKRLSK-GSGQGMEEFKNEVTLIARL-QHRNLVKLL 535
+GEG FG V K + + + A+KR+ + S +F E+ ++ +L H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 536 GCCIQADESMLIYEYMPNKSL-DF------------FIFDQARATFLDWQKRIHIVGGIA 582
G C L EY P+ +L DF F + A+ L Q+ +H +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
RG+ YL S+ + IHRDL A N+L+ + KI+DFG++R G E+
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+ E +++ SDV+S+GVL+ EIVS
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 480 KLGEGGFGPVYKG---TLVEGQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRNLVKL 534
+LG G FG V KG + +AVK L + +E E ++ +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+G C +A+ ML+ E L+ F+ T + + +H V + G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN-- 115
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL- 653
+HRDL A NVLL KISDFG+++ G DE N +K + YA E +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMN 171
Query: 654 ---FSVKSDVFSFGVLVLEIVS-GKKNWR 678
FS KSDV+SFGVL+ E S G+K ++
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVKLLGC 537
++G G FG V+ G L + +AVK + ++ +F E ++ + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
C Q ++ E + + DF F + L ++ I +V A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 598 HRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG-----TYGYMSPEYAAEG 652
HRDL A N L+ KISDFGM+R E + + G + +PE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 653 LFSVKSDVFSFGVLVLEIVS 672
+S +SDV+SFG+L+ E S
Sbjct: 172 RYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 48/224 (21%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIA 524
F N++GEG +G VY+ G+ +A+K++ M+ ++ E+TL+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR------MDNERDGIPISSLREITLLL 61
Query: 525 RLQHRNLVKLLGCCI--QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR---IHIVG 579
L+H N+V+L + D L+ EY +Q A+ LD V
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYC----------EQDLASLLDNMPTPFSESQVK 111
Query: 580 GIA----RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+ RG+ YLH++ IIHRDLK SN+LL + KI+DFG+AR + G + T
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTP 167
Query: 636 KVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
KVV T Y +PE L + D+++ G ++ E+++ K
Sbjct: 168 KVV-TLWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 63/202 (31%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 481 LGEGGFGPVYKGTLVEGQE-----IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VYKG + E +A+K L + S + +E +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSL-DFFIFDQAR---ATFLDWQKRIHIVGGIARGILYLHQ 590
LG C+ + L+ + MP L D+ ++ R L+W +I A+G+ YL +
Sbjct: 75 LGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+R++HRDL A NVL+ + + KI+DFG+AR+ DE + + +M+ E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 651 EGLFSVKSDVFSFGVLVLEIVS 672
F+ +SDV+S+GV V E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 480 KLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN--EVTLIARLQ-HRNLVKLL 535
+LG+G FG VY E E+ A+K++ K EE N EV + +L H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ DE ++EYM +L + D+ F + R I+ I +G+ ++H+
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIHKHGFF- 121
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-----TNTHKVVGTYGYMSPE-YA 649
HRDLK N+L+ KI+DFG+AR EI+ T+ V T Y +PE
Sbjct: 122 --HRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD---YVSTRWYRAPEILL 171
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGK 674
+S D+++ G ++ E+ + +
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 67/216 (31%), Positives = 99/216 (45%), Gaps = 45/216 (20%)
Query: 479 NKLGEGGFGPVYK----GTLVEGQEIAVKRLSKGSGQGMEEFKN----EVTLIARLQHRN 530
N++G G G VYK T G+ A+K + G + + E+ ++ + H N
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPN 133
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLD-------FFIFDQARATFLDWQKRIHIVGGIAR 583
+VK E ++ E+M SL+ F+ D AR I+ GIA
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----------QILSGIA- 182
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
YLH R I+HRD+K SN+L+++ N KI+DFG++RI N+ VGT Y
Sbjct: 183 ---YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAY 234
Query: 644 MSPEYAAEGLFSVK-----SDVFSFGVLVLEIVSGK 674
MSPE L D++S GV +LE G+
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
LGEG FG V +G G+++AVK L SG + + K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 534 LLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
G C + + LI E++P+ SL ++ L Q + + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--G 126
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD-EIQTNTHKVVGTYGYMSPEYAA 650
SR + +HRDL A NVL++++ KI DFG+ + D E T + + +PE
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 651 EGLFSVKSDVFSFGVLVLEIVS 672
+ F + SDV+SFGV + E+++
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 54/202 (26%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHRN 530
KLGEG FG VYK + G+ +A+K++ M K+ E+ ++ +L+H N
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKIL------MHNEKDGFPITALREIKILKKLKHPN 68
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLD-------FFIFDQARATFLDWQKRIH------- 576
+V L+ + E D + L+ +
Sbjct: 69 VVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIK 118
Query: 577 -IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+ + GI YLH++ I+HRD+KA+N+L+DN KI+DFG+AR + G
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP-PPNPKG 174
Query: 636 K----------VVGTYGYMSPE 647
+V T Y PE
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 18/220 (8%)
Query: 474 NFASYNKLGEGGFGPVY--KGTLVEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHR 529
+ K+GEG FG +Y K + + +K L+K + E K EV L+A+++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+V + ++ EY L I Q F + Q V I+ G+ ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV-QISLGLKHIH 118
Query: 590 QDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
+I+HRD+K+ N+ L N M K+ DFG+AR ++ + VGT Y+SPE
Sbjct: 119 D---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPEI 173
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
++ K+D++S G ++ E+ + K HP +NL
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLK------HPFEGNNL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 26/214 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRL---SKGSGQGMEEFKNEVTLIARLQH 528
D + N++ EG +G VY+ + EI A+K+L + G + + E+ ++ +LQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 529 RNLVKL----LGCCIQADESMLIYEYMPN--KSLDFFIFDQARATFLDWQKRIH-IVGGI 581
N+V + +G + D+ ++ EY+ + KSL + + FL Q + ++ +
Sbjct: 64 PNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSL----METMKQPFL--QSEVKCLMLQL 115
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
G+ +LH + I+HRDLK SN+LL+N KI DFG+AR + G ++ T VV T
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TL 170
Query: 642 GYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y +PE +S D++S G + E+++ K
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-17
Identities = 71/209 (33%), Positives = 102/209 (48%), Gaps = 35/209 (16%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTL-------IARLQHRNLV 532
LG+G FG V L E G+ AVK L K +++ E T+ +AR H L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLAR-NHPFLT 59
Query: 533 KLLGCCIQA-DESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGIL 586
+L CC Q D + E++ L F I FD+ARA F + I ++
Sbjct: 60 QLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALM 110
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYM 644
+LH II+RDLK NVLLD++ + K++DFGM + IF G T GT Y+
Sbjct: 111 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYI 163
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+PE E L+ D ++ GVL+ E++ G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 73/232 (31%), Positives = 109/232 (46%), Gaps = 38/232 (16%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR------LQHRN 530
LG+G FG V KGT + A+K L K +E+ E T++ R +H
Sbjct: 3 LGKGSFGKVMLAELKGT---NEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPF 57
Query: 531 LVKLLGCCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARG 584
L L C Q E + + EY+ L F I FD+ARA F + I G
Sbjct: 58 LTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE--------IICG 108
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LH+ II+RDLK NVLLD D + KI+DFGM + E + +T GT Y+
Sbjct: 109 LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYI 163
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHVRVEN 696
+PE ++ D +SFGVL+ E++ G+ + H + + L + +
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSPF---HGEDEDELFDSILNDR 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 33/235 (14%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLS-KGSGQ 511
WEF + D LGEG FG V + E +AVK L + +
Sbjct: 10 WEF-------SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK 62
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI---------- 560
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122
Query: 561 -FDQARAT--FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+D AR + ++ + +ARG+ YL + + IHRDL A NVL+ + KI+
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 179
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
DFG+AR + T +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
++G G +G VYK + E+ A+K + G E + E++++ +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
++ D+ ++ EY SL I+ R L + ++ +G+ YLH+ I
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD-IYQVTRGP-LSELQIAYVCRETLKGLAYLHE---TGKI 123
Query: 598 HRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE---GLF 654
HRD+K +N+LL D + K++DFG++ + + +GT +M+PE AA G +
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGY 181
Query: 655 SVKSDVFSFGVLVLEIVSGK 674
K D+++ G+ +E+ +
Sbjct: 182 DGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 29/232 (12%)
Query: 474 NFASYNKLGEGGFGPVYK-------GTLVEGQEIAVKRLSKGSG-----QGMEEFKNEVT 521
+A LG G FG VYK L+ +EI V + G + + + +EVT
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 522 LI-ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DFFI-FDQARATFLDWQKRI-HI 577
+I +L+H N+V+ ++ D ++ + + L + F + + F ++RI +I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT--EERIWNI 118
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ + YLH++ R I+HRDL +N++L D I+DFG+A+ + T+ V
Sbjct: 119 FVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS---V 173
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
VGT Y PE + K+DV++FG ++ ++ + P + N+L
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNML 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 480 KLGEGGFGPVYKGTLV--EGQEI--AVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKL 534
+GEG FG VY+G + E ++I AVK + + E+F E ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+G + + ++ E P L ++ Q LD I ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
R +HRD+ A NVL+ + K+ DFG++R + + K +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRF 185
Query: 655 SVKSDVFSFGVLVLEIVS-GKKNW 677
+ SDV+ FGV + EI+ G K +
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEI--AVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKLL 535
+LG G FG V KG + ++I A+K L + + + +E E ++ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G C +A+ ML+ E L+ F+ + + + ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY--GYMSPEYAAEGL 653
+HRDL A NVLL N KISDFG+++ G D+ + G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174
Query: 654 FSVKSDVFSFGVLVLEIVS-GKKNWR 678
FS +SDV+S+G+ + E S G+K ++
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 481 LGEGGFGPVYKGTLV--------EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARL-QHRN 530
LGEG FG V + + +AVK L + + + + +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI-----------FDQAR--ATFLDWQKRIHI 577
++ LLG C Q ++ EY +L ++ FD + L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ARG+ YL + + IHRDL A NVL+ D KI+DFG+AR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 64/236 (27%), Positives = 108/236 (45%), Gaps = 20/236 (8%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE 519
L + D +++ F +G G +G VYKG V+ ++A ++ + EE K E
Sbjct: 3 LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE 62
Query: 520 VTLIARL-QHRNLVKLLGCCI------QADESMLIYEYMPNKSL-DFFIFDQARATFLDW 571
+ ++ + HRN+ G I D+ L+ E+ S+ D + A DW
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
+I I RG+ +LH ++IHRD+K NVLL + K+ DFG++ +
Sbjct: 123 IA--YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177
Query: 632 TNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
NT +GT +M+PE A + + +SD++S G+ +E+ G HP
Sbjct: 178 RNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAV-KRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
+LG+G FG VYK E +A K + S + +E++ E+ ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ ++ E+ ++D + + R + Q R+ + + YLH++ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV------VGTYGYMSPEY---- 648
RDLKA N+L D + K++DFG++ NT + +GT +M+PE
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 649 -AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
+ + + K+DV+S G+ ++E+ + P H+ N
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMA------QIEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 1e-15
Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 63/227 (27%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRN 530
+G G +G V G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 531 LVKLLGCCIQADESM-------LIYEYMP---------NKSLDFFIFDQARATFLDWQKR 574
++ LL I S ++ E M + L D FL +Q
Sbjct: 61 IIGLLD--ILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT----DDHIQYFL-YQ-- 111
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN- 633
I RG+ YLH +IHRDLK SN+L++++ + KI DFG+AR DE +
Sbjct: 112 ------ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 634 -THKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
T VV T Y +PE L S D++S G + E+++ K
Sbjct: 163 LTEYVV-TRWYRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 481 LGEGGFGPVYKG--TLVEGQE--IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
LG G FG + +G L +E +A+ L G S + F E + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G + + M++ EYM N +LD F+ + L + + ++ G+A G+ YL S M
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG------YMSPEYA 649
+H+ L A VL+++D+ KIS F + D+ + + T + +PE
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEA----IYTTMSGKSPVLWAAPEAI 180
Query: 650 AEGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHPD 683
FS SDV+SFG+++ E++S + W S D
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 481 LGEGGFGPVYKGTLV--------EGQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHRN 530
LGEG FG V + ++AVK L S + + + + +E+ ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIF-------------DQARATFLDWQKRIHI 577
++ LLG C Q +I EY +L ++ Q L ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ARG+ YL + + IHRDL A NVL+ D KI+DFG+AR + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 484 GGFGPVYKGTLVE----GQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQHRNLVKLLG 536
G +G V+ L + G A+K + K +++ E ++++ Q +VKL
Sbjct: 4 GAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 537 CCIQADESM-LIYEYMPN---KSL--DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
Q +++ L+ EY+P SL + D+ A + I + YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLHS 111
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFG------MARIFGGDEIQTNTHKVVGTYGYM 644
+ IIHRDLK N+L+D++ + K++DFG + R ++ + ++VGT Y+
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+PE S D +S G ++ E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 480 KLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFK---NEVTLIARLQHRNLVKLL 535
++G+GG+G V+ + EI A+KR+ K + E + E ++ + LVKLL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 536 GCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
Q DE + L EY+P DF + R ++ + LH +
Sbjct: 68 -YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH---EL 120
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
IHRDLK N L+D + K++DFG+++ I T + VVG+ YM+PE +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGY 175
Query: 655 SVKSDVFSFGVLVLEIVSG 673
D +S G ++ E + G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 47/221 (21%)
Query: 473 DNFASYNKLGEGGFGPV----YKGTLVEGQEIAVKRLSKG----SGQGMEEFKNEVTLIA 524
D+F LG G FG V +KG+ G+ A+K LSK Q +E NE ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ-VEHVLNEKRILQ 56
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI-------FDQARATFLDWQKRIHI 577
++H LV L G L+ EY+P + F F + A F Q
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGG--ELFSHLRKSGRFPEPVARFYAAQ----- 109
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ + YLH + I++RDLK N+LLD+D KI+DFG A+ ++ T+ +
Sbjct: 110 ---VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTL 158
Query: 638 VGTYGYMSPEYAAEGLFSVK-----SDVFSFGVLVLEIVSG 673
GT Y++PE + K D ++ G+L+ E+++G
Sbjct: 159 CGTPEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 72/232 (31%), Positives = 109/232 (46%), Gaps = 38/232 (16%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR------LQHRN 530
LG+G FG V+ KGT Q A+K L K + + E T++ + +H
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPF 57
Query: 531 LVKLLGCCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARG 584
L L C Q E++ + EY+ L F I FD RATF I G
Sbjct: 58 LTHLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--------AAEIICG 108
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LH I++RDLK N+LLD D + KI+DFGM + + +T T GT Y+
Sbjct: 109 LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT--FCGTPDYI 163
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHVRVEN 696
+PE ++ D +SFGVL+ E++ G+ + H + L +R++N
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEELFQSIRMDN 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 57/205 (27%), Positives = 106/205 (51%), Gaps = 14/205 (6%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLS-KGSGQGMEEFK-NEVTLIARLQHRN 530
+ K+GEG +G V+K E EI A+KR+ +G+ E+ L+ L+H+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V+L + L++EY ++ L + FD +D + + + +G+ + H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHS 117
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--Y 648
++HRDLK N+L++ + K++DFG+AR F G ++ + +VV T Y P+ +
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLF 172
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSG 673
A+ L+S D++S G + E+ +
Sbjct: 173 GAK-LYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQ---HRNLVK 533
++G G +G VYK G +A+K + + + EV L+ RL+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 534 LLGCCI-----QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
L+ C + + L++E++ ++ L ++ D+ L + ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H + I+HRDLK N+L+ + K++DFG+ARI+ Q VV T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ ++ D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 72/227 (31%), Positives = 106/227 (46%), Gaps = 30/227 (13%)
Query: 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG+G FG V L +G+ AVK L K +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 537 CCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQ 590
C Q E + + E++ L F I FD RATF + I G+ +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAE--------IVCGLQFLHS 114
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMSPEY 648
II+RDLK NV+LD D + KI+DFGM + +FG + T GT Y++PE
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST----FCGTPDYIAPEI 167
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHVRVE 695
++ D +SFGVL+ E++ G+ + H D + L +RV+
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPF---HGDDEDELFESIRVD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 59/203 (29%)
Query: 480 KLGEGGFGPVYKG---TLVEGQEIAVKRLSKGSGQGMEEFK----NEVTLIARLQHRNLV 532
+G G +G VYK +G+E A+K+ KG + E+ L+ L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ--------KRIHIVGGIAR- 583
L+ ++ +Y +FD A WQ KR+ I + +
Sbjct: 66 SLVEVFLE-HADKSVY----------LLFDYAEHDL--WQIIKFHRQAKRVSIPPSMVKS 112
Query: 584 -------GILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIF------- 625
G+ YLH + ++HRDLK +N+L+ + KI D G+AR+F
Sbjct: 113 LLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 626 -GGDEIQTNTHKVVGTYGYMSPE 647
D VV T Y +PE
Sbjct: 170 ADLD-------PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 22/235 (9%)
Query: 479 NKLGEGGFGPVYKG---TLVEGQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
+++G G FG V G + + VK L + + F EV L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGILYLHQDS 592
LG CI++ +L+ E+ P L ++ QK + + +A G+L+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARI-FGGDEIQTNTHKVVGTYGYMSPEYAAE 651
IH DL N L D++ KI D+G+A + D T V +++PE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 652 ---GLFSVK----SDVFSFGVLVLEIVSGKKNWRFSHPDH-DHNLLGHVRVENNT 698
L S+++S GV + E+ + +PD D +L V E +
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ---PYPDLSDEQVLKQVVREQDI 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG GGFG V + + + A+K + K G +E +E ++ H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 537 CCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ + + ++ EY + + + R F ++ R + + YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGG--ELWTILRDRGLFDEYTARF-YIACVVLAFEYLHNRG--- 113
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
II+RDLK N+LLD++ K+ DFG A+ + T GT Y++PE +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 656 VKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
D +S G+L+ E+++G F D D
Sbjct: 171 FSVDYWSLGILLYELLTG--RPPFGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKG---SGQGMEEFKNE--VTLIA-RLQHRN 530
LG G FG V YK T G+ A+K L KG + +E E + A +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI----FDQARATFLDWQKRIHIVGGIARGIL 586
LV L C D + EY L I F + RA F + G+
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--------AACVVLGLQ 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YLH++ +I++RDLK N+LLD + KI+DFG+ + G +T+T GT +++P
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEFLAP 170
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSG 673
E E ++ D + GVL+ E++ G
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 44/228 (19%)
Query: 465 FASIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN----- 518
F ++ + T+ + +G G FG V + GQ +A+K++ M+ F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 519 ----EVTLIARLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQK 573
E+ L+ L+H N++ L I E + + E + D +R L+ Q
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRP--LEKQF 109
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ + I RG+ Y+H ++HRDLK SN+L++ + + KI DFG+ARI D T
Sbjct: 110 IQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI--QDPQMT- 163
Query: 634 THKVVGTYGYMSPEY--AAEGL-----FSVKSDVFSFGVLVLEIVSGK 674
GY+S Y A E + + V+ D++S G + E++ GK
Sbjct: 164 --------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 35/210 (16%)
Query: 481 LGEGGFGPVY----KGTLVEGQEI-AVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLV 532
LG+G FG V KGT E+ A+K L K +E E ++A +
Sbjct: 8 LGKGSFGKVMLAERKGT----DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 533 KLLGCCIQA-DESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGIL 586
L C Q D + EY+ L + I F + A F IA G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--------AAEIAIGLF 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYM 644
+LH II+RDLK NV+LD + + KI+DFGM + IFGG +T GT Y+
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT----FCGTPDYI 168
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+PE A + D ++FGVL+ E+++G+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFK----NEVTLIARLQ 527
D F ++GEG +G VYK G+ +A+K++ + + E F E+ ++ +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 528 HRNLVKLLGCCIQADESM----------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
HRN+V L +++ L++EYM + + + + F + +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFSEDHIK-SF 121
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ + G+ Y H+ + +HRD+K SN+LL+N K++DFG+AR++ +E + T+KV
Sbjct: 122 MKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 638 VGTYGYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ T Y PE E + DV+S G ++ E+ + K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 471 ATDNFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFK--NEVTLIARLQ 527
A ++ + KLGEG + VYKG + + GQ +A+K +S + +G+ F E +L+ L+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61
Query: 528 HRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
H N+V LL I E++ ++EYM + I Q + R+ + + RG+
Sbjct: 62 HANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMFQ-LLRGLA 117
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI--QTNTHKVVGTYGYM 644
Y+H I+HRDLK N+L+ K++DFG+AR I QT + +VV T Y
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVV-TLWYR 170
Query: 645 SPEY---AAEGLFSVKSDVFSFGVLVLEIVSGK 674
P+ A + +S D++ G + +E++ G+
Sbjct: 171 PPDVLLGATD--YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN----EVTLIARLQHRNLVKL 534
+GEG +G V K G+ +A+K+ K S + E+ K EV ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+ L++EY+ L+ +A L + + + I Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE------- 647
IIHRD+K N+L+ K+ DFG AR T V T Y +PE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSG 673
Y DV++ G ++ E++ G
Sbjct: 179 YGKP------VDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE--FKNEVTLIARLQHRNLVKLLG 536
+GEG +G V K E GQ +A+K+ + M + E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ L++E++ + LD + LD + + I RGI + H + I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVGTYGYMSPEY-AAEGLF 654
IHRD+K N+L+ K+ DFG AR + E+ T+ V T Y +PE + +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELLVGDTKY 178
Query: 655 SVKSDVFSFGVLVLEIVSG 673
D+++ G LV E+++G
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 50/217 (23%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGM---EEFKNEVTLIARLQH 528
D+ +G G FG V+ + A+K ++ + + NE ++ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 529 RNLVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
+++L + D+ L + EY+P L F + + F + + I +
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFY-ASEIVCALE 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YLH I++RDLK N+LLD + + K++DFG A+ +++ T + GT Y++P
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAP 167
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683
E + D ++ G+L+ E++ G + +P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF 204
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 475 FASYNKLGEGGFGPVYKGTLV----EGQEIAVKRL--SKGSGQGMEEFKNEVTLIARLQH 528
+ K+GEG FG K LV +G++ +K + SK S + EE + EV +++ ++H
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-----LDWQKRIHIVGGIAR 583
N+V+ + ++ +Y L I Q F LDW +I +
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ 112
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+ ++H +I+HRD+K+ N+ L D K+ DFG+AR+ T +GT Y
Sbjct: 113 ALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYY 167
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+SPE ++ KSD+++ G ++ E+ + K
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGC 537
+G G FG V K G +AVKR+ S + + ++ ++ R +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 538 CIQADESMLIYEYMPNKSLDFF---IFDQARATFLDWQKRIHIVGGIA----RGILYLHQ 590
+ + + E M + SLD F +++ ++ + I+G IA + + YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKALNYLKE 125
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--- 647
+ ++IIHRD+K SN+LLD + N K+ DFG++ +T + G YM+PE
Sbjct: 126 E--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT---RDAGCRPYMAPERID 180
Query: 648 -YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
A +G + V+SDV+S G+ + E+ +GK
Sbjct: 181 PSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 36/219 (16%)
Query: 480 KLGEGGFGPVYKGTLVE--GQEIAVKRLS-KGSGQGME-EFKNEVTLIARLQ---HRNLV 532
++GEG +G V+K ++ G+ +A+KR+ + +GM EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 533 KLLGCCI-----QADESMLIYEYMPNKSLDFFIFDQARATFLDW--------QKRIHIVG 579
+L C + + L++E++ DQ T+LD + ++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ RG+ +LH R++HRDLK N+L+ + K++DFG+ARI+ Q VV
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 171
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
T Y +PE + ++ D++S G + E+ K +R
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 19/229 (8%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ TD + +G+G +G VYK T +G AVK L S EE + E ++
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQS 74
Query: 526 L-QHRNLVKLLGCCIQADESM-----LIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIV 578
L H N+VK G +AD+ + L+ E S+ + LD +I+
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
G G+ +LH + RIIHRD+K +N+LL + K+ DFG++ ++ NT V
Sbjct: 135 YGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--V 189
Query: 639 GTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
GT +M+PE A + + + DV+S G+ +E+ G HP
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 54/224 (24%)
Query: 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARL-Q 527
KLG+G +G V+K + +A+K++ + F+N E+ + L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 528 HRNLVKLLGCCIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIH---IVGGI 581
H N+VKLL I+A+ IY EYM L I RA L + +H I+ +
Sbjct: 66 HPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANIL---EDVHKRYIMYQL 116
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG------GDEIQTNTH 635
+ + Y+H S +IHRDLK SN+LL++D K++DFG+AR + + T+
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD-- 171
Query: 636 KVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
V T Y +PE L D++S G ++ E++ GK
Sbjct: 172 -YVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG+G FG V L E+ A+K L K ++ E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 537 CCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQ 590
CC Q + + + EY+ L F I FD+ R+ F + +++LH+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFY--------AAEVTLALMFLHR 114
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMSPEY 648
+I+RDLK N+LLD + + K++DFGM + I G T GT Y++PE
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT----FCGTPDYIAPEI 167
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
E + D ++ GVL+ E+++G+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 36/154 (23%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E L+ + H +++++ + + ++ +P+ S D + + R+ L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
I G+ YLH RIIHRD+K N+ +++ I D G A+ + +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
GT +PE A ++ K+D++S G+++ E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 62/267 (23%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 420 IIASVL--LMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFA- 476
I L + + +VA F R + L ++ + ED WE F +K + +
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGR-NNLELKRVEN--ED-GTWELQFFD-SKVSKSITI 685
Query: 477 --------SYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ 527
N + G G YKG ++ G + VK ++ + +E+ + +LQ
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQ 741
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H N+VKL+G C + LI+EY+ K+L + + L W++R I GIA+ + +
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRF 795
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH ++ +L +++D P + + K + Y++PE
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPE 848
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ KSD++ FG++++E+++GK
Sbjct: 849 TRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKG------TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL 526
+ + KLGEG + V+KG LV +EI RL G + EV+L+ L
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 527 QHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+H N+V L + D+S+ L++EY+ +K L ++ D + + I RG+
Sbjct: 62 KHANIVTLHDI-VHTDKSLTLVFEYL-DKDLKQYMDDCG--NIMSMHNVKIFLYQILRGL 117
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH-KVVGTYGYM 644
Y H R +++HRDLK N+L++ K++DFG+AR + T T+ V T Y
Sbjct: 118 AYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 171
Query: 645 SPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
P+ +S + D++ G + E+ SG+
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKG------TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL 526
+ + +KLGEG + VYKG LV +EI RL G + EV+L+ L
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 527 QHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+H N+V L I ++S+ L++EY+ +K L ++ D + + K + + RG+
Sbjct: 62 KHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGL 117
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH-KVVGTYGYM 644
Y H R +++HRDLK N+L++ K++DFG+AR I T T+ V T Y
Sbjct: 118 NYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYR 171
Query: 645 SPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
P+ +S + D++ G + E+ +G+
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGS----GQGMEEFKNEVTLIAR 525
NF LG G +G V+ V G + A+K L K + + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
++ + L Q D + LI +Y+ L F R F + + +I+ G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYS-GEIVLA 117
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LH ++ II+RD+K N+LLD++ + ++DFG+++ F DE++ + GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 645 SPEYAA--EGLFSVKSDVFSFGVLVLEIVSG 673
+P+ +G D +S GVL+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 44/132 (33%), Positives = 75/132 (56%), Gaps = 21/132 (15%)
Query: 549 EYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIA----RGILYLHQDSRMRIIHRDLK 602
E+M SLD + +A RI +I+G I+ RG+ YL + + +I+HRD+K
Sbjct: 79 EHMDGGSLDQ-VLKKAG--------RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVK 127
Query: 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFS 662
SN+L+++ K+ DFG++ G I + + VGT YMSPE ++V+SD++S
Sbjct: 128 PSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 663 FGVLVLEIVSGK 674
G+ ++E+ G+
Sbjct: 184 LGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LG G G VYK + + I AVK + + + ++ +E+ ++ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA----RGILYLHQDSRM 594
+ + E+M SLD + + H++G IA +G+ YL +
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
+I+HRD+K SN+L++ K+ DFG++ + + VGT YM+PE + +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQY 170
Query: 655 SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
+ SDV+S G+ +E+ G RF +P N
Sbjct: 171 GIHSDVWSLGISFMELALG----RFPYPQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 45/214 (21%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
KLGEG + VYKG + + GQ +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69
Query: 537 CCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRI---HIVG----GIARGILYL 588
I +++ L++EY+ D ++D H V + RG+ Y
Sbjct: 70 DIIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT--HKVVGTYGYMSP 646
HQ R++HRDLK N+L+ K++DFG+AR + + T ++VV T Y P
Sbjct: 120 HQ---RRVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVV-TLWYRPP 172
Query: 647 -------EYAAEGLFSVKSDVFSFGVLVLEIVSG 673
EY S D++ G + E+ +G
Sbjct: 173 DVLLGSTEY------STSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 51/214 (23%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
++F ++G G +G VYK V G+ A+K + G+ + E+ ++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA--------- 582
V G ++ D+ + E+ SL Q H+ G ++
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSL---------------QDIYHVTGPLSESQIAYVSR 113
Query: 583 ---RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+G+ YLH +M HRD+K +N+LL ++ + K++DFG++ + + +G
Sbjct: 114 ETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIG 168
Query: 640 TYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEI 670
T +M+PE AA +G ++ D+++ G+ +E+
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 474 NFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKGS----GQGMEEFKNEVTLIAR 525
NF LG G +G V+ G G+ A+K L K + + E + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
++ + L Q D + LI +Y+ L F R F + + R++I I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGEL--FTHLYQREHFTESEVRVYI-AEIVLA 117
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LHQ + II+RD+K N+LLD++ + ++DFG+++ F +E + + GT YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 645 SPEY--AAEGLFSVKSDVFSFGVLVLEIVSG 673
+PE G D +S GVL E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-13
Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 20/191 (10%)
Query: 497 GQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLGCCIQADESML-IYEYMP 552
G E+A+K L + + + F+ E L ARL H N+V LL + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 553 NKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL--- 608
++L + D A L + ++ + + H I+HRDLK N+++
Sbjct: 63 GRTLREVLAADGA----LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 609 DNDMNPKISDFGMARIFGG----DEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSF 663
+ K+ DFG+ + G D T T +V+GT Y +PE + SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 664 GVLVLEIVSGK 674
G++ LE ++G+
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 57/230 (24%), Positives = 105/230 (45%), Gaps = 47/230 (20%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVKR--LSKGSGQGMEEFKN------------EVTLI 523
LGEG +G V K + G+ +A+K+ + + S ++ + E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLDFFIFDQARATFLDWQKRIHIVGG 580
++H N++ L+ ++ D L+ + M + K +D + + Q + I+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD------RKIRLTESQVKC-ILLQ 127
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN------- 633
I G+ LH+ +HRDL +N+ +++ KI+DFG+AR +G
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 634 ------THKVVGTYGYMSPE--YAAEGL-FSVKSDVFSFGVLVLEIVSGK 674
T KVV T Y +PE AE F+V D++S G + E+++GK
Sbjct: 185 QRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 53/235 (22%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
D+ +LG G +G V K V G +AVKR+ T+ ++ Q R L
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------------RATVNSQEQKRLL 47
Query: 532 VKL-----LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD------WQKRIHI--- 577
+ L C ++ Y + + D +I + T LD + K + I
Sbjct: 48 MDLDISMRSVDCPY---TVTFYGALFREG-DVWICMEVMDTSLDKFYKKVYDKGLTIPED 103
Query: 578 -VGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+G IA I+ YLH S++ +IHRD+K SNVL++ + K+ DFG++ G + +
Sbjct: 104 ILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDS 157
Query: 633 NTHKV-VGTYGYMSPE-----YAAEGLFSVKSDVFSFGVLVLEIVSGK---KNWR 678
+ G YM+PE +G + VKSDV+S G+ ++E+ +G+ +W+
Sbjct: 158 VAKTIDAGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFPYDSWK 211
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHR 529
D++ KLGEG + VYKG + V G+ +A+K RL + G + E +L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 530 NLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
N+V LL I E++ L++EY+ + D+ ++ + + RG+ Y+
Sbjct: 64 NIV-LLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQ-LLRGLSYI 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH-KVVGTYGYMSPE 647
HQ I+HRDLK N+L+ + K++DFG+AR + ++T+ V T Y P+
Sbjct: 120 HQ---RYILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPD 173
Query: 648 -YAAEGLFSVKSDVFSFGVLVLEIVSG 673
+S D++ G + +E++ G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 57/237 (24%), Positives = 105/237 (44%), Gaps = 69/237 (29%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTL 522
+ + + +GEG +G V T G ++A+K++S F++ E+ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--------FEHQTFCQRTLREIKI 56
Query: 523 IARLQHRNLVKLLGCCIQAD--ESM----LIYEYMP-------------NKSLDFFIFDQ 563
+ R +H N++ +L I+ ES ++ E M N + +F++
Sbjct: 57 LRRFKHENIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ- 114
Query: 564 ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
I RG+ Y+H + ++HRDLK SN+LL+ + + KI DFG+AR
Sbjct: 115 -----------------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
Query: 624 IFGGDEIQTNT-HKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
I + T + V T Y +PE + + K D++S G ++ E++S +
Sbjct: 155 IADPEHDHTGFLTEYVATRWYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKG---SGQGMEEFKNEVTLIARLQ 527
NF LG+G FG V E+ A+K L K +E E ++A
Sbjct: 1 DFNFLMV--LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 528 HRNLVKLLGCCIQA-DESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGI 581
+ L C Q D + EY+ L + I F + +A F I
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--------AAEI 110
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
+ G+ +LH R II+RDLK NV+LD++ + KI+DFGM + D + T T GT
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGTP 165
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y++PE A + D +++GVL+ E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
++ ++G G +G VYK + G+ AVK + G + E+ ++ +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA---------- 582
G + ++ + EY SL Q H+ G ++
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSL---------------QDIYHVTGPLSELQIAYVCRE 114
Query: 583 --RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+G+ YLH +M HRD+K +N+LL ++ + K++DFG+A + + +GT
Sbjct: 115 TLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGT 169
Query: 641 YGYMSPEYAA---EGLFSVKSDVFSFGVLVLEI 670
+M+PE AA G ++ D+++ G+ +E+
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 44/144 (30%), Positives = 78/144 (54%), Gaps = 9/144 (6%)
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V G E + E+M SLD + +A+ + ++ I + RG+ YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKEAKRIPEEILGKVSI--AVLRGLAYLRE 121
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ +I+HRD+K SN+L+++ K+ DFG++ G I + + VGT YMSPE
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
+SV+SD++S G+ ++E+ G+
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
+GEG FG + LV+ Q+ A+K RL K S +E+ + E L+A+++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFFIFDQ-----ARATFLDWQKRIHIVGGIARGILYL 588
+AD + ++ EY L I Q T L W ++ + G+ ++
Sbjct: 64 KES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H+ R++HRD+K+ N+ L + K+ DFG AR+ T+ VGT Y+ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPPEI 171
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ KSD++S G ++ E+ + K
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 42/214 (19%)
Query: 481 LGEGGFGPVYKGTLV----EGQEIAVKRLS--KGSGQGMEEFKNEVTLIARLQHRNLVK- 533
+G+G +G V +LV +G++ +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 534 -------------LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++G C D +Y + + +Q F+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLPENQVVEWFVQ---------- 110
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IA + YLH+ I+HRDLK NV L K+ D G+AR+ +T ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
YMSPE + ++ KSDV++ G V E+ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 37/191 (19%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN--------EVTLIARLQHR 529
K+G+G FG V+K + ++I A+K++ ME K E+ ++ L+H
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLLKHE 71
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD---QARATFLDWQKRIHIVGGIAR--- 583
N+V L+ C Y K + +F+ A L + + I +
Sbjct: 72 NVVNLIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 584 ----GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN---THK 636
G+ Y+H R +I+HRD+KA+N+L+ D K++DFG+AR F + T++
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 637 VVGTYGYMSPE 647
VV T Y PE
Sbjct: 184 VV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I RG+ YLH I+HRD+K N+L++++ KI DFG+AR+ DE + T +VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 641 YGYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y Y +PE ++ D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 62/210 (29%)
Query: 494 LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRNLVKLLGCCIQADES 544
V GQ +A+K+LS+ F+N E+ L+ + H+N++ LL
Sbjct: 38 TVTGQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------- 83
Query: 545 MLIYEYMPNKSLDFF--------------------IFDQARATFLDWQKRIHIVGGIARG 584
+ P KSL+ F D R ++L +Q + G
Sbjct: 84 -----FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ--------MLCG 130
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
I +LH IIHRDLK SN+++ +D KI DFG+AR G + T VV Y Y
Sbjct: 131 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRY-YR 184
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+PE + D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 49/218 (22%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN-----EVTLIARLQHR--NLV 532
+G G G VYK G +AVK++ + + EE K +V L H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVL---KSHDCPYIV 77
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD-WQKRI------HIVGGIARGI 585
K G I D FI + +T LD KRI I+G + I
Sbjct: 78 KCYGYFI--------------TDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAI 123
Query: 586 L----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH-KVVGT 640
+ YL + + +IHRD+K SN+LLD N K+ DFG++ G + + + G
Sbjct: 124 VKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSAGC 177
Query: 641 YGYMSPEY----AAEGLFSVKSDVFSFGVLVLEIVSGK 674
YM+PE + +++DV+S G+ ++E+ +G+
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 481 LGEGGFGPVYKGTLVE-------GQEIAVKRLSKGSGQGMEEF--KNEVTLIARLQHRNL 531
LG+G FG V+ LV GQ A+K L K + + + K E ++A + H +
Sbjct: 4 LGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
VKL + LI +++ + D F F + + ++ +A + +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYL-AELALALDHLH-- 115
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
+ II+RDLK N+LLD + + K++DFG+++ E + GT YM+PE
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNR 172
Query: 652 GLFSVKSDVFSFGVLVLEIVSG 673
+ +D +SFGVL+ E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-------EVTLIARLQHRNL 531
K+GEG +G V+K E GQ +A+K+ + E+ E+ ++ +L+H NL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V L+ + + L++EY + L+ + + I+ + + + H+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF-GGDEIQTNTHKVVGTYGYMSPEY-A 649
+ IHRD+K N+L+ K+ DFG ARI G + T+ V T Y +PE
Sbjct: 120 N---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD---YVATRWYRAPELLV 173
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ + DV++ G + E+++G+ W
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPLW 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRN 530
D+F ++LG G G V+K + I ++L + + E+ ++
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V G E + E+M SLD + +A + Q + + +G+ YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ +I+HRD+K SN+L+++ K+ DFG++ G I + + VGT YMSPE
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
+SV+SD++S G+ ++E+ G+
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-11
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 326 NGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK-NCSCTAYANSDVERGGSGCLLW- 383
+ D F + KLP S + +L+EC+ C NCSC ++ + G GCLLW
Sbjct: 2 SDDCFVRLPNTKLPGFSRIVISV-ASLEECASKCLNSNCSCRSFTYN---NGTKGCLLWS 57
Query: 384 FGDLMDMKEYNDGGQDLYIRI 404
L D + + GG DLY +I
Sbjct: 58 ESSLGDARLFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGI 585
L +L C D + EY+ L + I F + A F IA G+
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--------AAEIAIGL 114
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH II+RDLK NV+LD++ + KI+DFGM + D + T T GT Y++
Sbjct: 115 FFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGTPDYIA 169
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE A + D ++FGVL+ E+++G+
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 42/203 (20%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN 518
+WE D + + + +G G +G V + G+++A+K+LS+ Q K
Sbjct: 10 VWEVP--------DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKR 60
Query: 519 ---EVTLIARLQHRNLVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARA 566
E+ L+ + H N++ LL A L+ M N +
Sbjct: 61 TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 567 TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
FL +Q I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 121 QFLVYQ--------ILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR--- 166
Query: 627 GDEIQTNTHKV--VGTYGYMSPE 647
T+ V T Y +PE
Sbjct: 167 ----HTDDEMTGYVATRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHR 529
+ + +KLGEG + V+KG + + +A+K RL G + EV+L+ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHA 63
Query: 530 NLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
N+V L I + + L++EY+ + D + + + + RG+ Y
Sbjct: 64 NIVTLHDI-IHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH-KVVGTYGYMSPE 647
H + +I+HRDLK N+L++ K++DFG+AR + T T+ V T Y P+
Sbjct: 120 H---KRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPD 173
Query: 648 -YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+S D++ G ++ E+ +G+
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ARG+ +L + + IHRDL A N+LL + KI DFG+AR D
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++ +SDV+SFGVL+ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGS----GQGMEEFKNEVTLIAR 525
NF LG G +G V+ V G + A+K L K + + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
++ + L Q + + LI +Y+ + F R F + + R + G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEM--FTHLYQRDNFSEDEVRFY-SGEIILA 117
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LH ++ I++RD+K N+LLD++ + ++DFG+++ F +E + T+ GT YM
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYM 173
Query: 645 SPEYA-AEGLFSVKSDVFSFGVLVLEIVSG 673
+PE +G D +S G+L+ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 475 FASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQHRNL 531
+ S ++G G +G V G+++A+K+LS+ S + E+TL+ +QH N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 532 VKLLGCCIQA---DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
+ LL A DE Y MP D + L K ++V + G+ Y+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQMLCGLKYI 133
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H IIHRDLK N+ ++ D KI DFG+AR D T V T Y +PE
Sbjct: 134 HSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTG---YVVTRWYRAPEV 185
Query: 649 AAEGLFSVKS-DVFSFGVLVLEIVSGK 674
+ ++ D++S G ++ E+++GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 481 LGEGGFGPVYKGTLVE----GQ----EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
LG+G F ++KG E G+ E+ +K L K E F +++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
G C+ DES+++ EY+ SLD ++ + W ++ + +A + +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 593 RMRIIHRDLKASNVLL-----DNDMNP---KISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ H ++ A NVLL NP K+SD G++ EI ++ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLERIPWV 171
Query: 645 SPEYAAEGL-FSVKSDVFSFGVLVLEIVSG 673
PE S+ +D +SFG + EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 480 KLGEGGFGPVYKGTLVEG---QEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
++G G FG V G + G ++ VK L S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGILYLHQDSR 593
G C + +L+ E+ P L ++ +A + + IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARI-FGGDEIQTNTHKVVGTYGYMSPEYAAE- 651
IH DL N LL D+ KI D+G++ + D T V +++PE E
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-PLRWIAPELVDEV 177
Query: 652 --GLFSV----KSDVFSFGVLVLEI 670
L V +S+V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 481 LGEGGFGPVYKGTLVE---------GQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHRN 530
LG+G F +YKG L GQE++V GS F +L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
LVKL G C+ DE++++ EY+ LD F+ + L W ++ + +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 591 DSRMRIIHRDLKASNVLL----DNDMNP---KISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+++H ++ N+L+ N+ K+SD G+ E + V +
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIPW 170
Query: 644 MSPEYAAEGLFSVKS--DVFSFGVLVLEIVSGKK 675
++PE G S+ D +SFG +LEI S +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 65/238 (27%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 451 MSHMKEDMELWEFDFA-SIAKATDNFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKG 508
MS K D + + S + + +G G G V + + +A+K+LS+
Sbjct: 1 MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR- 59
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF--------I 560
F+N+ A+ +R LV L+ C + L+ + P KSL+ F +
Sbjct: 60 ------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 561 FD----QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616
D Q LD ++ +++ + GI +LH IIHRDLK SN+++ +D KI
Sbjct: 111 MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 167
Query: 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
DFG+AR G + T VV Y Y +PE + D++S G ++ E++ G
Sbjct: 168 LDFGLARTAGTSFMMTP--YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 481 LGEGGFGPVYKGTLVEGQE----IAVKRLSKG----SGQGMEEFKNEVTLIARLQHRNLV 532
LG+GG+G V++ V G + A+K L K + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
L+ + LI EY+ L F+ + F++ ++ I+ + +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYL-SEISLALEHLHQQG 120
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMSPEYAA 650
II+RDLK N+LLD + K++DFG+ + I G T TH GT YM+PE
Sbjct: 121 ---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEILM 173
Query: 651 EGLFSVKSDVFSFGVLVLEIVSG 673
D +S G L+ ++++G
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 473 DNFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEE------FKNEVTLI 523
D + K+GEG +G VYK G+ +A+K RL M+E E++L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLL 54
Query: 524 ARLQHRN-LVKLLGCCIQADESM------LIYEYMPNKSLDFFIFDQAR--ATFLDWQKR 574
L +V+LL +E L++EY+ + L F+ R L +
Sbjct: 55 QMLSESIYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTN 633
+ + +G+ + H+ ++HRDLK N+L+D KI+D G+ R F +++
Sbjct: 113 KSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSY 168
Query: 634 THKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSG 673
TH++V T Y +PE +S D++S G + E+
Sbjct: 169 THEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 49/238 (20%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEE---FKNEVTLIARLQH 528
D+F +G G FG V+ + ++ A+K L K + + E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 529 RNLVKLLGCCIQADESM-LIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIA 582
+VKL Q +E + L+ EYMP L +F + A F IA
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-----------IA 108
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-------------------- 622
+L L ++ IHRD+K N+L+D D + K++DFG+
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 623 -----RIFGGDEIQTNT--HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+ D Q + VGT Y++PE + ++ D +S GV++ E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 28/191 (14%)
Query: 495 VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554
V G +AVK+LS+ F+N+ A+ +R LV LL C + L+ + P K
Sbjct: 44 VLGINVAVKKLSR-------PFQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQK 93
Query: 555 SLDFF--------IFD----QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602
SL+ F + D Q LD ++ +++ + GI +LH IIHRDLK
Sbjct: 94 SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150
Query: 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFS 662
SN+++ +D KI DFG+AR + + T V T Y +PE + D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLARTACTNFMMT---PYVVTRYYRAPEVILGMGYKENVDIWS 207
Query: 663 FGVLVLEIVSG 673
G ++ E+V G
Sbjct: 208 VGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 7/100 (7%)
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H +R +++RDLK +N+LLD + +ISD G+A F + H VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEV 166
Query: 649 AAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
+G+ + +D FS G ++ +++ G +R H D +
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLG 536
+G GGFG VY + G+ A+K L K QG NE +++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIV 60
Query: 537 CCIQA----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
C A D+ I + M L + + F + + R + I G+ ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFY-ATEIILGLEHMH--N 115
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
R +++RDLK +N+LLD + +ISD G+A F + H VGT+GYM+PE +G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKG 170
Query: 653 L-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
+ +D FS G ++ +++ G +R H +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 24/180 (13%)
Query: 503 KRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE---YMPNKSLDF- 558
KR+ GS + + +NE+ + RL H N++K+ E +L E YM + DF
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFD 248
Query: 559 ---FIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
F++D+A + L Q R I+ + + Y+H ++IHRD+K N+ L+ D
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ DFG A F E + + VGT SPE A + +D++S G+++L+++S
Sbjct: 305 KIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 479 NKLGEGGFGPVYK------GTLVEGQEIAVKRLSKGSGQGMEEFK-NEVTLIARLQHR-- 529
++LG+G +G VYK G + +EI RL ++E K N++ + + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57
Query: 530 --NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
+V G + EYM SLD + I + +G+ +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
L ++ IIHRD+K +NVL++ + K+ DFG++ +TN +G YM+PE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPE 171
Query: 648 Y------AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
++V+SDV+S G+ +LE+ G R+ +P
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALG----RYPYP 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 34/240 (14%)
Query: 442 KLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQ--E 499
K K TK K M+ +F+F LG G FG V T
Sbjct: 11 KKKDSDSTKEPKRKNKMKYEDFNFI------------RTLGTGSFGRVILATYKNEDFPP 58
Query: 500 IAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556
+A+KR K + ++ +E ++ + H V L G L+ E++
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG-- 116
Query: 557 DFFIFDQARATFLDWQKRI-HIVGGI--ARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613
+FF TFL KR + VG A+ +L + I++RDLK N+LLD D
Sbjct: 117 EFF-------TFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
K++DFG A++ + T T+ + GT Y++PE +D ++ G+ + EI+ G
Sbjct: 170 IKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 484 GGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL---------VK 533
G FG VY G A+K L K M KN+VT + + + + K
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSD---MIA-KNQVTNV-KAERAIMMIQGESPYVAK 61
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
L D L+ EY+ I DW K+ + + G+ LHQ
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
IIHRD+K N+L+D + K++DFG++R G E K VGT Y++PE G+
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPE-TILGV 168
Query: 654 FSVK-SDVFSFGVLVLEIVSGKKNWRFSHPD 683
K SD +S G ++ E + G + PD
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQHRNLVKLLGC 537
+G G +G V Q++AVK+LS+ + + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 538 CIQA------DESMLIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
A +E L+ M N + FL +Q + RG+ Y+
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ--------LLRGLKYI 134
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H IIHRDLK SNV ++ D +I DFG+AR D+ T V T Y +PE
Sbjct: 135 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTG---YVATRWYRAPEI 186
Query: 649 AAEGL-FSVKSDVFSFGVLVLEIVSGK 674
+ ++ D++S G ++ E++ GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 29/236 (12%)
Query: 465 FASIAKATDNFASYNKLGEGGFGPVYK-GTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLI 523
F S +D + +G+G +G V+K G + AVK L EE + E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68
Query: 524 ARLQ-HRNLVKLLGC-----CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI-- 575
L H N+VK G D+ L+ E S + D + FL +R+
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGS----VTDLVKG-FLKRGERMEE 123
Query: 576 ----HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
+I+ G+ +LH + + IHRD+K +N+LL + K+ DFG++ ++
Sbjct: 124 PIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 180
Query: 632 TNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
NT VGT +M+PE A + + + DV+S G+ +E+ G HP
Sbjct: 181 RNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 35/234 (14%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---EVTL 522
+I + + + + + +G G +G V + G +AVK+LS+ Q + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRL 69
Query: 523 IARLQHRNLVKLLGCCIQA------DESMLIYEYMP---NKSLDFFIFDQARATFLDWQK 573
+ ++H N++ LL A ++ L+ M N + FL +Q
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ- 128
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR DE+
Sbjct: 129 -------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMT-- 175
Query: 634 THKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
V T Y +PE + ++ D++S G ++ E+++G R P DH
Sbjct: 176 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG----RTLFPGTDH 223
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 40/219 (18%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL----- 534
LG G G V+ + + +AVK++ Q ++ E+ +I RL H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 535 ---------LGCCIQADESMLIYEYMPN---KSLDFFIFDQARATFLDWQKRIHIVGGIA 582
+G + + ++ EYM L+ + A +Q +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LL 124
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHK----- 636
RG+ Y+H + ++HRDLK +NV ++ D+ KI DFG+ARI +HK
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY----SHKGYLSE 177
Query: 637 VVGTYGYMSPEYAAEGLFSVKS-DVFSFGVLVLEIVSGK 674
+ T Y SP K+ D+++ G + E+++GK
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 38/113 (33%), Positives = 63/113 (55%), Gaps = 13/113 (11%)
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
LD + +A+G+ +L + IHRD+ A NVLL + KI DFG+AR
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR----- 260
Query: 629 EIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKN 676
+I +++ VV +M+PE + +++V+SDV+S+G+L+ EI S K+
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ARG+ +L + + IHRDL A N+LL + KI DFG+AR D
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++ +SDV+SFGVL+ EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQ-HRNLVKL 534
K+GEG F V K + G+ A+K + K + +E+ N E+ + RL H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 535 LGCCIQADESM----LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYL 588
+ D L++E M D +++ + R L ++ + + + + ++
Sbjct: 64 --IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE- 647
H++ I HRD+K N+L+ +D K++DFG R G T + + T Y +PE
Sbjct: 117 HRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYT-EYISTRWYRAPEC 169
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVS 672
+G + K D+++ G + EI+S
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+A+G+ +L + + IHRDL A N+LL + KI DFG+AR D
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++++SDV+SFGVL+ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 25/235 (10%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIA---VKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
++G G FG V + +A VK L + S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQ----ARATFLDWQKRIHIVGGIARGILYLHQD 591
G C++A +L++EY L ++ + + L Q+ + IA G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMH-- 116
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI-FGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ +H DL N L +D+ K+ D+G+ + D I+T K V +++PE
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174
Query: 651 E---GLFSVK----SDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHVRVENNT 698
E GL + + S+V++ GV + E+ +SH D +L HV +
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQ-PYSHLS-DREVLNHVIKDQQV 227
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 59/233 (25%), Positives = 114/233 (48%), Gaps = 30/233 (12%)
Query: 480 KLGEGGFGPVYKGTLVEGQE---IAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
K+G G +G VYK +G++ A+K++ +G+G M + E+ L+ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 65
Query: 537 CCI-QADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY-----LH 589
+ AD + L+++Y + F +A +K + + G+ + +LY +H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIH 122
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNP-----KISDFGMARIFGGD-EIQTNTHKVVGTYGY 643
++HRDLK +N+L+ + P KI+D G AR+F + + VV T+ Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 644 MSPEYAAEGLFSVKS-DVFSFGVLVLEIVSG-------KKNWRFSHPDHDHNL 688
+PE K+ D+++ G + E+++ +++ + S+P H L
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 475 FASYNKLGEGGFGPV---YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
+ + +G G G V Y L + +A+K+LS+ F+N+ A+ +R L
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR-------PFQNQTH--AKRAYREL 67
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFF--------IFD----QARATFLDWQKRIHIVG 579
V L+ C + L+ + P KSL+ F + D Q LD ++ +++
Sbjct: 68 V-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ GI +LH IIHRDLK SN+++ +D KI DFG+AR G + T V
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVV 180
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
T Y +PE + D++S G ++ E+V K
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRL--SKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
+GEG +G V K E +EI A+K+ S+ + + E E+ ++ L+ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 538 CIQADESMLIYEYMPNKSLDFF-------IFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+ + L++EY+ L+ ++ R+ K IH + H+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIH----------WCHK 118
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ I+HRD+K N+L+ ++ K+ DFG AR + N + V T Y SPE
Sbjct: 119 ND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLL 174
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
+ D++S G ++ E+ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSK---GSGQGMEEFKNEVTLIAR 525
+F + +G G FG V K T G A+K + K + + + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMP--------NKSLDFFIFDQARATFLDWQKRIHI 577
+ +L D L+ EY P N+ D FD+ A F
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFY-------- 107
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+A +L +H +M +HRD+K NVL+D + K++DFG A ++ N+
Sbjct: 108 ---LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLP 163
Query: 638 VGTYGYMSPEY------AAEGLFSVKSDVFSFGVLVLEIVSGK 674
VGT Y++PE +G + V+ D +S GV+ E++ G+
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 39/236 (16%)
Query: 467 SIAKATDNFASYNKLGEGGFGPV-YKGTLVEGQEIAVKRLSK--GSGQGMEEFKNEVTLI 523
+I + D + ++G G +G V G ++A+K+L + S + E+ L+
Sbjct: 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 524 ARLQHRNLVKLLGCCIQADESML----IYEYMP------NKSLDFFIFDQARATFLDWQK 573
++H N++ LL D S+ Y MP K + + R FL +Q
Sbjct: 69 KHMKHENVIGLLDV-FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ- 126
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ +G+ Y+H IIHRDLK N+ ++ D KI DFG+AR QT+
Sbjct: 127 -------MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTD 169
Query: 634 THKV--VGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
+ V T Y +PE + ++ D++S G ++ E+++GK ++ HDH
Sbjct: 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK----GHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 34/97 (35%), Positives = 57/97 (58%), Gaps = 13/97 (13%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+A+G+ +L + IHRDL A N+LL + KI DFG+AR +I+ +++ VV
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274
Query: 641 YG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE +++ +SDV+S+G+L+ EI S
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 479 NKLGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNL 531
LG G FG V +KGT G+ A+K L K M++ ++ E +++ L H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL---YL 588
V ++ + + E++ L F +A D K H A +L YL
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGEL-FTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H II+RDLK N+LLDN + K++DFG A+ ++ T + GT Y++PE
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEV 186
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSG 673
D ++ GVL+ E ++G
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 39/122 (31%), Positives = 57/122 (46%), Gaps = 21/122 (17%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ARG+ +L + +HRDL A NVLL KI DFG+AR D +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG------------------KKNWRFSHP 682
+M+PE + L++ SDV+S+G+L+ EI S K +R + P
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP 362
Query: 683 DH 684
DH
Sbjct: 363 DH 364
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V +G+ AVK L K + +E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
AD+ + +Y+ L F + Q +F + + R + IA + YLH +
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFY-AAEIASALGYLHS---LN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
II+RDLK N+LLD+ + ++DFG+ + G E T GT Y++PE + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 656 VKSDVFSFGVLVLEIVSG 673
D + G ++ E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVK 533
LG+G FG V K T G+ A+K L K +E + VT LQ H L
Sbjct: 3 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF-----IFDQARATFLDWQKRIHIVGGIARGILYL 588
L D + EY L F +F + RA F + I + YL
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYL 111
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H +++RD+K N++LD D + KI+DFG+ + D T GT Y++PE
Sbjct: 112 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 166
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+ + D + GV++ E++ G+ F + DH+
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 63/233 (27%), Positives = 114/233 (48%), Gaps = 30/233 (12%)
Query: 480 KLGEGGFGPVYKGTLVEGQ---EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
K+G G +G VYK +G+ E A+K++ +G+G M + E+ L+ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIALQK 65
Query: 537 CCI-QADESM-LIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGG----IARGILYLH 589
+ +D + L+++Y + F +A +A Q +V I GI YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNP-----KISDFGMARIFGGD-EIQTNTHKVVGTYGY 643
+ ++HRDLK +N+L+ + P KI+D G AR+F + + VV T+ Y
Sbjct: 126 AN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 644 MSPEYAAEGLFSVKS-DVFSFGVLVLEIVSG-------KKNWRFSHPDHDHNL 688
+PE K+ D+++ G + E+++ +++ + S+P H L
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT---LIARLQHRNLVK 533
LG+G FG V K T G+ A+K L K +E + +T ++ +H L
Sbjct: 3 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF-----IFDQARATFLDWQKRIHIVGGIARGILYL 588
L D + EY L F +F + RA F + I + YL
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYL 111
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMSP 646
H S +++RDLK N++LD D + KI+DFG+ + I G ++T GT Y++P
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT----FCGTPEYLAP 165
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
E + + D + GV++ E++ G+ F + DH+
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 34/219 (15%)
Query: 476 ASYNKLGE----GGFGPVYK----GTLVEGQEIAVKRLSKGSGQGMEEFK---NEVTLIA 524
+G+ + K TLV AVK+++ S E+ K E+
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLV-----AVKKINLDS-CSKEDLKLLQQEIITSR 54
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI---HIVGGI 581
+LQH N++ + I E ++ M S + + + F + + I+ +
Sbjct: 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDV 110
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTH----K 636
+ Y+H IHR +KAS++LL D +S + + + Q H
Sbjct: 111 LNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167
Query: 637 VVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSG 673
V ++SPE + L ++ KSD++S G+ E+ +G
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT---LIARLQHRNLVK 533
LG+G FG V LV G+ A+K L K +E + +T ++ +H L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG-IARGILYLHQDS 592
L D + EY+ L FF + R D R G I + YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSED---RTRFYGAEIVSALDYLHSG- 114
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+I++RDLK N++LD D + KI+DFG+ + D T GT Y++PE +
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDN 170
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+ D + GV++ E++ G+ F + DH+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 481 LGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V +G AVK L K + +E + + L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
A++ + +Y+ L FF + R FL+ + R + +A I YLH +
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL-FFHLQRERC-FLEPRARFY-AAEVASAIGYLHS---LN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
II+RDLK N+LLD+ + ++DFG+ + G E + T GT Y++PE + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 656 VKSDVFSFGVLVLEIVSG 673
D + G ++ E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT---LIARLQHRNLVK 533
LG+G FG V K T G+ A+K L K +E + +T ++ +H L
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILY 587
L D + EY L FF +F + RA F + I + Y
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAE--------IVSALGY 110
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMS 645
LH +++RDLK N++LD D + KI+DFG+ + I G ++T GT Y++
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT----FCGTPEYLA 163
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
PE + + D + GV++ E++ G R + DH L
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG----RLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIF--DQARATFLDWQKRIH 576
E ++ + H ++++L G + LI +P D + + + D +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI---LA 186
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I + R I YLH++ RIIHRD+KA N+ +++ + + DFG A F D +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYG 242
Query: 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT +PE A + D++S G+++ E+ +
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
LV L C L+ EY+ L +F R L + I + +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMSPEY 648
II+RDLK NVLLD D + K++D+GM + + GD T GT Y++PE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEI 167
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
+ D ++ GVL+ E+++G+ + + D N
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 14/98 (14%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH--KVV 638
+ RG+ Y+H + +IHRDLK SN+L++ D +I DFGMAR + + V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 639 GTYGYMSPEYAAEGLFSV-----KSDVFSFGVLVLEIV 671
T Y +PE L S+ D++S G + E++
Sbjct: 173 ATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 14/170 (8%)
Query: 502 VKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEYMPNKSLDFFI 560
VK ++ G G E+ ++ + HR ++ L I A + MP D F
Sbjct: 124 VKAVTGGKTPG-----REIDILKTISHRAIINL----IHAYRWKSTVCMVMPKYKCDLFT 174
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+ R+ L ++ I I + + YLH IIHRD+K N+ LD N + DFG
Sbjct: 175 YVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFG 230
Query: 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEI 670
A + GT SPE A + K+D++S G+++ E+
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 49/230 (21%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKG-SGQGM--EEFKNEVTLIARLQHRNLVKLL 535
+G+GG G VY V + +A+K++ + S + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD--WQKR---------------IHIV 578
C D +Y MP +I + L WQK + I
Sbjct: 69 SICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ------- 631
I I Y+H S+ ++HRDLK N+LL I D+G A +E
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 632 ---------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
T K+VGT YM+PE S +D+++ GV++ ++++
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H LV L C + E++ L F + Q + L + I+ + +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK---LPEEHARFYSAEISLALNF 111
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMS 645
LH+ II+RDLK NVLLD + + K++D+GM + I GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIA 164
Query: 646 PEY--AAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + FSV D ++ GVL+ E+++G+
Sbjct: 165 PEILRGEDYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 74/244 (30%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRN 530
+G G +G V E +++A+K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 531 LVKLLGCCI-----QADESMLIYEYM---------PNKSL-----DFFIFDQARATFLDW 571
++ + ++ ++YE M +++L +F++
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ--------- 116
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
+ RG+ Y+H + ++HRDLK SN+LL+ + + KI DFG+AR ++
Sbjct: 117 ---------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGD 163
Query: 632 TNTHKVVGTYGYMSPE-------YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684
T VV T Y +PE Y DV+S G + E++ K F D+
Sbjct: 164 FMTEYVV-TRWYRAPELLLNCSEYTT------AIDVWSVGCIFAELLGRKP--LFPGKDY 214
Query: 685 DHNL 688
H L
Sbjct: 215 VHQL 218
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVKLLG 536
+G+G FG VY+ + + I A+K LSK +E + E ++ R ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 537 C--CIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYL 588
Q D + L+ +YM L + + F + RA F IA +L L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY-----------IAELVLAL 109
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE- 647
+ I++RDLK N+LLD + + DFG+++ D TNT GT Y++PE
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEV 167
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSG 673
E ++ D +S GVLV E+ G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 29/91 (31%), Positives = 53/91 (58%)
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+L +H +IHRD+K++N+LL ++ K+ DFG ++++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
+PE +S K+D+FS GVL+ E+++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H LV L C + EY+ L +F R L + I+ + Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH+ II+RDLK NVLLD++ + K++D+GM + G T GT Y++PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 166
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ D ++ GVL+ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V ++ AVK L K + +E K+ ++ L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
AD+ + +Y+ L F Q FL+ + R + IA + YLH +
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFY-AAEIASALGYLHS---LN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN--THKVVGTYGYMSPEYAAEGL 653
I++RDLK N+LLD+ + ++DFG+ + + I+ N T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 654 FSVKSDVFSFGVLVLEIVSG 673
+ D + G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 481 LGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V ++G+ AVK L K +E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
++ + +++ L F + Q +F + + R + IA + YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYA-AEIASALGYLHS---IN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
I++RDLK N+LLD+ + ++DFG+ + G T GT Y++PE + +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 656 VKSDVFSFGVLVLEIVSG 673
D + G ++ E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 480 KLGEGGFGPVYKGTLVEGQE---IAVKRLSKGSGQGM--EEFKNEVTLIARLQ-HRNLVK 533
+LG+G +G V E E +A+K+++ + + + E+ L+ + H+N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 534 LLGCCIQADES---MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
L I + + +YE + L I T +Q I+ I G+ Y+H
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY---QILCGLKYIHS 123
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH--KVVGTYGYMSPEY 648
+ ++HRDLK N+L++ D KI DFG+AR F + + + V T Y +PE
Sbjct: 124 AN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 649 AAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
+ S +S DV+S G ++ E++ K
Sbjct: 181 ----MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+A G+ +L + +HRDL A NVL+ KI DFG+AR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE L++ SDV+SFG+L+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 13/113 (11%)
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
FD +RA F A + L + +I+RDLK N+LLD + + DFG
Sbjct: 90 FDLSRARFY-----------TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138
Query: 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+ ++ D+ +TNT GT Y++PE ++ D ++ GVL+ E+++G
Sbjct: 139 LCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-07
Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 42/229 (18%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN-----EVTLIARLQHRNLVKL 534
K+G G FG V+ QE + S +G++E + EV ++ L+H+N+V+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 535 LGCCI-QADESMLI-YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YL 588
+ + +A++ + I E+ L I + F ++ H + I R +L Y
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNI-QKCYKMFGKIEE--HAIVDITRQLLHALAYC 134
Query: 589 HQ----DSRMRIIHRDLKASNVLLD-------------NDMN----PKISDFGMARIFGG 627
H + R++HRDLK N+ L N++N KI DFG+++ G
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG- 193
Query: 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSV--KSDVFSFGVLVLEIVSGK 674
I++ H VGT Y SPE S KSD+++ G ++ E+ SGK
Sbjct: 194 --IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLG 536
+G G FG V Q++ A+K LSK + F E ++A +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 109
Query: 537 CCIQADESM-LIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
C Q D+ + ++ EYMP L + +D W K A +L L
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE----KWAKFY-----TAEVVLALDAIHS 160
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI-QTNTHKVVGTYGYMSPEY---- 648
M +IHRD+K N+LLD + K++DFG DE VGT Y+SPE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSG 673
+G + + D +S GV + E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI-FGGDEIQTNTHKVVGTY 641
R + Y+H + + HRDLK N+L + D KI DFG+AR+ F V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 642 GYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGK 674
Y +PE ++ D++S G + E+++GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 63/253 (24%), Positives = 100/253 (39%), Gaps = 70/253 (27%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS----GQGMEEFKNEVTLIA 524
D+F S +G G FG V LV+ G A+K+L K Q + + E ++A
Sbjct: 1 DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILA 56
Query: 525 RLQHRNLVKLLGCCIQADESM-LIYEYMPNKSL-------DFFIFDQARATFLDWQKRIH 576
+ +VKL Q + + LI EY+P + D F ++ R F
Sbjct: 57 EADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR--FY------- 106
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM------------ARI 624
IA IL + ++ IHRD+K N+LLD + K+SDFG+ RI
Sbjct: 107 ----IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 625 FGGDEIQTNT------------------------HKVVGTYGYMSPEYAAEGLFSVKSDV 660
+ VGT Y++PE + ++ + D
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222
Query: 661 FSFGVLVLEIVSG 673
+S GV++ E++ G
Sbjct: 223 WSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD-EIQTNTHKVVG 639
IA +L +H ++ +HRD+K NVLLD + + +++DFG D +Q++ VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV--AVG 165
Query: 640 TYGYMSPEY--AAE---GLFSVKSDVFSFGVLVLEIVSGK 674
T Y+SPE A E G + + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVG 639
+A +L + ++ +HRD+K NVLLD + + +++DFG R+ +Q+N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165
Query: 640 TYGYMSPEY--AAE---GLFSVKSDVFSFGVLVLEIVSGK 674
T Y+SPE A E G + + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 24/166 (14%)
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGIL 586
+ N +KL +LI +Y+ + L FD + L + I+ + +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
LH + IIH D+K NVL D + + D+G+ +I G + + GT Y S
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG----TPSCYD--GTLDYFS 174
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP---DHDHNL 688
PE + V D ++ GVL E+++GK HP D D L
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK------HPFKEDEDEEL 214
|
Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 4/157 (2%)
Query: 517 KNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIH 576
++E+ +A H +VK D+ +LI EY L+ I Q L +Q+ +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEHLPFQE--Y 169
Query: 577 IVGGIARGI-LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
VG + I L L + +++HRDLK++N+ L K+ DFG ++ +
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
GT Y++PE +S K+D++S GV++ E+++
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 56/250 (22%), Positives = 95/250 (38%), Gaps = 61/250 (24%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGS---GQGMEEFKNEVTLIARLQHRN 530
F +G G FG V V+ + A+K L K K E ++A +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VKL D + +Y+P + IF++ A F + + I
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFY--------IAELTCAI 114
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF----------GGDEIQTNT- 634
+H +M IHRD+K N+L+D D + K++DFG+ F GD + ++
Sbjct: 115 ESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 635 ------------------------------HKVVGTYGYMSPEYAAEGLFSVKSDVFSFG 664
H +VGT Y++PE ++ D +S G
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231
Query: 665 VLVLEIVSGK 674
V++ E++ G+
Sbjct: 232 VILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 14/156 (8%)
Query: 518 NEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
+E L+ RL H ++ LL + + L+ +P D + + AR L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 578 VGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
V +AR +L Y+H + IIHRD+K NVL++ + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLE 669
+ + GT +PE A ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 41/216 (18%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-IAVKRLSKGSGQGMEEFKN-EVTLIARLQHRNLVKLLG 536
N +G G FG VY+ ++ E +A+K++ + ++KN E+ ++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 537 C----CIQADESML----IYEYMPNKSLDFFIF----DQARATFL----DWQKRIHIVGG 580
C + +E + + E++P + + A FL +Q
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ-------- 178
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMAR-IFGGDEIQTNTHKVV 638
+ R + Y+H I HRDLK N+L+D N K+ DFG A+ + G Q + +
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVSYIC 232
Query: 639 GTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSG 673
+ Y +PE ++ D++S G ++ E++ G
Sbjct: 233 SRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-05
Identities = 22/81 (27%), Positives = 30/81 (37%), Gaps = 8/81 (9%)
Query: 328 DEFPKYVKLKLPDTSSSWFNASMN-LKECSELCSKN---CSCTAYANSDVERGGSGCLLW 383
DEF K L + N EC+ C KN SC A+ R CL +
Sbjct: 2 DEFCKSAGTTLIKIALKIKTTKANTADECANRCEKNGLPFSCKAFV-FAKARK--QCLWF 58
Query: 384 -FGDLMDMKEYNDGGQDLYIR 403
F + +++ G DLY
Sbjct: 59 PFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
A +L L M IHRD+K N+LLD + K++DFG + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTP 207
Query: 642 GYMSPEY----AAEGLFSVKSDVFSFGVLVLEIVSG 673
Y+SPE +G + + D +S GV + E++ G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 36/211 (17%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVK 533
+G G FG V +K + Q A+K LSK + F E ++A +V+
Sbjct: 51 IGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 534 LLGCCIQADESML--IYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGIL 586
L D+ L + EYMP L ++ I + W + A +L
Sbjct: 108 L--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-------KWARFY-----TAEVVL 153
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
L M IHRD+K N+LLD + K++DFG + VGT Y+SP
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAVGTPDYISP 212
Query: 647 EY----AAEGLFSVKSDVFSFGVLVLEIVSG 673
E +G + + D +S GV + E++ G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 39/180 (21%), Positives = 84/180 (46%), Gaps = 20/180 (11%)
Query: 503 KRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM----LIYEYMPNKSLDF 558
K+ KG ++ +NE+ + R+ N++K+ G I + + LI EY L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 559 FIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ + L ++ ++ + +G+ L++ ++ +++L + + L+ + KI
Sbjct: 112 VLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKII 165
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS---VKSDVFSFGVLVLEIVSGK 674
G+ +I + + K V Y S + + +FS +K D++S GV++ EI +GK
Sbjct: 166 CHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 56/254 (22%), Positives = 95/254 (37%), Gaps = 65/254 (25%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGS---GQGMEEFKNEVTLIARLQHRN 530
F LG G FG V V+ + + A+K L K + K E ++A +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+V+L D + +Y+P + IF + A F IA
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY-----------IAELT 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF----------GGDEIQTNT- 634
+ +M IHRD+K N+L+D D + K++DFG+ F GD ++ ++
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 635 ----------------------------------HKVVGTYGYMSPEYAAEGLFSVKSDV 660
H +VGT Y++PE ++ D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 661 FSFGVLVLEIVSGK 674
+S GV++ E++ G+
Sbjct: 232 WSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 71/243 (29%)
Query: 480 KLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT-------LIARLQH 528
LG+G G V+ LV G+ A+K L K M + +N+V ++A L H
Sbjct: 8 LLGKGDVGRVF---LVRLKGTGKLFALKVLDKKE---MIK-RNKVKRVLTEQEILATLDH 60
Query: 529 RNLVKLLGCCIQADE-SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR---- 583
L L Q + L+ +Y P + F Q + K + +AR
Sbjct: 61 PFLPTLY-ASFQTETYLCLVMDYCPGG--ELFRLLQRQPG-----KCLSEE--VARFYAA 110
Query: 584 ----GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF---------GMARIFGG--- 627
+ YLH + I++RDLK N+LL + +SDF
Sbjct: 111 EVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 628 ---------------DEIQTNTHKVVGTYGYMSPEY-AAEG-LFSVKSDVFSFGVLVLEI 670
+E ++ VGT Y++PE + +G +V D ++ G+L+ E+
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEM 225
Query: 671 VSG 673
+ G
Sbjct: 226 LYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 58/254 (22%), Positives = 95/254 (37%), Gaps = 65/254 (25%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKG---SGQGMEEFKNEVTLIARLQHRN 530
F LG G FG V V+ + A+K L K + + K E ++A +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VKL D + +Y+P + +F + A F IA
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY-----------IAELT 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG------------------- 626
L + +M IHRD+K N+L+D D + K++DFG+ F
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171
Query: 627 --------------GDEIQT------------NTHKVVGTYGYMSPEYAAEGLFSVKSDV 660
GD ++T H +VGT Y++PE ++ D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
Query: 661 FSFGVLVLEIVSGK 674
+S GV++ E++ G+
Sbjct: 232 WSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 16/84 (19%)
Query: 546 LIYEYMPN---KSL--DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
L+ EY+ KSL + FD+ A + +A + YLH+ IIHRD
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKY--------ISEVALALDYLHRHG---IIHRD 129
Query: 601 LKASNVLLDNDMNPKISDFGMARI 624
LK N+L+ N+ + K++DFG++++
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 31/147 (21%), Positives = 59/147 (40%), Gaps = 15/147 (10%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV--KLLGC 537
L G VY + ++ +K S + + + EV ++ L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
S L+ E++ ++LD + +++ I +A + LHQ + +
Sbjct: 62 GESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 598 HRDLKASNVLLDNDMNPKISDFGMARI 624
H DL N+L+D+ I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 26/113 (23%)
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT---- 632
I+ G RG+ YLHQ+ IHR++KAS++L IS G+ + G + +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154
Query: 633 -NTHKVVGTYG--------YMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGK 674
KVV + ++SPE + L ++VKSD++S G+ E+ +G+
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 26/100 (26%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVG 639
+A ++ + ++ +HRD+K N+L+D + + +++DFG ++ +Q++ VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVG 165
Query: 640 TYGYMSPEYA-----AEGLFSVKSDVFSFGVLVLEIVSGK 674
T Y+SPE +G + + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 15/100 (15%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQE-----IAVKRL-SKGSGQ 511
E WEF DN LG G FG V + T G+E +AVK L +
Sbjct: 31 EKWEF-------PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD 83
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEY 550
E +E+ +++ L QH+N+V LLG C ++I EY
Sbjct: 84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 26/165 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKN--------EV 520
++F + +G+G FG V LV+ G+ A+K L K E FK E
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAER 52
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++A +V L A LI E++P L + TF + R ++
Sbjct: 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYM--- 107
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
A +L + ++ IHRD+K N+L+D + K+SDFG++ F
Sbjct: 108 -AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 56/242 (23%), Positives = 94/242 (38%), Gaps = 51/242 (21%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEE---FKNEVTLIAR 525
D+F S +G G FG V LV+ G A+K L K E+ + E ++
Sbjct: 1 DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VK+ LI E++P D + T + + +I A +
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYI----AETV 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM------------------------ 621
L + ++ IHRD+K N+LLD + K+SDFG+
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 622 ----------ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIV 671
A + + Q + VGT Y++PE + ++ D +S GV++ E++
Sbjct: 172 SFQNMNSKRKAETWKKNRRQL-AYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 672 SG 673
G
Sbjct: 231 IG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 47/211 (22%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 481 LGEGGFGPVYKGTLV-----------EGQEIAV--KRLSKGSGQGMEEFKNEVTLIARLQ 527
LG G +Y G L +EI V K L F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H+++V L G C++ E++++ E++ LD F+ ++ W + + +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 588 LHQDSRMRIIHRDLKASNVLL-----DNDMNP--KISDFGMARIFGGDEIQTNTHKVVGT 640
L +D + +H ++ N+LL D + P K+SD G+ + + V
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQECVER 171
Query: 641 YGYMSPEYAAEG-LFSVKSDVFSFGVLVLEI 670
+++PE + S+ +D +SFG + EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 16/156 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEE---FKNEVTLIAR 525
++F S +G G FG V LV+ G A+K L K E+ + E ++
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VK+ LI E++P D + T + + + +I A +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYI----AETV 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
L + ++ IHRD+K N+LLD+ + K+SDFG+
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 18/101 (17%)
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH----------- 635
YLH I+HRDLK N+L+ + + K++DFG+++I G + TN +
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI-GLMSLTTNLYEGHIEKDTREF 171
Query: 636 ---KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+V GT Y++PE + D ++ G+++ E + G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 21/114 (18%), Positives = 43/114 (37%), Gaps = 26/114 (22%)
Query: 517 KNEVTLIARLQHRNLVKLLGCC------IQADESMLIYEYMPNKSLDFFIFDQARATFLD 570
+ E ++A+ + G + D +++ EY+ + L +
Sbjct: 47 RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---------- 90
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
+ R ++ + R + LH + I+H DL SN++L DFG+
Sbjct: 91 EEARPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 46/180 (25%), Positives = 73/180 (40%), Gaps = 38/180 (21%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQGMEEFKNE------VT 521
D+F KLGEG FG VYK +LV + +K+ + G +E + NE
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-------DF------FIF----DQA 564
A + L + + DE L++ Y +L +F ++ D
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 565 RATFLDWQKRIHIVGGIARGILY-LHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMA 622
+ L+ + + I+ I R IL+ L I+HRD+K N++ KI D G A
Sbjct: 248 KG--LERENK--IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 698 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.98 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.98 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.47 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.35 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.39 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.33 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.29 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.15 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.09 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.73 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.72 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.68 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.64 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.62 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.62 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.62 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.53 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.51 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.91 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.89 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.87 | |
| PLN02236 | 344 | choline kinase | 96.82 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.68 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.59 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.53 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.37 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.26 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.09 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.88 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.82 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.79 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.67 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.56 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=389.81 Aligned_cols=231 Identities=48% Similarity=0.855 Sum_probs=202.9
Q ss_pred cccccchhhHHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEE
Q 005400 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538 (698)
Q Consensus 459 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~ 538 (698)
....|++.++.++|++|...+.||+|+||.||+|.+.+|+.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765433156699999999999999999999999
Q ss_pred EeCC-eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEe
Q 005400 539 IQAD-ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (698)
Q Consensus 539 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 617 (698)
.+.. +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999865443 78999999999999999999999998899999999999999999999999
Q ss_pred ecCCCcccCCCccccccccc-cccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccccccc
Q 005400 618 DFGMARIFGGDEIQTNTHKV-VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692 (698)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li~~~ 692 (698)
|||+|+...... ...... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+....+++.++
T Consensus 220 DFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 220 DFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred CccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 999997643211 111112 7999999999999999999999999999999999999999876666566666554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=353.64 Aligned_cols=202 Identities=30% Similarity=0.534 Sum_probs=181.7
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
.++|...++||+|+|++||+|+++ ++..||||.+.+. ..+..+.+..|+++|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888889999999999999985 4789999999876 5566777899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC------CceEEeecCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND------MNPKISDFGMA 622 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~------~~~kl~DFgla 622 (698)
|||.+|+|..++...+ .+++.....++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999996654 4899999999999999999999998 9999999999999764 45899999999
Q ss_pred cccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
+.+.... .....+|++-|||||+++.+.|+.|+|+||+|+||||+++|+.||+...+
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9986443 23447999999999999999999999999999999999999999995544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=332.50 Aligned_cols=205 Identities=26% Similarity=0.430 Sum_probs=182.6
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|+++++||+|+||+|+.++.++ ++.+|+|++++. .....+..++|..+|.+++||+||+++-.|+++..+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35789999999999999999998754 888999999876 33456788999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|+||+.||.|..+|.++. .+++..+.-++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++.-.
T Consensus 103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999996543 4788888888999999999999999 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
.... .+...+||+.|||||++....|+..+|.||||+++|||++|.+||...+..
T Consensus 177 ~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~ 231 (357)
T KOG0598|consen 177 KDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK 231 (357)
T ss_pred cCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH
Confidence 3322 233479999999999999999999999999999999999999999876643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.57 Aligned_cols=201 Identities=37% Similarity=0.623 Sum_probs=175.3
Q ss_pred ccCceeeecceeEEEEEeccccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-eeEEEEEecCC
Q 005400 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-ESMLIYEYMPN 553 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~-~~~lV~E~~~~ 553 (698)
+.+.||+|+||+||+|.+.....||||++..... ...++|.+|+.+|.+++|||||+++|+|.++. ...||||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3456999999999999995444499999976532 22568999999999999999999999999988 79999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-ceEEeecCCCcccCCCcccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFgla~~~~~~~~~~ 632 (698)
|+|..++... ....+++..+++++.|||+||.|||++.+ ||||||||.|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999764 45569999999999999999999999874 99999999999999997 99999999998764332 1
Q ss_pred ccccccccccccChhccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAA--EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~--~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
......||..|||||++. ...|+.|+|||||||+||||+||+.||+..++
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 222268999999999999 56999999999999999999999999997765
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=348.22 Aligned_cols=207 Identities=28% Similarity=0.429 Sum_probs=186.8
Q ss_pred cCccccCceeeecceeEEEEEe-ccccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+...+||+|.+.++|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688889999999999999997 77999999999875 4456678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
|+|++++|..++. +++.+++.+++.+.+||+.||.|||+.+ |+|||||..|++|+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999885 4456999999999999999999999998 999999999999999999999999999988765
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~ 687 (698)
..+.. ..+||+.|+|||++....++..+||||+|||||-||.|++||+.....+..+
T Consensus 172 ~Erk~--TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~ 228 (592)
T KOG0575|consen 172 GERKK--TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN 228 (592)
T ss_pred ccccc--eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH
Confidence 44333 3799999999999999999999999999999999999999999765544433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=324.76 Aligned_cols=209 Identities=30% Similarity=0.410 Sum_probs=179.6
Q ss_pred ccccCceeeecceeEEEEEecc-ccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-eeEEEEEec
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-ESMLIYEYM 551 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~-~~~lV~E~~ 551 (698)
.+.++.||+|..|+|||++++. ++-+|+|.+... .+...+++.+|++++++.+||+||.++|.|..+. ...|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 4455789999999999999864 778999999544 4556778999999999999999999999999998 499999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++|+|+.++... +.+++..+-+|+.++++||.|||+.. .||||||||+|||++..|++||+|||.+..+-+.
T Consensus 161 DgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999999654 34889999999999999999999732 3999999999999999999999999999876543
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CCCCcccccccc
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS--HPDHDHNLLGHV 692 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~--~~~~~~~li~~~ 692 (698)
......||..|||||.+.+..|+.++||||||+.++|+.+|+.||... .+....+|+.++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I 294 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI 294 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence 223478999999999999999999999999999999999999999854 223344454443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.02 Aligned_cols=213 Identities=34% Similarity=0.589 Sum_probs=184.8
Q ss_pred ccccccchhhHHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEE
Q 005400 458 MELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537 (698)
Q Consensus 458 ~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~ 537 (698)
...|+++.+++.. .++||+|.||.|+.|.+....+||+|.++.. ....++|.+|+++|++++|+|||+++++
T Consensus 198 ~d~wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV 269 (468)
T KOG0197|consen 198 RDPWEIPREELKL-------IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGV 269 (468)
T ss_pred cCCeeecHHHHHH-------HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEE
Confidence 3456677666543 4789999999999999977779999999764 3456789999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEe
Q 005400 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (698)
Q Consensus 538 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 617 (698)
|..+..++||||||+.|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++|||++++..+||+
T Consensus 270 ~~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIs 345 (468)
T KOG0197|consen 270 CTKQEPIYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKIS 345 (468)
T ss_pred EecCCceEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEc
Confidence 9998899999999999999999976 34456889999999999999999999998 9999999999999999999999
Q ss_pred ecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005400 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPD 683 (698)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~ 683 (698)
|||||+....+.+.. .....-+..|.|||.+..+.++.|+|||||||+||||+| |+.||......
T Consensus 346 DFGLAr~~~d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ 411 (468)
T KOG0197|consen 346 DFGLARLIGDDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE 411 (468)
T ss_pred ccccccccCCCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence 999999665544433 333456789999999999999999999999999999999 88888755443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=314.11 Aligned_cols=206 Identities=26% Similarity=0.456 Sum_probs=180.0
Q ss_pred cCccccCceeeecceeEEEEEe-ccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEE-EEEeCCe-eEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG-CCIQADE-SMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~-~~~~~~~-~~lV 547 (698)
.+|.+.++||+|.||+|||+.. .+|..+|.|.+... +.+..+....|+.+|++++|||||++++ .+.+... ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4588889999999999999974 57999999998754 4556678999999999999999999998 5555555 8999
Q ss_pred EEecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 548 YEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSR-MRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
||++..|+|..++..- ..+..+++..+++++.|++.||..+|.+-+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998743 345579999999999999999999999432 23999999999999999999999999999998
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.+... .....+|||.||+||.+.+..|+.|+||||+||++|||..-+.||...
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 76543 344589999999999999999999999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=319.37 Aligned_cols=203 Identities=28% Similarity=0.467 Sum_probs=172.1
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCC-------cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSG-------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~-------~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+... .......+|+++|++++|||||++++++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35677889999999999999975 4699999999976521 122335799999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC---CceEEeecC
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFG 620 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFg 620 (698)
.|||||||++|.|.+.+..+. .+.+..-..+++|++.|+.|||+++ |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999986543 3667777889999999999999999 9999999999999765 779999999
Q ss_pred CCcccCCCccccccccccccccccChhcccCCC--C-CcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL--F-SVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~-~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
+|+..+... .+...+||+.|.|||++.+.. + ..++|+||+||+||-+++|.+||..+..+
T Consensus 325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 999876332 334589999999999997654 3 34889999999999999999999865443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=301.60 Aligned_cols=201 Identities=30% Similarity=0.445 Sum_probs=181.5
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++++.||.|+||.|.+++.+. |.-+|+|++++.. -++.++..+|..+|+.+.||+++++++.+.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3678888999999999999999764 7789999998762 34566788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++|.|..++++.++ +++.....+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999966443 888899999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
. +...+||+.|+|||++....|+..+|.|+|||++|||+.|..||....+.
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~ 247 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI 247 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence 2 34489999999999999999999999999999999999999999877664
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=340.05 Aligned_cols=217 Identities=32% Similarity=0.505 Sum_probs=187.5
Q ss_pred cCccccCceeeecceeEEEEEecc------ccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
.+....++||+|+||+||+|+... .+.||||.++..... ..++|++|+++++.++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 445566899999999999998543 457999999887554 7789999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 546 LIYEYMPNKSLDFFIFDQAR-----------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
+|+|||..|+|.++|..... ...|+..+.+.||.|||.||+||-++. +|||||..+|+|+.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999974321 234889999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccccc
Q 005400 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHV 692 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~~~~~li~~~ 692 (698)
||+||||++.+.+.++........-+.+|||||.|..+.++.++|||||||+|||+++ |+.||....-+|-.++|++-
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 9999999998776666554444566889999999999999999999999999999998 99999766555555555443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.68 Aligned_cols=210 Identities=25% Similarity=0.382 Sum_probs=183.3
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|++++.||+|+||.||.++.+ .|..+|+|++++. .....+.++.|-.+|....+|.||+|+-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3578999999999999999999865 4889999999876 45567889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||++||++..+|.+. ..|++.....++.+++-|+..||+.+ +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999543 45889999999999999999999999 9999999999999999999999999975432
Q ss_pred CC----------------------ccc------cc-----------------cccccccccccChhcccCCCCCcchhHH
Q 005400 627 GD----------------------EIQ------TN-----------------THKVVGTYGYMSPEYAAEGLFSVKSDVF 661 (698)
Q Consensus 627 ~~----------------------~~~------~~-----------------~~~~~gt~~y~APE~l~~~~~~~k~DVw 661 (698)
.. +.. .. ....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 00 0024799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCcc
Q 005400 662 SFGVLVLEIVSGKKNWRFSHPDHDH 686 (698)
Q Consensus 662 SlGvil~elltG~~pf~~~~~~~~~ 686 (698)
|||||+||||.|-+||..+.|.+.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~ 397 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETY 397 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999988887643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=321.96 Aligned_cols=197 Identities=28% Similarity=0.503 Sum_probs=177.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.. .+..+.+.+|++|++.++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788899999999999999865 47889999998763 3456779999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+.+ +|..+|.... .+++..+..|+.+++.||.|||+.. |+|||+||+||||+..+.+|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999996544 4899999999999999999999988 9999999999999999999999999999876543
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
. ....+.||+-|||||+..+++|+..+|+||+||||||+.+|++||-
T Consensus 155 ~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 155 S--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred e--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 2 2234789999999999999999999999999999999999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.65 Aligned_cols=219 Identities=31% Similarity=0.550 Sum_probs=183.3
Q ss_pred cccccchhhHHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEE
Q 005400 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536 (698)
Q Consensus 459 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~ 536 (698)
+.|++.++++ .+.+.||+|.||+||+|++. ..||||++... ..+..++|++|+..+++.+|.||+-+.|
T Consensus 385 ~~WeIp~~ev-------~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG 455 (678)
T KOG0193|consen 385 EEWEIPPEEV-------LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG 455 (678)
T ss_pred cccccCHHHh-------hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence 4555665554 45578999999999999984 47999999765 4457889999999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 537 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
+|..+.. .||+.+|++.+|..+|+... ..++..+.+.||+||++||.|||.++ |||||||..||+|.++++|||
T Consensus 456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 456 ACMNPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred hhcCCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEE
Confidence 9998877 99999999999999997543 34889999999999999999999998 999999999999999999999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccccccc
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG---LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li~~~ 692 (698)
+||||+..-..-.........-|...|||||+++.+ +|++.+||||||+++|||+||..||....++...-.+++-
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG 608 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG 608 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence 999998753322111222234578899999998643 6899999999999999999999999977777766666543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.04 Aligned_cols=210 Identities=27% Similarity=0.411 Sum_probs=177.4
Q ss_pred cCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~lV 547 (698)
+.|+.+++||+|.||.|||++. .+|+.||+|++.... +....-..+||.||++++||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4577778999999999999985 468999999987653 44555668999999999999999999998876 689999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
+|||+. +|.-++... .-.++..++..+++|++.||+|+|..+ |+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999976 555555332 234889999999999999999999998 99999999999999999999999999998766
Q ss_pred CccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccccc
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li 689 (698)
......+. .+-|..|.|||++.+. .|+..+|+||.||||.||++|++.|+.....+..+.|
T Consensus 271 ~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI 332 (560)
T KOG0600|consen 271 SGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI 332 (560)
T ss_pred CCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH
Confidence 55443333 6789999999988765 7999999999999999999999999876655444433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.52 Aligned_cols=206 Identities=30% Similarity=0.457 Sum_probs=180.2
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
+...+|...+.||+|+|++|++++.. .++++|||++.+. .++..+-+..|-++|.+| .||.|++|+-.|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 44567888899999999999999864 5889999999765 234445677899999999 899999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
|+|+||.++|+|..+|.+.+ .+++.....++.+|+.||+|||+.+ ||||||||+|||||.++++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999996653 4888888999999999999999999 99999999999999999999999999998
Q ss_pred cCCCccc---------ccc--ccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 625 FGGDEIQ---------TNT--HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~---------~~~--~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+...... ... ...+||..|.+||++.....++.+|+|+||||||+|+.|++||....
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 8543221 111 33789999999999999999999999999999999999999997654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.75 Aligned_cols=202 Identities=24% Similarity=0.403 Sum_probs=173.1
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
+.|+.+.++|+|++|.|||++.++ |+.||||++.... +...+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 357777899999999999999865 9999999996553 2334557899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|++..-|+++-. .. .-++...+.+++.|+++|+.|+|+++ +|||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~dhTvL~eLe~-~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELER-YP--NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHh-cc--CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 998877765542 22 23788889999999999999999998 9999999999999999999999999999876321
Q ss_pred cccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
......+.|..|.|||.+.+ ..|+..+|||++||++.||++|++.|..+..
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 12234688999999999877 5899999999999999999999999986543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=314.59 Aligned_cols=201 Identities=31% Similarity=0.537 Sum_probs=177.0
Q ss_pred ccccccccchhhHHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEE
Q 005400 456 EDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535 (698)
Q Consensus 456 ~~~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~ 535 (698)
...++|++.+++|.+ ++-||.|+-|.||+|++ .++.||||+++.-. ..+|+-|++|+||||+.+.
T Consensus 114 qq~e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~Fk 178 (904)
T KOG4721|consen 114 QQEELWEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFK 178 (904)
T ss_pred hhhhhccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEe
Confidence 345789999988755 36899999999999999 57899999875322 3578899999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceE
Q 005400 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (698)
Q Consensus 536 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 615 (698)
|+|.....++||||||..|-|...|... ..+.......+..+||.||.|||.+. |||||||.-||||..+..+|
T Consensus 179 GVCtqsPcyCIiMEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 179 GVCTQSPCYCIIMEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred eeecCCceeEEeeeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEE
Confidence 9999999999999999999999999543 34777888899999999999999998 99999999999999999999
Q ss_pred EeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
|+|||-++.+... .+. ....||..|||||++++.+.+.|+|||||||+|||||||..||..-
T Consensus 253 IsDFGTS~e~~~~--STk-MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 253 ISDFGTSKELSDK--STK-MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred eccccchHhhhhh--hhh-hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 9999999876533 233 3478999999999999999999999999999999999999999853
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=306.41 Aligned_cols=198 Identities=32% Similarity=0.534 Sum_probs=169.5
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhc--CCCeeeeEEEEEEeCC----eeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL--QHRNLVKLLGCCIQAD----ESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l--~H~nIv~l~~~~~~~~----~~~l 546 (698)
+.....++||+|.||.||||.+ +++.||||++.. +..+.|.+|-+|.+.. +|+||+++++.-.... ++.|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4455667899999999999999 459999999964 4567788998888765 7999999999977666 8999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD------SRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
|+||.+.|+|.++|.. ..++|.+..+|+..+++||+|||+. .+++|+|||||++|||+.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999954 4589999999999999999999975 45789999999999999999999999999
Q ss_pred CCcccCCCccccccccccccccccChhcccCCC-CC-----cchhHHHHHHHHHHHHhCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL-FS-----VKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~-----~k~DVwSlGvil~elltG~~pf~ 678 (698)
||..+............+||.+|||||++.+.. +. .+.||||+|.+||||++.-..+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 999887665555566679999999999986543 22 35899999999999999776654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=310.39 Aligned_cols=204 Identities=27% Similarity=0.458 Sum_probs=177.3
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC----CC-cchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCC
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG----SG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQAD 542 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~----~~-~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~ 542 (698)
...++|.+.+.||+|.||+|+.|... .++.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999764 5899999987654 12 23456778999999999 999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC-CceEEeecCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGM 621 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFgl 621 (698)
..++||||+.+|+|.+++.+. ..+.+.+...++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999999663 34778999999999999999999998 9999999999999999 9999999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL-FS-VKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~-~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+...... .......+||+.|+|||++.... |+ .++||||+||+||.|++|+.||+...
T Consensus 168 s~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 168 SAISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred ccccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 9987311 12233478999999999999877 85 78999999999999999999999744
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=282.84 Aligned_cols=205 Identities=28% Similarity=0.461 Sum_probs=175.7
Q ss_pred cCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|...++||+|.||.||+|+. ..|+.||||+++.... .......+|++.|+.++|+||+.++++|-......||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577788999999999999986 4599999999976532 224567899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
||+. +|...+.. +...++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9964 78887754 3456899999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~ 685 (698)
..... .+-|..|.|||.+.+. .|+..+||||.|||+.||+-|.+-|......+.
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ 210 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ 210 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH
Confidence 33322 3789999999988664 699999999999999999999988876554333
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.98 Aligned_cols=209 Identities=29% Similarity=0.499 Sum_probs=185.6
Q ss_pred cCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
..|...++||+|+.|.||.++. ..++.||||++........+-+.+|+.+|+..+|+|||.++..+...++++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4567778999999999999975 458899999998776666778899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++|+|.+.+. ...+++.++..|++++++||+|||.++ |+|||||..|||++.++.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999998883 344899999999999999999999998 99999999999999999999999999987755443
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccccc
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG 690 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li~ 690 (698)
.....+||+.|||||++....|++|+||||||++++||+-|++||-.+.|..-.-||.
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa 482 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 482 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh
Confidence 2234789999999999999999999999999999999999999999877765554443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.29 Aligned_cols=208 Identities=27% Similarity=0.437 Sum_probs=181.4
Q ss_pred HhhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCee
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADES 544 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~ 544 (698)
...++|..+++||+|.||+|+++.++. ++.+|||.+++. .....+..+.|.+|+..+. ||.++.++.+|+.++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999998764 778999999887 3566788899999998885 99999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
+.||||+.||++..+. ....+++..+.-+|..|+.||.|||+++ ||+||||..|||||.+|.+||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999943332 3345889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~ 686 (698)
-..... .+...+||+.|||||++.+..|+..+|.|||||+|||||.|+.||...+.++..
T Consensus 518 ~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F 577 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF 577 (694)
T ss_pred cCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 432222 344589999999999999999999999999999999999999999966555433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=300.27 Aligned_cols=202 Identities=32% Similarity=0.514 Sum_probs=172.0
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC--eeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~--~~~lV~E 549 (698)
.++...+.||+|+||.||++...+ |+..|||.+........+.+.+|+++|.+++|||||+.+|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 446667899999999999998765 8999999987654333677899999999999999999999854444 6899999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-CCceEEeecCCCcccCC-
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGG- 627 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFgla~~~~~- 627 (698)
|+++|+|.+++.+.+. .+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999976543 4899999999999999999999998 999999999999999 79999999999987653
Q ss_pred CccccccccccccccccChhcccCCC-CCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
...........||+.|||||++..+. ...++|||||||++.||+||++||..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 11112233478999999999998643 34599999999999999999999985
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.37 Aligned_cols=204 Identities=25% Similarity=0.372 Sum_probs=175.3
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||+||+++.. .++.||+|++.+.. ......+.+|++++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 48899999997532 234457889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|..++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998653 34889999999999999999999988 999999999999999999999999998754321
Q ss_pred ccc---------------------------------cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCC
Q 005400 629 EIQ---------------------------------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675 (698)
Q Consensus 629 ~~~---------------------------------~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~ 675 (698)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00112479999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 005400 676 NWRFSHP 682 (698)
Q Consensus 676 pf~~~~~ 682 (698)
||....+
T Consensus 235 Pf~~~~~ 241 (363)
T cd05628 235 PFCSETP 241 (363)
T ss_pred CCCCCCH
Confidence 9976544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=293.54 Aligned_cols=208 Identities=25% Similarity=0.381 Sum_probs=180.3
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.+.|++.++||.|..++||+|+. ..+..||||++... .....+.+.+|+..|..++||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46788889999999999999985 45789999999765 33447889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
||.+|++.+++...-.. -+++..+..|++++++||.|||+++ .||||||+.||||+++|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999998754333 3889999999999999999999999 9999999999999999999999999976653321
Q ss_pred --cccccccccccccccChhcccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 630 --IQTNTHKVVGTYGYMSPEYAAEG--LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 630 --~~~~~~~~~gt~~y~APE~l~~~--~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
.........||+.|||||+++.. -|+.|+||||||+...||.+|+.||....|-
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 11221446899999999997654 5899999999999999999999999877664
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.44 Aligned_cols=202 Identities=30% Similarity=0.506 Sum_probs=175.3
Q ss_pred ccccCceeeecceeEEEEEecc----ccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..+.+.||.|.||+|++|+++- ...||||.++.. .++...+|+.|+.||.+++||||++|.|+........||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3567899999999999999853 346999999876 45567789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
||++|+|+.+|.++. ..+.+.++..++++||.||.||.+.+ +|||||.++|||++.+..+||+||||++.+..+.
T Consensus 711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999997654 34888899999999999999999988 9999999999999999999999999999876544
Q ss_pred cc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 630 IQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 630 ~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.. ..+....-+.+|.|||.+....++..+||||||++|||.++ |++||-...
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 21 11111223679999999999999999999999999999886 999996544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=304.60 Aligned_cols=207 Identities=30% Similarity=0.467 Sum_probs=171.4
Q ss_pred hcCccccCceeeecceeEEEEEe------ccccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCC-
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD- 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~- 542 (698)
.++|.+.++||+|+||.||+|.. ..++.||+|++.... ....+.+.+|++++.++ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788889999999999999974 235679999987543 23456789999999999 8999999999987654
Q ss_pred eeEEEEEecCCCChhHHHhhccc---------------------------------------------------------
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQAR--------------------------------------------------------- 565 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 565 (698)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864321
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccc
Q 005400 566 --ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643 (698)
Q Consensus 566 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y 643 (698)
...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788889999999999999999988 999999999999999999999999999865432222222224567889
Q ss_pred cChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 644 ~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
+|||++....++.++||||||++||||++ |+.||....
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999998899999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=328.63 Aligned_cols=209 Identities=33% Similarity=0.575 Sum_probs=180.8
Q ss_pred cCccccCceeeecceeEEEEEecc--cc----EEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE--GQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~--g~----~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
++.+..+.||+|+||.||+|...+ |. .||+|.+++. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344556789999999999998754 33 4899999876 5567788999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 546 LIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
|++|||++|+|..+|.+... ...+...+++.++.|||+|+.||++++ +|||||..+|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999976521 346899999999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDH 684 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~~ 684 (698)
|+.+...++........-+.+|||||.+..+.++.|+|||||||+|||++| |..||...+..+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~ 912 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE 912 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence 996655444333333355689999999999999999999999999999999 889998766544
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=309.42 Aligned_cols=203 Identities=25% Similarity=0.390 Sum_probs=173.0
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.|+.+++||+|+||+||+++.. +++.||+|++.+. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 4789999999654 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998643 34788888899999999999999988 9999999999999999999999999976431100
Q ss_pred c---------------------------------------------ccccccccccccccChhcccCCCCCcchhHHHHH
Q 005400 630 I---------------------------------------------QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFG 664 (698)
Q Consensus 630 ~---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlG 664 (698)
. ........||+.|+|||++....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001124699999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCCC
Q 005400 665 VLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 665 vil~elltG~~pf~~~~~ 682 (698)
|++|||++|+.||....+
T Consensus 236 ~il~elltG~~Pf~~~~~ 253 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP 253 (381)
T ss_pred hHHHHHHhCCCCCcCCCH
Confidence 999999999999975544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=298.29 Aligned_cols=199 Identities=23% Similarity=0.367 Sum_probs=174.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999875 58899999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999998543 34788999999999999999999998 999999999999999999999999999865332
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....+
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1225689999999999988899999999999999999999999975543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=300.17 Aligned_cols=201 Identities=28% Similarity=0.431 Sum_probs=173.9
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHH--HHHHHHHhhcC-CCeeeeEEEEEEeCC-eeE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEF--KNEVTLIARLQ-HRNLVKLLGCCIQAD-ESM 545 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~--~~Ei~il~~l~-H~nIv~l~~~~~~~~-~~~ 545 (698)
..++|.++++||.|.||.||+|+.. .+..||||++++.-.. .++. ++|++.|+++. |||||++.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3467899999999999999999854 5889999999876433 3333 68999999998 999999999999888 999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+|||||+. +|.+++..+ +..+++..+..|+.||++||+|+|.++ +.|||+||+|||+.....+||+|||||+.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999965 677776543 667999999999999999999999999 999999999999998899999999999987
Q ss_pred CCCccccccccccccccccChhcc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYA-AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l-~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.+.... ...+.|..|.|||++ +...|+.+.|||++|||++||.+-++.|....
T Consensus 161 ~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 161 RSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred ccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 665433 346889999999976 56689999999999999999999999997543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=303.58 Aligned_cols=200 Identities=25% Similarity=0.366 Sum_probs=175.0
Q ss_pred hcCccccCceeeecceeEEEEEecc--ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~--g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
.++|++.+.||+|+||.||+|+... +..||+|++.+. .....+.+.+|+++++.++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999998644 368999998643 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++++||+|||++..+.
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999998653 34888999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred CCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 321 235789999999999988899999999999999999999999976544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.66 Aligned_cols=200 Identities=30% Similarity=0.489 Sum_probs=173.1
Q ss_pred ccccCceeeecceeEEEEEe-ccccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 475 FASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
|+..+.||+|+||.||++.. .+++.||+|.+.+.. ......+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67778999999999999986 468999999986542 23344678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999988875432 235889999999999999999999988 99999999999999999999999999986533221
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 123568999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=309.10 Aligned_cols=204 Identities=24% Similarity=0.341 Sum_probs=173.2
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|.+.++||+|+||.||+++.. +++.||+|++.+. .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999864 5889999998653 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999988543 34788888999999999999999998 999999999999999999999999998643210
Q ss_pred cc-------------c--------------------------------cccccccccccccChhcccCCCCCcchhHHHH
Q 005400 629 EI-------------Q--------------------------------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSF 663 (698)
Q Consensus 629 ~~-------------~--------------------------------~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSl 663 (698)
.. . .......||+.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 00011469999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCC
Q 005400 664 GVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 664 Gvil~elltG~~pf~~~~~ 682 (698)
||++|||++|+.||....+
T Consensus 235 Gvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS 253 (377)
T ss_pred chhhhhhhcCCCCCCCCCH
Confidence 9999999999999975443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=302.13 Aligned_cols=199 Identities=25% Similarity=0.372 Sum_probs=175.2
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999875 4789999998653 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999988653 34788888899999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
. ....||+.|+|||++....++.++|||||||++|||++|+.||....+
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 2 125789999999999999999999999999999999999999975443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=303.28 Aligned_cols=199 Identities=26% Similarity=0.414 Sum_probs=175.7
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.++||+|+||.||+++.. .++.||+|++.+.. ....+.+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 48899999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999998543 34788999999999999999999998 99999999999999999999999999976433
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....+
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 12235789999999999988999999999999999999999999976544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=307.05 Aligned_cols=204 Identities=25% Similarity=0.389 Sum_probs=175.0
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||.||+++.. .++.||||++... .......+.+|++++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999875 5889999999753 2334556889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998653 34889999999999999999999998 999999999999999999999999998754321
Q ss_pred cccc------------------------------------ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh
Q 005400 629 EIQT------------------------------------NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672 (698)
Q Consensus 629 ~~~~------------------------------------~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt 672 (698)
.... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0012368999999999999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 005400 673 GKKNWRFSHP 682 (698)
Q Consensus 673 G~~pf~~~~~ 682 (698)
|+.||....+
T Consensus 235 G~~Pf~~~~~ 244 (364)
T cd05599 235 GYPPFCSDNP 244 (364)
T ss_pred CCCCCCCCCH
Confidence 9999975443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=308.55 Aligned_cols=203 Identities=24% Similarity=0.395 Sum_probs=172.7
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.|+.+++||+|+||.||+++.. .++.+|+|++.+.. ....+.+.+|++++++++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999874 47889999986542 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++|+|..++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999988543 34788888899999999999999998 9999999999999999999999999975321100
Q ss_pred ---------------------------------------------cccccccccccccccChhcccCCCCCcchhHHHHH
Q 005400 630 ---------------------------------------------IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFG 664 (698)
Q Consensus 630 ---------------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlG 664 (698)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCC
Q 005400 665 VLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 665 vil~elltG~~pf~~~~~ 682 (698)
|+||||++|+.||....+
T Consensus 236 vil~elltG~~Pf~~~~~ 253 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHHHHhCCCCCCCCCH
Confidence 999999999999976544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=280.40 Aligned_cols=203 Identities=26% Similarity=0.383 Sum_probs=171.3
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCc--chHHHHHHHHHHhhcCCCeeeeEEEEEEe--CCeeEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ--GMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESML 546 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--~~~~~l 546 (698)
.+.|+.+++|++|.||.||+|+.+ +++.||+|+++..... -.-.-.+||.+|.+++|||||.+..+... -+..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 456888899999999999999875 4788999999754321 12345889999999999999999988764 356999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|||||+. +|..++.... ..+...++..+..|+++|++|||... |+||||||+|+|+...|.+||+|||||+.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999975 6777775543 35788889999999999999999998 9999999999999999999999999999887
Q ss_pred CCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.... .....+-|..|.|||.+.+. .|+...|+||+|||+.||+++++.|.....
T Consensus 229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 6532 23346789999999988765 699999999999999999999999986543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=307.92 Aligned_cols=204 Identities=25% Similarity=0.390 Sum_probs=173.5
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
+|++++.||+|+||.||+++.. .++.||+|++.+. .....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999864 4889999998653 22345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++|+|.+++.+. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999998543 34788888899999999999999988 9999999999999999999999999975321000
Q ss_pred -----------------------------------------cccccccccccccccChhcccCCCCCcchhHHHHHHHHH
Q 005400 630 -----------------------------------------IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVL 668 (698)
Q Consensus 630 -----------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ 668 (698)
.........||+.|||||++....++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011246999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCC
Q 005400 669 EIVSGKKNWRFSHPD 683 (698)
Q Consensus 669 elltG~~pf~~~~~~ 683 (698)
||++|+.||....+.
T Consensus 236 ell~G~~Pf~~~~~~ 250 (376)
T cd05598 236 EMLVGQPPFLADTPA 250 (376)
T ss_pred ehhhCCCCCCCCCHH
Confidence 999999999865543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.46 Aligned_cols=200 Identities=33% Similarity=0.499 Sum_probs=171.8
Q ss_pred cccCceeeecceeEEEEEeccc-----cEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 476 ASYNKLGEGGFGPVYKGTLVEG-----QEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~~~g-----~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
...++||+|+||.||+|++... ..||||..+.. .....++|++|+++|++++|||||+++|++.....++||
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 3447999999999999987542 23899998742 456778999999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
||+|.||+|.++|.+... .++..+++.++.+.|.||+|||+.+ ++||||..+|+|++.++.+||+||||++.-..
T Consensus 240 mEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 999999999999976543 5899999999999999999999998 99999999999999999999999999876431
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
.........-+.+|+|||.+....++.++|||||||++||+++ |..||.....
T Consensus 315 --~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 315 --YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred --eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 1111111245789999999999999999999999999999999 7889875543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.15 Aligned_cols=205 Identities=23% Similarity=0.316 Sum_probs=174.4
Q ss_pred HHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
....++|++.+.||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+++++.++||||+++++++..+...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999875 4788999998643 223345688999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++|+|..++... .++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999988432 3788889999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccChhcccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGL----FSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+..... .......||+.|+|||++.... ++.++|||||||++|||++|+.||....
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 643221 1122357999999999986543 7889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=301.95 Aligned_cols=198 Identities=28% Similarity=0.415 Sum_probs=174.7
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
+-|+..+.||+|+-|.|-.|++. .|+.+|||++.+. .......+.+|+-||+.+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 44666788999999999999874 5999999999765 2233456789999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|.|.+++...+ .+.+.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999996543 4888999999999999999999998 999999999999999999999999999874333
Q ss_pred ccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
. .....+|.+.|.|||++++.+| +.++||||.|||||.||||+.||..
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 2 2233699999999999999998 5789999999999999999999983
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=298.04 Aligned_cols=194 Identities=25% Similarity=0.351 Sum_probs=168.5
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
+.||+|+||.||+++.. +|+.||+|++++. .......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 5889999998754 2234456789999999999999999999999999999999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccc
Q 005400 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634 (698)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 634 (698)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 998888543 35889999999999999999999998 99999999999999999999999999875322211 12
Q ss_pred ccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 635 ~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 2357999999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=289.69 Aligned_cols=208 Identities=27% Similarity=0.435 Sum_probs=170.5
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--------------cchHHHHHHHHHHhhcCCCee
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--------------QGMEEFKNEVTLIARLQHRNL 531 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--------------~~~~~~~~Ei~il~~l~H~nI 531 (698)
+-.+..++|++.+.||+|.||.|-+++.. +++.||||++.+... ...+...+||.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 33455688999999999999999999864 588999999976421 123578999999999999999
Q ss_pred eeEEEEEEeC--CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 532 VKLLGCCIQA--DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 532 v~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
|+|+.+..++ +.+|||+|||..|.+... ......++..+.++++.+++.||+|||.++ ||||||||.|+||+
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 9999998764 579999999999887432 122223899999999999999999999999 99999999999999
Q ss_pred CCCceEEeecCCCcccCCC---ccccccccccccccccChhcccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 610 NDMNPKISDFGMARIFGGD---EIQTNTHKVVGTYGYMSPEYAAEGL----FSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~---~~~~~~~~~~gt~~y~APE~l~~~~----~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+++++||+|||.+...... ..........||+.|+|||....+. .+.+.||||+||.||.|+.|+.||-..
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9999999999999866221 1112223478999999999886632 356789999999999999999999643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=286.61 Aligned_cols=198 Identities=26% Similarity=0.490 Sum_probs=178.7
Q ss_pred cCccccCceeeecceeEEEEEe-ccccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
.+|++.+.||+|.||+|-++.. ..|+.||||.+++. +.+..-.+++|++||..++||||+.++.+|+..+..+|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5678888999999999999975 67999999999876 3455667899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||..+|.|.+++.+.+ .|++.+...+++||..|+.|+|.+. ++|||||.+|||||.++++||+||||+.++...
T Consensus 133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999996543 4899999999999999999999988 999999999999999999999999999887554
Q ss_pred ccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.. .+..+|++-|.+||++.+.+| ++.+|-|||||+||-|+.|..||+.
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 32 334799999999999999988 5899999999999999999999974
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=296.46 Aligned_cols=195 Identities=24% Similarity=0.357 Sum_probs=168.6
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
+.||+|+||.||+++.. +|+.||+|++... .......+.+|+++++.++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999998754 2234556788999999999999999999999999999999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccc
Q 005400 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634 (698)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 634 (698)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 998887543 34889999999999999999999998 99999999999999999999999999875322211 11
Q ss_pred ccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 635 ~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 23568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.89 Aligned_cols=196 Identities=25% Similarity=0.358 Sum_probs=169.7
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999999754 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccc
Q 005400 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634 (698)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 634 (698)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 152 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM 152 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence 998887543 34889999999999999999999988 99999999999999999999999999875322211 12
Q ss_pred ccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 635 ~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 235789999999999988999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.62 Aligned_cols=205 Identities=25% Similarity=0.373 Sum_probs=175.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||.||+++.. .++.||+|++... .......+.+|++++.+++||||+++++.+.+....++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999875 4889999998653 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998543 34888999999999999999999998 999999999999999999999999998754221
Q ss_pred ccc---------------------------------cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCC
Q 005400 629 EIQ---------------------------------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675 (698)
Q Consensus 629 ~~~---------------------------------~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~ 675 (698)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 000 00112469999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 005400 676 NWRFSHPD 683 (698)
Q Consensus 676 pf~~~~~~ 683 (698)
||....+.
T Consensus 235 Pf~~~~~~ 242 (360)
T cd05627 235 PFCSETPQ 242 (360)
T ss_pred CCCCCCHH
Confidence 99765543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=294.04 Aligned_cols=192 Identities=23% Similarity=0.336 Sum_probs=167.6
Q ss_pred eeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
||+|+||.||+++.. +++.||+|++.+. .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 4788999998653 234456788999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccccc
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (698)
..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 9988643 34889999999999999999999988 99999999999999999999999999876432221 1223
Q ss_pred ccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 637 ~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 57999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=302.08 Aligned_cols=207 Identities=23% Similarity=0.315 Sum_probs=175.5
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~ 542 (698)
++....++|++.+.||+|+||.||+++.. .++.+|+|++.+. .....+.+.+|+++++.++||||+++++.+.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455688999999999999999999875 4788999998643 2233456789999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++||||+++++|..++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 999999999999999988532 3778888899999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhcccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEG----LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..+...... ......||+.|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 190 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 190 MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 876432211 12235799999999998654 37889999999999999999999997544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=302.63 Aligned_cols=204 Identities=24% Similarity=0.327 Sum_probs=173.4
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|++.++||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+++++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567999999999999999999875 4789999998643 22334567899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++|+|..++... .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988532 3678888899999999999999988 9999999999999999999999999998654
Q ss_pred CCccccccccccccccccChhcccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEG----LFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
..... ......||+.|+|||++... .++.++|||||||++|||++|+.||.....
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 33211 11235799999999998653 478899999999999999999999975443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=297.15 Aligned_cols=207 Identities=31% Similarity=0.487 Sum_probs=181.2
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.+...+.++||+|.||+|..+....+..||||+++..... ...+|..|+++|.+++|||||+++|+|...+.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 3445678899999999999999977899999999876444 458899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
|++|+|.+++.++.... +......+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+...++
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999997764322 455666789999999999999988 99999999999999999999999999998766665
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt--G~~pf~~~~~ 682 (698)
.......+-+.+|||||.+..+.++.++|||+||+.|||+++ .++||+..+.
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 554445677899999999999999999999999999999864 7899975543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=271.21 Aligned_cols=202 Identities=28% Similarity=0.423 Sum_probs=178.1
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.+.||+|.||.||.|+.+. +-.||+|++.+. ..+...++.+|++|-..++||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4678999999999999999998754 668999998765 334556899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
+||.+.|.+...|..+. ...+++.....++.|+|.||.|+|..+ ++||||||+|+|++.++..||+|||-+..-..
T Consensus 101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 99999999999997543 344777788899999999999999988 99999999999999999999999998865332
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. .....+||..|.+||+..+..++..+|+|++|++.||++.|.+||+...
T Consensus 177 ~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 177 N----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred C----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 2 2233799999999999999999999999999999999999999998654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.36 Aligned_cols=204 Identities=31% Similarity=0.499 Sum_probs=170.5
Q ss_pred cCccccCceeeecceeEEEEEecc-----------------ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKL 534 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l 534 (698)
++|.+.++||+|+||.||++...+ +..||+|.+.... ......|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997532 3369999987643 2345679999999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCChhHHHhhcc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceee
Q 005400 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQA----------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598 (698)
Q Consensus 535 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 598 (698)
++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885422 1134788899999999999999999988 999
Q ss_pred cCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh--CCCC
Q 005400 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS--GKKN 676 (698)
Q Consensus 599 ~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt--G~~p 676 (698)
|||||+|||+++++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986544332222223456789999999988899999999999999999997 5566
Q ss_pred CCC
Q 005400 677 WRF 679 (698)
Q Consensus 677 f~~ 679 (698)
|..
T Consensus 242 ~~~ 244 (304)
T cd05096 242 YGE 244 (304)
T ss_pred CCc
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.73 Aligned_cols=201 Identities=26% Similarity=0.362 Sum_probs=175.1
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.++||+|+||.||+++.. .+..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367899999999999999999875 47889999987542 2345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999998543 34789999999999999999999853 39999999999999999999999999987653221
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223568999999999998899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=282.04 Aligned_cols=210 Identities=24% Similarity=0.334 Sum_probs=179.5
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
+.|+.+++||.|.-|+||++++.+ +..+|+|++.+. ..+.......|.+||+.++||.++.|+..++.....+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457777899999999999999865 478999999876 3445567788999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC-
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG- 627 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~- 627 (698)
|||+||+|..++.++. .+.+++..+..++..++-||+|||-.+ ||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999998886654 456888889999999999999999998 99999999999999999999999999643210
Q ss_pred ------C---------------------c---c-c----------------------cccccccccccccChhcccCCCC
Q 005400 628 ------D---------------------E---I-Q----------------------TNTHKVVGTYGYMSPEYAAEGLF 654 (698)
Q Consensus 628 ------~---------------------~---~-~----------------------~~~~~~~gt~~y~APE~l~~~~~ 654 (698)
. . . . ......+||..|+|||++++.-.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0 0 01122579999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 005400 655 SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686 (698)
Q Consensus 655 ~~k~DVwSlGvil~elltG~~pf~~~~~~~~~ 686 (698)
+..+|+|+|||+|||||.|+.||......++.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl 344 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL 344 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhH
Confidence 99999999999999999999999877665543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.70 Aligned_cols=200 Identities=29% Similarity=0.418 Sum_probs=170.7
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
+|.+.+.||+|+||.||+++.. .++.||+|++.+.. ....+.+..|.+++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999875 46789999987542 23345567788888777 5899999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888543 34788999999999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. ......||+.|+|||++....++.++|||||||++|||+||+.||....
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 21 1223578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=288.78 Aligned_cols=202 Identities=25% Similarity=0.404 Sum_probs=170.9
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|.+.++||+|+||.||+++.. +++.||+|+++... ......+.+|++++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999875 57899999987542 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++ +|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 888877543 234788899999999999999999988 99999999999999999999999999876432221
Q ss_pred ccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
......++..|+|||++.+ ..++.++||||+||++|||+||+.||.....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1122467899999998865 5689999999999999999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.23 Aligned_cols=204 Identities=25% Similarity=0.411 Sum_probs=177.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|.+.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999875 5889999998754 2245567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|..++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998654 45889999999999999999999988 999999999999999999999999999865433
Q ss_pred c---------------------------cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 E---------------------------IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~---------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. .........||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011223568999999999999999999999999999999999999997654
Q ss_pred C
Q 005400 682 P 682 (698)
Q Consensus 682 ~ 682 (698)
+
T Consensus 235 ~ 235 (350)
T cd05573 235 L 235 (350)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.69 Aligned_cols=200 Identities=29% Similarity=0.398 Sum_probs=170.4
Q ss_pred CccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCC-eeeeEEEEEEeCCeeEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHR-NLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~-nIv~l~~~~~~~~~~~lV~ 548 (698)
+|++.+.||+|+||.||+|+... ++.||+|++.+. .....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999998754 678999998754 234456788899999999765 6888999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999888543 34788999999999999999999988 999999999999999999999999998753221
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 GK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred CC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 11 1223578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=291.96 Aligned_cols=210 Identities=25% Similarity=0.433 Sum_probs=184.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
..|...++||+|.||.||||... .++.||+|++... .....+.+.+|+.++.+++|+||.++++.+..+..+.++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666689999999999999864 4788999999765 445677889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
|.+|++.+.+.. ...+++..+.-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999843 334577888889999999999999998 99999999999999999999999999987765544
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccccc
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG 690 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li~ 690 (698)
.. ...+||+-|||||++....|+.|+||||||++.+||.+|.+|+...||....-+|.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp 224 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP 224 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc
Confidence 33 44799999999999998899999999999999999999999999999966555543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=284.86 Aligned_cols=192 Identities=21% Similarity=0.355 Sum_probs=166.1
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCcc---hHHHHHHHHHHhhcCCCeeeeEEEEEEe----CCeeEEEEEec
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESMLIYEYM 551 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~---~~~~~~Ei~il~~l~H~nIv~l~~~~~~----~~~~~lV~E~~ 551 (698)
..|++|+++.||+|++ +|+.||||+++...... .+.|.+|++++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4799999999999998 78999999997653322 4678899999999999999999999877 35688999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
++|+|.+++.+. ..+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999998653 3488999999999999999999985 5 7899999999999999999999999988654322
Q ss_pred ccccccccccccccChhcccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~--~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||....+
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 12467899999999976 6789999999999999999999999986543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.20 Aligned_cols=201 Identities=23% Similarity=0.375 Sum_probs=172.3
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|++.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999985 4788999998754 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|++++.+..+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9999877655422 234888999999999999999999988 9999999999999999999999999998754322
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 11 122356899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.82 Aligned_cols=203 Identities=25% Similarity=0.352 Sum_probs=172.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999875 4889999998642 2234456889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|..++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 234788899999999999999999998 999999999999999999999999998765432
Q ss_pred ccccccccccccccccChhcccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~-----~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 211 1122468999999999863 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=305.32 Aligned_cols=204 Identities=20% Similarity=0.258 Sum_probs=175.6
Q ss_pred CccccCceeeecceeEEEEEecc--ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.|.+.+.||+|+||.||++.... ++.||+|.+..........+.+|+++++.++|||||++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 38888999999999999997543 5778888876555455567888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 552 PNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 552 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
++|+|.+++... .....+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888643 23445889999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
........||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 22223357999999999999999999999999999999999999999754
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=295.31 Aligned_cols=203 Identities=24% Similarity=0.324 Sum_probs=173.2
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|.+.++||+|+||.||+++.. .++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999875 4788999998653 2233456888999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|..++.+. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998653 234788889999999999999999988 999999999999999999999999999876443
Q ss_pred ccccccccccccccccChhcccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~-----~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... .....||+.|+|||++.. ..++.++||||||++||||++|+.||....
T Consensus 156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 156 GTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred Ccee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 2211 122569999999998865 467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.99 Aligned_cols=195 Identities=27% Similarity=0.419 Sum_probs=167.5
Q ss_pred CceeeecceeEEEEEec----cccEEEEEEecCC----CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 479 NKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++||+|+||.||+++.. .++.||+|++++. .......+.+|+++++.++||||+++++++..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999753 4788999998753 223345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|..++... ..+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999888543 34778888899999999999999988 99999999999999999999999999875322221
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 1223578999999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.39 Aligned_cols=200 Identities=26% Similarity=0.414 Sum_probs=170.1
Q ss_pred CccccCceeeecceeEEEEEec----cccEEEEEEecCC----CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG----SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
+|++.++||+|+||.||+++.. .++.||+|++.+. .....+.+..|++++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999753 4788999998653 223345688899999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999988543 34889999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....... ......||..|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 5332211 12235799999999998765 4788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.53 Aligned_cols=203 Identities=23% Similarity=0.328 Sum_probs=172.0
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.++||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468888999999999999998754 678999998642 2233445889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998653 234788889999999999999999988 999999999999999999999999998764332
Q ss_pred ccccccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 156 GTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred Ccc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 211 122357999999999886 3468899999999999999999999997544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=286.93 Aligned_cols=201 Identities=26% Similarity=0.393 Sum_probs=169.3
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999875 58899999987543 2334467889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|++ ++|..++... ...++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 5676666442 234788889999999999999999998 9999999999999999999999999987543221
Q ss_pred cccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1122568899999998865 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.37 Aligned_cols=198 Identities=28% Similarity=0.464 Sum_probs=168.2
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHH---hhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLI---ARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il---~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
|++.+.||+|+||.||++... +++.||+|++++. .....+.+..|++++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999875 5889999999754 223345677776665 456799999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|...+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999887743 34899999999999999999999988 99999999999999999999999999875322
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 21 11223578999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=295.02 Aligned_cols=196 Identities=24% Similarity=0.348 Sum_probs=168.1
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
+.||+|+||.||+++.. +++.||+|++.+. .......+..|++++..++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999998754 2234566788999999999999999999999999999999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
+|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 998887543 358899999999999999999997 56 99999999999999999999999999875322211 1
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 1235699999999999988999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=280.46 Aligned_cols=212 Identities=27% Similarity=0.416 Sum_probs=177.6
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe-----CC
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-----AD 542 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~-----~~ 542 (698)
....|...+.||+|++|.|..+... +|+.||||++... ..-..+...+|+++|+.++|+||+.+.+++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455665789999999999999874 5899999999743 44456778999999999999999999999865 35
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..|+|+|+| ..+|...+..+. .++......+++|+++||.|+|+.+ |+||||||.|+|++.+...||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 689999999 668888885433 3889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccccc
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li 689 (698)
+..............+.|..|.|||++. ...|+...||||.|||+.||++|+..|...+..+...+|
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI 240 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI 240 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 9875432233334578899999999765 457999999999999999999999999887665544443
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.29 Aligned_cols=195 Identities=27% Similarity=0.427 Sum_probs=167.4
Q ss_pred CceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+|+... ++.||+|++.+. .....+.+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999998754 789999998754 233455678899998876 799999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|...+... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 9998888543 34788999999999999999999998 99999999999999999999999999875332221 1
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 223568999999999998899999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=288.95 Aligned_cols=195 Identities=30% Similarity=0.437 Sum_probs=165.3
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+++.. .++.||+|+++.. .....+.+..|.+++... +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 4778999998754 223344566677777654 899999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999888543 34788899999999999999999988 9999999999999999999999999997643222 12
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 233578999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=297.30 Aligned_cols=206 Identities=33% Similarity=0.486 Sum_probs=171.8
Q ss_pred cCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
++|++.+.||+|+||.||+++.. ++..||+|+++... ....+.+.+|+++++.+ +|+||++++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46888899999999999998742 23579999997543 33456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccc-----------------------------------------------------------
Q 005400 545 MLIYEYMPNKSLDFFIFDQAR----------------------------------------------------------- 565 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 565 (698)
++||||+++|+|.+++.+...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999998854211
Q ss_pred --------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccc
Q 005400 566 --------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637 (698)
Q Consensus 566 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 637 (698)
...+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 124788889999999999999999988 999999999999999999999999999765433221111223
Q ss_pred cccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 638 ~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.++..|||||++....++.++|||||||++|||++ |+.||....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 45678999999988899999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=289.69 Aligned_cols=196 Identities=30% Similarity=0.449 Sum_probs=168.0
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 4789999998753 234456678888888877 699999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 9999888543 34889999999999999999999988 99999999999999999999999999875322211 1
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 2235789999999999988999999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=276.42 Aligned_cols=204 Identities=26% Similarity=0.412 Sum_probs=170.2
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCe-eeeEEEEEEeCC------
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRN-LVKLLGCCIQAD------ 542 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~n-Iv~l~~~~~~~~------ 542 (698)
..|+.+++||+|.||+||+|+.. +|+.||+|++..... .......+|+.++++++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44666788999999999999864 588999999976533 23445689999999999999 999999998877
Q ss_pred eeEEEEEecCCCChhHHHhhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
..++|+||++ .+|..++...... ..++...+..+..||++||+|||+++ |+||||||+|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 4787777654321 34666888999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
|+...-+.. .....++|..|.|||++.+. .|+...||||+|||+.||++++..|.....
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 996542221 12235789999999998876 799999999999999999999999975443
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=295.07 Aligned_cols=203 Identities=25% Similarity=0.382 Sum_probs=174.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|.+.+.||+|+||.||+++.. +++.||+|+++... .+..+.+.+|+++++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999875 58899999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998654 235889999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccccccChhccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAA------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~------~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 221 122246899999999986 4567899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=289.71 Aligned_cols=193 Identities=26% Similarity=0.398 Sum_probs=166.2
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+++.. +++.+|+|++++. .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 4788999999754 223445678899888777 799999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~ 152 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence 9998887543 34889999999999999999999998 99999999999999999999999999875322111 1
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.....||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2235789999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=289.88 Aligned_cols=193 Identities=25% Similarity=0.394 Sum_probs=167.0
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+++.. +++.||+|++++. .....+.+..|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 4789999999754 223445688999999988 799999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 9998887543 34899999999999999999999998 9999999999999999999999999987422111 11
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 2235789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=289.33 Aligned_cols=193 Identities=27% Similarity=0.411 Sum_probs=166.9
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+++.. +++.+|+|++++. .....+.+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4788999999764 223455688999999888 699999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 9998887543 34899999999999999999999988 99999999999999999999999999875322111 1
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 2235789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=289.19 Aligned_cols=200 Identities=28% Similarity=0.428 Sum_probs=170.2
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~ 548 (698)
+|+..+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|.+++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999865 5889999998754 2234456788999998885 577888999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|..++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999888543 34889999999999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. ......||..|+|||++....++.++|||||||++|||++|+.||....
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 21 1223568999999999998899999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=289.33 Aligned_cols=201 Identities=26% Similarity=0.374 Sum_probs=174.1
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.++||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367899999999999999999875 4778999988654 22345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++... ..+++..+..++.+++.||.|||+.+ +|+|+||||+|||+++++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999998543 34788999999999999999999753 39999999999999999999999999987653221
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 122468999999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=292.17 Aligned_cols=204 Identities=25% Similarity=0.441 Sum_probs=181.7
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe-eEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-SMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~-~~lV~ 548 (698)
++|..++++|+|+||.++..+++ ++..+++|++... .....+....|+.++++++|||||.+.+.|.+.+. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999999875 4678999988654 33445578899999999999999999999999888 99999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
+|++||++.+.+.++. ...+++..+..++.|++.|+.|||++. |+|||||+.||+++.+..+||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997755 567899999999999999999999877 999999999999999999999999999998776
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.. ......||+.||.||++.+.+|+.|+|||||||++|||++-+++|+..+.
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 52 23347899999999999999999999999999999999999999985543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=281.55 Aligned_cols=204 Identities=27% Similarity=0.409 Sum_probs=163.6
Q ss_pred CccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe-----eEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-----SMLI 547 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~-----~~lV 547 (698)
.|...+++|.|+||.||+|++.+ ++.||||+.-...+ --..|+++|++++|||||+++-+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999999755 68999999754332 22469999999999999999999875432 3579
Q ss_pred EEecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC-CceEEeecCCCccc
Q 005400 548 YEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIF 625 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFgla~~~ 625 (698)
||||+. +|...+..- ..+..++...+.-+..||++||+|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 666666531 11233666677788999999999999988 9999999999999966 89999999999987
Q ss_pred CCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccc
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~l 688 (698)
...+.. ....-|..|.|||.+.+ ..|+.+.||||.||++.||+-|+.-|...+......+
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~e 237 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVE 237 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHH
Confidence 655433 22456889999998765 4799999999999999999999999987665444333
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=294.65 Aligned_cols=205 Identities=30% Similarity=0.441 Sum_probs=171.4
Q ss_pred cCccccCceeeecceeEEEEEe------ccccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
++|++.++||+|+||.||+++. ..+..||||+++... ....+.+.+|++++..+ +||||++++++|......
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688889999999999999963 235689999986542 33456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccc-----------------------------------------------------------
Q 005400 545 MLIYEYMPNKSLDFFIFDQAR----------------------------------------------------------- 565 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 565 (698)
++||||+++|+|..++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999998864221
Q ss_pred -------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 566 -------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 566 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 124788899999999999999999988 9999999999999999999999999998654332211
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
......++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 1222345678999999999999999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=281.26 Aligned_cols=195 Identities=31% Similarity=0.462 Sum_probs=168.1
Q ss_pred eeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
||+|+||+||++... +++.+|+|++.... ....+.+..|++++++++|+||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999864 58899999986542 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccc
Q 005400 557 DFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635 (698)
Q Consensus 557 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~ 635 (698)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 88875422 3345899999999999999999999988 999999999999999999999999999765433221 22
Q ss_pred cccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 636 ~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 357899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=303.41 Aligned_cols=213 Identities=23% Similarity=0.318 Sum_probs=178.6
Q ss_pred hhHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC
Q 005400 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (698)
Q Consensus 466 ~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~ 542 (698)
.......++|.+.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++..++|+||++++..+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344455689999999999999999999864 6899999998654 2344567889999999999999999988775432
Q ss_pred --------eeEEEEEecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc
Q 005400 543 --------ESMLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (698)
Q Consensus 543 --------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (698)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 3679999999999999986532 2346889999999999999999999988 999999999999999999
Q ss_pred eEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+||+|||+++.+.............||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999987543322222233679999999999999999999999999999999999999997543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-33 Score=284.83 Aligned_cols=203 Identities=30% Similarity=0.475 Sum_probs=179.8
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.+.|...+.||+|+||.||-++.. .|+.+|.|++.+. .+++....++|-.||.+++.+.||.+--.++..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 355788889999999999999764 5888999988654 344556678999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
+..|.||+|..+|.+... +.++++.++.+|.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987654 55899999999999999999999998 99999999999999999999999999988755
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..... ..+||.+|||||++.+..|+...|.|||||+||||+.|+.||+...
T Consensus 340 g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 340 GKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred CCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 43322 2489999999999999999999999999999999999999997543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=280.29 Aligned_cols=203 Identities=28% Similarity=0.432 Sum_probs=171.5
Q ss_pred cCccccCceeeecceeEEEEEec----cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888899999999999999763 35689999987653 23346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999986532 35889999999999999999999988 99999999999999999999999998765322
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.... ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 160 EAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 2111 1112345678999999998999999999999999999875 999997543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=288.48 Aligned_cols=195 Identities=26% Similarity=0.373 Sum_probs=163.7
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHH-HHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~-il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+++.. +++.||+|++.+.. ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47899999986532 222344555554 67889999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|...+... ..+....+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 9998887543 34778888899999999999999988 9999999999999999999999999987532221 11
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 233578999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=281.22 Aligned_cols=201 Identities=30% Similarity=0.491 Sum_probs=173.3
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
+|++.++||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999864 58899999986532 2233557889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998876432 235889999999999999999999988 9999999999999999999999999988653322
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. .....|+..|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 1 122468999999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=285.22 Aligned_cols=195 Identities=29% Similarity=0.435 Sum_probs=166.0
Q ss_pred CceeeecceeEEEEEecc-ccEEEEEEecCCC---CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+|+... ++.||+|+++... ....+.+..|.+++... +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998754 7889999987541 23345567788888764 899999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 9999988543 34788999999999999999999988 99999999999999999999999999875322111 1
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 223568999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=277.81 Aligned_cols=193 Identities=27% Similarity=0.474 Sum_probs=162.3
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhh--cCCCeeeeEEEEEEeCC----eeE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQAD----ESM 545 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~--l~H~nIv~l~~~~~~~~----~~~ 545 (698)
.++....+.||+|.||+||+|++ .|+.||||++... .++.+.+|.+|... ++|+||+.+++.-...+ .++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 45667788999999999999999 6899999999654 34567888888765 49999999998876543 578
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-----DSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
||++|.+.|+|.++|.+ ..++....++++..+|.||++||- ++++.|.|||||+.|||+..++.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999954 458999999999999999999995 478899999999999999999999999999
Q ss_pred CCcccCCC--ccccccccccccccccChhcccCCC----C--CcchhHHHHHHHHHHHHh
Q 005400 621 MARIFGGD--EIQTNTHKVVGTYGYMSPEYAAEGL----F--SVKSDVFSFGVLVLEIVS 672 (698)
Q Consensus 621 la~~~~~~--~~~~~~~~~~gt~~y~APE~l~~~~----~--~~k~DVwSlGvil~ellt 672 (698)
||...... .........+||.+|||||++.+.. + -..+||||||.++||+..
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99765432 3344445579999999999996542 1 235899999999999884
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=288.54 Aligned_cols=201 Identities=23% Similarity=0.406 Sum_probs=166.9
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-----eeE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESM 545 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~-----~~~ 545 (698)
+|++.++||+|+||.||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999864 5889999998643 2233456889999999999999999999886432 479
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+. ++|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 6788877543 34889999999999999999999998 999999999999999999999999999764
Q ss_pred CCCcc-ccccccccccccccChhcccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 626 GGDEI-QTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..... ........||..|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 32211 111123578999999999865 678999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=288.32 Aligned_cols=195 Identities=26% Similarity=0.370 Sum_probs=164.4
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHH-HHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~-il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||+||+++.. +|+.||+|++.+.. ....+.+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 58899999986531 223344555554 56789999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++.+. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 9999888543 34788899999999999999999998 9999999999999999999999999987532211 11
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 223578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=285.17 Aligned_cols=195 Identities=30% Similarity=0.438 Sum_probs=166.0
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+++.. +++.||+|++++.. ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999875 47899999987541 23445677788888765 899999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 9999888543 34788999999999999999999988 9999999999999999999999999987432111 11
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 223578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=291.96 Aligned_cols=195 Identities=28% Similarity=0.374 Sum_probs=168.7
Q ss_pred CceeeecceeEEEEEe----ccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 479 NKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~----~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
+.||+|+||.||+++. ..|+.+|+|++.+.. ......+..|++++++++||||+++++++..+...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 247899999997542 2234567789999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|..++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 99999888543 34899999999999999999999998 99999999999999999999999999876533221
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 1223578999999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=308.85 Aligned_cols=205 Identities=25% Similarity=0.341 Sum_probs=173.7
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.++||+|+||.||+|+.. .++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999875 48899999997542 223457899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 549 EYMPNKSLDFFIFDQA--------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
||+++++|.+++.... .....++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1223567788999999999999999988 9999999999999999999999999
Q ss_pred CCcccCCCcc----------------ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 621 MARIFGGDEI----------------QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 621 la~~~~~~~~----------------~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
++........ ........||+.|||||.+.+..++.++|||||||++|||+||+.||...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9986521100 00111246999999999999999999999999999999999999999753
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=293.13 Aligned_cols=192 Identities=20% Similarity=0.298 Sum_probs=165.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.+|++.++||+|+||.||+++.. .++.||+|... ...+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 56999999999999999999864 57899999753 235688999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
. ++|..++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 166 ~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 166 K-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred C-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 6 6777777443 34789999999999999999999988 99999999999999999999999999975322111
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
.......||+.|+|||++....++.++|||||||++|||++|+.||-
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 11223579999999999999999999999999999999999998864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=285.45 Aligned_cols=203 Identities=31% Similarity=0.533 Sum_probs=170.7
Q ss_pred cCccccCceeeecceeEEEEEec-ccc----EEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQ----EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
.+|++.+.||+|+||.||+|++. +++ .||+|+++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888899999999999999864 333 48999986543 34556899999999999999999999998764 5789
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999986533 34788999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
............++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 4332222222345678999999999999999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=288.77 Aligned_cols=195 Identities=24% Similarity=0.366 Sum_probs=164.7
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHH-HHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~-il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+++.. +|+.+|+|++.+. .....+.+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 5889999998654 2233345555655 46778999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 9998887543 34889999999999999999999988 9999999999999999999999999987532211 11
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 223578999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=280.48 Aligned_cols=201 Identities=26% Similarity=0.439 Sum_probs=166.2
Q ss_pred cCccccCceeeecceeEEEEEec--cccEEEEEEecCCC--CcchHHHHHHHHHHhhc---CCCeeeeEEEEEEe-----
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQ----- 540 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~--~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l---~H~nIv~l~~~~~~----- 540 (698)
++|++.++||+|+||.||+++.. +++.||+|+++... ......+.+|+++++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 46789999986542 22334566788777766 69999999999853
Q ss_pred CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
....++||||++ ++|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999997 58888875433 234789999999999999999999988 9999999999999999999999999
Q ss_pred CCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++....... ......|+..|+|||.+....++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 998654321 2223568999999999988899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=292.20 Aligned_cols=206 Identities=30% Similarity=0.436 Sum_probs=172.4
Q ss_pred hcCccccCceeeecceeEEEEEecc------ccEEEEEEecCCCC-cchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~ 543 (698)
.++|.+.++||+|+||.||+|+... +..||||++..... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678888999999999999997532 34699999975432 33467899999999996 9999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccc----------------------------------------------------------
Q 005400 544 SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------------------- 565 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 565 (698)
.+|||||+++|+|.+++.+...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864311
Q ss_pred -----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC
Q 005400 566 -----------------------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN 610 (698)
Q Consensus 566 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~ 610 (698)
...+++..++.++.|+++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124778888999999999999999988 999999999999999
Q ss_pred CCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 611 DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 611 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999986543322222222456788999999988899999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=284.57 Aligned_cols=195 Identities=30% Similarity=0.435 Sum_probs=167.4
Q ss_pred CceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+++... ++.||+|++++. .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998754 788999999754 233456678899999888 699999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence 9998888543 24889999999999999999999988 99999999999999999999999999875322211 1
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 223568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=276.24 Aligned_cols=200 Identities=38% Similarity=0.616 Sum_probs=167.7
Q ss_pred ccCceeeecceeEEEEEec-----cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 477 SYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
..+.||.|.||.||+|.+. .+..|+||.++... .+..+.|.+|++.+++++||||++++|++......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999986 26789999996543 33478899999999999999999999999988889999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++|+|.++|... ....+++..+..|+.|+++||+|||+.+ ++|++|+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999765 2345899999999999999999999988 99999999999999999999999999987633222
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
............|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 222233457789999999998889999999999999999999 78888654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=286.41 Aligned_cols=195 Identities=25% Similarity=0.347 Sum_probs=162.8
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHH-HHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEV-TLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei-~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+++.. +++.+|+|++.+.. ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 46789999986532 22233444444 456788999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++... ..+....+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 9999988543 34677888889999999999999998 99999999999999999999999999875322211 1
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 223579999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=293.61 Aligned_cols=200 Identities=22% Similarity=0.339 Sum_probs=172.6
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC-C-----CeeeeEEEEEEeCCeeEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-H-----RNLVKLLGCCIQADESML 546 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H-----~nIv~l~~~~~~~~~~~l 546 (698)
+|++.+.||+|.||.|.|+... .++.||||+++.. .....+...|+.+|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999764 5899999999654 345567788999999996 4 399999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC--CCceEEeecCCCcc
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--DMNPKISDFGMARI 624 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFgla~~ 624 (698)
|+|.+. .+|.++|..+... .++...++.|+.||++||.+||+.+ |||+||||+||||.+ ...+||+|||++..
T Consensus 266 VfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999984 5888998765544 4899999999999999999999988 999999999999964 44799999999987
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~ 684 (698)
....-. ...-+.-|.|||++.+.+|+.+.||||||||+.||++|.+.|..+...+
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 543322 2566789999999999999999999999999999999999988655443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=279.69 Aligned_cols=207 Identities=34% Similarity=0.566 Sum_probs=174.5
Q ss_pred cCccccCceeeecceeEEEEEecc------ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
++|++.+.||+|+||.||+|.... .+.||+|.+.... ......|.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 457888999999999999998643 2579999986543 234567899999999999999999999999989999
Q ss_pred EEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC
Q 005400 546 LIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (698)
++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145788999999999999999999988 99999999999999999
Q ss_pred ceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |+.||....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999986543332222233456789999999988899999999999999999998 9999875443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=300.59 Aligned_cols=209 Identities=28% Similarity=0.373 Sum_probs=175.8
Q ss_pred hhcCccccCceeeecceeEEEEEeccc-cEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEE-Ee------C
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEG-QEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCC-IQ------A 541 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g-~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~-~~------~ 541 (698)
...+.++.+.|.+|||+.||.+....+ .++|+|++-..++...+.+++|+++|++|+ |+|||.+++.. .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345567888999999999999998776 999999998878888999999999999997 99999999932 21 1
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
-+.+|.||||.+|.|-+++..+.... |++.++++|+.++++|+++||... ++|||||||-+||||..+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 35789999999999999987654444 999999999999999999999985 7899999999999999999999999999
Q ss_pred CcccCCCccccc-------cccccccccccChhcc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 622 ARIFGGDEIQTN-------THKVVGTYGYMSPEYA---AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 622 a~~~~~~~~~~~-------~~~~~gt~~y~APE~l---~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|........... .-...-|+.|+|||++ ++..+++|+|||+|||+||-|+....||+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 875322110000 0013468999999976 57789999999999999999999999999763
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=279.32 Aligned_cols=209 Identities=30% Similarity=0.500 Sum_probs=173.9
Q ss_pred hhcCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
..++|++.++||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999998753 24679999986432 2344578899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 544 SMLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
.++||||+++++|.+++.+... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864321 234678889999999999999999987 999999999999999999999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
+|||++..+.............++..|+|||.+....++.++||||||+++|||++ |+.||....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999876543322221222345778999999988899999999999999999999 7888875443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=289.79 Aligned_cols=196 Identities=30% Similarity=0.441 Sum_probs=164.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|+..++||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566789999999999999875 58899999986543 23456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|... ....+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.....
T Consensus 154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999998543 23466778899999999999999998 99999999999999999999999999987543221
Q ss_pred ccccccccccccccChhcccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG-----LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~-----~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
......||..|+|||++... ..+.++|||||||++|||++|+.||...
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11235789999999987432 2456899999999999999999999743
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=279.11 Aligned_cols=206 Identities=32% Similarity=0.555 Sum_probs=175.3
Q ss_pred cCccccCceeeecceeEEEEEecc------ccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
++|.+.+.||+|+||.||+|+..+ ++.||+|.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 567888999999999999998643 478999999765443 4578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 546 LIYEYMPNKSLDFFIFDQA-----------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
+||||+++++|.+++.... ....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986532 1234788999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
||+|||++................++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999976533322111222345788999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=274.59 Aligned_cols=202 Identities=34% Similarity=0.544 Sum_probs=174.8
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+......+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5688899999999999999998888899999986532 345789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999986542 345788899999999999999999987 9999999999999999999999999998764332211
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
.....++..|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 161 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred -cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 112345678999999988889999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=294.65 Aligned_cols=198 Identities=29% Similarity=0.471 Sum_probs=171.7
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC------eeEE
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ESML 546 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~------~~~l 546 (698)
+...+.||+|+||.||+|+.+ .|+.||||.+.+.. ....+....|++++++++|+|||+++++-++.. ..++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344568999999999999964 59999999997653 344567789999999999999999999865433 5689
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc--CCC--ceEEeecCCC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDM--NPKISDFGMA 622 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~~kl~DFgla 622 (698)
|||||.+|+|...+.+.....-|++.+.+.+..++..||.|||+++ |+||||||.||++- +++ -.||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988777777999999999999999999999988 99999999999994 333 4899999999
Q ss_pred cccCCCccccccccccccccccChhccc-CCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
+.+..+. ......||..|++||+.. .+.|+..+|.|||||++||.+||..||.
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9876554 334589999999999998 4789999999999999999999999997
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=272.79 Aligned_cols=202 Identities=31% Similarity=0.491 Sum_probs=173.4
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|++.+.||+|+||.||+++..++..+|+|.+.... ...+.+.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577888999999999999998888899999886432 335678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999886432 34889999999999999999999988 9999999999999999999999999987654322211
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.....++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 112345678999999988889999999999999999999 899997544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=285.80 Aligned_cols=205 Identities=28% Similarity=0.417 Sum_probs=181.6
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCC---cchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM 545 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~ 545 (698)
..+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+... ...+.+.+|+++|+++. |||||.+.+.++.....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44678888999999999999999866 99999999987643 24468999999999998 999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC----CceEEeecCC
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND----MNPKISDFGM 621 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFgl 621 (698)
+|||++.+|.|.+.+.+. . +++.+...++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999765 2 889999999999999999999988 9999999999999643 4799999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~ 685 (698)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||......+.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~ 246 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI 246 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH
Confidence 998765 2234458999999999999999999999999999999999999999987664443
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.31 Aligned_cols=205 Identities=34% Similarity=0.516 Sum_probs=172.4
Q ss_pred cCccccCceeeecceeEEEEEe-----ccccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|++.++||+|+||.||+|.. ..++.+++|.+.... .+....+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999974 245789999987543 3344678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC
Q 005400 547 IYEYMPNKSLDFFIFDQAR--------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (698)
||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853321 234788999999999999999999988 99999999999999999
Q ss_pred ceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
.+||+|||++................++..|+|||++....++.++||||||+++|||++ |..||...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999986543322222223445778999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=277.03 Aligned_cols=206 Identities=32% Similarity=0.562 Sum_probs=175.2
Q ss_pred cCccccCceeeecceeEEEEEec------cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999742 245689999876655566789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 547 IYEYMPNKSLDFFIFDQA----------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1234899999999999999999999988 999999999999999999999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
+|||++................++..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999986543322222222445778999999988889999999999999999998 899986544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=274.55 Aligned_cols=192 Identities=30% Similarity=0.468 Sum_probs=165.4
Q ss_pred eeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
||+|+||.||+++.. +|+.+|+|.+.... ....+.+..|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 48999999986431 12234566799999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccccc
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (698)
..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 88875443 234889999999999999999999988 99999999999999999999999999876543221 122
Q ss_pred ccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 637 ~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
..|+..|+|||++....++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 4689999999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=265.38 Aligned_cols=201 Identities=27% Similarity=0.450 Sum_probs=174.2
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
..++|++.+.||+|.|+.||+... ..|+.+|+|++... .....+++.+|++|-+.++|||||++.....+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456788888999999999999875 45899999887543 344678899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC---CceEEeecCCCcc
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMARI 624 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFgla~~ 624 (698)
+|+|++++|..-+... ...++..+-..++||+.+|.|+|..+ |||||+||+|+||-+. --+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997766543 34677788899999999999999998 9999999999999543 3499999999998
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
++.... .....||++|||||+++..+|+..+|||+-|||||-|+.|..||..+
T Consensus 163 l~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~ 215 (355)
T KOG0033|consen 163 VNDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 215 (355)
T ss_pred eCCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence 773332 23468999999999999999999999999999999999999999863
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-33 Score=272.45 Aligned_cols=205 Identities=28% Similarity=0.470 Sum_probs=182.1
Q ss_pred CccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
-|+++++||+|++|.||++.+++ |+.+|||++.. ....+++..|+.+|.+.+.|++|+++|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 47888999999999999998865 89999999864 3467889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
.|++.+++.. +++++.+.++..+++..++||+|||... -+|||||..||||+.+|.+||+|||.|..+.....
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-- 184 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-- 184 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence 9999999854 4567999999999999999999999987 89999999999999999999999999976543221
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~ 687 (698)
....+.||+-|||||++.+-.|+.++||||||+...||..|++||..-||-.-.-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF 239 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF 239 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE
Confidence 2234789999999999999999999999999999999999999999877765433
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=280.42 Aligned_cols=202 Identities=26% Similarity=0.418 Sum_probs=169.9
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|.+.++||+|+||.||+|+.. .++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999875 47789999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++ +|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 777776443 234788899999999999999999988 99999999999999999999999999876433221
Q ss_pred ccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
......++..|+|||++.+ ..++.++||||||+++|||+||+.||.....
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1122467899999998865 4688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-33 Score=299.09 Aligned_cols=209 Identities=32% Similarity=0.482 Sum_probs=181.9
Q ss_pred ccCceeeecceeEEEEEe-cccc----EEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 477 SYNKLGEGGFGPVYKGTL-VEGQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~-~~g~----~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
..++||+|+||+||||.+ .+|+ +||+|++... ..+..+++++|+-+|.+++|||+++|+++|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 346899999999999976 3443 6899988655 5566789999999999999999999999998776 7899999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
|+.|+|.++++.++ ..+-.+..+.|..|||+||.|||++. ++||||..+|||+.+-..+||.|||+++.+..+..
T Consensus 779 mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999997643 34888999999999999999999987 99999999999999999999999999999876655
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCccccccc
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGH 691 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~~~~~li~~ 691 (698)
........-.+.|||-|.+....|+.++|||||||.+||++| |.+|+.....++..++++.
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ 915 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK 915 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc
Confidence 544444455779999999999999999999999999999998 9999998877777776653
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=271.37 Aligned_cols=204 Identities=31% Similarity=0.505 Sum_probs=175.1
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.++|++.+.||+|++|.||++...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778899999986543 34567999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986543 345899999999999999999999988 999999999999999999999999999876532211
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
. ......+..|+|||++....++.++||||||++++||++ |+.||....
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1 111233458999999988899999999999999999999 999996543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=270.80 Aligned_cols=204 Identities=25% Similarity=0.414 Sum_probs=174.2
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|++.++||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.+++||||+++++.+......++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35688999999999999999986 45788999998765545566788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999988543 34789999999999999999999987 99999999999999999999999999986542221
Q ss_pred ccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
......++..|+|||.+. ...++.++||||||+++|||++|+.||....+.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 112246888999999874 345788999999999999999999999654443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=287.76 Aligned_cols=201 Identities=25% Similarity=0.407 Sum_probs=168.4
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-----eeE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESM 545 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~-----~~~ 545 (698)
+|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4678899999999999999864 6899999998654 2234567889999999999999999999998776 789
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+|+||+. ++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 467766643 235889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
...... ......++..|+|||++.+. .++.++|||||||++|||++|+.||...++
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 432221 12224678899999998764 578999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=283.34 Aligned_cols=207 Identities=30% Similarity=0.472 Sum_probs=171.3
Q ss_pred hcCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeC-C
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA-D 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~-~ 542 (698)
.++|++.+.||+|+||.||+|+.. .++.||+|++.... ....+.+..|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 356888999999999999999642 24789999987543 23345678899999999 899999999988654 5
Q ss_pred eeEEEEEecCCCChhHHHhhccc---------------------------------------------------------
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQAR--------------------------------------------------------- 565 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 565 (698)
..++++||+++++|..++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998854221
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccccccccccccc
Q 005400 566 -ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644 (698)
Q Consensus 566 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~ 644 (698)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125789999999999999999999988 9999999999999999999999999998764332222222345677899
Q ss_pred ChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 645 APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
|||++.+..++.++|||||||+||||++ |+.||....
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=270.15 Aligned_cols=202 Identities=31% Similarity=0.504 Sum_probs=172.9
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|++.+.||+|+||.||+++..++..+|+|.+.... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577888999999999999988777789999986543 335679999999999999999999999999889999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999886532 25899999999999999999999988 9999999999999999999999999987654332211
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 112345678999999988889999999999999999999 999986443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=275.43 Aligned_cols=207 Identities=31% Similarity=0.529 Sum_probs=175.3
Q ss_pred cCccccCceeeecceeEEEEEec------cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999742 345689999876555556789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc
Q 005400 547 IYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (698)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999865321 234789999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
++|+|||++................++..|+|||.+....++.++||||||+++|||+| |+.||....+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999976543322222223456788999999998899999999999999999999 9999865443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=289.20 Aligned_cols=199 Identities=23% Similarity=0.330 Sum_probs=169.9
Q ss_pred hcCccccCceeeecceeEEEEEec---cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
..+|.+.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357899999999999999999753 3578999988543 23568999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
|++. ++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 57777773 2345899999999999999999999998 999999999999999999999999999765443
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
..........||..|+|||++....++.++|||||||++|||++|+.||.....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 322222335799999999999999999999999999999999999999965443
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=272.11 Aligned_cols=202 Identities=31% Similarity=0.517 Sum_probs=172.5
Q ss_pred cCccccCceeeecceeEEEEEecc----ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|++.+.||+|+||.||+|++.. ...||+|.++... .....+|.+|+.++++++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998743 3579999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999986532 35889999999999999999999987 99999999999999999999999999987652
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRF 679 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~ 679 (698)
...........++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 222111222345678999999998899999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=276.30 Aligned_cols=214 Identities=24% Similarity=0.346 Sum_probs=185.2
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
+-|+..+.||+|.|+.|-++++. .|.+||||++.+. +.-...++..|++.|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 44666788999999999999864 6999999999876 33455678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceEEeecCCCcccCCC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFgla~~~~~~ 628 (698)
.=++|+|.++|.++..+ +.+....+++.||+.|+.|+|+.+ +|||||||+||.+- .-|-+||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999876543 788888899999999999999988 99999999999875 5678999999999876543
Q ss_pred ccccccccccccccccChhcccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCcccccccccc
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFS-VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHVRV 694 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~-~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li~~~~~ 694 (698)
.. ....+|...|.|||++.+..|+ +.+||||||||||-|++|+.||+....-|.+.+|-..+.
T Consensus 173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY 236 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY 236 (864)
T ss_pred ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc
Confidence 32 2336899999999999999986 678999999999999999999998887777776655443
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=275.02 Aligned_cols=205 Identities=30% Similarity=0.474 Sum_probs=169.5
Q ss_pred cCccccCceeeecceeEEEEEec-ccc----EEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQ----EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|++.+.||+|+||.||+|+.. +++ ++++|.+.... .....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45777889999999999999864 344 47888875432 233467788888999999999999999875 455788
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999986432 35899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPD 683 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~ 683 (698)
............++..|+|||.+....++.++||||||+++|||++ |+.||...++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 3322222223457789999999988899999999999999999998 99999765544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=269.80 Aligned_cols=201 Identities=31% Similarity=0.500 Sum_probs=171.5
Q ss_pred CccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+|++.+.||+|+||.||+++...+..+|+|.+.... .....+.+|++++++++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 467788999999999999998777789999986533 2345788999999999999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 99999986533 25889999999999999999999988 9999999999999999999999999987654322211
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 111234458999999998899999999999999999999 899987543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=273.41 Aligned_cols=199 Identities=29% Similarity=0.482 Sum_probs=171.2
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
|+..+.||+|+||.||++... .++.+|+|.+.... ....+.+..|+.++++++|++++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999875 58899999986542 22234578899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|..++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999988854332 34888999999999999999999987 99999999999999999999999999876432221
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 11246899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=272.65 Aligned_cols=200 Identities=29% Similarity=0.474 Sum_probs=171.9
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
|+..+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++.+.+...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999874 58899999986542 22334578899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998876432 235899999999999999999999988 99999999999999999999999999876432211
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....|+..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 122468999999999988899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=271.31 Aligned_cols=206 Identities=32% Similarity=0.537 Sum_probs=179.7
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
...+|++.++||+|+||.||+|...+++.+++|.+..........+..|+++++.++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999888999999999876655667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++.+.. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996543 345789999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
.. ....++..|+|||.+....++.++||||||++++||++ |+.||.....
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 11 12346778999999988899999999999999999998 8999975443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=276.11 Aligned_cols=200 Identities=26% Similarity=0.357 Sum_probs=172.1
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|++.++||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++.+++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999875 47788999886542 23445688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++.+. ..+++..+..++.|+++||.|||+.. +++|+||||+|||+++++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999998653 34788999999999999999999842 39999999999999999999999999987653221
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 123568899999999988889999999999999999999999986443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.25 Aligned_cols=203 Identities=26% Similarity=0.497 Sum_probs=176.9
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
...+|++.+.||+|++|.||+|+. .+++.|++|.+........+.+.+|+++++.++|+||+++++.+......++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 345788889999999999999986 4588999999977655566788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|..++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998843 24788999999999999999999988 9999999999999999999999999987643322
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.. .....+++.|+|||.+....++.++|||||||++|||++|+.||....+
T Consensus 171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred cc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11 1224688899999999888899999999999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=273.91 Aligned_cols=208 Identities=30% Similarity=0.503 Sum_probs=172.9
Q ss_pred hhcCccccCceeeecceeEEEEEecc------ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
.+++|.+.+.||+|++|.||+|...+ +..|++|.+.... ......|..|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999998754 5678999886543 2334578999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC---ceEE
Q 005400 544 SMLIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKI 616 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl 616 (698)
.++||||+++++|.+++..... ...+++..+++++.||++||+|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865432 235889999999999999999999988 99999999999998654 5999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999987643322111112234568999999988899999999999999999997 999997544
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=289.86 Aligned_cols=200 Identities=21% Similarity=0.367 Sum_probs=162.4
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--------
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-------- 541 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-------- 541 (698)
..++|.+.++||+|+||.||+|+.. .++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999874 58899999885432 2345799999999999999999886432
Q ss_pred CeeEEEEEecCCCChhHHHhh-ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-ceEEeec
Q 005400 542 DESMLIYEYMPNKSLDFFIFD-QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDF 619 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DF 619 (698)
...++||||+++ +|..++.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 236689999986 56555542 223446889999999999999999999998 99999999999999665 7999999
Q ss_pred CCCcccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99986543221 1225689999999988654 68999999999999999999999997543
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=273.98 Aligned_cols=207 Identities=28% Similarity=0.490 Sum_probs=172.1
Q ss_pred hhcCccccCceeeecceeEEEEEecc------ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
..++|++.++||+|+||.||+|..++ +..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45778999999999999999997532 4579999886543 2334568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 544 SMLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999864321 234577888999999999999999988 999999999999999999999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
+|||+++.+.............++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999886543322222222345678999999988899999999999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=267.61 Aligned_cols=202 Identities=31% Similarity=0.468 Sum_probs=172.9
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-----CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|++.+.||+|++|.||++... +++++|+|.+.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888899999999999999864 58899999986432 1234568899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|+||+++++|.+++... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||+++++++++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988543 34788889999999999999999988 9999999999999999999999999987654
Q ss_pred CCccccc-cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 627 GDEIQTN-THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 627 ~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 3221111 12245788999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=282.85 Aligned_cols=198 Identities=28% Similarity=0.370 Sum_probs=167.0
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-----
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----- 542 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~----- 542 (698)
..++|++.+.||+|+||.||+++.. .++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 4889999998654 2334567889999999999999999999986543
Q ss_pred -eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 543 -ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 543 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
..++||||++++ |...+.. .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 479999999764 5444421 2778888999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+....... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 97643222 112357899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=270.13 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=161.6
Q ss_pred CceeeecceeEEEEEecc---ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~---g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
++||+|+||.||+|.... ...+++|.+.... ......+.+|+++++.++|+||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468888876443 233457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 555 SLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 555 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++++||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233567788899999999999999988 9999999999999999999999999987543322211
Q ss_pred ccccccccccccChhcccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAE-------GLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~-------~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
......++..|+|||++.. ..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 1222346778999998642 356889999999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.92 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=164.5
Q ss_pred CceeeecceeEEEEEecc---ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~---g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
+.||+|+||.||+|+..+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998643 4579999886543 233457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 555 SLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 555 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+|.+++..... ....++..+..++.|+++||+|||+.+ ++|+||||+||+++.++++||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865322 234677788899999999999999988 9999999999999999999999999987644333222
Q ss_pred ccccccccccccChhcccCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEG-------LFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~-------~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
......++..|+|||++... .++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 22234577889999988542 35789999999999999996 999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=270.30 Aligned_cols=192 Identities=24% Similarity=0.406 Sum_probs=168.4
Q ss_pred CccccCceeeecceeEEEEEe-ccccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 474 NFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
+|++.+.||+|+||.||+++. .+++.||+|.+... .....+++.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999986 45889999998654 2334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++..+....
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999996542 2678888899999999999999988 9999999999999999999999999997654321
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.....++..|+|||++....++.++||||||+++|||++|+.||..
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 1235789999999999988999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=266.20 Aligned_cols=202 Identities=28% Similarity=0.460 Sum_probs=175.3
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|++.+.||+|++|.||+++.. +++.|++|.+... .....+++.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999875 5889999998643 334567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998654 2345889999999999999999999987 99999999999999999999999999887644322
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. .....++..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1 122467889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=275.35 Aligned_cols=206 Identities=33% Similarity=0.499 Sum_probs=171.6
Q ss_pred CccccCceeeecceeEEEEEecc------ccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
+|.+.++||+|+||.||+|.... ++.||+|+++..... ..+.+.+|++++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46677899999999999998632 578999999755332 34568899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc
Q 005400 547 IYEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (698)
++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||.||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1234788889999999999999999988 999999999999999999
Q ss_pred eEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
+||+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |..||....+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999886543322222223456789999999988889999999999999999998 8888865433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=271.97 Aligned_cols=209 Identities=28% Similarity=0.468 Sum_probs=175.9
Q ss_pred hhcCccccCceeeecceeEEEEEecc-----ccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe-CCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-----g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~-~~~ 543 (698)
..++|.+.+.||+|+||.||+|...+ ++.|++|++... .....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678888999999999999999865 688999998754 23345678899999999999999999998876 467
Q ss_pred eEEEEEecCCCChhHHHhhcccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEee
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARA-----TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 618 (698)
.++++||+++++|..++...... ..+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 46899999999999999999999987 99999999999999999999999
Q ss_pred cCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
||+++.+.............++..|+|||.+....++.++||||||+++||+++ |+.||....+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 225 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH
Confidence 999986543332222222456778999999988889999999999999999999 9999975443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=287.32 Aligned_cols=193 Identities=29% Similarity=0.485 Sum_probs=165.8
Q ss_pred cCceeeecceeEEEEEec-cccEEEEEEecC----CCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe--eEEEEEe
Q 005400 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSK----GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE--SMLIYEY 550 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~----~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~--~~lV~E~ 550 (698)
..+||+|+|-+||||... +|-+||--.++. ..+...+.|..|+++|+.|+||||++++..+.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 358999999999999874 366776333321 144556889999999999999999999999987665 7789999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceEEeecCCCcccCCCc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFgla~~~~~~~ 629 (698)
|..|+|..|+.+.++ ++...+..|++||++||.|||++. +||||||||..||+|+ .-|.+||+|+|||..+....
T Consensus 125 ~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999976654 778899999999999999999987 6899999999999997 56899999999999876544
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.. ...|||.|||||+.. ..|+..+|||||||+++||+|+..||..
T Consensus 201 ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 201 AK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred cc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 32 278999999999886 7899999999999999999999999973
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=272.45 Aligned_cols=207 Identities=28% Similarity=0.486 Sum_probs=174.6
Q ss_pred hcCccccCceeeecceeEEEEEecc------ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
.++|.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+++++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3568888999999999999998643 3689999986543 23456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEe
Q 005400 545 MLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 617 (698)
++||||+++++|..++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864322 234788999999999999999999987 9999999999999999999999
Q ss_pred ecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
|||+++.+.............++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999886543332222223456789999999988889999999999999999998 999986544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=268.89 Aligned_cols=203 Identities=31% Similarity=0.491 Sum_probs=173.0
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.+|.+.++||+|++|.||++... .++.||+|++... ....+++.+|++++++++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34777889999999999999875 4788999998654 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999885432 345889999999999999999999987 999999999999999999999999999876443221
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1112334668999999988899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=288.08 Aligned_cols=195 Identities=24% Similarity=0.309 Sum_probs=166.4
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
...+|.+.+.||+|+||.||+++... ++.||||... ...+.+|++++++++|+|||++++++......++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34579999999999999999998754 7889999642 2346789999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
++. ++|..++... ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 241 ~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 6777777543 235899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf 677 (698)
.........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 221222356999999999999999999999999999999999988654
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.73 Aligned_cols=205 Identities=30% Similarity=0.525 Sum_probs=173.3
Q ss_pred cCccccCceeeecceeEEEEEec------cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
+++...++||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999642 356789999876665666789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 547 IYEYMPNKSLDFFIFDQAR------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
++||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 134789999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
||+|||++................+++.|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 9999999876543222111122345678999999998899999999999999999998 89998543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=268.02 Aligned_cols=203 Identities=26% Similarity=0.436 Sum_probs=174.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.++||+|+||.||+|+.. +++.||+|.+... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999864 5889999987543 2334456889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 549 EYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
||+++++|..++.... ....++...+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345788999999999999999999988 99999999999999999999999999887643
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 321 112246888999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=257.26 Aligned_cols=209 Identities=24% Similarity=0.327 Sum_probs=177.0
Q ss_pred hhcCccccCceeeecceeEEEEE-eccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-----ee
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ES 544 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~-----~~ 544 (698)
..++|.+.++||+|||+.||.++ ..+++.+|+|++.....+..+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999998 4568899999998877788889999999999999999999998875443 48
Q ss_pred EEEEEecCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 545 MLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
||+++|...|+|.+.+..... +..+++.+++.|+.++.+||++||+.. +++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999875543 448999999999999999999999986 579999999999999999999999999987
Q ss_pred ccCCC-----c---cccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGD-----E---IQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~-----~---~~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
...-. + .+. .....-|..|.|||.+. +...+.++|||||||+||+|+.|..||+...
T Consensus 178 ~a~i~i~~~~~a~~lQe-~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQE-WAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred ccceEeechHHHHHHHH-HHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 64211 0 000 01235688999999874 4568899999999999999999999997543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=268.13 Aligned_cols=198 Identities=29% Similarity=0.456 Sum_probs=166.5
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
++||+|+||.||+++.. +++.+|+|.+.... .+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 68899999886543 34456799999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccccc
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (698)
.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||.||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998543 235789999999999999999999988 99999999999999999999999999876442211111111
Q ss_pred ccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 637 ~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
...+..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 223457999999988889999999999999999998 888886433
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.34 Aligned_cols=201 Identities=24% Similarity=0.437 Sum_probs=173.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
++|.+.++||+|+||.||+++.. +++.||+|.++.........+.+|+.+++.++||||+++++.+......++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 56788889999999999999864 58899999987665555567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 999999988543 34889999999999999999999998 99999999999999999999999999876543221
Q ss_pred cccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......|+..|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 122356899999999874 4568899999999999999999999986443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=272.37 Aligned_cols=203 Identities=27% Similarity=0.497 Sum_probs=177.6
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..++|++.+.||+|++|.||+++. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346789999999999999999986 4689999999976655556778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|..++.+ ..+++..+..++.+++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998843 24788899999999999999999988 9999999999999999999999999987654332
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||....+
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred cC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 11 1224688899999999988899999999999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=283.41 Aligned_cols=193 Identities=25% Similarity=0.369 Sum_probs=161.4
Q ss_pred eeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhc---CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l---~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
||+|+||.||+++.. .++.||+|++.+.. ......+..|..++.+. +||||++++..+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 48899999986531 22334455677777665 699999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++.+. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 9999888543 34889999999999999999999998 99999999999999999999999999875432221 1
Q ss_pred cccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 2235799999999998754 47899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.33 Aligned_cols=198 Identities=33% Similarity=0.562 Sum_probs=171.2
Q ss_pred ccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcch--HHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~--~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
|++.+.||+|+||.||+++... ++.+|+|++........ .....|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999999865 66899999987643322 23456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|..++. ....+++..+..++.|+++||++||+.+ ++|+||||+||+++++++++|+|||++.......
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-- 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-- 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence 9999999986 2345799999999999999999999998 9999999999999999999999999997642111
Q ss_pred cccccccccccccChhccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~-~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.......++..|+|||++. ...++.++||||+|+++++|++|+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2223367899999999998 788999999999999999999999999854
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=292.91 Aligned_cols=203 Identities=21% Similarity=0.293 Sum_probs=164.8
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCC------CeeeeEEEEEE
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH------RNLVKLLGCCI 539 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H------~nIv~l~~~~~ 539 (698)
++...+++|++.++||+|+||.||+++.. .++.||||+++... ...+.+..|++++++++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455788999999999999999999875 47789999996432 234456677777777754 45889999887
Q ss_pred eC-CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCC-----
Q 005400 540 QA-DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDM----- 612 (698)
Q Consensus 540 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~----- 612 (698)
.. ...++|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 64 4688999988 66787777543 3488999999999999999999984 6 99999999999998765
Q ss_pred -----------ceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 613 -----------NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 613 -----------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998764221 1223679999999999999999999999999999999999999997654
Q ss_pred C
Q 005400 682 P 682 (698)
Q Consensus 682 ~ 682 (698)
.
T Consensus 350 ~ 350 (467)
T PTZ00284 350 N 350 (467)
T ss_pred h
Confidence 3
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=270.67 Aligned_cols=202 Identities=28% Similarity=0.440 Sum_probs=173.7
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
+.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+++++.++|+||+++++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 668899999999999999998754 7899999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|..++.+.. ..+++..+..++.|++++|+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 9999988775432 34889999999999999999999987 99999999999999999999999999875432211
Q ss_pred cccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......++..|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 112246788999999884 3457889999999999999999999996543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=269.18 Aligned_cols=201 Identities=30% Similarity=0.474 Sum_probs=169.9
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|++.+.||+|++|.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999875 58899999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
++ ++|..++........+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 578777755444456899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
. .....++..|+|||++.+. .++.++||||||++++||+||+.||...
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 157 V--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred c--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 1 1123568899999987654 5789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=314.93 Aligned_cols=191 Identities=26% Similarity=0.500 Sum_probs=162.8
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
...+...+.||+|+||.||+|+. .+++.||+|++...... ..+|++++++++|||||+++++|.+....++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577778999999999999987 46889999998654321 23568899999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++|+|.+++.. ++|.++.+++.|+++||+|||+....+|+||||||+||+++.++.+++. |+........
T Consensus 765 ~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 999999999842 7899999999999999999997655669999999999999999888876 6665432211
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
....++..|||||++....++.++|||||||++|||+||+.||..
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 123678999999999999999999999999999999999999853
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=268.46 Aligned_cols=204 Identities=29% Similarity=0.484 Sum_probs=169.0
Q ss_pred ccccCceeeecceeEEEEEecc----ccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe-----
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~----- 543 (698)
|.+.+.||+|+||.||+|.+.. +..||+|+++... ....+.+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998743 3679999987542 2345678999999999999999999999876554
Q ss_pred -eEEEEEecCCCChhHHHhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeec
Q 005400 544 -SMLIYEYMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (698)
Q Consensus 544 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 619 (698)
.++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999998885432 2235889999999999999999999988 999999999999999999999999
Q ss_pred CCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
|+++...............++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 99987543322211222345678999999988889999999999999999999 889886543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=282.66 Aligned_cols=205 Identities=29% Similarity=0.451 Sum_probs=170.7
Q ss_pred cCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~ 544 (698)
++|.+.++||+|+||.||++++. .++.||+|++.... ....+.+..|++++.++. ||||+++++++......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45677789999999999999853 24679999997653 233457889999999997 99999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccc-----------------------------------------------------------
Q 005400 545 MLIYEYMPNKSLDFFIFDQAR----------------------------------------------------------- 565 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 565 (698)
++|+||+++|+|.+++.....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999864321
Q ss_pred ------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 566 ------------------------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 566 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
...+++..++.++.|+++||+|||+.+ ++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 124677888999999999999999987 99999999999999
Q ss_pred CCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
+++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999986533221111122356788999999988889999999999999999998 88998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=270.87 Aligned_cols=204 Identities=30% Similarity=0.487 Sum_probs=169.6
Q ss_pred hcCccccCceeeecceeEEEEEec-ccc----EEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
.++|++.++||+|+||.||+|+.. +++ .||+|.+... .....+.+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356888899999999999999853 344 4899998754 33345678899999999999999999999875 4578
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998643 235889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 43322211222345678999999988899999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=265.59 Aligned_cols=202 Identities=32% Similarity=0.546 Sum_probs=171.5
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|++++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999988888999999875433 3567999999999999999999999875 456899999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999986532 234789999999999999999999988 9999999999999999999999999998654322111
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 112345668999999988889999999999999999999 899996543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=266.67 Aligned_cols=202 Identities=30% Similarity=0.534 Sum_probs=171.2
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|.+.++||+|+||.||+|+..+...||+|+++... ...+.+.+|++++++++||||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5688899999999999999988777789999987533 33467899999999999999999999874 456799999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|.+++.+.. ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++..+.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999986532 345789999999999999999999988 9999999999999999999999999997654332211
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.....++..|+|||......++.++||||||+++|||+| |+.||....
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred -ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 122346678999999988889999999999999999999 888887543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=268.20 Aligned_cols=204 Identities=30% Similarity=0.480 Sum_probs=171.4
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeC------
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA------ 541 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~------ 541 (698)
.+++.|++.+.||+|+||.||+|... .++.||+|++.... .....+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678888999999999999999875 47889999986543 3456788999999998 699999999998753
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
...++||||+++++|..++... ....+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999988653 2345889999999999999999999988 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 876533221 122356889999999885 345788999999999999999999999643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=274.76 Aligned_cols=207 Identities=30% Similarity=0.475 Sum_probs=172.1
Q ss_pred hcCccccCceeeecceeEEEEEecc--------ccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeC
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~ 541 (698)
.++|.+.+.||+|+||.||+++... ...+|+|.++... ......+.+|++++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578899999999999999997532 3469999987542 33456788999999999 799999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (698)
...++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975421 234889999999999999999999987 9999999999999
Q ss_pred cCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
+.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999876543221111122234568999999988889999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=280.74 Aligned_cols=198 Identities=26% Similarity=0.369 Sum_probs=167.5
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC------
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------ 541 (698)
..++|.+.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999864 4788999998754 233456788999999999999999999987543
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
...++||||+++ +|...+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 56555522 3778889999999999999999988 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
++....... .....+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 173 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 986543221 12356899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=271.23 Aligned_cols=202 Identities=28% Similarity=0.520 Sum_probs=177.0
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|++.+.||.|++|.||+++. .+++.|++|.+........+.+.+|+++++.++||||+++++.+......++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35688999999999999999985 46889999999766555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|..++.. ..+++.++..++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999998843 24789999999999999999999998 99999999999999999999999999876543321
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
. .....++..|+|||.+....++.++|||||||++|||++|+.||....+
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 1224688899999999888899999999999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=270.18 Aligned_cols=198 Identities=29% Similarity=0.421 Sum_probs=174.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|++|.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999875 4889999998653 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++... ..++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998554 35889999999999999999999988 999999999999999999999999999875433
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||....
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 223568899999999988888999999999999999999999997544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=271.98 Aligned_cols=206 Identities=33% Similarity=0.486 Sum_probs=170.9
Q ss_pred CccccCceeeecceeEEEEEecc------ccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
+|.+.+.||+|+||.||+|+... ...+++|.+..... ...+.+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46777899999999999997532 35688888865432 345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 005400 547 IYEYMPNKSLDFFIFDQA---------------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 605 (698)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885421 1134788999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 606 VLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 606 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999976533222111222345678999999988889999999999999999999 9999875444
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=265.69 Aligned_cols=202 Identities=29% Similarity=0.448 Sum_probs=169.8
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-----CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--Cee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~ 544 (698)
.+|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 48899999875321 12345788899999999999999999998764 467
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|.+++.+. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988543 23788888999999999999999988 99999999999999999999999999876
Q ss_pred cCCCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 5322111 1122346888999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=267.07 Aligned_cols=202 Identities=30% Similarity=0.529 Sum_probs=165.7
Q ss_pred cccCceeeecceeEEEEEecccc---EEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC------Cee
Q 005400 476 ASYNKLGEGGFGPVYKGTLVEGQ---EIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------DES 544 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~~~g~---~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------~~~ 544 (698)
.+.++||+|+||.||+|+..+.. .+|+|.++.. .....+.+..|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999875432 5899988654 234456789999999999999999999987532 246
Q ss_pred EEEEEecCCCChhHHHhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 545 MLIYEYMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998875322 2345889999999999999999999987 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
++.+.............++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 987643322111122345678999999999999999999999999999999 88898643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=273.58 Aligned_cols=207 Identities=29% Similarity=0.479 Sum_probs=173.4
Q ss_pred hcCccccCceeeecceeEEEEEec--------cccEEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeC
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~ 541 (698)
.++|.+.+.||+|+||.||+++.. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 466888899999999999999742 2457999998654 234456789999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (698)
...++||||+++++|..++..... ...+++..++.++.|+++||+|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999875321 234788899999999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999987654332222222446678999999988889999999999999999998 788886443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=269.06 Aligned_cols=199 Identities=27% Similarity=0.447 Sum_probs=164.3
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhc---CCCeeeeEEEEEEeC-----C
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQA-----D 542 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l---~H~nIv~l~~~~~~~-----~ 542 (698)
+|++.+.||+|+||.||+++.. +++.||+|.++... ......+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999875 58899999987542 22234566777777665 699999999988642 4
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++|+||+++ +|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 7877775432 234889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
........ .....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 87543221 12256889999999998888999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=271.64 Aligned_cols=204 Identities=31% Similarity=0.475 Sum_probs=169.2
Q ss_pred cCccccCceeeecceeEEEEEecc-c--cEEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-G--QEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g--~~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|++.+.||+|+||.||+|+..+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999998754 3 24788888643 334456789999999999 799999999999999999999
Q ss_pred EEecCCCChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 548 YEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1135888999999999999999999987 9999999999999999999
Q ss_pred EEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |+.||....+
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999986432111 1111233567999999988889999999999999999997 9999975543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=267.77 Aligned_cols=200 Identities=27% Similarity=0.437 Sum_probs=171.4
Q ss_pred ccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
|++.++||+|+||.||++.... +..+++|.+........+.+.+|+++++.++||||+++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5677899999999999998754 678899998766556677899999999999999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++.+. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 9998887542 235899999999999999999999988 99999999999999999999999999876432211 1
Q ss_pred cccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....++..|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 22356889999999874 3457889999999999999999999986443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.70 Aligned_cols=208 Identities=30% Similarity=0.478 Sum_probs=174.1
Q ss_pred hhcCccccCceeeecceeEEEEEecc------ccEEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCC
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~ 542 (698)
..++|++.+.||+|+||.||++.... ...+|+|.+... ..+...++.+|++++.++ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34568888999999999999998643 357999998754 233445788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQ-------------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
..+++|||+++++|..++... .....+++..++.++.|++.||+|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 12345889999999999999999999987 99999999999999
Q ss_pred CCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
+++.+||+|||+++.+.............++..|+|||.+....++.++|||||||++|||++ |..||....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999999987654332222222345678999999988899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=265.55 Aligned_cols=206 Identities=29% Similarity=0.447 Sum_probs=172.6
Q ss_pred HHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
+.+++++.....||+|+||.||+|+.. +++.|++|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345666666679999999999999865 4778999998776656677899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-CCceEEeecCCCcccC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFG 626 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFgla~~~~ 626 (698)
+||+++++|..++.........++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999865322111277888899999999999999988 999999999999976 6799999999987654
Q ss_pred CCccccccccccccccccChhcccCCC--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.... ......++..|+|||++.... ++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 3221 112245789999999986543 78899999999999999999999964
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=279.50 Aligned_cols=199 Identities=27% Similarity=0.357 Sum_probs=167.5
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC------
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------ 541 (698)
..++|.+.+.||+|+||.||++... .++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 58899999987542 23446788899999999999999999988643
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
...++||||+++ ++...+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 347999999976 45555422 3788888999999999999999988 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 166 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 986543221 123578999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=264.47 Aligned_cols=203 Identities=34% Similarity=0.545 Sum_probs=173.0
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.++|.+.++||+|+||.||++...+++.+|+|.+.... ...+.+.+|++++++++|+||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35688889999999999999998889999999987543 34568999999999999999999999864 56789999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999886543 345889999999999999999999988 999999999999999999999999999765432221
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
. .....++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 1 112345678999999988889999999999999999999 999996443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=263.98 Aligned_cols=203 Identities=27% Similarity=0.448 Sum_probs=175.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|++|.||+|... +++.+|+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999886 6899999988642 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 549 EYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
||+++++|..++.... ....+++..+..++.++++||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886432 2345889999999999999999999988 99999999999999999999999999876543
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 2211 12246788999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=271.56 Aligned_cols=205 Identities=31% Similarity=0.466 Sum_probs=172.9
Q ss_pred cCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
++|.+.+.||+|+||.||++... .+..||+|+++... ....+.+.+|+++++++ +||||+++++++......
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56888899999999999999742 24579999987553 33456789999999999 799999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|..++.... ...+++.++..++.+++.||+|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999986432 234899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
+.............++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 543322111222346778999999998899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=254.42 Aligned_cols=204 Identities=27% Similarity=0.442 Sum_probs=173.1
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC----C----cchHHHHHHHHHHhhc-CCCeeeeEEEEEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS----G----QGMEEFKNEVTLIARL-QHRNLVKLLGCCI 539 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~----~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~ 539 (698)
....+|.-.+.||.|..+.|.+..++ .|++.|+|++.... . ...++-..|+.||+++ .||+|+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34456777789999999999988764 48899999986431 1 1234557799999998 5999999999999
Q ss_pred eCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeec
Q 005400 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (698)
Q Consensus 540 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 619 (698)
.+.-.++|+|.|+.|.|.++|... -.+++.+..+|++|++.|++|||..+ ||||||||+|||+|++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 999999999999999999999543 34889999999999999999999998 999999999999999999999999
Q ss_pred CCCcccCCCccccccccccccccccChhccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAA------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
|++..+.... .....+||++|+|||.+. ...|+..+|+|+.|||||-|+.|.+||-+...
T Consensus 168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 9998875543 234589999999999874 23478899999999999999999999976543
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=268.78 Aligned_cols=203 Identities=26% Similarity=0.426 Sum_probs=175.3
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|++.++||.|++|.||++... +++.+|+|.+........+.+..|++++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467889999999999999999875 5789999998766556667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|..++.+.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999885432 35889999999999999999999998 99999999999999999999999999876433221
Q ss_pred ccccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......++..|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 112246889999999874 3457789999999999999999999997544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=271.49 Aligned_cols=204 Identities=29% Similarity=0.467 Sum_probs=169.3
Q ss_pred cCccccCceeeecceeEEEEEecc---------------ccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE---------------GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLG 536 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~---------------g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~ 536 (698)
++|++.++||+|+||.||+++..+ ...||+|.+... .....+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987632 224899998754 2334557899999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCChhHHHhhccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 005400 537 CCIQADESMLIYEYMPNKSLDFFIFDQAR---------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (698)
Q Consensus 537 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 607 (698)
++......++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 124688899999999999999999988 999999999999
Q ss_pred EcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 005400 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS--GKKNWRF 679 (698)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt--G~~pf~~ 679 (698)
+++++.+||+|||++................++..|+|||.+....++.++||||||++++||++ +..||..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999976543222221222345778999999988889999999999999999998 5567654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=273.04 Aligned_cols=196 Identities=25% Similarity=0.422 Sum_probs=159.1
Q ss_pred CceeeecceeEEEEEec---cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe--CCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--~~~~~lV~E~~~~ 553 (698)
++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 58999999999999864 46789999986542 23457889999999999999999999864 4567899999865
Q ss_pred CChhHHHhhcc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE----cCCCceEEeecCCCc
Q 005400 554 KSLDFFIFDQA------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (698)
Q Consensus 554 gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFgla~ 623 (698)
+|..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 6766664321 1234888999999999999999999998 9999999999999 456789999999998
Q ss_pred ccCCCcc-ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 624 IFGGDEI-QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 624 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....... ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 7643321 1122335789999999998764 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=269.77 Aligned_cols=205 Identities=30% Similarity=0.469 Sum_probs=172.8
Q ss_pred hcCccccCceeeecceeEEEEEecc-----------------ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVK 533 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~ 533 (698)
.++|++.++||+|+||.||+++..+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999987643 2458999987653 334667899999999999999999
Q ss_pred EEEEEEeCCeeEEEEEecCCCChhHHHhhccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 005400 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQAR--------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (698)
Q Consensus 534 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 605 (698)
+++++......++++|++++++|..++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999865431 225899999999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 005400 606 VLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS--GKKNWRF 679 (698)
Q Consensus 606 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt--G~~pf~~ 679 (698)
|++++++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++ +..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999886543332222223456788999999988889999999999999999998 6677754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=262.08 Aligned_cols=197 Identities=30% Similarity=0.457 Sum_probs=167.7
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCChh
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~ 557 (698)
+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876533 33457889999999999999999999999999999999999999999
Q ss_pred HHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccc
Q 005400 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637 (698)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 637 (698)
.++.... ..+++..+..++.+++++|.|||+.+ ++|+||+|+||++++++.+||+|||++.......... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 9885432 34789999999999999999999988 9999999999999999999999999987543222111 1112
Q ss_pred cccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 638 ~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 34668999999988889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=266.93 Aligned_cols=201 Identities=26% Similarity=0.448 Sum_probs=175.6
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|++.+.||.|++|.||+++.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778889999999999999875 58899999987553 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999988543 5889999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
......++..|+|||++.+..++.++||||||+++|||+||+.||...++
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~ 203 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch
Confidence 12234678899999999988899999999999999999999999975443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=266.69 Aligned_cols=201 Identities=25% Similarity=0.413 Sum_probs=171.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|+..+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999876 48899999986542 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|..++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999888776432 24899999999999999999999988 9999999999999999999999999998764432
Q ss_pred cccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 155 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 155 DD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred cc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 11 112457889999998865 567899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=279.52 Aligned_cols=210 Identities=31% Similarity=0.513 Sum_probs=179.7
Q ss_pred cccccchhhHHHhhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEE
Q 005400 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537 (698)
Q Consensus 459 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~ 537 (698)
+.|+++..+ ....++||-|.||.||.|.++. .-.||||.++.. .-..++|+.|..+|+.++|||+|+|+|+
T Consensus 260 DkWEmeRtd-------ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGV 331 (1157)
T KOG4278|consen 260 DKWEMERTD-------ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 331 (1157)
T ss_pred chhhccchh-------eeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhh
Confidence 445555544 3556799999999999999865 678999999654 4567899999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEe
Q 005400 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (698)
Q Consensus 538 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 617 (698)
|..+...|||+|||.+|+|.++|.+..+ ..++...++++|.||+.||+||...+ +|||||..+|+|+.++..+||+
T Consensus 332 CT~EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 332 CTHEPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred hccCCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEee
Confidence 9999999999999999999999976543 34677778899999999999999988 9999999999999999999999
Q ss_pred ecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
||||++++..+.+.. .....-++.|.|||-+....++.|+|||+|||+||||.| |-.||..-+
T Consensus 408 DFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 408 DFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred ccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 999999986654322 222345789999999999999999999999999999998 778876433
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=298.54 Aligned_cols=208 Identities=24% Similarity=0.407 Sum_probs=170.7
Q ss_pred HhhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--Cee
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~ 544 (698)
...++|.++++||+|+||.||+++... ++.+|+|.+... .......|..|+.++.+++|||||++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345789999999999999999998754 678899988654 233456789999999999999999999988653 568
Q ss_pred EEEEEecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceeecCCCCCCEEEcCC--------
Q 005400 545 MLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSR----MRIIHRDLKASNVLLDND-------- 611 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dlkp~NILl~~~-------- 611 (698)
+|||||+++++|..+|.... ....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999986432 23458999999999999999999998542 249999999999999642
Q ss_pred ---------CceEEeecCCCcccCCCccccccccccccccccChhcccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 612 ---------MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 612 ---------~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
..+||+|||++..+..... .....||+.|+|||++.. ..++.++||||||||||||+||+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3489999999987543221 223578999999998854 45889999999999999999999999643
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=272.42 Aligned_cols=206 Identities=31% Similarity=0.483 Sum_probs=171.4
Q ss_pred cCccccCceeeecceeEEEEEec--------cccEEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~ 542 (698)
++|.+.++||+|+||.||+++.. ....+|+|.++.. .......+..|+++++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56788899999999999999742 2456899988754 234456788999999999 6999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
..++||||+++++|..++..... ...+++.++..++.|++.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999865321 235889999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999986543222111222234567999999988899999999999999999999 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=263.39 Aligned_cols=204 Identities=34% Similarity=0.556 Sum_probs=175.5
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.++|.+.++||+|+||.||++...+++.+|+|.+.... ...+++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788899999999999999998888899999987543 34577999999999999999999999999889999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999986532 235889999999999999999999988 999999999999999999999999998876432211
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
. ......+..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 1 112334678999999998889999999999999999999 999986433
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=269.97 Aligned_cols=202 Identities=25% Similarity=0.441 Sum_probs=171.3
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|++.+.||+|+||.||+++.. .++.+|+|.+... .......+.+|++++.+++|+||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788899999999999999875 5889999988654 333456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|..++........+++..+..++.++++||.|||+.. +|+|+||||+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 999999988865433346899999999999999999999742 399999999999999999999999999876532221
Q ss_pred ccccccccccccccChhcccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG------LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~------~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....++..|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 159 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 159 ----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 224578899999988543 3578999999999999999999999644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=269.79 Aligned_cols=201 Identities=26% Similarity=0.415 Sum_probs=169.3
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|.+.++||+|+||.||+++.. +++.||+|.+.... ......+.+|++++++++||||+++++++......++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999875 47889999986542 33345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
++ ++|..++... ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5787777543 234788999999999999999999988 99999999999999999999999999876432221
Q ss_pred ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......++..|+|||.+.+. .++.++||||||+++|||+||+.||....
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11224578899999987654 57889999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=262.66 Aligned_cols=201 Identities=29% Similarity=0.493 Sum_probs=176.3
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
++|++.++||+|+||.||+++..+ ++.+++|.+..... .+++.+|++++++++||||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999865 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998542 345899999999999999999999988 99999999999999999999999999887543321
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 11224578899999999888999999999999999999999999976544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=276.50 Aligned_cols=205 Identities=30% Similarity=0.467 Sum_probs=168.8
Q ss_pred cCccccCceeeecceeEEEEEe------ccccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeC-Ce
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA-DE 543 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~-~~ 543 (698)
++|++.+.||+|+||.||+|+. ..++.||||+++... ......+.+|++++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788999999999999999973 346789999997543 33456788999999999 689999999988654 46
Q ss_pred eEEEEEecCCCChhHHHhhccc----------------------------------------------------------
Q 005400 544 SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------------------- 565 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 565 (698)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999998864210
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccc
Q 005400 566 ------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639 (698)
Q Consensus 566 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~g 639 (698)
...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++++||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 123678888999999999999999988 99999999999999999999999999876533222111222345
Q ss_pred cccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 640 t~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
+..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 678999999988899999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=263.00 Aligned_cols=202 Identities=25% Similarity=0.353 Sum_probs=175.8
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
-++|+.+++||+|.||+|.+++-+ .++-+|+|++++. ......+-..|-++|...+||.+..+--.|+..+.++.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888999999999999999764 5889999999876 234455678899999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||..+|.|..+|.+ ...+++.....+-..|+.||.|||+.+ ||.||||.+|.|||.+|++||+||||++.--.
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999988854 345777777778889999999999988 99999999999999999999999999986322
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. ..+...+||+.|+|||++....|+..+|.|.+||++|||++|+.||...+
T Consensus 321 ~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 321 YG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred cc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 22 22344899999999999999999999999999999999999999997544
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=262.93 Aligned_cols=202 Identities=25% Similarity=0.399 Sum_probs=174.0
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
+|++.++||+|+||.||++... +++.+|+|.++.. .....+.+.+|++++++++|+||+++++.+......++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999865 5889999998643 2344567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|..++... ....++...+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999998887543 2345788999999999999999999988 999999999999999999999999998765432211
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....++..|+|||++....++.++||||||+++|+|++|+.||....
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 122468889999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=263.79 Aligned_cols=201 Identities=30% Similarity=0.484 Sum_probs=171.7
Q ss_pred CccccCceeeecceeEEEEEeccccEEEEEEecCCCC------cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~------~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
+|.+.+.||+|+||.||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3667789999999999999887899999998864321 2235688999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998543 24788888999999999999999988 99999999999999999999999999876432
Q ss_pred Ccc----ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEI----QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~----~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
... ........++..|+|||++....++.++||||||++++||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 111 11112246889999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=262.67 Aligned_cols=202 Identities=25% Similarity=0.450 Sum_probs=175.9
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999875 47789999998765556788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|..++... ...++...+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988543 234889999999999999999999988 99999999999999999999999999876543211
Q ss_pred cccccccccccccChhcccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEG---LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~---~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......++..|+|||.+... .++.++||||||+++|||+||+.||....
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 11224678899999998776 78999999999999999999999997544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=261.97 Aligned_cols=203 Identities=25% Similarity=0.428 Sum_probs=175.8
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|+..+.||+|+||.||.++.. +++.+++|++... .....+++.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999998764 4888999987654 344566789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++.... ...+++..+..++.|++++|+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986543 345789999999999999999999988 99999999999999999999999999986543331
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
......++..|+|||.+.+..++.++||||||++++||++|+.||....+
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 12235689999999999888889999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=277.41 Aligned_cols=198 Identities=27% Similarity=0.424 Sum_probs=167.1
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-----
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA----- 541 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~----- 541 (698)
...++|.+.+.||+|+||.||++... .++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999864 57899999987542 23345678899999999999999999987543
Q ss_pred -CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 542 -DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 542 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
...++++|++ +++|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 7788777632 34889999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
++...... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99865432 122568999999999876 56899999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=258.86 Aligned_cols=196 Identities=27% Similarity=0.409 Sum_probs=166.7
Q ss_pred CceeeecceeEEEEE-eccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
+.||+|+++.|--++ +..|.++|||++.+..........+|++++.+.+ |+||++|+++|+++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 479999999998876 4679999999999887777888999999999986 99999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC---ceEEeecCCCcccCC--C---
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARIFGG--D--- 628 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFgla~~~~~--~--- 628 (698)
..+|.++ ..+++.+..++.++|+.||.|||.++ |.||||||+|||-.+-. -+||+||.|..-+.. +
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999654 34889999999999999999999999 99999999999996443 389999999765421 1
Q ss_pred ccccccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.........+|+..|||||+.. ...|+.+.|.||||||||-||.|..||...
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 1111122357899999999753 235889999999999999999999999754
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=262.08 Aligned_cols=200 Identities=36% Similarity=0.580 Sum_probs=173.1
Q ss_pred CceeeecceeEEEEEecc----ccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 778999999765433 367899999999999999999999999999999999999999
Q ss_pred CChhHHHhhccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 554 KSLDFFIFDQAR------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 554 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
++|.+++..... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 256899999999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
...........++..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 332122233567889999999988889999999999999999999 699997653
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=262.05 Aligned_cols=196 Identities=29% Similarity=0.497 Sum_probs=162.7
Q ss_pred ceeeecceeEEEEEec---cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCC
Q 005400 480 KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (698)
Q Consensus 480 ~LG~G~fG~Vy~g~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 555 (698)
.||+|+||.||+|++. .+..||+|++.... ....+.+.+|++++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 34579999987653 234567899999999999999999999885 457899999999999
Q ss_pred hhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc-c
Q 005400 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN-T 634 (698)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~-~ 634 (698)
|.+++... ...+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++........... .
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99988542 335899999999999999999999988 99999999999999999999999999986543321111 1
Q ss_pred ccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 635 ~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 11233578999999988889999999999999999996 999997543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=264.09 Aligned_cols=194 Identities=32% Similarity=0.499 Sum_probs=163.3
Q ss_pred ceeeecceeEEEEEec---cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 480 KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 480 ~LG~G~fG~Vy~g~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
+||+|+||.||+|.+. +++.+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999653 47889999986543 234567899999999999999999999875 45678999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc-
Q 005400 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN- 633 (698)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~- 633 (698)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||.||++++++.+||+|||++..+........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998543 34889999999999999999999988 99999999999999999999999999987644322111
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 111234578999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=262.17 Aligned_cols=202 Identities=31% Similarity=0.531 Sum_probs=170.7
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|.+.++||+|++|.||++....+..+|+|++.... ...+.+.+|++++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578888999999999999998777789999886433 34567899999999999999999999875 456889999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 999999986532 335789999999999999999999988 999999999999999999999999999765432211
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
......++..|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 1112346678999999988889999999999999999999 899997543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=276.97 Aligned_cols=204 Identities=26% Similarity=0.447 Sum_probs=179.8
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
-...|.+.+.||+|.|++|..+++. .+.+||+|.+++. .....+.+.+|+++|+.++|||||+++.+.+.+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567899999999999999999874 5899999999876 334456689999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||..+|.+.+++.++.+ ....+...++.|+..+++|||+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999987665 344777889999999999999998 99999999999999999999999999998763
Q ss_pred CccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
.. .....+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+.....
T Consensus 208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk 261 (596)
T KOG0586|consen 208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK 261 (596)
T ss_pred cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence 32 2334789999999999988876 68999999999999999999999865543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=265.30 Aligned_cols=202 Identities=26% Similarity=0.439 Sum_probs=174.2
Q ss_pred cCccccCceeeecceeEEEEEe-ccccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||.||+++. .+++.+++|.+... ......++.+|+++++.++||||+++++++.+....+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677888999999999999986 46889999987643 2234467889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 549 EYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 549 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
||+++++|..++... .....+++..+..++.++++||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 22346899999999999999999999988 99999999999999999999999999876543
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.... .....++..|+|||++....++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 3211 1224688899999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=272.12 Aligned_cols=203 Identities=32% Similarity=0.507 Sum_probs=168.6
Q ss_pred cCccccCceeeecceeEEEEEecc-cc--EEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|++.+.||+|+||.||+|+... +. .+++|.++.. .....+.+.+|++++.++ +|+||+++++++......++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 567888999999999999998743 43 4678777643 234456788999999999 899999999999999999999
Q ss_pred EEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 548 YEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
+||+++++|.+++.+... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999865321 235789999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
||+|||++...... .......++..|+|||.+....++.++||||||++++||+| |+.||....
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 99999998642211 11111234668999999988889999999999999999998 999996443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=267.72 Aligned_cols=204 Identities=30% Similarity=0.516 Sum_probs=171.3
Q ss_pred cCccccCceeeecceeEEEEEecc-cc----EEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~----~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|.+.+.||+|+||.||+|.... |+ .+|+|.+.... .....++.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999998643 32 58999887653 3345678999999999999999999999987 78899
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999986532 24889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
............++..|+|||.+....++.++||||||+++|||++ |+.||...++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 3322221112234568999999988889999999999999999999 9999976544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=269.23 Aligned_cols=205 Identities=30% Similarity=0.480 Sum_probs=170.3
Q ss_pred cCccccCceeeecceeEEEEEec-----------------cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-----------------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKL 534 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l 534 (698)
++|++.++||+|+||.||++... +...+|+|++.... ....+.+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999998532 23468999987543 3345679999999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCChhHHHhhccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCE
Q 005400 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQAR--------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606 (698)
Q Consensus 535 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 606 (698)
++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 124778889999999999999999998 99999999999
Q ss_pred EEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCC
Q 005400 607 LLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS--GKKNWRFS 680 (698)
Q Consensus 607 Ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt--G~~pf~~~ 680 (698)
|++.++.++|+|||++..+.............++..|+|||......++.++|||||||++|||++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999986543322111222344678999999888889999999999999999998 77888643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=263.51 Aligned_cols=192 Identities=22% Similarity=0.404 Sum_probs=161.1
Q ss_pred CceeeecceeEEEEEecc-------------ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 479 NKLGEGGFGPVYKGTLVE-------------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~-------------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
+.||+|+||.||+|+... ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899887655555668899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc-------eEEee
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-------PKISD 618 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------~kl~D 618 (698)
+||||+++++|+.++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999998887543 234889999999999999999999988 999999999999987654 89999
Q ss_pred cCCCcccCCCccccccccccccccccChhccc-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIV-SGKKNWRFSH 681 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~k~DVwSlGvil~ell-tG~~pf~~~~ 681 (698)
||++...... ....++..|+|||.+. ...++.++|||||||++|||+ +|+.||....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9998754322 1245788999999886 466899999999999999998 5888876443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=261.79 Aligned_cols=206 Identities=27% Similarity=0.452 Sum_probs=176.9
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|++.+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999864 57889999986542 33567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|..++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865443346899999999999999999999988 99999999999999999999999999877643322
Q ss_pred cc--ccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QT--NTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~--~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. ......++..|+|||.+... .++.++||||||++++||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 11 12234688999999998777 78999999999999999999999997544
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=266.08 Aligned_cols=198 Identities=34% Similarity=0.484 Sum_probs=166.2
Q ss_pred cccCceeeecceeEEEEEe-----ccccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeEEE
Q 005400 476 ASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLI 547 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~lV 547 (698)
...+.||+|+||+||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988653 347789999987643 23456789999999999999999999998764 357899
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++... .+++..++.++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||++..+..
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999998542 3899999999999999999999988 99999999999999999999999999987543
Q ss_pred Cccccc-cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTN-THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
...... .....++..|+|||.+....++.++||||||++++||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 221111 11134566799999998888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=268.00 Aligned_cols=206 Identities=29% Similarity=0.497 Sum_probs=172.3
Q ss_pred hcCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
.++|++.+.||+|+||.||++... ++..||+|++.... ....+++.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888899999999999999863 36789999987543 23456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccc-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 005400 545 MLIYEYMPNKSLDFFIFDQAR-------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 605 (698)
++|+||+++++|..++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999864321 124788889999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 606 VLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 606 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
|++++++.++|+|||++.................+..|+|||.+....++.++|||||||++|||++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999876543322111122344678999999988899999999999999999998 88888543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=274.62 Aligned_cols=206 Identities=29% Similarity=0.468 Sum_probs=171.7
Q ss_pred cCccccCceeeecceeEEEEEecc--------ccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~ 542 (698)
.+|.+.+.||+|+||.||+++... +..||+|.++... ....+++.+|+++++++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 458888999999999999997421 2368999887542 33457899999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
..++++||+++++|.+++.+.. ....+++..++.++.|+++||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1234788999999999999999999988 99999999999999
Q ss_pred CCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999986543222211222344568999999999999999999999999999998 888886544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=264.77 Aligned_cols=204 Identities=29% Similarity=0.495 Sum_probs=171.2
Q ss_pred cCccccCceeeecceeEEEEEecc----ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.+|++.+.||+|+||.||+|+... +..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 567888999999999999998642 3379999986542 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|..++.... ..+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999986532 34789999999999999999999988 99999999999999999999999999987643
Q ss_pred Cccccc-cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 628 DEIQTN-THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
...... .....++..|+|||.+....++.++||||||+++||+++ |+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 221111 111223568999999988889999999999999999886 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=261.71 Aligned_cols=197 Identities=32% Similarity=0.484 Sum_probs=168.9
Q ss_pred CceeeecceeEEEEEecc--c--cEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLVE--G--QEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~--g--~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
++||+|++|.||+|.+.. + ..||+|.+..... ...+.+..|++++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998743 2 3689999987655 567789999999999999999999999988 889999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc-c
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-T 632 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~-~ 632 (698)
++|..++.+... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999866432 46899999999999999999999988 999999999999999999999999999876442211 1
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1112456789999999988899999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=273.72 Aligned_cols=193 Identities=30% Similarity=0.484 Sum_probs=169.3
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 555 (698)
+.||+|.||+||-|+++ .|+.||||++.+. ..+...++++|+.||.+++||.||.+.-.|+..+..+.|||-+.+.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 68999999999999874 5999999999765 44566889999999999999999999999999999999999997776
Q ss_pred hhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC---CceEEeecCCCcccCCCcccc
Q 005400 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFgla~~~~~~~~~~ 632 (698)
|..+|... ...+++..-..++.||+.||.|||.++ |+|+||||+||||.+. -.+||+|||.|++++....+.
T Consensus 650 LEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 650 LEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred HHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 76666443 334777777788899999999999998 9999999999999643 469999999999987654432
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
..+||+.|+|||+++++.|...-|+||.|||+|--++|..||..
T Consensus 725 ---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 725 ---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred ---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 37899999999999999999999999999999999999999973
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=268.81 Aligned_cols=203 Identities=20% Similarity=0.309 Sum_probs=171.4
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||.||+++... ++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999998754 7889999987542 234557889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|..++... ..+++..+..++.++++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999998543 34788999999999999999999987 999999999999999999999999998642110
Q ss_pred c-------------cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 E-------------IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~-------------~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. .........++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0 0001112357889999999988889999999999999999999999997443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=261.50 Aligned_cols=200 Identities=31% Similarity=0.548 Sum_probs=170.3
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCCCc---------chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ---------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---------~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999864 4789999988654221 235688999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++|+||+++++|..++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 9999999999999998543 34788889999999999999999988 99999999999999999999999999887
Q ss_pred cCCCccc----cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEIQ----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....... .......|+..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 6422111 1111245788999999998888999999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=281.01 Aligned_cols=192 Identities=29% Similarity=0.520 Sum_probs=168.8
Q ss_pred ceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCChhH
Q 005400 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558 (698)
Q Consensus 480 ~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 558 (698)
+||+|.+|+||.|+..+ ...+|||.+.....+..+.+.+|+.+-++++|.|||+++|.+.++...-|.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999765 55799999988777778889999999999999999999999999999999999999999999
Q ss_pred HHhhccccCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceEEeecCCCcccCCCccccccc
Q 005400 559 FIFDQARATFL--DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTH 635 (698)
Q Consensus 559 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFgla~~~~~~~~~~~~~ 635 (698)
+|... =+++ .+.++-.+.+||++||.|||++. |||||||-.|||++ -.|.+||+|||-++.+..- .+.+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 98642 2234 67778889999999999999998 99999999999996 5789999999999876432 23344
Q ss_pred cccccccccChhcccCCC--CCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 636 KVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 636 ~~~gt~~y~APE~l~~~~--~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
...||..|||||++..++ |+..+|||||||.+.||.||++||-
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 478999999999998775 8899999999999999999999994
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=264.57 Aligned_cols=203 Identities=29% Similarity=0.515 Sum_probs=169.7
Q ss_pred CccccCceeeecceeEEEEEecc-c---cEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE-G---QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
.|++.+.||+|+||.||+|+... + ..||+|.+... .....++|..|++++++++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998753 3 36999998754 3344568999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|..++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999988643 235889999999999999999999988 999999999999999999999999998765432
Q ss_pred ccccc-ccccc--ccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 629 EIQTN-THKVV--GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~-~~~~~--gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
..... ..... .+..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 21111 11111 2457999999998899999999999999999886 999986543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=269.83 Aligned_cols=197 Identities=28% Similarity=0.475 Sum_probs=170.9
Q ss_pred cccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 476 ASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
+...+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..+...++|+||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999874 58899999987655555677889999999999999999999999999999999999999
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccc
Q 005400 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634 (698)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 634 (698)
+|..++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+..... ..
T Consensus 104 ~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 174 (297)
T cd06659 104 ALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR 174 (297)
T ss_pred CHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence 99887733 34789999999999999999999988 99999999999999999999999999876543221 11
Q ss_pred ccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 635 ~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
....++..|+|||++....++.++||||||++++||++|+.||....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22568899999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=264.70 Aligned_cols=201 Identities=30% Similarity=0.515 Sum_probs=168.5
Q ss_pred cCccccCceeeecceeEEEEEec-----cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~ 545 (698)
++|++.+.||+|+||.||++... +++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999999743 4788999999776666677899999999999999999999987543 4678
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+|+||+++++|.+++.+. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++..+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 234889999999999999999999988 999999999999999999999999999875
Q ss_pred CCCcccc-ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 626 GGDEIQT-NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 626 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
....... ......++..|+|||.+.+..++.++||||||++++||++|..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 4322111 1111223456999999988889999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=261.42 Aligned_cols=202 Identities=31% Similarity=0.470 Sum_probs=169.7
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-----CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--Cee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~ 544 (698)
.+|+..+.||+|+||.||++... .++.|++|++.... .+..+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999874 48899999886432 12345688999999999999999999998753 567
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++++||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999988543 24788889999999999999999987 99999999999999999999999999876
Q ss_pred cCCCcc-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+..... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 532111 11112245788999999998888999999999999999999999999744
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=268.98 Aligned_cols=196 Identities=26% Similarity=0.422 Sum_probs=158.5
Q ss_pred CceeeecceeEEEEEecc---ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe--CCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~---g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--~~~~~lV~E~~~~ 553 (698)
++||+|+||.||+++..+ +..||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 479999999999998653 5689999986542 23467899999999999999999999854 4567899999876
Q ss_pred CChhHHHhhc------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE----cCCCceEEeecCCCc
Q 005400 554 KSLDFFIFDQ------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (698)
Q Consensus 554 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFgla~ 623 (698)
+|..++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 565555321 12235788999999999999999999988 9999999999999 566789999999998
Q ss_pred ccCCCccc-cccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 624 IFGGDEIQ-TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 624 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
........ .......+|..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76433211 11223568999999998876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=296.98 Aligned_cols=206 Identities=25% Similarity=0.335 Sum_probs=179.9
Q ss_pred hhHHHhhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC
Q 005400 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (698)
Q Consensus 466 ~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~ 541 (698)
.++....++|.+++.||+|+||.|..++++. ++.+|+|++.+- ......-|.+|-.+|..-+.+-|+.++-.|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 3444556889999999999999999999865 778899999762 345567799999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
.++|+|||||+||+|..++.+.. .+++..+..++..|+-||.-||+.+ +|||||||.|||||..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999986543 4788888889999999999999998 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhcccC-----CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
+-.+..+.. ......+|||.|++||++.. +.|+..+|.||+||++|||+.|..||-
T Consensus 222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 987764432 23344789999999999852 579999999999999999999999995
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=266.40 Aligned_cols=201 Identities=28% Similarity=0.435 Sum_probs=173.3
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|++.+.||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999865 48889999876543 34457889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|..++.+. ..+++..+..++.+++.+|.|||+.. +++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 9999999887543 34889999999999999999999742 29999999999999999999999999986542221
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.....|+..|+|||.+....++.++|||||||++|||++|+.||....+
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 1235689999999999888899999999999999999999999985443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=270.35 Aligned_cols=199 Identities=19% Similarity=0.280 Sum_probs=164.3
Q ss_pred ccCceeee--cceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 477 SYNKLGEG--GFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 477 ~~~~LG~G--~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
+.++||+| +|++||+++.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 78999999874 58899999987542 233456788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999865332 24789999999999999999999988 999999999999999999999999865433211100
Q ss_pred -----cccccccccccccChhcccC--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 632 -----TNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 632 -----~~~~~~~gt~~y~APE~l~~--~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 00112356778999999875 4589999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=262.20 Aligned_cols=204 Identities=30% Similarity=0.552 Sum_probs=170.7
Q ss_pred hcCccccCceeeecceeEEEEEecc-c---cEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-G---QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
.++|+..+.||+|+||.||+|+... + ..+++|.++.. .....+.+..|++++++++||||+++++++......++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567788999999999999998753 3 36999998654 23345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|..++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999985432 35889999999999999999999988 9999999999999999999999999987654
Q ss_pred CCcccccc-ccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 627 GDEIQTNT-HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 627 ~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
........ .....+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 32211111 11223457999999988889999999999999999998 99999644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=263.28 Aligned_cols=201 Identities=28% Similarity=0.480 Sum_probs=173.5
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.|+..++||+|+||.||+|... .++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667789999999999999875 47899999987543 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++.. ..+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+......
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999998843 24788889999999999999999987 999999999999999999999999999765433211
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
.....++..|+|||.+....++.++||||||+++|||++|+.||....+.
T Consensus 158 --~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06640 158 --RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM 207 (277)
T ss_pred --cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH
Confidence 12246788999999998888999999999999999999999999755443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=269.68 Aligned_cols=199 Identities=28% Similarity=0.485 Sum_probs=171.7
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
|.....||+|+||.||++... +++.||+|.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 344467999999999999864 5889999998765555667789999999999999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++.. ..+++.++..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++.........
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-- 174 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-- 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--
Confidence 999988743 23788999999999999999999988 999999999999999999999999998765332211
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.....++..|+|||.+....++.++||||||+++|||++|+.||....+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 223 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1224688999999999888899999999999999999999999975443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=258.06 Aligned_cols=198 Identities=32% Similarity=0.492 Sum_probs=168.9
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCChh
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~ 557 (698)
++||+|+||.||++...+++.|++|++...... ..+.+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5668999999999999999999999999999999999999999999
Q ss_pred HHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccc
Q 005400 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637 (698)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 637 (698)
.++.... ..+++..+..++.+++.+|+|||+++ ++||||+|+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9985432 34788999999999999999999988 999999999999999999999999999865422211111112
Q ss_pred cccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 638 ~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
..+..|+|||.+....++.++||||||+++|||+| |..||....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 34667999999988889999999999999999999 888886544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=261.13 Aligned_cols=202 Identities=33% Similarity=0.526 Sum_probs=172.2
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.++|.+.++||+|+||.||++...++..+|+|.+... ....+.+.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3678888999999999999999877888999988653 2345678999999999999999999999887 7789999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++.+.. ...+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999986542 345788899999999999999999987 999999999999999999999999998765432211
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
. .....++..|+|||++....++.++|+||||+++|||+| |+.||...
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 159 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred c-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 1 112345678999999988889999999999999999999 99999754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=266.38 Aligned_cols=200 Identities=28% Similarity=0.489 Sum_probs=172.1
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.|+..+.||+|+||.||+|... .++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3666788999999999999864 47789999987543 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|..++.. ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999988743 34788999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
......++..|+|||.+....++.++||||||++++||++|+.||....+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch
Confidence 11224678899999999888899999999999999999999999875443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=265.48 Aligned_cols=213 Identities=27% Similarity=0.410 Sum_probs=175.4
Q ss_pred chhhHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEE--
Q 005400 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCI-- 539 (698)
Q Consensus 464 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~-- 539 (698)
.+..+..+.++|++.+.||+|+||.||+++.. .++.+|+|++.... ....++.+|+.++.++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34456677899999999999999999999874 47889999876432 2345688899999999 6999999999884
Q ss_pred ---eCCeeEEEEEecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceE
Q 005400 540 ---QADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (698)
Q Consensus 540 ---~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 615 (698)
.+...++||||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 345689999999999999887542 23345788999999999999999999987 99999999999999999999
Q ss_pred EeecCCCcccCCCccccccccccccccccChhcccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
|+|||++..+...... .....|+..|+|||++.. ..++.++|||||||++|||++|+.||...++
T Consensus 165 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 165 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred EccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 9999998765432211 122468999999998753 4578899999999999999999999975544
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=264.98 Aligned_cols=193 Identities=23% Similarity=0.377 Sum_probs=160.0
Q ss_pred ceeeecceeEEEEEecc-------------------------ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeE
Q 005400 480 KLGEGGFGPVYKGTLVE-------------------------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534 (698)
Q Consensus 480 ~LG~G~fG~Vy~g~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l 534 (698)
+||+|+||.||+|.+.. ...|++|.+.........++.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998866544455678999999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC--
Q 005400 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-- 612 (698)
Q Consensus 535 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-- 612 (698)
++++.+....++||||+++++|..++.+. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888543 235788999999999999999999987 99999999999997643
Q ss_pred -----ceEEeecCCCcccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCC
Q 005400 613 -----NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIV-SGKKNWRFSHPD 683 (698)
Q Consensus 613 -----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~ell-tG~~pf~~~~~~ 683 (698)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....+.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 3799999987643221 11356788999998865 56899999999999999994 799999755443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=259.45 Aligned_cols=199 Identities=30% Similarity=0.492 Sum_probs=172.1
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC-----CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3566689999999999999876 68899999986543 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
+||+++++|.+++.+. ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998543 34789999999999999999999988 99999999999999999999999999887543
Q ss_pred CccccccccccccccccChhcccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. ......++..|+|||.+.... ++.++|+||||+++|||++|+.||....
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 32 122356888999999987766 8999999999999999999999996443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=264.28 Aligned_cols=202 Identities=27% Similarity=0.391 Sum_probs=168.0
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++.+++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 58899999987543 233346789999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+. +++..++.... ..+.+..+..++.|++.||+|||+.+ |+|+||||+||+++.++++||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 56666654322 34678888899999999999999988 999999999999999999999999998764322
Q ss_pred ccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 11 11224578899999998754 5788999999999999999999999643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=278.43 Aligned_cols=195 Identities=30% Similarity=0.487 Sum_probs=168.4
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCC---cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.|..++.||.|+||.||.++.. +.+.||||++..... +....+..|++.|.+++|||++.+.||+..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3666789999999999999864 577899999976644 345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
||-| +-.+++.-. ++++.+.++..|..+.++||+|||+.+ .||||||..||||.+.|.+||+|||.|.+....
T Consensus 107 YClG-SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHhc-cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 9954 555665332 345889999999999999999999998 999999999999999999999999999875432
Q ss_pred cccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
...+||+.|||||++. .+.|+-|+||||||+...||.-.++|+-..
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 3378999999999874 578999999999999999999999997543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=258.47 Aligned_cols=202 Identities=25% Similarity=0.391 Sum_probs=171.8
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-CeeEEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYE 549 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-~~~~lV~E 549 (698)
+|++.+.||+|++|.||+++.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999865 47889999986542 34456788999999999999999999987643 45789999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++... ....+++.++..++.+++.|+++||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888653 2345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. ......+++.|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 1 1223568899999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=264.24 Aligned_cols=201 Identities=27% Similarity=0.412 Sum_probs=168.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|++.+.||+|++|.||++... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888899999999999999875 578999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++ +|..++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8888875432 35789999999999999999999988 99999999999999999999999999875432111
Q ss_pred ccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 111346789999998865 458899999999999999999999996443
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=258.90 Aligned_cols=197 Identities=33% Similarity=0.536 Sum_probs=172.4
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|++.+.||+|+||.||++.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 5677889999999999999987 488999999976543 56789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999865432 35899999999999999999999988 99999999999999999999999999987532211
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
....+..|+|||.+....++.++||||||++++||++ |+.||...
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 1345678999999988889999999999999999997 99998644
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=270.02 Aligned_cols=202 Identities=34% Similarity=0.579 Sum_probs=167.4
Q ss_pred cCccccCceeeecceeEEEEEec-ccc----EEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQ----EIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|++.+.||+|+||.||+|... +++ .+|+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56778889999999999999864 343 578888865432 3344788999999999999999999998754 5679
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999886432 34788899999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3322222222345778999999988899999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=261.03 Aligned_cols=198 Identities=22% Similarity=0.388 Sum_probs=159.2
Q ss_pred CceeeecceeEEEEEecccc---EEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 479 NKLGEGGFGPVYKGTLVEGQ---EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~---~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
++||+|+||.||+++..++. .+++|.+.... ....+.+.+|+++++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999764433 45677665442 334568999999999999999999999999999999999999999
Q ss_pred ChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 555 SLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 555 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
+|..++.+... ....+...+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865432 234667778899999999999999987 99999999999999999999999999864322221122
Q ss_pred cccccccccccChhcccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAE-------GLFSVKSDVFSFGVLVLEIVS-GKKNWRF 679 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~-------~~~~~k~DVwSlGvil~ellt-G~~pf~~ 679 (698)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 223567889999998743 245789999999999999997 4667753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=263.78 Aligned_cols=214 Identities=30% Similarity=0.438 Sum_probs=176.5
Q ss_pred cchhhHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEe
Q 005400 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (698)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~ 540 (698)
+...++.++.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344566677899999999999999999999874 58899999986532 2346678899999999 79999999999875
Q ss_pred CC-----eeEEEEEecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 541 AD-----ESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 541 ~~-----~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
.+ ..++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 589999999999999887542 22345889999999999999999999987 9999999999999999999
Q ss_pred EEeecCCCcccCCCccccccccccccccccChhcccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-----LFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
||+|||++.......... ....++..|+|||.+... .++.++|||||||++|||++|+.||...++
T Consensus 168 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 999999988654322211 224678899999987543 368899999999999999999999975443
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=258.40 Aligned_cols=197 Identities=30% Similarity=0.495 Sum_probs=167.9
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEE-eCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI-QADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~-~~~~~~lV~E~~ 551 (698)
++|.+.+.||+|+||.||++.. .+..+|+|.++.. ...+.+.+|+.++++++|+|++++++++. +....++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999977 4788999998643 23567899999999999999999999764 456789999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++.+.. ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999986533 335889999999999999999999988 9999999999999999999999999987643221
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.....+..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 11344668999999988889999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=264.42 Aligned_cols=200 Identities=30% Similarity=0.499 Sum_probs=168.7
Q ss_pred cCccccCceeeecceeEEEEEe-----ccccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--Cee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~ 544 (698)
+.|+++++||+|+||.||+++. ..++.||+|.++... ....+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 247789999987543 34456799999999999999999999998875 568
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|..++.+.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999985432 34799999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005400 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (698)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf 677 (698)
+...... .......++..|+|||++.+..++.++||||||+++|||+|++.|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 6433211 1112245677899999998888999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=257.95 Aligned_cols=202 Identities=30% Similarity=0.531 Sum_probs=172.2
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
.+|++.+.||+|+||.||++...+++.+|+|++.... ....++.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4577788999999999999988778899999986543 234678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|.+++.... ..+++..+..++.+++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999998885432 34788999999999999999999988 9999999999999999999999999987654332211
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.....++.+|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 112335678999999988889999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=266.75 Aligned_cols=205 Identities=24% Similarity=0.346 Sum_probs=174.4
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCC---cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|+..+.||+|++|.||++.... ++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999998764 88999999876532 24567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988643 2345889999999999999999999988 999999999999999999999999998754321
Q ss_pred ccc---------------------------cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQ---------------------------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~---------------------------~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01112467889999999988889999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=258.86 Aligned_cols=201 Identities=28% Similarity=0.411 Sum_probs=177.3
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|++.+.||+|++|.||+++... ++.|++|++..... ...+.+.+|++++.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999998864 89999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
+++++|.+++... ..++...+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998653 458999999999999999999999 87 9999999999999999999999999998764433
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... ....++..|+|||.+....++.++||||||+++|||+||+.||....
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 221 22467889999999988899999999999999999999999997554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=273.45 Aligned_cols=191 Identities=21% Similarity=0.323 Sum_probs=162.6
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
..+|.+.+.||+|+||.||+|+... ++.||+|+.... ....|+.++++++||||+++++++......++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 4579999999999999999998754 678999975432 235699999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+. ++|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 139 ~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 139 YS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred cC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 95 5777777542 345899999999999999999999998 9999999999999999999999999997532221
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf 677 (698)
......||..|+|||++....++.++|||||||++|||+++..++
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 112356899999999999999999999999999999999976655
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=259.52 Aligned_cols=190 Identities=26% Similarity=0.488 Sum_probs=161.2
Q ss_pred CceeeecceeEEEEEecccc-----------EEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 479 NKLGEGGFGPVYKGTLVEGQ-----------EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~-----------~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999886533 5788877654333 6789999999999999999999999988 778999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-------ceEEeecC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-------NPKISDFG 620 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~~kl~DFg 620 (698)
+||+++++|..++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999865432 5889999999999999999999988 99999999999999887 79999999
Q ss_pred CCcccCCCccccccccccccccccChhcccCC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG--LFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
++...... ....++..|+|||++... .++.++||||||+++|||++ |..||....
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 98865431 123567789999998776 78999999999999999999 577776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=262.50 Aligned_cols=199 Identities=36% Similarity=0.581 Sum_probs=167.0
Q ss_pred CceeeecceeEEEEEecc-------ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 479 NKLGEGGFGPVYKGTLVE-------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~-------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886543 34566889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-----ceEEeecCC
Q 005400 551 MPNKSLDFFIFDQA----RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-----NPKISDFGM 621 (698)
Q Consensus 551 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~DFgl 621 (698)
+++++|.+++.... ....+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234788999999999999999999987 99999999999999877 899999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
+..+.............++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 976543322222222345678999999999999999999999999999998 99998643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=260.38 Aligned_cols=196 Identities=33% Similarity=0.527 Sum_probs=163.0
Q ss_pred CceeeecceeEEEEEecc-cc--EEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||+|+..+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 5788888643 234556789999999999 799999999999999999999999999
Q ss_pred CChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 554 KSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 554 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1234789999999999999999999987 9999999999999999999999999
Q ss_pred CCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
++...... ........+..|+|||++....++.++||||||++++||++ |+.||...
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 98632211 11111234567999999988889999999999999999997 99999644
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=264.91 Aligned_cols=202 Identities=28% Similarity=0.514 Sum_probs=175.6
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|.+.+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367888999999999999999854 5788999998765555567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|..++.+ ..+++.++..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 23788899999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
. .....++..|+|||.+....++.++||||||+++|||++|+.||....+
T Consensus 171 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred c--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1 1224688899999999888899999999999999999999999975544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=261.57 Aligned_cols=203 Identities=29% Similarity=0.458 Sum_probs=171.9
Q ss_pred cCccccCceeeecceeEEEEEecc------ccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
++|++.+.||+|+||.||+++... .+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 568888999999999999998642 457999988664433 4578999999999999999999999999989999
Q ss_pred EEEEecCCCChhHHHhhcccc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeec
Q 005400 546 LIYEYMPNKSLDFFIFDQARA------TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 619 (698)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654422 25899999999999999999999988 999999999999999999999999
Q ss_pred CCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRF 679 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~ 679 (698)
|++......... ......++..|+|||.+....++.++||||||++++||++ |..||..
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 998754322211 1222456778999999988888999999999999999999 7888854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=261.63 Aligned_cols=202 Identities=28% Similarity=0.481 Sum_probs=171.2
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
+|++.++||+|++|.||+|+.. +|+.||+|+++.... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 588999999876532 33466788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++ +|..++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78777765444456899999999999999999999988 99999999999999999999999999976533211
Q ss_pred cccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......++..|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11224578899999987654 57889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=260.25 Aligned_cols=201 Identities=27% Similarity=0.500 Sum_probs=171.1
Q ss_pred CccccCceeeecceeEEEEEe-ccccEEEEEEecCCCC------cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~------~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
+|+..+.||+|++|.||++.. .+++.+|+|.+..... ...+.+..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467778999999999999986 4588999999865421 235678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-ceEEeecCCCccc
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIF 625 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFgla~~~ 625 (698)
|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998543 34788999999999999999999998 99999999999998775 5999999998776
Q ss_pred CCCccc--cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 626 GGDEIQ--TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 626 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
...... .......++..|+|||.+.+..++.++||||+|++++||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 433211 1112246788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=265.25 Aligned_cols=200 Identities=27% Similarity=0.409 Sum_probs=170.0
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|++.++||+|+||.||++... .++.+|+|++..... ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999985 488999999865422 235678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|..+.... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998776432 23899999999999999999999988 9999999999999999999999999987654332
Q ss_pred cccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.. .....++..|+|||++.. ..++.++||||||++++||++|+.||...
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 155 EV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred cc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 11 122457889999998865 45788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=259.58 Aligned_cols=200 Identities=29% Similarity=0.465 Sum_probs=168.9
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCC----------cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG----------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~----------~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~ 542 (698)
+|.+.+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|++++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566789999999999999864 588999998854211 12346788999999999999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998654 35888999999999999999999987 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccChhcccCCC--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
................++..|+|||.+.... ++.++||||||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 7654322111222356889999999987654 78999999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=261.54 Aligned_cols=199 Identities=28% Similarity=0.409 Sum_probs=175.2
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
+|++.+.||.|+||.||+++.. .++.+|+|.+.+.. ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999875 48899999987542 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|..++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998543 35889999999999999999999988 9999999999999999999999999988754332
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......++..|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 1223568889999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=256.37 Aligned_cols=196 Identities=35% Similarity=0.524 Sum_probs=164.3
Q ss_pred CceeeecceeEEEEEecc----ccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999876543 34567899999999999999999999875 5568999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc-
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT- 632 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~- 632 (698)
++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999986543 5889999999999999999999988 9999999999999999999999999998764332111
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 1111234568999999988899999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=257.62 Aligned_cols=202 Identities=30% Similarity=0.459 Sum_probs=169.8
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC-----CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--Cee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~ 544 (698)
.+|.+.+.||+|+||.||+++.. +++.+|+|.+... ..+..+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999864 4889999987532 223456788999999999999999999998764 457
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++++||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999988543 23788889999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcc-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
...... ........++..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 532111 01112246889999999998888999999999999999999999999743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=265.66 Aligned_cols=205 Identities=24% Similarity=0.390 Sum_probs=169.0
Q ss_pred CccccCceeeecceeEEEEEecc---ccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESM 545 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~---g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~ 545 (698)
+|++.++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|++++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 37778899999999999998754 7899999997642 34456788999999999999999999999988 7899
Q ss_pred EEEEecCCCChhHHHhhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC----CCceEEeec
Q 005400 546 LIYEYMPNKSLDFFIFDQA--RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN----DMNPKISDF 619 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~DF 619 (698)
+||||+++ +|..++.... ....++...+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 5555554322 1235888999999999999999999988 999999999999999 999999999
Q ss_pred CCCcccCCCcc-ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 620 GMARIFGGDEI-QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 620 gla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
|++..+..... ........++..|+|||.+.+. .++.++||||||++++||++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99987543322 1112234678899999987664 578999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=257.79 Aligned_cols=201 Identities=29% Similarity=0.524 Sum_probs=173.5
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|.+.+.||+|+||.||++... +++.|++|.++.... ...+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999864 588999999876543 3677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++.+. ..+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998543 34788899999999999999999988 99999999999999999999999999887644322
Q ss_pred ccc--cccccccccccChhcccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTN--THKVVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~--~~~~~gt~~y~APE~l~~~~---~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
... .....++..|+|||++.... ++.++||||||++++||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 111 11246788999999987766 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=259.33 Aligned_cols=201 Identities=26% Similarity=0.493 Sum_probs=172.3
Q ss_pred CccccCceeeecceeEEEEEe-ccccEEEEEEecCC-CCcchHHHHHHHHHHhhcC---CCeeeeEEEEEEeCCeeEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~---H~nIv~l~~~~~~~~~~~lV~ 548 (698)
.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999986 45889999998754 3345567889999999997 999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++.. ..+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 25889999999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
... .....|+..|+|||.+..+ .++.++||||||+++|||++|+.||....+.
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 208 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 311 2224688899999988654 5789999999999999999999999755443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=262.23 Aligned_cols=200 Identities=24% Similarity=0.395 Sum_probs=171.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|++.+.||+|++|.||++... +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999875 4789999998654 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|++++.+..+..+ ...+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777665533 233789999999999999999999988 9999999999999999999999999988765433
Q ss_pred cccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
... .....++..|+|||++... .++.++||||||+++|||++|+.||..
T Consensus 155 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 155 ASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred ccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 211 1225678899999999887 789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=256.68 Aligned_cols=201 Identities=24% Similarity=0.423 Sum_probs=173.0
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|++.++||+|+||.||+++.. +++.+|+|++... .....+++.+|++++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999864 5889999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999998885432 234788999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
. .....|+..|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 1 12245788999999998888999999999999999999999999744
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=263.33 Aligned_cols=197 Identities=25% Similarity=0.409 Sum_probs=165.6
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|++.+.||+|+||.||+++.. +|+.+|+|+++... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999875 58899999986542 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++ +|..++... ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++++||+|||++........
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 676666432 234899999999999999999999988 99999999999999999999999999886543221
Q ss_pred ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
. .....++..|+|||.+.+. .++.++||||||+++|||+||+.|+.
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 1 1224578899999988664 47899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=259.45 Aligned_cols=202 Identities=27% Similarity=0.415 Sum_probs=169.0
Q ss_pred cCccccCceeeecceeEEEEEeccc----cEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEG----QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g----~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|.+.++||+|+||.||+|...+. ..|++|...... .+..+.+.+|++++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577888999999999999986432 468999886554 3456689999999999999999999999875 557899
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++.... ..+++..+..++.++++||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999986532 34899999999999999999999988 99999999999999999999999999987544
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
...... ....++..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus 160 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 160 ESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 322111 12344568999999988889999999999999999996 999996543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=260.74 Aligned_cols=200 Identities=28% Similarity=0.425 Sum_probs=164.6
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHH-HhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTL-IARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~i-l~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|++.+.||+|+||.||+++.. +|+.||+|+++... .+....+..|+.+ ++..+||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999875 58999999987642 2334456666665 566789999999999999999999999
Q ss_pred ecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 550 YMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 550 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|++ ++|..++... .....+++..+..++.|++.||+|||++ + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6777776542 2335689999999999999999999986 5 99999999999999999999999999886533
Q ss_pred CccccccccccccccccChhcccC----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAE----GLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~----~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
... .....++..|+|||.+.. ..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 211 112457889999998754 4568899999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=260.69 Aligned_cols=199 Identities=27% Similarity=0.435 Sum_probs=171.0
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999874 58899999987653 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+ +++|..++.... ..+++..+..++.|++++|+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886433 45899999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
. ......++..|+|||.+.+. .++.++||||+|++++||++|+.+|..
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 155 R-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred C-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 1 12224688999999988654 468999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=261.26 Aligned_cols=205 Identities=29% Similarity=0.499 Sum_probs=178.4
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
..+++|+..+.||+|++|.||++... +++.+++|++..... ..+.+.+|++++++++|+|++++++.+......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888899999999999999986 588999999976543 5677899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999986543 35899999999999999999999987 999999999999999999999999998765432
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.||....+
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 11224578899999999888899999999999999999999999975443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=258.20 Aligned_cols=198 Identities=29% Similarity=0.490 Sum_probs=171.1
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
|+..++||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++.+++||||+++++++..+...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667789999999999999864 57899999986542 3345678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|..++.. ..+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 86 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 9999988743 34789999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 1122467889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=262.74 Aligned_cols=200 Identities=29% Similarity=0.419 Sum_probs=168.8
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCCc-----chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ-----GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
+|++.+.||+|++|.||+|... +++.||+|++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999875 5889999999765322 344577899999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+ +++|..++.... ..+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999885432 35899999999999999999999998 99999999999999999999999999987644
Q ss_pred CccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|..+|....
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 3211 112346788999998854 467899999999999999999988776433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=253.90 Aligned_cols=205 Identities=26% Similarity=0.408 Sum_probs=168.8
Q ss_pred cCccccCceeeecceeEEEEEecc-----ccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEe-CCee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~-~~~~ 544 (698)
..|+.+.+||+|.+|.||+++-.+ ...+|+|+++.... .......+|+.+++.++||||+.+..++.+ ....
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 457888999999999999996433 23689999975421 223457789999999999999999999987 7789
Q ss_pred EEEEEecCCCChhHHHhhc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC----CceEEee
Q 005400 545 MLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND----MNPKISD 618 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~D 618 (698)
+|++||.+. +|..+++.+ .....++...+..|+.||+.|+.|||++. |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 565666532 33457888999999999999999999998 9999999999999877 8999999
Q ss_pred cCCCcccCCCcccc-ccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 619 FGMARIFGGDEIQT-NTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 619 Fgla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
||+++++.+.-... ....++-|..|.|||.+.+. .|++..|||+.|||+.||+|-++.|....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999886543222 23346789999999988765 68999999999999999999999986543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=259.98 Aligned_cols=199 Identities=27% Similarity=0.417 Sum_probs=173.6
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999876 58899999987653 34556789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
+++++|.+++.... ..++...+..++.|++.+|+|||+ .+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999986532 458889999999999999999999 76 9999999999999999999999999987653221
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
. ....++..|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 1156788999999998889999999999999999999999999644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=261.00 Aligned_cols=212 Identities=28% Similarity=0.474 Sum_probs=174.9
Q ss_pred cchhhHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEe
Q 005400 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (698)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~ 540 (698)
.+..++..+.+.|++.+.||+|+||.||+|+.. .++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 355566667788999999999999999999874 47889999986543 3345788899999998 69999999999853
Q ss_pred ------CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 541 ------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 541 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
....+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 456899999999999999886533 334788888999999999999999988 9999999999999999999
Q ss_pred EEeecCCCcccCCCccccccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 9999999876532211 112256889999999875 3457889999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=259.72 Aligned_cols=201 Identities=27% Similarity=0.389 Sum_probs=171.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~lV~ 548 (698)
++|+..++||.|++|.||++... .++.+|+|.+.... ......+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999975 47889999987542 24556789999999999999999999998654 4689999
Q ss_pred EecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 549 EYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 549 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
||+++++|.+++... .....++...+..++.|++.||+|||+.+ ++|+||+|.||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998887532 23345788999999999999999999988 99999999999999999999999999876432
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
... ....++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 1245788999999999889999999999999999999999999755
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=255.69 Aligned_cols=199 Identities=38% Similarity=0.598 Sum_probs=170.5
Q ss_pred cccCceeeecceeEEEEEecc-----ccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 476 ASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++.+.||.|+||.||+++..+ +..||+|++...... ..+.+..|++++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456799999999999998754 378999999765433 56789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++...... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999998653321 2799999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRF 679 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~ 679 (698)
..... ...++..|+|||.+....++.++||||||++++||++ |+.||..
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 22111 2346789999999988889999999999999999998 7888864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=256.60 Aligned_cols=196 Identities=31% Similarity=0.494 Sum_probs=159.6
Q ss_pred CceeeecceeEEEEEecc----ccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe-CCeeEEEEEecC
Q 005400 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADESMLIYEYMP 552 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~-~~~~~lV~E~~~ 552 (698)
+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 357999988543 23445688899999999999999999998764 456789999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc-
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ- 631 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~- 631 (698)
+++|..++.... ..+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999986432 23677888899999999999999987 999999999999999999999999998765322111
Q ss_pred -cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 005400 632 -TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG-KKNWRF 679 (698)
Q Consensus 632 -~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG-~~pf~~ 679 (698)
.......++..|+|||.+....++.++||||||+++|||++| ..||..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 111123457789999999888999999999999999999995 556653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=267.97 Aligned_cols=198 Identities=28% Similarity=0.493 Sum_probs=172.8
Q ss_pred cccCceeeecceeEEEEEecc---cc--EEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 476 ASYNKLGEGGFGPVYKGTLVE---GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~~~---g~--~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
...+.||+|.||.||+|.+.+ |. .||||..+.. ..+..+.|+.|..+|++++||||++++|+|.+ ...+||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 334679999999999998643 33 5899998875 55668899999999999999999999999975 46799999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
.++-|.|..+|..++ ..++......++.||..+|+|||+.. +|||||..+|||+.+..-+||+||||++.+..+.
T Consensus 471 L~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 471 LAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred cccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999996543 34888999999999999999999988 9999999999999999999999999999987666
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
+.... ...-+..|||||-+.-..++..+|||.|||++||++. |.+||..-
T Consensus 546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 54433 3566889999999999999999999999999999886 99999753
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=259.14 Aligned_cols=198 Identities=27% Similarity=0.467 Sum_probs=171.7
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999864 5889999998765555566789999999999999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-- 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-- 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence 999998854 24788999999999999999999988 999999999999999999999999988765432211
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....|+..|+|||.+....++.++||||||++++||++|+.||....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 122468899999999988889999999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=260.58 Aligned_cols=200 Identities=27% Similarity=0.444 Sum_probs=168.3
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|++.+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 58899999986542 23345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+. ++|..++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 57888775432 345889999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccccccChhcccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~-~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
. .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||...
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 1 11235688999999876544 688999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=259.91 Aligned_cols=199 Identities=28% Similarity=0.422 Sum_probs=168.7
Q ss_pred CccccCceeeecceeEEEEEec----cccEEEEEEecCCC----CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS----GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
+|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|++++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677889999999999999863 58899999986532 23346788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++|+||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998643 34788899999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccChhcccCC--CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEG--LFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
....... ......|+..|+|||.+... .++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 5433221 11234688999999998653 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=253.94 Aligned_cols=201 Identities=27% Similarity=0.468 Sum_probs=172.6
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|+..+.||+|++|.||++... .++.+|+|.+... .....+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 5788999998654 234466789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC-CceEEeecCCCcccCCCc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFGGDE 629 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFgla~~~~~~~ 629 (698)
+++++|.+++.... ...+++..+.+++.+++++|+|||+++ ++|+||+|+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999986532 345789999999999999999999988 9999999999999855 468999999998764332
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. .....++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 1 122467889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=266.02 Aligned_cols=202 Identities=26% Similarity=0.402 Sum_probs=171.5
Q ss_pred HhhcCccccCceeeecceeEEEEEeccccEEEEEEecCC--CCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESML 546 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~l 546 (698)
.....|+++++||+||.+.||++...+.+.+|+|++... +.+...-|.+|+..|.+++ |.+||+|++|-..+..+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 345678999999999999999999888888998876543 5667788999999999996 9999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|||+= ..+|..+|.+... ....| .+..+..|++.++.++|+++ |||.||||.|+|+- +|.+||+|||+|.-+.
T Consensus 438 vmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99984 5678888865433 23334 67788999999999999998 99999999999995 5699999999999887
Q ss_pred CCccccccccccccccccChhcccCCC-----------CCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGL-----------FSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~-----------~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
.+.........+||+.||+||.+.... .+.++||||||||||+|+.|+.||.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 776655555679999999999875322 5678999999999999999999995
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=258.01 Aligned_cols=194 Identities=30% Similarity=0.487 Sum_probs=166.6
Q ss_pred eeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
||+|+||+||++... +|+.+|+|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 58899999986532 23345678899999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccccc
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (698)
.+++.+... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 998865432 35889999999999999999999988 9999999999999999999999999987654321 1122
Q ss_pred ccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 637 ~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..++..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 457889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=259.89 Aligned_cols=192 Identities=27% Similarity=0.445 Sum_probs=161.1
Q ss_pred CceeeecceeEEEEEecc--------ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+.||+|+||.||+|.... ..++++|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997642 234888888665555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc--------eEEeecCCC
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--------PKISDFGMA 622 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl~DFgla 622 (698)
+++|+|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999986543 25789999999999999999999988 999999999999987765 599999998
Q ss_pred cccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCC-CCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGK-KNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~-~pf~~~~ 681 (698)
...... ....++..|+|||++.+. .++.++||||||+++|||++|. .||...+
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~ 210 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence 654322 124578899999998764 5789999999999999999995 5655433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=257.13 Aligned_cols=191 Identities=28% Similarity=0.425 Sum_probs=157.8
Q ss_pred ceeeecceeEEEEEec-cccEEEEEEecCCCC---cchHHHHHHHHHHhh---cCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 480 KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIAR---LQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 480 ~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~---l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..++.. .+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 488999998865421 222334455444433 479999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|..++... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999888543 34899999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.....|+..|+|||.+.. ..++.++||||||++++||++|+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 122468999999998864 56889999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=256.39 Aligned_cols=202 Identities=25% Similarity=0.442 Sum_probs=170.1
Q ss_pred CccccCceeeecceeEEEEEecc--ccEEEEEEecCC----------CCcchHHHHHHHHHHhh-cCCCeeeeEEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKG----------SGQGMEEFKNEVTLIAR-LQHRNLVKLLGCCIQ 540 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~--g~~vavK~l~~~----------~~~~~~~~~~Ei~il~~-l~H~nIv~l~~~~~~ 540 (698)
+|++.+.||+|+||.||++.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999765 678999987532 12234557788888865 799999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEEcCCCceEEee
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISD 618 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~D 618 (698)
....++||||+++++|.+++... .....+++..++.++.|++.+|.|||+ .+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887532 223458899999999999999999996 44 99999999999999999999999
Q ss_pred cCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 99998754432 2223568899999999998889999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=257.62 Aligned_cols=206 Identities=28% Similarity=0.451 Sum_probs=172.7
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCC-----
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD----- 542 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~----- 542 (698)
.++++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45688999999999999999999875 478899999865433 446789999999999 6999999999997655
Q ss_pred -eeEEEEEecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 543 -ESMLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 543 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999998886432 2346889999999999999999999988 9999999999999999999999999
Q ss_pred CCcccCCCccccccccccccccccChhcccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++........ ......++..|+|||++.. ..++.++||||||++++||++|+.||...+
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 9876543221 1122468889999998753 346789999999999999999999997443
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=257.11 Aligned_cols=203 Identities=29% Similarity=0.477 Sum_probs=165.9
Q ss_pred ccccCceeeecceeEEEEEec----cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC------
Q 005400 475 FASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~------ 542 (698)
|.+.+.||+|+||.||+|.+. .++.||+|++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456679999999999999864 3678999998654 2334667899999999999999999999886543
Q ss_pred eeEEEEEecCCCChhHHHhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeec
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 619 (698)
..++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988875322 1224788899999999999999999987 999999999999999999999999
Q ss_pred CCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 99986543322222222345678999999988889999999999999999999 88888644
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=259.21 Aligned_cols=202 Identities=25% Similarity=0.368 Sum_probs=166.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCe-----
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADE----- 543 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~----- 543 (698)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999875 58899999876542 223457888999999995 6999999999987665
Q ss_pred eEEEEEecCCCChhHHHhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-CCceEEeecC
Q 005400 544 SMLIYEYMPNKSLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFG 620 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFg 620 (698)
.++||||+++ +|..++..... ...+++..+..++.||++||+|||+.+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78777754322 345899999999999999999999988 999999999999998 8899999999
Q ss_pred CCcccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
++..+...... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 98765332111 111356788999998765 45789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=259.42 Aligned_cols=202 Identities=30% Similarity=0.474 Sum_probs=171.0
Q ss_pred cCccccCceeeecceeEEEEEec-----cccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEe--CCee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--~~~~ 544 (698)
+.|++.+.||+|+||.||++++. .++.+|+|.+...... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677789999999999999864 3678999999765433 56789999999999999999999999887 5678
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999986543 24899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcc-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 625 FGGDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 625 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
...... ........++..|+|||.+....++.++||||||++++||++|+.|+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 653221 1111123455679999999888899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=250.18 Aligned_cols=198 Identities=31% Similarity=0.548 Sum_probs=175.7
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667789999999999999875 5889999999776555667899999999999999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|.+++.... ..+++..+..++.+++.+|.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999886532 45899999999999999999999987 99999999999999999999999999887654321
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.....++..|+|||.+....++.++||||||++++||++|+.||...
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 22356889999999998888999999999999999999999999755
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=254.99 Aligned_cols=197 Identities=30% Similarity=0.512 Sum_probs=167.6
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|++.+.||+|+||.||++.. .++.+|+|.++... ..+.+.+|+.++.+++|||++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4578889999999999999975 67889999986532 34678999999999999999999999865 45799999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|..++.... ...+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999986543 335789999999999999999999987 9999999999999999999999999987543211
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||....+
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 11334568999999988899999999999999999998 9999875543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=261.48 Aligned_cols=203 Identities=30% Similarity=0.426 Sum_probs=172.7
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCC---CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV 547 (698)
.+|..+.+||+|+||+|.++..+. .+.+|||++++.. ....+--+.|-++|+.. +-|.+++++.+|+.-+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 457778899999999999997654 5679999998762 23445567788888877 567999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+.+|+|-.++.+-++ +.+..+..+|..||-||-+||+++ |+.||||..|||||.+|++||+|||+++.--.
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999999865433 556677789999999999999999 99999999999999999999999999986322
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
.. ..+...+||+.|+|||++..++|+..+|.|||||+||||+.|+.||+.++.+
T Consensus 503 ~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 503 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred CC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 22 2334479999999999999999999999999999999999999999975543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=259.29 Aligned_cols=201 Identities=27% Similarity=0.404 Sum_probs=168.9
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~lV 547 (698)
++|++.+.||+|+||.||+|... +++.+++|.++... ......+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888899999999999999875 47889999987542 22334577899999999999999999999877 889999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
+||+++ +|..++.... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 8888775432 35899999999999999999999988 99999999999999999999999999887654
Q ss_pred CccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... ......++..|+|||.+.+. .++.++|+||||++++||++|+.||....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 11224578899999988654 46899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=253.41 Aligned_cols=196 Identities=24% Similarity=0.342 Sum_probs=163.1
Q ss_pred HHHhhcCccccCce--eeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCe
Q 005400 468 IAKATDNFASYNKL--GEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (698)
Q Consensus 468 l~~~~~~f~~~~~L--G~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~ 543 (698)
.....++|++.+.+ |+|+||.||+++.. +++.+|+|.+........ |+.....+ +||||+++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34445677777776 99999999999864 578899998865322111 22222222 79999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-ceEEeecCCC
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMA 622 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFgla 622 (698)
.++||||+++++|..++.... .+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 999999999999999985432 5899999999999999999999988 99999999999999988 9999999998
Q ss_pred cccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....... ...++..|+|||++....++.++||||||++++||++|+.||...
T Consensus 158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 7654322 245789999999999889999999999999999999999999744
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=254.33 Aligned_cols=192 Identities=27% Similarity=0.399 Sum_probs=167.9
Q ss_pred eeeecceeEEEEEecc-ccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
||.|++|.||+++... ++.+|+|++.+.. ....+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999754 8899999987542 23456799999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccccc
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (698)
.+++.+. ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9998543 34788999999999999999999988 9999999999999999999999999998764332 1122
Q ss_pred ccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 637 ~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 467889999999988889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=253.90 Aligned_cols=206 Identities=27% Similarity=0.456 Sum_probs=171.7
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe--CCeeEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESMLIY 548 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--~~~~~lV~ 548 (698)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999864 5788999998654 23345678899999999999999999998764 34678999
Q ss_pred EecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 549 EYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
||+++++|..++.... ....+++..++.++.++++||+|||..+ ..+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999986532 2346899999999999999999999332 233999999999999999999999999999876
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
...... .....++..|+|||.+....++.++||||||+++++|++|+.||....
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 543321 122468899999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=273.92 Aligned_cols=203 Identities=26% Similarity=0.443 Sum_probs=175.1
Q ss_pred cCccccCceeeecceeEEEEEeccc-cEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEG-QEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g-~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
+-+.|+..||.|+||.||++..++. -..|.|.+.....+..+.++-||+||...+||+||+|++.+...+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4567788999999999999987653 345778887777788899999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
.||-.+.++..-. ..|....+..++++++.||.|||++. |||||||..|||++-+|.++|+|||.+...... .
T Consensus 112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R 184 (1187)
T ss_pred CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence 9999998886543 35899999999999999999999998 999999999999999999999999997643221 1
Q ss_pred cccccccccccccChhcc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYA-----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l-----~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.......||+.|||||+. ...+|+.++||||||+.|.||..+.+|...-.|
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 122347899999999976 456899999999999999999999999875444
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=255.82 Aligned_cols=191 Identities=28% Similarity=0.440 Sum_probs=158.7
Q ss_pred ceeeecceeEEEEEec-cccEEEEEEecCCCC---cchHHHHHHHHH---HhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 480 KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTL---IARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 480 ~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~i---l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
.||+|+||.||+++.. .++.||+|.+.+... .....+..|..+ +....||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 488999999875421 222234445443 444579999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999888543 35899999999999999999999988 9999999999999999999999999987653322
Q ss_pred ccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 1224689999999998754 6899999999999999999999999755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=250.46 Aligned_cols=202 Identities=30% Similarity=0.482 Sum_probs=176.0
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIY 548 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~lV~ 548 (698)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999876 588999999876542 4567899999999999999999999999988 8899999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++.... .+++..+..++.+++++|+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986543 5899999999999999999999987 999999999999999999999999999876544
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..........++..|+|||.+....++.++||||||++++||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32111223568889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=257.10 Aligned_cols=201 Identities=28% Similarity=0.414 Sum_probs=165.8
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|++.++||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 58899999986542 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-CCceEEeecCCCcccCCC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGGD 628 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFgla~~~~~~ 628 (698)
|++ ++|..++.... ....++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 46777664332 223577888899999999999999987 999999999999985 567999999999765432
Q ss_pred ccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.. ......++..|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1112357889999998865 45789999999999999999999999754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=272.35 Aligned_cols=210 Identities=30% Similarity=0.480 Sum_probs=177.6
Q ss_pred ccccCceeeecceeEEEEEecc--cc--EEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE--GQ--EIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~--g~--~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
....++||+|.||.|++|.+.. |+ .||||.++..... ....|++|+.+|.+++|+|+++|+|+..+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3445789999999999998754 43 6899999876443 67899999999999999999999999987 77889999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
.++.|+|.+.|.+ .....+-...+..++.|||.||.||..+. +|||||..+|+||-....+||+||||.+-++..+
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999987 44556778888999999999999999998 9999999999999999999999999999876443
Q ss_pred c-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCccccc
Q 005400 630 I-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLL 689 (698)
Q Consensus 630 ~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~~~~~li 689 (698)
. ........-...|.|||.++...++.++|||+|||.||||+| |+.||-.......+..|
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i 328 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI 328 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence 2 222333455778999999999999999999999999999998 78899765554444333
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=259.61 Aligned_cols=197 Identities=29% Similarity=0.479 Sum_probs=166.5
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.+.|...+.||+|+||.||+|+.. +++.||+|++.... .+..+.+.+|+++++.++||||+++++++......++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 355888899999999999999875 58899999986442 23345788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
+||++ +++.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 4665655432 234899999999999999999999988 99999999999999999999999999876432
Q ss_pred CccccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
. ....++..|+|||++. ...++.++||||||+++|||+||+.||...
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 2 1245788999999874 456889999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=281.02 Aligned_cols=201 Identities=24% Similarity=0.354 Sum_probs=157.6
Q ss_pred hhcCccccCceeeecceeEEEEEecc--ccEEEEE------------------EecCCCCcchHHHHHHHHHHhhcCCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE--GQEIAVK------------------RLSKGSGQGMEEFKNEVTLIARLQHRN 530 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~--g~~vavK------------------~l~~~~~~~~~~~~~Ei~il~~l~H~n 530 (698)
..++|+++++||+|+||+||++.... +...++| .+. ........+.+|++++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987532 1112222 111 11223456889999999999999
Q ss_pred eeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE
Q 005400 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (698)
Q Consensus 531 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (698)
|+++++++...+..++|+|++.. +|..++..... ...........++.||+.||+|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999864 55555543211 112335567789999999999999988 9999999999999
Q ss_pred cCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005400 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (698)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf 677 (698)
+.++.+||+|||++..+...... ......||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999876433221 112257999999999999999999999999999999999998543
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=255.13 Aligned_cols=196 Identities=26% Similarity=0.418 Sum_probs=168.7
Q ss_pred eeeecceeEEEEEecc-ccEEEEEEecCCCC---cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|++++.+++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999865432 4556789999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc------
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI------ 630 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~------ 630 (698)
..++.+.. .+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99986533 5899999999999999999999988 99999999999999999999999999876433211
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
........++..|+|||.......+.++||||||++++||++|+.||....+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 0112235678899999999888899999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=258.09 Aligned_cols=194 Identities=27% Similarity=0.454 Sum_probs=168.9
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCChh
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~ 557 (698)
.+||+|+||.||++... +++.||+|++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999874 58899999986655555667899999999999999999999999999999999999999999
Q ss_pred HHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccc
Q 005400 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637 (698)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 637 (698)
+++.. ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++......... ....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 176 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSL 176 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc--cccc
Confidence 87743 23788999999999999999999988 999999999999999999999999998765432211 1224
Q ss_pred cccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 638 ~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 68899999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=265.15 Aligned_cols=198 Identities=28% Similarity=0.395 Sum_probs=167.6
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC------
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------ 541 (698)
..++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|++++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999864 5889999998653 233445678899999999999999999998643
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
...++||||+.+ +|...+... ++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999965 776666321 788889999999999999999988 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+........ .....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 987543321 12245788999999999999999999999999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=259.53 Aligned_cols=202 Identities=29% Similarity=0.437 Sum_probs=167.4
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESML 546 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~l 546 (698)
.++|++.+.||+|+||.||+++.. +|+.||+|+++... ......+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999875 48899999986542 22234567899999999999999999998765 46899
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++ +|..++... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 777776543 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33211 112345788999998865 457899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=264.93 Aligned_cols=210 Identities=24% Similarity=0.392 Sum_probs=178.5
Q ss_pred CccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
-|..++.||-|+||+|.+++..+ ...+|+|.+++. .+......++|..||+....+-||+|+-.|++.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 46777889999999999997655 456899999876 34566778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC-
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD- 628 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~- 628 (698)
|++||++-.+|.+. ..+++.....++..+..|+++.|..+ +|||||||.|||||.+|++||.||||+.-+.-.
T Consensus 710 YIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999988554 34777777788889999999999988 999999999999999999999999997543100
Q ss_pred ---------------------------------------ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHH
Q 005400 629 ---------------------------------------EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLE 669 (698)
Q Consensus 629 ---------------------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~e 669 (698)
..+...+..+||+.|+|||++....|+..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 00011123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCccccc
Q 005400 670 IVSGKKNWRFSHPDHDHNLL 689 (698)
Q Consensus 670 lltG~~pf~~~~~~~~~~li 689 (698)
|+.|+.||-...|.+...-+
T Consensus 864 m~~g~~pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKV 883 (1034)
T ss_pred HhhCCCCccCCCCCcceeee
Confidence 99999999988888766443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=259.14 Aligned_cols=207 Identities=29% Similarity=0.433 Sum_probs=171.1
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCC-------CCcchHHHHHHHHHHhhcCCCeeeeEEEEEE-eCC
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG-------SGQGMEEFKNEVTLIARLQHRNLVKLLGCCI-QAD 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~-------~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~-~~~ 542 (698)
.++|-.+++||+|||+.||++.. .+.+-||+|+-... .....+...+|.+|-+.+.||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 34577788999999999999964 56778999985433 1123456788999999999999999999986 456
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc---CCCceEEeec
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDF 619 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DF 619 (698)
..+-|+||+++.+|+.+|..+ +.+++.+...|+.||+.||.||.+.. +||||-||||.||||- .-|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 789999999999999999654 45889999999999999999999885 7899999999999995 4578999999
Q ss_pred CCCcccCCCccc-----cccccccccccccChhcccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 620 GMARIFGGDEIQ-----TNTHKVVGTYGYMSPEYAAE----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 620 gla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~----~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
||++++..+... ..++...||..|++||.+-- ..++.|+||||+|||+|..+.|++||.+...
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 999998654332 22344679999999997632 3478999999999999999999999986543
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=256.03 Aligned_cols=199 Identities=28% Similarity=0.444 Sum_probs=167.4
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
|++.++||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999864 68999999987542 233467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
+ ++|..++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 688888754332 35899999999999999999999987 999999999999999999999999999765322111
Q ss_pred cccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.....++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1123568899999987654 5789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=260.61 Aligned_cols=205 Identities=23% Similarity=0.386 Sum_probs=166.7
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-----
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----- 542 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~----- 542 (698)
..++|++.++||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999875 58899999886542 223345678999999999999999999987654
Q ss_pred ---eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeec
Q 005400 543 ---ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (698)
Q Consensus 543 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 619 (698)
..++||||+.+ +|...+... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 34999999975 676666432 235899999999999999999999988 999999999999999999999999
Q ss_pred CCCcccCCCccc--cccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 620 GMARIFGGDEIQ--TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 620 gla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999865432211 111224578899999988654 47889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=263.41 Aligned_cols=201 Identities=26% Similarity=0.419 Sum_probs=166.2
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-----ee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~-----~~ 544 (698)
+++|++.++||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999864 5889999998643 2334567889999999999999999999876543 57
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++|+||+++ +|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 67666532 34889999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcccc-ccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEIQT-NTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~~~-~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 54322111 1123468899999998654 56889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=251.83 Aligned_cols=201 Identities=25% Similarity=0.436 Sum_probs=171.6
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|++.+.||+|+||.||++... +|+.+|+|.+... .....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999875 4788999998654 223456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-ceEEeecCCCcccCCCc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDE 629 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFgla~~~~~~~ 629 (698)
+++++|.+++.... ...+++..+..++.++++||+|||+.+ ++|+||+|+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999886533 234789999999999999999999988 99999999999999875 46999999988764322
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.. .....|+..|+|||++....++.++||||||++++||++|+.||...
T Consensus 157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 11 11245888999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=254.17 Aligned_cols=200 Identities=27% Similarity=0.435 Sum_probs=168.5
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeEEEEE
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIYE 549 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~lV~E 549 (698)
|++.++||+|++|.||+++.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999875 47899999997653 33456788999999999999999999999888 88999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++ +|..++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 7877775432 35889999999999999999999988 9999999999999999999999999998764432
Q ss_pred cccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 1122456788999997754 467899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=250.11 Aligned_cols=191 Identities=27% Similarity=0.349 Sum_probs=160.8
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCCCC---cchHHHHHHHHHH-hhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLI-ARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il-~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.||+|+||.||++... .++.||+|.+.+... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999874 488999999865421 2223344555444 455899999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
++|..++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999998543 34788999999999999999999988 99999999999999999999999999875432
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 122467889999999988888999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=256.49 Aligned_cols=204 Identities=26% Similarity=0.440 Sum_probs=168.0
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC----
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD---- 542 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~---- 542 (698)
...++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999985 48899999987542 233456788999999999999999999987655
Q ss_pred ------eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 543 ------ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 543 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 565655432 335899999999999999999999988 999999999999999999999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+|||++..+....... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 158 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 158 ADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred CcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998764332211 112345778999998764 45789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=255.12 Aligned_cols=202 Identities=18% Similarity=0.229 Sum_probs=151.7
Q ss_pred hcCccccCceeeecceeEEEEEeccc----cEEEEEEecCCCCcch-----------HHHHHHHHHHhhcCCCeeeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEG----QEIAVKRLSKGSGQGM-----------EEFKNEVTLIARLQHRNLVKLLG 536 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g----~~vavK~l~~~~~~~~-----------~~~~~Ei~il~~l~H~nIv~l~~ 536 (698)
.++|.+.++||+|+||.||+|...+. ..+|+|+......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36799999999999999999987543 4556665332221110 11223334456678999999999
Q ss_pred EEEeCC----eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC
Q 005400 537 CCIQAD----ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (698)
Q Consensus 537 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (698)
++.... ..++++|++.. ++...+... ...++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 34677777643 454444322 22467788899999999999999988 99999999999999999
Q ss_pred ceEEeecCCCcccCCCcc-----ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 613 NPKISDFGMARIFGGDEI-----QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 613 ~~kl~DFgla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.++|+|||+++.+..... ........||+.|+|||.+.+..++.++|||||||+++||++|+.||...
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999987532211 11112246999999999999999999999999999999999999999754
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=246.58 Aligned_cols=198 Identities=32% Similarity=0.479 Sum_probs=173.8
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|++.+.||+|++|.||+++.. .++.+++|.+..... ...+.+.+|++++.+++|+|++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999865 578999999976643 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++... ..+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988543 45899999999999999999999988 99999999999999999999999999987654332
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
. .....++..|+|||......++.++||||+|++++||++|+.||..
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1 1224678899999998888889999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=261.70 Aligned_cols=203 Identities=28% Similarity=0.444 Sum_probs=167.7
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeC--Cee
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA--DES 544 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~--~~~ 544 (698)
..++|++.+.||+|+||.||+|... .++.+|+|++... .......+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999875 4788999988543 233445678899999999 999999999998654 368
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||++ ++|..++... .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5888777432 5788999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc---cccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 625 FGGDEIQ---TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~---~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+...... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 5433211 12223468899999998754 467889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=259.83 Aligned_cols=204 Identities=26% Similarity=0.415 Sum_probs=169.7
Q ss_pred hhhHHHhhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC
Q 005400 465 FASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (698)
Q Consensus 465 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~ 541 (698)
..++...+++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345666789999999999999999999986 468899999987542 23346688899999999999999999988643
Q ss_pred ------CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceE
Q 005400 542 ------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (698)
Q Consensus 542 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 615 (698)
...+++++++ +++|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467788876 7788777643 24889999999999999999999988 99999999999999999999
Q ss_pred EeecCCCcccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998764321 122467889999998866 568899999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=251.47 Aligned_cols=197 Identities=24% Similarity=0.351 Sum_probs=162.5
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeC--CeeEEEEE
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQA--DESMLIYE 549 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~--~~~~lV~E 549 (698)
|++.++||+|+||.||++... +++.+|+|+++... .........|+.++.++. |+|++++++++.+. ...++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999864 58899999987642 222234567888898885 99999999999987 88999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++ +|.+.+... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++. +.+||+|||++..+....
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9974 777766442 245899999999999999999999988 999999999999999 999999999998764332
Q ss_pred cccccccccccccccChhccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~-~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. ....++..|+|||.+. ...++.++|||||||++|||++|+.||...+
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 11 1245788999999764 4567889999999999999999999997544
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=292.18 Aligned_cols=205 Identities=28% Similarity=0.446 Sum_probs=171.5
Q ss_pred HHhhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
...+-++.....||.|.||.||-+.. .+|.-.|+|.+... .........+|+.++..++|||+|+++|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 33444555667899999999999985 45888999987654 3345567889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
|.||||++|+|.+.+.... .+++.....+..|++.|++|||+++ ||||||||.||+|+.+|-+|++|||.|..+
T Consensus 1311 IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999985432 3566666677889999999999999 999999999999999999999999999887
Q ss_pred CCCc--cccccccccccccccChhcccCCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 626 GGDE--IQTNTHKVVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 626 ~~~~--~~~~~~~~~gt~~y~APE~l~~~~---~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.... .....+...||+-|||||++.+.. ..-++||||+||++.||+||++||..
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 5542 223334578999999999996543 56679999999999999999999963
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=240.84 Aligned_cols=198 Identities=23% Similarity=0.424 Sum_probs=163.6
Q ss_pred ccccCceeeecceeEEEEEecc-ccEEEEEEecCC-CCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEEec
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.+.+..||.|..|.|++.+... |..+|||.+.+. ..+..+.++..++++.+-+ .|.||+.+|+|.......+.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 4455689999999999998754 788999999876 3455667788888877665 899999999999999999999998
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
. ..++.++.. ...++++.-+-++...+.+||.||.+++ .|+|||+||+|||+|+.|++|++|||++..+-.....
T Consensus 174 s-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 174 S-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred H-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 4 345555533 2345788888889999999999999876 6999999999999999999999999999876433322
Q ss_pred cccccccccccccChhcccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~---~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+ ...|-+.|||||.+.. ..|+.++||||||+.|+||.||+.||...
T Consensus 249 t---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 249 T---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred c---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 2 2468899999999864 36889999999999999999999999863
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-28 Score=254.98 Aligned_cols=193 Identities=31% Similarity=0.510 Sum_probs=164.5
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
|+..+.||+|+||.||+++.. +++.+|+|++.... .+..+.+.+|++++++++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999864 57899999986542 23345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++ +|.+.+... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 975 676666432 234899999999999999999999988 999999999999999999999999998754321
Q ss_pred ccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
....++..|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2246788999999873 45688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=254.12 Aligned_cols=200 Identities=27% Similarity=0.420 Sum_probs=163.6
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|...++||+|+||.||+++.. +++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999875 47899999987543 234567889999999996 99999999999999999999999
Q ss_pred cCCCChhHHHhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 551 MPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 551 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
+.. ++..+... ......+++..+..++.++++||+|||+. + ++||||||+||+++.++.+||+|||++..+..
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 44443211 11234588999999999999999999975 5 99999999999999999999999999976543
Q ss_pred CccccccccccccccccChhcccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEG---LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~---~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.... ....|+..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 161 SIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred CCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 2211 223578899999998766 6899999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-28 Score=245.86 Aligned_cols=203 Identities=25% Similarity=0.423 Sum_probs=176.6
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|.+.+.||+|++|.||++... +++.+++|++..... ...+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999875 488999999876532 4566789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 551 MPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 551 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
+++++|..++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886532 2356899999999999999999999987 9999999999999999999999999998764432
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. ......+++.|+|||.+....++.++||||+|+++++|++|+.||....
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 1 1223468889999999988889999999999999999999999997553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=248.63 Aligned_cols=202 Identities=29% Similarity=0.473 Sum_probs=174.5
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|++.++||+|++|.||+++.. +++.+++|.+... .......+.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999764 5789999998754 233456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 551 MPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 551 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
+++++|..++.+.. ....+++..+..++.+++.||+|||+.+ ++|+||+|.||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886532 2345889999999999999999999988 9999999999999999999999999998765431
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.....++..|+|||.+.+..++.++|+||||++++||++|+.||...+.
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1124578899999999988899999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=261.25 Aligned_cols=202 Identities=22% Similarity=0.394 Sum_probs=168.0
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEe----CCee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~----~~~~ 544 (698)
.++|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 377899999999999999999865 58899999987542 2345678889999999999999999988763 3468
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++|+||+. ++|..++... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 5788877432 34899999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCccc--cccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEIQ--TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 5432211 11122468889999998865 46889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=259.19 Aligned_cols=196 Identities=29% Similarity=0.459 Sum_probs=163.8
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC------
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~------ 542 (698)
.++|.+.+.||+|+||.||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999864 5899999998754 2233456889999999999999999999987543
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 565543 224788999999999999999999988 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764321 122467889999999876 468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=265.85 Aligned_cols=208 Identities=26% Similarity=0.364 Sum_probs=182.2
Q ss_pred cCccccCceeeecceeEEEEEecccc-EEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQ-EIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~-~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
.+++++..||-|+||.|-+++.+... .+|+|++++. +....+++..|-.||...+.|.||+++..|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566678999999999999875443 3788888765 4566778999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
|-|-+|.|...|.+.+ .++..+...++..+++|++|||.++ ||.|||||+|.||+.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999996543 3777778889999999999999998 999999999999999999999999999988654
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccccc
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li 689 (698)
. .+...+||+.|.|||++.+.-++..+|.||||+++|||++|++||+..+|...-++|
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I 631 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI 631 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 3 334589999999999999999999999999999999999999999988887665554
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=253.08 Aligned_cols=199 Identities=27% Similarity=0.410 Sum_probs=167.8
Q ss_pred CccccCceeeecceeEEEEEec----cccEEEEEEecCCC----CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS----GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
+|++.+.||+|++|.||+++.. +++.+|+|.+++.. ....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999753 46789999986532 23345688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|..++... ..+++..+..++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999888543 34788999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCccccccccccccccccChhcccCCC--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
+...... ......++..|+|||.+.... .+.++||||||++++||++|+.||..
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 5433211 112246788999999987655 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=253.42 Aligned_cols=198 Identities=24% Similarity=0.443 Sum_probs=164.0
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCC-CcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|++.+.||+|++|.||+++... ++.||||.++... .....++..|++++.+.. ||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999865 8899999997543 234456677887777775 9999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
|+++ ++..++... ...+++..+..++.++++||+|||+. + |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 666665432 23688999999999999999999974 5 999999999999999999999999998765432
Q ss_pred ccccccccccccccccChhcccCCC----CCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGL----FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~----~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
... ....++..|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 211 1235778999999986543 78899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=256.94 Aligned_cols=200 Identities=28% Similarity=0.439 Sum_probs=168.1
Q ss_pred HHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe-CCee
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADES 544 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~-~~~~ 544 (698)
...+++|++.+.||+|+||.||++... +++.||+|++.+. .....+.+..|++++.+++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 446788999999999999999999864 6889999988653 22345678899999999999999999999876 5678
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++|+||+ +++|..++.. ..+++.....++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 4578777632 24778888899999999999999988 99999999999999999999999999875
Q ss_pred cCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 122457889999998765 568999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=252.99 Aligned_cols=203 Identities=32% Similarity=0.478 Sum_probs=174.7
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV 547 (698)
++|.+.+.||+|++|.||+++.. +++.||+|++... .....+.+.+|++++.+++ ||||+++++++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999875 5889999998653 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
||++++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999998653 25899999999999999999999988 99999999999999999999999999886543
Q ss_pred Cccc------------------cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQ------------------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~------------------~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... .......++..|+|||.+....++.++||||||++++|+++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 3211 11222457889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=257.77 Aligned_cols=198 Identities=26% Similarity=0.427 Sum_probs=166.8
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC----
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD---- 542 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~---- 542 (698)
...++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999854 5889999998643 2233456889999999999999999999987543
Q ss_pred --eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 543 --ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 543 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
..++||||+ +++|..++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 6788877642 34889999999999999999999988 9999999999999999999999999
Q ss_pred CCcccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
++....... ....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...
T Consensus 164 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 164 LARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 987653221 22457889999998876 45889999999999999999999999744
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-29 Score=229.93 Aligned_cols=205 Identities=27% Similarity=0.393 Sum_probs=166.4
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~l 546 (698)
...+...-...||+|++|.|-+-++. +|+..|+|++... ..+..+..++|+.+..+. .+|.+|+++|........++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 33444555678999999999988874 5889999999765 445566788888877655 79999999999999999999
Q ss_pred EEEecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 547 IYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
.||.|. .+|+.+-.+- .....+++.-+-+||..+.+||.|||++- .++|||+||+|||++.+|++||+|||++-.+
T Consensus 123 cME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999995 4676654321 23456888888999999999999999964 6999999999999999999999999999876
Q ss_pred CCCccccccccccccccccChhcccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAE----GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
...-..+ ...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.||+..
T Consensus 200 ~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 200 VDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 4332211 1357789999998743 36899999999999999999999999743
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-30 Score=246.52 Aligned_cols=212 Identities=26% Similarity=0.410 Sum_probs=169.8
Q ss_pred ccccccccchhhHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeee
Q 005400 456 EDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLV 532 (698)
Q Consensus 456 ~~~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv 532 (698)
.+..++.|+...++. +..||.|+||+|+|-.++ .|+.+|||+++... ....++++.|.+...+- +.||||
T Consensus 54 ~~~~~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IV 126 (361)
T KOG1006|consen 54 DDAHLHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIV 126 (361)
T ss_pred CcccccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHH
Confidence 445567777666554 358999999999999875 48999999998764 35667888888876655 699999
Q ss_pred eEEEEEEeCCeeEEEEEecCCCChhHHHhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC
Q 005400 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN 610 (698)
Q Consensus 533 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~ 610 (698)
+++|.+..+..-++.||.|+ .+|+.+-.. ......+++.-+-.|+.-.++||.||-+.- .|||||+||+||||+.
T Consensus 127 kfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 127 KFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDR 203 (361)
T ss_pred HHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEec
Confidence 99999999999999999994 466555321 123345788888888888999999998764 5999999999999999
Q ss_pred CCceEEeecCCCcccCCCccccccccccccccccChhcccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 611 DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG--LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 611 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.|.+||+|||++..+...... ..-.|-..|||||.+... .|+.++||||||+.|+|+.||+.||+..
T Consensus 204 ~G~vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred CCCEeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 999999999998765432221 124688899999998654 4899999999999999999999999743
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=249.28 Aligned_cols=199 Identities=28% Similarity=0.472 Sum_probs=165.7
Q ss_pred ccccCceeeecceeEEEEEecc-ccEEEEEEecCCCC--cchHHHHHHHHHHhhc---CCCeeeeEEEEEEeCCe-----
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARL---QHRNLVKLLGCCIQADE----- 543 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l---~H~nIv~l~~~~~~~~~----- 543 (698)
|++.+.||+|+||.||+++... ++.+|+|++..... .....+.+|+++++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999864 88999999975422 2234566788877666 59999999999988776
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.+++|||+.+ +|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++++||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 78877754322 34899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
....... .....++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 7643321 122357889999999998899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=254.21 Aligned_cols=197 Identities=20% Similarity=0.250 Sum_probs=162.3
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
+.+|.|+++.|++++. +++.||+|++... .....+.+.+|++++++++|+||+++++++.+....+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455566666666655 6899999998754 344567899999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc-----c
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI-----Q 631 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~-----~ 631 (698)
.+++..... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+||+.+........ .
T Consensus 87 ~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999865422 34788889999999999999999988 99999999999999999999999998865432111 1
Q ss_pred cccccccccccccChhcccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~--~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11122456788999999865 35889999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=223.80 Aligned_cols=109 Identities=50% Similarity=0.797 Sum_probs=81.0
Q ss_pred CCeEEEeeCCCCCCCCC--CcceEEecCceEEe-CCCCceEEee-ccCCCC-CCcEEEEeccceEEEecCCCCceeeecc
Q 005400 64 PRTVAWVANRETPLTDQ--SGLLNVTSKGIVLL-DGRDRIFWSS-NTSITM-KNPVVQLMDSGNLVLTDGNYNSLLWQSF 138 (698)
Q Consensus 64 ~~t~vW~anr~~p~~~~--~~~l~~~~~g~l~l-~~~~~~~ws~-~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~WqSF 138 (698)
++||||+|||+.|+... ..+|.++.||+|+| ++.++++|++ ++.+.. .+..|+|+|+|||||++.. +.+|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-~~~lW~Sf 79 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-GNVLWQSF 79 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-SEEEEEST
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-ceEEEeec
Confidence 47999999999999653 47899999999999 7888999999 555443 5789999999999999965 89999999
Q ss_pred CCCCcccCCCCeecccccCCCceeEEeeccCCCCC
Q 005400 139 DHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPA 173 (698)
Q Consensus 139 d~PTDTlLpg~~l~~~~~~g~~~~l~s~~~~~d~s 173 (698)
||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 80 ~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 80 DYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999988888777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=258.07 Aligned_cols=200 Identities=24% Similarity=0.408 Sum_probs=166.9
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-----Ce
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-----~~ 543 (698)
.++|.+.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999864 5889999998653 233455678899999999999999999987654 34
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++|+||+. ++|..++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 6787777433 34889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 157 TTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 6543221 1122467889999998765 46889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=249.90 Aligned_cols=199 Identities=28% Similarity=0.421 Sum_probs=169.1
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
|++.+.||+|++|.||++... +++.+++|++..... .....+..|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999875 588899999876532 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++ +|..++.... ..+++..+..++.++++||.|||+.+ |+|+||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 76 7777765432 35889999999999999999999988 99999999999999999999999999987654331
Q ss_pred cccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11224577889999998776 78999999999999999999999996543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=254.18 Aligned_cols=203 Identities=27% Similarity=0.436 Sum_probs=164.6
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC------
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~------ 542 (698)
.++|++.++||+|++|.||+++.. +++.+|+|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 588999999865422 22346788999999999999999999875543
Q ss_pred --eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 543 --ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 543 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
..++|+||+.. ++...+... ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46899999975 565555432 335899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCcccc---------ccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 621 MARIFGGDEIQT---------NTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 621 la~~~~~~~~~~---------~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
++.......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 997654322111 11123567889999987654 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=215.39 Aligned_cols=109 Identities=41% Similarity=0.939 Sum_probs=104.1
Q ss_pred EeeCCCCCCCccCCCCCcccccceeeEEEecCceEEEEEcc-CCCceeEEEEeeCCCEEEEEEecCCCcEEEEEecCCCC
Q 005400 199 YRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA-KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDR 277 (698)
Q Consensus 199 ~~~g~w~~~~~~~~p~~~~~~~~~~~~~~~n~~~~~~~~~~-~~~~~~r~~l~~~G~~~~~~w~~~~~~W~~~~~~p~~~ 277 (698)
||+|+|||..|+|+|++..+ ..+.+.|+.+++|.+|+|.. +.+.++|++||.+|+++++.|+++.+.|.+.|++|.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~-~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSN-SLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCccccccc-ceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccC
Confidence 89999999999999999955 78899999999999999998 88889999999999999999999999999999999999
Q ss_pred CccCCCCCCCcccCCCCCCcccccCCCccCC
Q 005400 278 CDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308 (698)
Q Consensus 278 C~~~~~CG~~g~C~~~~~~~C~C~~Gf~~~~ 308 (698)
||+|+.||+||+|+.+..|.|+|||||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999998899999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=254.68 Aligned_cols=202 Identities=24% Similarity=0.351 Sum_probs=164.9
Q ss_pred cCccc-cCceeeecceeEEEEEec-cccEEEEEEecCCCCcc--------------hHHHHHHHHHHhhcCCCeeeeEEE
Q 005400 473 DNFAS-YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQG--------------MEEFKNEVTLIARLQHRNLVKLLG 536 (698)
Q Consensus 473 ~~f~~-~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~--------------~~~~~~Ei~il~~l~H~nIv~l~~ 536 (698)
++|.. .+.||+|+||.||+++.. .++.||+|+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45553 467999999999999865 58899999986542211 124778999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 537 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
++...+..++||||++ ++|.+++.. ...+++.....++.|+++||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 588888743 234889999999999999999999988 999999999999999999999
Q ss_pred eecCCCcccCCCcc------------ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 617 SDFGMARIFGGDEI------------QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 617 ~DFgla~~~~~~~~------------~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+|||++........ ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999876541110 0111123467889999988764 46899999999999999999999997543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=249.77 Aligned_cols=194 Identities=30% Similarity=0.488 Sum_probs=163.4
Q ss_pred ccccCceeeecceeEEEEEec-cccEEEEEEecCCCC---cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
|...++||+|+||.||+|+.. .++.|++|++..... ...+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 578999999865422 3345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+. +++..++... ...+++.++..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 4666665432 235889999999999999999999988 99999999999999999999999999864321
Q ss_pred ccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.....|+..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12256888999999874 456889999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=253.37 Aligned_cols=198 Identities=22% Similarity=0.308 Sum_probs=161.3
Q ss_pred Cceeee--cceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEG--GFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G--~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
++||+| +|++||+++.. .|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999874 68999999987542 23456788999999999999999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc-
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT- 632 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~- 632 (698)
++|..++.+... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999998865432 34788889999999999999999987 9999999999999999999999998654322111000
Q ss_pred ----ccccccccccccChhcccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 633 ----NTHKVVGTYGYMSPEYAAEG--LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 633 ----~~~~~~gt~~y~APE~l~~~--~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
......++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 00112345679999998764 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=255.74 Aligned_cols=201 Identities=27% Similarity=0.402 Sum_probs=170.7
Q ss_pred CccccCceeeecceeEEEEEecc-ccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-----eeE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESM 545 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~-----~~~ 545 (698)
+|.+.+.||+|++|.||+++... ++.+|+|++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999998754 8899999987653 345567999999999999999999999988775 789
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+++ +|..++... ..+++..+..++.++++||+|||+.+ |+|+||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 787777432 25899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 626 GGDEI-QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..... ........++..|+|||.+.+. .++.++||||||++++||++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 44321 0112234678899999999877 78999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=252.77 Aligned_cols=201 Identities=26% Similarity=0.374 Sum_probs=163.2
Q ss_pred CccccCceeeecceeEEEEEecc---ccEEEEEEecCC--CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeC----Ce
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE---GQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA----DE 543 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~---g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~----~~ 543 (698)
+|++.+.||+|+||.||+++... +..+|+|++... .....+.+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47778899999999999998753 678999998653 222356788999999999 599999999876433 45
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++++|++. ++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 578877743 335889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDEI--QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~~--~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.+..... ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 6543221 111223468999999998765 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=256.28 Aligned_cols=202 Identities=26% Similarity=0.403 Sum_probs=165.7
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC---------
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--------- 541 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--------- 541 (698)
..+|.+.+.||.|+||.||+|... .++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367899999999999999999874 4889999998776666677899999999999999999999776543
Q ss_pred -----CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceE
Q 005400 542 -----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPK 615 (698)
Q Consensus 542 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~k 615 (698)
...++|+||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 578777632 24788999999999999999999988 99999999999997 456789
Q ss_pred EeecCCCcccCCCcccc-ccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 616 ISDFGMARIFGGDEIQT-NTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 616 l~DFgla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|+|||++..+....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999997654321111 1122357889999997654 567889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=248.17 Aligned_cols=198 Identities=28% Similarity=0.394 Sum_probs=166.2
Q ss_pred ccccCceeeecceeEEEEEecc-ccEEEEEEecCCCC-cchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEEec
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
|.+.+.||+|++|.||+|+..+ ++.|++|++..... .......+|+..+++++ |+||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5667899999999999999854 78899999865422 22334567999999999 999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
+++|..++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 788888875533 245899999999999999999999988 999999999999999999999999999865432211
Q ss_pred cccccccccccccChhccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~-~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....++..|+|||++. ...++.++|+||||++++||++|+.||...
T Consensus 156 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 156 ---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred ---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 2245788999999874 445789999999999999999999999644
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=250.33 Aligned_cols=196 Identities=30% Similarity=0.494 Sum_probs=164.9
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667789999999999999875 4788999998643 2234457889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+. +++...+... ...+++.++..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 5776666432 234789999999999999999999987 999999999999999999999999998765322
Q ss_pred ccccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 1245788999999874 356788999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=246.91 Aligned_cols=198 Identities=30% Similarity=0.463 Sum_probs=168.9
Q ss_pred ccccCceeeecceeEEEEEecc-ccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
|+..+.||+|++|.||+|+... ++.+|+|++.... ....+.+..|++++++++|+|++++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999998764 8999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
+ ++|.+++.+.. ..+++..+..++.++++||+|||+.+ |+|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58988886542 35889999999999999999999988 999999999999999999999999998875433211
Q ss_pred cccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.....++..|+|||.+... .++.++||||||++++||++|+.||...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 1123457789999998766 7899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=274.58 Aligned_cols=198 Identities=29% Similarity=0.489 Sum_probs=157.8
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC------
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------ 541 (698)
+-..+|+.++.||+||||.|||++.+ +|+.+|||++... .......+.+|++.+++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888999999999999999865 7999999999765 344556788999999999999999998432100
Q ss_pred --------------------------------------------------------------------------------
Q 005400 542 -------------------------------------------------------------------------------- 541 (698)
Q Consensus 542 -------------------------------------------------------------------------------- 541 (698)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHH
Q 005400 542 ---------------------------------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588 (698)
Q Consensus 542 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL 588 (698)
..+||-||||+..++.+++.++.... .....++++.+|+.||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 12356788888888877775433211 4667789999999999999
Q ss_pred HhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC----C------------CccccccccccccccccChhcccCC
Q 005400 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG----G------------DEIQTNTHKVVGTYGYMSPEYAAEG 652 (698)
Q Consensus 589 H~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~----~------------~~~~~~~~~~~gt~~y~APE~l~~~ 652 (698)
|+++ ||||||||.||+|+++..+||+|||+|.... . ..........+||.-|+|||++...
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998721 0 0011112236899999999998654
Q ss_pred ---CCCcchhHHHHHHHHHHHHh
Q 005400 653 ---LFSVKSDVFSFGVLVLEIVS 672 (698)
Q Consensus 653 ---~~~~k~DVwSlGvil~ellt 672 (698)
.|+.|+|+|||||||+||+.
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc
Confidence 49999999999999999983
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=240.46 Aligned_cols=193 Identities=30% Similarity=0.427 Sum_probs=167.9
Q ss_pred eeeecceeEEEEEec-cccEEEEEEecCCCC---cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
||+|+||.||++... +++.+++|.+..... ...+.+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 488999999876532 2456789999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccccc
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (698)
.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT 152 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence 99985432 4889999999999999999999987 99999999999999999999999999887543321 1223
Q ss_pred ccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 637 ~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..++..|+|||.+.+...+.++|+||||+++|||++|+.||....
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 567889999999988888999999999999999999999996544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=270.34 Aligned_cols=204 Identities=32% Similarity=0.473 Sum_probs=171.3
Q ss_pred cCccccCceeeecceeEEEEEecc--------ccEEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~--------g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~ 542 (698)
++..+.+.||+|.||.|++|.... ...||||.++.. .....+.+..|+++|+.+ +|+||+.++|+|.+..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 334455689999999999997531 357999999765 334667899999999999 5999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcc-----------cc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQA-----------RA--TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
..++|+||+..|+|..+|.+.+ .. ..++..+++.++.|||.||+||++.. ++||||..+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999997654 00 23889999999999999999999987 99999999999999
Q ss_pred CCCceEEeecCCCcccCCCcccc-ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 005400 610 NDMNPKISDFGMARIFGGDEIQT-NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRF 679 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~ 679 (698)
++..+||+|||+++......... ......-+..|||||.+....|+.|+|||||||+||||+| |..||..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999654443332 1111114567999999999999999999999999999999 8889875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=218.31 Aligned_cols=200 Identities=26% Similarity=0.416 Sum_probs=164.9
Q ss_pred CccccCceeeecceeEEEEEecc-ccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+|+..++||+|.+|+||+++..+ ++.||+|+++.. ++.......+|+-+++.++|.|||++++.......+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566799999999999998754 778999988654 334456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
|.. +|..+.. .-...++.+....++.|+++||.++|+++ +.||||||.|.|++.+|+.|++|||+++-++-.-.
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 4544432 23445888999999999999999999998 99999999999999999999999999987754321
Q ss_pred ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
. .+..+-|..|.+|.++-+. .|+...|+||-|||+.|+.. |++.|...+
T Consensus 157 -c-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 157 -C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred -e-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 1 2234678999999988665 58899999999999999987 566665443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=236.93 Aligned_cols=200 Identities=26% Similarity=0.406 Sum_probs=172.7
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~l 546 (698)
..+|..+++||+|++++|..++++. .+.+|+|++++. ..+..+-...|-.+..+. +||.+|-+..+|+.+..++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 3568888999999999999999864 678899998765 334455567788888777 69999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|.||+++|+|-.++.++ ..++++.+..+...|.-||.|||+.+ |+.||||..|+|||.+|++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999997666443 34888888889999999999999998 9999999999999999999999999998632
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.+. ..++..+||+.|+|||++++..|+..+|.|+|||+++||+.|+.||+.
T Consensus 403 ~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 403 GPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 221 234458999999999999999999999999999999999999999963
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=270.56 Aligned_cols=145 Identities=26% Similarity=0.445 Sum_probs=130.0
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|.+.++||+|+||.||+|+.. .++.||+|++.... ......+..|+++++.++||||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67889999999999999999875 58899999987542 223467889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
||+++++|..++... ..+++..++.++.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998543 34788889999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=236.60 Aligned_cols=199 Identities=24% Similarity=0.315 Sum_probs=165.2
Q ss_pred hhcCcccc-CceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEe----CCe
Q 005400 471 ATDNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ----ADE 543 (698)
Q Consensus 471 ~~~~f~~~-~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~----~~~ 543 (698)
.+++|.+. ++||-|-.|+|-.+..+ .++++|+|++... ...++|+++--.. .|||||.++++++. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666553 47999999999998765 5889999998542 3457888877666 69999999998754 456
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc---CCCceEEeecC
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFG 620 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFg 620 (698)
+++|||.|+||.|...+.+++ ...+++.++..|..||..|+.|||+.+ |.||||||+|+|.. .+-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 789999999999999886654 345889999999999999999999998 99999999999996 45569999999
Q ss_pred CCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+|+.-... ......+-|+.|.|||++....|+...|+||+||++|-||+|.+||-..+
T Consensus 210 FAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 210 FAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred cccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 99874322 22233678999999999999999999999999999999999999996443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=254.77 Aligned_cols=199 Identities=29% Similarity=0.454 Sum_probs=167.5
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe---
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE--- 543 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~--- 543 (698)
...++|++.+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999875 4789999998653 22344567889999999999999999988766554
Q ss_pred ---eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 544 ---SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 544 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5688887743 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99865332 122467889999998865 367899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=241.82 Aligned_cols=200 Identities=29% Similarity=0.407 Sum_probs=164.8
Q ss_pred CccccCceeeecceeEEEEEecc-ccEEEEEEecCC-----CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788899999999999998643 444555555432 122334577899999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 548 YEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
+||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888642 23346899999999999999999999988 999999999999975 569999999987654
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.... ......++..|+|||.+....++.++|+||||+++|+|++|+.||..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3221 11224578899999999888889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=258.34 Aligned_cols=220 Identities=28% Similarity=0.456 Sum_probs=185.8
Q ss_pred cchhhHHHhhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEe
Q 005400 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (698)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~ 540 (698)
.++..+...++.|++.+.||.|.+|.||+++. ++++..|+|++... ....+++..|.++++.. .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 44555666778899999999999999999986 45888999988654 34456788899999888 59999999999864
Q ss_pred -----CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceE
Q 005400 541 -----ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (698)
Q Consensus 541 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 615 (698)
++.++||||||.+|+..+++..-. ...+.|..+..|++.++.||++||... ++|||||-.||||+.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 467999999999999999987654 556899999999999999999999987 99999999999999999999
Q ss_pred EeecCCCcccCCCccccccccccccccccChhcccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccccc
Q 005400 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-----LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689 (698)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li 689 (698)
|.|||++..+...... .....||+.|||||++.-. .|+.++|+||||++..||--|.+|+.+.||-...-+|
T Consensus 164 LvDFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I 240 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 240 (953)
T ss_pred Eeeeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence 9999998876543332 2336899999999998533 4778999999999999999999999998886544443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=235.91 Aligned_cols=180 Identities=21% Similarity=0.192 Sum_probs=153.6
Q ss_pred ecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhh
Q 005400 484 GGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD 562 (698)
Q Consensus 484 G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 562 (698)
|.+|.||+++.. +++.+|+|++.... .+..|...+....||||+++++++......++||||+++++|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999874 57899999986542 234455566666799999999999999999999999999999998865
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccccccccccc
Q 005400 563 QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642 (698)
Q Consensus 563 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 642 (698)
.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++..+.... ....++..
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 32 3889999999999999999999988 9999999999999999999999999876553321 12345678
Q ss_pred ccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 643 y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
|+|||.+....++.++||||+|+++|||++|+.|+..
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999999888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=255.84 Aligned_cols=204 Identities=21% Similarity=0.285 Sum_probs=153.4
Q ss_pred hhcCccccCceeeecceeEEEEEe-----------------ccccEEEEEEecCCCCcchHH--------------HHHH
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-----------------VEGQEIAVKRLSKGSGQGMEE--------------FKNE 519 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 519 (698)
..++|++.++||+|+||.||+|.. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 235679999986543222222 3446
Q ss_pred HHHHhhcCCCee-----eeEEEEEEe--------CCeeEEEEEecCCCChhHHHhhccc---------------------
Q 005400 520 VTLIARLQHRNL-----VKLLGCCIQ--------ADESMLIYEYMPNKSLDFFIFDQAR--------------------- 565 (698)
Q Consensus 520 i~il~~l~H~nI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 565 (698)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677777753 3568999999999999998864210
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccC
Q 005400 566 ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645 (698)
Q Consensus 566 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~A 645 (698)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++..+...... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123567788899999999999999988 999999999999999999999999999765432211 1112345789999
Q ss_pred hhcccCCC--------------------C--CcchhHHHHHHHHHHHHhCCC-CCC
Q 005400 646 PEYAAEGL--------------------F--SVKSDVFSFGVLVLEIVSGKK-NWR 678 (698)
Q Consensus 646 PE~l~~~~--------------------~--~~k~DVwSlGvil~elltG~~-pf~ 678 (698)
||.+.... + ..+.||||+||+++||++|.. ||.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 99875332 1 124799999999999999985 664
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=250.37 Aligned_cols=197 Identities=27% Similarity=0.406 Sum_probs=168.0
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCC--------CcchHHHHHHHHHHhhcC---CCeeeeEEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--------GQGMEEFKNEVTLIARLQ---HRNLVKLLGCCI 539 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~--------~~~~~~~~~Ei~il~~l~---H~nIv~l~~~~~ 539 (698)
...|..++.+|+|+||.|+.+.++. ...|+||.+.+.. .......-.|+.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3458889999999999999999865 5578999887642 112234567999999997 999999999999
Q ss_pred eCCeeEEEEEec-CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEee
Q 005400 540 QADESMLIYEYM-PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (698)
Q Consensus 540 ~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 618 (698)
+.+.+||+||-. ++.+|.+++..+ +.+++.+...|++|++.|+++||+++ |||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999976 456777777443 34889999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccCCCccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~ 678 (698)
||.+....+.... ..+||.+|.|||++.+..| +..-|||++|++||-++..+.||-
T Consensus 714 fgsaa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999886654433 3789999999999998887 456799999999999999999984
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=235.67 Aligned_cols=221 Identities=25% Similarity=0.355 Sum_probs=184.7
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEecc------ccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEE
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~ 539 (698)
++.....+++....+-+|.||.||+|.+.+ .+.|.+|.++.. +.-+...+..|.-.+..+.|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 344455667777789999999999996543 456788888655 3345567889999999999999999999987
Q ss_pred eC-CeeEEEEEecCCCChhHHHh-----hccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc
Q 005400 540 QA-DESMLIYEYMPNKSLDFFIF-----DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (698)
Q Consensus 540 ~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (698)
+. ...+.+|.++.-|+|..+|. +......+...+...++.|++.||+|||.++ +||.||..+|.+||+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 65 55788899999999999997 3333445777888899999999999999998 999999999999999999
Q ss_pred eEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCcccccc
Q 005400 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLG 690 (698)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~~~~~li~ 690 (698)
+||+|=.+++-+-..++..-......+..||+||.+.+..|+..+|||||||+||||+| |+.||..-+|.|....+.
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 99999999998766666555555567889999999999999999999999999999998 999998878877655443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=251.32 Aligned_cols=194 Identities=25% Similarity=0.375 Sum_probs=163.7
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++.|.....+|.|+|+.|-++... .++..++|++.+.. .+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 566777778999999999999764 57889999997652 2234567666555 69999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE-cCCCceEEeecCCCcccCCC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL-DNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~DFgla~~~~~~ 628 (698)
.+.++-+.+.+..... .. .++..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988777754332 22 677789999999999999998 9999999999999 69999999999999876544
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
....+-|..|.|||++....|++.+|+||||++|||||+|+.||....
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 122467889999999999999999999999999999999999997533
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=241.45 Aligned_cols=209 Identities=21% Similarity=0.283 Sum_probs=174.2
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcC-C-C----eeeeEEEEEEeCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-H-R----NLVKLLGCCIQADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H-~----nIv~l~~~~~~~~~ 543 (698)
.+++|.++..+|+|.||.|-+..... +..||||+++. .....++.+-|++++.++. + | -+|.+.++|....+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36889999999999999999997644 68899999864 3455677888999999994 2 2 57888899999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-------------
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN------------- 610 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~------------- 610 (698)
.+||+|.| +-++.+++.++.. .+++...+..|+.|+++++++||+.. ++|-||||+|||+-+
T Consensus 166 iCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999998 5588888865433 45788999999999999999999998 999999999999932
Q ss_pred -------CCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 611 -------DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 611 -------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
+..+||+|||.|..-.... ..++.|..|.|||++.+-.++.++||||+||||+||.||...|+..+..
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 2358999999998754333 3378899999999999999999999999999999999999999866544
Q ss_pred Ccccccc
Q 005400 684 HDHNLLG 690 (698)
Q Consensus 684 ~~~~li~ 690 (698)
|...+.+
T Consensus 316 EHLaMMe 322 (415)
T KOG0671|consen 316 EHLAMME 322 (415)
T ss_pred HHHHHHH
Confidence 4444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-26 Score=225.66 Aligned_cols=199 Identities=32% Similarity=0.477 Sum_probs=171.7
Q ss_pred ccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
|.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999875 889999999866544 67789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+++|..++...... +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 99999998653321 788999999999999999999987 999999999999999999999999998876443210
Q ss_pred ccccccccccccChhcc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYA-AEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l-~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11234677899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-28 Score=236.31 Aligned_cols=205 Identities=27% Similarity=0.413 Sum_probs=170.5
Q ss_pred CceeeecceeEEEEEe-ccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-----eeEEEEEe
Q 005400 479 NKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESMLIYEY 550 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~-----~~~lV~E~ 550 (698)
+.||-|+||.||.+.. ++|+.||+|++... .-...+.+.+|++++.-++|.|++..+++-+-.. +.|.++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 5899999999999986 46999999998654 2234567899999999999999999988765432 45677888
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
|. .+|+.++... ..++-..+.-+.+||++||.|||+.+ |.||||||.|.|++++...||+|||+++....++.
T Consensus 139 mQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 139 MQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 74 5677776443 24777788889999999999999998 99999999999999999999999999998766555
Q ss_pred ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCccccccc
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li~~ 691 (698)
...++ .+-|..|.|||++++. .|+...||||.|||+.||+..+..|+...|.+..++|..
T Consensus 212 ~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 212 LNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred hhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 44444 4678999999999876 689999999999999999999999999888887776654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=202.32 Aligned_cols=114 Identities=46% Similarity=0.765 Sum_probs=101.9
Q ss_pred CccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CCCCceEEe
Q 005400 25 QSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWS 103 (698)
Q Consensus 25 ~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~~~~~~ws 103 (698)
++|++|++|+|++|.|++|||.+......+.+|||.+++ +++||.||++.| ....+.|.++.||+|+| |.+|.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~ 79 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWS 79 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEE
Confidence 578999999999999999999987665589999999887 899999999998 45567899999999988 889999999
Q ss_pred eccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCC
Q 005400 104 SNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHP 141 (698)
Q Consensus 104 ~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~P 141 (698)
|+++......+|+|+|+|||||++.+ +.++|||||||
T Consensus 80 S~~~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~~P 116 (116)
T cd00028 80 SNTTRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFDYP 116 (116)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCC-CCEEEcCCCCC
Confidence 99875345678999999999999987 78999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=223.46 Aligned_cols=186 Identities=32% Similarity=0.492 Sum_probs=164.4
Q ss_pred cceeEEEEEecc-ccEEEEEEecCCCCcc-hHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhh
Q 005400 485 GFGPVYKGTLVE-GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD 562 (698)
Q Consensus 485 ~fG~Vy~g~~~~-g~~vavK~l~~~~~~~-~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 562 (698)
+||.||+++..+ ++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8899999997664444 68899999999999999999999999999999999999999999998854
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccccccccccc
Q 005400 563 QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642 (698)
Q Consensus 563 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 642 (698)
... +++..+..++.++++++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 332 789999999999999999999987 9999999999999999999999999998765432 1223567889
Q ss_pred ccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 643 y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
|++||.+....++.++||||||++++||++|+.||..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888899999999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-28 Score=228.63 Aligned_cols=212 Identities=23% Similarity=0.441 Sum_probs=166.6
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe--------C
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--------A 541 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--------~ 541 (698)
..|+...+||+|.||+||+++..+ |++||+|++--. .........+|+++|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345556789999999999998754 778898875332 22334557889999999999999999988753 2
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
...++|+++++. +|.-+|... ...++..++.++..++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999975 566666433 234788999999999999999999987 99999999999999999999999999
Q ss_pred CcccCCCc--cccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcccccc
Q 005400 622 ARIFGGDE--IQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG 690 (698)
Q Consensus 622 a~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~~li~ 690 (698)
++.+.... ........+-|..|.+||.+.+. .|+++.|||.-|||+.||.|+.+-++.........+|.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 97664322 11222235569999999987664 79999999999999999999999998665544444443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=214.59 Aligned_cols=199 Identities=21% Similarity=0.402 Sum_probs=166.3
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCC--eeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQAD--ESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~--~~~l 546 (698)
..++|++++++|+|.+++||.|.. .+.++++||+++.. ..+.+.+|+.||..+. ||||++++++..++. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 357899999999999999999974 56788999999653 3467899999999997 999999999987654 5679
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-CCceEEeecCCCccc
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIF 625 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFgla~~~ 625 (698)
|+||+.+.+...+- +.++..++...+.++++||.|+|+.+ |.|||+||.|+++|. .-+.+|+|+|||.+.
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876553 23777888899999999999999999 999999999999985 456999999999987
Q ss_pred CCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~ 684 (698)
..... .+..+.+..|.-||.+-. ..|+..-|+|||||+|.+|+..+.||-+.+...
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~ 240 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 240 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH
Confidence 54321 222456778899998754 468889999999999999999999998776553
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=251.72 Aligned_cols=200 Identities=23% Similarity=0.286 Sum_probs=140.8
Q ss_pred hhcCccccCceeeecceeEEEEEecc-----ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEE------EE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC------CI 539 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~------~~ 539 (698)
..++|++.++||+|+||.||+|++.+ ++.||+|++..... .+....| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998754 68999998864321 1112222 1222222222222211 24
Q ss_pred eCCeeEEEEEecCCCChhHHHhhcccc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 005400 540 QADESMLIYEYMPNKSLDFFIFDQARA-----------------TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (698)
Q Consensus 540 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (698)
.....+||+||+++++|.+++...... .......+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999888543210 01122345679999999999999988 9999999
Q ss_pred CCCEEEcC-CCceEEeecCCCcccCCCccccccccccccccccChhcccCC----------------------CCCcchh
Q 005400 603 ASNVLLDN-DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG----------------------LFSVKSD 659 (698)
Q Consensus 603 p~NILl~~-~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------------------~~~~k~D 659 (698)
|+|||+++ ++.+||+|||+++.+..... .......+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 57999999999986543221 112235789999999965322 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCC
Q 005400 660 VFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 660 VwSlGvil~elltG~~pf~ 678 (698)
||||||+||||+++..++.
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999776543
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=191.13 Aligned_cols=112 Identities=48% Similarity=0.782 Sum_probs=99.5
Q ss_pred CccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CCCCceEEe
Q 005400 25 QSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWS 103 (698)
Q Consensus 25 ~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~~~~~~ws 103 (698)
+.|.++++|+|+++.|++|||.+... ..+.+|||...+ +++||+||++.|+.++ ..|.+++||+|+| +.+|.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~ 78 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWS 78 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEE
Confidence 57889999999999999999998755 578999999887 8999999999998664 7899999999998 888999999
Q ss_pred eccCCCCCCcEEEEeccceEEEecCCCCceeeeccCC
Q 005400 104 SNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (698)
Q Consensus 104 ~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~ 140 (698)
|+++......+|+|+|+|||||++.. +.++||||||
T Consensus 79 S~t~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~~ 114 (114)
T smart00108 79 SNTTGANGNYVLVLLDDGNLVIYDSD-GNFLWQSFDY 114 (114)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCC-CCEEeCCCCC
Confidence 99863345678999999999999987 6899999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=242.79 Aligned_cols=196 Identities=29% Similarity=0.430 Sum_probs=157.4
Q ss_pred ccCceeeeccee-EEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 477 SYNKLGEGGFGP-VYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 477 ~~~~LG~G~fG~-Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
..+.+|.|..|+ ||+|.. +|+.||||++-. +...-..+|+..++.- +|||||++++.-.+++..||..|.|. .
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~ 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C 587 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence 345678988874 699998 789999999853 2334567899999888 59999999999999999999999995 5
Q ss_pred ChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC---C--CceEEeecCCCcccCCC
Q 005400 555 SLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---D--MNPKISDFGMARIFGGD 628 (698)
Q Consensus 555 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~--~~~kl~DFgla~~~~~~ 628 (698)
+|.+++..... .....-...+.+..|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.+...
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 88888865311 111111345678899999999999987 999999999999975 2 57999999999987654
Q ss_pred cc-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCC
Q 005400 629 EI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG-KKNWRFS 680 (698)
Q Consensus 629 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG-~~pf~~~ 680 (698)
.. ........||.+|+|||.+....-+..+||||+||++|+.++| ..||...
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 32 2224457899999999999998888899999999999999997 8999743
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=213.46 Aligned_cols=194 Identities=29% Similarity=0.380 Sum_probs=159.8
Q ss_pred cCccccCceeeecceeEEEEE-eccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe------CCe
Q 005400 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ------ADE 543 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~-~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~------~~~ 543 (698)
.+|..++.++.|.- .|-.+- ...+++||+|++... .....+...+|...+..++|+||++++.++.- ..+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888887 444443 235899999998654 34456677899999999999999999999853 345
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.|+|||+|. .+|...+.- .++-.++..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 799999995 467666642 2666778899999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.-... -.....+.|..|.|||++.+..+.+.+||||+||++.||++|+..|..
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 65433 233457889999999999988899999999999999999999999874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-22 Score=198.04 Aligned_cols=183 Identities=36% Similarity=0.622 Sum_probs=158.2
Q ss_pred eeeecceeEEEEEecc-ccEEEEEEecCCCCc-chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCChhH
Q 005400 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 558 (698)
||+|.+|.||++...+ ++++++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999854 889999999765432 35679999999999999999999999999999999999999999999
Q ss_pred HHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-CCceEEeecCCCcccCCCccccccccc
Q 005400 559 FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGGDEIQTNTHKV 637 (698)
Q Consensus 559 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFgla~~~~~~~~~~~~~~~ 637 (698)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 34789999999999999999999998 999999999999999 89999999999987543321 12224
Q ss_pred cccccccChhcccCC-CCCcchhHHHHHHHHHHH
Q 005400 638 VGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEI 670 (698)
Q Consensus 638 ~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~el 670 (698)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 578899999998877 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=225.69 Aligned_cols=206 Identities=19% Similarity=0.258 Sum_probs=174.2
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC------CCeeeeEEEEEEeCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ------HRNLVKLLGCCIQADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~------H~nIv~l~~~~~~~~~ 543 (698)
.-.+|.+....|+|-|+.|.+|... .|+.||||++.... --.+.=+.|++||++|+ .-++++++-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4467888888999999999999864 48899999997642 22234467999999995 3489999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC-CceEEeecCCC
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMA 622 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFgla 622 (698)
+|||+|-+ .-+|.+.|.+-+..--|....+..++.|++-||..|-..+ |+|.||||.|||+++. ..+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999987 4578899988777777899999999999999999999988 9999999999999865 46899999999
Q ss_pred cccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~ 685 (698)
.........+ ..-+.-|.|||++.+-+|+...|+||.||.||||.||+..|........
T Consensus 585 ~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 585 SFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred cccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 8876554332 3456689999999999999999999999999999999999987655433
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-23 Score=200.42 Aligned_cols=194 Identities=22% Similarity=0.409 Sum_probs=155.1
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEE-EEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLG-CCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~-~~~~~~~~~lV~E 549 (698)
+.|.+.+.||+|.||.+-+++++. .+.+++|.+...- ...++|.+|...--.+ .|.||+.-++ .|+..+.++.++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 568888999999999999999865 5678999886542 3457888888765555 5899988665 4677788889999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc--CCCceEEeecCCCcccCC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDMNPKISDFGMARIFGG 627 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFgla~~~~~ 627 (698)
|++.|+|..-+.. .-+.+....+++.|++.|+.|+|+++ +||||||.+|||+- +..++||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999877633 33667777889999999999999998 99999999999993 455899999999876432
Q ss_pred CccccccccccccccccChhcccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEG-----LFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
. .....-+..|.|||..... ...+.+|||.||++++..+||+.||+-
T Consensus 176 t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 176 T-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred e-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 2 1223346679999976432 246779999999999999999999983
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-23 Score=210.36 Aligned_cols=202 Identities=26% Similarity=0.454 Sum_probs=166.1
Q ss_pred HHHhhcCccccCceeeecceeEEEEEecc----ccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCC
Q 005400 468 IAKATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQAD 542 (698)
Q Consensus 468 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~ 542 (698)
+....+.|..+++||+|.|++||++.+.. .+.||+|.+...+ ....+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 33445668889999999999999997643 5789999987653 3456899999999995 999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-CCceEEeecCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGM 621 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFgl 621 (698)
...+|+||++.....+++.. ++..++..+++.+++||+++|..+ ||||||||.|+|.+. -+.-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999998888743 668888999999999999999999 999999999999984 46789999999
Q ss_pred CcccCCCc------------------------------------------cccccccccccccccChhcccCC-CCCcch
Q 005400 622 ARIFGGDE------------------------------------------IQTNTHKVVGTYGYMSPEYAAEG-LFSVKS 658 (698)
Q Consensus 622 a~~~~~~~------------------------------------------~~~~~~~~~gt~~y~APE~l~~~-~~~~k~ 658 (698)
|....... .........||+||.|||++... ..++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87211000 00000124699999999988654 578999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCC
Q 005400 659 DVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 659 DVwSlGvil~elltG~~pf~~~ 680 (698)
||||.|||++-+++++.||-..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ceeeccceeehhhccccccccC
Confidence 9999999999999999999643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=210.44 Aligned_cols=167 Identities=18% Similarity=0.212 Sum_probs=128.7
Q ss_pred HhhcCccccCceeeecceeEEEEEec--cccEEEEEEecCC-----CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~g~~vavK~l~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~ 542 (698)
...++|.+.+.||+|+||+||+|++. +++.+|||++... .....+.|.+|++++++++|+|+++.+.. ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34577999999999999999999875 4677899987533 11234568999999999999999863322 24
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC-CCCCEEEcCCCceEEeecCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDL-KASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DFgl 621 (698)
..+|||||+++++|... . .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++++||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~--~--~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA--R--PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHh--C--cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 67999999999999632 1 10 1 1467889999999999988 999999 99999999999999999999
Q ss_pred CcccCCCccccc------cccccccccccChhcccCC
Q 005400 622 ARIFGGDEIQTN------THKVVGTYGYMSPEYAAEG 652 (698)
Q Consensus 622 a~~~~~~~~~~~------~~~~~gt~~y~APE~l~~~ 652 (698)
++.+........ .....+++.|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 997654321111 1235688899999988654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-23 Score=224.79 Aligned_cols=208 Identities=25% Similarity=0.417 Sum_probs=178.6
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..++|+.+.++|.|.+|.|||++.. .++..|+|.++........-...|+-+++..+|||||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3467888899999999999999874 588899999988777777778899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+.+|+|.+.-+- ..++++.++....+..++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+..+...-
T Consensus 93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999877632 345888888899999999999999998 8999999999999999999999999987654322
Q ss_pred cccccccccccccccChhcc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 005400 630 IQTNTHKVVGTYGYMSPEYA---AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l---~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~ 686 (698)
. ......||+.|||||+. +.+.|..++|||++|+...|+---+.|--..+|....
T Consensus 167 ~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l 224 (829)
T KOG0576|consen 167 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL 224 (829)
T ss_pred h--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH
Confidence 1 12236899999999976 5667999999999999999999888887777775443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=201.46 Aligned_cols=133 Identities=25% Similarity=0.328 Sum_probs=109.5
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC-----C---CeeeeEEEEEEe--
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----H---RNLVKLLGCCIQ-- 540 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-----H---~nIv~l~~~~~~-- 540 (698)
..+|.+.++||-|.|++||++... ..+-||+|+.+. .....+..+.||++|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 367889999999999999999875 467899999854 3345677899999999984 3 479999999975
Q ss_pred --CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 541 --ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 541 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
+.+.+||+|++. -+|..+|..... .-++...+.+|++||+.||.|||.++ .|||-||||+||||-
T Consensus 156 pNG~HVCMVfEvLG-dnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLG-DNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhhh-hHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 468999999994 456666654333 34888999999999999999999987 699999999999993
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=198.34 Aligned_cols=203 Identities=24% Similarity=0.323 Sum_probs=164.8
Q ss_pred CccccCceeeecceeEEEEEeccc--cEEEEEEecCCCCcchHHHHHHHHHHhhcCC----CeeeeEEEEE-EeCCeeEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVEG--QEIAVKRLSKGSGQGMEEFKNEVTLIARLQH----RNLVKLLGCC-IQADESML 546 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~g--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H----~nIv~l~~~~-~~~~~~~l 546 (698)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999987553 4788887765433322368889999988873 5888888888 46778899
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC-----CceEEeecCC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-----MNPKISDFGM 621 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~DFgl 621 (698)
||+.+ +.+|.++..... ...++..+.+.|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99887 778888765444 456899999999999999999999998 9999999999999754 4699999999
Q ss_pred Cc--ccCCCc------cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 622 AR--IFGGDE------IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 622 a~--~~~~~~------~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++ ...... ........+||.+|.+++...+.+.+.+.|+||++.++.|++.|..||+...
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 98 321111 1111223569999999999999999999999999999999999999997544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-19 Score=187.02 Aligned_cols=202 Identities=33% Similarity=0.508 Sum_probs=169.2
Q ss_pred ccccCceeeecceeEEEEEeccccEEEEEEecCCCCc---chHHHHHHHHHHhhcCCC-eeeeEEEEEEeCCeeEEEEEe
Q 005400 475 FASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ---GMEEFKNEVTLIARLQHR-NLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~H~-nIv~l~~~~~~~~~~~lV~E~ 550 (698)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566778999999999999886 78899998766332 467899999999999988 799999999777778999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-ceEEeecCCCcccCCCc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDE 629 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFgla~~~~~~~ 629 (698)
+.++++..++........+.......++.+++.++.|+|+.+ ++|||+||+||+++... .++++|||++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643321125888899999999999999999998 99999999999999988 79999999998654332
Q ss_pred ccc----ccccccccccccChhcccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQT----NTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~----~~~~~~gt~~y~APE~l~~---~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... ......|+..|+|||.+.. ..+....|+||+|++++++++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 2344789999999999987 578889999999999999999999976543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-20 Score=222.94 Aligned_cols=148 Identities=20% Similarity=0.220 Sum_probs=112.1
Q ss_pred hcCC-CeeeeEEEEE-------EeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005400 525 RLQH-RNLVKLLGCC-------IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596 (698)
Q Consensus 525 ~l~H-~nIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 596 (698)
.++| +||+++++.| .+....++++|++ .++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5777788877 2334567788887 55999998543 345899999999999999999999988 9
Q ss_pred eecCCCCCCEEEcCC-------------------CceEEeecCCCcccCCCcc--------------ccccccccccccc
Q 005400 597 IHRDLKASNVLLDND-------------------MNPKISDFGMARIFGGDEI--------------QTNTHKVVGTYGY 643 (698)
Q Consensus 597 vH~Dlkp~NILl~~~-------------------~~~kl~DFgla~~~~~~~~--------------~~~~~~~~gt~~y 643 (698)
+||||||+||||+.. +.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4456666666653211000 0000113578889
Q ss_pred cChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 644 ~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
||||++.+..++.++|||||||+||||++|..|+.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 99999999999999999999999999999998875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=175.64 Aligned_cols=139 Identities=17% Similarity=0.138 Sum_probs=108.0
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCc--c-------hHH-----------------HHHHHHHHhhcCCCee
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--G-------MEE-----------------FKNEVTLIARLQHRNL 531 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~--~-------~~~-----------------~~~Ei~il~~l~H~nI 531 (698)
.+.||+|+||.||+|...+|+.||+|+++..... . ... ...|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999888999999999754211 1 112 2349999999988776
Q ss_pred eeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeecCCCCCCEEEcC
Q 005400 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL-HQDSRMRIIHRDLKASNVLLDN 610 (698)
Q Consensus 532 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~NILl~~ 610 (698)
.....+. ....+|||||++++++....... ..++..+...++.|++.+|.++ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433322 22348999999998776543222 3478899999999999999999 6777 99999999999998
Q ss_pred CCceEEeecCCCccc
Q 005400 611 DMNPKISDFGMARIF 625 (698)
Q Consensus 611 ~~~~kl~DFgla~~~ 625 (698)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=172.54 Aligned_cols=204 Identities=22% Similarity=0.306 Sum_probs=166.5
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCC-CeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H-~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|.++++||.|+||.+|.|.. .+|.+||||.-+.... .-++.-|.++.+.++| ..|..+..+..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 47899999999999999999975 5799999998654432 2357789999999975 688888889899999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC---CCceEEeecCCCcccC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFG 626 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFgla~~~~ 626 (698)
.+ +-+|.++..--.+ .++..+++-++.|++.-++|+|..+ ++||||||.|.|+.- ...+.++||||++.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 6678776643222 3788899999999999999999998 999999999999963 4569999999998764
Q ss_pred CCcc-----ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 627 GDEI-----QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 627 ~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
.... ........||.+|.+-....+.+.+.+.|+=|+|.+|.++.-|..||+.-.+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 3221 11122367999999888777778889999999999999999999999865554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=176.97 Aligned_cols=203 Identities=21% Similarity=0.317 Sum_probs=167.1
Q ss_pred hcCccccCceeeecceeEEEEE-eccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.-+|.+.++||+|.||.++.|+ +-+++.||||.-...+ ..-++..|.+..+.|. .++|...+-+-.++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3568999999999999999997 4578999999754332 2346788999988885 7899999988888989999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-----CCceEEeecCCCcc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARI 624 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFgla~~ 624 (698)
.+ +-+|+++..-.. ..++..++..+|.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 98 667777653322 23889999999999999999999998 999999999999963 34599999999998
Q ss_pred cCCCcccc-----ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 625 FGGDEIQT-----NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 625 ~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
........ ......||.+||+=....+.+.+.+.|+-|||.++++.|-|..||+....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 75433211 11236799999999999999999999999999999999999999986543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=179.31 Aligned_cols=171 Identities=15% Similarity=0.169 Sum_probs=133.2
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchH---H------HHHHHHHHhhcCCCeeeeEEEEEEeC
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME---E------FKNEVTLIARLQHRNLVKLLGCCIQA 541 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~---~------~~~Ei~il~~l~H~nIv~l~~~~~~~ 541 (698)
..++|...+.+|.|+||.||.... +++.+|+|.+........+ . +.+|++.+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368899999999999999999755 6778999999755322222 2 67899999999999999998886543
Q ss_pred --------CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc
Q 005400 542 --------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (698)
Q Consensus 542 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (698)
...+|||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||++|+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977631 222 24558999999999998 99999999999999988
Q ss_pred eEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHH
Q 005400 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIV 671 (698)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ell 671 (698)
++|+|||.......... ...++....+..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998765321110 011455566778999999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=170.07 Aligned_cols=141 Identities=18% Similarity=0.218 Sum_probs=111.3
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCc--c------------------------hHHHHHHHHHHhhcCCCee
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--G------------------------MEEFKNEVTLIARLQHRNL 531 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~--~------------------------~~~~~~Ei~il~~l~H~nI 531 (698)
.+.||+|++|.||+|+..+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998764211 0 1123578999999999987
Q ss_pred eeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEEcC
Q 005400 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDN 610 (698)
Q Consensus 532 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~ 610 (698)
.....+... ..+|||||++++++....... ..++..+...++.+++.++.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 555444332 348999999988654432222 236778889999999999999999 77 99999999999999
Q ss_pred CCceEEeecCCCcccCC
Q 005400 611 DMNPKISDFGMARIFGG 627 (698)
Q Consensus 611 ~~~~kl~DFgla~~~~~ 627 (698)
+++++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.6e-20 Score=175.83 Aligned_cols=196 Identities=24% Similarity=0.390 Sum_probs=156.3
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
-+|.+...|+.|+|++ .|..+++|++... .....+.|.+|.-.|+.+.||||+++++.|..+.+..++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 4788999999999999 5677777877543 233446799999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccccccc
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (698)
...|+.+. .-..+-.+..+++.++++||+|||+..+ -|.---|.++.+++|++.+++|+- +-+++ .-....
T Consensus 275 ynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kf------sfqe~g 345 (448)
T KOG0195|consen 275 YNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQEVG 345 (448)
T ss_pred HHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cccee------eeeccc
Confidence 99997643 3457778889999999999999999873 255557899999999999988852 11111 001111
Q ss_pred ccccccccChhcccCCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005400 637 VVGTYGYMSPEYAAEGLFS---VKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684 (698)
Q Consensus 637 ~~gt~~y~APE~l~~~~~~---~k~DVwSlGvil~elltG~~pf~~~~~~~ 684 (698)
..-.+.||+||.+...+-+ ..+|+|||+++||||.|.+.||....|.|
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 3346899999998766533 46899999999999999999998766643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.8e-18 Score=163.08 Aligned_cols=184 Identities=18% Similarity=0.133 Sum_probs=137.8
Q ss_pred ccCceeeecceeEEEEEeccccEEEEEEecCCCCc----chHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEEec
Q 005400 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ----GMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~----~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
+...|++|+||+||.+.- .+++++.+.+.....- ....+.+|+++|++++ |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997765 6788888887654321 1125789999999995 5789999886 4569999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC-CCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDL-KASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
++.+|...+.. ....++.+++++|.++|+++ |+|||| ||.|||+++++.++|+|||++........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99988644311 11356789999999999998 999999 79999999999999999999986443221
Q ss_pred c----cc-------cccccccccccChhcccCC-CCC-cchhHHHHHHHHHHHHhCCCCCC
Q 005400 631 Q----TN-------THKVVGTYGYMSPEYAAEG-LFS-VKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 631 ~----~~-------~~~~~gt~~y~APE~l~~~-~~~-~k~DVwSlGvil~elltG~~pf~ 678 (698)
. .. ......++.|++|+-..-. ..+ ...+.++-|.-+|.++|++.++-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00 1112367788888743222 223 56799999999999999998864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-18 Score=166.59 Aligned_cols=107 Identities=20% Similarity=0.197 Sum_probs=93.3
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
|+|.+++... ...+++.+++.++.|+++||+|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6788888543 335899999999999999999999875 999999999999999 99988654321
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
..||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 35889999999999999999999999999999999999999654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.7e-17 Score=158.70 Aligned_cols=137 Identities=19% Similarity=0.304 Sum_probs=105.6
Q ss_pred ccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhc-----CCCeeeeEEEEEEeCC---e-eEEE
Q 005400 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-----QHRNLVKLLGCCIQAD---E-SMLI 547 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-----~H~nIv~l~~~~~~~~---~-~~lV 547 (698)
..+.||+|+||.||. +++....+||++........+.+.+|+++++.+ .||||++++++++++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 346899999999996 433333479988765445567899999999999 5799999999998874 3 3378
Q ss_pred EEe--cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceeecCCCCCCEEEcC----CCceEEee-c
Q 005400 548 YEY--MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI-LYLHQDSRMRIIHRDLKASNVLLDN----DMNPKISD-F 619 (698)
Q Consensus 548 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~D-F 619 (698)
+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +.+++|+| |
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5589999999542 14444 35577778777 9999998 999999999999974 34799999 5
Q ss_pred CCCcc
Q 005400 620 GMARI 624 (698)
Q Consensus 620 gla~~ 624 (698)
|....
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 54443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.3e-18 Score=193.19 Aligned_cols=201 Identities=24% Similarity=0.373 Sum_probs=157.1
Q ss_pred cCceeeecceeEEEEEec-cccEEEEEEec----CC-C-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLS----KG-S-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~----~~-~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.+.+|.|++|.|+..... .....+.|... .. . ......+..|+.+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 468999999977766532 23333334332 11 1 11122266677788888999998887777766666666999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++ +|..++... ..+...++..+++|++.|+.|+|+.+ |.|||+|++|+++..++.+||+|||.+..+.....
T Consensus 403 ~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred ccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999 998888543 34788888999999999999999999 99999999999999999999999999987654433
Q ss_pred c--cccccccccccccChhcccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 005400 631 Q--TNTHKVVGTYGYMSPEYAAEGLFSVK-SDVFSFGVLVLEIVSGKKNWRFSHPDHD 685 (698)
Q Consensus 631 ~--~~~~~~~gt~~y~APE~l~~~~~~~k-~DVwSlGvil~elltG~~pf~~~~~~~~ 685 (698)
. .......|...|+|||++....|++. .||||.|+++..|++|+.||.......+
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 2 34455789999999999999999875 7999999999999999999987665533
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.8e-16 Score=156.35 Aligned_cols=134 Identities=21% Similarity=0.330 Sum_probs=113.8
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCc--------chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+.||+|++|.||+|+. .|..+++|+....... ....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6788999986543211 123577899999999999998888887788889999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
+++++|.+++.... . .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999998874321 2 77889999999999999998 99999999999999 78999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.8e-18 Score=182.98 Aligned_cols=185 Identities=28% Similarity=0.351 Sum_probs=153.3
Q ss_pred eeeecceeEEEEEe----ccccEEEEEEecCCCC--cchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 481 LGEGGFGPVYKGTL----VEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 481 LG~G~fG~Vy~g~~----~~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+|+|.+|.|+.++- ..|.-+|+|.+++... ........|..++...+ ||.+|++...++.+...++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999998753 3466788888876521 11225667888899997 99999999999999999999999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
|.|...+.+. ...+..........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 82 g~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 82 GDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred chhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 9998777433 33556666667778999999999998 99999999999999999999999999987532221
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.+||..|||||++. .....+|.||||++++||+||-.||..
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999997 567789999999999999999999985
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.3e-16 Score=152.88 Aligned_cols=131 Identities=24% Similarity=0.365 Sum_probs=107.7
Q ss_pred ceeeecceeEEEEEeccccEEEEEEecCCCC--c------chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--Q------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 480 ~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--~------~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.||+|++|.||+|.. +++++++|....... . ..+.+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 678899998654321 1 1245778999999999887766666666777789999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
++++|.+.+..... .++.+++++|.+||+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999887643211 78899999999999998 99999999999999 889999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-16 Score=183.69 Aligned_cols=198 Identities=23% Similarity=0.269 Sum_probs=156.8
Q ss_pred HHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcC---CCeeeeEEEEEEeCCeeE
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESM 545 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~---H~nIv~l~~~~~~~~~~~ 545 (698)
+.-.+.|.|.+.||+|+||+||+|...+|+.||+|+=+....= +|.--.+++.+|+ -+-|..+..+..-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3445678899999999999999999888999999987654321 1222233444444 233444455555677789
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-------CCCceEEee
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-------NDMNPKISD 618 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-------~~~~~kl~D 618 (698)
||+||.+.|+|.+++. ..+.++|.-...++.|+++.++.||..+ |||+||||.|.||. +..-++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999995 4556899999999999999999999998 99999999999994 234589999
Q ss_pred cCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~ 675 (698)
||-+--+.--.........++|..+--+|+..+.+++..+|.|.|+-+++-||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999865543222234455788999999999999999999999999999999999974
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.5e-16 Score=156.98 Aligned_cols=145 Identities=19% Similarity=0.169 Sum_probs=111.6
Q ss_pred cCccccCceeeecceeEEEEE--eccccEEEEEEecCCCCc------------------------chHHHHHHHHHHhhc
Q 005400 473 DNFASYNKLGEGGFGPVYKGT--LVEGQEIAVKRLSKGSGQ------------------------GMEEFKNEVTLIARL 526 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~Ei~il~~l 526 (698)
.-|.+.+.||+|++|.||+|+ ..+|+.||+|+++..... ....+..|++++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347888999999999999998 567999999998754210 012356899999999
Q ss_pred CCCe--eeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCC
Q 005400 527 QHRN--LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKAS 604 (698)
Q Consensus 527 ~H~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 604 (698)
.+.. +.++++. ...++||||+++.+|....... ..+...+...++.|++.++++||+.+ .++||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 7533 3444443 2358999999998886654222 23455667889999999999999876 4999999999
Q ss_pred CEEEcCCCceEEeecCCCcccCC
Q 005400 605 NVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 605 NILl~~~~~~kl~DFgla~~~~~ 627 (698)
||+++ +++++|+|||.+.....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCC
Confidence 99999 88999999999886543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-17 Score=186.14 Aligned_cols=199 Identities=20% Similarity=0.267 Sum_probs=151.7
Q ss_pred CccccCceeeecceeEEEEEeccccEEEEEEecCCC-CcchHHHHHHHHHH--hhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS-GQGMEEFKNEVTLI--ARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~il--~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++...+.||++.|=+|.+++.++|. |+||++-+.. .-..+.|.++++-+ ...+|||.+++.-.-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566689999999999999998887 9999987664 34455565554444 455899999988776666667788788
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC--CC
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG--GD 628 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~--~~ 628 (698)
+.+ +|.+.| ..++++...+...|+.|+++||.-+|..+ |+|+|||.+|||+++-.-+.|+||..-+... .+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 754 555555 46678889999999999999999999998 9999999999999999999999998865432 11
Q ss_pred ---ccccccccccccccccChhcccC----------C-CCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 629 ---EIQTNTHKVVGTYGYMSPEYAAE----------G-LFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 629 ---~~~~~~~~~~gt~~y~APE~l~~----------~-~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
+........+.-..|+|||.+-. . ..+++.||||+||++.||++ |+++|..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 11111111233457999997633 1 15778999999999999998 68888643
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.7e-16 Score=174.52 Aligned_cols=139 Identities=20% Similarity=0.325 Sum_probs=112.5
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEE-ecCCCC-------cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKR-LSKGSG-------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~-l~~~~~-------~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~ 542 (698)
....|...++||+|+||.||+|.+... .+++|+ +.+... ...+.+.+|++++.+++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344456678999999999999987544 444443 222111 12346889999999999999998888888878
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 8899999999999988873 34678999999999999998 9999999999999 5779999999999
Q ss_pred ccc
Q 005400 623 RIF 625 (698)
Q Consensus 623 ~~~ 625 (698)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=150.79 Aligned_cols=142 Identities=20% Similarity=0.199 Sum_probs=109.9
Q ss_pred HHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCc----------------------chHHHHHHHHHHhhc
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ----------------------GMEEFKNEVTLIARL 526 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~----------------------~~~~~~~Ei~il~~l 526 (698)
......|.+.+.||+|+||.||++...+|+.||||++...... ....+..|+.++..+
T Consensus 11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 3333347777899999999999999888999999987543210 112356788899998
Q ss_pred CCCe--eeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCC
Q 005400 527 QHRN--LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKAS 604 (698)
Q Consensus 527 ~H~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 604 (698)
.|++ +++.++ ....++||||+++++|...... .....++.++++++.++|+.+ ++|+||+|+
T Consensus 91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 8774 444443 2455899999999998665310 234578899999999999987 999999999
Q ss_pred CEEEcCCCceEEeecCCCcccC
Q 005400 605 NVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 605 NILl~~~~~~kl~DFgla~~~~ 626 (698)
||++++++.++|+|||++....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.6e-16 Score=158.26 Aligned_cols=204 Identities=23% Similarity=0.339 Sum_probs=133.6
Q ss_pred CccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcC----------CCeeeeEEEEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ----------HRNLVKLLGCCI 539 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~----------H~nIv~l~~~~~ 539 (698)
.+...+.||.|+++.||.+++.+ ++++|+|++... .....+++++|.-.+..+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34455689999999999999865 899999987543 2345667777776655543 223333332221
Q ss_pred ---------eCC--------eeEEEEEecCCCChhHHHh---hccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceee
Q 005400 540 ---------QAD--------ESMLIYEYMPNKSLDFFIF---DQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598 (698)
Q Consensus 540 ---------~~~--------~~~lV~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 598 (698)
... +.+++|+-+ .++|..++. .... ...+....++.+..|+++.+++||..+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 236677777 567766643 2111 122445566778899999999999999 999
Q ss_pred cCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccC--------CCCCcchhHHHHHHHHHHH
Q 005400 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE--------GLFSVKSDVFSFGVLVLEI 670 (698)
Q Consensus 599 ~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~k~DVwSlGvil~el 670 (698)
+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999877654322111 234578999997643 2478899999999999999
Q ss_pred HhCCCCCCCCCCCCcc
Q 005400 671 VSGKKNWRFSHPDHDH 686 (698)
Q Consensus 671 ltG~~pf~~~~~~~~~ 686 (698)
.+++.||....+....
T Consensus 244 WC~~lPf~~~~~~~~~ 259 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADP 259 (288)
T ss_dssp HHSS-STCCCGGGSTS
T ss_pred HHccCCCCCCCccccc
Confidence 9999999876655433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.2e-15 Score=160.64 Aligned_cols=157 Identities=26% Similarity=0.464 Sum_probs=128.7
Q ss_pred HhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 005400 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (698)
Q Consensus 523 l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (698)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.... -.+++.....++++|++||+|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 356889999999999999999999999999999999997633 34899999999999999999999875 23999999
Q ss_pred CCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCC-------CCcchhHHHHHHHHHHHHhCCC
Q 005400 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL-------FSVKSDVFSFGVLVLEIVSGKK 675 (698)
Q Consensus 603 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-------~~~k~DVwSlGvil~elltG~~ 675 (698)
+.|.++|....+||+|||+..+..............-..-|.|||.++... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988763211111111123445799999987631 4677999999999999999999
Q ss_pred CCCCCCCC
Q 005400 676 NWRFSHPD 683 (698)
Q Consensus 676 pf~~~~~~ 683 (698)
||......
T Consensus 157 ~~~~~~~~ 164 (484)
T KOG1023|consen 157 PFDLRNLV 164 (484)
T ss_pred cccccccc
Confidence 99875444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.8e-14 Score=132.98 Aligned_cols=135 Identities=22% Similarity=0.231 Sum_probs=113.9
Q ss_pred ccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCC--CeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H--~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
+++.|++|.++.||++...+ +.+++|....... ...+..|+.++..++| .++++++.+....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999844 7899999865433 4678999999999976 58999998888778899999999988
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
.+..+ +......++.+++++|++||......++|+|++|+||++++.+.++++||+.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77432 4556677889999999999987545699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.2e-14 Score=139.74 Aligned_cols=137 Identities=21% Similarity=0.252 Sum_probs=98.5
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCc--chHH----------------------HHHHHHHHhhcCCC--ee
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--GMEE----------------------FKNEVTLIARLQHR--NL 531 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~Ei~il~~l~H~--nI 531 (698)
.+.||+|+||.||++...+++.||||++...... .... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998653211 1111 13566666666443 24
Q ss_pred eeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEEcC
Q 005400 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDN 610 (698)
Q Consensus 532 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~ 610 (698)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 246899999999654322111111 11 5567899999999999999 76 99999999999999
Q ss_pred CCceEEeecCCCcccC
Q 005400 611 DMNPKISDFGMARIFG 626 (698)
Q Consensus 611 ~~~~kl~DFgla~~~~ 626 (698)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-15 Score=119.05 Aligned_cols=66 Identities=52% Similarity=1.111 Sum_probs=58.4
Q ss_pred ccCCCCcceeeecCCCCCCcccccccccHHHHHhhcCCCCCcccccCccCCCCCcceeeeccccccc
Q 005400 324 CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDM 390 (698)
Q Consensus 324 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~C~C~a~~~~~~~~~~~~c~~w~g~l~~~ 390 (698)
|+.+|+|.++.+|++|++....+..+.++++|++.|++||+|+||+|.+.. ++++|.+|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 555699999999999999877776779999999999999999999997655 778999999999884
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.1e-13 Score=137.84 Aligned_cols=135 Identities=21% Similarity=0.278 Sum_probs=104.1
Q ss_pred Ccee-eecceeEEEEEeccccEEEEEEecCCC-------------CcchHHHHHHHHHHhhcCCCee--eeEEEEEEeCC
Q 005400 479 NKLG-EGGFGPVYKGTLVEGQEIAVKRLSKGS-------------GQGMEEFKNEVTLIARLQHRNL--VKLLGCCIQAD 542 (698)
Q Consensus 479 ~~LG-~G~fG~Vy~g~~~~g~~vavK~l~~~~-------------~~~~~~~~~Ei~il~~l~H~nI--v~l~~~~~~~~ 542 (698)
..|| .|+.|+||++.. .++.++||++.... ......+.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 3687 899999999987 47789999875321 1123457889999999998875 66777654432
Q ss_pred e----eEEEEEecCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEe
Q 005400 543 E----SMLIYEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (698)
Q Consensus 543 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 617 (698)
. .++|+|++++ .+|..++... .++.. .+.+++.+|.+||+.+ |+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 6888877432 24433 3568999999999998 9999999999999998899999
Q ss_pred ecCCCccc
Q 005400 618 DFGMARIF 625 (698)
Q Consensus 618 DFgla~~~ 625 (698)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2e-14 Score=162.41 Aligned_cols=169 Identities=23% Similarity=0.368 Sum_probs=121.7
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.+|..++.|..|++|.||..+++. .+++|+|+-+... -+++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCccee-------------------
Confidence 568888999999999999999865 5678885432211 0111 33333445444
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC----
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG---- 627 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~---- 627 (698)
|+=...+...+ .++. +++.+++|||+.+ |+|||+||.|.+|+.-|++|+.|||+.+....
T Consensus 136 --gDc~tllk~~g---~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKNIG---PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcccCC---CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 22222232211 2332 2278999999998 99999999999999999999999999765311
Q ss_pred ----Ccccc-----ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005400 628 ----DEIQT-----NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684 (698)
Q Consensus 628 ----~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~ 684 (698)
..+.. ....++||+.|+|||++...-|+..+|+|++|+|+||.+-|..||....|++
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 11111 1123689999999999999999999999999999999999999998776554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.7e-15 Score=154.81 Aligned_cols=124 Identities=27% Similarity=0.434 Sum_probs=107.6
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++.|+++...+|.++|.........++...+.++.|++.++.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468899999999999999876666678889999999999999999 55 899999999999999999999999998
Q ss_pred cccCCCc----cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh
Q 005400 623 RIFGGDE----IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672 (698)
Q Consensus 623 ~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt 672 (698)
....... .........||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7654433 1112223679999999999999999999999999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=6e-13 Score=135.63 Aligned_cols=145 Identities=22% Similarity=0.372 Sum_probs=106.4
Q ss_pred CCCeeeeEEEEEEe---------------------------CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHH
Q 005400 527 QHRNLVKLLGCCIQ---------------------------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579 (698)
Q Consensus 527 ~H~nIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 579 (698)
+|||||++.++|.+ +..+|+||...+ .+|..++..+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 68999988877642 234678888775 46777775432 45555667889
Q ss_pred HHHHHHHHHHhCCCCceeecCCCCCCEEEc--CCC--ceEEeecCCCcccCCC----ccccccccccccccccChhcccC
Q 005400 580 GIARGILYLHQDSRMRIIHRDLKASNVLLD--NDM--NPKISDFGMARIFGGD----EIQTNTHKVVGTYGYMSPEYAAE 651 (698)
Q Consensus 580 ~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~~kl~DFgla~~~~~~----~~~~~~~~~~gt~~y~APE~l~~ 651 (698)
|+++|+.|||.++ |.|||+|+.|||+. +|. ...|+|||++---... .+....-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999993 333 4789999986432211 11122223567888999998754
Q ss_pred CC------CCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 652 GL------FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 652 ~~------~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.+ .-.|+|.|+.|-+.||+++...||-.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 32 23589999999999999999999953
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=143.44 Aligned_cols=140 Identities=21% Similarity=0.285 Sum_probs=100.3
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCcch----------------------------------------HHHHH
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM----------------------------------------EEFKN 518 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~~ 518 (698)
+.||.|++|.||+|++.+|+.||||+.+....+.. -.|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999865421110 02445
Q ss_pred HHHHHhhcC-----CCeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 005400 519 EVTLIARLQ-----HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR-GILYLHQDS 592 (698)
Q Consensus 519 Ei~il~~l~-----H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 592 (698)
|.+.+.+++ ++++.-..-+.......+|||||+++++|.+........ . .+..++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 665555552 344332222223345679999999999998876432111 2 23456666666 467889887
Q ss_pred CCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
++|+|+||.||+++++++++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.6e-14 Score=157.52 Aligned_cols=206 Identities=23% Similarity=0.360 Sum_probs=161.5
Q ss_pred cCccccCceeeecceeEEEEEecc--ccEEEEEEecCCC--CcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~--g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV 547 (698)
..|...+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 346667789999999998876543 3456666665442 333444556777777776 99999999999999999999
Q ss_pred EEecCCCChhHHHh-hccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeecCCCCCCEEEcCCC-ceEEeecCCCcc
Q 005400 548 YEYMPNKSLDFFIF-DQARATFLDWQKRIHIVGGIARGILYLH-QDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARI 624 (698)
Q Consensus 548 ~E~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFgla~~ 624 (698)
.|+..++++...+. .... ..+.......+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999987773 2211 2344445678899999999999 776 99999999999999999 999999999987
Q ss_pred cCC-Cccccccccccc-cccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 625 FGG-DEIQTNTHKVVG-TYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 625 ~~~-~~~~~~~~~~~g-t~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 665 333333444678 9999999998775 4467899999999999999999999865443
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-12 Score=105.88 Aligned_cols=72 Identities=24% Similarity=0.415 Sum_probs=61.9
Q ss_pred ccCCCCcceeeecCCCCCCcccccccccHHHHHhhcCC---CCCcccccCccCCCCCcceeeecccc-cccccccCCCcc
Q 005400 324 CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK---NCSCTAYANSDVERGGSGCLLWFGDL-MDMKEYNDGGQD 399 (698)
Q Consensus 324 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---~C~C~a~~~~~~~~~~~~c~~w~g~l-~~~~~~~~~~~~ 399 (698)
|...++|.++.+|++|++.. .+++||++.|++ ||+|.||+|.+. +.+|.+|+++| ++++.+.+.+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 44457899999999998754 689999999999 999999998642 35899999999 999888888999
Q ss_pred eEEee
Q 005400 400 LYIRI 404 (698)
Q Consensus 400 ~y~rl 404 (698)
+|+|.
T Consensus 76 Ly~r~ 80 (80)
T cd00129 76 LYENK 80 (80)
T ss_pred eEeEC
Confidence 99984
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.9e-11 Score=114.72 Aligned_cols=131 Identities=20% Similarity=0.186 Sum_probs=97.5
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeee-EEEEEEeCCeeEEEEEecCCCCh
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK-LLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~-l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
++.|+.|.++.||+++. .++.+++|....... ....+..|++++..+.+.++++ ++.+ .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 35789999999999987 478899998754422 2335678999999887655544 4443 23346899999999887
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
.... . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 0 11235678999999999976 23369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.2e-11 Score=102.06 Aligned_cols=80 Identities=46% Similarity=0.950 Sum_probs=65.0
Q ss_pred cccccCC---CCcceeeecCCCCCCcccccccccHHHHHhhcCCCCCcccccCccCCCCCcceeeecccccccccccCCC
Q 005400 321 ELKCRNG---DEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGG 397 (698)
Q Consensus 321 ~~~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~C~C~a~~~~~~~~~~~~c~~w~g~l~~~~~~~~~~ 397 (698)
+++|+.+ ++|..+.++++|+..... .+.++++|++.|++||+|.||+|.+ ++++|.+|.+.+.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 3467544 689999999999875543 6789999999999999999999863 3678999999999977655556
Q ss_pred cceEEeee
Q 005400 398 QDLYIRIA 405 (698)
Q Consensus 398 ~~~y~rla 405 (698)
.++|+|++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 88999974
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.5e-11 Score=130.30 Aligned_cols=146 Identities=17% Similarity=0.225 Sum_probs=93.8
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcc----------------------------------hH---
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG----------------------------------ME--- 514 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~----------------------------------~~--- 514 (698)
..|+. +.||+|++|+||++++++ |+.||||+++....+. .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44665 789999999999999987 9999999997542110 11
Q ss_pred ---HHHHHHHHHhhcC----CCeeeeEEEEEE-eCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHH-H
Q 005400 515 ---EFKNEVTLIARLQ----HRNLVKLLGCCI-QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG-I 585 (698)
Q Consensus 515 ---~~~~Ei~il~~l~----H~nIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L 585 (698)
.+..|+..+.+++ +.+.+.+-.++. -....+|||||++|+.+.++..-.... .+.. .++...++. +
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHHH
Confidence 2344554444442 433344333332 256678999999999997653211111 1211 122222211 2
Q ss_pred HHHHhCCCCceeecCCCCCCEEEcCCC----ceEEeecCCCcccCC
Q 005400 586 LYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFGMARIFGG 627 (698)
Q Consensus 586 ~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFgla~~~~~ 627 (698)
.-++..+ ++|+|+||.||+++.++ +++++|||++..+..
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2233455 99999999999999888 999999999877643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-10 Score=124.38 Aligned_cols=167 Identities=16% Similarity=0.239 Sum_probs=127.3
Q ss_pred EeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHH
Q 005400 493 TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572 (698)
Q Consensus 493 ~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 572 (698)
+..++.+|.|...+.......+...+-++.|+.++||||++++...++....|||+|-+ ..|..++.+. ...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l------~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL------GKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh------HHH
Confidence 34468899999887765555566788899999999999999999999999999999987 3566666432 245
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCC
Q 005400 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652 (698)
Q Consensus 573 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 652 (698)
.....+.||++||.|||+.+ .++|++|.-..|++++.|+.||++|.++........ ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 55677889999999999766 599999999999999999999999998754321111 11112223356666654333
Q ss_pred CCCcchhHHHHHHHHHHHHhC
Q 005400 653 LFSVKSDVFSFGVLVLEIVSG 673 (698)
Q Consensus 653 ~~~~k~DVwSlGvil~elltG 673 (698)
. -..|.|.||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.7e-09 Score=104.83 Aligned_cols=136 Identities=13% Similarity=0.102 Sum_probs=97.9
Q ss_pred CceeeecceeEEEEEecc-------ccEEEEEEecCCC------------C----------cchHHHH----HHHHHHhh
Q 005400 479 NKLGEGGFGPVYKGTLVE-------GQEIAVKRLSKGS------------G----------QGMEEFK----NEVTLIAR 525 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~-------g~~vavK~l~~~~------------~----------~~~~~~~----~Ei~il~~ 525 (698)
..||.|--+.||.|.-.+ +..+|||+.+... . ...+.+. .|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997643 4789999874321 0 0122233 79999999
Q ss_pred cCC--CeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeecCCC
Q 005400 526 LQH--RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL-HQDSRMRIIHRDLK 602 (698)
Q Consensus 526 l~H--~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlk 602 (698)
+.. .++.+++++ ...+|||||+.+..+.....+ ...++..+...+..+++.+|..| |+.+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 853 456666654 567899999987544222211 11244455667889999999999 7777 9999999
Q ss_pred CCCEEEcCCCceEEeecCCCccc
Q 005400 603 ASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 603 p~NILl~~~~~~kl~DFgla~~~ 625 (698)
+.|||++ ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-09 Score=108.91 Aligned_cols=142 Identities=19% Similarity=0.276 Sum_probs=108.3
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCC-cchHHHHHHHHHHhhcCC--CeeeeEEEEEEeCC---eeEEEEEecC
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQH--RNLVKLLGCCIQAD---ESMLIYEYMP 552 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H--~nIv~l~~~~~~~~---~~~lV~E~~~ 552 (698)
+.|+.|..+.||+++..+|+.+++|....... .....+..|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887678999998765432 245678999999999976 34566777765532 5689999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS---------------------------------------- 592 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 592 (698)
+.++...+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888665421 23566677777888888888887531
Q ss_pred -------------CCceeecCCCCCCEEEcC--CCceEEeecCCCcc
Q 005400 593 -------------RMRIIHRDLKASNVLLDN--DMNPKISDFGMARI 624 (698)
Q Consensus 593 -------------~~~ivH~Dlkp~NILl~~--~~~~kl~DFgla~~ 624 (698)
...++|+|++|.||++++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.5e-09 Score=101.56 Aligned_cols=131 Identities=21% Similarity=0.353 Sum_probs=102.0
Q ss_pred CceeeecceeEEEEEeccccEEEEEEe-cCC--CCc-----chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRL-SKG--SGQ-----GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l-~~~--~~~-----~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
..+.+|+-+.+|.+.+. |.++++|.- ++. .++ ..+.-.+|++++.+++--.|....-+..++....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36789999999999763 445666643 222 111 123467899999999877777777777888999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
+++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888543 2456677788888999998 99999999999998764 99999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.1e-10 Score=124.42 Aligned_cols=200 Identities=22% Similarity=0.299 Sum_probs=154.2
Q ss_pred CccccCceee--ecceeEEEEEe---ccccEEEEEEecCC--CCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeE
Q 005400 474 NFASYNKLGE--GGFGPVYKGTL---VEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM 545 (698)
Q Consensus 474 ~f~~~~~LG~--G~fG~Vy~g~~---~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~ 545 (698)
.|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. .+.....=.+|+....+++ |+|.++....++..+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556678999 99999999987 34778999984333 2233333456666666664 999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceeecCCCCCCEEEcCC-CceEEeecC
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR----GILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFG 620 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFg 620 (698)
+-+|.+. .+|..+... ....++...+.....+... ||..+|... ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999986 566665532 3344666667777777777 999999988 9999999999999998 899999999
Q ss_pred CCcccCCCcccccc---ccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 621 MARIFGGDEIQTNT---HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 621 la~~~~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+...++........ ....|...|++||.+ ++.++...|+|++|.+..|..++..++...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 99887655422211 123678899999976 567788999999999999999988777544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.2e-09 Score=98.81 Aligned_cols=143 Identities=24% Similarity=0.338 Sum_probs=108.1
Q ss_pred ccCceeeecceeEEEEEeccccEEEEEE-ecCCC-------CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKR-LSKGS-------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~~g~~vavK~-l~~~~-------~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
.+..|-+|+-+.|+++.. .|+...||. +.+.- .-..+..++|++++.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 557899999999999988 567766664 33221 112345788999999998777777777778888889999
Q ss_pred EecCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC---ceEEeecCCCcc
Q 005400 549 EYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARI 624 (698)
Q Consensus 549 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFgla~~ 624 (698)
||+++ .++.+++...-... ........++..|-+.+.-||..+ |+|+||..+||+|.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 46777776543322 222333678889999999999998 99999999999997655 358999999865
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-09 Score=109.61 Aligned_cols=157 Identities=21% Similarity=0.243 Sum_probs=117.8
Q ss_pred HHHHHhhcCCCeeeeEEEEEEeC-----CeeEEEEEecCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005400 519 EVTLIARLQHRNLVKLLGCCIQA-----DESMLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDS 592 (698)
Q Consensus 519 Ei~il~~l~H~nIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~ 592 (698)
-..-|-++.|.|||+++.++.+. ....++.|||..|++..+|.+..+ ...+......+++-||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34445566799999999988543 346789999999999999976433 334677778899999999999999975
Q ss_pred CCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc---cccccccccccccccChhcccCCCCCcchhHHHHHHHHHH
Q 005400 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE---IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLE 669 (698)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~e 669 (698)
++|+|+++..+.|++..++-+||.--.-. ...... .........+-++|.|||.-.....+..+|||+||+..+|
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred -CccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 77999999999999999988887532111 111000 0111122356789999998777777788999999999999
Q ss_pred HHhCCCCC
Q 005400 670 IVSGKKNW 677 (698)
Q Consensus 670 lltG~~pf 677 (698)
|.-+...-
T Consensus 275 mailEiq~ 282 (458)
T KOG1266|consen 275 MAILEIQS 282 (458)
T ss_pred HHHheecc
Confidence 99887654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.1e-08 Score=94.15 Aligned_cols=125 Identities=27% Similarity=0.331 Sum_probs=81.6
Q ss_pred eEEEEEeccccEEEEEEecCCC-------------Cc-------------chHHHHHHHHHHhhcCCC--eeeeEEEEEE
Q 005400 488 PVYKGTLVEGQEIAVKRLSKGS-------------GQ-------------GMEEFKNEVTLIARLQHR--NLVKLLGCCI 539 (698)
Q Consensus 488 ~Vy~g~~~~g~~vavK~l~~~~-------------~~-------------~~~~~~~Ei~il~~l~H~--nIv~l~~~~~ 539 (698)
.||.|...+|..+|+|+.+... .. ......+|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899998889999999875421 00 022467899999999765 45666644
Q ss_pred eCCeeEEEEEecC--CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 540 QADESMLIYEYMP--NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY-LHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 540 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
...+|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999999 65554443211 1122344567777786555 56777 9999999999999988 9999
Q ss_pred eecCCCccc
Q 005400 617 SDFGMARIF 625 (698)
Q Consensus 617 ~DFgla~~~ 625 (698)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-07 Score=96.80 Aligned_cols=139 Identities=20% Similarity=0.147 Sum_probs=98.5
Q ss_pred eeeecceeEEEEEeccccEEEEEEecCCCCc-ch----------HHHHHHHHHHhhcCCCee--eeEEEEEEe-----CC
Q 005400 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ-GM----------EEFKNEVTLIARLQHRNL--VKLLGCCIQ-----AD 542 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-~~----------~~~~~Ei~il~~l~H~nI--v~l~~~~~~-----~~ 542 (698)
+-.-....|.+..+ +|+.+.||........ .. ..+.+|.+.+.++...+| ++++++.+. ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667665 6788999976433211 11 147789999988854333 444555543 23
Q ss_pred eeEEEEEecCCC-ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-------CCce
Q 005400 543 ESMLIYEYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-------DMNP 614 (698)
Q Consensus 543 ~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~~ 614 (698)
..+||+|++++. +|.+++.... ....+......++.+++..+.-||+.+ |+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 468999999986 7888874321 123455667789999999999999999 999999999999985 4689
Q ss_pred EEeecCCCcc
Q 005400 615 KISDFGMARI 624 (698)
Q Consensus 615 kl~DFgla~~ 624 (698)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.4e-09 Score=114.37 Aligned_cols=197 Identities=23% Similarity=0.250 Sum_probs=147.9
Q ss_pred HhhcCccccCceeeecceeEEEEEec--cccEEEEEEecCCCCcchHH--HHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKGSGQGMEE--FKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~g~~vavK~l~~~~~~~~~~--~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
....+|..+..||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+-+...+ .|.++++....+..-+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888889999999999998643 46788999886653322222 23455555555 588999988888888888
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC-CceEEeecCCCc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMAR 623 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFgla~ 623 (698)
++=-||++++++...+. ....++...++++..+++.++.++|+.. ++|+|++|.||++..+ +..++.||++..
T Consensus 342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 89999999999877662 2334777888899999999999999887 9999999999999875 889999999986
Q ss_pred ccCCCcccccccccccccccc--ChhcccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYM--SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~--APE~l~~~~~~~k~DVwSlGvil~elltG~~pf 677 (698)
.+.... .......+++ +|+......+..+.|++|||.-+.|.+++...-
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 422111 0122334455 455556667889999999999999999987544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.2e-07 Score=99.13 Aligned_cols=169 Identities=21% Similarity=0.336 Sum_probs=126.9
Q ss_pred ceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe----CCeeEEEEEecCCC-ChhHH
Q 005400 486 FGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESMLIYEYMPNK-SLDFF 559 (698)
Q Consensus 486 fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~----~~~~~lV~E~~~~g-sL~~~ 559 (698)
-.+.||+.. .+|..+++|++.....+.......-+++++++.|+|+|++..++.. ...+++||+|.++. +|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788864 4799999999954433333344556889999999999999999873 34688999999864 45444
Q ss_pred Hhhcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 560 IFDQA------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 560 l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
-+... .....++..++.++.|+..||.++|+.+ +..+-|.+++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 33221 1234678899999999999999999999 88899999999999999999998888766543
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKN 676 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~p 676 (698)
+.. |.+.. -.+-|.=.||.+++.|.||...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 331 11111 2356888999999999999655
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.1e-09 Score=120.19 Aligned_cols=209 Identities=19% Similarity=0.261 Sum_probs=144.8
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..+.+.+.+-+-+|.++.++..+-.. |...+.|..... .....+....+-.+.-..+||-+++..--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 44567777788889999888775432 333333333221 11222333333333333456766665544555677899
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
+++|..+++|...|+... ..+..-....+..+.++++|||... +.|+|++|.|+|...++..++.||+.....+
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999988876543 2333333445567788999999876 8999999999999999999999998432211
Q ss_pred C-------------------------Cccc----cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005400 627 G-------------------------DEIQ----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (698)
Q Consensus 627 ~-------------------------~~~~----~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf 677 (698)
- .... .......+|+.|.+||.+.+......+|.|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0000 1122357899999999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 005400 678 RFSHPDHD 685 (698)
Q Consensus 678 ~~~~~~~~ 685 (698)
....|...
T Consensus 1036 na~tpq~~ 1043 (1205)
T KOG0606|consen 1036 NAETPQQI 1043 (1205)
T ss_pred CCcchhhh
Confidence 87776543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.9e-07 Score=101.00 Aligned_cols=141 Identities=17% Similarity=0.272 Sum_probs=95.4
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCcc------------------------------hH----------HHHH
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG------------------------------ME----------EFKN 518 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~------------------------------~~----------~~~~ 518 (698)
+-|+.++-|+||+|++++|+.||||+.+....+. .+ .+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5689999999999999999999999986542110 01 1334
Q ss_pred HHHHHhhcC-----CCeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 005400 519 EVTLIARLQ-----HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG-ILYLHQDS 592 (698)
Q Consensus 519 Ei~il~~l~-----H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~ 592 (698)
|...+.+++ .+++.-..-+.+-....+|+|||++|..+.+...... ...+... ++..++++ +.-+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 555454442 4454444444455678899999999999988853322 1244333 33333333 12222234
Q ss_pred CCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=7e-07 Score=88.76 Aligned_cols=133 Identities=23% Similarity=0.253 Sum_probs=96.7
Q ss_pred ccCceeeecceeEEEEEeccccEEEEEEecCCCC----------------------cchHHHHHHHHHHhhcCCC--eee
Q 005400 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG----------------------QGMEEFKNEVTLIARLQHR--NLV 532 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~----------------------~~~~~~~~Ei~il~~l~H~--nIv 532 (698)
+.++||-|--+.||.|...+|.++|||.-+.... -......+|.++|.++.-. .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 4468999999999999999999999996432200 0123467899999998654 666
Q ss_pred eEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC
Q 005400 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (698)
Q Consensus 533 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (698)
+.++. +...+|||++++-.|...- ++....-.++..|+.-+.-+-..+ |||+|+++-||+++++|
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 66655 4567999999997664321 122223345555566555555666 99999999999999999
Q ss_pred ceEEeecCCCcc
Q 005400 613 NPKISDFGMARI 624 (698)
Q Consensus 613 ~~kl~DFgla~~ 624 (698)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=8e-07 Score=92.53 Aligned_cols=191 Identities=15% Similarity=0.177 Sum_probs=125.6
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEE----E---EeCCeeEEEEE
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGC----C---IQADESMLIYE 549 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~----~---~~~~~~~lV~E 549 (698)
.+.||+|+.+.+|-.-- -+.-+.|++.........+. ++.|... .||-+-.-+.+ - ..+...-+.|+
T Consensus 16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 35799999999986522 12234577766544333222 2233333 46643321111 0 11122456677
Q ss_pred ecCCCC-hhHHHh---hccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 550 YMPNKS-LDFFIF---DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 550 ~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
.+++.- +..++. +.+..+...|.-.++.++.++.+.+.||+.+ .+-+|+.++|+|+.+++.+.|.|=..-.+.
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 766543 222221 2233456889999999999999999999998 899999999999999999999986654432
Q ss_pred CCCccccccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSG-KKNWRF 679 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG-~~pf~~ 679 (698)
.+.. ...-.+|...|.+||... +..-+...|-|.||+++++|+.| +.||..
T Consensus 168 ~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 168 ANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred cCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 2111 111246888999999754 33456789999999999999987 999964
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.4e-06 Score=84.47 Aligned_cols=106 Identities=27% Similarity=0.303 Sum_probs=82.6
Q ss_pred HHHHHHHHHHhhcCC--CeeeeEEEEEEeCC----eeEEEEEecCCC-ChhHHHhhccccCCCCHHHHHHHHHHHHHHHH
Q 005400 514 EEFKNEVTLIARLQH--RNLVKLLGCCIQAD----ESMLIYEYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586 (698)
Q Consensus 514 ~~~~~Ei~il~~l~H--~nIv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~ 586 (698)
....+|.+.+.++.. -...+.+++.+... ..+||+|++++. +|.+++..... .+......++.++++.++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 457788888877753 34555666665532 358999999984 78888754222 455667789999999999
Q ss_pred HHHhCCCCceeecCCCCCCEEEcCCC---ceEEeecCCCccc
Q 005400 587 YLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARIF 625 (698)
Q Consensus 587 yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFgla~~~ 625 (698)
-||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 99999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=7.1e-06 Score=79.90 Aligned_cols=138 Identities=17% Similarity=0.173 Sum_probs=101.5
Q ss_pred eeeecceeEEEEEeccccEEEEEEecCC---C---CcchHHHHHHHHHHhhcCCC--eeeeEEEEEE-eC----CeeEEE
Q 005400 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKG---S---GQGMEEFKNEVTLIARLQHR--NLVKLLGCCI-QA----DESMLI 547 (698)
Q Consensus 481 LG~G~fG~Vy~g~~~~g~~vavK~l~~~---~---~~~~~~~~~Ei~il~~l~H~--nIv~l~~~~~-~~----~~~~lV 547 (698)
-++||-+.|++..+ +|+.+-+|+-... + +-....|.+|+..|.++... .+.++. ++. .. ..-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 35688889999877 4557888876422 1 33567899999999998532 344444 332 21 235799
Q ss_pred EEecCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc--eEEeecCCCcc
Q 005400 548 YEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--PKISDFGMARI 624 (698)
Q Consensus 548 ~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFgla~~ 624 (698)
+|-+++ .+|.+++.+.. ....+...+..++.++++.++-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 57877774432 223566777899999999999999998 999999999999986666 99999987765
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.4e-06 Score=77.48 Aligned_cols=85 Identities=22% Similarity=0.405 Sum_probs=60.2
Q ss_pred eEEecCceEEe-CCC-CceEEeeccCCCC-CCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCc
Q 005400 84 LNVTSKGIVLL-DGR-DRIFWSSNTSITM-KNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (698)
Q Consensus 84 l~~~~~g~l~l-~~~-~~~~ws~~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~ 160 (698)
+.+..||++++ +.. +.++|++++.... .+..+.|.++|||||++.+ +.++|+| +|-
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-g~~vW~S-----~t~--------------- 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-GRVVWSS-----NTT--------------- 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-CCEEEEe-----ccc---------------
Confidence 44567899999 322 5899999975332 3367899999999999877 6789998 110
Q ss_pred eeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEee
Q 005400 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRA 201 (698)
Q Consensus 161 ~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~ 201 (698)
...|.|.+.++.+|+..++-.. ....|.+
T Consensus 83 -----------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~S 111 (114)
T smart00108 83 -----------GANGNYVLVLLDDGNLVIYDSD-GNFLWQS 111 (114)
T ss_pred -----------CCCCceEEEEeCCCCEEEECCC-CCEEeCC
Confidence 1236789999999988765333 3456754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.2e-06 Score=82.22 Aligned_cols=140 Identities=17% Similarity=0.220 Sum_probs=85.7
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe--eeeEEEEEEeCCeeEEEEEecCCCC-
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGCCIQADESMLIYEYMPNKS- 555 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~~~~~~~~~~~lV~E~~~~gs- 555 (698)
..|++|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+.+........+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47999999999984 35577888875432 3345788999999886443 4667777777777889999999974
Q ss_pred hhHHH--------------hh-----cc-ccCCCCHHHHH-HHHH----------HHHH-HHHHHHh-CCCCceeecCCC
Q 005400 556 LDFFI--------------FD-----QA-RATFLDWQKRI-HIVG----------GIAR-GILYLHQ-DSRMRIIHRDLK 602 (698)
Q Consensus 556 L~~~l--------------~~-----~~-~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~-~~~~~ivH~Dlk 602 (698)
+...+ .+ +. ........... .+.. .+.+ ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 00 00 00001111100 0000 0111 1122221 123457899999
Q ss_pred CCCEEEcCCCceEEeecCCCcc
Q 005400 603 ASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 603 p~NILl~~~~~~kl~DFgla~~ 624 (698)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999887 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.2e-06 Score=75.29 Aligned_cols=85 Identities=21% Similarity=0.352 Sum_probs=60.5
Q ss_pred EEec-CceEEe-CC-CCceEEeeccCC-CCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCc
Q 005400 85 NVTS-KGIVLL-DG-RDRIFWSSNTSI-TMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (698)
Q Consensus 85 ~~~~-~g~l~l-~~-~~~~~ws~~~~~-~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~ 160 (698)
.+.. +|++++ +. .+.++|++|+.. ......+.|.++|||||.+.+ +.++|+|=-.
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-g~~vW~S~~~-------------------- 83 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-GTVVWSSNTT-------------------- 83 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-CcEEEEeccc--------------------
Confidence 3555 899988 33 268999999754 235567899999999999887 6789987210
Q ss_pred eeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeC
Q 005400 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (698)
Q Consensus 161 ~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g 202 (698)
.+.+.+.+.|+.+|+..++-.+ ....|.+.
T Consensus 84 -----------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 84 -----------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred -----------CCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 0246789999999987765433 45567653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.1e-05 Score=76.98 Aligned_cols=137 Identities=15% Similarity=0.194 Sum_probs=90.7
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHH---------HHHHHHHHhhcC---CCeeeeEEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEE---------FKNEVTLIARLQ---HRNLVKLLGCCI 539 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~---------~~~Ei~il~~l~---H~nIv~l~~~~~ 539 (698)
..+|.+.+.+-......|.+-.. +|+.+++|..+.......+. ..+++..+.+++ -.....++.+.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46777777787777777777766 67899999876543222222 223333333442 223333333322
Q ss_pred -----eCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 540 -----QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 540 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
.....+|+|||++|..|.+... ++. .++..+.+++.-||+.+ ++|+|.+|.|+++.++ .+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence 2345678999999988865431 221 24566788899999998 9999999999999865 59
Q ss_pred EEeecCCCcc
Q 005400 615 KISDFGMARI 624 (698)
Q Consensus 615 kl~DFgla~~ 624 (698)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.2e-05 Score=86.93 Aligned_cols=141 Identities=16% Similarity=0.204 Sum_probs=90.4
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCcc-------------------------------------hHHHHHHHH
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG-------------------------------------MEEFKNEVT 521 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~~~Ei~ 521 (698)
+.|+..+.|.||++++++|+.||||+-+..-++. +-.|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999875542111 112444554
Q ss_pred HHhhc----CCCee---eeEEEE-EEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005400 522 LIARL----QHRNL---VKLLGC-CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593 (698)
Q Consensus 522 il~~l----~H~nI---v~l~~~-~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 593 (698)
-..++ +|-++ |.+=.+ ..-...++|+||||+|..+.+...-... -++...+..-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf~~---- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIFKT---- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHHhc----
Confidence 44333 35551 112222 2334578999999999988776432211 2454444333333322222222
Q ss_pred CceeecCCCCCCEEEcC----CCceEEeecCCCcccC
Q 005400 594 MRIIHRDLKASNVLLDN----DMNPKISDFGMARIFG 626 (698)
Q Consensus 594 ~~ivH~Dlkp~NILl~~----~~~~kl~DFgla~~~~ 626 (698)
+++|+|-+|.||++.. ++++.+-|||+...+.
T Consensus 321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3999999999999984 6789999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.9e-05 Score=76.72 Aligned_cols=153 Identities=16% Similarity=0.203 Sum_probs=102.4
Q ss_pred cchhhHHHhhcCccccCc---eeeecceeEEEEEeccccEEEEEEecCCCCc-------------------chH-----H
Q 005400 463 FDFASIAKATDNFASYNK---LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ-------------------GME-----E 515 (698)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~---LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-------------------~~~-----~ 515 (698)
.+.+.+.....+..+... |..|.-+.||+|.-.++..+|+|+++..... ..+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 445555555555555444 5577778999998878999999998543110 011 1
Q ss_pred HHHHHHHHhhcC--CCeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 005400 516 FKNEVTLIARLQ--HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DS 592 (698)
Q Consensus 516 ~~~Ei~il~~l~--H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~ 592 (698)
...|+.-|.++. +-.+.+.+.+. +..|||||+...-...-.. ....+...+...+..++++.+.-|-. .+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 345777777773 55666666663 4579999997652211100 11112222556677788888888877 44
Q ss_pred CCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
+||+||+.=|||+. ++++.|+|++-|....
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999887654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.4e-05 Score=76.58 Aligned_cols=144 Identities=20% Similarity=0.211 Sum_probs=84.8
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCC--eeeeEEEEEEe---CCeeEEEEEecC
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR--NLVKLLGCCIQ---ADESMLIYEYMP 552 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~--nIv~l~~~~~~---~~~~~lV~E~~~ 552 (698)
++.|+.|..+.||+....+ +.+++|..... .....+..|..++..+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999866 69999997543 3456778898888888533 35566664433 334689999999
Q ss_pred CCChhH----------------HHh---hc-cccCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005400 553 NKSLDF----------------FIF---DQ-ARATFLDWQK---------RIHI------------VGGIAR-GILYLHQ 590 (698)
Q Consensus 553 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~ 590 (698)
+..+.. .+. .. .......... .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 111 00 0001111100 0000 111222 2333332
Q ss_pred ----CCCCceeecCCCCCCEEEc-CCCceEEeecCCCcc
Q 005400 591 ----DSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARI 624 (698)
Q Consensus 591 ----~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFgla~~ 624 (698)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666678999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.2e-06 Score=68.53 Aligned_cols=72 Identities=38% Similarity=0.756 Sum_probs=55.4
Q ss_pred CCcceeeecCCCCCCcccccccccHHHHHhhcCC-CCCcccccCccCCCCCcceeeec-ccccccccccCCCcceEEe
Q 005400 328 DEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK-NCSCTAYANSDVERGGSGCLLWF-GDLMDMKEYNDGGQDLYIR 403 (698)
Q Consensus 328 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-~C~C~a~~~~~~~~~~~~c~~w~-g~l~~~~~~~~~~~~~y~r 403 (698)
..|..+.++.+++..... ....++++|++.|++ +|.|.||.|.. ++.+|.+|. +.+.+.+..+..+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 458888999998654432 346799999999999 99999999853 567899999 7777776455556666665
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.6e-05 Score=77.50 Aligned_cols=141 Identities=14% Similarity=0.164 Sum_probs=85.9
Q ss_pred ceeeecc-eeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEEecCCCChh
Q 005400 480 KLGEGGF-GPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (698)
Q Consensus 480 ~LG~G~f-G~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~ 557 (698)
.|..|.. ..||+.... +..+.+|+..... ...+..|+++++.+. +--+.+++++.......++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 788999764 4778888875432 345678999888884 444566777776666789999999998876
Q ss_pred HHHh-------------------hccc-cCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 005400 558 FFIF-------------------DQAR-ATFLD--WQKRIHIVG--------------------GIARGILYLHQ----D 591 (698)
Q Consensus 558 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~ 591 (698)
.... .... ..... ....+.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4320 0000 00011 001010000 01111222211 1
Q ss_pred CCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 592 ~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234599999999999999987789999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=6.1e-07 Score=98.01 Aligned_cols=193 Identities=16% Similarity=0.147 Sum_probs=137.1
Q ss_pred HHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe-eeeEEEEEEeCCeeEE
Q 005400 468 IAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-LVKLLGCCIQADESML 546 (698)
Q Consensus 468 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n-Iv~l~~~~~~~~~~~l 546 (698)
++..++-+...+.+++++.++++|.+-...+....+.+... ....-++++|.+++||| .++.++-+..+....+
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 34444555556678999999999987644444445554332 45667899999999999 7777777777788889
Q ss_pred EEEecCCC-ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 547 IYEYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 547 V~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+++++..+ +-.... ......+...+...+.+.-++++++||+.. -+|+| ||+..+ ...|..||+....+
T Consensus 312 ~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence 99999877 211110 001111333344456666778999999875 58998 777765 68899999998766
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
.... ......+++.++|||+.....+..+.|+|++|+--.++--|-.|-.
T Consensus 382 ~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 382 TRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred Cccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 5433 2233679999999999999999999999999987777777766654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.2e-05 Score=74.18 Aligned_cols=105 Identities=22% Similarity=0.219 Sum_probs=83.1
Q ss_pred HHHHHHHhhcCC-CeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005400 517 KNEVTLIARLQH-RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (698)
Q Consensus 517 ~~Ei~il~~l~H-~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 595 (698)
.+|.-++..+++ +++++++|.| ..++|.||...+++...-..-..--..+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 6999999999 34789999987765321000001113689999999999999999999866566
Q ss_pred eeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 596 IIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+..+|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0002 Score=85.62 Aligned_cols=79 Identities=19% Similarity=0.400 Sum_probs=57.5
Q ss_pred cCceeeecceeEEEEEeccc---cEEEEEEecCCC-CcchHHHHHHHHHHhhcC-CCee--eeEEEEEEeC---CeeEEE
Q 005400 478 YNKLGEGGFGPVYKGTLVEG---QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNL--VKLLGCCIQA---DESMLI 547 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~-H~nI--v~l~~~~~~~---~~~~lV 547 (698)
++.++.|.+..+|+.....+ ..+++|+..... ......+.+|+++++.+. |+++ .+++.+|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877554 467777764432 123456889999999995 6655 7778877654 357899
Q ss_pred EEecCCCCh
Q 005400 548 YEYMPNKSL 556 (698)
Q Consensus 548 ~E~~~~gsL 556 (698)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=5.2e-06 Score=92.04 Aligned_cols=98 Identities=24% Similarity=0.484 Sum_probs=75.5
Q ss_pred HHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC------ccccccc-cccccccccChhcccC
Q 005400 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD------EIQTNTH-KVVGTYGYMSPEYAAE 651 (698)
Q Consensus 579 ~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~------~~~~~~~-~~~gt~~y~APE~l~~ 651 (698)
.+++.||.|+|..- .+||++|.|++|.++..+..||+.|+.+...... ....... -......|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34569999999865 5999999999999999999999999987654331 1111110 0224568999999999
Q ss_pred CCCCcchhHHHHHHHHHHHH-hCCCCCC
Q 005400 652 GLFSVKSDVFSFGVLVLEIV-SGKKNWR 678 (698)
Q Consensus 652 ~~~~~k~DVwSlGvil~ell-tG~~pf~ 678 (698)
...+.++|+||+|+++|.+. .|+.-+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhh
Confidence 88899999999999999999 5555554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00024 Score=66.60 Aligned_cols=131 Identities=21% Similarity=0.225 Sum_probs=88.7
Q ss_pred cccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCC
Q 005400 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 555 (698)
...+.|++|.+|.||+|.+. |..+|+|+-+.++ ....+..|++++..++-.++.+=+-.+- .-.+.|||+.|-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcc
Confidence 34468999999999999984 5688998876543 3467889999999998766655332222 2245599999988
Q ss_pred hhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC-CCCEEEcCCCceEEeecCCCccc
Q 005400 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK-ASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk-p~NILl~~~~~~kl~DFgla~~~ 625 (698)
|...-.. .+..++ ..++..---|...+ |-|+.|. |..++|-.+..+.|+||..|..-
T Consensus 99 L~~~~~~------~~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIG------GDRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhc------ccHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 8655421 122222 23444444455555 8888886 55555656669999999999854
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00052 Score=66.97 Aligned_cols=131 Identities=15% Similarity=0.243 Sum_probs=90.5
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCC----------------CcchHHHHHHHHHHhhcC------CCeeeeEEE
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS----------------GQGMEEFKNEVTLIARLQ------HRNLVKLLG 536 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~----------------~~~~~~~~~Ei~il~~l~------H~nIv~l~~ 536 (698)
..||+|+.-.||. +++.....||+..... ....++..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 5799999999985 4456667888876544 123456777777666665 889999999
Q ss_pred EEEeCCeeEEEEEecCC------CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC
Q 005400 537 CCIQADESMLIYEYMPN------KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN 610 (698)
Q Consensus 537 ~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~ 610 (698)
+.+++...-+|+|.+.+ -+|.+++.+. .++. ...+. +-+-..||-++. |+.+|++|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 99999999999998753 3466666322 2444 33333 334455666666 999999999999963
Q ss_pred C---C-ceEEee-cCCC
Q 005400 611 D---M-NPKISD-FGMA 622 (698)
Q Consensus 611 ~---~-~~kl~D-Fgla 622 (698)
. . .+.|+| ||-.
T Consensus 154 ~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cCCCceEEEEEeCCCCc
Confidence 2 2 577777 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00042 Score=69.93 Aligned_cols=74 Identities=20% Similarity=0.309 Sum_probs=48.6
Q ss_pred CceeeecceeEEEEEecc--ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeee-eEEEEEEeCCeeEEEEEecCCCC
Q 005400 479 NKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYEYMPNKS 555 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~~~~~~~~~~~lV~E~~~~gs 555 (698)
+.|..|-...+|+....+ ++.+++|+...... ....-..|+.++..+...+++ +++..+. ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467778888999998754 67888997754322 122335788888888544443 3443322 248999999877
Q ss_pred hh
Q 005400 556 LD 557 (698)
Q Consensus 556 L~ 557 (698)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00032 Score=71.92 Aligned_cols=139 Identities=16% Similarity=0.107 Sum_probs=79.5
Q ss_pred ceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeee-eEEEEEEeCCeeEEEEEecCCCChhH
Q 005400 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYEYMPNKSLDF 558 (698)
Q Consensus 480 ~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~~~~~~~~~~~lV~E~~~~gsL~~ 558 (698)
.+..|-...+|+... +++++++|..............+|.++++.+....++ +++... . ..+|+||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 455677788998873 5778888876543222112457889999888644343 344332 1 368999999877542
Q ss_pred H--------------H---hhcc-ccCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCceeecCCCCCC
Q 005400 559 F--------------I---FDQA-RATFLDWQKR-IHIVGG---------IARGILYLHQD-----SRMRIIHRDLKASN 605 (698)
Q Consensus 559 ~--------------l---~~~~-~~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~ivH~Dlkp~N 605 (698)
. + +... ....++.... .....+ +.+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 0 1100 0111222211 111111 11122222211 12358999999999
Q ss_pred EEEcCCCceEEeecCCCcc
Q 005400 606 VLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 606 ILl~~~~~~kl~DFgla~~ 624 (698)
|++++++ ++|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 79999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00055 Score=66.29 Aligned_cols=136 Identities=24% Similarity=0.362 Sum_probs=96.0
Q ss_pred cccccccchhhHHHhhcCccccCceeeecc-eeEEEEEeccccEEEEEEecC---CCC------------------cchH
Q 005400 457 DMELWEFDFASIAKATDNFASYNKLGEGGF-GPVYKGTLVEGQEIAVKRLSK---GSG------------------QGME 514 (698)
Q Consensus 457 ~~~~~~~~~~~l~~~~~~f~~~~~LG~G~f-G~Vy~g~~~~g~~vavK~l~~---~~~------------------~~~~ 514 (698)
...+..|+. -+.+++.++.||.|.. |.||+++. +|+.+|+|.++. ... ....
T Consensus 26 gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~ 99 (207)
T PF13095_consen 26 GPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYAD 99 (207)
T ss_pred CCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcC
Confidence 334555555 2267888899999999 99999998 688999999321 100 1234
Q ss_pred HHHHHHHHHhhcC---CCee--eeEEEEEEeC------------------CeeEEEEEecCCCChhHHHhhccccCCCCH
Q 005400 515 EFKNEVTLIARLQ---HRNL--VKLLGCCIQA------------------DESMLIYEYMPNKSLDFFIFDQARATFLDW 571 (698)
Q Consensus 515 ~~~~Ei~il~~l~---H~nI--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~ 571 (698)
.|..|.+...+++ +.++ |+.+|+..-. ....||.||++... .+..
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~ 167 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI 167 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch
Confidence 5889999998886 4455 8999987322 12357888775543 1222
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 572 ~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
.-+.+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 168 ----~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 ----RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ----hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 23456778888899988 999999999975 4689999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00033 Score=70.79 Aligned_cols=73 Identities=15% Similarity=0.272 Sum_probs=45.2
Q ss_pred Cceeeecce-eEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCC---eeeeEEEEEEeC---CeeEEEEEec
Q 005400 479 NKLGEGGFG-PVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR---NLVKLLGCCIQA---DESMLIYEYM 551 (698)
Q Consensus 479 ~~LG~G~fG-~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~---nIv~l~~~~~~~---~~~~lV~E~~ 551 (698)
+.|+.|+.. .||+. +..+++|..+. ......+..|.+++..+... -+.+++...... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766665 58875 34567776543 22345788999999887532 334444433222 1347899999
Q ss_pred CCCChh
Q 005400 552 PNKSLD 557 (698)
Q Consensus 552 ~~gsL~ 557 (698)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00071 Score=70.89 Aligned_cols=78 Identities=10% Similarity=0.075 Sum_probs=56.7
Q ss_pred cccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCC---CeeeeEEEEEEeC---CeeEEEEE
Q 005400 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH---RNLVKLLGCCIQA---DESMLIYE 549 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H---~nIv~l~~~~~~~---~~~~lV~E 549 (698)
...+.|+.|..+.||+....++ ++.+|..+.. .....+..|.+.++.+.. ..+.++++++..+ ...+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3346799999999999876555 4666764331 123578899999988853 4678888887543 55899999
Q ss_pred ecCCCCh
Q 005400 550 YMPNKSL 556 (698)
Q Consensus 550 ~~~~gsL 556 (698)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.001 Score=71.84 Aligned_cols=75 Identities=15% Similarity=0.238 Sum_probs=54.0
Q ss_pred CceeeecceeEEEEEeccc-cEEEEEEecCC------C-CcchHHHHHHHHHHhhcC---CCeeeeEEEEEEeCCeeEEE
Q 005400 479 NKLGEGGFGPVYKGTLVEG-QEIAVKRLSKG------S-GQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g-~~vavK~l~~~------~-~~~~~~~~~Ei~il~~l~---H~nIv~l~~~~~~~~~~~lV 547 (698)
+.||.|.+..||++...+| +.++||.-... . +...+.+..|.+.|..+. -..+++++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 58999984311 1 224556778888888763 2356667766 44567899
Q ss_pred EEecCCCC
Q 005400 548 YEYMPNKS 555 (698)
Q Consensus 548 ~E~~~~gs 555 (698)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0012 Score=58.47 Aligned_cols=98 Identities=23% Similarity=0.415 Sum_probs=63.5
Q ss_pred CEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCC-CCCCCCCCcceEEecCceEEe-CCCCceEEeeccCC
Q 005400 31 ETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANR-ETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSI 108 (698)
Q Consensus 31 ~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr-~~p~~~~~~~l~~~~~g~l~l-~~~~~~~ws~~~~~ 108 (698)
+++.+.+|.+.|-|-..|+ |-| |+ ...+++|.++. ..+.. ....+.+.++|+|+| |..+.++|++...
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~--~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~- 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVL-YD--SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY- 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEE-EE--TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS-
T ss_pred cccccccccccceECCCCe-----EEE-Ec--CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC-
Confidence 4455545778888876654 344 32 23577999933 33322 467899999999999 8899999999532
Q ss_pred CCCCcEEEEec--cceEEEecCCCCceeeeccCCC
Q 005400 109 TMKNPVVQLMD--SGNLVLTDGNYNSLLWQSFDHP 141 (698)
Q Consensus 109 ~~~~~~~~l~d--~GNlvl~~~~~~~~~WqSFd~P 141 (698)
.....+..++ .||++ .... ..+.|.|=+.|
T Consensus 82 -ptdt~L~~q~l~~~~~~-~~~~-~~~sw~s~~dp 113 (114)
T PF01453_consen 82 -PTDTLLPGQKLGDGNVT-GKND-SLTSWSSNTDP 113 (114)
T ss_dssp -SS-EEEEEET--TSEEE-EEST-SSEEEESS---
T ss_pred -CccEEEeccCcccCCCc-cccc-eEEeECCCCCC
Confidence 3456667777 89998 5433 57889887666
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.002 Score=67.73 Aligned_cols=141 Identities=24% Similarity=0.340 Sum_probs=83.9
Q ss_pred CceeeecceeEEEEEecc-------ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCee-eeEEEEEEeCCeeEEEEEe
Q 005400 479 NKLGEGGFGPVYKGTLVE-------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~-------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nI-v~l~~~~~~~~~~~lV~E~ 550 (698)
+.+..|-...+|+....+ ++.+++|+..... ........|.+++..+...++ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899887654 4789999875543 233456788888888854333 345555432 368999
Q ss_pred cCCCChhHHH-----------------hhcccc--C----CCC--HHHHHH--------------------------HHH
Q 005400 551 MPNKSLDFFI-----------------FDQARA--T----FLD--WQKRIH--------------------------IVG 579 (698)
Q Consensus 551 ~~~gsL~~~l-----------------~~~~~~--~----~l~--~~~~~~--------------------------i~~ 579 (698)
++|..+.... ++.... . ..+ +..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764311 000000 0 000 111100 111
Q ss_pred HHHHHHHHHHh------CCCCceeecCCCCCCEEEcCC----CceEEeecCCCcc
Q 005400 580 GIARGILYLHQ------DSRMRIIHRDLKASNVLLDND----MNPKISDFGMARI 624 (698)
Q Consensus 580 ~ia~gL~yLH~------~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFgla~~ 624 (698)
.+.+.+..|.. ..+..++|+|+.+.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 234569999999999999975 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.015 Score=61.66 Aligned_cols=143 Identities=20% Similarity=0.213 Sum_probs=77.2
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCC--eeeeEEE------EEEeCCeeEEEEE
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR--NLVKLLG------CCIQADESMLIYE 549 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~--nIv~l~~------~~~~~~~~~lV~E 549 (698)
.+.|..|....+|+....+| .+++|++.... .+....|++++..+... .+.+++. +.......++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677777789999876544 78889875212 23344455555555311 2333332 1223456789999
Q ss_pred ecCCCChhH-----------HHh---hccc------cC--CC-CHHHHHH------------HH-HHHHHHHHHHHhC--
Q 005400 550 YMPNKSLDF-----------FIF---DQAR------AT--FL-DWQKRIH------------IV-GGIARGILYLHQD-- 591 (698)
Q Consensus 550 ~~~~gsL~~-----------~l~---~~~~------~~--~l-~~~~~~~------------i~-~~ia~gL~yLH~~-- 591 (698)
|++|..+.. .+. .... .. .+ .|..... .. ..+...++.+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 111 0000 00 11 1111111 11 1111122333211
Q ss_pred --CCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 592 --SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 592 --~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
-+..++|+|++|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999999765568999998753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0078 Score=62.90 Aligned_cols=138 Identities=14% Similarity=0.232 Sum_probs=82.8
Q ss_pred ccCceeeecceeEEEEEeccccEEEEEEecC--CCCcchHHHHHHHHHHhhcCC--CeeeeEEEEEEeCC--eeEEEEEe
Q 005400 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQAD--ESMLIYEY 550 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~--~~~~~~~~~~~Ei~il~~l~H--~nIv~l~~~~~~~~--~~~lV~E~ 550 (698)
+++++..|..-.+|..... +++++++ ... ..........+|.++|+.+.- .-+.+.+++|.++. ..+.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3344544444444444433 7788888 331 233445566788888888743 23445567776666 56899999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHH-HHHHHHHHHHHh---------------------------------------
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIV-GGIARGILYLHQ--------------------------------------- 590 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~gL~yLH~--------------------------------------- 590 (698)
+++..+...+... ... .+++ ..+++.|+-||+
T Consensus 107 veGe~~~~~~~~~------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 107 VEGEVVWSALPPE------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred ecceeccCcCCcc------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 9885332221100 000 0111 133333333332
Q ss_pred -----------C-----CCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 591 -----------D-----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 591 -----------~-----~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
. ++..++|+|+++.||+++.+.-+-|.||+++.+
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2 345699999999999999988899999999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0088 Score=62.06 Aligned_cols=73 Identities=19% Similarity=0.305 Sum_probs=47.9
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcC---CCeeeeEEEEEEeCCeeEEEEEecCCC
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLIYEYMPNK 554 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~---H~nIv~l~~~~~~~~~~~lV~E~~~~g 554 (698)
.+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.+. -..+.+++++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4578889999999987 5788999998763 23356778888777773 456778888888777889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.016 Score=60.55 Aligned_cols=143 Identities=20% Similarity=0.217 Sum_probs=85.7
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe--eeeEEEE------EEeCCeeEEEEE
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGC------CIQADESMLIYE 549 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~~~------~~~~~~~~lV~E 549 (698)
.+.|..|....+|+.... +..+++|+... ...+....|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777877899998763 45788898754 23345667888887774332 4444431 233455689999
Q ss_pred ecCCCChhH----HH----------hhccc--------cCCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 005400 550 YMPNKSLDF----FI----------FDQAR--------ATFLDWQKRI----------HIVGGIARGILYLHQ----DSR 593 (698)
Q Consensus 550 ~~~~gsL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~ 593 (698)
+++|..+.. .. +.... .....|.... .....+..++.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 10 00000 0111222211 011123334445443 122
Q ss_pred CceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 594 ~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
..++|+|+.|.||+++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987789999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0095 Score=63.79 Aligned_cols=140 Identities=17% Similarity=0.245 Sum_probs=81.4
Q ss_pred ceeeecceeEEEEEecc-----ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeee-eEEEEEEeCCeeEEEEEecCC
Q 005400 480 KLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 480 ~LG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~~~~~~~~~~~lV~E~~~~ 553 (698)
.|..|-.-.+|+....+ ++.+++|+......... .-.+|.+++..+...++. ++++.+..+ .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45557777888886532 36789998765443322 236788888888654444 455555322 58999988
Q ss_pred CChhHHH-----------------hhcc-c--cCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-C
Q 005400 554 KSLDFFI-----------------FDQA-R--ATFLDWQKRIHIVGGI-----------------ARGILYL----HQ-D 591 (698)
Q Consensus 554 gsL~~~l-----------------~~~~-~--~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~-~ 591 (698)
.++...- +... . .....+.++.++..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 7764220 0000 0 0111233332332111 1111122 21 2
Q ss_pred CCCceeecCCCCCCEEEcC-CCceEEeecCCCcc
Q 005400 592 SRMRIIHRDLKASNVLLDN-DMNPKISDFGMARI 624 (698)
Q Consensus 592 ~~~~ivH~Dlkp~NILl~~-~~~~kl~DFgla~~ 624 (698)
....++|+|+++.|||+++ ++.++++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2345899999999999986 46799999998765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.036 Score=58.40 Aligned_cols=144 Identities=22% Similarity=0.235 Sum_probs=82.4
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCC--eeeeEEEE------EEeCCeeEEEEE
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR--NLVKLLGC------CIQADESMLIYE 549 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~--nIv~l~~~------~~~~~~~~lV~E 549 (698)
.+.++.|....+|+.... +..+++|+..... ..+....|.+++..+... .+.+++.. .......++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeC-CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 456777777899988754 4467788765422 234456677777776422 23444432 122345689999
Q ss_pred ecCCCChhH----H----------Hhhcccc---------CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 005400 550 YMPNKSLDF----F----------IFDQARA---------TFLDWQKRI------------HIVGGIARGILYLHQ---- 590 (698)
Q Consensus 550 ~~~~gsL~~----~----------l~~~~~~---------~~l~~~~~~------------~i~~~ia~gL~yLH~---- 590 (698)
|++|..+.. . ++..... ....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 0 1110000 001121110 011123344555542
Q ss_pred CCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 591 ~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
..+..++|+|+++.||++++++...|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2234699999999999999887778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.012 Score=60.82 Aligned_cols=31 Identities=26% Similarity=0.567 Sum_probs=26.1
Q ss_pred CceeecCCCCCCEEEcCCCc-eEEeecCCCcc
Q 005400 594 MRIIHRDLKASNVLLDNDMN-PKISDFGMARI 624 (698)
Q Consensus 594 ~~ivH~Dlkp~NILl~~~~~-~kl~DFgla~~ 624 (698)
..++|+|++|.|||++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.027 Score=59.74 Aligned_cols=74 Identities=14% Similarity=0.216 Sum_probs=48.4
Q ss_pred CceeeecceeEEEEEeccc-cEEEEEEecCC-------CCcchHHHHHHHHHHhhcC--CCe-eeeEEEEEEeCCeeEEE
Q 005400 479 NKLGEGGFGPVYKGTLVEG-QEIAVKRLSKG-------SGQGMEEFKNEVTLIARLQ--HRN-LVKLLGCCIQADESMLI 547 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g-~~vavK~l~~~-------~~~~~~~~~~Ei~il~~l~--H~n-Iv~l~~~~~~~~~~~lV 547 (698)
++||.|....||++...+| +.|+||.-... -+-..+...-|.+.|+... -|. +.+++.+ ++....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 3689999999999998654 58999974211 1233445566777776653 343 4444444 45566799
Q ss_pred EEecCCC
Q 005400 548 YEYMPNK 554 (698)
Q Consensus 548 ~E~~~~g 554 (698)
||+++..
T Consensus 79 MEdL~~~ 85 (370)
T TIGR01767 79 MEDLSHH 85 (370)
T ss_pred HhhCccc
Confidence 9998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.036 Score=59.96 Aligned_cols=73 Identities=12% Similarity=0.114 Sum_probs=50.0
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCC----CC---cchHHHHHHHHHHhhcC---CCeeeeEEEEEEeCCeeEEE
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG----SG---QGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~----~~---~~~~~~~~Ei~il~~l~---H~nIv~l~~~~~~~~~~~lV 547 (698)
.+.||.|....||+... .++.++||+-... .. .....-..|.+.|+.+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46799999999999886 4567999975421 11 13334455566666553 247777888876 456889
Q ss_pred EEecCC
Q 005400 548 YEYMPN 553 (698)
Q Consensus 548 ~E~~~~ 553 (698)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.0032 Score=64.61 Aligned_cols=144 Identities=17% Similarity=0.230 Sum_probs=96.1
Q ss_pred cchhhHHHhhcC---ccccCceeeecceeEEEEEeccccEEEEEEecCC---------CC-----------c--chHHHH
Q 005400 463 FDFASIAKATDN---FASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG---------SG-----------Q--GMEEFK 517 (698)
Q Consensus 463 ~~~~~l~~~~~~---f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~---------~~-----------~--~~~~~~ 517 (698)
+++-.|.....+ +.+.++||-|.-+-||.+...+|++.++|.-+.. .+ . +.-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 455444433332 4567899999999999999988999998853211 00 0 112356
Q ss_pred HHHHHHhhcCC-C-eeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005400 518 NEVTLIARLQH-R-NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (698)
Q Consensus 518 ~Ei~il~~l~H-~-nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 595 (698)
.|...|+.+.. - -+.+.+++ +..++|||++.+-.|...- ...+..+ +...+..-+.-|..++
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G--- 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG--- 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---
Confidence 68888888852 2 23444444 4567899999888775432 1123333 3334444555666677
Q ss_pred eeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 596 IIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
+||+|..--||++++++.++++||--.
T Consensus 223 lIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred ceecccchheeEEecCCCEEEeechHh
Confidence 999999999999999999999999754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.024 Score=60.87 Aligned_cols=74 Identities=11% Similarity=0.143 Sum_probs=50.0
Q ss_pred cCceeeecceeEEEEEecc-ccEEEEEEecCC------CCcchHHHHHHHHHHhhcC--CCe-eeeEEEEEEeCCeeEEE
Q 005400 478 YNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG------SGQGMEEFKNEVTLIARLQ--HRN-LVKLLGCCIQADESMLI 547 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~------~~~~~~~~~~Ei~il~~l~--H~n-Iv~l~~~~~~~~~~~lV 547 (698)
.+.||.|.-..||++.... ++.|+||.-..- -+-..+...-|.+.|+... -|. +.+++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4689999999999999743 568999963211 1334556677888887663 343 4445544 45566789
Q ss_pred EEecCC
Q 005400 548 YEYMPN 553 (698)
Q Consensus 548 ~E~~~~ 553 (698)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.057 Score=56.65 Aligned_cols=139 Identities=19% Similarity=0.198 Sum_probs=94.0
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCC-----Cc-------------------c-hH-HHHHHHHHHhhcCCCeee
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS-----GQ-------------------G-ME-EFKNEVTLIARLQHRNLV 532 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~-----~~-------------------~-~~-~~~~Ei~il~~l~H~nIv 532 (698)
.-|..|--+-||.+.-.+|..+|||+++... +. . .+ -...|++-|.+++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4578899999999999899999999875320 00 0 00 134577778777654443
Q ss_pred eEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC
Q 005400 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (698)
Q Consensus 533 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (698)
-.--+.. ...+|||+|+....-..-. -+...++...+..+-.+++.-|.-|-+.+ .+||.||.--|+|+. +|
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CC
Confidence 2221111 2347999998632221111 12234666777888889999999998877 599999999999996 56
Q ss_pred ceEEeecCCCccc
Q 005400 613 NPKISDFGMARIF 625 (698)
Q Consensus 613 ~~kl~DFgla~~~ 625 (698)
.+.|+|-+-+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 8999998876543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.019 Score=56.86 Aligned_cols=30 Identities=33% Similarity=0.523 Sum_probs=21.4
Q ss_pred ceeecCCCCCCEEE-cCCCceEEeecCCCcc
Q 005400 595 RIIHRDLKASNVLL-DNDMNPKISDFGMARI 624 (698)
Q Consensus 595 ~ivH~Dlkp~NILl-~~~~~~kl~DFgla~~ 624 (698)
.++|+|+.|.|||+ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48899999999999 8899999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.0022 Score=77.14 Aligned_cols=160 Identities=13% Similarity=-0.025 Sum_probs=111.4
Q ss_pred HHHHHHHHhhcCCCeeeeEEEEEE--eCCeeEEEEEecCCCChhHHHhhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Q 005400 516 FKNEVTLIARLQHRNLVKLLGCCI--QADESMLIYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQD- 591 (698)
Q Consensus 516 ~~~Ei~il~~l~H~nIv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~- 591 (698)
...|....+..+|+++.....-.. +..+.+.+++++..|.+...|.+...+ +.++..-+...-.+...+..-+|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555666678998877554432 234568899999999999998765433 2333333332222324444444433
Q ss_pred -CCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHH
Q 005400 592 -SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEI 670 (698)
Q Consensus 592 -~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~el 670 (698)
....-+|+++|+-|.+|..+.++|++++|+.+...... .......+++-|++|+...+-.++.++|+|..++.+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 23457999999999999999999999999998433221 112224678889999988888889899999999999998
Q ss_pred HhCCCCC
Q 005400 671 VSGKKNW 677 (698)
Q Consensus 671 ltG~~pf 677 (698)
-.|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887777
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.077 Score=56.51 Aligned_cols=141 Identities=16% Similarity=0.214 Sum_probs=79.2
Q ss_pred CceeeecceeEEEEEecc----ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeee-eEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~~~~~~~~~~~lV~E~~~~ 553 (698)
+.|..|=.-.+|+....+ +..+++|+....... .-.-.+|..+++.+...++. ++++++.. . +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN--G--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC--c--EeehhhcC
Confidence 345556667788886543 237888887654332 22346788888888655553 45555522 2 58999987
Q ss_pred CChhHH-------H----------hhcc-c--cCCCCHHHHHHHHHHH----------------------HHHHH----H
Q 005400 554 KSLDFF-------I----------FDQA-R--ATFLDWQKRIHIVGGI----------------------ARGIL----Y 587 (698)
Q Consensus 554 gsL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~~i----------------------a~gL~----y 587 (698)
..+... + +... . ..+.-|..+.++..++ .+-+. .
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 1 0100 0 0111233222222111 11111 1
Q ss_pred HHh-CCCCceeecCCCCCCEEEcC-CCceEEeecCCCcc
Q 005400 588 LHQ-DSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARI 624 (698)
Q Consensus 588 LH~-~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFgla~~ 624 (698)
+.. ..+.-++|+|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 12234799999999999975 57899999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.038 Score=65.62 Aligned_cols=154 Identities=18% Similarity=0.182 Sum_probs=108.8
Q ss_pred HHHHHHHHhhcCCCeeeeEEEEEEeCCeeE----EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005400 516 FKNEVTLIARLQHRNLVKLLGCCIQADESM----LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591 (698)
Q Consensus 516 ~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 591 (698)
..-|++.+.++.|+|++.++.+-.+....- +..|++..-++...+.. -..++....+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345677788889999999999987655443 23467777777766643 23477888888999999999999998
Q ss_pred CCCceeecCCCCC---CEEEcCCCceEEe--ecCCCcccCCCccccccccccccccccChhcccCCCCCcc--hhHHHHH
Q 005400 592 SRMRIIHRDLKAS---NVLLDNDMNPKIS--DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVK--SDVFSFG 664 (698)
Q Consensus 592 ~~~~ivH~Dlkp~---NILl~~~~~~kl~--DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k--~DVwSlG 664 (698)
. ..|.-+..+ +-..+.++...++ ||+..+.+....... ...-+..+.|||.........+ .|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 555555444 5555667777777 888877654332111 1234556788887776665544 7999999
Q ss_pred HHHHHHHhCCCCCC
Q 005400 665 VLVLEIVSGKKNWR 678 (698)
Q Consensus 665 vil~elltG~~pf~ 678 (698)
..+..+..|..+-.
T Consensus 380 ll~~~~~~~~~i~~ 393 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISE 393 (1351)
T ss_pred HHHhhhhhcCcccc
Confidence 99999998876654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 698 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-33 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-119
Identities = 90/241 (37%), Positives = 127/241 (52%), Gaps = 17/241 (7%)
Query: 463 FDFASIAKATDNF------ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG----SGQG 512
F F + T+NF NK+GEGGFG VYKG + +AVK+L+ + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
++F E+ ++A+ QH NLV+LLG D+ L+Y YMPN SL + L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
R I G A GI +LH++ IHRD+K++N+LLD KISDFG+AR
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
T ++VGT YM+PE G + KSD++SFGV++LEI++G LL
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIK 247
Query: 693 R 693
Sbjct: 248 E 248
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-116
Identities = 97/238 (40%), Positives = 145/238 (60%), Gaps = 11/238 (4%)
Query: 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME-EFKNEVT 521
F + A+DNF++ N LG GGFG VYKG L +G +AVKRL + QG E +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARAT-FLDWQKRIHIVGG 580
+I+ HRNL++L G C+ E +L+Y YM N S+ + ++ + LDW KR I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH---KV 637
ARG+ YLH +IIHRD+KA+N+LLD + + DFG+A++ +TH V
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK----DTHVTTAV 195
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP--DHDHNLLGHVR 693
GT G+++PEY + G S K+DVF +GV++LE+++G++ + + D D LL V+
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 324 bits (833), Expect = e-106
Identities = 89/231 (38%), Positives = 137/231 (59%), Gaps = 10/231 (4%)
Query: 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTL 522
+ +AT+NF +G G FG VYKG L +G ++A+KR + S QG+EEF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-LDWQKRIHIVGGI 581
++ +H +LV L+G C + +E +LIY+YM N +L ++ T + W++R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH---KVV 638
ARG+ YLH + IIHRD+K+ N+LLD + PKI+DFG+++ + TH V
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD---QTHLSTVVK 202
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
GT GY+ PEY +G + KSDV+SFGV++ E++ + S P NL
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 1e-82
Identities = 60/257 (23%), Positives = 110/257 (42%), Gaps = 22/257 (8%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ 511
H + ++ + G FG V+K + + +AVK Q
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQ 61
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----ESMLIYEYMPNKSLDFFIFDQARAT 567
+ + EV + ++H N+++ +G + + LI + SL F+ +A
Sbjct: 62 SWQ-NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KAN 116
Query: 568 FLDWQKRIHIVGGIARGILYLHQD-------SRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+ W + HI +ARG+ YLH+D + I HRD+K+ NVLL N++ I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL-----FSVKSDVFSFGVLVLEIVSGKK 675
+A F + +TH VGT YM+PE + ++ D+++ G+++ E+ S
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 676 NWRFSHPDHDHNLLGHV 692
++ +
Sbjct: 237 AADGPVDEYMLPFEEEI 253
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 225 bits (574), Expect = 7e-68
Identities = 63/260 (24%), Positives = 106/260 (40%), Gaps = 30/260 (11%)
Query: 462 EFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT 521
E + + DN +G G +G VYKG+L + + +AVK S + Q K +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIY 59
Query: 522 LIARLQHRNLVKLLGCCIQADES-----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIH 576
+ ++H N+ + + + +L+ EY PN SL ++ DW
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCR 115
Query: 577 IVGGIARGILYLHQD------SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG--- 627
+ + RG+ YLH + + I HRDL + NVL+ ND ISDFG++ G
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 628 ---DEIQTNTHKVVGTYGYMSPEYAAEGL-------FSVKSDVFSFGVLVLEIVSGKKNW 677
E VGT YM+PE + + D+++ G++ EI +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 678 RFSHPDHDHNLLGHVRVENN 697
++ + V N+
Sbjct: 236 FPGESVPEYQMAFQTEVGNH 255
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 8e-63
Identities = 62/220 (28%), Positives = 112/220 (50%), Gaps = 13/220 (5%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGME 514
D + + + + K+G G FG V++ G ++AVK L + + +
Sbjct: 28 DGDDMDIPWCDLNIK-------EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVN 79
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
EF EV ++ RL+H N+V +G Q ++ EY+ SL + LD ++R
Sbjct: 80 EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+ + +A+G+ YLH I+HR+LK+ N+L+D K+ DFG++R+ + + +
Sbjct: 140 LSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT +M+PE + + KSDV+SFGV++ E+ + +
Sbjct: 199 --AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-62
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 25/230 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNE 519
F + + LG+G FG K T G+ + +K L + + F E
Sbjct: 5 RIFRPSDLIHG-------EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
V ++ L+H N++K +G + I EY+ +L I W +R+
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAK 115
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK--- 636
IA G+ YLH M IIHRDL + N L+ + N ++DFG+AR+ ++ Q +
Sbjct: 116 DIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 637 ---------VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
VVG +M+PE + K DVFSFG+++ EI+
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-60
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
+G G FG V K +++A+K++ S + F E+ ++R+ H N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ L+ EY SL + + + ++G+ YLH +IH
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 599 RDLKASNVLLDNDMN-PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVK 657
RDLK N+LL KI DFG A +IQT+ G+ +M+PE +S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 658 SDVFSFGVLVLEIVSGKK 675
DVFS+G+++ E+++ +K
Sbjct: 184 CDVFSWGIILWEVITRRK 201
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 7e-60
Identities = 72/231 (31%), Positives = 113/231 (48%), Gaps = 28/231 (12%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG----SGQGMEE 515
L E DFA + +G GGFG VY+ G E+AVK Q +E
Sbjct: 1 LLEIDFAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIEN 52
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
+ E L A L+H N++ L G C++ L+ E+ L+ + + +
Sbjct: 53 VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILV 108
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--------KISDFGMARIFGG 627
+ IARG+ YLH ++ + IIHRDLK+SN+L+ + KI+DFG+AR +
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
+ G Y +M+PE +FS SDV+S+GVL+ E+++G+ +R
Sbjct: 169 TTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 8e-59
Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 20/237 (8%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAV 502
+KK ++ + WE I ++G G FG VYKG ++AV
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVG-------QRIGSGSFGTVYKGKW--HGDVAV 51
Query: 503 KRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI 560
K L+ + Q ++ FKNEV ++ + +H N++ +G + ++ ++ SL +
Sbjct: 52 KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHL 110
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
A T + +K I I ARG+ YLH IIHRDLK++N+ L D KI DFG
Sbjct: 111 --HASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFG 165
Query: 621 MARIFGGDEIQTNTHKVVGTYGYMSPE---YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+A ++ G+ +M+PE +S +SDV++FG+++ E+++G+
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-58
Identities = 62/232 (26%), Positives = 116/232 (50%), Gaps = 32/232 (13%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG----- 512
L I ++G+GGFG V+KG LV+ +A+K L G +G
Sbjct: 12 RLPTLADNEIEYE-------KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 513 --MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD 570
+EF+ EV +++ L H N+VKL G ++ E++P L + D+A +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IK 120
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARIF 625
W ++ ++ IA GI Y+ I+HRDL++ N+ L + + K++DFG+++
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 626 GGDEIQTNTHKVVGTYGYMSPE--YAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
+ + ++G + +M+PE A E ++ K+D +SF +++ I++G+
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 4e-57
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536
KL E G ++KG +G +I VK L S + +F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 537 CCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
C LI +MP SL + + +D + + +ARG+ +LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE---YAAE 651
I L + +V++D DM +IS + F + + +++PE E
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPE 185
Query: 652 GLFSVKSDVFSFGVLVLEIVSGK 674
+D++SF VL+ E+V+ +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-55
Identities = 60/244 (24%), Positives = 102/244 (41%), Gaps = 29/244 (11%)
Query: 449 TKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG 508
K S ++ W+ F + +G+G FG VY G E+A++ +
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEIG-------ELIGKGRFGQVYHGRW--HGEVAIRLIDIE 66
Query: 509 --SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA 566
+ ++ FK EV + +H N+V +G C+ +I ++L + +
Sbjct: 67 RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV--RDAK 124
Query: 567 TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
LD K I I +G+ YLH I+H+DLK+ NV DN I+DFG+ I G
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDN-GKVVITDFGLFSISG 180
Query: 627 GDEIQTNTHK---VVGTYGYMSPE---------YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ K G +++PE + FS SDVF+ G + E+ + +
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 675 KNWR 678
++
Sbjct: 241 WPFK 244
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-51
Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE--VTLIARLQHRNLVKLLG 536
+G+G +G V++G+ +G+ +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 537 CCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD- 591
+ + S LI Y SL +D + T LD + IV IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 592 ----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMS 645
+ I HRDLK+ N+L+ + I+D G+A + +++ + VGT YM+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 646 PE------YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
PE + D+++FG+++ E+ +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE--VTLIARLQHRNLVKLLG 536
++G+G +G V+ G G+++AVK + E + ++H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 537 CCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD- 591
I+ S LI +Y N SL +D ++T LD + + + G+ +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 592 ----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMS 645
+ I HRDLK+ N+L+ + I+D G+A F +E+ + VGT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 646 PEYAAEGLFSV------KSDVFSFGVLVLEIVSG 673
PE E L +D++SFG+++ E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 28/236 (11%)
Query: 449 TKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVK 503
M ED + +F+ + +LG+G FG V G+ +AVK
Sbjct: 24 GAMGSAFEDRDPTQFEERHLKFL-------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76
Query: 504 RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIF 561
+L + + + +F+ E+ ++ LQH N+VK G C A LI EY+P SL ++
Sbjct: 77 KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL- 135
Query: 562 DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
Q +D K + I +G+ YL R IHRDL N+L++N+ KI DFG+
Sbjct: 136 -QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGL 191
Query: 622 ARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
++ D+ + V G + +PE E FSV SDV+SFGV++ E+ +
Sbjct: 192 TKVLPQDK----EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE--VTLIARLQHRNLVKLLG 536
+G+G FG V++G G+E+AVK S + + E + L+H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 537 CCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD- 591
+ + + L+ +Y + SL FD + + I + A G+ +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 592 ----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMS 645
+ I HRDLK+ N+L+ + I+D G+A D I + VGT YM+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 646 PE------YAAEGLFSVKSDVFSFGVLVLEIVSG 673
PE ++D+++ G++ EI
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQGMEE 515
+F+ + +LG+G FG V G+ +AVK+L + + + +
Sbjct: 5 TQFEERHLKFL-------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 57
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQK 573
F+ E+ ++ LQH N+VK G C A LI EY+P SL ++ Q +D K
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIK 115
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ I +G+ YL R IHRDL N+L++N+ KI DFG+ ++ D+
Sbjct: 116 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK---- 168
Query: 634 THKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
V G + +PE E FSV SDV+SFGV++ E+ +
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-47
Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 29/230 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQGMEE 515
F+ + ++LG+G FG V G +AVK+L +
Sbjct: 18 TIFEERHLKYI-------SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQK 573
F+ E+ ++ L +VK G L+ EY+P+ L F+ Q LD +
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASR 128
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ I +G+ YL R +HRDL A N+L++++ + KI+DFG+A++ D+
Sbjct: 129 LLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---- 181
Query: 634 THKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNW 677
+ VV G + +PE ++ +FS +SDV+SFGV++ E+ + K+
Sbjct: 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 9e-47
Identities = 73/239 (30%), Positives = 113/239 (47%), Gaps = 40/239 (16%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+L E +++ +LGE FG VYKG L + Q +A+K L G
Sbjct: 2 KLKEISLSAVRFM-------EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP 54
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF------------ 559
EEF++E L ARLQH N+V LLG + +I+ Y + L F
Sbjct: 55 LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 560 -IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618
D+ + L+ +H+V IA G+ YL S ++H+DL NVL+ + +N KISD
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISD 171
Query: 619 FGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
G+ R E+ + + +M+PE G FS+ SD++S+GV++ E+ S
Sbjct: 172 LGLFR-----EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 1e-46
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG-SGQGMEEFKN 518
W + + ++G G FG V+ G L + +AVK + +F
Sbjct: 109 WVLNHEDLVLG-------EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ 161
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E ++ + H N+V+L+G C Q ++ E + F+ + L + + +V
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMV 219
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
G A G+ YL IHRDL A N L+ KISDFGM+R E +
Sbjct: 220 GDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYAAS 271
Query: 639 GTYGY-----MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
G +PE G +S +SDV+SFG+L+ E S
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 69/231 (29%), Positives = 100/231 (43%), Gaps = 32/231 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSG-QGME 514
F + K LGEG FG V G+ +AVK L +G Q
Sbjct: 26 TVFHKRYLKKI-------RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS 78
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+K E+ ++ L H +++K GCC A + L+ EY+P SL ++ +
Sbjct: 79 GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLA 134
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+ + I G+ YLH IHRDL A NVLLDND KI DFG+A+
Sbjct: 135 QLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--- 188
Query: 633 NTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNW 677
+ V G + +PE E F SDV+SFGV + E+++ +
Sbjct: 189 -EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-46
Identities = 65/243 (26%), Positives = 107/243 (44%), Gaps = 39/243 (16%)
Query: 454 MKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSK 507
M + + I +LGEG FG V+ + +AVK L
Sbjct: 3 MHSGIHVQHIKRRDIVLK-------RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD 55
Query: 508 GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF-------- 559
+ ++F+ E L+ LQH ++VK G C D ++++EYM + L+ F
Sbjct: 56 PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDA 115
Query: 560 -----IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
+ L + +HI IA G++YL + +HRDL N L+ ++
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLV 172
Query: 615 KISDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLE 669
KI DFGM+R ++ + + VG + +M PE F+ +SDV+SFGV++ E
Sbjct: 173 KIGDFGMSR-----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 227
Query: 670 IVS 672
I +
Sbjct: 228 IFT 230
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSG-QGME 514
F+ + + LGEG FG V G+++AVK L SG +
Sbjct: 16 THFEKRFLKRI-------RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA 68
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+ K E+ ++ L H N+VK G C + + LI E++P+ SL ++ ++ +
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLK 126
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+++ I +G+ YL + +HRDL A NVL++++ KI DFG+ + D+
Sbjct: 127 QQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--- 180
Query: 633 NTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ V + +PE + F + SDV+SFGV + E+++
Sbjct: 181 -EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 38/239 (15%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG 510
D + I +LGEG FG V+ + +AVK L + S
Sbjct: 32 DACVHHIKRRDIVLK-------WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE 84
Query: 511 QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF----------- 559
++F+ E L+ LQH+++V+ G C + ++++EYM + L+ F
Sbjct: 85 SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 560 -IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618
+ L + + + +A G++YL + + +HRDL N L+ + KI D
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGD 201
Query: 619 FGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
FGM+R +I + + VG +M PE F+ +SDV+SFGV++ EI +
Sbjct: 202 FGMSR-----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
LG G FG VYKG + E +A+K L + + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+LLG C+ LI + MP L ++ + + Q ++ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPE 647
R++HRDL A NVL+ + KI+DFG+A++ G +E + + G +M+ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVS-GKK 675
+++ +SDV+S+GV V E+++ G K
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 24/218 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNE 519
WE + I +KLG G +G VY+G +AVK L + + + +EEF E
Sbjct: 8 WEMERTDITMK-------HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 59
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R + +++
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMAT 118
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH---- 635
I+ + YL + IHRDL A N L+ + K++DFG++R+ GD +
Sbjct: 119 QISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 636 -KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K + +PE A FS+KSDV++FGVL+ EI +
Sbjct: 176 IK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV---EGQEI--AVKRLSKGSG-QGME 514
F + K LG G FG V+KG + E +I +K + SG Q +
Sbjct: 8 RIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
+ + I L H ++V+LLG C L+ +Y+P SL + + L Q
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQLL 117
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
++ IA+G+ YL ++HR+L A NVLL + +++DFG+A + D+ Q
Sbjct: 118 LNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
Query: 635 HKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +M+ E G ++ +SDV+S+GV V E+++
Sbjct: 175 SE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-45
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W D + + ++G G FG V+ G + ++A+K + +G+ E+F E
Sbjct: 3 WVIDPSELTFV-------QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEA 54
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ +L H LV+L G C++ L+ E+M + L ++ + + + + +
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLD 112
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH----- 635
+ G+ YL +IHRDL A N L+ + K+SDFGM R D+ ++T
Sbjct: 113 VCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K + SPE + +S KSDV+SFGVL+ E+ S
Sbjct: 170 K------WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE D + +LG G FG V G ++A+K + +GS +EF E
Sbjct: 19 WEIDPKDLTFL-------KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEA 70
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ L H LV+L G C + +I EYM N L ++ + Q+ + +
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKD 128
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH----- 635
+ + YL + +HRDL A N L+++ K+SDFG++R DE ++
Sbjct: 129 VCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 185
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + PE FS KSD+++FGVL+ EI S
Sbjct: 186 R------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-45
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEG----QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
+G G FG VY GTL++ AVK L++ + +F E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LLG C++++ S +++ YM + L FI + + I +A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG------YMSP 646
+ +HRDL A N +LD K++DFG+AR D + V G +M+
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVS 672
E F+ KSDV+SFGVL+ E+++
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-44
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 14/213 (6%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNE 519
WE + I +KLG G +G VY+G +AVK L + + + +EEF E
Sbjct: 215 WEMERTDITMK-------HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 266
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R + +++
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMAT 325
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
I+ + YL + IHR+L A N L+ + K++DFG++R+ GD T
Sbjct: 326 QISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKF 381
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE A FS+KSDV++FGVL+ EI +
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 34/233 (14%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+ WE I + +LG+G FG VY+G +A+K +++ S +
Sbjct: 18 DEWEVAREKITMS-------RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF-------IFDQA 564
EF NE +++ ++V+LLG Q +++I E M L + + +
Sbjct: 71 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 565 RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
K I + G IA G+ YL + + +HRDL A N ++ D KI DFGM R
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR- 186
Query: 625 FGGDEIQTNTHKVVGTYGY-----MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+I + G G MSPE +G+F+ SDV+SFGV++ EI +
Sbjct: 187 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
E I +LG G FG V G ++AVK + +GS +EF E
Sbjct: 3 MELKREEITLL-------KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEA 54
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
+ +L H LVK G C + ++ EY+ N L ++ ++ L+ + + +
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYD 112
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ G+ +L + IHRDL A N L+D D+ K+SDFGM R D+ VGT
Sbjct: 113 VCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGT 165
Query: 641 ---YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE +S KSDV++FG+L+ E+ S
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W + + +G+G FG V G G ++AVK + + + F E
Sbjct: 16 WALNMKELKLL-------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEA 65
Query: 521 TLIARLQHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
+++ +L+H NLV+LLG ++ ++ EYM SL ++ + R+ L +
Sbjct: 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSL 124
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ + YL +HRDL A NVL+ D K+SDFG+ + + T
Sbjct: 125 DVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST------- 170
Query: 640 TYG------YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE E FS KSDV+SFG+L+ EI S
Sbjct: 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSK 507
++ +E D + LGEG FG V +G L ++AVK +
Sbjct: 20 EELQNKLEDVVIDRNLLILG-------KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL 72
Query: 508 G--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESMLIYEYMPNKSLDFFI 560
S + +EEF +E + H N+++LLG CI+ + M+I +M L ++
Sbjct: 73 DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
Query: 561 ---FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ + Q + + IA G+ YL S +HRDL A N +L +DM ++
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVA 189
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
DFG+++ +I + + G +++ E A+ +++ KSDV++FGV + EI +
Sbjct: 190 DFGLSK-----KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 70/214 (32%), Positives = 111/214 (51%), Gaps = 18/214 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE ++ +LG G FG V+ G ++AVK L +GS + F E
Sbjct: 8 WEVPRETLKLV-------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEA 59
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
L+ +LQH+ LV+L Q + +I EYM N SL F+ + L K + +
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQ 117
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IA G+ ++ IHRDL+A+N+L+ + ++ KI+DFG+AR+ +E T +
Sbjct: 118 IAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAK 171
Query: 641 YGY--MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE G F++KSDV+SFG+L+ EIV+
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-44
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W + + +G+G FG V G G ++AVK + + + F E
Sbjct: 188 WALNMKELKLL-------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEA 237
Query: 521 TLIARLQHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
+++ +L+H NLV+LLG ++ ++ EYM SL ++ + R+ L +
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSL 296
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ + YL +HRDL A NVL+ D K+SDFG+ + E +
Sbjct: 297 DVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKL 348
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE E FS KSDV+SFG+L+ EI S
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 70/233 (30%), Positives = 104/233 (44%), Gaps = 34/233 (14%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+L E +I LG G FG VY+G + ++AVK L + S Q
Sbjct: 23 DLKEVPRKNITLI-------RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 75
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI----FDQARAT 567
+F E +I++ H+N+V+ +G +Q+ ++ E M L F+ ++ +
Sbjct: 76 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARI 624
L +H+ IA G YL IHRD+ A N LL KI DFGMAR
Sbjct: 136 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 191
Query: 625 FGGDEIQTNTHKVVGTYGY-----MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+I ++ G M PE EG+F+ K+D +SFGVL+ EI S
Sbjct: 192 ----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-44
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
+G+G FG VY G ++ + A+K LS+ + +E F E L+ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
L+G + + ++ YM + L FI ++ + I +ARG+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL---A 141
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG-------YMS 645
+ +HRDL A N +LD K++DFG+AR +I + V + + +
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLAR-----DILDREYYSVQQHRHARLPVKWTA 196
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVS 672
E F+ KSDV+SFGVL+ E+++
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-44
Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 35/241 (14%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSK 507
+KE +E LG+G FG V + L ++AVK L
Sbjct: 9 DELKEKLEDVLIPEQQFTLG-------RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61
Query: 508 G--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES------MLIYEYMPNKSLDFF 559
+ +EEF E + H ++ KL+G +++ M+I +M + L F
Sbjct: 62 DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
Query: 560 IFD---QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616
+ L Q + + IA G+ YL S IHRDL A N +L DM +
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCV 178
Query: 617 SDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIV 671
+DFG++R +I + + G +++ E A+ L++V SDV++FGV + EI+
Sbjct: 179 ADFGLSR-----KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
Query: 672 S 672
+
Sbjct: 234 T 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-44
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
LG G FG VYKG + E +A+K L + + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+LLG C+ LI + MP L ++ + + Q ++ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPE 647
R++HRDL A NVL+ + KI+DFG+A++ G +E + + G +M+ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVS 672
+++ +SDV+S+GV V E+++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 70/233 (30%), Positives = 103/233 (44%), Gaps = 34/233 (14%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+L E +I LG G FG VY+G + ++AVK L + S Q
Sbjct: 64 DLKEVPRKNITLI-------RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 116
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI----FDQARAT 567
+F E +I++ H+N+V+ +G +Q+ ++ E M L F+ ++ +
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 176
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARI 624
L +H+ IA G YL IHRD+ A N LL KI DFGMAR
Sbjct: 177 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 232
Query: 625 FGGDEIQTNTHKVVGTYGY-----MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+I + G M PE EG+F+ K+D +SFGVL+ EI S
Sbjct: 233 ----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-43
Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE S+ KLG G FG V+ T + ++AVK + GS +E F E
Sbjct: 183 WEIPRESLKLE-------KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEA 234
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ LQH LVKL + + +I E+M SL F+ + K I
Sbjct: 235 NVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQ 292
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IA G+ ++ + IHRDL+A+N+L+ + KI+DFG+AR+ +E T +
Sbjct: 293 IAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAK 346
Query: 641 YGY--MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE G F++KSDV+SFG+L++EIV+
Sbjct: 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEG----QEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
+G G FG VY GTL++ AVK L++ + G + +F E ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LLG C++++ S +++ YM + L FI + + I +A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVGTYG-----YMSP 646
+ +HRDL A N +LD K++DFG+AR ++ + + T +M+
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK----TGAKLPVKWMAL 265
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVS 672
E F+ KSDV+SFGVL+ E+++
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 29/224 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKG-SGQGME 514
E + + + +G G FG VYKG L +A+K L G + +
Sbjct: 39 TEIHPSCVTRQ-------KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV 91
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
+F E ++ + H N+++L G + M+I EYM N +LD F+ + + +
Sbjct: 92 DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQL 149
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+ ++ GIA G+ YL + M +HRDL A N+L+++++ K+SDFG++R+ D T T
Sbjct: 150 VGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 635 HKVVGTYG------YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
G + +PE + F+ SDV+SFG+++ E+++
Sbjct: 207 TS-----GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 41/237 (17%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQE---IAVKRLSKG-SGQGME 514
D+ I + +GEG FG V K + + A+KR+ + S
Sbjct: 18 IYPVLDWNDIKFQ-------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 70
Query: 515 EFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF-------------I 560
+F E+ ++ +L H N++ LLG C L EY P+ +L F
Sbjct: 71 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+ A+ L Q+ +H +ARG+ YL S+ + IHRDL A N+L+ + KI+DFG
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 187
Query: 621 MARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
++R G E+ G +M+ E +++ SDV+S+GVL+ EIVS
Sbjct: 188 LSR---GQEVYVKKTM-----GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 65/243 (26%), Positives = 104/243 (42%), Gaps = 42/243 (17%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-S 509
D WEF + LG G FG V + + +AVK L +G +
Sbjct: 18 DASKWEFPRDRLKLG-------KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 70
Query: 510 GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES-MLIYEYMPNKSL-DF-------- 558
+E+ ++ + H N+V LLG C + M+I E+ +L +
Sbjct: 71 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 559 ----FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
+ FL + I +A+G+ +L + + IHRDL A N+LL
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 187
Query: 615 KISDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLE 669
KI DFG+AR +I + V +M+PE + +++++SDV+SFGVL+ E
Sbjct: 188 KICDFGLAR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242
Query: 670 IVS 672
I S
Sbjct: 243 IFS 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 46/235 (19%), Positives = 94/235 (40%), Gaps = 45/235 (19%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL--------VEGQEIAVKRLSKGSGQ 511
+ + LG+G F ++KG + E+ +K L K
Sbjct: 2 FHKIRNEDLIFN-------ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN 54
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDW 571
E F +++++L H++LV G C+ DE++L+ E++ SLD ++ + ++
Sbjct: 55 YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINI 112
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--------KISDFGMAR 623
++ + +A + +L +IH ++ A N+LL + + K+SD G++
Sbjct: 113 LWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
Query: 624 IFGGDEIQTNTHKVVGTYGY-----MSPEYAAEG-LFSVKSDVFSFGVLVLEIVS 672
+ + PE ++ +D +SFG + EI S
Sbjct: 170 TVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 40/229 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQGM-EE 515
E + + I +G G G V G L +A+K L G + +
Sbjct: 44 REIEASRIHIE-------KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD 96
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F +E +++ + H N+++L G + +M++ EYM N SLD F+ + + +
Sbjct: 97 FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLV 154
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ G+ G+ YL S + +HRDL A NVL+D+++ K+SDFG++R+ D
Sbjct: 155 GMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP------ 205
Query: 636 KVVGTYGY------------MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+PE A FS SDV+SFGV++ E+++
Sbjct: 206 -----DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-43
Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 43/240 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQ 511
WEF + LGEG FG V V E +AVK L + +
Sbjct: 30 WEFPRDKLTLG-------KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF----------- 558
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 83 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 559 -FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ ++ + ++ + +ARG+ YL + + IHRDL A NVL+ + KI+
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
DFG+AR +I + T G +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 200 DFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 479 NKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNL 531
+GEG FG V++ +AVK L + S +F+ E L+A + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFF---------------------IFDQARATFLD 570
VKLLG C L++EYM L+ F L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630
+++ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R I
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NI 224
Query: 631 QTNTHKVVGTYGY-----MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + M PE ++ +SDV+++GV++ EI S
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 29/222 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--EGQEI--AVKRLSKG-SGQGMEE 515
+E I +GEG FG V++G + E + A+K S E+
Sbjct: 10 YEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 62
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E + + H ++VKL+G + + +I E L F+ Q R LD I
Sbjct: 63 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLI 119
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ + YL R +HRD+ A NVL+ ++ K+ DFG++R +
Sbjct: 120 LYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 636 -----KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K +M+PE F+ SDV+ FGV + EI+
Sbjct: 177 GKLPIK------WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-42
Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
+ WE S+ KLG+G FG V+ GT +A+K L G+ E F
Sbjct: 177 DAWEIPRESLRLE-------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQ 228
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E ++ +L+H LV+L + + ++ EYM SL F+ + +L + + +
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMA 286
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
IA G+ Y+ RM +HRDL+A+N+L+ ++ K++DFG+AR+ +E
Sbjct: 287 AQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE A G F++KSDV+SFG+L+ E+ +
Sbjct: 344 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 22/220 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGSG-QGMEE 515
E D +I+ +G G FG V G L + +A+K L G + +
Sbjct: 40 KELDATNISID-------KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E +++ + H N+++L G ++ M++ EYM N SLD F+ + + +
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLV 150
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ GIA G+ YL S M +HRDL A N+L+++++ K+SDFG+ R+ D +
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP--EAAY 205
Query: 636 KVVGT---YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
G + SPE A F+ SDV+S+G+++ E++S
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 480 KLGEGGFGPVYKGTLVEGQE---IAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLL 535
+LG G FG V +G ++ +A+K L +G+ EE E ++ +L + +V+L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G C QA+ ML+ E L F+ + + ++ ++ G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT---YGYMSPEYAAEG 652
+HRDL A NVLL N KISDFG+++ G D+ + +PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFR 188
Query: 653 LFSVKSDVFSFGVLVLEIVS 672
FS +SDV+S+GV + E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 68/246 (27%), Positives = 107/246 (43%), Gaps = 50/246 (20%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGM 513
WEF ++ LGEG FG V K T +AVK L + S +
Sbjct: 18 WEFPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF-------------- 558
+ +E ++ ++ H +++KL G C Q +LI EY SL F
Sbjct: 71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 559 ------FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
D L I I++G+ YL + M+++HRDL A N+L+
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGR 187
Query: 613 NPKISDFGMAR-IFGGDEIQTNTH-----KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
KISDFG++R ++ D + K +M+ E + +++ +SDV+SFGVL
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVL 241
Query: 667 VLEIVS 672
+ EIV+
Sbjct: 242 LWEIVT 247
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 3e-42
Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
+ WE S+ KLG+G FG V+ GT +A+K L G+ E F
Sbjct: 260 DAWEIPRESLRLE-------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQ 311
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E ++ +L+H LV+L + + ++ EYM SL F+ + +L + + +
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMA 369
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
IA G+ Y+ RM +HRDL+A+N+L+ ++ K++DFG+AR+ +E
Sbjct: 370 AQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE A G F++KSDV+SFG+L+ E+ +
Sbjct: 427 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 43/240 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQ 511
WEF + LGEG FG V V E +AVK L + +
Sbjct: 76 WEFPRDKLTLG-------KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 128
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF----------- 558
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 129 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 188
Query: 559 -FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ ++ + ++ + +ARG+ YL + + IHRDL A NVL+ + KI+
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
DFG+AR +I + T G +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 246 DFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-42
Identities = 58/222 (26%), Positives = 88/222 (39%), Gaps = 25/222 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL--VEGQEI--AVKRLSKG---SGQGM 513
+ KLG+G FG V +G G+ + AVK L + M
Sbjct: 13 CLIGEKDLRLL-------EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573
++F EV + L HRNL++L G + ++ E P SL + +
Sbjct: 66 DDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGHFLLGT 122
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+A G+ YL R IHRDL A N+LL KI DFG+ R ++
Sbjct: 123 LSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 634 THKVVGT---YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + + +PE FS SD + FGV + E+ +
Sbjct: 180 MQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--EGQEI--AVKRLSKG-SGQGMEE 515
+ + LGEG FG VY+G +G++I AVK K + E+
Sbjct: 7 YGIAREDVVLN-------RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK 59
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F +E ++ L H ++VKL+G + + + +I E P L ++ + L +
Sbjct: 60 FMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKVLTLV 116
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
I + + YL + +HRD+ N+L+ + K+ DFG++R ++ +
Sbjct: 117 LYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 173
Query: 636 -----KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K +MSPE F+ SDV+ F V + EI+S
Sbjct: 174 TRLPIK------WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 9e-42
Identities = 66/238 (27%), Positives = 106/238 (44%), Gaps = 39/238 (16%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
E WEF ++ LG G FG V + T ++AVK L
Sbjct: 39 EKWEFPRNNLQFG-------KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-----------DFF 559
E +E+ +++ L QH N+V LLG C ++I EY L +
Sbjct: 92 EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 560 IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619
+ + +H +A+G+ +L + IHRD+ A NVLL N KI DF
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 620 GMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
G+AR +I +++ +V +M+PE + +++V+SDV+S+G+L+ EI S
Sbjct: 209 GLAR-----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 64/240 (26%), Positives = 107/240 (44%), Gaps = 43/240 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQ 511
WE + LGEG FG V + ++AVK L + +
Sbjct: 64 WELPRDRLVLG-------KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 116
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF----------- 558
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 176
Query: 559 -FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ L + + +ARG+ YL + + IHRDL A NVL+ D KI+
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 233
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
DFG+AR +I + T G +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 234 DFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGM 513
WEF ++ LG G FG V + T +AVK L
Sbjct: 18 WEFPRNRLSFG-------KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL---------------D 557
E +E+ +++ L H N+V LLG C +++I EY L
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ LD + + +A+G+ +L + IHRDL A N+LL + KI
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKIC 187
Query: 618 DFGMAR-IFGGDEIQTNTH-----KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIV 671
DFG+AR I + K +M+PE +++ +SDV+S+G+ + E+
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 672 S 672
S
Sbjct: 242 S 242
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-41
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEI--AVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKL 534
+LG G FG V KG ++ AVK L +E E ++ +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+G C +A+ ML+ E L+ ++ + + I +V ++ G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL---EES 136
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG------YMSPEY 648
+HRDL A NVLL KISDFG+++ DE + +PE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVS 672
FS KSDV+SFGVL+ E S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-40
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--EGQEI--AVKRLSKG-SGQGMEE 515
+E I +GEG FG V++G + E + A+K S E+
Sbjct: 385 YEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK 437
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E + + H ++VKL+G + + +I E L F+ Q R LD I
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLI 494
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ + YL R +HRD+ A NVL+ ++ K+ DFG++R +
Sbjct: 495 LYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +M+PE F+ SDV+ FGV + EI+
Sbjct: 552 GKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 65/246 (26%), Positives = 105/246 (42%), Gaps = 50/246 (20%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGM 513
WEF ++ LG G FG V T ++AVK L +
Sbjct: 40 WEFPRENLEFG-------KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 92
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF------------- 558
E +E+ ++ +L H N+V LLG C + LI+EY L ++
Sbjct: 93 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152
Query: 559 ------FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
+ ++ L ++ + +A+G+ +L +HRDL A NVL+ +
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGK 209
Query: 613 NPKISDFGMAR-IFGGDEIQTNTH-----KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
KI DFG+AR I + K +M+PE EG++++KSDV+S+G+L
Sbjct: 210 VVKICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGIL 263
Query: 667 VLEIVS 672
+ EI S
Sbjct: 264 LWEIFS 269
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 4e-40
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEI--AVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKLL 535
+LG G FG V +G + ++I A+K L +G+ + EE E ++ +L + +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G C QA+ ML+ E L F+ + + ++ ++ G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT---YGYMSPEYAAEG 652
+HR+L A NVLL N KISDFG+++ G D+ + +PE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFR 514
Query: 653 LFSVKSDVFSFGVLVLEIVS 672
FS +SDV+S+GV + E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
+F +G GGFG V+K ++G+ +KR+ + E+ + EV +A+L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 532 VKLLGCCIQADESM----------------LIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
V GC D + E+ +L+ +I ++ R LD +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+ I +G+ Y+H ++I+RDLK SN+ L + KI DFG+ D +T
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--- 179
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
+ GT YMSPE + + + D+++ G+++ E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 61/245 (24%), Positives = 101/245 (41%), Gaps = 32/245 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS-KGSGQGMEEFKNEVTLIARLQHRN 530
+F LG GGFG V++ V+ A+KR+ E+ EV +A+L+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 531 LVKLLGCCI---------QADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
+V+ + + + +Y + ++L ++ + + +HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH--- 635
IA + +LH ++HRDLK SN+ D K+ DFG+ DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 636 -------KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
VGT YMSPE +S K D+FS G+++ E++ + FS
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVRT 236
Query: 689 LGHVR 693
L VR
Sbjct: 237 LTDVR 241
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-39
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+ + K+GEG FG +G++ +K ++ S + EE + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-----LDW--QKRIHIVGGIA 582
N+V+ + ++ +Y L I Q F LDW Q I
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ--------IC 135
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
+ ++H +I+HRD+K+ N+ L D ++ DFG+AR+ +GT
Sbjct: 136 LALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPY 190
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y+SPE ++ KSD+++ G ++ E+ + K
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
++G G F VYKG E+A + K + + FK E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 537 CCIQADESM----LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+ L+ E M + +L ++ R + + I +G+ +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 593 RMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
IIHRDLK N+ + + KI D G+A + + V+GT +M+PE E
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEE 204
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ DV++FG+ +LE+ + + +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQN 234
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
NF K+G G F VY+ L++G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILY 587
N++K I+ +E ++ E L I + + + + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
+H R++HRD+K +NV + K+ D G+ R F ++ +VGT YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
E ++ KSD++S G L+ E+ + +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 10/210 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+++ +G G +G K +G+ + K L G + + +EV L+ L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 530 NLVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGIL 586
N+V+ I + L + EY L I + +LD + + ++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 587 YLHQ--DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
H+ D ++HRDLK +NV LD N K+ DFG+ARI D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
SPE ++ KSD++S G L+ E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 56/247 (22%), Positives = 98/247 (39%), Gaps = 34/247 (13%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+F LG+G FG V K ++ + A+K++ + + +EV L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI---------FD--QARATFLDWQKRIHIVG 579
+V+ ++ + + KS F +D + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF------------GG 627
I + Y+H IIHRDLK N+ +D N KI DFG+A+
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 628 DEIQTNTHKVVGTYGYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
N +GT Y++ E G ++ K D++S G++ E++ FS
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FSTGMERV 235
Query: 687 NLLGHVR 693
N+L +R
Sbjct: 236 NILKKLR 242
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G +G VY G L IA+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSRMR 595
+ + E +P S + R+ + + +G + IL YLH +
Sbjct: 90 ENGFIKIFMEQVPGGS----LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142
Query: 596 IIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE---YAAE 651
I+HRD+K NVL++ KISDFG ++ G T T GT YM+PE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPR 200
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNW 677
G + +D++S G ++E+ +GK +
Sbjct: 201 G-YGKAADIWSLGCTIIEMATGKPPF 225
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNL--VKL 534
++G GG V++ + Q A+K ++ Q ++ ++NE+ + +LQ + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
I ++ E N L+ ++ + +D +R + + +HQ
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 146
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE------- 647
I+H DLK +N L+ + K+ DFG+A D VGT YM PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 648 ----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ S KSDV+S G ++ + GK
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNL--VKL 534
++G GG V++ + Q A+K ++ Q ++ ++NE+ + +LQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
I ++ E N L+ ++ + +D +R + + +HQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE------- 647
I+H DLK +N L+ + K+ DFG+A D VGT YM PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 648 ----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ S KSDV+S G ++ + GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNL--VKL 534
++G GG V++ + Q A+K ++ Q ++ ++NE+ + +LQ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
I ++ E N L+ ++ + +D +R + + +HQ
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE------- 647
I+H DLK +N L+ + K+ DFG+A D VG YM PE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 648 ----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ S KSDV+S G ++ + GK
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLGEGGF V L +G A+KR+ Q EE + E + H N+++L+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 539 IQADESM----LIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
++ + L+ + +L + + + FL + + ++ GI RG+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMAR-----IFGGDEIQTNTH--KVVGTYGYMSP 646
HRDLK +N+LL ++ P + D G + G + T T Y +P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 647 EYAAEGLFSV--------KSDVFSFGVLVLEIVSGK 674
E LFSV ++DV+S G ++ ++ G+
Sbjct: 213 E-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 50/232 (21%), Positives = 96/232 (41%), Gaps = 25/232 (10%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGC 537
LG+G V++G + G A+K + S + E ++ +L H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 538 CIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+ + E+ P SL + + + A L + + ++ + G+ +L +
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 595 RIIHRDLKASNVLL----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--- 647
I+HR++K N++ D K++DFG AR DE + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYE 188
Query: 648 -----YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR-FSHPDHDHNLLGHVR 693
+ + D++S GV +G +R F P + ++ +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-34
Identities = 50/234 (21%), Positives = 96/234 (41%), Gaps = 25/234 (10%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGC 537
LG+G V++G + G A+K + S + E ++ +L H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74
Query: 538 CIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+ + E+ P SL + + + A L + + ++ + G+ +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 595 RIIHRDLKASNVLL----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--- 647
I+HR++K N++ D K++DFG AR DE + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYE 188
Query: 648 -----YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR-FSHPDHDHNLLGHVRVE 695
+ + D++S GV +G +R F P + ++ +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 59/236 (25%), Positives = 109/236 (46%), Gaps = 12/236 (5%)
Query: 440 RKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQ 498
+ ++H + L SY K+GEG G V G+
Sbjct: 14 GTENLYFQSGVVTHEQFKAALRMV--VDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR 71
Query: 499 EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558
++AVK + Q E NEV ++ QH N+V++ + +E ++ E++ +L
Sbjct: 72 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT- 130
Query: 559 FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618
D L+ ++ + + + + YLH +IHRD+K+ ++LL D K+SD
Sbjct: 131 ---DIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSD 184
Query: 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
FG D + + +VGT +M+PE + L++ + D++S G++V+E+V G+
Sbjct: 185 FGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 54/204 (26%), Positives = 105/204 (51%), Gaps = 10/204 (4%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ + K+G+G G VY V GQE+A+++++ E NE+ ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V L + DE ++ EY+ SL D T +D + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
+ K D++S G++ +E++ G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 46/216 (21%), Positives = 78/216 (36%), Gaps = 28/216 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QH 528
+F ++LG G +G V+K +G+ AVKR + EV ++ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 529 RNLVKLLGCCIQADESMLIY-EYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGI 581
V+L + + + E SL +A+
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD--------T 166
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
+ +LH ++H D+K +N+ L K+ DFG+ G G
Sbjct: 167 LLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDP 220
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
YM+PE + +DVFS G+ +LE+ +
Sbjct: 221 RYMAPELLQGS-YGTAADVFSLGLTILEVACNMELP 255
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+GGF ++ + + + A K + K E E+++ L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 537 CCIQADESM--LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDS 592
D ++ E +SL + + R + + R + + I G YLH++
Sbjct: 109 FF--EDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN- 160
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV-GTYGYMSPEYAAE 651
R+IHRDLK N+ L+ D+ KI DFG+A D KV+ GT Y++PE ++
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKVLCGTPNYIAPEVLSK 215
Query: 652 GLFSVKSDVFSFGVLVLEIVSGK 674
S + DV+S G ++ ++ GK
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK 238
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-33
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFK-NEVTLIARLQHRNLVKLLG 536
++G G FG V++ G + AVK++ +E F+ E+ A L +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG 117
Query: 537 CCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ + E + SL + RA ++ +G G+ YLH
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA--------LYYLGQALEGLEYLHT- 168
Query: 592 SRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHK---VVGTYGYMSPE 647
RI+H D+KA NVLL +D + + DFG A D + + + GT +M+PE
Sbjct: 169 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
K D++S ++L +++G W
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
KLG GG VY + ++A+K + + + ++ F+ EV ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ D L+ EY+ +L +I L I+ I GI + H MR
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
I+HRD+K N+L+D++ KI DFG+A+ + T T+ V+GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATD 190
Query: 656 VKSDVFSFGVLVLEIVSGK 674
+D++S G+++ E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-33
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQ 527
+ + +LG GGFG V + + G+++A+K+ + E + E+ ++ +L
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 528 HRNLVKLL------GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
H N+V D +L EY L ++ L ++ I
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ + YLH+ RIIHRDLK N++L + KI D G A+ E + V
Sbjct: 131 SSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFV 184
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT Y++PE + ++V D +SFG L E ++G
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+GGF ++ + + + A K + K E E+++ L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 537 CCIQADESM--LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDS 592
D ++ E +SL + + R + + R + + I G YLH
Sbjct: 83 FF--EDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH--- 132
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
R R+IHRDLK N+ L+ D+ KI DFG+A D + + GT Y++PE ++
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 190
Query: 653 LFSVKSDVFSFGVLVLEIVSGK 674
S + DV+S G ++ ++ GK
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 51/242 (21%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+++D E + K +F + LG G G + + + +++AVKR+ +
Sbjct: 6 SLEQDDGDEETSVVIVGK--ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---EC 60
Query: 513 MEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM--LIYEYMPNKSLDFFIFDQARATFL 569
EV L+ +H N+++ C + D + E +L ++ + +
Sbjct: 61 FSFADREVQLLRESDEHPNVIRYF--CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAH 115
Query: 570 DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARI 624
+ I ++ G+ +LH + I+HRDLK N+L+ + ISDFG+ +
Sbjct: 116 LGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 625 FGGDEIQTNTHK-VVGTYGYMSPEY---AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680
+ V GT G+++PE + + D+FS G + ++S
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS----- 227
Query: 681 HP 682
HP
Sbjct: 228 HP 229
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHR 529
D+ +LG G +G V K V GQ +AVKR+ + + Q + ++ + R
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGIL- 586
V G + + + E M + SLD F +D + I I+G IA I+
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 587 ---YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+LH S++ +IHRD+K SNVL++ K+ DFG++ D++ + G Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDI--DAGCKPY 175
Query: 644 MSPE----YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
M+PE + +SVKSD++S G+ ++E+ RF +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAIL----RFPYDSWGT 218
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 24/242 (9%)
Query: 441 KKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQE 499
KKL++ L + + + L + K D F ++LG G G V+K + G
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 500 IAVKRLS-KGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558
+A K + + + E+ ++ +V G E + E+M SLD
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD- 119
Query: 559 FIFDQARATFLDWQKRI--HIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDM 612
L RI I+G ++ ++ YL + +I+HRD+K SN+L+++
Sbjct: 120 --------QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRG 169
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K+ DFG++ G I + + VGT YMSPE +SV+SD++S G+ ++E+
Sbjct: 170 EIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 673 GK 674
G+
Sbjct: 226 GR 227
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+G F VY+ + G E+A+K + K + GM + +NEV + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 537 CCIQADESM--LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDS 592
D + L+ E N + + R + H + I G+LYLH
Sbjct: 79 YF--EDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH--- 129
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
I+HRDL SN+LL +MN KI+DFG+A + T + GT Y+SPE A
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRS 187
Query: 653 LFSVKSDVFSFGVLVLEIVSGK 674
++SDV+S G + ++ G+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGR 209
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 10/204 (4%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ F KLGEG +G VYK E GQ +A+K++ ++E E++++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VK G + + ++ EY S+ I + R L + I+ +G+ YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
MR IHRD+KA N+LL+ + + K++DFG+A + NT V+GT +M+PE
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
E ++ +D++S G+ +E+ GK
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 54/237 (22%), Positives = 87/237 (36%), Gaps = 39/237 (16%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
L EGGF VY+ + G+E A+KRL + EV + +L H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 538 CIQADESM-------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
E L+ + L F+ L + I R + ++H+
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK----------VVGT 640
+ IIHRDLK N+LL N K+ DFG A + + + T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 641 YGYMSPEYAAEGLFSV--------KSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
Y +PE + + K D+++ G ++ + + HP D L
Sbjct: 214 PMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ------HPFEDGAKL 259
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
LG GG V+ L + +++AVK L F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 536 GCCIQADESMLIY----EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ + EY+ +L + + + ++ I ++ + + + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH-- 133
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYGYMSPEYAA 650
+ IIHRD+K +N+++ K+ DFG+AR T T V+GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
+SDV+S G ++ E+++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 41/213 (19%), Positives = 82/213 (38%), Gaps = 24/213 (11%)
Query: 480 KLGEGGFGPVYKG--TLVEGQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLL- 535
+ GG G +Y V G+ + +K L G + E +A + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 536 -GCCIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ Y EY+ +SL +++ L + I + I + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
+ +++ DLK N++L + K+ D G + + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQAPEI-VR 250
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684
+V +D+++ G + + + D
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHR 529
++ ++G G +G V K GQ +AVKR+ S + ++ ++ ++ R
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGIL- 586
+V+ G + + + E M + S D F + + I I+G I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 587 ---YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+L ++IIHRD+K SN+LLD N K+ DFG++ +T G Y
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191
Query: 644 MSPE----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
M+PE A+ + V+SDV+S G+ + E+ +G+
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 54/209 (25%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ + +LG+G FG VYK E G A K + S + +E++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKLLG + ++ E+ P ++D I + + Q ++ + + + +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--- 647
RIIHRDLKA NVL+ + + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 648 --YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + K+D++S G+ ++E+ +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHR 529
+ F K+G+G FG V+KG + +A+K + + +E+ + E+T++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
+ K G ++ + +I EY+ S D LD + I+ I +G+ YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
+ IHRD+KA+NVLL K++DFG+A +I+ NT VGT +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + K+D++S G+ +E+ G+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGE 216
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 42/225 (18%), Positives = 71/225 (31%), Gaps = 28/225 (12%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT------LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
+ ++ LGEG F VY+ T Q+ +K + EF L+ R
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMER 120
Query: 526 LQ---HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF--LDWQKRIHIVGG 580
L+ +K + + S+L+ E +L I + I
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-----------KISDFGMARIFGGDE 629
+ I +H IIH D+K N +L N + D G +
Sbjct: 181 MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
T T G+ E + ++ + D F V ++ G
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 480 KLGEGGFGPVYKGTLVE--GQEIAVKRLSK----------------GSGQGMEE-FKNEV 520
L +G F + L E + A+K+ K S + + FKNE+
Sbjct: 38 TLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 521 TLIARLQHRNLVKLLGCCIQADESM--LIYEYMPNKSL-----DFFIFDQARATFLDWQK 573
+I +++ + G I + +IYEYM N S+ FF+ D+ F+ Q
Sbjct: 95 QIITDIKNEYCLTCEG--IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
I+ + Y+H + I HRD+K SN+L+D + K+SDFG + +I+
Sbjct: 153 IKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG- 209
Query: 634 THKVVGTYGYMSPE-YAAEGLFS-VKSDVFSFGVLVLEIVSGK 674
GTY +M PE ++ E ++ K D++S G+ + +
Sbjct: 210 ---SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 53/237 (22%), Positives = 89/237 (37%), Gaps = 36/237 (15%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARL-Q 527
T F K+G G FG V+K ++G A+KR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 528 HRNLVKLLGCCIQADESMLIY-EYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGI 585
H ++V+ + D+ MLI EY SL I + R ++ + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNP-------------------KISDFGMARIFG 626
Y+H M ++H D+K SN+ + P KI D G
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 627 GDEIQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
++ G +++ E E K+D+F+ + V+ + R
Sbjct: 185 -----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 54/186 (29%), Positives = 95/186 (51%), Gaps = 26/186 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+NF K+GEG +G VYK + G+ +A+K++ ++ E++L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN--KSLDFFIFDQARATFLDWQKRIHIVGGI 581
L H N+VKLL ++ L++E++ K D + T + + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQL 112
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
+G+ + H R++HRDLK N+L++ + K++DFG+AR F G ++T TH+VV T
Sbjct: 113 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TL 167
Query: 642 GYMSPE 647
Y +PE
Sbjct: 168 WYRAPE 173
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEE-FKNEVTLIARLQH 528
++F LG+G FG VY + +A+K L K G+E + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 529 RNLVKLLGCCIQADES--MLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGI 581
N+++L G D + LI EY P ++ + FD+ R + +
Sbjct: 69 PNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE--------L 118
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
A + Y H R+IHRD+K N+LL + KI+DFG + + GT
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTL 171
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y+ PE + K D++S GVL E + GK
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 17/202 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHRNLVKL- 534
+G GG G VY+ V + +A+K +S + E RLQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 535 -LGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
G + D + + + L + Q L + + IV I + H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH--- 151
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
HRD+K N+L+ D + DFG+A DE T VGT YM+PE +E
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 653 LFSVKSDVFSFGVLVLEIVSGK 674
+ ++D+++ ++ E ++G
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 28/229 (12%), Positives = 53/229 (23%), Gaps = 43/229 (18%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
L G V+ VE ++ A+K + S +E ARL + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 537 CC--------------------------IQADESMLIYEYMPNKSLDFFIFDQARATF-- 568
+L+ F F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 569 -LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
+ + R L ++H N+ + D + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG- 245
Query: 628 DEIQTNTHKVVGTYGYMSPEY--AAEGLFSVKSDVFSFGVLVLEIVSGK 674
T Y E+ A+ F+ + + G+ + +
Sbjct: 246 ----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 54/188 (28%), Positives = 94/188 (50%), Gaps = 32/188 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIA 524
+ + K+GEG +G VYK +G+ +A+KR+ ++ E++L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIVG 579
L H N+V L+ L++E+M K LD ++ +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ RG+ + H + RI+HRDLK N+L+++D K++DFG+AR F G +++ TH+VV
Sbjct: 128 -LLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV- 181
Query: 640 TYGYMSPE 647
T Y +P+
Sbjct: 182 TLWYRAPD 189
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-29
Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 36/229 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNL 531
+ S LG G G V +G+ +AVKR+ + E+ L+ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 532 VKLLGCCIQADESM-LIYEYMPNKSLDFFI----FDQARATFLDWQKRIHIVGGIARGIL 586
++ C D + + E N +L + I ++ IA G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 587 YLHQDSRMRIIHRDLKASNVLLDN-------------DMNPKISDFGMARIFGGDE--IQ 631
+LH ++IIHRDLK N+L+ ++ ISDFG+ + + +
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 632 TNTHKVVGTYGYMSPE-------YAAEGLFSVKSDVFSFGVLVLEIVSG 673
TN + GT G+ +PE + + D+FS G + I+S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 29/233 (12%), Positives = 63/233 (27%), Gaps = 43/233 (18%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH-------- 528
LG+ + T G+ V +++ K EV + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 529 --------RNLVKLLGCC-----IQADESMLIYEY---MPNKSLDFF-----IFDQARAT 567
+LVK + M + P + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 568 -FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
L R+ + + R + LH ++H L+ +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 627 GDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGK 674
G + + + L + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 44/189 (23%), Positives = 85/189 (44%), Gaps = 33/189 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ K+GEG +G V+K + +A+KR+ +++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIV 578
L+H+N+V+L + L++E+ K D D +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ +G+ + H ++HRDLK N+L++ + K+++FG+AR F G ++ + +VV
Sbjct: 110 --LLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
Query: 639 GTYGYMSPE 647
T Y P+
Sbjct: 164 -TLWYRPPD 171
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQ 527
F+ ++G G FG VY V + +A+K++S K S + ++ EV + +L+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H N ++ GC ++ + L+ EY + D + + + + + + G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH +IHRD+KA N+LL K+ DFG A N+ VGT +M+PE
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPE 220
Query: 648 YAA---EGLFSVKSDVFSFGVLVLEIVSGK 674
EG + K DV+S G+ +E+ K
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 32/188 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIA 524
+ + K+GEG +G VYK G+ A+K++ +E+ E++++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIVG 579
L+H N+VKL +L++E++ K LD + A Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ GI Y H R++HRDLK N+L++ + KI+DFG+AR F G ++ TH++V
Sbjct: 109 -LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV- 162
Query: 640 TYGYMSPE 647
T Y +P+
Sbjct: 163 TLWYRAPD 170
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 22/238 (9%)
Query: 451 MSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS 509
M+ L E D +++ F +G G +G VYKG V+ GQ A+K + +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVT 60
Query: 510 GQGMEEFKNEVTLIARL-QHRNLVKLLGC------CIQADESMLIYEYMPNKSL-DFFIF 561
G EE K E+ ++ + HRN+ G D+ L+ E+ S+ D +
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LI 118
Query: 562 DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
+ L + +I I RG+ +LHQ ++IHRD+K NVLL + K+ DFG+
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 622 ARIFGGDEIQTNTHKVVGTYGYMSPE-----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + NT +GT +M+PE + + KSD++S G+ +E+ G
Sbjct: 176 SAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 60/243 (24%), Positives = 101/243 (41%), Gaps = 30/243 (12%)
Query: 444 KKQGLTKMSHMKEDMELWEFDFASIAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQ 498
++ L ++ ++ I + + KLG G +G V
Sbjct: 10 GRENLYFQGDLQATPGMF------ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 499 EIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556
E A+K + K S + EV ++ L H N++KL L+ E L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 557 DFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---D 611
FD R F + I+ + G+ YLH+ I+HRDLK N+LL++ D
Sbjct: 124 ----FDEIIHRMKFNEVDAA-VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKD 175
Query: 612 MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIV 671
KI DFG++ +F + + +GT Y++PE + K DV+S GV++ ++
Sbjct: 176 ALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILL 231
Query: 672 SGK 674
+G
Sbjct: 232 AGY 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 20/229 (8%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--S 509
H + + + LG+G FG V K QE AVK ++K
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 510 GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARAT 567
+ EV L+ +L H N++KL + ++ E L FD R
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKR 117
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARI 624
F + I+ + GI Y+H+ I+HRDLK N+LL++ D + KI DFG++
Sbjct: 118 FSEHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
F + +GT Y++PE G + K DV+S GV++ ++SG
Sbjct: 174 FQQNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 8e-28
Identities = 50/242 (20%), Positives = 90/242 (37%), Gaps = 26/242 (10%)
Query: 451 MSHMK--EDMELWEFDFASIAKATDNFASYNKLGEG--GFGPVYKGTLVE-GQEIAVKR- 504
M+H L+ +S + +G+G V G+ + V+R
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI 60
Query: 505 -LSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ 563
L S + + + E+ + H N+V I +E ++ +M S D
Sbjct: 61 NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA----KDL 116
Query: 564 ARATFLDWQKRIHIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619
F+D + I I +G+L Y+H M +HR +KAS++L+ D +S
Sbjct: 117 ICTHFMDGMNELAI-AYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGL 172
Query: 620 GMARIFGGDEIQTNT-----HKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVS 672
+ V ++SPE + L + KSD++S G+ E+ +
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232
Query: 673 GK 674
G
Sbjct: 233 GH 234
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 33/232 (14%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGME 514
+ + ++ + ++G G G V+K + G IAVK++ G+ + +
Sbjct: 14 TIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68
Query: 515 EFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573
++ ++ + +V+ G I + + E M + Q
Sbjct: 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--------KRMQG 119
Query: 574 RI--HIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
I I+G + I+ YL + +IHRD+K SN+LLD K+ DFG++
Sbjct: 120 PIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177
Query: 628 DEIQTNTHKVVGTYGYMSPE-----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
D+ + + G YM+PE + + +++DV+S G+ ++E+ +G+
Sbjct: 178 DKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 468 IAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK---GSGQGMEEFKNE 519
+ +T F+ LG+G FG V GQE AVK +SK E E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHI 577
V L+ +L H N++KL L+ E L FD +R F + I
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RI 131
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQTNT 634
+ + GI Y+H+ +I+HRDLK N+LL++ D N +I DFG++ F +
Sbjct: 132 IRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--- 185
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+GT Y++PE G + K DV+S GV++ ++SG
Sbjct: 186 KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 463 FDFASIAKATDNFASY------NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE 515
FD + S+ LG G FG V+K G ++A K + + EE
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQK 573
KNE++++ +L H NL++L ++ +L+ EY+ L FD+ + L
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELD 188
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQ 631
I + I GI ++HQ M I+H DLK N+L N KI DFG+AR + E
Sbjct: 189 TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245
Query: 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
GT +++PE S +D++S GV+
Sbjct: 246 K---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 20/237 (8%)
Query: 440 RKKLKKQGLTKMSHMKEDMELWE-FDFASIAKATDNFASY----NKLGEGGFGPVYKGTL 494
+ + K G + K ++W+ + + + Y +LG G FG V++
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72
Query: 495 VE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553
G+ K ++ KNE++++ +L H L+ L E +LI E++
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 554 KSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611
L FD+ A + + I+ + G+ ++H+ I+H D+K N++ +
Sbjct: 133 GEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETK 185
Query: 612 MNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
KI DFG+A DEI T + +PE +D+++ GVL
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGC 537
KLG G FG V+ G E +K ++K Q E + E+ ++ L H N++K+
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 538 CIQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
++ E L + + QAR L ++ + + Y H +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 597 IHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
+H+DLK N+L + KI DFG+A +F DE T GT YM+PE +
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST---NAAGTALYMAPE-VFKRD 201
Query: 654 FSVKSDVFSFGV 665
+ K D++S GV
Sbjct: 202 VTFKCDIWSAGV 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+G FG VY + +A+K L K +G+E + E+ + + L+H N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 537 CCIQADESM--LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLH 589
D L+ E+ P L + FD+ R+ + +A + Y H
Sbjct: 82 YF--HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH 131
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
++IHRD+K N+L+ KI+DFG + +T + GT Y+ PE
Sbjct: 132 ---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MCGTLDYLPPEMI 184
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGK 674
K D++ GVL E + G
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 30/189 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ + LGEG F VYK Q +A+K++ G E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN--KSL---DFFIFDQARATFLDWQKRIHIV 578
L H N++ LL L++++M + + + + +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM------ 120
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+G+ YLHQ I+HRDLK +N+LLD + K++DFG+A+ F G + TH+VV
Sbjct: 121 --TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV 174
Query: 639 GTYGYMSPE 647
T Y +PE
Sbjct: 175 -TRWYRAPE 182
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 51/245 (20%), Positives = 89/245 (36%), Gaps = 19/245 (7%)
Query: 435 LFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL 494
+ I R +L + L + M+E L + + I + +N E +
Sbjct: 33 NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR------YFNAWLETPPEKWQEEMD 86
Query: 495 VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554
+ S M+ ++ + +N V L + + +
Sbjct: 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKE 146
Query: 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
+L ++ + + +HI IA + +LH ++HRDLK SN+ D
Sbjct: 147 NLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVV 203
Query: 615 KISDFGMARIFGGDEIQTNT----------HKVVGTYGYMSPEYAAEGLFSVKSDVFSFG 664
K+ DFG+ DE + VGT YMSPE +S K D+FS G
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263
Query: 665 VLVLE 669
+++ E
Sbjct: 264 LILFE 268
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 37/195 (18%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN-----EVTLIA 524
++ F KLG G + VYKG G +A+K + S +G E++L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLMK 58
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA-- 582
L+H N+V+L ++ L++E+M D ++D + + G+
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFM----------DNDLKKYMDSRTVGNTPRGLELN 108
Query: 583 ----------RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+G+ + H +I+HRDLK N+L++ K+ DFG+AR F G + T
Sbjct: 109 LVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNT 164
Query: 633 NTHKVVGTYGYMSPE 647
+ +VV T Y +P+
Sbjct: 165 FSSEVV-TLWYRAPD 178
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVK-----RLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
+G+G F V + E GQ+ AVK + + G E+ K E ++ L+H ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQDS 592
LL +++E+M L F I +A A H + I + Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 593 RMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
IIHRD+K VLL +N K+ FG+A G VGT +M+PE
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVV 205
Query: 650 AEGLFSVKSDVFSFGVL 666
+ DV+ GV+
Sbjct: 206 KREPYGKPVDVWGCGVI 222
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 55/213 (25%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLS-KGSGQGMEEFKNEVTLIARLQHRN 530
D++ +G G V +++A+KR++ + M+E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+V + DE L+ + + S+ + ++ LD I+ + G+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM-ARIFGGDEIQTNTHK--VVGTYG 642
YLH + IHRD+KA N+LL D + +I+DFG+ A + G +I N + VGT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 643 YMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGK 674
+M+PE + + K+D++SFG+ +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 7e-27
Identities = 32/239 (13%), Positives = 69/239 (28%), Gaps = 54/239 (22%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ--------- 527
LG+ + T E G+ V +++ K EV + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 528 ----------------HRNLVKLLGCCIQADESM--LIYEYMPNKSLDFF--IFDQARA- 566
+ ++++ +Y M + F + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 567 TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
L R+ + + R + LH ++H L+ +++LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 627 GDEIQTNTHKVVGTYGYMSPEYAA-----------EGLFSVKSDVFSFGVLVLEIVSGK 674
+ G+ PE A L + D ++ G+++ I
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQH 528
+DN+ +LG+G F V + G E A K ++ S + ++ + E + +LQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGIL 586
N+V+L + L+++ + L F+ AR + + H + I I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
Y H I+HR+LK N+LL K++DFG+A E H GT GY
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 173
Query: 644 MSPEYAAEGLFSVKSDVFSFGV 665
+SPE + +S D+++ GV
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGV 195
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 20/213 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFK 517
+ + + LG+G FG V K QE AVK ++K +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 518 NEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRI 575
EV L+ +L H N++KL + ++ E L FD+ R F +
Sbjct: 70 REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA- 124
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQT 632
I+ + GI Y+H+ I+HRDLK N+LL + D + KI DFG++ F +
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGV 665
+GT Y++PE G + K DV+S GV
Sbjct: 182 ---DRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 468 IAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNEV 520
+ A+ F+ +LG+G F V + G E A K ++ S + ++ + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIV 578
+ +LQH N+V+L + L+++ + L F+ AR + + H +
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCI 134
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTH 635
I I Y H I+HR+LK N+LL K++DFG+A E H
Sbjct: 135 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WH 188
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGV 665
GT GY+SPE + +S D+++ GV
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 469 AKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLI 523
+ Y N +G G +G V A K++ K + ++ FK E+ ++
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGI 581
L H N+++L + L+ E L F++ + F + I+ +
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAA-RIMKDV 115
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ Y H+ + + HRDLK N L D K+ DFG+A F ++ V
Sbjct: 116 LSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR---TKV 169
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGV 665
GT Y+SP+ EGL+ + D +S GV
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGV 195
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
D++ + +LG G FG V++ T G A K + E + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYL 588
LV L +E ++IYE+M L F++ + + + + + +G+ ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
H+ +H DLK N++ + K+ DFG+ + + GT + +P
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325
Query: 647 EYAAEGLFSVKSDVFSFGVLV 667
E A +D++S GVL
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 38/202 (18%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LG G F V+ G+ A+K + K +NE+ ++ +++H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------------HIVGGIARGIL 586
L+ + + L FD RI ++ + +
Sbjct: 76 ESTTHYYLVMQLVSGGEL----FD-----------RILERGVYTEKDASLVIQQVLSAVK 120
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
YLH+ I+HRDLK N+L + + I+DFG++++ + T GT GY
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGY 173
Query: 644 MSPEYAAEGLFSVKSDVFSFGV 665
++PE A+ +S D +S GV
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGV 195
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 41/195 (21%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
D + KLGEG +G VYK V + +A+KR+ +E + EV+L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIH------I 577
LQHRN+++L LI+EY + ++D +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSF 137
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-----KISDFGMARIFGGDEIQT 632
+ + G+ + H R +HRDLK N+LL KI DFG+AR F G I+
Sbjct: 138 LYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 633 NTHKVVGTYGYMSPE 647
TH+++ T Y PE
Sbjct: 194 FTHEII-TLWYRPPE 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 41/192 (21%), Positives = 81/192 (42%), Gaps = 16/192 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LG G FG V++ + K + G K E++++ +HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+E ++I+E++ + F++ A L+ ++ + V + + +LH I
Sbjct: 71 ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 597 IHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
H D++ N++ + KI +FG AR + + Y +PE +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVV 180
Query: 655 SVKSDVFSFGVL 666
S +D++S G L
Sbjct: 181 STATDMWSLGTL 192
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-26
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 468 IAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK-------------GS 509
+ K KLG G +G V E A+K + K
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 510 GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARAT 567
+ EE NE++L+ L H N++KL L+ E+ L F+ R
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHK 142
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARI 624
F + +I+ I GI YLH+ I+HRD+K N+LL+N +N KI DFG++
Sbjct: 143 FDE-CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
F D +GT Y++PE + ++ K DV+S GV++ ++ G
Sbjct: 199 FSKDYKL---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 28/186 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-----EVTLIARL 526
+ + +KLGEG + VYKG +A+K + +G EV+L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 527 QHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIVGGI 581
+H N+V L L++EY+ + LD I + +Q +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
RG+ Y H R +++HRDLK N+L++ K++DFG+AR +T ++VV T
Sbjct: 110 LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TL 164
Query: 642 GYMSPE 647
Y P+
Sbjct: 165 WYRPPD 170
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 22/199 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG G F V K G E A K + K G EE + EV+++ ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD 591
L + +LI E + L FD A+ L ++ + I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 592 SRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
+I H DLK N++L + P K+ DFG+A N + GT +++PE
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPE 188
Query: 648 YAAEGLFSVKSDVFSFGVL 666
+++D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVI 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 45/214 (21%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGCC 538
LGEG +G V V + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 539 IQADESM--LIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGI 585
+ + ++ L EY L FD A+ F Q ++ G+
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQ----LMAGVV--- 119
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH + I HRD+K N+LLD N KISDFG+A +F + + +K+ GT Y++
Sbjct: 120 -YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 646 PE------YAAEGLFSVKSDVFSFGVLVLEIVSG 673
PE + AE DV+S G+++ +++G
Sbjct: 176 PELLKRREFHAE-----PVDVWSCGIVLTAMLAG 204
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGMEEFKNEVTLIA 524
D + +LG G F V K G E A K + K G EE + EV+++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIAR 583
++ H N++ L + +LI E + L FD A+ L ++ + I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVG 639
G+ YLH +I H DLK N++L + P K+ DFG+A N + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVL 666
T +++PE +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 46/223 (20%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ + + +GEG +G V K + G+ +A+K+ + E+ L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLL 78
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLDFF--IFDQARATFLDWQKRIHIV 578
+L+H NLV LL C + L++E++ + L+ F D +Q
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ------ 132
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
I GI + H IIHRD+K N+L+ K+ DFG AR + +V
Sbjct: 133 --IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA 186
Query: 639 GTYGYMSPE-------YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
T Y +PE Y +V DV++ G LV E+ G+
Sbjct: 187 -TRWYRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 45/206 (21%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGCC 538
LGEG +G V V + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 539 IQADESM--LIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGI 585
+ + ++ L EY L FD A+ F Q ++ G+
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQ----LMAGVV--- 119
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH + I HRD+K N+LLD N KISDFG+A +F + + +K+ GT Y++
Sbjct: 120 -YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 646 PE------YAAEGLFSVKSDVFSFGV 665
PE + AE DV+S G+
Sbjct: 176 PELLKRREFHAE-----PVDVWSCGI 196
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 33/189 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ + K+GEG +G V+K + GQ +A+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLDFF--IFDQARATFLDWQKRIHIV 578
+L+H NLV LL + L++EY + LD + + + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ------ 110
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ + + H+ IHRD+K N+L+ K+ DFG AR+ +V
Sbjct: 111 --TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
Query: 639 GTYGYMSPE 647
T Y SPE
Sbjct: 165 -TRWYRSPE 172
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 43/219 (19%)
Query: 451 MSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGS 509
M+ + +E D + K+G+G FG V+K + + A+K++
Sbjct: 1 MAKQYDSVECPFCDEV------SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--- 51
Query: 510 GQGMEEFKN--------EVTLIARLQHRNLVKLLGCCIQADESM--------LIYEYMPN 553
ME K E+ ++ L+H N+V L+ C L++++ +
Sbjct: 52 ---MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 108
Query: 554 --KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611
L F + + ++ + G+ Y+H R +I+HRD+KA+NVL+ D
Sbjct: 109 DLAGL----LSNVLVKFTLSEIK-RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRD 160
Query: 612 MNPKISDFGMARIFG---GDEIQTNTHKVVGTYGYMSPE 647
K++DFG+AR F + T++VV T Y PE
Sbjct: 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN-EVTLIARLQHRN 530
+ + +G G FG V++ LVE E+A+K++ + + FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 531 LVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGGI 581
+V L + L+ EY+P ++ + + L + ++ +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY---QL 150
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVVGT 640
R + Y+H + I HRD+K N+LLD K+ DFG A+I + N +
Sbjct: 151 LRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSR 205
Query: 641 YGYMSPEYAAEGLF-----SVKSDVFSFGVLVLEIVSGK 674
Y Y +PE +F + D++S G ++ E++ G+
Sbjct: 206 Y-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 50/271 (18%), Positives = 89/271 (32%), Gaps = 52/271 (19%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVK-----RLS 506
H E F S+ + + +G+G +G V + A+K ++
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 507 KGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA 566
+ + + +E K EV L+ +L H N+ +L L+ E L +
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 567 TFLDWQKRI-------------------------------------HIVGGIARGILYLH 589
+ + +I+ I + YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 590 QDSRMRIIHRDLKASNVLL--DNDMNPKISDFGMARIFGGDEIQTNT--HKVVGTYGYMS 645
I HRD+K N L + K+ DFG+++ F GT +++
Sbjct: 186 N---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 646 PE--YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + K D +S GVL+ ++ G
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 34/219 (15%)
Query: 470 KATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM---------EE 515
+T F LG G V + +E AVK + G E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 516 FKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQ 572
EV ++ ++ H N+++L L+++ M L FD + T + +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKE 125
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
R I+ + I LH+ + I+HRDLK N+LLD+DMN K++DFG + E
Sbjct: 126 TR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179
Query: 633 NTHKVVGTYGYMSPE------YAAEGLFSVKSDVFSFGV 665
+V GT Y++PE + + D++S GV
Sbjct: 180 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG G F V K G+E A K + K G EE + EV ++ ++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD 591
L + +LI E + L FD A L + + I G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHS- 126
Query: 592 SRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
RI H DLK N++L + P K+ DFG+A N + GT +++PE
Sbjct: 127 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPE 181
Query: 648 YAAEGLFSVKSDVFSFGVL 666
+++D++S GV+
Sbjct: 182 IVNYEPLGLEADMWSIGVI 200
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
+G+G F V ++ G+E+A+K + K + +++ EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 538 CIQADESMLIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGIL 586
LI EY + FD +AR+ F Q I +
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKF--RQ--------IVSAVQ 128
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF-GGDEIQTNTHKVVGTYGYMS 645
Y H + RI+HRDLKA N+LLD DMN KI+DFG + F G ++ G Y +
Sbjct: 129 YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA----FCGAPPYAA 181
Query: 646 PE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + + + DV+S GV++ +VSG
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG--------MEEFKNEVTLIARL-QHR 529
+G G V + G E AVK + + + E + E ++ ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILY 587
+++ L+ + L+++ M L FD + + + R I+ + + +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMRSLLEAVSF 215
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH I+HRDLK N+LLD++M ++SDFG + E ++ GT GY++PE
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPE 269
Query: 648 ------YAAEGLFSVKSDVFSFGV 665
+ + D+++ GV
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGV 293
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQH 528
T+ + + +LG+G F V + V GQE A ++ S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGIL 586
N+V+L + LI++ + L F+ AR + + H + I +L
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS-HCIQQILEAVL 124
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+ HQ M ++HR+LK N+LL K++DFG+A G+ Q GT GY
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGY 179
Query: 644 MSPEYAAEGLFSVKSDVFSFGV 665
+SPE + + D+++ GV
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGV 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 466 ASIAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGME 514
++ + +N Y +LG G F V K G + A K + K G E
Sbjct: 1 GTVFR-QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 59
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQK 573
+ + EV+++ +QH N++ L + +LI E + L FD A L ++
Sbjct: 60 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEE 115
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDE 629
+ I G+ YLH ++I H DLK N++L + P KI DFG+A
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
N + GT +++PE +++D++S GV+
Sbjct: 173 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 36/198 (18%)
Query: 470 KATDNFASYNKLGEGGFGPVYKG--TLVEGQEIAVKRLSKGSGQGMEEFKN--------E 519
+A + ++GEG +G V+K G+ +A+KR+ ++ + E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIRE 61
Query: 520 VTLIARLQ---HRNLVKLLGCCIQADES-----MLIYEYMPN--KSLDFFIFDQARATFL 569
V ++ L+ H N+V+L C + L++E++ + D+ +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY----LDKVPEPGV 117
Query: 570 DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ ++ + RG+ +LH R++HRDLK N+L+ + K++DFG+ARI+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ- 173
Query: 630 IQTNTHKVVGTYGYMSPE 647
T VV T Y +PE
Sbjct: 174 -MALTSVVV-TLWYRAPE 189
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 57/225 (25%), Positives = 88/225 (39%), Gaps = 36/225 (16%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLL 535
LGEG +G V + AVK L K G K E+ L+ RL+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 536 GCCIQADESM--LIYEYMPNKSLDFFIF--------DQARATFLDWQKRIHIVGGIARGI 585
++ ++ EY + QA F Q ++ G+
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF--CQ----LIDGLE--- 123
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH I+H+D+K N+LL KIS G+A G+ +
Sbjct: 124 -YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 646 PEYAA-EGLFS-VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
PE A FS K D++S GV + I +G +P N+
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTG------LYPFEGDNI 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 47/220 (21%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE--------FKNEVTL 522
D + LG G G V + +++A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD-----------QARATFLDW 571
+ +L H ++K+ A++ ++ E M L FD + F
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ- 122
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGD 628
+ + YLH IIHRDLK NVLL + D KI+DFG ++I G
Sbjct: 123 ---------MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 629 EIQTNTHKVVGTYGYMSPE---YAAEGLFSVKSDVFSFGV 665
+ + GT Y++PE ++ D +S GV
Sbjct: 171 SL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIAR 525
D F + LG GGFG V+ K T G+ A K+L+K +G + E ++A+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFI---------FDQARATFLDWQKRI 575
+ R +V L + + L+ M + + I F + RA F Q
Sbjct: 242 VHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ--- 297
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
I G+ +LHQ II+RDLK NVLLD+D N +ISD G+A + +T
Sbjct: 298 -----IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG- 348
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT G+M+PE + D F+ GV + E+++ +
Sbjct: 349 -YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 25/203 (12%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCC 538
LGEG V L+ QE AVK + K G EV ++ + Q HRN+++L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 539 IQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ D L++E M S+ R F + + +V +A + +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGI 132
Query: 597 IHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNT-----HKVVGTYGYMSPE- 647
HRDLK N+L + KI DF + + + G+ YM+PE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 648 ----YAAEGLFSVKSDVFSFGVL 666
++ + D++S GV+
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVI 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 27/204 (13%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSK--------GSGQGMEEFKNEVTLIARLQHRN 530
LG G G V + +++A++ +SK + E+ ++ +L H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLH 589
++K+ A++ ++ E M L FD+ L + + YLH
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 590 QDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
+ IIHRDLK NVLL + D KI+DFG ++I G + + GT Y++P
Sbjct: 257 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAP 310
Query: 647 E---YAAEGLFSVKSDVFSFGVLV 667
E ++ D +S GV++
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 45/224 (20%), Positives = 80/224 (35%), Gaps = 60/224 (26%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSK--------GSGQGMEEFKNEVTLIARLQHRNL 531
LG G FG V+ E +E+ VK + K + + E+ +++R++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFI----------FD-----------QARATFLD 570
+K+ + N+ + F A F
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF-- 136
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630
Q + + YL IIHRD+K N+++ D K+ DFG A ++
Sbjct: 137 RQ--------LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
Query: 631 QTNTHKVVGTYGYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSG 673
+ GT Y +PE + +++S GV + +V
Sbjct: 186 ---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 38/200 (19%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQ-GMEEFKN----EVTLI 523
AT + ++G G +G VYK G +A+K + +G G EV L+
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 524 ARLQ---HRNLVKLLGCCIQADES-----MLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
RL+ H N+V+L+ C + L++E++ DQ T+LD
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----------DQDLRTYLDKAPPP 115
Query: 576 HIVGG--------IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
+ RG+ +LH + I+HRDLK N+L+ + K++DFG+ARI+
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
Query: 628 DEIQTNTHKVVGTYGYMSPE 647
T VV T Y +PE
Sbjct: 173 Q--MALTPVVV-TLWYRAPE 189
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 47/233 (20%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK------GSGQGMEEFKNEVTLIARLQHR--NL 531
LG GGFG VY G + + +A+K + K G EV L+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIF---------DQARATFLDWQKRIHIVGGIA 582
++LL + D +LI E P D F F + AR+ F WQ +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFF--WQ--------VL 159
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
+ + H ++HRD+K N+L+D N K+ DFG + GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTR 212
Query: 642 GYMSPEYAAEGLFS-VKSDVFSFGVLVLEIVSGK---------KNWRFSHPDH 684
Y PE+ + + V+S G+L+ ++V G +
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 265
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVKLLG 536
LGEG F V + A+K L K + E +++RL H VKL
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 537 CCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQ 590
Q DE + Y N L +I FD+ F + I + YLH
Sbjct: 98 TF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLHG 148
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
IIHRDLK N+LL+ DM+ +I+DFG A++ + Q + VGT Y+SPE
Sbjct: 149 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
E SD+++ G ++ ++V+G
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGL 229
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIAR 525
+ F Y LG+GGFG V + T G+ A K+L K +G NE ++ +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
+ R +V L + +++ L+ M L F I+ +A F + + + I G
Sbjct: 241 VNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA-AEICCG 298
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ LH R RI++RDLK N+LLD+ + +ISD G+A + VGT GYM
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYM 352
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+PE ++ D ++ G L+ E+++G+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 53/242 (21%), Positives = 88/242 (36%), Gaps = 63/242 (26%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK------GSGQGMEEFKNEVTLIARL----QHR 529
LG+GGFG V+ G L + ++A+K + + EV L+ ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 530 NLVKLLGCCIQADESM--LIYEYMPNKSLDFFIF---------DQARATFLDWQKRIHIV 578
+++LL + L+ E P + D F + +R F Q
Sbjct: 99 GVIRLLD--WFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFF--GQ------ 147
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKV 637
+ I + H ++HRD+K N+L+D K+ DFG + +
Sbjct: 148 --VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----F 198
Query: 638 VGTYGYMSPE------YAAEGLFSVKSDVFSFGVLVLEIVSGK---------KNWRFSHP 682
GT Y PE Y A + V+S G+L+ ++V G P
Sbjct: 199 DGTRVYSPPEWISRHQYHAL-----PATVWSLGILLYDMVCGDIPFERDQEILEAELHFP 253
Query: 683 DH 684
H
Sbjct: 254 AH 255
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 468 IAKATDNFASY-----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNE 519
++ +NF ++ +LG G F V + GQE A K L K E +E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 520 VTLIARLQHR-NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD---QARATFLDWQKRI 575
+ ++ + ++ L E +LI EY + F A + I
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVI 134
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQT 632
++ I G+ YLHQ I+H DLK N+LL + + KI DFGM+R G
Sbjct: 135 RLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-- 189
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
+++GT Y++PE + +D+++ G++
Sbjct: 190 -LREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 40/221 (18%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKG---SGQGMEEFKNE---VTL 522
++F+ + +G GGFG VY T G+ A+K L K QG NE ++L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 523 IARLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIH 576
++ +V + + + I + M L + + F +A F +
Sbjct: 246 VSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE---- 300
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I G+ ++H +++RDLK +N+LLD + +ISD G+A F + H
Sbjct: 301 ----IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA 349
Query: 637 VVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLEIVSGK 674
VGT+GYM+PE +G+ S D FS G ++ +++ G
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 38/192 (19%)
Query: 480 KLGEGGFGPVYKG---TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
K+G G +G VYK + ++ A+K++ +G+G M + E+ L+ L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 537 CCIQADES--MLIYEYM-------------PNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
+ + L+++Y + + L +Q I
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ--------I 137
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTH-- 635
GI YLH ++HRDLK +N+L+ + KI+D G AR+F ++
Sbjct: 138 LDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLD 193
Query: 636 KVVGTYGYMSPE 647
VV T+ Y +PE
Sbjct: 194 PVVVTFWYRAPE 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-23
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-EVTLIARLQHR 529
++ +G G FG VY+ L + G+ +A+K++ + + FKN E+ ++ +L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 530 NLVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGG 580
N+V+L + E L+ +Y+P + + + + + ++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY---Q 164
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVVG 639
+ R + Y+H I HRD+K N+LLD D K+ DFG A+ E N +
Sbjct: 165 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICS 219
Query: 640 TYGYMSPE-------YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y Y +PE Y + DV+S G ++ E++ G+
Sbjct: 220 RY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-23
Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 39/202 (19%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
+LG G VY+ + A+K L K + + + E+ ++ RL H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------------HIVGGIARGIL 586
E L+ E + L FD RI V I +
Sbjct: 118 ETPTEISLVLELVTGGEL----FD-----------RIVEKGYYSERDAADAVKQILEAVA 162
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
YLH+ I+HRDLK N+L D KI+DFG+++I + V GT GY
Sbjct: 163 YLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGY 216
Query: 644 MSPEYAAEGLFSVKSDVFSFGV 665
+PE + + D++S G+
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGI 238
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 55/224 (24%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK-------------------------GSGQGME 514
+G+G +G V + A+K LSK +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 515 EF-KNEVTLIARLQHRNLVKLLGCCIQADESML--IYEYMPNKSLDFFIF-------DQA 564
E E+ ++ +L H N+VKL+ +E L ++E + + + DQA
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-MEVPTLKPLSEDQA 139
Query: 565 RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
R F D + +GI YLH +IIHRD+K SN+L+ D + KI+DFG++
Sbjct: 140 RFYFQD----------LIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 625 FGGDEIQTNTHKVVGTYGYMSPE--YAAEGLFS-VKSDVFSFGV 665
F G + VGT +M+PE +FS DV++ GV
Sbjct: 187 FKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 22/203 (10%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHR 529
TD + +G G + + E AVK + K + E+ ++ R QH
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS----KRDPTEEIEILLRYGQHP 76
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILY 587
N++ L ++ E M L D + F + + ++ I + + Y
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEY 131
Query: 588 LHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
LH ++HRDLK SN+L N + +I DFG A+ + T T +
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANF 186
Query: 644 MSPEYAAEGLFSVKSDVFSFGVL 666
++PE + D++S GVL
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVL 209
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 20/194 (10%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
LGEG F K Q AVK +SK + + E+T + + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 538 CIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ L+ E + L F+ + + F + + +I+ + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRKLVSAVSHMHD---VG 126
Query: 596 IIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
++HRDLK N+L ++++ KI DFG AR+ D T T Y +PE +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQN 184
Query: 653 LFSVKSDVFSFGVL 666
+ D++S GV+
Sbjct: 185 GYDESCDLWSLGVI 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 72/239 (30%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG G FG V G + G ++AVK L++ S + + K E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 537 CCIQADESMLIYEYMPNKSLDFFI---------FD-----------QARATFLDWQKRIH 576
Y+ + + F + FD +AR F Q
Sbjct: 77 -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF--QQ---- 119
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI-QTNTH 635
I+ + Y H R ++HRDLK NVLLD MN KI+DFG++ + E +T
Sbjct: 120 ILSAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT--- 169
Query: 636 KVVGTYGYMSPEYAAEGLFS------VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
+ G SP YAA + S + D++S GV++ ++ G + P D ++
Sbjct: 170 ----SCG--SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG------TLPFDDEHV 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 26/198 (13%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
LG G G V + GQ+ A+K L + + EV + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90
Query: 538 CIQADESM----LIYEYMPNKSLDFF--IFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+I E M L F I ++ F + + I+ I I +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL--FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLHS- 146
Query: 592 SRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
I HRD+K N+L + D K++DFG A+ + +QT T Y++PE
Sbjct: 147 --HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTPYYVAPEV 200
Query: 649 AAEGLFSVKSDVFSFGVL 666
+ D++S GV+
Sbjct: 201 LGPEKYDKSCDMWSLGVI 218
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 65/224 (29%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LGEG FG V T Q++A+K +S+ M + E++ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 537 CCIQADESMLIYEYMPNKSLDFFI--------FD-----------QARATFLDWQKRIHI 577
Y+ + + + FD + R F Q
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFF--QQ----- 116
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI-QTNTHK 636
I I Y H R +I+HRDLK N+LLD+++N KI+DFG++ I +T
Sbjct: 117 ---IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---- 166
Query: 637 VVGTYGYMSPEYAAEGLFS------VKSDVFSFGVLVLEIVSGK 674
+ G SP YAA + + + DV+S G+++ ++ G+
Sbjct: 167 ---SCG--SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 64/224 (28%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG G FG V G + G ++AVK L++ S + + + E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 537 CCIQADESMLIYEYMPNKSLDFFI---------FD-----------QARATFLDWQKRIH 576
Y+ + S F + FD ++R F Q
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF--QQ---- 124
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I+ G+ Y H R ++HRDLK NVLLD MN KI+DFG++ + E
Sbjct: 125 ILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRT 174
Query: 637 VVGTYGYMSPEYAAEGLFS------VKSDVFSFGVLVLEIVSGK 674
G SP YAA + S + D++S GV++ ++ G
Sbjct: 175 SCG-----SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 41/228 (17%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN----EVTLIA 524
K D F G+G FG V G G +A+K++ + F+N + +A
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLA 74
Query: 525 RLQHRNLVKLLGCCIQADES-------MLIYEYMP---NKSLDFFIFDQARATFLDWQKR 574
L H N+V+L E ++ EY+P ++ + Q + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTN 633
+ + R I LH S + HRD+K NVL++ K+ DFG A+ E N
Sbjct: 135 LF---QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PN 188
Query: 634 THKVVGTYGYMSPE-------YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ Y Y +PE Y + D++S G + E++ G+
Sbjct: 189 VAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 48/206 (23%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGCC 538
+G G FG + + +AVK + +G ++E + E+ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 539 IQADESMLIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGILY 587
+ +I EY L ++ +AR F Q ++ G++ Y
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFF--QQ----LLSGVS----Y 131
Query: 588 LHQDSRMRIIHRDLKASNVLLDND--MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
H M+I HRDLK N LLD KI DFG ++ VGT Y++
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIA 185
Query: 646 PE------YAAEGLFSVKSDVFSFGV 665
PE Y + +DV+S GV
Sbjct: 186 PEVLLRQEYDGK-----IADVWSCGV 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 25/198 (12%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
LG G G V + ++ A+K L + + EV L R ++V+++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 123
Query: 538 C---IQADESM-LIYEYMPNKSLDFF--IFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ + ++ E + L F I D+ F + + I+ I I YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL--FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS- 179
Query: 592 SRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
+ I HRD+K N+L + K++DFG A+ T Y++PE
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEV 234
Query: 649 AAEGLFSVKSDVFSFGVL 666
+ D++S GV+
Sbjct: 235 LGPEKYDKSCDMWSLGVI 252
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 13/97 (13%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+A+G+ +L + + IHRDL A N+LL KI DFG+AR +I + V
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253
Query: 641 YG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++++SDV+SFGVL+ EI S
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 38/176 (21%), Positives = 62/176 (35%), Gaps = 26/176 (14%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG 510
D WEF D LG G FG V + + +AVK L +G+
Sbjct: 13 DASKWEFPR-------DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65
Query: 511 QG-MEEFKNEVTLIARL-QHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQARAT 567
+E+ ++ + H N+V LLG C + M+I E+ +L ++
Sbjct: 66 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL------- 118
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
KR V +G + + I DLK + + + S F +
Sbjct: 119 ---RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 54/257 (21%), Positives = 98/257 (38%), Gaps = 44/257 (17%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKAT---DNFASYNKLGEGGFGPVY----KGTLV 495
L L + ++ + ++ E + + D+F +G G F V K T
Sbjct: 28 LGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT-- 85
Query: 496 EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM-LIYEYM 551
GQ A+K ++K + F+ E ++ R + +L Q + + L+ EY
Sbjct: 86 -GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYY 143
Query: 552 PNKSLDFF-------IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKAS 604
L A F + I I +H+ + +HRD+K
Sbjct: 144 VGGDL-LTLLSKFGERIPAEMARFY--------LAEIVMAIDSVHR---LGYVHRDIKPD 191
Query: 605 NVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE-------YAAEGLFSV 656
N+LLD + +++DFG ++ +++ VGT Y+SPE G +
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 657 KSDVFSFGVLVLEIVSG 673
+ D ++ GV E+ G
Sbjct: 250 ECDWWALGVFAYEMFYG 266
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 9e-19
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 40/213 (18%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVK 533
+G+G FG V +V+ + A+K ++K E +N E+ ++ L+H LV
Sbjct: 23 IGKGSFGKVC---IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 534 LLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGIL 586
L Q +E M ++ + + L + F + + + +
Sbjct: 80 LW-YSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLF--------ICELVMALD 129
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YL RIIHRD+K N+LLD + I+DF +A + + Q T + GT YM+P
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITT--MAGTKPYMAP 183
Query: 647 E--YAAEGL---FSVKSDVFSFGVLVLEIVSGK 674
E + +G F+V D +S GV E++ G+
Sbjct: 184 EMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR 214
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 52/247 (21%), Positives = 101/247 (40%), Gaps = 26/247 (10%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKAT---DNFASYNKLGEGGFGPVY----KGTLV 495
L + ++ E +E + + + + ++F +G G FG V K
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA-- 98
Query: 496 EGQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLGCCIQADESM-LIYEYM 551
+ A+K L+K E F+ E ++ + + L Q D ++ L+ +Y
Sbjct: 99 -DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYY 156
Query: 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611
L + + + R ++ + I +HQ + +HRD+K N+L+D +
Sbjct: 157 VGGDL-LTLLSKFEDRLPEEMARFYL-AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMN 211
Query: 612 MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-----YAAEGLFSVKSDVFSFGVL 666
+ +++DFG D + VGT Y+SPE +G + + D +S GV
Sbjct: 212 GHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 667 VLEIVSG 673
+ E++ G
Sbjct: 271 MYEMLYG 277
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 44/217 (20%), Positives = 91/217 (41%), Gaps = 35/217 (16%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HR 529
D++ KLG G + V++ + +++ VK L ++ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 530 NLVKLLGCCIQADESM---LIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARG 584
N++ L ++ S L++E++ N F ++ I +
Sbjct: 92 NIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKA 142
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+ Y H M I+HRD+K NV++D++ ++ D+G+A Q +V Y +
Sbjct: 143 LDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-F 196
Query: 644 MSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGKK 675
PE L + D++S G ++ ++ K+
Sbjct: 197 KGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 39/252 (15%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKAT---DNFASYNKLGEGGFGPVY----KGTLV 495
L L K ++ + ++ I +++ +G G FG V K T
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST-- 93
Query: 496 EGQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLGCCIQADESM-LIYEYM 551
+ A+K LSK + F E ++A +V+L Q D + ++ EYM
Sbjct: 94 -RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYM 151
Query: 552 PNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606
P L + + A F + + + +H M IHRD+K N+
Sbjct: 152 PGGDL-VNLMSNYDVPEKWARFYTAE--------VVLALDAIHS---MGFIHRDVKPDNM 199
Query: 607 LLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE----YAAEGLFSVKSDVF 661
LLD + K++DFG ++ ++ +T VGT Y+SPE +G + + D +
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRECDWW 257
Query: 662 SFGVLVLEIVSG 673
S GV + E++ G
Sbjct: 258 SVGVFLYEMLVG 269
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 31/208 (14%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVK 533
LG+G FG V LV+ G+ A+K L K +E E ++ +H L
Sbjct: 156 LGKGTFGKVI---LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 534 LLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGIL 586
L Q + + + EY L FF +F + RA F I +
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFY--------GAEIVSALD 262
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YLH S +++RDLK N++LD D + KI+DFG+ + D T GT Y++P
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 318
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
E + + D + GV++ E++ G+
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 43/223 (19%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + +G G G V + + +A+K+LS+ F+N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMPNKSLDFFI---FDQARATFLDW 571
L+ + H+N++ LL +S+ ++ E M +L I D R ++L +
Sbjct: 77 LMKCVNHKNIIGLLNV-FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLY 134
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q + GI +LH IIHRDLK SN+++ +D KI DFG+AR G +
Sbjct: 135 Q--------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
T V T Y +PE + D++S G ++ E++ G
Sbjct: 184 TPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 49/230 (21%), Positives = 85/230 (36%), Gaps = 46/230 (20%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEE--FKN---------EV 520
+ + G +G V G EG +A+KR+ G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 521 TLIARLQHRNLVKLLGCCI-QADESM----LIYEYMPN------KSLDFFIFDQARATFL 569
L+ H N++ L + + +M L+ E M I Q +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ-HIQYF 139
Query: 570 DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ I G+ LH+ ++HRDL N+LL ++ + I DF +AR D
Sbjct: 140 MYH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
+T+ V Y +PE + K D++S G ++ E+ + K
Sbjct: 189 NKTHY---VTHRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 42/201 (20%), Positives = 83/201 (41%), Gaps = 41/201 (20%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
D + + +G G +G V + +E + +A+K++ + F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 522 LIARLQHRNLVKLLGCCIQADESM-----LIYEYMPN------KSLDFFIFDQARATFLD 570
++ RL H ++VK+L I D ++ E + ++ + + T L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-TLL- 162
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630
+ + G+ Y+H S I+HRDLK +N L++ D + K+ DFG+AR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 631 QTNTHKVVGTYGYMSPEYAAE 651
+ + M+
Sbjct: 212 GNSQLPISPREDDMNLVTFPH 232
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 26/205 (12%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVKLLG 536
LG+G FG V A+K L K +E E ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 537 CCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYLH 589
Q + + + EY L FF +F + RA F I + YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFY--------GAEIVSALEYLH 122
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
+++RD+K N++LD D + KI+DFG+ + D T GT Y++PE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVL 177
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + D + GV++ E++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 71/254 (27%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-EVTLIARLQHR 529
+ ++ LG G FG V + +E G+ A+K++ + +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 530 NLVKLLGCCIQADESM--------------------------------------LIYEYM 551
N++KL+ + +I EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 552 P---NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608
P +K L FI I+ + R + ++H + I HRD+K N+L+
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIY---QLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 609 D-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-------YAAEGLFSVKSDV 660
+ D K+ DFG A+ + + + + Y +PE Y + D+
Sbjct: 175 NSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEY------TPSIDL 225
Query: 661 FSFGVLVLEIVSGK 674
+S G + E++ GK
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 28/207 (13%)
Query: 481 LGEGGFGPVY---KGTLVEGQEI-AVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG V+ K + + +++ A+K L K + + K E ++ + H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILY 587
Q + + LI +++ L F +F + F + +A + +
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEEDVKFY--------LAELALALDH 141
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH + II+RDLK N+LLD + + K++DFG+++ E + + GT YM+PE
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE 196
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ +D +SFGVL+ E+++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 481 LGEGGFGPVY---KGTLVEGQEI-AVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLV 532
LG+GG+G V+ K T +I A+K L K + K E ++ ++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
L+ Q + LI EY+ L F IF + A F + I+ +
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMEDTACFY--------LAEISMAL 134
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LHQ II+RDLK N++L++ + K++DFG+ + D T+T GT YM+
Sbjct: 135 GHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMA 189
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + D +S G L+ ++++G
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLV 532
LG+G FG V +K T Q A+K L K ++ + + L +H L
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
+ C Q E++ + EY+ L + FD +RATF I G+
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLSRATF--------YAAEIILGL 131
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH I++RDLK N+LLD D + KI+DFGM + + +TNT GT Y++
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIA 186
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
PE ++ D +SFGVL+ E++ G
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 24/221 (10%), Positives = 56/221 (25%), Gaps = 43/221 (19%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLL 535
G ++ +++A+ + ++E + ++R+ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+++ E++ SL + T I + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ-----EVADTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
+ S V + D G V+ M
Sbjct: 150 VALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDANPQ----- 182
Query: 656 VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHVRVEN 696
D+ G + ++ + W L R
Sbjct: 183 --DDIRGIGASLYALLVNR--WPLPEAGVRSGLAPAERDTA 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 43/223 (19%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + +G G G V V + +A+K+LS+ F+N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMPNKSLDFFI---FDQARATFLDW 571
L+ + H+N++ LL +++ L+ E M L I D R ++L +
Sbjct: 114 LMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELDHERMSYLLY 171
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q + GI +LH S IIHRDLK SN+++ +D KI DFG+AR G +
Sbjct: 172 Q--------MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
Query: 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
T V T Y +PE + D++S G ++ E+V K
Sbjct: 221 TPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 27/211 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQH 528
D F LG G FG V E A+K L K +++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGIA 582
LVKL ++ EY+ + F F + A F I
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARF--------YAAQIV 151
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
YLH + +I+RDLK N+L+D +++DFG A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPE 203
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
++PE ++ D ++ GVL+ E+ +G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
LG+G FG V + E ++ AVK L K ++ + +T L H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 536 GCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYL 588
CC Q + + + E++ L F FD+ARA F I +++L
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARF--------YAAEIISALMFL 140
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H II+RDLK NVLLD++ + K++DFGM + + + T T GT Y++PE
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEI 195
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
E L+ D ++ GVL+ E++ G
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
LG+G FG V E+ AVK L K ++ + + L + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 536 GCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYL 588
C Q + + + EY+ L + F + A F IA G+ +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHAVF--------YAAEIAIGLFFL 137
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
II+RDLK NV+LD++ + KI+DFGM + D + T T GT Y++PE
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 192
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
A + D ++FGVL+ E+++G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLV 532
+G G + V LV + A+K + K E+ T H LV
Sbjct: 17 IGRGSYAKVL---LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
L C Q + + + EY+ L F + A F I+ +
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFY--------SAEISLAL 123
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH+ II+RDLK NVLLD++ + K++D+GM + T+T GT Y++
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 178
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + D ++ GVL+ E+++G+
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 6e-16
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 473 DNFASYNKLGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT----LIA 524
+F LG+G FG V KGT + AVK L K ++ + + L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 525 RLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHI 577
+ L +L C Q + + + EY+ L + F + A F
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHAVFY-------- 447
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
IA G+ +L II+RDLK NV+LD++ + KI+DFGM + D + T T
Sbjct: 448 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--F 502
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT Y++PE A + D ++FGVL+ E+++G+
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLV 532
+G G + V LV + A++ + K E+ T H LV
Sbjct: 60 IGRGSYAKVL---LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
L C Q + + + EY+ L F + A F I+ +
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFY--------SAEISLAL 166
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH+ II+RDLK NVLLD++ + K++D+GM + T+T GT Y++
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 221
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + D ++ GVL+ E+++G+
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V + AVK L K + +E K+ ++ L+ ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 536 GCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYL 588
Q + + + +Y+ L F+ F + RA F IA + YL
Sbjct: 106 -FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFY--------AAEIASALGYL 155
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H + I++RDLK N+LLD+ + ++DFG+ + T+T GT Y++PE
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEV 210
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + D + G ++ E++ G
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 41/210 (19%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVKLLG 536
LG G FG V+ A+K L K +++ +E +++ + H ++++ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 537 CCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYLH 589
Q + + +I +Y+ L F F A F + + + YLH
Sbjct: 74 TF-QDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVAKFYAAE--------VCLALEYLH 123
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-- 647
II+RDLK N+LLD + + KI+DFG A+ + T+ + GT Y++PE
Sbjct: 124 S---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVV 175
Query: 648 ----YAAEGLFSVKSDVFSFGVLVLEIVSG 673
Y S+ D +SFG+L+ E+++G
Sbjct: 176 STKPYNK----SI--DWWSFGILIYEMLAG 199
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 49/228 (21%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + + +GEG +G V + +A+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 522 LIARLQHRNLVKLLGCCI-QADESM----LIYEYMP---NKSLDFFIFDQARATFLDWQK 573
++ R +H N++ + E M ++ + M K L + +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
I RG+ Y+H S ++HRDLK SN+LL+ + KI DFG+AR+ D T
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 634 --THKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
T V T Y +PE + + K D++S G ++ E++S +
Sbjct: 187 FLTEYVA-TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 53/238 (22%), Positives = 95/238 (39%), Gaps = 60/238 (25%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ LG GG G V+ + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 522 LIARLQHRNLVKLL----------GCCIQADESM----LIYEYMP---NKSLDFFIFDQA 564
+I RL H N+VK+ + + + ++ EYM L+ +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 565 RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMAR 623
A +Q + RG+ Y+H + ++HRDLK +N+ ++ D+ KI DFG+AR
Sbjct: 121 HARLFMYQ--------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 624 IFGGDEIQTN--THKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
I + +V T Y SP L S + D+++ G + E+++GK
Sbjct: 170 IMDPHYSHKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 36/161 (22%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGC 537
LG G G V + ++ A+K L + + EV L R Q ++V+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 79
Query: 538 C---IQADESM-LIYEYMP---------NKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
+ + ++ E + ++ F +A I+ I
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSIGEA 129
Query: 585 ILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMA 622
I YLH + I HRD+K N+L + K++DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 481 LGEGGFGPVY---KGTLVEGQEI-AVKRLSKGS----GQGMEEFKNEVTLIARLQHRN-L 531
LG G +G V+ K + + ++ A+K L K + + E + E ++ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 532 VKLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARG 584
V L Q + + LI +Y+ L F F + VG I
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQI--------YVGEIVLA 171
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LH+ + II+RD+K N+LLD++ + ++DFG+++ F DE + + GT YM
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYM 227
Query: 645 SPE---YAAEG-LFSVKSDVFSFGVLVLEIVSGK 674
+P+ G +V D +S GVL+ E+++G
Sbjct: 228 APDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 37/194 (19%), Positives = 76/194 (39%), Gaps = 41/194 (21%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHR 529
+G G +G VY + +A+K++++ F++ E+T++ RL+
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREITILNRLKSD 85
Query: 530 NLVKLLGCCIQADESM-----LIYEYMPN------KSLDFFIFDQARATFLDWQKRIHIV 578
+++L I D ++ E + K+ F + + + +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK--TILYN------ 137
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ G ++H IIHRDLK +N LL+ D + K+ DFG+AR ++ + +
Sbjct: 138 --LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 639 GTYGYMSPEYAAEG 652
+
Sbjct: 193 ENEEPGPHNKNLKK 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 54/226 (23%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHR 529
LGEG +G V T G+ +A+K++ F E+ ++ +H
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHE 69
Query: 530 NLVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGG 580
N++ + + D +I E M ++ + + + +Q
Sbjct: 70 NIITIFNI-QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-------- 120
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
R + LH + +IHRDLK SN+L++++ + K+ DFG+ARI DE + + G
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQ 175
Query: 641 YGYMSPEY-------AAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
M E+ A E + + DV+S G ++ E+ +
Sbjct: 176 QSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 48/225 (21%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ S +G G +G V G+++A+K+LS+ F++ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMPNKSLDFFIFDQARATFLDWQKR 574
L+ +QH N++ LL S+ L+ +M L + F + + +
Sbjct: 76 LLKHMQHENVIGLLDV-FTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQ 129
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
++V + +G+ Y+H ++HRDLK N+ ++ D KI DFG+AR + T
Sbjct: 130 -YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----T 181
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
VV T Y +PE + S D++S G ++ E+++GK
Sbjct: 182 GYVV-TRWYRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 47/216 (21%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRN 530
+G G +G V G ++A+K+L + F++ E+ L+ ++H N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELRLLKHMRHEN 85
Query: 531 LVKLLGCCIQADESM-------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
++ LL DE++ L+ +M L + + L + +V + +
Sbjct: 86 VIGLLDV-FTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLK 139
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
G+ Y+H IIHRDLK N+ ++ D KI DFG+AR + T VV T Y
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVV-TRWY 191
Query: 644 MSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
+PE + + D++S G ++ E+++GK
Sbjct: 192 RAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 53/228 (23%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + + + +G G +G V + G +AVK+LS+ F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------PFQSIIHAKRTYRELR 80
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMP---NKSLDFFIFDQARATFLDW 571
L+ ++H N++ LL S+ L+ M N + FL +
Sbjct: 81 LLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR +
Sbjct: 140 Q--------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEM 186
Query: 632 TNTHKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
T V T Y +PE + + D++S G ++ E+++G+
Sbjct: 187 TGY---VATRWYRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 6e-13
Identities = 34/199 (17%), Positives = 56/199 (28%), Gaps = 46/199 (23%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRL--------SKGSGQGMEEFKNEVTL 522
T+ K+GEG FG V++ + +A+K + + + EE E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 523 IARLQ---------HRNLVKLLGCCI----------QADESMLIYEYMPNKSLDFFIFDQ 563
L + L +A + + N DFF DQ
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 564 A----------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607
R I+ + + +R HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 608 LDNDMNPKISDFGMARIFG 626
L K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 38/200 (19%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ KLG+G +G V+K G+ +AVK++ F+N E+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 522 LIARLQ-HRNLVKLLGCCIQADESM----LIYEYMP---NKSLDFFIFDQARATFLDWQK 573
++ L H N+V LL + ++ L+++YM + + I + ++ +Q
Sbjct: 61 ILTELSGHENIVNLLN--VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ- 117
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ + I YLH S ++HRD+K SN+LL+ + + K++DFG++R F TN
Sbjct: 118 -------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 634 THKVVGTYGYMSPEYAAEGL 653
+ + + L
Sbjct: 168 NIPLSINENTENFDDDQPIL 187
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 50/230 (21%), Positives = 83/230 (36%), Gaps = 58/230 (25%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRL---SKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
KLG G F V+ +V +A+K + + +E +KLL
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----------------IKLL 69
Query: 536 GCCIQADESMLIYEYMPN--KSLDFFIFDQARATFL------------DWQKR------- 574
AD + + K LD F + K+
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 575 IHIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNP------KISDFGMARI 624
+ V I++ +L Y+H R IIH D+K NVL++ +P KI+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-C 186
Query: 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + + T Y SPE + +D++S L+ E+++G
Sbjct: 187 WYDEHYTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-10
Identities = 21/122 (17%), Positives = 43/122 (35%), Gaps = 15/122 (12%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
+ +T + + G++L + + Y T W +N
Sbjct: 2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCNL------VLYDH---STSVWASNTGILGK 50
Query: 79 DQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSF 138
+ + V+ D R W+S++ N V+ L + GN+V+ Y S +W +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI----YGSDIWSTG 106
Query: 139 DH 140
+
Sbjct: 107 TY 108
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 6e-10
Identities = 22/120 (18%), Positives = 47/120 (39%), Gaps = 17/120 (14%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
++++ S+ G +L V ++ L + Y W +N T
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS---GKPVWASN--TGGL 49
Query: 79 DQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137
L + + G +V+ D +R+ W + T+ + V+ L N+V+ Y ++W +
Sbjct: 50 GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVI----YGPVVWAT 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 3e-09
Identities = 21/125 (16%), Positives = 46/125 (36%), Gaps = 14/125 (11%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
+D + + G +L G + + L ++ W + T
Sbjct: 1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDC-----NLVLYDNN----RAVWASG--TNG 47
Query: 78 TDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137
+L + + G +++ R W+SNT+ N + L N+V+ D + N+ +W +
Sbjct: 48 KASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-NNAIWAT 106
Query: 138 FDHPC 142
+
Sbjct: 107 HTNVG 111
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 4e-09
Identities = 21/121 (17%), Positives = 39/121 (32%), Gaps = 18/121 (14%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
++ + Q++ +L G + L + + Y+ W +N T
Sbjct: 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCNL------VKYQN---GRQIWASN--TDR 48
Query: 78 TDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQ 136
L + S G +V+ D + W S + L G V+ Y +LW
Sbjct: 49 RGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVI----YGPVLWS 104
Query: 137 S 137
Sbjct: 105 L 105
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.7 bits (130), Expect = 3e-08
Identities = 40/262 (15%), Positives = 72/262 (27%), Gaps = 35/262 (13%)
Query: 14 ASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSA--KRYLGIWYKRVSPRTVAWVA 71
+ Q++ G+ L+S N F+L G +W + +
Sbjct: 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIP 69
Query: 72 NRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSI-----TMKNPVVQLMDSGNLVLT 126
R ++ L G L D R W ++ S + L D GN+V
Sbjct: 70 LR----NKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIV-L 124
Query: 127 DGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGF 186
+ + + L + + G L G
Sbjct: 125 VDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---------GASKLVFQGDGN 175
Query: 187 PQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVI--NENEVYYECDAKGPAV 244
G+ +WN T V D V+ N V + G A
Sbjct: 176 LVAYGPNGAA------TWN--AGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHAS 227
Query: 245 SRLWVNQSG-LVL---RSIWSS 262
+ L + +G + + + +W+
Sbjct: 228 AVLRLQANGSIAILDEKPVWAR 249
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 6e-08
Identities = 26/121 (21%), Positives = 45/121 (37%), Gaps = 18/121 (14%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
++ + +++ GE L NG + + Y W N T
Sbjct: 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCNL------VLYDV---DKPIWATN--TGG 47
Query: 78 TDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQ 136
D+ L++ S G +V+ R+ W+SNT N V L N+V+ Y + W
Sbjct: 48 LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVI----YGTARWA 103
Query: 137 S 137
+
Sbjct: 104 T 104
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 49/222 (22%), Positives = 82/222 (36%), Gaps = 50/222 (22%)
Query: 478 YNKLGEGGFGPVYKGT-LVEGQEIAVK---RLSKGSGQGMEEFKNEVTLIARLQHR---- 529
+ +G+G FG V K VE + +A+K Q EV L+ +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEM 114
Query: 530 --NLVKLLGC-------CIQADE--SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
+V L C+ E S +Y+ + N + + R
Sbjct: 115 KYYIVHLKRHFMFRNHLCL-VFEMLSYNLYDLLRNTNFRGVSLNLTR----------KFA 163
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHK 636
+ +L+L + IIH DLK N+LL N KI DFG + +
Sbjct: 164 QQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---------CQLGQ 213
Query: 637 VVGTY----GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ Y Y SPE + + D++S G +++E+ +G+
Sbjct: 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 42/178 (23%), Positives = 77/178 (43%), Gaps = 22/178 (12%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGC 537
K+G G FG +Y GT + G+E+A+K + E + +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
+ D ++++ E + SL+ +F+ F + + + + I Y+H + I
Sbjct: 74 GAEGDYNVMVMELL-GPSLE-DLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKN---FI 127
Query: 598 HRDLKASNVLLDNDMNPK---ISDFGMARIFGGDEIQTNTH-------KVVGTYGYMS 645
HRD+K N L+ I DFG+A+ + + +T+ H + GT Y S
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRENKNLTGTARYAS 183
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 1e-07
Identities = 47/396 (11%), Positives = 113/396 (28%), Gaps = 101/396 (25%)
Query: 25 QSIRDGETLVSVNGTFELGFFSPGTS-----AKRYLGIWYKRVSPRTVAW--VANRETPL 77
+R + ++ ++G LG G + + + + W + N +P
Sbjct: 145 LELRPAKNVL-IDGV--LGS---GKTWVALDVCLSYKV--QCKMDFKIFWLNLKNCNSPE 196
Query: 78 TD----QSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGN--LVLTDGNYN 131
T Q L + D I ++ +++ N LVL N
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL-LNVQN 255
Query: 132 SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWK----SINDPAPG----E----FSL 179
+ W +F+ C LL R K D LS+ S++ + E
Sbjct: 256 AKAWNAFNLSCKILL----TTRF-KQVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 180 WIDT----------HGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLC------- 222
++D P+ + ++ +W+ L +
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 223 DYKFVINENEVYYEC-----DAKGPA--VSRLWVNQSGLVLRSIWSS-------QQDVWF 268
+Y+ +++ A P +S +W + + + + ++
Sbjct: 370 EYR------KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 269 LAYYAP---LD-RCDLYSVCGANARCTTN-SSRRCDCLEGFVPKSPNNWS--------EG 315
P L+ + L + + + + + + +P + + +
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 316 CVRERELKCRNGDEFPK------YVKLKLPDTSSSW 345
+ F +++ K+ S++W
Sbjct: 484 IEHPERM-----TLFRMVFLDFRFLEQKIRHDSTAW 514
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 3e-04
Identities = 52/413 (12%), Positives = 121/413 (29%), Gaps = 93/413 (22%)
Query: 306 PKSPNNWSEGCVRERELKCRNGDEFPKY--------VKLKLPDTSSSWFNASMNLKECSE 357
+ P+ + + +R+ + F KY +KL+ A + L+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---------QALLELRPAKN 152
Query: 358 L-------CSKNC-SCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGG------QDLYIR 403
+ K + + V+ + W +++K N Q L +
Sbjct: 153 VLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW----LNLKNCNSPETVLEMLQKLLYQ 208
Query: 404 IASERGRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWE- 462
I +++ L I A L + + K + L + +++ + + W
Sbjct: 209 IDPN------WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ-NAKAWNA 261
Query: 463 FDF----------ASIAKATDNFASYNKLGE---GGFGPVYKGTLVEGQEIAVKRLSKGS 509
F+ + + + + T E + + L K
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL------TPDEVKSL----LLKYL 311
Query: 510 GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY--EYMPNK-------SLDFFI 560
++ EV + ++ I+ + +K SL+
Sbjct: 312 DCRPQDLPREVLTTNPR----RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 561 FDQARATFLD---WQKRIHIVGGIARGILYLHQDSR--MRIIHRDLKASNVLLDNDMNP- 614
+ R F + HI + +++ M ++++ K S L++
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILL-SLIWFDVIKSDVMVVVNKLHKYS--LVEKQPKES 424
Query: 615 KISDFGMA-RIFGGDEIQTNTHK-VVGTYGYMSPEYAAEGLFSVKSD--VFSF 663
IS + + E + H+ +V Y + ++ L D +S
Sbjct: 425 TISIPSIYLELKVKLENEYALHRSIVDHYNIPK-TFDSDDLIPPYLDQYFYSH 476
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 40/187 (21%), Positives = 68/187 (36%), Gaps = 38/187 (20%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
K+G G FG + G L + +A+K S + + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGIPQVYYFG 74
Query: 539 IQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKR---IHIVGGIARGIL----YLHQ 590
+ ++ E + SL D F D R + V IA ++ Y+H
Sbjct: 75 PCGKYNAMVLELL-GPSLEDLF----------DLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPK-----ISDFGMARIFGGDEIQTNTH-------KVV 638
+ +I+RD+K N L+ N I DF +A+ + + +T H +
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY--IDPETKKHIPYREHKSLT 178
Query: 639 GTYGYMS 645
GT YMS
Sbjct: 179 GTARYMS 185
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 39/182 (21%), Positives = 75/182 (41%), Gaps = 30/182 (16%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGC 537
K+G G FG +Y GT + +E+A+K + + E + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSR 593
++ D ++L+ + + SL+ +F+ + V +A ++ ++H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLE-DLFNFCSRKL-----SLKTVLMLADQMINRVEFVHS--- 121
Query: 594 MRIIHRDLKASNVLLDNDMNPK---ISDFGMARIFGGDEIQTNTH-------KVVGTYGY 643
+HRD+K N L+ I DFG+A+ + + T+ H + GT Y
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY--RDTSTHQHIPYRENKNLTGTARY 179
Query: 644 MS 645
S
Sbjct: 180 AS 181
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 30/203 (14%), Positives = 62/203 (30%), Gaps = 50/203 (24%)
Query: 479 NKLGEGGFGPVYKGT---------LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR 529
+ G +Y+ + Q+ ++K L G+ E LQ
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 530 NLVKLLGC---CI---------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
KL I Q L+ + +SL + +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL-----SERS 160
Query: 578 VGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKI--SDFGMARIFGGDEIQ 631
V +A +L +LH++ +H ++ A N+ +D + ++ + +G A +
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY----CP 213
Query: 632 TNTHK---------VVGTYGYMS 645
+ H G ++S
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFIS 236
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 52/219 (23%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRL---SKGSGQGMEEFKNEVTLIARLQHR------N 530
+G+G FG V K Q +A+K + + Q EE + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160
Query: 531 LVKLLGC-------CIQADE--SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
++ +L C+ E SM +YE + F R I
Sbjct: 161 VIHMLENFTFRNHICM-TFELLSMNLYELIKKNKFQGFSLPLVR----------KFAHSI 209
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVG 639
+ + LH + RIIH DLK N+LL K+ DFG + H+ V
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---------CYEHQRVY 257
Query: 640 TY----GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
TY Y +PE + + D++S G ++ E+++G
Sbjct: 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 38/200 (19%), Positives = 69/200 (34%), Gaps = 46/200 (23%)
Query: 480 KLGEGGFGPVYKGTLVEGQEI------AVKRLSKGSGQGMEEFK-----NEVTLIARLQH 528
+G+GGFG +Y + + + VK +G E K + I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 529 RNLVKLLG-----CCIQADESMLIYEYMP----NKSLDFFIFDQARATFLDWQKR---IH 576
+K LG D++ Y +M L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ---------KIYEANAKRFSRK 152
Query: 577 IVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKI--SDFGMARIF----G 626
V ++ IL Y+H+ +H D+KASN+LL+ ++ D+G+A +
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 627 GDEIQTNTHKV-VGTYGYMS 645
+ + GT + S
Sbjct: 210 HKAYAADPKRCHDGTIEFTS 229
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 39/184 (21%), Positives = 76/184 (41%), Gaps = 32/184 (17%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGC 537
++GEG FG +++GT L+ Q++A+K + S ++E L + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYF 74
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSR 593
+ ++L+ + + SL+ + D F + V A+ +L +H
Sbjct: 75 GQEGLHNVLVIDLLG-PSLE-DLLDLCGRKF-----SVKTVAMAAKQMLARVQSIH---E 124
Query: 594 MRIIHRDLKASNVLLDNDMNPK-----ISDFGMARIFGGDEIQTNTH-------KVVGTY 641
+++RD+K N L+ + + DFGM + + + T H + GT
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY--RDPVTKQHIPYREKKNLSGTA 182
Query: 642 GYMS 645
YMS
Sbjct: 183 RYMS 186
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 9e-07
Identities = 24/133 (18%), Positives = 42/133 (31%), Gaps = 26/133 (19%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
+ + Q++ L NG F+L + Y G W ++ R+
Sbjct: 2 GTNYLLSGQTLDTEGHLK--NGDFDLVMQDDC-NLVLYNGNW------QSNTANNGRDCK 52
Query: 77 LTDQS-GLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135
LT G L V+ +G W S N + G LV+ + ++
Sbjct: 53 LTLTDYGEL-------VIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVV----FGPSVF 101
Query: 136 QSFDHPCDTLLPG 148
+ D + G
Sbjct: 102 KI-----DPWVRG 109
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-06
Identities = 21/122 (17%), Positives = 41/122 (33%), Gaps = 19/122 (15%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
N+ + Q + L + +L + W +N T
Sbjct: 5 TNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCNLV----------LYGGKYGWQSN--TH 50
Query: 77 LTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135
+ L + KG +++ D + WSS +S V+ L D G V+ Y ++
Sbjct: 51 GNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI----YGPAIF 106
Query: 136 QS 137
++
Sbjct: 107 ET 108
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-06
Identities = 14/73 (19%), Positives = 25/73 (34%), Gaps = 7/73 (9%)
Query: 66 TVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLV 124
W N T + G +V++ + W S + + V+ L N+V
Sbjct: 49 NPIWATN--TGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVV 106
Query: 125 LTDGNYNSLLWQS 137
+ Y LW +
Sbjct: 107 I----YGDALWAT 115
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 37/192 (19%), Positives = 72/192 (37%), Gaps = 33/192 (17%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIA---VKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
K+G GGFG +Y + ++ A VK + +G +E+ R+ ++ +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP----LFSELKFYQRVAKKDCIKKW 99
Query: 536 GCCIQADES---MLIY---EYMPNKSLDFFIFD---QARATFLDWQKR--IHIVGGIARG 584
Q D + +S F + + V +
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIR 159
Query: 585 IL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKI--SDFGMARIF----GGDEIQTNT 634
+L Y+H++ +H D+KA+N+LL ++ +D+G++ + + Q N
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 635 HKV-VGTYGYMS 645
K GT + S
Sbjct: 217 RKGHNGTIEFTS 228
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 8e-06
Identities = 22/122 (18%), Positives = 41/122 (33%), Gaps = 16/122 (13%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
+ + SQ + D L + + L + K S + W + T
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKG-SKTNIVWESG--TS 53
Query: 77 LTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135
Q + + G + + D R + SNT + V+ L +G V+ Y +W
Sbjct: 54 GRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV----YGPAVW 109
Query: 136 QS 137
+
Sbjct: 110 ST 111
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 50/268 (18%), Positives = 86/268 (32%), Gaps = 94/268 (35%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLG G F V+ + + +A+K + K + E +E+ +LL
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEI------------RLLKSV 90
Query: 539 IQADESMLIYEYMPNKSLDFF------------IFDQARATFLDWQKR-------IHIVG 579
+D + E + + LD F +F+ L W + + V
Sbjct: 91 RNSDPNDPNREMVV-QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 580 GIARGIL----YLHQDSRMRIIHRDLKASNVLL--------------------------- 608
I + +L YLH ++ RIIH D+K N+LL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 609 ----------------------DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
+ KI+D G A + T + T Y S
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTE---DIQTRQYRSL 262
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
E ++ +D++S + E+ +G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 4e-04
Identities = 14/70 (20%), Positives = 24/70 (34%), Gaps = 5/70 (7%)
Query: 69 WVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTD 127
V + T + G + +L ++ W+S S + V L NL +
Sbjct: 170 RVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAI-- 227
Query: 128 GNYNSLLWQS 137
Y LW +
Sbjct: 228 --YGGALWTT 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 698 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.98 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.98 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.98 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.83 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.82 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.82 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.8 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.79 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.67 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.65 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.64 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.61 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.55 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.52 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.43 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.19 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.05 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.01 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.78 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.62 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.12 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.02 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.01 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.93 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.93 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.84 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.79 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.57 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.06 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.58 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.79 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.92 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.58 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.85 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 83.88 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.67 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=387.16 Aligned_cols=207 Identities=32% Similarity=0.552 Sum_probs=181.1
Q ss_pred cCccccCceeeecceeEEEEEec------cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|.+.++||+|+||+||+|++. +++.||||+++....+..++|.+|+++|++++|||||+++++|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999864 367899999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 547 IYEYMPNKSLDFFIFDQA----------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
|||||++|+|.++|.+.. ....++|.+++.|+.||++||+|||+++ |+||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 2346999999999999999999999988 999999999999999999999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||....+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999987654443333334579999999999999999999999999999999999 8999976443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=387.21 Aligned_cols=206 Identities=29% Similarity=0.518 Sum_probs=173.7
Q ss_pred cCccccCceeeecceeEEEEEec------cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999864 378899999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 547 IYEYMPNKSLDFFIFDQAR------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
|||||++|+|.+++.+... ...++|.+++.|+.||++||+|||+.+ |+||||||+||||++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975432 245899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 9999999987654443333344679999999999999999999999999999999999 899997544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=385.84 Aligned_cols=205 Identities=34% Similarity=0.523 Sum_probs=178.0
Q ss_pred CccccCceeeecceeEEEEEec------cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++++.++||+|+||+||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566789999999999999863 4678999999755 33456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc
Q 005400 547 IYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (698)
|||||++|+|.++|..... ...++|.++++|+.|||+||+|||+++ ||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999965321 345899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
+||+|||+++.+.............||++|||||++..+.++.++|||||||+||||+| |+.||....
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 99999999987654433333444689999999999999999999999999999999999 899997544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=380.34 Aligned_cols=203 Identities=30% Similarity=0.439 Sum_probs=182.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.++||+|+||+||+++.. +++.||||++.+. .....+.+.+|++++++++|||||++++++++.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999874 5899999999754 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|.+++.+. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999654 34899999999999999999999998 999999999999999999999999999987544
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.........+||+.|||||++.+..|+.++||||+||+||||+||+.||...+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 43334445789999999999999999999999999999999999999997543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=378.29 Aligned_cols=201 Identities=29% Similarity=0.512 Sum_probs=168.1
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
+++.+.++||+|+||+||+|++. ..||||+++.. ..+..+.|.+|++++++++|||||++++++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 45677789999999999999874 36999998654 33456789999999999999999999998854 568999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
|++|+|.++|... ...+++.+++.|+.||++||+|||+++ ||||||||+||||++++++||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999653 235899999999999999999999988 99999999999999999999999999987654333
Q ss_pred ccccccccccccccChhcccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~---~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
........||+.|||||++.. ..|+.++|||||||+||||+||+.||....
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 333344689999999999863 468999999999999999999999997544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=382.12 Aligned_cols=201 Identities=27% Similarity=0.458 Sum_probs=181.1
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56889999999999999999875 58999999998766566678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++|+|.+++.+ ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999998854 24899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.....+||+.|||||++....|+.++|||||||+||||++|+.||....+
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 275 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 22346899999999999999999999999999999999999999976543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=383.44 Aligned_cols=203 Identities=24% Similarity=0.430 Sum_probs=174.1
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|+++++||+|+||+||+++.. +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999874 5899999999765 33445679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++|+|.++|.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999996543 345789999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......+||+.|||||++.+..|+.++|||||||+||||+||+.||....
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 12233679999999999999999999999999999999999999997543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=385.71 Aligned_cols=202 Identities=26% Similarity=0.451 Sum_probs=181.9
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999875 5899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
|++|+|.+++... .+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999988532 3899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.....+||+.|||||++....|+.++|||||||+||||++|+.||....+
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 352 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 22346899999999999999999999999999999999999999975443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=364.32 Aligned_cols=196 Identities=27% Similarity=0.424 Sum_probs=168.6
Q ss_pred cccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe----CCeeEEEE
Q 005400 476 ASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESMLIY 548 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~----~~~~~lV~ 548 (698)
+..++||+|+||.||+|+.. .++.||+|++... .....+.|.+|++++++++|||||++++++.. +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55568999999999999875 4889999999654 33445679999999999999999999999875 34579999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceEEeecCCCcccCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGG 627 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFgla~~~~~ 627 (698)
|||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999653 35899999999999999999999975 3599999999999998 478999999999986433
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.. .....||+.|||||++.+ .|+.++|||||||+||||+||+.||...
T Consensus 185 ~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 185 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred Cc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 22 234689999999998864 6999999999999999999999999743
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=369.61 Aligned_cols=233 Identities=20% Similarity=0.237 Sum_probs=180.4
Q ss_pred hhcccccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCC----CcceEEec
Q 005400 13 GASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQ----SGLLNVTS 88 (698)
Q Consensus 13 ~~~~~~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~----~~~l~~~~ 88 (698)
.++++.|+|++||+|++|++|+||+|+|+||||+++ ++|| |+ +.+ |||+|||++|++++ +++|.++.
T Consensus 9 ~~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~ 79 (276)
T 3m7h_A 9 FNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAF 79 (276)
T ss_dssp CCCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEE
T ss_pred eccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeC
Confidence 357889999999999999999999999999999543 5677 76 777 99999999999885 78999999
Q ss_pred CceEEe---CCCCceEEeeccCCC-----CCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCc
Q 005400 89 KGIVLL---DGRDRIFWSSNTSIT-----MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (698)
Q Consensus 89 ~g~l~l---~~~~~~~ws~~~~~~-----~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~ 160 (698)
||+|+| |++|.+||+|+++.. ..+.+|+|+|+|||||++ +.+|||| |||||+|||||+|.++++|..
T Consensus 80 ~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~---~~~lWqS--~ptdtlLpg~~~~~~l~~g~~ 154 (276)
T 3m7h_A 80 YVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD---SLALWNG--TPAIPLVPGAIDSLLLAPGSE 154 (276)
T ss_dssp EESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---EEEEEES--CTTSCCCCSCTTCEEECSSEE
T ss_pred CCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC---CceeeCc--ccccccccccccccccccCcc
Confidence 998866 678999999997542 245789999999999997 6799999 999999999999999998865
Q ss_pred eeEEeeccCCCCCCCceEEeecCCCCceEEEec-CcEEEEeeCCCCCCCccCCCCCcccccceeeEEEecCc-eEEEEEc
Q 005400 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRK-GSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINEN-EVYYECD 238 (698)
Q Consensus 161 ~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~-~~~~~~~~g~w~~~~~~~~p~~~~~~~~~~~~~~~n~~-~~~~~~~ 238 (698)
| ++.+||++|.|++.+|++|.. ++++ +...||++|.|++.... ..++.. ..+.+..+++ ...++++
T Consensus 155 --L---~S~~dps~G~fsl~l~~dGnl--vLy~~~~~~yW~Sgt~~~~~~~--l~l~~d---GnLvl~d~~~~~vWsS~t 222 (276)
T 3m7h_A 155 --L---VQGVVYGAGASKLVFQGDGNL--VAYGPNGAATWNAGTQGKGAVR--AVFQGD---GNLVVYGAGNAVLWHSHT 222 (276)
T ss_dssp --E---CTTCEEEETTEEEEECTTSCE--EEECTTSSEEEECCCTTTTCCE--EEECTT---SCEEEECTTSCEEEECSC
T ss_pred --c---ccCCCCCCceEEEeecCCceE--EEEeCCCeEEEECCCCCCccEE--EEEcCC---CeEEEEeCCCcEEEEecC
Confidence 5 678999999999999999954 4444 46899999998753211 111111 1122233322 3333332
Q ss_pred cCCCceeEEEEeeCCCEEEEEEecCCCcEEEEEecCC
Q 005400 239 AKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPL 275 (698)
Q Consensus 239 ~~~~~~~r~~l~~~G~~~~~~w~~~~~~W~~~~~~p~ 275 (698)
......|++|+.||++++|.| ...|..+|.+|.
T Consensus 223 -~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 223 -GGHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp -TTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred -CCCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 233458999999999999998 345666655554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=371.45 Aligned_cols=201 Identities=25% Similarity=0.341 Sum_probs=173.3
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.+.|++.++||+|+||.||+|+.. .|+.||||+++.... ..+|++++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888889999999999999875 589999999975422 24799999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-ceEEeecCCCcccCCCc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDE 629 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFgla~~~~~~~ 629 (698)
|++|+|.+++.+. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999654 34899999999999999999999998 99999999999999987 69999999998765432
Q ss_pred ccc---ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 630 IQT---NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 630 ~~~---~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||....+.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 262 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 211 122357999999999999999999999999999999999999999865544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=374.07 Aligned_cols=202 Identities=26% Similarity=0.364 Sum_probs=170.9
Q ss_pred cCccccCceeeecceeEEEEEec----cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|++.++||+|+||+||+++.. .++.||+|++++.. ......+.+|++++++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 36789999997642 2334568899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++|+|.+++.+. ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999654 34899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.... ......||+.|||||++.+..|+.++|||||||+||||+||+.||...++
T Consensus 178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 231 (304)
T 3ubd_A 178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231 (304)
T ss_dssp ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH
Confidence 3222 22336899999999999999999999999999999999999999986443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=376.55 Aligned_cols=216 Identities=29% Similarity=0.445 Sum_probs=183.4
Q ss_pred chhhHHHhhcCccccCceeeecceeEEEEEecc------ccEEEEEEecCCCC-cchHHHHHHHHHHhhcCC-CeeeeEE
Q 005400 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQH-RNLVKLL 535 (698)
Q Consensus 464 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H-~nIv~l~ 535 (698)
+..+.+...++|++.++||+|+||+||+|++.. ++.||||++..... ...++|.+|+++|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 333334445789999999999999999998643 46799999976533 345679999999999965 8999999
Q ss_pred EEEEeC-CeeEEEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Q 005400 536 GCCIQA-DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDL 601 (698)
Q Consensus 536 ~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl 601 (698)
|+|.+. ...+||||||++|+|.++|..... ...+++.+++.++.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 568999999999999999975432 345899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 602 KASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 602 kp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
||+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997755443334445689999999999999999999999999999999998 99999765
Q ss_pred CC
Q 005400 681 HP 682 (698)
Q Consensus 681 ~~ 682 (698)
..
T Consensus 292 ~~ 293 (353)
T 4ase_A 292 KI 293 (353)
T ss_dssp CC
T ss_pred CH
Confidence 43
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=358.62 Aligned_cols=198 Identities=28% Similarity=0.482 Sum_probs=162.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||+||+++.. +|+.||+|++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999874 5899999999754 2334567999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+ +|+|.+++.+. ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 67898888653 34899999999999999999999998 999999999999999999999999999875433
Q ss_pred ccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.. .....||+.|||||++.+..+ +.++||||+||+||||+||+.||...
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 166 NF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 21 223689999999999988876 57999999999999999999999754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=356.62 Aligned_cols=200 Identities=27% Similarity=0.462 Sum_probs=163.0
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe-------
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE------- 543 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~------- 543 (698)
++|++++.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999874 589999999976543 345678999999999999999999999876543
Q ss_pred -----eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEee
Q 005400 544 -----SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (698)
Q Consensus 544 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 618 (698)
.++||||+++|+|.+++.........++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999976555455677888999999999999999998 99999999999999999999999
Q ss_pred cCCCcccCCCcccc----------ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 619 FGMARIFGGDEIQT----------NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 619 Fgla~~~~~~~~~~----------~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 99998765432111 1123579999999999999999999999999999999996 665
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=359.07 Aligned_cols=199 Identities=24% Similarity=0.373 Sum_probs=162.4
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHH--HHHHHHhhcCCCeeeeEEEEEEeCC----eeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFK--NEVTLIARLQHRNLVKLLGCCIQAD----ESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~--~Ei~il~~l~H~nIv~l~~~~~~~~----~~~l 546 (698)
++|.+.++||+|+||+||+|++ +|+.||||+++... .+.+. .|+..+.+++|||||+++++|.+++ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4577788999999999999998 68999999996532 23333 4555667889999999999998764 5799
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-----SRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
|||||++|+|.++|... .++|..+++++.|+++||+|||++ ..++|+||||||+||||++++++||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999999543 489999999999999999999987 123599999999999999999999999999
Q ss_pred CcccCCCccc--cccccccccccccChhcccCC------CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 622 ARIFGGDEIQ--TNTHKVVGTYGYMSPEYAAEG------LFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 622 a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~------~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
++........ .......||+.|||||++.+. .++.++|||||||+||||+||+.||..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 9876543221 122335799999999998754 367899999999999999999887753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.67 Aligned_cols=203 Identities=23% Similarity=0.387 Sum_probs=171.9
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC------C
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------D 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------~ 542 (698)
.++|+++++||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|+++|++++|||||++++++... .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999874 58999999997653 23456788999999999999999999997643 5
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..+||||||+ |+|..++.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 678888854 345999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCc--cccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 623 RIFGGDE--IQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 8764321 11223346899999999998775 56999999999999999999999997543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=368.08 Aligned_cols=201 Identities=27% Similarity=0.423 Sum_probs=173.3
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHH---HHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKN---EVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~---Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
.++|++.+.||+|+||.||+++.. +|+.||+|++.+. .......+.+ ++++++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999875 5899999999653 1222333444 45666778999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
||||||+++|+|..+|.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999654 34899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
+.... ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||.....
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 65433 233689999999999965 5799999999999999999999999975443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=344.62 Aligned_cols=203 Identities=24% Similarity=0.365 Sum_probs=172.5
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEec----cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeC
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~ 541 (698)
.+....++|++.++||+|+||+||+|+.+ .++.||+|++.+.. ....+.+|++++..+ +|||||++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34455688999999999999999999753 36789999986543 345688999999998 699999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC-CceEEeecC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFG 620 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFg 620 (698)
+..+|||||+++++|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999882 2889999999999999999999998 9999999999999877 799999999
Q ss_pred CCcccCCCccc--------------------------cccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhC
Q 005400 621 MARIFGGDEIQ--------------------------TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSG 673 (698)
Q Consensus 621 la~~~~~~~~~--------------------------~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG 673 (698)
+|+........ ......+||+.|||||++.+. .|+.++||||+||++|||+||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865432110 111235799999999998775 589999999999999999999
Q ss_pred CCCCCCC
Q 005400 674 KKNWRFS 680 (698)
Q Consensus 674 ~~pf~~~ 680 (698)
+.||...
T Consensus 244 ~~Pf~~~ 250 (361)
T 4f9c_A 244 RYPFYKA 250 (361)
T ss_dssp CSSSSCC
T ss_pred CCCCCCC
Confidence 9999643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=362.34 Aligned_cols=203 Identities=24% Similarity=0.387 Sum_probs=180.7
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|++.++||+|+||.||+++.. +|+.||+|++........+.+.+|+++|+.++|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367999999999999999999875 5899999999876555667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC--CceEEeecCCCcccCCC
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND--MNPKISDFGMARIFGGD 628 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~DFgla~~~~~~ 628 (698)
|++|+|.+++.+. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999988542 235899999999999999999999998 9999999999999854 79999999999987544
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.. ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.....
T Consensus 311 ~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~ 361 (573)
T 3uto_A 311 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361 (573)
T ss_dssp SE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred Cc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 32 2236899999999999999999999999999999999999999975543
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=311.41 Aligned_cols=216 Identities=14% Similarity=0.168 Sum_probs=168.0
Q ss_pred ccccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-
Q 005400 16 AANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL- 94 (698)
Q Consensus 16 ~~~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l- 94 (698)
++.|+|++||+|++|++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| ..+.|.+++||+|+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS---DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 678999999999999999 59999999987664 233 442 799999999988 568899999999988
Q ss_pred CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCccc-CCCCeecccc-cCCC-----ceeEEeec
Q 005400 95 DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTL-LPGMKLGRNF-KTGM-----DRHLSSWK 167 (698)
Q Consensus 95 ~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTl-Lpg~~l~~~~-~~g~-----~~~l~s~~ 167 (698)
|++|.+||+|++........|+|+|+|||||++ .++||||||||||+ ||+| |.|. .+|+ +++|++
T Consensus 72 d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~----~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s-- 143 (236)
T 1dlp_A 72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG----PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLHA-- 143 (236)
T ss_dssp CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC----SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEECS--
T ss_pred cCCCcEEEeCCccccCCcEEEEEeCCCCEEEec----CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEEc--
Confidence 888999999997644445689999999999994 28999999999877 5654 4444 4444 567774
Q ss_pred cCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCCCCCCCccCCCCCcccccceeeEEEecCceEEEEEccCCCceeEE
Q 005400 168 SINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAVSRL 247 (698)
Q Consensus 168 ~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~w~~~~~~~~p~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~r~ 247 (698)
..||++|.|+|.++++| +++++++...||++++|++. +...+.+.....+.. +..++++.+.++........|+
T Consensus 144 -~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~l--y~~~~~~vw~s~~~~~~~~~rl 217 (236)
T 1dlp_A 144 -TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDV--LTNQNIAVWTSGNSRSAGRYVF 217 (236)
T ss_dssp -SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEE--EETTTEEEEECCCCCSSSCCEE
T ss_pred -CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEE--EeCCCcEEEEeCCCCCCCCEEE
Confidence 78999999999999999 67788878899999999754 555566554422222 2234445555555543457899
Q ss_pred EEeeCCCEEEEE
Q 005400 248 WVNQSGLVLRSI 259 (698)
Q Consensus 248 ~l~~~G~~~~~~ 259 (698)
+|+++|++++|.
T Consensus 218 ~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 218 VLQPDRNLAIYG 229 (236)
T ss_dssp EECSSSCEEEEC
T ss_pred EEcCCCcEEEeC
Confidence 999999999883
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.96 Aligned_cols=222 Identities=38% Similarity=0.673 Sum_probs=192.3
Q ss_pred ccchhhHHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC
Q 005400 462 EFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (698)
Q Consensus 462 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~ 541 (698)
.+...++...+++|++.+.||+|+||.||+|+..+++.||+|++........+.+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34455666788999999999999999999999888999999998877667778899999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
+..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999998864332 235899999999999999999999988 9999999999999999999999999
Q ss_pred CCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~~~ 686 (698)
++................||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~ 250 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH
Confidence 998654332222223356899999999998889999999999999999999999999876655443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.97 Aligned_cols=212 Identities=22% Similarity=0.314 Sum_probs=182.7
Q ss_pred chhhHHHhhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEE
Q 005400 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (698)
Q Consensus 464 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~ 539 (698)
.+.++....++|++.++||+|+||+||+++... ++.||+|++.+. .....+.+.+|++++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 445556677899999999999999999999865 788999999653 2233445899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeec
Q 005400 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (698)
Q Consensus 540 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 619 (698)
+....++||||+++|+|..++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999652 235899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccCCCccccccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 999876443322 222357999999999986 5678999999999999999999999997544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=313.47 Aligned_cols=202 Identities=25% Similarity=0.483 Sum_probs=180.6
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..++|++.++||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346799999999999999999986 4588999999976665667789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999998543 4889999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 171 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp CC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 223579999999999999999999999999999999999999997543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=318.20 Aligned_cols=202 Identities=24% Similarity=0.358 Sum_probs=178.1
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367899999999999999999875 5889999999754 234566789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++|+|..++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999988643 34889999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 158 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 221 2233679999999999999999999999999999999999999997543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.30 Aligned_cols=211 Identities=27% Similarity=0.448 Sum_probs=184.7
Q ss_pred ccchhhHHHhhcC----------ccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe
Q 005400 462 EFDFASIAKATDN----------FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530 (698)
Q Consensus 462 ~~~~~~l~~~~~~----------f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n 530 (698)
.++++++..+++. |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3566666666543 667789999999999999976 68999999998776667788999999999999999
Q ss_pred eeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC
Q 005400 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN 610 (698)
Q Consensus 531 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~ 610 (698)
|+++++++......++||||+++++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999998843 34899999999999999999999998 999999999999999
Q ss_pred CCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 611 DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 611 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++.+||+|||++......... .....||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp TCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999876543221 223579999999999999999999999999999999999999997543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=316.41 Aligned_cols=201 Identities=29% Similarity=0.460 Sum_probs=177.9
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
.++|++.+.||+|+||.||+++. .+|+.||||++... .....+.+.+|++++++++||||+++++++......++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999987 46899999999754 3344567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999986543 4889999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccccccChhcccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFS-VKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~-~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. ......||+.|+|||++.+..+. .++|||||||++|||++|+.||....
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 2 12336799999999999888765 89999999999999999999997544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.93 Aligned_cols=219 Identities=41% Similarity=0.750 Sum_probs=190.1
Q ss_pred cccccchhhHHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEE
Q 005400 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGC 537 (698)
Q Consensus 459 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~ 537 (698)
.+..++..++....++|++.+.||+|+||.||+++..+++.||||++.... ......+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 355688899999999999999999999999999998889999999997653 2233478999999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 538 CIQADESMLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 538 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
+......++||||+++++|.+++.... ....+++..+..++.|++.||+|||+....+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999997543 3345899999999999999999999992223999999999999999999999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
+|||++.......... .....||+.|+|||++....++.++||||||+++|||++|+.||.
T Consensus 176 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999998765433222 223569999999999988889999999999999999999999995
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.12 Aligned_cols=208 Identities=23% Similarity=0.306 Sum_probs=180.0
Q ss_pred hhHHHhhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC
Q 005400 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (698)
Q Consensus 466 ~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~ 541 (698)
.++....++|++.++||+|+||.||+++... ++.||+|++.+. .....+.+.+|+++++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3455567889999999999999999999764 789999998653 223345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
...++||||+++|+|..++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999988542 3789999999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL----FSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++.+...... ......||+.|+|||++.... ++.++|||||||++|||++|+.||....
T Consensus 215 a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 215 CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp CEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 9876543321 223468999999999997665 7899999999999999999999997544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=327.75 Aligned_cols=212 Identities=22% Similarity=0.319 Sum_probs=182.6
Q ss_pred chhhHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEE
Q 005400 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (698)
Q Consensus 464 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~ 539 (698)
.+.++....++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|++++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44455566789999999999999999999985 5899999999653 2233456899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeec
Q 005400 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (698)
Q Consensus 540 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 619 (698)
+....++||||+++|+|..++.+.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999996532 35899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccCCCccccccccccccccccChhccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~-------~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|+++.+...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 207 GSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 999876543321 122357999999999987 3568999999999999999999999997544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.63 Aligned_cols=207 Identities=30% Similarity=0.479 Sum_probs=180.2
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|.+.++||+|+||.||+++.. +++.||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367888899999999999999875 4889999999776666778899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999653 335899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccc------------cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 631 QTN------------THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 631 ~~~------------~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
... .....||+.|+|||.+.+..++.++||||||+++|||++|..||....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~ 228 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence 110 11357999999999999999999999999999999999999999765443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=320.76 Aligned_cols=203 Identities=30% Similarity=0.462 Sum_probs=173.8
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~ 545 (698)
..++|++.+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|.+++..+ +||||+++++++.+....+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999875 4889999999754 233456788999999988 6999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+++|+|..++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998654 34899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 175 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 175 ICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 32221 2233679999999999998889999999999999999999999997544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.33 Aligned_cols=201 Identities=25% Similarity=0.400 Sum_probs=174.8
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~l 546 (698)
.++|++.++||+|+||.||+++... ++.||+|++++. .....+.+..|..++.++ +||||+++++++.+....++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4678999999999999999998754 788999999764 233445688999999887 89999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++|+|..++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999998654 34899999999999999999999998 9999999999999999999999999998632
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 222 1223468999999999999999999999999999999999999999643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=321.89 Aligned_cols=208 Identities=30% Similarity=0.477 Sum_probs=179.7
Q ss_pred hcCccccCceeeecceeEEEEEec--------cccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeC
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~ 541 (698)
.++|++.+.||+|+||.||+++.. ++..||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999853 35679999997653 33456799999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (698)
...++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999975432 235889999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999987654433333334567889999999999999999999999999999999 9999976443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.98 Aligned_cols=219 Identities=40% Similarity=0.640 Sum_probs=191.2
Q ss_pred cccccchhhHHHhhcCcccc------CceeeecceeEEEEEeccccEEEEEEecCC----CCcchHHHHHHHHHHhhcCC
Q 005400 459 ELWEFDFASIAKATDNFASY------NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG----SGQGMEEFKNEVTLIARLQH 528 (698)
Q Consensus 459 ~~~~~~~~~l~~~~~~f~~~------~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~----~~~~~~~~~~Ei~il~~l~H 528 (698)
....|.+.++.+++++|... +.||+|+||.||+|+. +++.||+|++... .....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999876 8899999999999987 6889999998653 23345679999999999999
Q ss_pred CeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE
Q 005400 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (698)
Q Consensus 529 ~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (698)
|||+++++++.+....++||||+++++|.+++........+++..+..++.|+++||+|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976555567999999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
+.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 9999999999999987654332223334579999999998864 588999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.61 Aligned_cols=203 Identities=28% Similarity=0.468 Sum_probs=173.2
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.+.||+|+||.||+++.. .++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999864 58899999986542 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998654 34899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 164 TSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3221 2233579999999999999999999999999999999999999997543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=314.52 Aligned_cols=209 Identities=30% Similarity=0.530 Sum_probs=172.7
Q ss_pred HHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
....++|++.++||+|+||.||+++. .++.||||++.... ....+.+.+|++++++++||||+++++++......++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 33456799999999999999999987 68899999987653 3345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|.+++........+++..++.++.|+++||+|||+.+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999976544445899999999999999999999875 349999999999999999999999999998654
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 191 STFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3321 1223579999999999999999999999999999999999999997544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.63 Aligned_cols=199 Identities=27% Similarity=0.415 Sum_probs=177.2
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.+.||+|+||.||+++.. +|+.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999875 5889999999754 224456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999998653 34889999999999999999999998 99999999999999999999999999987543
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2 223679999999999999999999999999999999999999997543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.78 Aligned_cols=204 Identities=27% Similarity=0.421 Sum_probs=177.7
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
...++|.+.+.||+|+||.||+++.. +++.||+|++++.. ....+.+..|.+++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999975 48899999997541 34456788999999887 899999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999998653 34899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 168 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 432221 2234689999999999999999999999999999999999999997543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.34 Aligned_cols=204 Identities=21% Similarity=0.172 Sum_probs=176.0
Q ss_pred HhhcCccccCceeeecceeEEEEE------eccccEEEEEEecCCCCcchHHHHHHHHHHhhcC---CCeeeeEEEEEEe
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGT------LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQ 540 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~------~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~---H~nIv~l~~~~~~ 540 (698)
...++|.+.++||+|+||.||+|+ ...++.||+|++... ...++..|++++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 455789999999999999999994 345889999999653 3557888888888887 9999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHhhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC--------
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQA--RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-------- 610 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-------- 610 (698)
.+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999996432 2446999999999999999999999988 999999999999998
Q ss_pred ---CCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 611 ---DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 611 ---~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999765422222233446799999999999999999999999999999999999999854
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.28 Aligned_cols=204 Identities=28% Similarity=0.428 Sum_probs=175.0
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 68899999986542 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999888433 34899999999999999999999998 9999999999999999999999999998754333
Q ss_pred cccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.........||+.|+|||++....+ +.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 2222334679999999999987765 778999999999999999999997543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.07 Aligned_cols=199 Identities=26% Similarity=0.402 Sum_probs=175.3
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|++++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57889999999999999999975 48899999997642 23455688999999988 899999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|..++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999998653 34899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 22 122336899999999999999999999999999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.43 Aligned_cols=203 Identities=29% Similarity=0.407 Sum_probs=177.6
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~ 545 (698)
..++|++.+.||+|+||.||+++... ++.||+|++++. .....+.+..|.+++..+ +||||+++++++.+....+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34789999999999999999999864 788999999754 234556788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999986533 4899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 172 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 32221 2234689999999999999999999999999999999999999997543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=311.68 Aligned_cols=202 Identities=26% Similarity=0.379 Sum_probs=177.9
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCc------chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
..++|++.+.||+|+||.||+++.. +|+.||+|++.+.... ..+.+.+|++++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999875 5889999999765321 35679999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC----ceEEeec
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDF 619 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DF 619 (698)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999854 335899999999999999999999998 99999999999998776 7999999
Q ss_pred CCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|++..+..... .....||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 164 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp SSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99987654321 223579999999999999999999999999999999999999997543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.14 Aligned_cols=218 Identities=29% Similarity=0.455 Sum_probs=183.7
Q ss_pred cccchhhHHHhhcCccccCceeeecceeEEEEEe------ccccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeee
Q 005400 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLV 532 (698)
Q Consensus 461 ~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv 532 (698)
..++..+.....++|++.++||+|+||.||++++ .+++.||||++.... ....+.+.+|++++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 3455556666778999999999999999999974 246789999997653 33456799999999999 799999
Q ss_pred eEEEEEEeCCe-eEEEEEecCCCChhHHHhhccc----------------------------------------------
Q 005400 533 KLLGCCIQADE-SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------- 565 (698)
Q Consensus 533 ~l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------- 565 (698)
++++++.+... .++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999987654 8999999999999999975432
Q ss_pred -----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 566 -----------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 566 -----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122889999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
..........||..|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 33333344678999999999999999999999999999999998 999997544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.07 Aligned_cols=202 Identities=23% Similarity=0.410 Sum_probs=177.0
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+++++.++|||||++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367899999999999999999875 4788999998653 234567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999998543 34899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccChhcccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~---~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 32 2233679999999999864 4589999999999999999999999975443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=313.39 Aligned_cols=199 Identities=25% Similarity=0.337 Sum_probs=177.8
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.+.||+|+||.||+++.. +|+.||+|++.+. .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367899999999999999999875 5889999998654 234567789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|..++.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999986543 4899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 2 223579999999999999999999999999999999999999997543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=310.08 Aligned_cols=202 Identities=26% Similarity=0.394 Sum_probs=167.6
Q ss_pred hcCccccCceeeecceeEEEEEe----ccccEEEEEEecCCC----CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
.++|++.+.||+|+||.||+++. .+++.||+|++++.. ......+.+|++++++++||||+++++++.....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999987 468899999997642 2344568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++||||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999998643 34889999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
....... ......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 6432221 1223579999999999999999999999999999999999999997543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=309.34 Aligned_cols=204 Identities=26% Similarity=0.427 Sum_probs=174.1
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe-----
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~----- 543 (698)
..++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467899999999999999999986 68999999997543 3456789999999999999999999999876542
Q ss_pred ----------------------------------------------------eEEEEEecCCCChhHHHhhccccCCCCH
Q 005400 544 ----------------------------------------------------SMLIYEYMPNKSLDFFIFDQARATFLDW 571 (698)
Q Consensus 544 ----------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~ 571 (698)
.++||||+++++|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 7999999999999999987666566778
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc----------cccccccccc
Q 005400 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ----------TNTHKVVGTY 641 (698)
Q Consensus 572 ~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~----------~~~~~~~gt~ 641 (698)
..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 889999999999999999998 999999999999999999999999999876543211 1122357999
Q ss_pred cccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005400 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (698)
Q Consensus 642 ~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf 677 (698)
.|+|||++.+..++.++||||||+++|||++|..|+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 999999999999999999999999999999997765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=306.62 Aligned_cols=206 Identities=28% Similarity=0.427 Sum_probs=174.6
Q ss_pred HhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
...++|++.++||+|+||.||+++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3457899999999999999999999889999999997542 23356789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++ +|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999985 677776543 234899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
.... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 172 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 172 PVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp CCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred Cccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 3221 223578999999999876 56899999999999999999999999755443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.80 Aligned_cols=201 Identities=27% Similarity=0.442 Sum_probs=176.4
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999875 58899999997542 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC---ceEEeecCCCcc
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARI 624 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFgla~~ 624 (698)
|||+++++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999888543 45899999999999999999999998 99999999999998654 599999999987
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
...... .....||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 653321 22357999999999999989999999999999999999999999754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.69 Aligned_cols=203 Identities=28% Similarity=0.418 Sum_probs=176.2
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC-----CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+....+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356899999999999999999874 5899999998542 1224678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc---eEEeecCC
Q 005400 546 LIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGM 621 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFgl 621 (698)
+||||+++++|.+.+.+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988876543 3345899999999999999999999998 999999999999987655 99999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
+........ ......||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 987654322 12235799999999999999999999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.34 Aligned_cols=205 Identities=28% Similarity=0.448 Sum_probs=176.7
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|.+.++||+|+||.||+|+.. +++.||||+++... ....+.|.+|++++++++||||+++++++......++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888899999999999999986 68899999987553 2344578999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999986532 34889999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.........++..|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2221122346788999999998899999999999999999998 999997543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=299.33 Aligned_cols=203 Identities=30% Similarity=0.517 Sum_probs=178.3
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.++|++.+.||+|+||.||+++..+++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35788899999999999999999889999999997643 34567999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999998543 335899999999999999999999998 999999999999999999999999999876433221
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
......+|..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 2223467788999999998999999999999999999999 999997543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.49 Aligned_cols=202 Identities=25% Similarity=0.397 Sum_probs=176.5
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC--eeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~--~~~lV 547 (698)
.++|.+.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3678999999999999999998754 8899999997542 344677889999999999999999999998765 67999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE----cCCCceEEeecCCCc
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFgla~ 623 (698)
|||+++++|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999977655555999999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCccccccccccccccccChhccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAA--------EGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
....... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 7654332 12357999999999886 56789999999999999999999999964
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=308.64 Aligned_cols=201 Identities=26% Similarity=0.445 Sum_probs=175.0
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|.+.+.||+|+||.||+++. .+++.||+|++... .....+.+.+|+++++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999997 46889999998653 223346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+ +|+|.+++.... .+++.++..++.|++.||.|||+.+ |+||||||+|||+++++++||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 678888875533 4899999999999999999999998 99999999999999999999999999987644
Q ss_pred CccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
... .....||+.|+|||++.+..+ ++++||||||+++|||++|+.||.....
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 322 223579999999999988776 7899999999999999999999976543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.08 Aligned_cols=202 Identities=29% Similarity=0.460 Sum_probs=172.4
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC----eeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----ESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~----~~~l 546 (698)
..++|++.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3467999999999999999999874 7899999996543 33445667899999999999999999998754 3699
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceeecCCCCCCEEEcCCCceEE
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD----------SRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 99999999999999542 389999999999999999999998 6 999999999999999999999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-----LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999999876554433333346799999999998763 45678899999999999999999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.59 Aligned_cols=201 Identities=22% Similarity=0.344 Sum_probs=177.1
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|.+.+.||+|+||.||+++.. +++.+|+|.+... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999875 4788999998654 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC--CCceEEeecCCCcccCCC
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIFGGD 628 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFgla~~~~~~ 628 (698)
+++++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++..+...
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999998542 235899999999999999999999998 999999999999987 789999999999876543
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 22 223578999999999998889999999999999999999999997543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=314.33 Aligned_cols=202 Identities=23% Similarity=0.337 Sum_probs=167.4
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCC---CcchHHHHHHHHH-HhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTL-IARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~i-l~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
.++|++.+.||+|+||.||+++... ++.||+|++.+.. ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4679999999999999999999754 7889999997652 2334556777776 467899999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++|+|..++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999998653 34788999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 191 EHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred cCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 2221 2234689999999999999999999999999999999999999997543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.40 Aligned_cols=200 Identities=26% Similarity=0.388 Sum_probs=176.5
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC------cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
.++|.+.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|++++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356889999999999999999875 488999999875422 1357799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC----ceEEeecC
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFG 620 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFg 620 (698)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999854 345899999999999999999999998 99999999999999887 89999999
Q ss_pred CCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
++..+..... .....||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 9987643321 22357999999999999899999999999999999999999999754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.24 Aligned_cols=200 Identities=26% Similarity=0.413 Sum_probs=170.4
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|++.++||+|+||.||+++...++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999998779999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++ +|..++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 888877543 235889999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11235689999999998754 5899999999999999999999999753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.51 Aligned_cols=202 Identities=30% Similarity=0.484 Sum_probs=178.0
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.++|++.+.||+|+||.||+++..+++.||+|++.... ...+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46789999999999999999999888899999997543 34567999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999986542 34899999999999999999999998 999999999999999999999999999876544322
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
. .....+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 2 223456778999999988889999999999999999999 99999743
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=311.26 Aligned_cols=211 Identities=28% Similarity=0.473 Sum_probs=180.3
Q ss_pred HHHhhcCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEe
Q 005400 468 IAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (698)
Q Consensus 468 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~ 540 (698)
+....++|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445688999999999999999999874 34789999997653 3345679999999999999999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHhhccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeec
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQAR---------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 599 (698)
....++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999975321 146899999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 005400 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWR 678 (698)
Q Consensus 600 Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~ 678 (698)
||||+|||++.++.+||+|||++................+|+.|+|||.+....++.++||||||+++|||+| |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643332222333568899999999998899999999999999999999 999997
Q ss_pred CCC
Q 005400 679 FSH 681 (698)
Q Consensus 679 ~~~ 681 (698)
...
T Consensus 279 ~~~ 281 (343)
T 1luf_A 279 GMA 281 (343)
T ss_dssp TSC
T ss_pred CCC
Confidence 543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.77 Aligned_cols=205 Identities=20% Similarity=0.266 Sum_probs=177.4
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999986 468899999987543 234688999999999 99999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc-----eEEeecCCCcc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-----PKISDFGMARI 624 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DFgla~~ 624 (698)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998653 345899999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCcccc-----ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005400 625 FGGDEIQT-----NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684 (698)
Q Consensus 625 ~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~ 684 (698)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~ 224 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT 224 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc
Confidence 64332211 1234679999999999999999999999999999999999999998755443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=308.53 Aligned_cols=204 Identities=30% Similarity=0.527 Sum_probs=168.9
Q ss_pred cCccccCceeeecceeEEEEEec-ccc----EEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|++.++||+|+||.||+|++. +++ +||+|.+... .....+.+.+|++++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56889999999999999999864 343 4688888644 3355678999999999999999999999998754 789
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.+.
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999986543 35899999999999999999999998 9999999999999999999999999998875
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
............+|..|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 5443333334567889999999999999999999999999999999 9999976544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=307.41 Aligned_cols=210 Identities=30% Similarity=0.466 Sum_probs=180.8
Q ss_pred hhcCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
..++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3577899999999999999999862 35789999997653 3445778999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 005400 544 SMLIYEYMPNKSLDFFIFDQAR---------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (698)
.++||||+++++|.+++..... ...+++.+++.++.|+++||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999975432 234889999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 603 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
|+|||+++++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654433333334567889999999988889999999999999999999 999997654
Q ss_pred CC
Q 005400 682 PD 683 (698)
Q Consensus 682 ~~ 683 (698)
+.
T Consensus 258 ~~ 259 (314)
T 2ivs_A 258 PE 259 (314)
T ss_dssp GG
T ss_pred HH
Confidence 43
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.28 Aligned_cols=205 Identities=25% Similarity=0.406 Sum_probs=168.9
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe---
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE--- 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~--- 543 (698)
..++|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 346799999999999999999986 468899999997652 2334578999999999999999999999876554
Q ss_pred -eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 544 -SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 544 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
.++||||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 39999999999999998653 34899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcc-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 623 RIFGGDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..+..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 87643321 122233568999999999999999999999999999999999999997544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=323.50 Aligned_cols=205 Identities=29% Similarity=0.473 Sum_probs=180.5
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|.+.+.||+|+||.||+++.. +|+.||+|++.+. .....+.+.+|++++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999985 5899999999654 224456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 548 YEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|||+++|+|..++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++..+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865432 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 43221 223589999999999999999999999999999999999999997643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=318.00 Aligned_cols=203 Identities=25% Similarity=0.417 Sum_probs=175.7
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
...++|++.++||+|+||.||+++.. +|+.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34577999999999999999999864 58899999987653 2345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc---CCCceEEeecCCCc
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMAR 623 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFgla~ 623 (698)
||||+++|+|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999988653 34899999999999999999999998 99999999999998 46789999999998
Q ss_pred ccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
........ .....||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 162 EVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp CCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 76543221 22367999999999999999999999999999999999999999643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.06 Aligned_cols=198 Identities=23% Similarity=0.368 Sum_probs=169.6
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999875 48899999997543 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|++++.+ ..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++.......
T Consensus 82 ~~~~~l~-~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLK-KYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHH-HHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHH-HHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9987544 44433 2345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccChhcccCCC-CCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~-~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
. ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 2 122357899999999987765 8999999999999999999998863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=325.58 Aligned_cols=204 Identities=28% Similarity=0.470 Sum_probs=179.9
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|++.+.||+|+||.||+++.. +|+.||+|++.+. .....+.+.+|++++++++||||+++++++.+....++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999875 5899999999653 23445678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++..+.
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999986543 234899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 3322 123579999999999999899999999999999999999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.96 Aligned_cols=202 Identities=24% Similarity=0.357 Sum_probs=177.9
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|++.+.||+|+||.||+++.. +++.||+|++..........+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999875 5889999999766555566789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC--CCceEEeecCCCcccCCC
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIFGGD 628 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFgla~~~~~~ 628 (698)
+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++..+...
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988543 234899999999999999999999998 999999999999974 467999999999876543
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... ....||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 205 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 205 EIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp SCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 321 22479999999999999999999999999999999999999997543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.04 Aligned_cols=204 Identities=29% Similarity=0.493 Sum_probs=173.6
Q ss_pred hcCccccCceeeecceeEEEEEec----cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
.++|.+.+.||+|+||.||+|+.. .+..||||+++.. .....+.+.+|++++++++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888999999999999999874 3456999999765 33445679999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998543 235899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcc-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 627 GDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 627 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
.... ........+|..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 4321 111222456778999999998899999999999999999999 99999654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=322.48 Aligned_cols=202 Identities=24% Similarity=0.352 Sum_probs=167.0
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.++||+|+||.||+++.. +++.||+|++... .......+.+|++++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367899999999999999999864 5889999999753 334456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|||+++++|..++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999988653 358999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 3221 2233679999999999999999999999999999999999999997543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.46 Aligned_cols=200 Identities=28% Similarity=0.406 Sum_probs=168.1
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--------------------------cchHHHHHHHHHHh
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--------------------------QGMEEFKNEVTLIA 524 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--------------------------~~~~~~~~Ei~il~ 524 (698)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999874 588999999865421 12356899999999
Q ss_pred hcCCCeeeeEEEEEEe--CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 005400 525 RLQHRNLVKLLGCCIQ--ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (698)
Q Consensus 525 ~l~H~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (698)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.|+++||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999997754 2345899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCC---CCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 603 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
|+|||++.++++||+|||++..+...... .....||+.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999876543221 22357999999999987665 37889999999999999999999975
Q ss_pred C
Q 005400 680 S 680 (698)
Q Consensus 680 ~ 680 (698)
.
T Consensus 243 ~ 243 (298)
T 2zv2_A 243 E 243 (298)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.58 Aligned_cols=208 Identities=30% Similarity=0.467 Sum_probs=180.2
Q ss_pred hhcCccccCceeeecceeEEEEEec--------cccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~ 540 (698)
..++|.+.++||+|+||.||+++.. .+..||+|++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467899999999999999999853 24679999997653 34457789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 607 (698)
....++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999976432 235899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999987654433333344567899999999999999999999999999999999 999997543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=310.64 Aligned_cols=209 Identities=18% Similarity=0.271 Sum_probs=178.6
Q ss_pred HhhcCccccCceeee--cceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 470 KATDNFASYNKLGEG--GFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G--~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
...++|++.++||+| +||.||+++.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+....
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 345789999999999 99999999986 58999999997542 33456788899999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999986542 234899999999999999999999998 99999999999999999999999999865
Q ss_pred cCCCcc-----ccccccccccccccChhcccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 625 FGGDEI-----QTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 625 ~~~~~~-----~~~~~~~~gt~~y~APE~l~~--~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
...... ........||..|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 422111 111122478999999999987 5789999999999999999999999975443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.31 Aligned_cols=205 Identities=30% Similarity=0.520 Sum_probs=165.0
Q ss_pred hcCccccCceeeecceeEEEEEec----cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
.++|++.+.||+|+||.||+|+.. .+..||||+++.. .....+.|.+|++++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999875 4778999999765 33445679999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999643 335899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 627 GDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
..... .......++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 33211 11122345778999999999999999999999999999998 999996543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.61 Aligned_cols=209 Identities=31% Similarity=0.476 Sum_probs=177.5
Q ss_pred hhcCccccCceeeecceeEEEEEec------cccEEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCC
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~ 542 (698)
..++|.+.+.||+|+||.||+++.. .++.||+|++... .....+.+.+|++++.++ +||||+++++++....
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999862 3568999999754 334567899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhcccc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARA--------------------TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 602 (698)
..++||||+++++|.+++...... ..+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999754321 34789999999999999999999998 9999999
Q ss_pred CCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 603 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
|+|||++.++.+||+|||++................+|+.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433233334567889999999998999999999999999999998 999997654
Q ss_pred C
Q 005400 682 P 682 (698)
Q Consensus 682 ~ 682 (698)
.
T Consensus 280 ~ 280 (344)
T 1rjb_A 280 V 280 (344)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.04 Aligned_cols=204 Identities=26% Similarity=0.446 Sum_probs=161.6
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999875 58899999997553 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 550 YMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888886432 1235889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3221 1223578999999999876 468999999999999999999999997543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=307.27 Aligned_cols=216 Identities=26% Similarity=0.352 Sum_probs=185.2
Q ss_pred cccccccccchhhHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC-----C
Q 005400 455 KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----H 528 (698)
Q Consensus 455 ~~~~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-----H 528 (698)
+.+.+...+.+.+.....++|.+.++||+|+||.||+++.. +++.||||++... ....+.+..|++++++++ |
T Consensus 17 ~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h 95 (360)
T 3llt_A 17 QGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINN 95 (360)
T ss_dssp ---CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTG
T ss_pred ecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCC
Confidence 34445566777777778899999999999999999999874 5889999999643 344567788999999996 9
Q ss_pred CeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE
Q 005400 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (698)
Q Consensus 529 ~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (698)
|||+++++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 170 (360)
T 3llt_A 96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILL 170 (360)
T ss_dssp GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEE
Confidence 99999999999999999999999 9999999865432 34899999999999999999999998 9999999999999
Q ss_pred cC-------------------------CCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHH
Q 005400 609 DN-------------------------DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSF 663 (698)
Q Consensus 609 ~~-------------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSl 663 (698)
+. ++.+||+|||++....... ....||+.|+|||++.+..++.++|||||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHH
Confidence 75 7899999999998643322 23578999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 005400 664 GVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 664 Gvil~elltG~~pf~~~~ 681 (698)
||++|||++|+.||....
T Consensus 246 G~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHHCCCCCCCCc
Confidence 999999999999997543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.85 Aligned_cols=210 Identities=28% Similarity=0.464 Sum_probs=163.2
Q ss_pred HHhhcCccccCceeeecceeEEEEEecccc----EEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQ----EIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~----~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~ 542 (698)
....++|++.+.||+|+||.||+++..... .||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 345578999999999999999999875432 7999998765 3455678999999999999999999999998776
Q ss_pred ee------EEEEEecCCCChhHHHhhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc
Q 005400 543 ES------MLIYEYMPNKSLDFFIFDQAR---ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (698)
Q Consensus 543 ~~------~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (698)
.. ++||||+++++|..++..... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 65 999999999999999865432 225899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
+||+|||++................+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 99999999987654433222333567889999999999999999999999999999999 999997544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=322.20 Aligned_cols=205 Identities=33% Similarity=0.513 Sum_probs=177.6
Q ss_pred HhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
...++|.+.++||+|+||.||+|++.+++.||||+++... ...+.|.+|++++++++||||+++++++. ....++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3456788999999999999999999888999999997643 45788999999999999999999999986 667899999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999996432 234788999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.. ......+|..|+|||++....++.++||||||++||||+| |+.||....
T Consensus 339 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 339 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp HH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 11 1122456789999999998999999999999999999999 999997543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.86 Aligned_cols=204 Identities=30% Similarity=0.479 Sum_probs=175.8
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
..++|++.+.||+|+||.||+++..+++.||+|++.... ...+++.+|++++.+++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 346789999999999999999999888899999997643 3457799999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999986532 34899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
. ......+|+.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 176 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 176 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp H-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred c-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 1 1222456788999999998899999999999999999998 999997543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.45 Aligned_cols=203 Identities=31% Similarity=0.520 Sum_probs=171.7
Q ss_pred hcCccccCceeeecceeEEEEEe-----ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--Cee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~ 544 (698)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999984 25889999999876666677899999999999999999999998653 568
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999996543 24899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
....... .......++..|+|||.+.+..++.++||||||+++|||+||+.|+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 6433211 112234577889999999999999999999999999999999998863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.08 Aligned_cols=207 Identities=32% Similarity=0.492 Sum_probs=175.9
Q ss_pred hcCccccCceeeecceeEEEEEec------cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
.++|++.++||+|+||.||+|+.. .++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367889999999999999999853 3678999999754 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC---ceEEe
Q 005400 545 MLIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKIS 617 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~ 617 (698)
++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999975432 235899999999999999999999998 99999999999999555 59999
Q ss_pred ecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999986532222222233567899999999999999999999999999999998 999997543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.59 Aligned_cols=196 Identities=30% Similarity=0.424 Sum_probs=168.1
Q ss_pred cCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
.+.||+|+||.||+++.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999874 5889999999876555677899999999999999999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE--cCCCceEEeecCCCcccCCCcccccc
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL--DNDMNPKISDFGMARIFGGDEIQTNT 634 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl--~~~~~~kl~DFgla~~~~~~~~~~~~ 634 (698)
.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..... .
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 98886532 34889999999999999999999998 9999999999999 5678999999999987654322 1
Q ss_pred ccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 635 ~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
....||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22469999999999998899999999999999999999999997543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=292.70 Aligned_cols=200 Identities=23% Similarity=0.366 Sum_probs=176.9
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..++|++.++||+|+||.||+++... ++.+|+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999998754 67899999987666667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE---cCCCceEEeecCCCcccC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFG 626 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFgla~~~~ 626 (698)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999888653 34899999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.... .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 4322 2235799999999988654 899999999999999999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.17 Aligned_cols=210 Identities=31% Similarity=0.466 Sum_probs=179.3
Q ss_pred HHhhcCccccCceeeecceeEEEEEecc------ccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEe
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~ 540 (698)
....++|.+.+.||+|+||.||+++... ...||+|.+.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3456789999999999999999998643 2479999997653 23456789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHhhccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQAR-----------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
....++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 9999999999999999999875421 335789999999999999999999998 99999999999999
Q ss_pred CCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.++.+||+|||++................+|..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 999999999999986544332222333567889999999998999999999999999999999 999997543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=306.91 Aligned_cols=200 Identities=27% Similarity=0.422 Sum_probs=161.2
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..++|++.+.||+|+||.||+++... ++.||||++.... ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45789999999999999999999864 7889999997543 34568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC---CCceEEeecCCCcccC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFG 626 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFgla~~~~ 626 (698)
|+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999988543 34899999999999999999999998 999999999999975 8899999999998754
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 203 HQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred cccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 3221 223578999999999999999999999999999999999999997543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.98 Aligned_cols=205 Identities=28% Similarity=0.451 Sum_probs=172.4
Q ss_pred cCccccCceeeecceeEEEEEecc-cc----EEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~----~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
++|++.++||+|+||.||+|+... ++ +||+|.+... .....+.+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 568889999999999999998643 44 3888887544 2344567889999999999999999999986 566899
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998653 234788899999999999999999998 9999999999999999999999999999875
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPD 683 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~ 683 (698)
............+|..|+|||.+....++.++||||||+++|||+| |+.||......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 224 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence 5443333344678889999999998999999999999999999999 99999865443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.64 Aligned_cols=201 Identities=25% Similarity=0.398 Sum_probs=168.3
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCC--CeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H--~nIv~l~~~~~~~~~~~l 546 (698)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++| |||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 45679999999999999999999888999999998754 23345778999999999986 999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||| +.+++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||++..+.
T Consensus 87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 5688999998653 35889999999999999999999998 99999999999997 5789999999998765
Q ss_pred CCccccccccccccccccChhcccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAE-----------GLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~-----------~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
............||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 4433222334679999999999864 6789999999999999999999999974
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=300.41 Aligned_cols=208 Identities=28% Similarity=0.439 Sum_probs=179.8
Q ss_pred hhcCccccCceeeecceeEEEEEe------ccccEEEEEEecCCCC-cchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCC
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~ 542 (698)
..++|.+.+.||+|+||.||+++. ..++.||+|++..... ...+.+.+|++++.++ +||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346789999999999999999985 2467899999976533 3457799999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhccc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQAR---------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 607 (698)
..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999875432 124899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
++.++.+||+|||++................+|+.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999987655433333334567889999999999999999999999999999999 999997544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.37 Aligned_cols=211 Identities=29% Similarity=0.494 Sum_probs=180.3
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEec------cccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEE
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~ 539 (698)
+.....++|++.+.||+|+||.||+|+.. .++.||+|++..... .....+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33455678999999999999999999764 367899999975532 34557899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChhHHHhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC
Q 005400 540 QADESMLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (698)
Q Consensus 540 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (698)
+....++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 99999999999999999999865321 245789999999999999999999998 99999999999999999
Q ss_pred ceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 999999999986543332222333567889999999998999999999999999999999 89998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=313.90 Aligned_cols=201 Identities=29% Similarity=0.479 Sum_probs=174.5
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC-eeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-ESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~-~~~lV~E 549 (698)
..++|++.++||+|+||.||+|+.. ++.||||+++... ..+.|.+|++++++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467888999999999999999884 7899999997643 4578999999999999999999999988765 7899999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999997543 334789999999999999999999998 9999999999999999999999999998643221
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPD 683 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~ 683 (698)
....++..|+|||.+....++.++||||||++||||+| |+.||......
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 12357889999999999999999999999999999998 99999765443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=299.79 Aligned_cols=197 Identities=24% Similarity=0.295 Sum_probs=164.9
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--cchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.++||+|+||+||+|+.. +++.||||++..... .....+..|+..+.++ +||||+++++++.+....++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999986 689999999865432 2334455566666555 899999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+ +++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 66888887654 235899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
... .....||+.|+|||++.+ .++.++||||||+++|||++|+.|+.
T Consensus 210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 322 223569999999998875 78999999999999999999977664
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=323.15 Aligned_cols=205 Identities=30% Similarity=0.485 Sum_probs=179.2
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|++.++||+|+||.||+|++.. ++.||||+++... ...++|.+|++++++++||||+++++++......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568888999999999999999865 7899999997643 3467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999996543 345899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
. ......++..|+|||++....++.++|||||||+||||+| |+.||.....
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 2 1223456789999999998899999999999999999999 9999976543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=300.57 Aligned_cols=192 Identities=26% Similarity=0.358 Sum_probs=151.1
Q ss_pred CceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
+.||+|+||.||+++.. +++.||||++.+. ....+.+|++++++++ ||||+++++++.+....++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999875 5889999999643 4567889999999997 99999999999999999999999999999
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC---ceEEeecCCCcccCCCccccc
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFgla~~~~~~~~~~~ 633 (698)
.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++.........
T Consensus 94 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 94 FERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp HHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 9998653 35899999999999999999999998 99999999999998765 8999999999865433221
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 223578999999999999999999999999999999999999997543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.21 Aligned_cols=217 Identities=29% Similarity=0.459 Sum_probs=182.8
Q ss_pred ccchhhHHHhhcCccccCceeeecceeEEEEEe------ccccEEEEEEecCCCC-cchHHHHHHHHHHhhc-CCCeeee
Q 005400 462 EFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVK 533 (698)
Q Consensus 462 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~H~nIv~ 533 (698)
.++........++|.+.+.||+|+||.||+++. .+++.||+|++..... ...+.+.+|++++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 344555555678899999999999999999974 3468899999976533 3456789999999999 7999999
Q ss_pred EEEEEEeCC-eeEEEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeec
Q 005400 534 LLGCCIQAD-ESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599 (698)
Q Consensus 534 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 599 (698)
+++++...+ ..++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ |+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 999988755 48999999999999999975432 223789999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 005400 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWR 678 (698)
Q Consensus 600 Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~ 678 (698)
||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654433333334568899999999999999999999999999999998 999997
Q ss_pred CCC
Q 005400 679 FSH 681 (698)
Q Consensus 679 ~~~ 681 (698)
...
T Consensus 253 ~~~ 255 (316)
T 2xir_A 253 GVK 255 (316)
T ss_dssp TCC
T ss_pred ccc
Confidence 544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=292.43 Aligned_cols=200 Identities=34% Similarity=0.558 Sum_probs=164.7
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCC----CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~----~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.+.||+|+||.||+++. .++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 36788999999999999999997 48899999987542 23356789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC--------CCceEEeec
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--------DMNPKISDF 619 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~--------~~~~kl~DF 619 (698)
|||+++++|.+++. ...+++..+..++.|+++||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999884 235899999999999999999999987556899999999999986 678999999
Q ss_pred CCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
|++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99986543321 2357899999999999999999999999999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=308.53 Aligned_cols=204 Identities=28% Similarity=0.456 Sum_probs=163.8
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCC--e
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQAD--E 543 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~--~ 543 (698)
...++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999864 5889999998654 2344567889999999997 999999999998654 6
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 588888754 35889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCc-------------------cccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDE-------------------IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~-------------------~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 653211 0111223579999999999876 678999999999999999999999997544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=305.98 Aligned_cols=201 Identities=25% Similarity=0.352 Sum_probs=166.3
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..++|++.++||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999976 58899999997643 334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc--eEEeecCCCcccCC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--PKISDFGMARIFGG 627 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFgla~~~~~ 627 (698)
|+++++|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999986533 4899999999999999999999998 999999999999987765 99999999975322
Q ss_pred CccccccccccccccccChhcccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVK-SDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k-~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||....
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 21 1223579999999999988887665 899999999999999999997543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=305.24 Aligned_cols=211 Identities=23% Similarity=0.290 Sum_probs=173.1
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC-----CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~ 540 (698)
++....++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34566788999999999999999999874 5788999998643 34556789999999999999999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHhhccc-------------------------------------cCCCCHHHHHHHHHHHHH
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQAR-------------------------------------ATFLDWQKRIHIVGGIAR 583 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~ 583 (698)
....++||||+++++|.+++..... ...+++..+..++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999998842110 112356778899999999
Q ss_pred HHHHHHhCCCCceeecCCCCCCEEEcCCC--ceEEeecCCCcccCCCc--cccccccccccccccChhcccC--CCCCcc
Q 005400 584 GILYLHQDSRMRIIHRDLKASNVLLDNDM--NPKISDFGMARIFGGDE--IQTNTHKVVGTYGYMSPEYAAE--GLFSVK 657 (698)
Q Consensus 584 gL~yLH~~~~~~ivH~Dlkp~NILl~~~~--~~kl~DFgla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~--~~~~~k 657 (698)
||+|||+.+ |+||||||+|||++.++ .+||+|||++..+.... .........||+.|+|||++.. ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999998 99999999999998776 89999999998653211 1111233579999999999865 678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC
Q 005400 658 SDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 658 ~DVwSlGvil~elltG~~pf~~~ 680 (698)
+||||||+++|||++|+.||...
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=302.23 Aligned_cols=208 Identities=30% Similarity=0.485 Sum_probs=178.3
Q ss_pred hhcCccccCceeeecceeEEEEEec--------cccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~ 540 (698)
..++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999863 46789999997653 34456789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEE
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 607 (698)
....++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999975432 234889999999999999999999998 999999999999
Q ss_pred EcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999987655433333334567889999999988889999999999999999999 999997543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=292.09 Aligned_cols=204 Identities=28% Similarity=0.428 Sum_probs=176.9
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999875 5889999998654 33455788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999988843 234899999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.........|+..|+|||.+....+ +.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 2222334678999999999987665 788999999999999999999997544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=306.56 Aligned_cols=203 Identities=27% Similarity=0.393 Sum_probs=173.3
Q ss_pred hcCccccCceeeecceeEEEEEe----ccccEEEEEEecCCC----CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCC
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~ 542 (698)
.++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999987 368899999986532 23446678899999999 6999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++||||+++++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++++||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998653 34889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhcccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+.+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 865432221 2223579999999999975 357899999999999999999999997543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=292.57 Aligned_cols=205 Identities=29% Similarity=0.492 Sum_probs=158.4
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|.+.+.||+|+||.||+++. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346789999999999999999987 46899999998643 12335678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|..++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998643 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
..... .....||+.|+|||.+....++.++||||||+++|||++|+.||.....
T Consensus 164 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 164 MPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred CCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 32211 1235789999999999988899999999999999999999999976543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=291.17 Aligned_cols=201 Identities=27% Similarity=0.447 Sum_probs=176.2
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
..++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999875 4889999998654 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc---eEEeecCCCcc
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGMARI 624 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFgla~~ 624 (698)
|||+++++|...+... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998888654 34899999999999999999999998 999999999999987665 99999999987
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
...... .....||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 643322 12357899999999999999999999999999999999999999643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.58 Aligned_cols=201 Identities=26% Similarity=0.395 Sum_probs=170.0
Q ss_pred cCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|++.++||+|+||.||+++... ++.||+|++..... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 678999999999999999998754 88999999865532 235668899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999998887543 34899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. ......||..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1223578999999999875 578999999999999999999999997543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=309.11 Aligned_cols=200 Identities=25% Similarity=0.394 Sum_probs=168.6
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCC--CCcchHHHHHHHHHHhhcC--CCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~--H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.+.||+|+||.||++....++.||||++... .....+.+.+|++++.+++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999998654 2345578999999999996 59999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|| +.+++|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 67889999986543 5788899999999999999999998 99999999999995 57999999999987654
Q ss_pred CccccccccccccccccChhcccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAE-----------GLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~-----------~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
...........||+.|+|||++.. ..++.++|||||||+||||++|+.||..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 332222334679999999999865 4689999999999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=291.15 Aligned_cols=203 Identities=30% Similarity=0.510 Sum_probs=177.7
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
.++|++.+.||+|+||.||+++..+++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 35788889999999999999999888999999997653 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999998653 235889999999999999999999998 99999999999999999999999999987543221
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.......++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 11223467789999999998899999999999999999999 899997543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=293.52 Aligned_cols=204 Identities=18% Similarity=0.294 Sum_probs=176.6
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.+.||+|+||.||+++. .+++.||+|++.... ..+.+.+|+++++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999986 468999999986543 335688999999999 79999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc-----eEEeecCCCcc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-----PKISDFGMARI 624 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DFgla~~ 624 (698)
|+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998653 234899999999999999999999988 999999999999987776 99999999987
Q ss_pred cCCCccc-----cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 625 FGGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 625 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 6543221 1123357999999999999999999999999999999999999999865443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=315.16 Aligned_cols=201 Identities=28% Similarity=0.490 Sum_probs=176.9
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++++.++||||+++++++......++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367899999999999999999875 6899999999654 223456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++.+. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999998543 35899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 322 223579999999999988765 689999999999999999999997543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=331.69 Aligned_cols=203 Identities=29% Similarity=0.408 Sum_probs=177.9
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~ 545 (698)
..++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+..|.+++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3567999999999999999999875 4788999999753 234556788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
|||||+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999996543 4899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..... ......||+.|+|||++....++.++|||||||+||||++|+.||....
T Consensus 493 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 493 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 33222 2234689999999999999999999999999999999999999998644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.36 Aligned_cols=204 Identities=25% Similarity=0.374 Sum_probs=170.4
Q ss_pred hcCcccc-CceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEE
Q 005400 472 TDNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 472 ~~~f~~~-~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
.+.|.+. +.||+|+||.||+++.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 67999999999999864 5889999999876666678899999999985 7999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc---eEEeecCCCccc
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGMARIF 625 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFgla~~~ 625 (698)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998654 34889999999999999999999998 999999999999998776 999999998765
Q ss_pred CCCcc-----ccccccccccccccChhcccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 626 GGDEI-----QTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~-----~~~~~~~~gt~~y~APE~l~~-----~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 32211 111122469999999999865 457899999999999999999999997654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=293.01 Aligned_cols=201 Identities=29% Similarity=0.446 Sum_probs=173.3
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
+.++|++.+.||+|+||.||+++... ++.||+|++... .....+.+.+|++++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34679999999999999999998754 678999998653 12335678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998654 34899999999999999999999988 9999999999999999999999999986543
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 222 123578999999999999999999999999999999999999997544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=315.89 Aligned_cols=204 Identities=30% Similarity=0.532 Sum_probs=171.5
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
..++|++.++||+|+||.||+|++..+..||||+++... ...++|.+|++++++++||||+++++++.+ ...++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346788889999999999999999888889999997643 345789999999999999999999999866 678999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999996432 245899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
. ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 1 1222457789999999998999999999999999999999 999997543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=297.00 Aligned_cols=201 Identities=26% Similarity=0.390 Sum_probs=177.0
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCc------chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
..++|++.+.||+|+||.||+++.. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467899999999999999999875 5889999998764321 35679999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC----ceEEeec
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDF 619 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DF 619 (698)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999998543 34889999999999999999999998 99999999999999887 7999999
Q ss_pred CCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
|++........ .....||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 99987654321 22357899999999999999999999999999999999999999754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.91 Aligned_cols=200 Identities=28% Similarity=0.425 Sum_probs=167.0
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhh--cCCCeeeeEEEEEEeC----Cee
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQA----DES 544 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~--l~H~nIv~l~~~~~~~----~~~ 544 (698)
..++|++.+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 346799999999999999999988 6899999998643 34566777777776 7899999999997653 457
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH--------QDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
++||||+++++|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 899999999999999843 34899999999999999999999 666 999999999999999999999
Q ss_pred eecCCCcccCCCcccc--ccccccccccccChhcccCC------CCCcchhHHHHHHHHHHHHhC----------CCCCC
Q 005400 617 SDFGMARIFGGDEIQT--NTHKVVGTYGYMSPEYAAEG------LFSVKSDVFSFGVLVLEIVSG----------KKNWR 678 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~------~~~~k~DVwSlGvil~elltG----------~~pf~ 678 (698)
+|||++.......... ......||+.|+|||++... .++.++||||||+++|||+|| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998754332211 12234799999999999776 455789999999999999999 88886
Q ss_pred CCC
Q 005400 679 FSH 681 (698)
Q Consensus 679 ~~~ 681 (698)
...
T Consensus 235 ~~~ 237 (301)
T 3q4u_A 235 DVV 237 (301)
T ss_dssp TTS
T ss_pred ccC
Confidence 543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.49 Aligned_cols=196 Identities=29% Similarity=0.481 Sum_probs=170.5
Q ss_pred cCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCC---cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
+.|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999986 4688999999975432 23457899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||++ |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9998 5777776432 245899999999999999999999998 999999999999999999999999999865322
Q ss_pred ccccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2357999999999884 567899999999999999999999999643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=294.07 Aligned_cols=204 Identities=26% Similarity=0.386 Sum_probs=163.6
Q ss_pred hhcCccccCceeeecceeEEEEEecc----ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
..++|++.+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 34678999999999999999998743 4579999987643 33456789999999999999999999997 456789
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999998643 235899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
...... ......+|+.|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 443221 1222456789999999998899999999999999999997 999997544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=294.48 Aligned_cols=203 Identities=28% Similarity=0.452 Sum_probs=170.3
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC-----CcchHHHHHHHHHHhhcC---CCeeeeEEEEEEeC
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQA 541 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~---H~nIv~l~~~~~~~ 541 (698)
..++|++.++||+|+||.||+++. .+++.||+|++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999986 458899999986432 122356777888877764 99999999999876
Q ss_pred C-----eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 542 D-----ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 542 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
. ..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 599888865432 34899999999999999999999998 999999999999999999999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred eeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999987643322 233678999999999999999999999999999999999999996543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=291.13 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=177.0
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|.+.+.||+|+||.||+++... ++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34678999999999999999998764 7889999986542 2345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999988543 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
..... .....||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 167 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 32211 22357899999999999888999999999999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=296.42 Aligned_cols=206 Identities=30% Similarity=0.483 Sum_probs=180.5
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..++|++.+.||+|+||.||+++... ++.||+|++... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45778999999999999999999865 788999999654 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999986543 345899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
.. ......+|+.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 166 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred cc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 22 2223567889999999998999999999999999999999 9999976544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.77 Aligned_cols=198 Identities=28% Similarity=0.464 Sum_probs=166.0
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|++.+.||+|+||.||+++. .++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5688889999999999999987 4789999998643 34578999999999999999999999876 45899999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc-eEEeecCCCcccCCCccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-PKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~kl~DFgla~~~~~~~~~ 631 (698)
+++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 9999999976555456889999999999999999999943334999999999999998886 7999999997653221
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 2246899999999999999999999999999999999999999743
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=291.66 Aligned_cols=202 Identities=27% Similarity=0.407 Sum_probs=171.5
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|.+.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367899999999999999999874 58899999987653 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE---cCCCceEEeecCCCccc
Q 005400 550 YMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIF 625 (698)
Q Consensus 550 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFgla~~~ 625 (698)
|+++++|.+++... .....+++..+..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988643 23356899999999999999999999998 9999999999999 45678999999999875
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
..... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||...
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 43322 22357899999999885 56899999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=302.00 Aligned_cols=201 Identities=24% Similarity=0.375 Sum_probs=175.0
Q ss_pred HhhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCC--------cchHHHHHHHHHHhhcCCCeeeeEEEEEEe
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSG--------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~--------~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~ 540 (698)
...++|++.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999999986 4588999999976521 134467889999999999999999999999
Q ss_pred CCeeEEEEEecCCC-ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeec
Q 005400 541 ADESMLIYEYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (698)
Q Consensus 541 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 619 (698)
....++||||+..| +|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 898888543 34899999999999999999999998 999999999999999999999999
Q ss_pred CCCcccCCCccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
|++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 99987654332 123579999999999988776 8899999999999999999999964
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.50 Aligned_cols=195 Identities=25% Similarity=0.452 Sum_probs=170.6
Q ss_pred hcCccccCceeeecceeEEEEEecc-c-------cEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-G-------QEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g-------~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
.++|.+.+.||+|+||.||+++... + ..||+|++........+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578889999999999999998654 2 4799999977666677889999999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc--------eE
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--------PK 615 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~k 615 (698)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999996543 23889999999999999999999998 999999999999998887 99
Q ss_pred EeecCCCcccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 005400 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNW 677 (698)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf 677 (698)
|+|||++...... ....+|..|+|||++.. ..++.++||||||+++|||++|..|+
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9999998754321 12468899999999987 67899999999999999999965544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=305.50 Aligned_cols=203 Identities=20% Similarity=0.275 Sum_probs=167.5
Q ss_pred hhcCccccCceeeecceeEEEEEecc------ccEEEEEEecCCCCcc-----------hHHHHHHHHHHhhcCCCeeee
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQG-----------MEEFKNEVTLIARLQHRNLVK 533 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~~~~~-----------~~~~~~Ei~il~~l~H~nIv~ 533 (698)
..++|.+.++||+|+||.||+|++.. ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 4789999987643211 112345566677788999999
Q ss_pred EEEEEEeC----CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 534 LLGCCIQA----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 534 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
+++++... ...+|||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998775 4589999999 99999998653 245899999999999999999999998 99999999999999
Q ss_pred --CCCceEEeecCCCcccCCCcccc-----ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 610 --NDMNPKISDFGMARIFGGDEIQT-----NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 610 --~~~~~kl~DFgla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 88999999999998764322111 11224599999999999999999999999999999999999999984
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=290.42 Aligned_cols=203 Identities=33% Similarity=0.553 Sum_probs=175.6
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
..++|++.+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 346789999999999999999998888899999997543 34678999999999999999999999976 4568999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999985432 224899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
.. .....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 165 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 165 TA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp EC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 21 223457789999999988889999999999999999999 99999754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=298.11 Aligned_cols=217 Identities=26% Similarity=0.465 Sum_probs=169.9
Q ss_pred cchhhHHHhhcCccccCceeeecceeEEEEEecc----ccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEE
Q 005400 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLG 536 (698)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~ 536 (698)
....++....++|.+.+.||+|+||.||+|+... ++.||+|++.... ....+.+.+|++++++++||||+++++
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 3344455566789999999999999999998643 4589999987542 334567899999999999999999999
Q ss_pred EEEeCCe-----eEEEEEecCCCChhHHHhhc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE
Q 005400 537 CCIQADE-----SMLIYEYMPNKSLDFFIFDQ---ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (698)
Q Consensus 537 ~~~~~~~-----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 608 (698)
++.+... .++||||+++++|..++... .....+++..++.++.|+++||.|||+.+ |+||||||+|||+
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli 180 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCML 180 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEE
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEE
Confidence 9987653 49999999999999998543 23346899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
+.++.+||+|||++................+++.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 9999999999999987654332222233567889999999999999999999999999999999 8899975443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.00 Aligned_cols=205 Identities=30% Similarity=0.524 Sum_probs=167.4
Q ss_pred hcCccccCceeeecceeEEEEEec-ccc----EEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
.++|++.++||+|+||.||+|+.. +++ +||+|.+... .....+.+.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999864 344 3688877544 3456678999999999999999999999998754 78
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+|+|++++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999986542 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
.............+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 54433333333567889999999999999999999999999999999 9999976544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=303.85 Aligned_cols=198 Identities=24% Similarity=0.382 Sum_probs=170.6
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
..++|++.+.||+|+||.||+++.. +++.||+|++.+... ...+|++++.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999875 588999999976532 345788888888 7999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC----CceEEeecCCCcc
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND----MNPKISDFGMARI 624 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFgla~~ 624 (698)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||++..
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999988643 35899999999999999999999998 9999999999998543 3599999999987
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 170 LRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 6443221 22357899999999998888899999999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.30 Aligned_cols=202 Identities=31% Similarity=0.528 Sum_probs=161.6
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
..++|++.++||+|+||.||+++.. ..||+|+++... ....+.+.+|++++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3577999999999999999999864 369999987553 34456799999999999999999999965 566789999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999988543 345899999999999999999999998 999999999999999999999999999865433
Q ss_pred ccccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
..........||+.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 3223333467999999999986 567889999999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=288.03 Aligned_cols=200 Identities=26% Similarity=0.400 Sum_probs=173.6
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC------cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999886 588999999875421 23678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC----ceEEeecCC
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFGM 621 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFgl 621 (698)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999998643 34899999999999999999999998 99999999999998877 899999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+........ .....|++.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 987643321 223568999999999998999999999999999999999999997543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=314.23 Aligned_cols=198 Identities=27% Similarity=0.361 Sum_probs=165.5
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC------C
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------D 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------~ 542 (698)
.++|++.++||+|+||.||+++.. .++.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999864 5889999999764 334456788999999999999999999999654 3
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999875 544442 13889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8764332 1233679999999999999999999999999999999999999997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.16 Aligned_cols=202 Identities=26% Similarity=0.394 Sum_probs=177.3
Q ss_pred hhcCccccCceeeecceeEEEEEecc-ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|.+.+.||+|+||.||+++..+ ++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34678999999999999999998754 788999998654 22345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999988543 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.... ......||..|+|||++....++.++||||||+++|||++|+.||...
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 3221 122357899999999999888999999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.84 Aligned_cols=200 Identities=24% Similarity=0.404 Sum_probs=173.5
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..++|.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467899999999999999999875 588999999986654455678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE---cCCCceEEeecCCCcccC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFG 626 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFgla~~~~ 626 (698)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999988653 34889999999999999999999998 9999999999999 788899999999987643
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
... .....||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 161 NGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp CBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 221 22356899999999999999999999999999999999999999653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=289.67 Aligned_cols=199 Identities=25% Similarity=0.394 Sum_probs=175.5
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367899999999999999999875 4778999998643 223456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999986543 4889999999999999999999988 99999999999999999999999999876543
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.. .....|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 22 12357899999999999999999999999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=294.28 Aligned_cols=203 Identities=21% Similarity=0.300 Sum_probs=166.4
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++......++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3478999999999999999999875 58899999987542 2234678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998653 34899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 33221 122357899999999999999999999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=304.10 Aligned_cols=199 Identities=23% Similarity=0.302 Sum_probs=163.3
Q ss_pred hcCcccc-CceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHh-hcCCCeeeeEEEEEEe----CCee
Q 005400 472 TDNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIA-RLQHRNLVKLLGCCIQ----ADES 544 (698)
Q Consensus 472 ~~~f~~~-~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~-~l~H~nIv~l~~~~~~----~~~~ 544 (698)
.++|.+. +.||+|+||.||+++.. +++.||||++.. ...+.+|++++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3566665 68999999999999875 588999999863 245778888874 4589999999999876 5678
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC---CCceEEeecCC
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFgl 621 (698)
+|||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999996532 235899999999999999999999998 999999999999997 78899999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
++....... .....||+.|+|||++....++.++|||||||++|||++|+.||...+.
T Consensus 211 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 211 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 987543221 2235789999999999999999999999999999999999999976543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=289.51 Aligned_cols=201 Identities=28% Similarity=0.483 Sum_probs=177.9
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.+.|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356889999999999999999864 58899999997553 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998843 35899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. .....|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 174 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 174 IK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 21 223578999999999999999999999999999999999999997543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=309.02 Aligned_cols=202 Identities=25% Similarity=0.395 Sum_probs=175.1
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC--eeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~--~~~lV 547 (698)
.++|.+.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4678999999999999999998754 8899999997542 344577889999999999999999999998765 67999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE----cCCCceEEeecCCCc
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFgla~ 623 (698)
|||+++++|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555555899999999999999999999998 9999999999999 778889999999998
Q ss_pred ccCCCccccccccccccccccChhcccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAE--------GLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
....... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 7644321 223579999999998864 4677899999999999999999999964
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.46 Aligned_cols=201 Identities=29% Similarity=0.484 Sum_probs=171.9
Q ss_pred cCccccCceeeecceeEEEEEe-----ccccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--Cee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~ 544 (698)
+.|++.++||+|+||.||++++ ..++.||+|++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5588899999999999999983 35889999999754 334567899999999999999999999999876 668
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999985432 34899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 6543221 22233568889999999998899999999999999999999998864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.90 Aligned_cols=215 Identities=30% Similarity=0.483 Sum_probs=174.5
Q ss_pred ccccchhhHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEE
Q 005400 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGC 537 (698)
Q Consensus 460 ~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~ 537 (698)
..++++.++....++|++.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+++++++ +||||++++++
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 445666777778899999999999999999999874 68899999986543 3457889999999999 79999999999
Q ss_pred EEe------CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC
Q 005400 538 CIQ------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611 (698)
Q Consensus 538 ~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~ 611 (698)
+.. ....++||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTEN 165 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTT
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCC
Confidence 987 467899999999999999986543 345889999999999999999999998 9999999999999999
Q ss_pred CceEEeecCCCcccCCCccccccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 612 MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 612 ~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+.+||+|||++........ ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999986543221 122357899999999986 5678999999999999999999999997543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=287.95 Aligned_cols=199 Identities=25% Similarity=0.368 Sum_probs=171.9
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999875 6899999998764 334556788999999999 99999999999999999999
Q ss_pred EEEecCCCChhHHHhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC--------------
Q 005400 547 IYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-------------- 611 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-------------- 611 (698)
||||+++++|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999975432 255899999999999999999999998 9999999999999844
Q ss_pred -----CceEEeecCCCcccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 612 -----MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 612 -----~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|+.++.
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 479999999998764332 24589999999998766 56789999999999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.96 Aligned_cols=201 Identities=26% Similarity=0.427 Sum_probs=165.6
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|.+.++||+|+||.||+++.. +++.||+|++..... .....+.+|++++++++||||+++++++......++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999875 588999999875432 2223456799999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
++ ++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 98 4888877543 345899999999999999999999998 99999999999999999999999999976543221
Q ss_pred ccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223578999999999876 568999999999999999999999997644
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.86 Aligned_cols=200 Identities=26% Similarity=0.377 Sum_probs=175.4
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++......++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999875 5889999999765 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
|+++++|.+++.... .+++..+..++.+++.||+|||+. + |+||||||+|||++.++++||+|||++..+...
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999986543 488999999999999999999985 6 999999999999999999999999999764321
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223578999999999999999999999999999999999999997543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.75 Aligned_cols=204 Identities=17% Similarity=0.211 Sum_probs=164.7
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCC---CCcchHHHHHHH---HHHhhcCCCeeeeEE-------E
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEV---TLIARLQHRNLVKLL-------G 536 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei---~il~~l~H~nIv~l~-------~ 536 (698)
..++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357789999999999999999996 45899999999743 334567889999 455556899999998 7
Q ss_pred EEEeCCe-----------------eEEEEEecCCCChhHHHhhcccc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005400 537 CCIQADE-----------------SMLIYEYMPNKSLDFFIFDQARA----TFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (698)
Q Consensus 537 ~~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 595 (698)
++...+. .++||||+ +|+|.+++...... ..+++..++.++.||++||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 7665532 78999999 68999998754321 12336888899999999999999998
Q ss_pred eeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCC-----------CCCcchhHHHHH
Q 005400 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-----------LFSVKSDVFSFG 664 (698)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~k~DVwSlG 664 (698)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999986432 1223567 999999999877 899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCC
Q 005400 665 VLVLEIVSGKKNWRFSHPDH 684 (698)
Q Consensus 665 vil~elltG~~pf~~~~~~~ 684 (698)
|++|||++|+.||.......
T Consensus 301 ~il~elltg~~Pf~~~~~~~ 320 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALG 320 (377)
T ss_dssp HHHHHHHHSSCCC------C
T ss_pred HHHHHHHHCCCCCccccccc
Confidence 99999999999997655433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.95 Aligned_cols=202 Identities=27% Similarity=0.397 Sum_probs=164.6
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
...++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999864 58899999997543 2334567899999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-----CCCceEEeecCC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-----NDMNPKISDFGM 621 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-----~~~~~kl~DFgl 621 (698)
||||+++ +|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 8888885533 4899999999999999999999998 99999999999994 455699999999
Q ss_pred CcccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 987643321 12235689999999998774 5899999999999999999999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=307.83 Aligned_cols=201 Identities=25% Similarity=0.396 Sum_probs=167.4
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-----C
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----D 542 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-----~ 542 (698)
..++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3478999999999999999999875 47889999997642 23456789999999999999999999999776 5
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++||||++ ++|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 7899999987 589888854 345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccc--------------------cccccccccccccChhcc-cCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 623 RIFGGDEIQ--------------------TNTHKVVGTYGYMSPEYA-AEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 623 ~~~~~~~~~--------------------~~~~~~~gt~~y~APE~l-~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
+........ .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876433211 112346799999999986 56679999999999999999999666654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=287.70 Aligned_cols=199 Identities=24% Similarity=0.372 Sum_probs=171.1
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~lV 547 (698)
.++|.+.+.||+|+||.||+|+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35688889999999999999998 48899999997653 34456799999999999999999999999887 778999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++.... ...+++..+..++.|+++||+|||+.+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999996532 335899999999999999999999875 3599999999999999999999999998764322
Q ss_pred CccccccccccccccccChhcccCCCCC---cchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFS---VKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~---~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....||+.|+|||.+.+..++ .++||||||+++|||++|+.||...
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 124689999999999876544 4899999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=289.26 Aligned_cols=201 Identities=28% Similarity=0.456 Sum_probs=171.3
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
.|.....||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3455568999999999999864 578999999987666667889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-CCceEEeecCCCcccCCCccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFgla~~~~~~~~~ 631 (698)
+++|.+++........+++..+..++.|++.||+|||+.+ |+|+||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 9999999976544445778999999999999999999998 999999999999987 89999999999987643221
Q ss_pred cccccccccccccChhcccCCC--CCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~--~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
......|++.|+|||++.... ++.++||||||+++|||++|+.||..
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 122357899999999987643 88999999999999999999999963
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.63 Aligned_cols=202 Identities=28% Similarity=0.430 Sum_probs=170.3
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
.++|++.+.||+|+||.||+++... ++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3678999999999999999998754 88999999865532 23456789999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999998876433 34899999999999999999999998 999999999999999999999999999865433
Q ss_pred ccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. ......||..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 12235789999999998775 78999999999999999999999997543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=319.37 Aligned_cols=204 Identities=30% Similarity=0.536 Sum_probs=176.4
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
..++|++.++||+|+||.||+|++..++.||||+++... ...++|.+|+++|++++||||+++++++.+ ...+|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346788889999999999999999888889999997643 345789999999999999999999999866 678999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++|+|.+++.... ...+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 343 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999996432 235899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
.......++..|+|||++....++.++||||||++||||++ |+.||....
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 11222456789999999998999999999999999999999 999997543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.84 Aligned_cols=202 Identities=27% Similarity=0.439 Sum_probs=175.8
Q ss_pred cCccccCceeeecceeEEEEEe-----ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe--CCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--~~~~~ 545 (698)
++|++.++||+|+||.||++++ ..++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6788999999999999999984 3588999999987766667789999999999999999999999874 55689
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999986532 24899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 626 GGDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 626 ~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
..... ........+|..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 53322 1122235688889999999988899999999999999999999999853
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=289.08 Aligned_cols=205 Identities=31% Similarity=0.517 Sum_probs=174.2
Q ss_pred hcCccccC-ceeeecceeEEEEEec---cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 472 TDNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 472 ~~~f~~~~-~LG~G~fG~Vy~g~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
.++|.+.+ .||+|+||.||+|+.. .++.||+|+++... ....+.+.+|++++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566666 8999999999999853 57789999997653 34567799999999999999999999999 5667899
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999998543 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 627 GDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 627 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
..... .......+|+.|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 43221 11222456889999999988889999999999999999998 9999975443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=306.39 Aligned_cols=201 Identities=25% Similarity=0.374 Sum_probs=163.4
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--------CcchHHHHHHHHHHhhcCCCeeeeEEEEEEe
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~ 540 (698)
...++|.+.++||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999875 47899999986531 122345889999999999999999999975
Q ss_pred CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC---ceEEe
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKIS 617 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~ 617 (698)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 55689999999999998887543 45899999999999999999999998 99999999999997544 59999
Q ss_pred ecCCCcccCCCccccccccccccccccChhcccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
|||+++...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999998765332 1223679999999999853 56889999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=297.69 Aligned_cols=205 Identities=22% Similarity=0.415 Sum_probs=177.1
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--------cchHHHHHHHHHHhhc-CCCeeeeEEE
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--------QGMEEFKNEVTLIARL-QHRNLVKLLG 536 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ei~il~~l-~H~nIv~l~~ 536 (698)
......++|.+.+.||+|+||.||+++.. +|+.||||++..... ...+.+.+|+++++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33455678999999999999999999985 689999999875432 1245678999999999 7999999999
Q ss_pred EEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 537 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999998643 34899999999999999999999998 999999999999999999999
Q ss_pred eecCCCcccCCCccccccccccccccccChhcccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE------GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+|||++..+..... .....||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 99999987654321 223679999999998853 35889999999999999999999999753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=310.85 Aligned_cols=195 Identities=25% Similarity=0.397 Sum_probs=153.7
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-----Ce
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-----~~ 543 (698)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999865 58899999996542 23456789999999999999999999998543 56
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++||||+. ++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 6888887543 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-------------------------cccccccccccccChhcc-cCCCCCcchhHHHHHHHHHHHHhC
Q 005400 624 IFGGDEIQ-------------------------TNTHKVVGTYGYMSPEYA-AEGLFSVKSDVFSFGVLVLEIVSG 673 (698)
Q Consensus 624 ~~~~~~~~-------------------------~~~~~~~gt~~y~APE~l-~~~~~~~k~DVwSlGvil~elltG 673 (698)
........ .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76422110 112235789999999976 566799999999999999999993
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=290.58 Aligned_cols=204 Identities=31% Similarity=0.463 Sum_probs=171.2
Q ss_pred hhcCccccC-ceeeecceeEEEEEec---cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 471 ATDNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 471 ~~~~f~~~~-~LG~G~fG~Vy~g~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
..++|.+.+ .||+|+||.||++... .++.||||++.... ....+.+.+|++++++++||||+++++++ +....
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788777 9999999999999643 36889999997652 33467899999999999999999999999 66788
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999999653 34889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
....... .......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 6543221 11122356789999999988889999999999999999999 999997543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-33 Score=295.61 Aligned_cols=204 Identities=24% Similarity=0.400 Sum_probs=171.0
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-------
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------- 541 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------- 541 (698)
.++|++.++||+|+||.||+++. .+++.||+|++.... ......+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46799999999999999999987 468899999986542 23356788999999999999999999999874
Q ss_pred -CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 542 -DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 542 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
...++||||+++ +|...+... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 666666432 234899999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCcc--ccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 621 MARIFGGDEI--QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 621 la~~~~~~~~--~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++..+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9987642211 112233578999999998876 468999999999999999999999997543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=287.84 Aligned_cols=203 Identities=28% Similarity=0.436 Sum_probs=170.6
Q ss_pred hhcCccccCceeeecceeEEEEEecc----ccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
..++|.+.+.||+|+||.||+|+... +..||+|++... .....+.+.+|++++++++||||+++++++.+ ...+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678899999999999999998643 346999998765 33456789999999999999999999999764 5678
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998653 234889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
....... .....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 164 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 164 EDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 4432211 223467889999999988899999999999999999998 99999743
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.15 Aligned_cols=197 Identities=25% Similarity=0.423 Sum_probs=165.6
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC------
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~------ 542 (698)
.++|.+.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 478999999999999999999874 58999999986542 234567889999999999999999999997653
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++||||+ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7899988854 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...+
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 875432 223578999999999877 679999999999999999999999997543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=300.93 Aligned_cols=200 Identities=24% Similarity=0.361 Sum_probs=167.0
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe------eE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE------SM 545 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~------~~ 545 (698)
..+|.+.+.||+|+||.||+++...+..+|+|++..... ...+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 356899999999999999999998777899998865432 22369999999999999999999976443 78
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceEEeecCCCcc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARI 624 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFgla~~ 624 (698)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988665544433333456899999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 643322 1235789999999998665 58999999999999999999999997543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=286.93 Aligned_cols=197 Identities=27% Similarity=0.480 Sum_probs=172.4
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe---------
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--------- 540 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--------- 540 (698)
..++|++.+.||+|+||.||+++.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467899999999999999999985 68999999997543 457789999999999999999999864
Q ss_pred -------CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc
Q 005400 541 -------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (698)
Q Consensus 541 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 613 (698)
....++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 445799999999999999996542 345899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
+||+|||++........ .....|++.|+|||++....++.++||||||+++|||++|+.|+.
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999999987654322 123568999999999999999999999999999999999998874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=298.17 Aligned_cols=201 Identities=18% Similarity=0.271 Sum_probs=165.5
Q ss_pred hcCccccCceeeecceeEEEEEec----cccEEEEEEecCCCCc-----------chHHHHHHHHHHhhcCCCeeeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQ-----------GMEEFKNEVTLIARLQHRNLVKLLG 536 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~~~~-----------~~~~~~~Ei~il~~l~H~nIv~l~~ 536 (698)
.++|.+.+.||+|+||.||+|+.. .+..+|+|++...... ..+.+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999875 5778999998765322 1234667888999999999999999
Q ss_pred EEEe----CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC
Q 005400 537 CCIQ----ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (698)
Q Consensus 537 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 612 (698)
++.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 77899999999 999999986543 5899999999999999999999998 99999999999999887
Q ss_pred --ceEEeecCCCcccCCCcc-----ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 613 --NPKISDFGMARIFGGDEI-----QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 613 --~~kl~DFgla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.+||+|||+++.+..... ........||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999987642211 1111335799999999999999999999999999999999999999964
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=309.67 Aligned_cols=201 Identities=29% Similarity=0.443 Sum_probs=174.0
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
..++|++.++||+|+||.||+++.. +++.||||++.+. .......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999875 5889999998643 234567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc---CCCceEEeecCCCcc
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARI 624 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFgla~~ 624 (698)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999888654 34899999999999999999999998 99999999999995 456799999999987
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||....
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 644321 223579999999999875 59999999999999999999999997543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=320.41 Aligned_cols=204 Identities=30% Similarity=0.504 Sum_probs=168.9
Q ss_pred cCccccC-ceeeecceeEEEEEec---cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~-~LG~G~fG~Vy~g~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
+++.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|++++++++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999874 46679999997653 3456789999999999999999999999976 568999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 9999999999998543 345899999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 628 DEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 628 ~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
.... .......+++.|+|||++....++.++|||||||+||||++ |+.||.....
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 3211 11122345689999999999999999999999999999998 9999986543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=286.54 Aligned_cols=200 Identities=30% Similarity=0.584 Sum_probs=169.2
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcc-------hHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQG-------MEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~-------~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
.++|++.+.||+|+||.||+++.. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467899999999999999999874 68899999986543221 267899999999999999999999986554
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc-----eEEee
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-----PKISD 618 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~D 618 (698)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999998888643 345899999999999999999999875 34999999999999988776 99999
Q ss_pred cCCCcccCCCccccccccccccccccChhcc--cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYA--AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l--~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
||+++..... .....||+.|+|||++ ....++.++||||||+++|||++|+.||....
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9999754322 2235789999999998 34567899999999999999999999997543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=292.80 Aligned_cols=210 Identities=25% Similarity=0.392 Sum_probs=176.7
Q ss_pred chhhHHHhhcCcccc-CceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcC-CCeeeeEEEEE
Q 005400 464 DFASIAKATDNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCC 538 (698)
Q Consensus 464 ~~~~l~~~~~~f~~~-~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~ 538 (698)
.+.......+.|.+. +.||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344445566778777 88999999999999875 5899999998764 2334678999999999995 69999999999
Q ss_pred EeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC---CCceE
Q 005400 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPK 615 (698)
Q Consensus 539 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~k 615 (698)
.+....++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999888543 2345899999999999999999999998 999999999999987 78999
Q ss_pred EeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
|+|||++........ .....||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 175 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 175 IVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999987643321 22357999999999999999999999999999999999999999654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=297.84 Aligned_cols=210 Identities=25% Similarity=0.338 Sum_probs=170.9
Q ss_pred cchhhHHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCc-----------chHHHHHHHHHHhhcCCCee
Q 005400 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ-----------GMEEFKNEVTLIARLQHRNL 531 (698)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~-----------~~~~~~~Ei~il~~l~H~nI 531 (698)
....++....++|.+.+.||+|+||.||+++..+++.||||++...... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456677888999999999999999999999888999999998653221 13678999999999999999
Q ss_pred eeEEEEEEeC-----CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCE
Q 005400 532 VKLLGCCIQA-----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606 (698)
Q Consensus 532 v~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 606 (698)
+++++++... ...++||||++ ++|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999998653 35799999998 5777777532 345899999999999999999999998 99999999999
Q ss_pred EEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 607 LLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 607 Ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999975433221 223578999999998876 678999999999999999999999997543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=285.25 Aligned_cols=200 Identities=27% Similarity=0.466 Sum_probs=168.2
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++......++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467899999999999999999975 6899999998653 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999986543 4889999999999999999999998 99999999999999999999999999987644
Q ss_pred CccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
... .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 321 123568999999999987765 68999999999999999999999754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=294.37 Aligned_cols=204 Identities=29% Similarity=0.506 Sum_probs=168.0
Q ss_pred hcCccccCceeeecceeEEEEEecc-----ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
.++|.+.+.||+|+||.||+|+... +..||+|++.... ......+.+|++++++++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567788999999999999998653 2469999997653 334567899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999998653 235899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 626 GGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 626 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
...... .......+|..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 433211 11122356789999999998999999999999999999999 99999643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=309.12 Aligned_cols=201 Identities=27% Similarity=0.411 Sum_probs=170.6
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
..++|++.++||+|+||.||+++.. .++.||+|++.+.. ......+.+|++++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3456999999999999999999875 58899999987652 34467789999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC---CceEEeecCCCcc
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMARI 624 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFgla~~ 624 (698)
|||+++++|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999998888654 34889999999999999999999998 9999999999999764 4599999999987
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
...... .....||+.|+|||++. ..++.++|||||||++|||++|+.||....
T Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 189 FENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp CBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 654322 22357999999999886 568999999999999999999999997544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.06 Aligned_cols=207 Identities=32% Similarity=0.498 Sum_probs=172.0
Q ss_pred hcCccccCceeeecceeEEEEEec------cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
.++|.+.+.||+|+||.||+|+.. .++.||+|++... .......+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 467999999999999999999842 4678999999754 334556789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC---CCceEEe
Q 005400 545 MLIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKIS 617 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~ 617 (698)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 235889999999999999999999998 999999999999984 4469999
Q ss_pred ecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
|||++................+|+.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 9999986543332222233567899999999988999999999999999999998 999997543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=284.70 Aligned_cols=198 Identities=26% Similarity=0.410 Sum_probs=169.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe----CCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~----~~~~~ 545 (698)
+.|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45778889999999999999874 4778999998754 33445678999999999999999999999876 35589
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceEEeecCCCcc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARI 624 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFgla~~ 624 (698)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ .+|+||||||+|||++ +++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999653 34889999999999999999999875 3499999999999997 789999999999976
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
..... .....||+.|+|||++. ..++.++||||||+++|||++|+.||..
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 54332 12357899999999886 4589999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.27 Aligned_cols=205 Identities=25% Similarity=0.429 Sum_probs=166.2
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|++.+.||+|+||.||+++. .+++.||+|++... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999986 46899999999753 23345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 547 IYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999986432 3456899999999999999999999998 999999999999999999999999999875
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
..... ......|+..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 43321 122356899999999999999999999999999999999999999643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=309.71 Aligned_cols=201 Identities=31% Similarity=0.442 Sum_probs=176.1
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
..++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467899999999999999999875 68999999986542 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE---cCCCceEEeecCCCc
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMAR 623 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFgla~ 623 (698)
||||+.+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999888643 34899999999999999999999998 9999999999999 467899999999998
Q ss_pred ccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.+..... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||....
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 7654322 223579999999999865 68999999999999999999999997544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=287.98 Aligned_cols=201 Identities=28% Similarity=0.471 Sum_probs=172.1
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..++|++.+.||+|+||.||+++.. +|+.||+|++.... ..+.+.+|++++++++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4577999999999999999999875 48899999997543 45678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++++||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999998532 345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
. ......|+..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 2 122357899999999999989999999999999999999999999754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.95 Aligned_cols=206 Identities=21% Similarity=0.333 Sum_probs=170.0
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEE-EeCCeeEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC-IQADESMLIY 548 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~-~~~~~~~lV~ 548 (698)
..++|++.+.||+|+||.||+++. .+++.||+|++.... ..+.+.+|++++++++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 468899999876542 234688999999999988777766655 6677889999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE---cCCCceEEeecCCCccc
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIF 625 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFgla~~~ 625 (698)
||+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998643 234899999999999999999999998 9999999999999 78899999999999876
Q ss_pred CCCccc-----cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005400 626 GGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684 (698)
Q Consensus 626 ~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~~ 684 (698)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh
Confidence 543221 11223579999999999999999999999999999999999999998655443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=291.78 Aligned_cols=198 Identities=32% Similarity=0.471 Sum_probs=170.7
Q ss_pred ccccCceeeecceeEEEEEec-----cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC--CeeEE
Q 005400 475 FASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESML 546 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~--~~~~l 546 (698)
|++.++||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999988642 57889999997653 34456799999999999999999999999884 67899
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999998543 3899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 627 GDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 627 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 43221 122235678889999999988899999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=291.14 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=171.6
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
..++|++.+.||+|+||.||+++.. +++.||+|++........+.+.+|++++++++||||+++++++......++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999986 488999999987666677889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999988653 234899999999999999999999998 9999999999999999999999999875432111
Q ss_pred cccccccccccccccChhcc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYA-----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l-----~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.......||..|+|||++ ....++.++||||||+++|||++|+.||....
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 111225689999999988 46678999999999999999999999997543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=296.37 Aligned_cols=203 Identities=28% Similarity=0.419 Sum_probs=166.5
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC-----cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-----QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-----~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~ 543 (698)
...++|++.+.||+|+||.||+++.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 488999999875321 123468899999999999999999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++||||+++ +|..++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 787777543 235788889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.+..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 7643321 12235789999999998654 5899999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=284.56 Aligned_cols=205 Identities=21% Similarity=0.335 Sum_probs=173.0
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEE-EeCCeeEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC-IQADESMLIY 548 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~-~~~~~~~lV~ 548 (698)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... .+.+.+|++++++++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999986 5689999999865432 34689999999999988766665555 6677889999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE---cCCCceEEeecCCCccc
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIF 625 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFgla~~~ 625 (698)
||+ +++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 99999998643 235899999999999999999999998 9999999999999 58889999999999876
Q ss_pred CCCcccc-----ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 626 GGDEIQT-----NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 626 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch
Confidence 5432211 123357999999999999999999999999999999999999999865443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=287.52 Aligned_cols=208 Identities=28% Similarity=0.435 Sum_probs=173.7
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEe--CCeeEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESML 546 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--~~~~~l 546 (698)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999875 58899999997542 3345678999999999999999999998865 567899
Q ss_pred EEEecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 547 IYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987543 2345899999999999999999999875 2349999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
........ .....|+..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 76433211 123568999999999998899999999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=287.37 Aligned_cols=205 Identities=24% Similarity=0.328 Sum_probs=170.3
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC----CcchHHHHHHHHHHhhcCCCeeeeEEEEEE--eCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLLGCCI--QADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~--~~~~ 543 (698)
..++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999874 57899999986542 345678999999999999999999999984 4557
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++||||++++ |.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999987 666665432 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccChhcccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
...............||..|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 765332222233457899999999987654 378999999999999999999999754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=300.73 Aligned_cols=204 Identities=29% Similarity=0.476 Sum_probs=161.6
Q ss_pred CccccCceeeecceeEEEEEecc----ccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe-CCeeEEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADESMLI 547 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~-~~~~~lV 547 (698)
.|.+.+.||+|+||.||+|+..+ +..||+|.+... .....+.|.+|++++++++||||+++++++.+ ....++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999998643 246899998654 33456789999999999999999999998755 4578999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999998543 335789999999999999999999998 99999999999999999999999999986543
Q ss_pred Ccccc--ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 628 DEIQT--NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 628 ~~~~~--~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
..... ......+|..|+|||.+....++.++||||||+++|||+| |+.||.....
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 32111 1122457889999999999999999999999999999999 6777765443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=307.29 Aligned_cols=201 Identities=30% Similarity=0.447 Sum_probs=172.8
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC-------------cchHHHHHHHHHHhhcCCCeeeeEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-------------QGMEEFKNEVTLIARLQHRNLVKLLG 536 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-------------~~~~~~~~Ei~il~~l~H~nIv~l~~ 536 (698)
..++|.+.++||+|+||.||+++.. .++.||+|++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999875 478999999875421 33567899999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC---c
Q 005400 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---N 613 (698)
Q Consensus 537 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~ 613 (698)
++.+....++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999888653 34899999999999999999999998 99999999999998775 6
Q ss_pred eEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|||++|+.||....
T Consensus 188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999987654321 22357999999999986 568999999999999999999999997544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=295.21 Aligned_cols=208 Identities=25% Similarity=0.321 Sum_probs=160.6
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEe--------
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQ-------- 540 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~-------- 540 (698)
...+|++.++||+|+||.||+++.. +++.||+|++........+.+.+|+.++.++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4467999999999999999999874 58899999987666566778999999999996 9999999999953
Q ss_pred CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
....++||||++ |+|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 334789999996 788888865444556999999999999999999999875 349999999999999999999999999
Q ss_pred CCcccCCCcccc----------ccccccccccccChhcc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 621 MARIFGGDEIQT----------NTHKVVGTYGYMSPEYA---AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 621 la~~~~~~~~~~----------~~~~~~gt~~y~APE~l---~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
++.......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 998764322111 11124689999999998 5667899999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.94 Aligned_cols=198 Identities=26% Similarity=0.365 Sum_probs=162.6
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC------
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~------ 542 (698)
.++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999864 5889999999754 2334567889999999999999999999997665
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 68999999985 6777663 23889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8754322 1223578999999999999999999999999999999999999997543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=300.45 Aligned_cols=201 Identities=12% Similarity=0.159 Sum_probs=155.7
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC---cchHHHHHHHHHHhhc--CCCeeeeEE-------EEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIARL--QHRNLVKLL-------GCC 538 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l--~H~nIv~l~-------~~~ 538 (698)
..+|.+.++||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 455888999999999999999965 688999999987532 3345677885555444 699988755 555
Q ss_pred EeC-----------------CeeEEEEEecCCCChhHHHhhccccCCCCHHHH------HHHHHHHHHHHHHHHhCCCCc
Q 005400 539 IQA-----------------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKR------IHIVGGIARGILYLHQDSRMR 595 (698)
Q Consensus 539 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ 595 (698)
... ...++||||++ ++|.+++..... .+.+..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 443 23799999999 899999976432 2455555 788899999999999998
Q ss_pred eeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccC--CCCCcchhHHHHHHHHHHHHhC
Q 005400 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSG 673 (698)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~k~DVwSlGvil~elltG 673 (698)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.. ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998754221 12467799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCC
Q 005400 674 KKNWRFSHPD 683 (698)
Q Consensus 674 ~~pf~~~~~~ 683 (698)
+.||....+.
T Consensus 290 ~~Pf~~~~~~ 299 (371)
T 3q60_A 290 FLPFGLVTPG 299 (371)
T ss_dssp SCSTTBCCTT
T ss_pred CCCCCCcCcc
Confidence 9999876443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.23 Aligned_cols=198 Identities=25% Similarity=0.375 Sum_probs=162.5
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC----C--eeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA----D--ESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~----~--~~~ 545 (698)
.+|++.+.||+|+||.||+++.. +++.||||++.... +.+.+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 45888899999999999999985 48999999986542 2234799999999999999999998642 1 267
Q ss_pred EEEEecCCCChhHHHhh-ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC-CceEEeecCCCc
Q 005400 546 LIYEYMPNKSLDFFIFD-QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMAR 623 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFgla~ 623 (698)
+||||+++ ++...+.. ......+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 45554432 223456899999999999999999999988 9999999999999965 578999999998
Q ss_pred ccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||....
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 7643322 1235789999999998765 78999999999999999999999997543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=292.40 Aligned_cols=203 Identities=32% Similarity=0.506 Sum_probs=170.2
Q ss_pred cCccccCceeeecceeEEEEEecc-ccE--EEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQE--IAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~~--vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|++.+.||+|+||.||+++... ++. +|+|.+... .....+.+.+|+++++++ +||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 568888999999999999998754 554 499988754 334556789999999999 899999999999999999999
Q ss_pred EEecCCCChhHHHhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 548 YEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
|||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986542 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
||+|||++...... .......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 99999998743211 11122457889999999988889999999999999999998 999997543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-32 Score=289.11 Aligned_cols=196 Identities=27% Similarity=0.441 Sum_probs=161.6
Q ss_pred HhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhc--CCCeeeeEEEEEEeC----Ce
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL--QHRNLVKLLGCCIQA----DE 543 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l--~H~nIv~l~~~~~~~----~~ 543 (698)
...++|++.++||+|+||.||+|+.. ++.||||++... ....+..|.+++... +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34578999999999999999999884 899999998543 234556666666655 899999999999987 78
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeecCCCCCCEEEcCCCceEEee
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS-----RMRIIHRDLKASNVLLDNDMNPKISD 618 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~D 618 (698)
.++||||+++++|.+++... .+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 89999999999999999543 4899999999999999999999880 11299999999999999999999999
Q ss_pred cCCCcccCCCcccc--ccccccccccccChhcccCCCCCcc------hhHHHHHHHHHHHHhC
Q 005400 619 FGMARIFGGDEIQT--NTHKVVGTYGYMSPEYAAEGLFSVK------SDVFSFGVLVLEIVSG 673 (698)
Q Consensus 619 Fgla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~k------~DVwSlGvil~elltG 673 (698)
||++..+....... ......||+.|+|||++.......+ +|||||||++|||+||
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 99997654332211 1123579999999999987766655 9999999999999999
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-32 Score=287.73 Aligned_cols=194 Identities=20% Similarity=0.387 Sum_probs=169.8
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEe--CCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQ--ADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~--~~~~~lV 547 (698)
.++|++.++||+|+||.||+++. .+++.||+|++.. ...+.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999986 4688999999964 33567899999999997 9999999999988 5678999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-ceEEeecCCCcccC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFG 626 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFgla~~~~ 626 (698)
|||+++++|..++.. +++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++....
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999888732 788999999999999999999998 99999999999999776 89999999998764
Q ss_pred CCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 3322 223578999999999877 67899999999999999999999999643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-32 Score=283.90 Aligned_cols=202 Identities=26% Similarity=0.397 Sum_probs=174.6
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC---------cchHHHHHHHHHHhhcC-CCeeeeEEEEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---------QGMEEFKNEVTLIARLQ-HRNLVKLLGCC 538 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---------~~~~~~~~Ei~il~~l~-H~nIv~l~~~~ 538 (698)
...++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|++++++++ ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999875 588999999975431 22456889999999996 99999999999
Q ss_pred EeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEee
Q 005400 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (698)
Q Consensus 539 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 618 (698)
......++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999998653 34899999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccCCCccccccccccccccccChhccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
||++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 999987643321 22357899999999885 456889999999999999999999999643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=289.18 Aligned_cols=201 Identities=25% Similarity=0.387 Sum_probs=168.2
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--------CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~ 541 (698)
..++|.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999875 47899999986532 12234688999999999999999999998765
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc---eEEee
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISD 618 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~D 618 (698)
. .++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 89999999999999888543 35899999999999999999999998 999999999999987665 99999
Q ss_pred cCCCcccCCCccccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
||++........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999987643321 12356899999999873 5678999999999999999999999997544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=291.60 Aligned_cols=205 Identities=25% Similarity=0.373 Sum_probs=171.9
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe----CCeeE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESM 545 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~----~~~~~ 545 (698)
..++|++.+.||+|+||.||+++. .+++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346799999999999999999987 4689999999876666667789999999999999999999999873 34688
Q ss_pred EEEEecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 546 LIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
+||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999986532 2456899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCccc-------cccccccccccccChhcccCCC---CCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 625 FGGDEIQ-------TNTHKVVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 625 ~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~---~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
....... .......||+.|+|||++.... ++.++||||||+++|||++|+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 4321100 0011245799999999987554 6889999999999999999999995
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=297.43 Aligned_cols=200 Identities=16% Similarity=0.229 Sum_probs=171.1
Q ss_pred hcCccccCceeeecceeEEEEEecc---------ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeee---------
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE---------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK--------- 533 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~--------- 533 (698)
.++|.+.+.||+|+||.||+++... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998764 789999998653 46889999999999999988
Q ss_pred ------EEEEEEe-CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCE
Q 005400 534 ------LLGCCIQ-ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606 (698)
Q Consensus 534 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 606 (698)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6778776 67889999999 999999997542 345899999999999999999999998 99999999999
Q ss_pred EEcCCC--ceEEeecCCCcccCCCccc-----cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 607 LLDNDM--NPKISDFGMARIFGGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 607 Ll~~~~--~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999875432111 111234799999999999999999999999999999999999999986
Q ss_pred CC
Q 005400 680 SH 681 (698)
Q Consensus 680 ~~ 681 (698)
..
T Consensus 271 ~~ 272 (352)
T 2jii_A 271 CL 272 (352)
T ss_dssp GT
T ss_pred CC
Confidence 54
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.15 Aligned_cols=202 Identities=25% Similarity=0.418 Sum_probs=165.5
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEE-----------
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI----------- 539 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~----------- 539 (698)
.++|.+.+.||+|+||.||+++... ++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4679999999999999999999864 8899999998766666788999999999999999999999873
Q ss_pred ---eCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceE
Q 005400 540 ---QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPK 615 (698)
Q Consensus 540 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~k 615 (698)
+....++||||++ ++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 689888843 34889999999999999999999998 99999999999997 567999
Q ss_pred EeecCCCcccCCCcc-ccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 616 ISDFGMARIFGGDEI-QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 616 l~DFgla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|+|||++........ ........+|..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 999999987643211 111223467899999998765 678999999999999999999999998544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=300.44 Aligned_cols=200 Identities=20% Similarity=0.267 Sum_probs=172.2
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhc------CCCeeeeEEEEEEeCCe
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL------QHRNLVKLLGCCIQADE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l------~H~nIv~l~~~~~~~~~ 543 (698)
...+|++.++||+|+||.||+|+.. .++.||||++... ....+.+.+|+++++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467999999999999999999875 4889999999653 23446778888888887 57799999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc--eEEeecCC
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--PKISDFGM 621 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFgl 621 (698)
.++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 588888765432 34899999999999999999999998 999999999999999887 99999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+....... ....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 249 a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 97643321 23578999999999999999999999999999999999999997544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.38 Aligned_cols=205 Identities=30% Similarity=0.466 Sum_probs=169.0
Q ss_pred hcCccccCceeeecceeEEEEEecc----ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEe-CCeeE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADESM 545 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~-~~~~~ 545 (698)
..+|++.++||+|+||.||+|+..+ ...+|+|.+.... ....+.+.+|++++++++||||+++++++.+ ....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568888999999999999998643 2358999987643 3445779999999999999999999998654 56789
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 104 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999999643 345789999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc--cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 626 GGDEIQ--TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
...... .......+|+.|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 433211 11223467889999999999999999999999999999999 555665433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=292.50 Aligned_cols=202 Identities=31% Similarity=0.529 Sum_probs=174.3
Q ss_pred hcCccccCceeeecceeEEEEEe-----ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC--ee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~--~~ 544 (698)
.++|++.+.||+|+||.||+++. .+++.||+|++........+.+.+|++++++++||||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999984 358899999998776667788999999999999999999999986544 68
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999996542 34899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
....... .......++..|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 6543221 11222457788999999988889999999999999999999998886
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=289.69 Aligned_cols=203 Identities=26% Similarity=0.441 Sum_probs=171.9
Q ss_pred HhhcCccccCceeeecceeEEEEEe--ccccEEEEEEecCCC--CcchHHHHHHHHHHhhc---CCCeeeeEEEEEE---
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTL--VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARL---QHRNLVKLLGCCI--- 539 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~--~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l---~H~nIv~l~~~~~--- 539 (698)
.+.++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4567899999999999999999987 357899999986432 22334677888877776 8999999999987
Q ss_pred --eCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEe
Q 005400 540 --QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (698)
Q Consensus 540 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 617 (698)
.....++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69988886543 234889999999999999999999998 9999999999999999999999
Q ss_pred ecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
|||++....... ......||..|+|||++....++.++||||||+++|||++|+.||...
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999998654222 222357899999999999999999999999999999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=292.16 Aligned_cols=208 Identities=25% Similarity=0.427 Sum_probs=158.9
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
..++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999864 58899999986542 344567889999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhc-----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 549 EYMPNKSLDFFIFDQ-----ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 549 E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
||+++++|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998642 12345899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCcc---ccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDEI---QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~~---~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
....... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 6543211 111223578999999999865 568999999999999999999999997543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=286.82 Aligned_cols=199 Identities=30% Similarity=0.421 Sum_probs=168.0
Q ss_pred CccccCceeeecceeEEEEEecc----ccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee-EEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES-MLI 547 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~-~lV 547 (698)
.|...++||+|+||.||+|+..+ +..+|+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35566899999999999998643 23799999976433 4557889999999999999999999999876665 999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+.+++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999998652 345889999999999999999999998 99999999999999999999999999986543
Q ss_pred Ccc--ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005400 628 DEI--QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (698)
Q Consensus 628 ~~~--~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf 677 (698)
... ........+|..|+|||.+....++.++||||||+++|||++|+.|+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 221 11222356789999999999999999999999999999999966554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=292.64 Aligned_cols=208 Identities=24% Similarity=0.304 Sum_probs=160.9
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe--
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-- 543 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~-- 543 (698)
......++|.+.+.||+|+||.||+++.. +++.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556789999999999999999999875 58899999986543 334567788889999999999999999976443
Q ss_pred -----eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceeecCCCCCCEEEcC-CCceE
Q 005400 544 -----SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH--QDSRMRIIHRDLKASNVLLDN-DMNPK 615 (698)
Q Consensus 544 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlkp~NILl~~-~~~~k 615 (698)
.++||||++++.+..+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987544333322234456889999999999999999999 777 999999999999996 89999
Q ss_pred EeecCCCcccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|+|||++..+..... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 999999987654332 1235689999999998655 48999999999999999999999997643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-32 Score=295.76 Aligned_cols=201 Identities=22% Similarity=0.336 Sum_probs=166.2
Q ss_pred HhhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-------
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------- 541 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------- 541 (698)
...++|++.+.||+|+||.||+++. .+|+.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999986 4689999999865432 234799999999999999999998543
Q ss_pred -------------------------------CeeEEEEEecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHH
Q 005400 542 -------------------------------DESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLH 589 (698)
Q Consensus 542 -------------------------------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH 589 (698)
...++||||++ ++|...+... .....+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34789999998 4777776532 23456899999999999999999999
Q ss_pred hCCCCceeecCCCCCCEEEc-CCCceEEeecCCCcccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHH
Q 005400 590 QDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLV 667 (698)
Q Consensus 590 ~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil 667 (698)
+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....+|+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 988 99999999999998 688999999999987644332 1235789999999988765 589999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 005400 668 LEIVSGKKNWRFSH 681 (698)
Q Consensus 668 ~elltG~~pf~~~~ 681 (698)
|||++|+.||....
T Consensus 233 ~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 233 GELILGKPLFSGET 246 (383)
T ss_dssp HHHHHSSCSSCCSS
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999998543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=319.10 Aligned_cols=197 Identities=32% Similarity=0.476 Sum_probs=165.1
Q ss_pred CceeeecceeEEEEEec---cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|++++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 36789999997642 334678999999999999999999999986 4568899999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc-cc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI-QT 632 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~-~~ 632 (698)
|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999543 35899999999999999999999998 99999999999999999999999999987654322 11
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
......+|..|+|||++....++.++|||||||+||||++ |+.||.....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 1222456789999999999999999999999999999998 9999976443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-33 Score=297.56 Aligned_cols=198 Identities=27% Similarity=0.429 Sum_probs=155.2
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC------
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------ 541 (698)
..++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 347899999999999999999986 458899999997542 23456788999999999999999999998754
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
...++|+|++ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 6889888743 34899999999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865322 223578999999999876 678999999999999999999999997544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=285.40 Aligned_cols=198 Identities=30% Similarity=0.491 Sum_probs=165.6
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-CeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-~~~~lV~E~ 550 (698)
.++|++.+.||+|+||.||+++. .++.||+|++... ...+.+.+|++++++++||||+++++++.+. ...++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46789999999999999999987 5889999998754 3457899999999999999999999997654 478999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++++|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999986542 223788999999999999999999998 9999999999999999999999999987643321
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 12457889999999998999999999999999999998 999997543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=287.49 Aligned_cols=202 Identities=26% Similarity=0.353 Sum_probs=158.5
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
..++|++.++||+|+||.||+++. .+++.||+|++..... ...+.+.++...++.++||||+++++++.++...++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 347799999999999999999987 4688999999976522 2233445556668888999999999999999999999
Q ss_pred EEecCCCChhHHHhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 548 YEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
|||+++ +|.+++... .....+++..+..++.|++.||+|||++ + |+||||||+|||++.++++||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 777776532 2345689999999999999999999997 7 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccChhcc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYA----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
..... .....||+.|+|||++ ....++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 44322 1224689999999996 556789999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=294.76 Aligned_cols=205 Identities=24% Similarity=0.381 Sum_probs=172.6
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-----C
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----D 542 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-----~ 542 (698)
...++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++.+++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34578999999999999999999865 57889999997543 23446789999999999999999999999765 3
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++||||++ ++|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 6899999998 488888743 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccc-ccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 623 RIFGGDEIQT-NTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 623 ~~~~~~~~~~-~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 8764322111 1233579999999998654 4589999999999999999999999976543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.9e-33 Score=294.74 Aligned_cols=202 Identities=25% Similarity=0.442 Sum_probs=175.7
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCc---c--------------hHHHHHHHHHHhhcCCCeeeeE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ---G--------------MEEFKNEVTLIARLQHRNLVKL 534 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~---~--------------~~~~~~Ei~il~~l~H~nIv~l 534 (698)
.++|.+.+.||+|+||.||+++. +++.||+|++...... . .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998654211 1 1789999999999999999999
Q ss_pred EEEEEeCCeeEEEEEecCCCChhHH------HhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEE
Q 005400 535 LGCCIQADESMLIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVL 607 (698)
Q Consensus 535 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NIL 607 (698)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.|++.||+|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 432 124568999999999999999999999 77 999999999999
Q ss_pred EcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSV-KSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~-k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999876433 22336789999999999877 6666 99999999999999999999975443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=289.93 Aligned_cols=209 Identities=25% Similarity=0.393 Sum_probs=171.0
Q ss_pred cchhhHHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCC--CCcchHHHHHHHHHHhhcC--CCeeeeEEEEE
Q 005400 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ--HRNLVKLLGCC 538 (698)
Q Consensus 463 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~--H~nIv~l~~~~ 538 (698)
+.+..+....++|++.+.||+|+||.||+++..+++.||+|++... .....+.+.+|++++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3444455566889999999999999999999888999999998654 2345577899999999997 59999999999
Q ss_pred EeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEee
Q 005400 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (698)
Q Consensus 539 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 618 (698)
......++||| +.+++|.+++... ..+++..+..++.|+++||.|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 6788999998653 35889999999999999999999998 999999999999975 8999999
Q ss_pred cCCCcccCCCccccccccccccccccChhcccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-----------GLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----------~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
||++..+.............||+.|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 999987654332222233578999999999865 4688899999999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=289.67 Aligned_cols=197 Identities=31% Similarity=0.523 Sum_probs=160.3
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHH--hhcCCCeeeeEEEEEEe-----CCee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLI--ARLQHRNLVKLLGCCIQ-----ADES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il--~~l~H~nIv~l~~~~~~-----~~~~ 544 (698)
.++|++.++||+|+||.||+|+. +++.||||++... ....+..|.+++ ..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46799999999999999999987 6899999999643 234455555554 45899999999986653 2256
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceeecCCCCCCEEEcCCCceE
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD---------SRMRIIHRDLKASNVLLDNDMNPK 615 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivH~Dlkp~NILl~~~~~~k 615 (698)
++||||+++++|.+++.... .++..+..++.|+++||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 89999999999999985432 48899999999999999999998 6 99999999999999999999
Q ss_pred EeecCCCcccCCCcc------ccccccccccccccChhcccC-------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 616 ISDFGMARIFGGDEI------QTNTHKVVGTYGYMSPEYAAE-------GLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 616 l~DFgla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~-------~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
|+|||++..+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999987643221 111223569999999999876 3566789999999999999999877643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=296.14 Aligned_cols=200 Identities=22% Similarity=0.303 Sum_probs=169.1
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC--------CCeeeeEEEEEE---
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ--------HRNLVKLLGCCI--- 539 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~--------H~nIv~l~~~~~--- 539 (698)
.++|++.++||+|+||.||+++.. +++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 5889999999643 344567899999999985 788999999987
Q ss_pred -eCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCC-----
Q 005400 540 -QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDM----- 612 (698)
Q Consensus 540 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~----- 612 (698)
.....++||||+ +++|...+.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 456789999999 555555554432 24589999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------ceEEeecCCCcccCCCccccccccccccccccChhc
Q 005400 613 --------------------------------------------NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648 (698)
Q Consensus 613 --------------------------------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~ 648 (698)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999875432 223578999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 649 l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
+.+..++.++|||||||+||||++|+.||.....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 9999999999999999999999999999975543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.2e-32 Score=286.27 Aligned_cols=199 Identities=23% Similarity=0.348 Sum_probs=172.5
Q ss_pred hcCccccCceeeecceeEEEEEe--ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe------eeeEEEEEEeCCe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL--VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN------LVKLLGCCIQADE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~--~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n------Iv~l~~~~~~~~~ 543 (698)
.++|++.+.||+|+||.||++.. .+++.||+|+++.. ....+.+.+|+++++.++|++ ++++++++.....
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 35889999999653 344567889999999987654 9999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-------------
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN------------- 610 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~------------- 610 (698)
.++||||+ +++|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889998886543 235889999999999999999999998 999999999999987
Q ss_pred ------CCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 611 ------DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 611 ------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6689999999998643321 23578999999999999899999999999999999999999997644
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-32 Score=288.43 Aligned_cols=202 Identities=24% Similarity=0.385 Sum_probs=171.0
Q ss_pred HHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhh--cCCCeeeeEEEEEEeCC----
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQAD---- 542 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~--l~H~nIv~l~~~~~~~~---- 542 (698)
....++|.+.+.||+|+||.||+++. +++.||+|++... ..+.+..|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34567899999999999999999998 5899999999643 34678889999987 78999999999998876
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeecCCCCCCEEEcCCCce
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH--------QDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
..++||||+++++|.+++.+. .+++..++.++.|++.||+||| +.+ |+||||||+|||++.++++
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 789999999999999999542 4889999999999999999999 666 9999999999999999999
Q ss_pred EEeecCCCcccCCCcccc--ccccccccccccChhcccCCC------CCcchhHHHHHHHHHHHHhC----------CCC
Q 005400 615 KISDFGMARIFGGDEIQT--NTHKVVGTYGYMSPEYAAEGL------FSVKSDVFSFGVLVLEIVSG----------KKN 676 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~------~~~k~DVwSlGvil~elltG----------~~p 676 (698)
||+|||++.......... ......||+.|+|||++.... ++.++||||||+++|||+|| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765432211 123357999999999987653 33689999999999999999 778
Q ss_pred CCCCC
Q 005400 677 WRFSH 681 (698)
Q Consensus 677 f~~~~ 681 (698)
|....
T Consensus 267 ~~~~~ 271 (342)
T 1b6c_B 267 YYDLV 271 (342)
T ss_dssp TTTTS
T ss_pred ccccC
Confidence 86543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=298.77 Aligned_cols=203 Identities=25% Similarity=0.414 Sum_probs=155.0
Q ss_pred cCccc-cCceeeecceeEEEEEec---cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe--CCeeEE
Q 005400 473 DNFAS-YNKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESML 546 (698)
Q Consensus 473 ~~f~~-~~~LG~G~fG~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--~~~~~l 546 (698)
+.|++ .++||+|+||.||+++.. +++.||+|++.... ..+.+.+|++++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44655 357999999999999865 47889999997542 33578899999999999999999999965 667899
Q ss_pred EEEecCCCChhHHHhhcc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE----cCCCceEE
Q 005400 547 IYEYMPNKSLDFFIFDQA------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKI 616 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl 616 (698)
||||+++ +|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 6766664321 1224899999999999999999999998 9999999999999 67889999
Q ss_pred eecCCCcccCCCcc-ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 617 SDFGMARIFGGDEI-QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 617 ~DFgla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987643211 1122336789999999998774 58999999999999999999999997543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=290.71 Aligned_cols=203 Identities=25% Similarity=0.379 Sum_probs=170.3
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-----Ce
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-----~~ 543 (698)
..++|.+.+.||+|+||.||+++.. +|+.||||++.... ......+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999875 58899999996543 23456788999999999999999999998764 67
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++||||++ ++|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 588888754 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccc--------ccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDEIQT--------NTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~~~~--------~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
......... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 764322111 1122468999999998754 678999999999999999999999997543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=279.03 Aligned_cols=201 Identities=28% Similarity=0.433 Sum_probs=174.0
Q ss_pred HhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
...++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++......++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999875 5889999998654 23456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC---CceEEeecCCCc
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMAR 623 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFgla~ 623 (698)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999988886533 4899999999999999999999998 9999999999999754 469999999998
Q ss_pred ccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
....... .....+++.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 7643321 122468999999998865 4899999999999999999999999754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=298.54 Aligned_cols=203 Identities=21% Similarity=0.334 Sum_probs=172.9
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcCC-CeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H-~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.++||+|+||.||+|+. .+++.||||++..... ...+..|+++++.++| +++..+..++.+....+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999986 4588999998865432 3468899999999986 566667777788889999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE---cCCCceEEeecCCCcccC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFG 626 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFgla~~~~ 626 (698)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998643 235899999999999999999999998 9999999999999 688999999999998765
Q ss_pred CCcccc-----ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 627 GDEIQT-----NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 627 ~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
...... ......||..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 432211 11246799999999999999999999999999999999999999986544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=292.38 Aligned_cols=196 Identities=26% Similarity=0.421 Sum_probs=166.5
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee----
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES---- 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~---- 544 (698)
.++|.+.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999865 58899999997642 23356788999999999999999999999877655
Q ss_pred --EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 545 --MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 545 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
++||||++ ++|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 57776662 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
...... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865432 223578999999999877 678999999999999999999999997543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=282.90 Aligned_cols=203 Identities=29% Similarity=0.443 Sum_probs=163.7
Q ss_pred hcCccccCceeeecceeEEEEEecc--c--cEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE--G--QEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~--g--~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
.++|++.+.||+|+||.||+|++.. + ..||+|+++.. .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3678999999999999999998632 3 36899998754 2345678999999999999999999999987654 8
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++|+||+++++|.+++.... ..+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999986542 34889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
....... .......+|..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 6443221 12223467889999999988889999999999999999999 99999754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=289.34 Aligned_cols=206 Identities=22% Similarity=0.311 Sum_probs=172.8
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CC-----eeeeEEEEEE
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HR-----NLVKLLGCCI 539 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~-----nIv~l~~~~~ 539 (698)
......++|++.+.||+|+||.||+|+.. +++.||||+++.. ....+++..|+++++.++ |+ +|+++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 34455789999999999999999999875 5788999999643 234567788999988885 44 4999999999
Q ss_pred eCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc--CCCceEEe
Q 005400 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDMNPKIS 617 (698)
Q Consensus 540 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~ 617 (698)
.....++||||++ ++|.+++.... ...+++..+..++.|++.||+|||.+. .+|+||||||+|||++ .++.+||+
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999996 48988886543 234899999999999999999999531 2499999999999994 57789999
Q ss_pred ecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
|||++....... ....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 204 DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998764321 23578999999999999999999999999999999999999998543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-32 Score=288.14 Aligned_cols=196 Identities=26% Similarity=0.419 Sum_probs=166.0
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe-----
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~----- 543 (698)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999874 58899999997642 2335678999999999999999999999987654
Q ss_pred -eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 544 -SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 544 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
.++||||++ ++|..++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 57776652 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
...... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865322 123578999999999876 678999999999999999999999997543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=283.37 Aligned_cols=199 Identities=21% Similarity=0.346 Sum_probs=169.7
Q ss_pred hcCccccCceeeecceeEEEEEecc-c-cEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe------eeeEEEEEEeCCe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-G-QEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN------LVKLLGCCIQADE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g-~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n------Iv~l~~~~~~~~~ 543 (698)
.++|++.+.||+|+||.||+++... + +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4789999999999999999998743 4 68999999653 344567889999999998766 9999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEE---------------
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL--------------- 608 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl--------------- 608 (698)
.++||||+ ++++..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 556666664432 235899999999999999999999998 9999999999999
Q ss_pred ----cCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 609 ----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 609 ----~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 667899999999998643322 23578999999999999999999999999999999999999997543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=283.59 Aligned_cols=202 Identities=24% Similarity=0.390 Sum_probs=151.3
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHH-HHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~-il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
.++|++.+.||+|+||.||+++.. +++.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367889999999999999999875 58899999997653 233445556665 777789999999999999999999999
Q ss_pred EecCCCChhHHHhhc--cccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 549 EYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 549 E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
||+++ +|..++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 777666431 1245689999999999999999999998 7 999999999999999999999999999875
Q ss_pred CCCccccccccccccccccChhcc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYA----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
..... .....||+.|+|||++ ....++.++||||||+++|||++|+.||...
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 43321 1224689999999998 4567899999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=278.44 Aligned_cols=196 Identities=26% Similarity=0.446 Sum_probs=161.7
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe---------
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--------- 540 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--------- 540 (698)
..++|++.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3467999999999999999999874 6889999999643 3445778999999999999999999999865
Q ss_pred ----CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEE
Q 005400 541 ----ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (698)
Q Consensus 541 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 616 (698)
....++||||+++++|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 346789999999999999996532 34778899999999999999999998 999999999999999999999
Q ss_pred eecCCCcccCCCcc------------ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHh
Q 005400 617 SDFGMARIFGGDEI------------QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVS 672 (698)
Q Consensus 617 ~DFgla~~~~~~~~------------~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~ellt 672 (698)
+|||++........ ........||..|+|||++.+. .++.++||||||+++|||++
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999986542210 1112235689999999998764 78999999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=283.56 Aligned_cols=201 Identities=24% Similarity=0.425 Sum_probs=163.8
Q ss_pred HHhhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC------cchHHHHHHHHHHhhc----CCCeeeeEEEE
Q 005400 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARL----QHRNLVKLLGC 537 (698)
Q Consensus 469 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~il~~l----~H~nIv~l~~~ 537 (698)
....++|.+.+.||+|+||.||+++.. +++.||+|++..... .....+.+|++++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445678999999999999999999864 588999999975432 1234567799999998 89999999999
Q ss_pred EEeCCeeEEEEEe-cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceE
Q 005400 538 CIQADESMLIYEY-MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPK 615 (698)
Q Consensus 538 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~k 615 (698)
+...+..++|+|+ +.+++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 78999999986533 4899999999999999999999998 99999999999999 889999
Q ss_pred EeecCCCcccCCCccccccccccccccccChhcccCCCCC-cchhHHHHHHHHHHHHhCCCCCCC
Q 005400 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS-VKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~k~DVwSlGvil~elltG~~pf~~ 679 (698)
|+|||++........ ....|+..|+|||++....+. .++||||||+++|||++|+.||..
T Consensus 181 l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 181 LIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp ECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999987654322 235689999999998776664 589999999999999999999963
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=308.82 Aligned_cols=203 Identities=26% Similarity=0.386 Sum_probs=170.4
Q ss_pred hhcCccccCceeeecceeEEEEEecc----ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
..++|++.+.||+|+||.||+|++.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 45678999999999999999998743 4579999987543 334567999999999999999999999984 56789
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999998643 234899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
...... ......+|+.|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 443221 1223457789999999998899999999999999999997 99999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=284.55 Aligned_cols=200 Identities=25% Similarity=0.385 Sum_probs=171.9
Q ss_pred HhhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCc------chHHHHHHHHHHhhcC--CCeeeeEEEEEEe
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQ------GMEEFKNEVTLIARLQ--HRNLVKLLGCCIQ 540 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~------~~~~~~~Ei~il~~l~--H~nIv~l~~~~~~ 540 (698)
...++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++++++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999986 45889999998754221 2356778999999996 5999999999999
Q ss_pred CCeeEEEEEecCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceEEee
Q 005400 541 ADESMLIYEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISD 618 (698)
Q Consensus 541 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~D 618 (698)
.+..++|+|++.+ ++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 8999988653 34889999999999999999999998 99999999999999 789999999
Q ss_pred cCCCcccCCCccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
||++....... .....||+.|+|||++....+ +.++||||||+++|||++|+.||..
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99998765332 123578999999999877665 6889999999999999999999964
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.08 Aligned_cols=199 Identities=23% Similarity=0.283 Sum_probs=146.7
Q ss_pred hhcCccccC-ceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe----CCee
Q 005400 471 ATDNFASYN-KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADES 544 (698)
Q Consensus 471 ~~~~f~~~~-~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~----~~~~ 544 (698)
..++|.+.+ .||+|+||.||+++.. +++.||+|++... .....+....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346788855 5999999999999876 5899999998643 1222333344667799999999999876 4458
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC---CCceEEeecCC
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFgl 621 (698)
++||||+++++|.+++.... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999996543 245899999999999999999999998 999999999999986 44599999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+....... .....||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 98654322 123578999999999988889999999999999999999999996544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=285.83 Aligned_cols=204 Identities=27% Similarity=0.433 Sum_probs=167.8
Q ss_pred HhhcCccccCceeeecceeEEEEEeccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
...++|++.+.||+|+||.||+|+.. ..+|+|++... .....+.+.+|++++++++||||+++++++......++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 34578999999999999999999874 35999998654 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999998543 235889999999999999999999998 99999999999998 67999999999876532
Q ss_pred Cc---cccccccccccccccChhcccC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DE---IQTNTHKVVGTYGYMSPEYAAE---------GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~---~~~~~~~~~gt~~y~APE~l~~---------~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. .........|+..|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 1111223468999999999864 457899999999999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=287.67 Aligned_cols=199 Identities=24% Similarity=0.364 Sum_probs=167.8
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-----------CCeeeeEEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----------HRNLVKLLGCCI 539 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-----------H~nIv~l~~~~~ 539 (698)
.++|.+.+.||+|+||.||+++. .+++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36799999999999999999986 46889999999643 234567889999999886 899999999988
Q ss_pred eCC----eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEc-----
Q 005400 540 QAD----ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLD----- 609 (698)
Q Consensus 540 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~----- 609 (698)
... ..++|||++ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 889999886543 23488999999999999999999998 7 99999999999994
Q ss_pred -CCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 610 -NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 610 -~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4458999999999875432 123578999999999999999999999999999999999999998543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=292.69 Aligned_cols=201 Identities=26% Similarity=0.354 Sum_probs=157.0
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 344556789999999998766667999999998643 345678999999876 8999999999999999999999999
Q ss_pred CCCChhHHHhhccccC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC-------------Cce
Q 005400 552 PNKSLDFFIFDQARAT----FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-------------MNP 614 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~-------------~~~ 614 (698)
+ ++|.+++....... ...+..++.++.||+.||+|||+.+ |+||||||+|||++.+ ..+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999986543211 1133345789999999999999998 9999999999999754 489
Q ss_pred EEeecCCCcccCCCccc--cccccccccccccChhcccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 615 KISDFGMARIFGGDEIQ--TNTHKVVGTYGYMSPEYAAE-------GLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~-------~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
||+|||++..+...... .......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999876543221 11223579999999999865 568999999999999999999 99999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=277.44 Aligned_cols=200 Identities=22% Similarity=0.408 Sum_probs=151.4
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC--cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
..++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467889999999999999999885 588999999976532 2223445556678888999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
|||+ ++.+..+... ....+++..+..++.|+++||+|||+. + |+|+||||+|||++.++.+||+|||++..+.
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4455444432 134589999999999999999999985 7 9999999999999999999999999997654
Q ss_pred CCccccccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.... .....||+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 177 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 177 DDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 3221 12356899999999984 45688999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=308.92 Aligned_cols=192 Identities=20% Similarity=0.329 Sum_probs=165.8
Q ss_pred hcCccccCceeeecceeEEEEEec--cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe-----
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~--~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~----- 543 (698)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999875 58899999986543 3445678999999999999999999999987665
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.+|||||+++++|.+++.. .+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 4899999999999999999999998 9999999999999986 99999999998
Q ss_pred ccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
..... ....||+.|+|||++.... +.++|||||||+||||++|..||..
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 75432 2357999999999987654 8999999999999999999998864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=304.31 Aligned_cols=202 Identities=28% Similarity=0.451 Sum_probs=173.7
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe------CCe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ------ADE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~------~~~ 543 (698)
.++|++.++||+|+||.||+++.. +|+.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999874 5889999998764 33445678999999999999999999999765 667
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCc---eEEeecC
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFG 620 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFg 620 (698)
.++||||+++++|.+++........+++..+..++.+++.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555556889999999999999999999998 999999999999997665 9999999
Q ss_pred CCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9987654332 2235799999999999999999999999999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=281.22 Aligned_cols=191 Identities=17% Similarity=0.199 Sum_probs=162.2
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCC--------CcchHHHHHHHHHHhhcC---------CCeeeeE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--------GQGMEEFKNEVTLIARLQ---------HRNLVKL 534 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~--------~~~~~~~~~Ei~il~~l~---------H~nIv~l 534 (698)
.++|++.++||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999998 78999999997642 223477899999999886 8888888
Q ss_pred EEEEE------------------------------eCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHH
Q 005400 535 LGCCI------------------------------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584 (698)
Q Consensus 535 ~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 584 (698)
.+.+. .....+|||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 88754 26789999999999976666532 358999999999999999
Q ss_pred HHHHH-hCCCCceeecCCCCCCEEEcCCC--------------------ceEEeecCCCcccCCCccccccccccccccc
Q 005400 585 ILYLH-QDSRMRIIHRDLKASNVLLDNDM--------------------NPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643 (698)
Q Consensus 585 L~yLH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y 643 (698)
|+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999875432 24799999
Q ss_pred cChhcccCCCCCcchhHHHHHHH-HHHHHhCCCCCC
Q 005400 644 MSPEYAAEGLFSVKSDVFSFGVL-VLEIVSGKKNWR 678 (698)
Q Consensus 644 ~APE~l~~~~~~~k~DVwSlGvi-l~elltG~~pf~ 678 (698)
+|||++.+.. +.++||||++++ .+++++|..||.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998666 899999998766 788999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=290.15 Aligned_cols=201 Identities=23% Similarity=0.355 Sum_probs=158.7
Q ss_pred hhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
...+|.+.+.||+|+||+|+.....+++.||||++.... ...+.+|+++++++ +|||||++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 345688889999999999665555579999999996533 23467899999999 79999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-----CCceEEeecCCCcc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARI 624 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFgla~~ 624 (698)
|++ ++|.+++..... .....++..++.||+.||+|||+.+ |+||||||+|||++. ..++||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 997 589888865432 2344456789999999999999998 999999999999953 33588999999987
Q ss_pred cCCCcc-ccccccccccccccChhccc---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 005400 625 FGGDEI-QTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (698)
Q Consensus 625 ~~~~~~-~~~~~~~~gt~~y~APE~l~---~~~~~~k~DVwSlGvil~ellt-G~~pf~~~ 680 (698)
+..... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||...
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 643221 11223367999999999997 4567889999999999999999 99999643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-30 Score=265.52 Aligned_cols=175 Identities=10% Similarity=0.052 Sum_probs=152.4
Q ss_pred hcCccccCceeeecceeEEEEEecc-ccEEEEEEecCCCC---cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
.++|++.+.||+|+||.||+++... ++.||+|++..... ...+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999999854 89999999976532 3346799999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++++|.+++... ....++.+++.|++.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999998431 345578899999999999999998 9999999999999999999997432
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
|++| ++.++||||||+++|||+||+.||......
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 3333 688999999999999999999999865543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=280.32 Aligned_cols=204 Identities=16% Similarity=0.206 Sum_probs=155.7
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC---CcchHHHHHHHHHHhhcCC-Ce---------eee---
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQH-RN---------LVK--- 533 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H-~n---------Iv~--- 533 (698)
.+.+|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.+++.++| +| ++.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 445677788999999999999995 458999999987442 2346789999999999987 21 111
Q ss_pred ---------EEEEEEe-----CCeeEEEEEecCCCChhHHHhh----ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005400 534 ---------LLGCCIQ-----ADESMLIYEYMPNKSLDFFIFD----QARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (698)
Q Consensus 534 ---------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 595 (698)
+..+... ....+++|+.+ +++|.+++.. ......+++..++.++.|+++||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 22356666654 6889888742 122344778899999999999999999998
Q ss_pred eeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcc----------cCCCCCcchhHHHHHH
Q 005400 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA----------AEGLFSVKSDVFSFGV 665 (698)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~~~k~DVwSlGv 665 (698)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999998864322 223567 999999998 5556889999999999
Q ss_pred HHHHHHhCCCCCCCCCCCC
Q 005400 666 LVLEIVSGKKNWRFSHPDH 684 (698)
Q Consensus 666 il~elltG~~pf~~~~~~~ 684 (698)
++|||++|+.||....+.+
T Consensus 306 il~elltg~~Pf~~~~~~~ 324 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALG 324 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGS
T ss_pred HHHHHHHCCCCCCCcchhh
Confidence 9999999999998654433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=257.12 Aligned_cols=177 Identities=24% Similarity=0.332 Sum_probs=151.0
Q ss_pred hcCcccc-CceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHH-hhcCCCeeeeEEEEEEe----CCee
Q 005400 472 TDNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLI-ARLQHRNLVKLLGCCIQ----ADES 544 (698)
Q Consensus 472 ~~~f~~~-~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il-~~l~H~nIv~l~~~~~~----~~~~ 544 (698)
.++|.+. +.||+|+||.||++... +++.||+|++.. ...+.+|++++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 67999999999999874 588999999854 24677888888 56689999999999987 6678
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC---CCceEEeecCC
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFgl 621 (698)
++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999997643 235899999999999999999999998 999999999999998 78899999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+.... +..++.++||||||+++|||++|+.||....
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 86532 1345778999999999999999999997544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-28 Score=274.39 Aligned_cols=185 Identities=18% Similarity=0.174 Sum_probs=129.8
Q ss_pred ceeeecceeEEEEE-eccccEEEEEEecCCC----------CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEE
Q 005400 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGS----------GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 480 ~LG~G~fG~Vy~g~-~~~g~~vavK~l~~~~----------~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV 547 (698)
..+.|++|.+..++ ..-|+.+++|.+.+.. ....++|.+|+++|+++ .|+||+++++++++....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45666666665554 2358899999997542 12345799999999999 699999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||++|++|.++|.+. ..++.. +|+.||+.||+|+|+++ ||||||||+||||++++++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999654 335554 58899999999999999 99999999999999999999999999987654
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKN 676 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~p 676 (698)
... .....+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2233689999999999865 466789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-25 Score=250.91 Aligned_cols=185 Identities=18% Similarity=0.212 Sum_probs=147.5
Q ss_pred ccCceeeecceeEEEEEeccccEEEEEEecCCCC--c------chHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--Q------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--~------~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
..++||+|+||.||++.. .++.+++|+...... . ..+.+.+|++++++++||||+++..++......+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999955 578899998654321 1 1345899999999999999997766777888889999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||+++ ++||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999844 4579999999999999998 999999999999998 9999999999987543
Q ss_pred cccc-----ccccccccccccChhcccC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 629 EIQT-----NTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 629 ~~~~-----~~~~~~gt~~y~APE~l~~--~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
.... ......||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2211 1124689999999999976 567888999999999999999988875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.6e-22 Score=204.44 Aligned_cols=150 Identities=19% Similarity=0.143 Sum_probs=119.2
Q ss_pred HHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCC------------------cchHHHHHHHHHHhhcCCC
Q 005400 468 IAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG------------------QGMEEFKNEVTLIARLQHR 529 (698)
Q Consensus 468 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~il~~l~H~ 529 (698)
+......|.+.+.||+|+||.||+|+..+|+.||+|+++.... .....+.+|++++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 3444556677799999999999999997799999999964321 134568999999999994
Q ss_pred eeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 530 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
+++.+++.. +..++||||+++++|.. +.. .....++.|+++||+|||+.+ |+||||||+|||++
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 555554433 55699999999999987 411 123469999999999999998 99999999999999
Q ss_pred CCCceEEeecCCCcccCCCccccccccccccccccChhccc
Q 005400 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~ 650 (698)
++.+||+|||++.. +..++|||++.
T Consensus 228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999999999863 34578999874
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.2e-20 Score=165.63 Aligned_cols=107 Identities=14% Similarity=0.243 Sum_probs=93.3
Q ss_pred ccccccCCCCccCCCCEEE--eCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEE
Q 005400 16 AANDNITPSQSIRDGETLV--SVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVL 93 (698)
Q Consensus 16 ~~~~~~~~~~~l~~~~~l~--s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~ 93 (698)
++.|+|++|++|.+|++|+ |++|.|+|+|+++++ -+||++ +++||+||++.| +.++.+.+.+||+|+
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 6789999999999999999 999999999998775 257875 799999999876 345789999999999
Q ss_pred e-CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeec
Q 005400 94 L-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (698)
Q Consensus 94 l-~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqS 137 (698)
| |.++.++|+|++....+...++|+|+|||||++ .++|||
T Consensus 75 l~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~----~~~W~S 115 (119)
T 1b2p_A 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG----DALWAT 115 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE----SEEEEC
T ss_pred EEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC----ccEeCC
Confidence 9 888999999997654456689999999999996 389998
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.82 E-value=5e-20 Score=159.55 Aligned_cols=104 Identities=19% Similarity=0.362 Sum_probs=89.6
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CC
Q 005400 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (698)
Q Consensus 18 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (698)
.|+|.+||.|.+||.|.| |.|.|.|...++ |.++. ..++||+|||+.|... .+.|.++.||+|+| |+
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~ 68 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDS 68 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECC
Confidence 478999999999999998 789999987775 66654 4689999999999754 56899999999988 99
Q ss_pred CCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeec
Q 005400 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (698)
Q Consensus 97 ~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqS 137 (698)
++.+||+|+++......+|+|+|+|||||++ ..+|||
T Consensus 69 ~~~~vWss~t~~~~~~~~l~L~ddGNlVly~----~~~W~S 105 (105)
T 4h3o_A 69 SGRSLWASHSTRGSGNYILILQDDGNVIIYG----SDIWST 105 (105)
T ss_dssp TCCEEEECCCCCCSSCEEEEECTTSCEEEEE----SEEEEC
T ss_pred CcEEEEEecCCCCCCCEEEEEeCCCeEEEEC----CcEecC
Confidence 9999999998765566789999999999995 369998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=6.5e-20 Score=160.55 Aligned_cols=109 Identities=18% Similarity=0.357 Sum_probs=93.4
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CC
Q 005400 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (698)
Q Consensus 18 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (698)
+|+|.+||.|.+|++|+ ++|.|+|+|+..++ -++|+ ..++||.||++.|. ..+.+.+.+||+|+| |.
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn------lvl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN------FVLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC------EEEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc------EEEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECC
Confidence 48999999999999999 99999999988775 26676 37999999998763 357899999999999 88
Q ss_pred CCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCC
Q 005400 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPC 142 (698)
Q Consensus 97 ~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PT 142 (698)
++.++|+|++....+...++|+|+|||||++. ++||||+||.
T Consensus 69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP----VVWATGSGPA 110 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS----EEEECSCCC-
T ss_pred CCcEEEecCCCCCCCCEEEEEeCCccEEEECC----CEecCCCcCC
Confidence 89999999986554556899999999999863 7999999984
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=158.81 Aligned_cols=109 Identities=18% Similarity=0.342 Sum_probs=92.1
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CC
Q 005400 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (698)
Q Consensus 18 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (698)
.|||.+||+|.+|++|+ +|.|+|+|+.+++ + ++|+ ..++||+||++.|. .++.|.+.++|+|+| |.
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence 58999999999999998 8999999987764 2 2355 48999999999883 457899999999999 88
Q ss_pred CCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCc
Q 005400 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCD 143 (698)
Q Consensus 97 ~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTD 143 (698)
++.++|+|++.......+++|+|+|||||++. ++||||.++..
T Consensus 69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYGP----VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS----EEECSSTTCBC
T ss_pred CceEEEEcCCCCCCCCEEEEEeCCCeEEEECC----CEEECCCCCCc
Confidence 88999999976444567899999999999952 89999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-19 Score=156.28 Aligned_cols=109 Identities=18% Similarity=0.402 Sum_probs=92.0
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CC
Q 005400 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (698)
Q Consensus 18 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (698)
+|||.+||+|.+|++| ++|.|+|+|+.+++ -+||++ .++||+||++.+ +.++.+.+.++|+|+| |
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn------lvl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN------LVLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc------EEEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 4899999999999999 58999999998876 245764 689999999753 3457899999999999 7
Q ss_pred CCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCC
Q 005400 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHP 141 (698)
Q Consensus 97 ~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~P 141 (698)
++.++|+|++....+...++|+++|||||++.+ +.++||||++.
T Consensus 67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-NNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCCSCCCCEEEECTTSCEEEECTT-SCEEEECCCCC
T ss_pred CCEEEEECCccCCCCCEEEEEeCCCcEEEECCC-CceEEECCCcc
Confidence 888999999765445678999999999999855 67999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=7.2e-18 Score=147.36 Aligned_cols=104 Identities=23% Similarity=0.354 Sum_probs=86.4
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CC
Q 005400 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (698)
Q Consensus 18 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (698)
.+||.|||.|.+|+.|+ +|.|+|.|...++ |.+ |.. .++||++|++.+ +..+.|.+.+||+|+| |.
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~ 67 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSP 67 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECC
Confidence 36899999999999997 7999999988775 333 554 689999999876 3457899999999999 88
Q ss_pred CCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeecc
Q 005400 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSF 138 (698)
Q Consensus 97 ~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSF 138 (698)
++.++|++++.......+|+|+|+|||||++. ++|||=
T Consensus 68 ~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~----~~W~s~ 105 (109)
T 3dzw_A 68 RNNPIWASNTGGENGNYVCVLQKDRNVVIYGT----ARWATG 105 (109)
T ss_dssp TSCEEEECCCCCSSSCEEEEECTTSCEEEEES----CCCCCC
T ss_pred CCCEEEECCCCCCCCCEEEEEeCCCEEEEECC----CEEeCC
Confidence 88999999986544456899999999999963 799983
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8.8e-18 Score=171.25 Aligned_cols=136 Identities=16% Similarity=0.180 Sum_probs=105.2
Q ss_pred ccccCceeeecceeEEEEEe-ccccE--EEEEEecCCCCc------------------------chHHHHHHHHHHhhcC
Q 005400 475 FASYNKLGEGGFGPVYKGTL-VEGQE--IAVKRLSKGSGQ------------------------GMEEFKNEVTLIARLQ 527 (698)
Q Consensus 475 f~~~~~LG~G~fG~Vy~g~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~Ei~il~~l~ 527 (698)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67888 999987543111 0135788999999998
Q ss_pred CCee--eeEEEEEEeCCeeEEEEEecCC-C----ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeec
Q 005400 528 HRNL--VKLLGCCIQADESMLIYEYMPN-K----SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH-QDSRMRIIHR 599 (698)
Q Consensus 528 H~nI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~ 599 (698)
|+++ +.++.. ...+|||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8754 444432 356899999942 4 56555422 123456789999999999999 887 9999
Q ss_pred CCCCCCEEEcCCCceEEeecCCCccc
Q 005400 600 DLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 600 Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
||||.|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=139.15 Aligned_cols=104 Identities=20% Similarity=0.317 Sum_probs=84.2
Q ss_pred ccccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-
Q 005400 16 AANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL- 94 (698)
Q Consensus 16 ~~~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l- 94 (698)
.+.|||.|||.|.+|+.|+|. .|.|-|...++ |.+ |.. ++||.+|++.. +..+.+.+.++|+|++
T Consensus 4 ~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred cccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 578999999999999999985 58886655543 455 543 48999999762 3456899999999999
Q ss_pred CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeec
Q 005400 95 DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (698)
Q Consensus 95 ~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqS 137 (698)
|.++.++|++++.......+|+|+|+|||||++ ..+|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~----~~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG----PAIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec----CCEecC
Confidence 888999999998644445789999999999996 479997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.65 E-value=8.8e-16 Score=134.83 Aligned_cols=107 Identities=19% Similarity=0.248 Sum_probs=87.8
Q ss_pred ccccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-
Q 005400 16 AANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL- 94 (698)
Q Consensus 16 ~~~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l- 94 (698)
.+.|+|.+||.|.+|+.|.+ |.|.|-|...++ |.++.. ...++||.+|+..+ +....+.+.++|+|++
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~--~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG--SKTNIVWESGTSGR--GQHCFMRLGHSGELDIT 72 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET--TTTEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC--CCCEEEEECCcccC--CcCEEEEEeCCCcEEEE
Confidence 47899999999999999975 889998876665 566432 14789999999865 3357899999999999
Q ss_pred CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeec
Q 005400 95 DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (698)
Q Consensus 95 ~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqS 137 (698)
|.++.++|++++.......+|+|+|+|||||++ ..+|+|
T Consensus 73 d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~----~~~W~s 111 (113)
T 3mez_B 73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG----PAVWST 111 (113)
T ss_dssp CTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred CCCCCEEEECCCcCCCCCEEEEEcCCceEEEec----CCEecC
Confidence 888899999998654445789999999999996 579997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.64 E-value=6.3e-16 Score=135.81 Aligned_cols=96 Identities=20% Similarity=0.363 Sum_probs=77.7
Q ss_pred CCCCCCCcceEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecc
Q 005400 75 TPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGR 153 (698)
Q Consensus 75 ~p~~~~~~~l~~~~~g~l~l-~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~ 153 (698)
.|+.+....|.++.||+|++ +. ++++|++++.....+.+|+|+|+|||||++ + +.++||||+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~-~~~~W~S~~-------------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G-SRAIWASNT-------------- 76 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T-TEEEEECCC--------------
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C-CEEEEECCc--------------
Confidence 34444467899999999988 55 889999998644445789999999999998 5 789999993
Q ss_pred cccCCCceeEEeeccCCCCCCCceEEeecCCCCceEEEec-CcEEEEeeCCCCC
Q 005400 154 NFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRK-GSVLQYRAGSWNG 206 (698)
Q Consensus 154 ~~~~g~~~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~-~~~~~~~~g~w~~ 206 (698)
||++|.|++.++++|+ ++++. +...+|++++|+|
T Consensus 77 -----------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -----------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp -----------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred -----------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999998 44554 5678999999986
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=132.67 Aligned_cols=88 Identities=24% Similarity=0.338 Sum_probs=73.0
Q ss_pred CCcceEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCC
Q 005400 80 QSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTG 158 (698)
Q Consensus 80 ~~~~l~~~~~g~l~l-~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g 158 (698)
...+|.++.||+|+| + .+++||++|+.....+.+++|+|+|||||++.+ +.++||||
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-~~~~W~S~-------------------- 77 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-NRVIWQTK-------------------- 77 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-CCEEEECC--------------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-CcEEEecC--------------------
Confidence 356899999999999 6 589999999865445678999999999999976 78999999
Q ss_pred CceeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCCC
Q 005400 159 MDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSW 204 (698)
Q Consensus 159 ~~~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~w 204 (698)
+++++|.|++.++++|+ ++++++ .||+++++
T Consensus 78 -----------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 -----------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp -----------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred -----------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35667999999999997 455665 79998864
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.8e-15 Score=129.81 Aligned_cols=107 Identities=21% Similarity=0.383 Sum_probs=86.3
Q ss_pred cccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-C
Q 005400 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-D 95 (698)
Q Consensus 17 ~~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~ 95 (698)
|+|||.|||.|.+|+.| .+|.|.|.|...++ |-+ |.. +|.+|+..+ +....|.+.+||+|++ |
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG------NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT------TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC------eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 78999999999999999 57999999977665 223 432 699998764 3457899999999999 8
Q ss_pred CCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCC
Q 005400 96 GRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPG 148 (698)
Q Consensus 96 ~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg 148 (698)
.++.++|++++.......+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~----~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG----PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC----SEEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe----cCEECC-----CCccCC
Confidence 88899999998644345689999999999995 579998 555553
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=7.2e-16 Score=163.77 Aligned_cols=136 Identities=13% Similarity=0.174 Sum_probs=99.5
Q ss_pred CccccCceeeecceeEEEEEeccccEEEEEEecCCCC--------------cchHH--------HHHHHHHHhhcCCCee
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--------------QGMEE--------FKNEVTLIARLQHRNL 531 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~--------------~~~~~--------~~~Ei~il~~l~H~nI 531 (698)
-|.+.+.||+|++|.||+|...+|+.||||+++.... ..... ...|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3888999999999999999998999999998754210 00111 2346666666654443
Q ss_pred e--eEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 532 V--KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 532 v--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
. ..+.. . ..+|||||+++++|..+.. ......++.|++.+|.+||+.+ ||||||||.|||++
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 2 22322 2 3479999999988854421 1123467899999999999998 99999999999998
Q ss_pred CCC----------ceEEeecCCCccc
Q 005400 610 NDM----------NPKISDFGMARIF 625 (698)
Q Consensus 610 ~~~----------~~kl~DFgla~~~ 625 (698)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 3899999987654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.55 E-value=2.1e-14 Score=127.16 Aligned_cols=85 Identities=19% Similarity=0.246 Sum_probs=70.4
Q ss_pred cceEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCc
Q 005400 82 GLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (698)
Q Consensus 82 ~~l~~~~~g~l~l-~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~ 160 (698)
..|.+..||+|++ +. +++||++|+.....+..|+|+|+|||||++.+ +.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~-~~~lW~S~---------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-NVTVWQSP---------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-CCEEEECS----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC-CcEEEcCC----------------------
Confidence 4688899999988 54 89999999864444678999999999999876 78999999
Q ss_pred eeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCC
Q 005400 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (698)
Q Consensus 161 ~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (698)
+||++|.|++.++++|+ ++++. ..||++|+
T Consensus 88 ---------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 ---------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp ---------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred ---------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999998 45555 37999875
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=4.1e-14 Score=124.72 Aligned_cols=91 Identities=24% Similarity=0.337 Sum_probs=73.9
Q ss_pred CcceEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCc
Q 005400 81 SGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (698)
Q Consensus 81 ~~~l~~~~~g~l~l~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~ 160 (698)
...|.+..||+|+|-..++++|++|+.....+..++|+++|||||++.+ +.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-~~~vW~S~~~-------------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-NNDVWGSACW-------------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEETTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-CCEEEECCCC--------------------
T ss_pred CEEEEEcCCCcEEEEeCCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-ceEEEEcCCC--------------------
Confidence 4568889999998832588999999764444578999999999999876 7899999997
Q ss_pred eeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCCCCCC
Q 005400 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGL 207 (698)
Q Consensus 161 ~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~w~~~ 207 (698)
+++|.|++.++++|+ +++++. .+|++++|...
T Consensus 80 -----------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 -----------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -----------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 346889999999997 455654 79999999754
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.43 E-value=4.3e-13 Score=117.15 Aligned_cols=102 Identities=13% Similarity=0.233 Sum_probs=80.6
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CC
Q 005400 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (698)
Q Consensus 18 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (698)
+|+|.|||.|.+|+.|. +|.|.|-|...++ |.+ |.. .. +|.+|+..+ +....+.+.++|+|++ +.
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence 58999999999999994 7899999976665 333 442 23 999999766 3357899999999999 77
Q ss_pred CCc-eEEeeccCC--CCCCcEEEEeccceEEEecCCCCceeeec
Q 005400 97 RDR-IFWSSNTSI--TMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (698)
Q Consensus 97 ~~~-~~ws~~~~~--~~~~~~~~l~d~GNlvl~~~~~~~~~WqS 137 (698)
++. ++|+|++.. .....+++|+|+|||||++ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG----PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC----SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec----cCEEcc
Confidence 665 599999642 2245689999999999995 579998
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-11 Score=107.80 Aligned_cols=94 Identities=20% Similarity=0.287 Sum_probs=71.3
Q ss_pred CCCCCCCCcceEEecCceEEe-CC-CCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCee
Q 005400 74 ETPLTDQSGLLNVTSKGIVLL-DG-RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKL 151 (698)
Q Consensus 74 ~~p~~~~~~~l~~~~~g~l~l-~~-~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l 151 (698)
+.|+......|.++.||+|+| +. .+.++|++++.....+..++|+++|||||++.+ +.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-~~~iW~S~t~----------- 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-LNTVFVSNTV----------- 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-SCEEEECSCC-----------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-CCEEEECCCc-----------
Confidence 345555567899999999999 66 589999999864444678999999999999876 6789998221
Q ss_pred cccccCCCceeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCC
Q 005400 152 GRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (698)
Q Consensus 152 ~~~~~~g~~~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (698)
...|.|.+.++.+|+..++ + ...|.+|+
T Consensus 86 --------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 --------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp --------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred --------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0125589999999987655 3 46788764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.3e-11 Score=123.67 Aligned_cols=146 Identities=17% Similarity=0.100 Sum_probs=114.1
Q ss_pred HhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEE
Q 005400 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 470 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~ 548 (698)
...+.|.+...++.|+.+.||+... .++.+++|+...........+.+|+++++.+. |..+.++++++......++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3446788778888889999999975 47899999986532223356889999999884 678889999999888999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD------------------------------------- 591 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------- 591 (698)
||++|.+|...+. +......++.+++++|+.||+.
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876531 1112346788999999999982
Q ss_pred -------------------CCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 592 -------------------SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 592 -------------------~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
....++|+|++|.|||++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113489999999999998766677999998754
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.19 E-value=5.1e-11 Score=103.89 Aligned_cols=93 Identities=14% Similarity=0.179 Sum_probs=68.8
Q ss_pred CCCCCCcceEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeeccc
Q 005400 76 PLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRN 154 (698)
Q Consensus 76 p~~~~~~~l~~~~~g~l~l-~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~ 154 (698)
++......|.++.||+|+| +.++ +|++++........++|+++|||||++.+.+.++|||..+
T Consensus 16 ~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~-------------- 79 (111)
T 3mez_A 16 QLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS-------------- 79 (111)
T ss_dssp EEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS--------------
T ss_pred EEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc--------------
Confidence 3444456799999999999 5555 9999986544457899999999999987734469999621
Q ss_pred ccCCCceeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCC
Q 005400 155 FKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (698)
Q Consensus 155 ~~~g~~~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (698)
.....|.|.+.++.+|+..++ . ..+|.++.
T Consensus 80 ---------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 ---------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp ---------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred ---------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011347899999999987655 3 56787763
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=4.1e-11 Score=122.03 Aligned_cols=112 Identities=16% Similarity=0.300 Sum_probs=86.6
Q ss_pred ccccccCCCCc----cCCCCEEEeCCCeEEEeeeCCC--CCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecC
Q 005400 16 AANDNITPSQS----IRDGETLVSVNGTFELGFFSPG--TSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSK 89 (698)
Q Consensus 16 ~~~~~~~~~~~----l~~~~~l~s~~g~f~~gf~~~~--~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~ 89 (698)
..+|||.||+. |..|+.|.| ..+++.|+|... .....+ + |.+ ..+++|.+++..+- ...+.++.+
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S-~~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~~---~~~l~l~~d 204 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQ-GVVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGKG---AVRAVFQGD 204 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECT-TCEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTTT---CCEEEECTT
T ss_pred ccccccccccccccccccCccccc-CCCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCCc---cEEEEEcCC
Confidence 56799999999 889999865 457777776542 222333 3 322 36899999998762 268999999
Q ss_pred ceEEe-CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCC
Q 005400 90 GIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (698)
Q Consensus 90 g~l~l-~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~ 140 (698)
|+|++ |.++.++|++++... ...+|+|+++|||||++. +++||||||
T Consensus 205 GnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~---~~~Wqsf~~ 252 (276)
T 3m7h_A 205 GNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE---KPVWARFGF 252 (276)
T ss_dssp SCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred CeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence 99988 777889999997643 457899999999999974 589999997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=2e-10 Score=116.10 Aligned_cols=139 Identities=17% Similarity=0.176 Sum_probs=101.9
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe--eeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~~~~~~~~~~~lV~E 549 (698)
..++.+....+.|..+.||+....+|+.+++|..... ....+..|+++++.+.+.+ +.+++++...+...++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445543333455669999998777888999997543 2356788999999886544 5568888887778899999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS------------------------------------- 592 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 592 (698)
|+++.++. ... .+ ...++.++++.|+.||+..
T Consensus 96 ~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 211 11 1256677788888888643
Q ss_pred ------------------CCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 593 ------------------RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 593 ------------------~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999999764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.05 E-value=5.4e-10 Score=97.23 Aligned_cols=84 Identities=21% Similarity=0.392 Sum_probs=64.0
Q ss_pred CcceEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCC
Q 005400 81 SGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (698)
Q Consensus 81 ~~~l~~~~~g~l~l-~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~ 159 (698)
...|.++.||+|+| +. .++|++++........++|+|+|||||++.+ +.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-~~~iW~S~t~~------------------ 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-FKTIWSSRSSS------------------ 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT-CCEEEECCCCC------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-CCEEEEcCCcC------------------
Confidence 45788999999999 44 6899999865444568999999999999876 68999984210
Q ss_pred ceeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeC
Q 005400 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (698)
Q Consensus 160 ~~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g 202 (698)
..|.|.+.++.+|+..++ + ...|.+|
T Consensus 84 -------------~~~~~~~~L~~dGNlvly--~--~~~W~t~ 109 (110)
T 3r0e_B 84 -------------KQGEYVLILQDDGFGVIY--G--PAIFETS 109 (110)
T ss_dssp -------------SSSCCEEEECTTSCEEEE--C--SEEEESC
T ss_pred -------------CCCCEEEEEcCCccEEEe--c--CCEecCC
Confidence 124588999999987654 3 3578765
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.01 E-value=8.3e-10 Score=95.84 Aligned_cols=90 Identities=22% Similarity=0.406 Sum_probs=67.7
Q ss_pred CCCCCCCcceEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecc
Q 005400 75 TPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGR 153 (698)
Q Consensus 75 ~p~~~~~~~l~~~~~g~l~l-~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~ 153 (698)
.|+......|.++.||+|+| ++ +|++++.....+..++|+++|||||++.+ +.++|+|-.
T Consensus 16 ~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-~~~vWss~t-------------- 76 (109)
T 3r0e_A 16 GHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD-GSTVWKSGA-------------- 76 (109)
T ss_dssp CEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT-SCEEEECCC--------------
T ss_pred CEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-CCEEEcCCC--------------
Confidence 34444456799999999999 53 79999875445678999999999999876 678997621
Q ss_pred cccCCCceeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCCC
Q 005400 154 NFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSW 204 (698)
Q Consensus 154 ~~~~g~~~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~w 204 (698)
....+.|.+.++++|+..++ . ...|.+++|
T Consensus 77 -----------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 -----------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp -----------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred -----------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 00235689999999976654 3 568999876
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=1.2e-09 Score=95.04 Aligned_cols=86 Identities=16% Similarity=0.259 Sum_probs=64.4
Q ss_pred CcceEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCc
Q 005400 81 SGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (698)
Q Consensus 81 ~~~l~~~~~g~l~l~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~ 160 (698)
...|.+..||+|+|-..+.++|++++.....+..++|+++|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-~~~~W~S~t~~------------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-NNPIWASNTGG------------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEETTEEEEECCCTTSSSSCEEEECTTSCEEEECTT-SCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEeCCEEEEECCcccCCCCEEEEEeCCCCEEEECCC-CCEEEECCCCC-------------------
Confidence 4568899999999933378999999865434578999999999999876 68999984311
Q ss_pred eeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeC
Q 005400 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (698)
Q Consensus 161 ~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g 202 (698)
..+.|.+.++.+|+..++ +. ..|.++
T Consensus 80 ------------~~~~~~~~L~ddGNlvly--~~--~~W~s~ 105 (109)
T 3dzw_A 80 ------------ENGNYVCVLQKDRNVVIY--GT--ARWATG 105 (109)
T ss_dssp ------------SSSCEEEEECTTSCEEEE--ES--CCCCCC
T ss_pred ------------CCCCEEEEEeCCCEEEEE--CC--CEEeCC
Confidence 125688999999987654 32 456554
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.9e-09 Score=112.37 Aligned_cols=142 Identities=17% Similarity=0.248 Sum_probs=106.4
Q ss_pred ccCceeeecceeEEEEEeccccEEEEEEec--CCC-CcchHHHHHHHHHHhhcC--CCeeeeEEEEEEeC---CeeEEEE
Q 005400 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLS--KGS-GQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQA---DESMLIY 548 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~--~~~-~~~~~~~~~Ei~il~~l~--H~nIv~l~~~~~~~---~~~~lV~ 548 (698)
.++.|+.|.+..||+.... ++.+++|+.. ... ......+.+|+++++.+. +..+++++.++.+. ...++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567999999999999874 5678888875 321 123457888999999997 45678889888766 3489999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS------------------------------------ 592 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 592 (698)
||+++..+.+.. ...++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774321 123677888889999999999999731
Q ss_pred -------------------CCceeecCCCCCCEEEcCCCc--eEEeecCCCcc
Q 005400 593 -------------------RMRIIHRDLKASNVLLDNDMN--PKISDFGMARI 624 (698)
Q Consensus 593 -------------------~~~ivH~Dlkp~NILl~~~~~--~kl~DFgla~~ 624 (698)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=4.3e-09 Score=109.34 Aligned_cols=183 Identities=20% Similarity=0.258 Sum_probs=121.0
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCe--eeeEEEEEEeCC---eeEEEEEec
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRN--LVKLLGCCIQAD---ESMLIYEYM 551 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~n--Iv~l~~~~~~~~---~~~lV~E~~ 551 (698)
++.++.|....||+.. +.+++|+.... .....+.+|.++++.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999873 56888886432 34567889999998873 333 344544433332 347899999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD---------------------------------------- 591 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 591 (698)
+|..+...... .++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99988654321 256667778888888888888862
Q ss_pred ---------------CCCceeecCCCCCCEEEcC--CCceEEeecCCCcccCCCccccccccccccccc---cChhcccC
Q 005400 592 ---------------SRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY---MSPEYAAE 651 (698)
Q Consensus 592 ---------------~~~~ivH~Dlkp~NILl~~--~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y---~APE~l~~ 651 (698)
....++|+|++|.||++++ ...+.|+||+.+..-... .. ....... ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~D-----l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-ND-----FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HH-----HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HH-----HHHHHhhccccCHHHHHH
Confidence 1235899999999999998 556889999998653211 00 0000011 12221110
Q ss_pred -----CCC---------CcchhHHHHHHHHHHHHhCCCCC
Q 005400 652 -----GLF---------SVKSDVFSFGVLVLEIVSGKKNW 677 (698)
Q Consensus 652 -----~~~---------~~k~DVwSlGvil~elltG~~pf 677 (698)
+.. ....+.|+++.++|++.+|+.+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12268999999999999999876
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.78 E-value=2.4e-08 Score=85.87 Aligned_cols=77 Identities=22% Similarity=0.332 Sum_probs=59.7
Q ss_pred cceEEecCceEEeCCCCceEEeeccCCC-CCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCc
Q 005400 82 GLLNVTSKGIVLLDGRDRIFWSSNTSIT-MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (698)
Q Consensus 82 ~~l~~~~~g~l~l~~~~~~~ws~~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~ 160 (698)
-+|.+..||+|+|-..+.+||++|+... ..+..++|.++|||||+|.+ ++++|+|=.
T Consensus 21 y~l~~q~DgNLvly~~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-~~~vWss~t--------------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-GRSLWASHS--------------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-CCEEEECCC---------------------
T ss_pred EEEEECCCCeEEEEECCEEEEEecCCCCCCccEEEEEeCCccEEEECCC-cEEEEEecC---------------------
Confidence 3578999999999556789999997532 24568999999999999987 788998711
Q ss_pred eeEEeeccCCCCCCCceEEeecCCCCceEE
Q 005400 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLV 190 (698)
Q Consensus 161 ~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~ 190 (698)
....+.|.+.++.+|+..++
T Consensus 79 ----------~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 ----------TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ----------CCCSSCEEEEECTTSCEEEE
T ss_pred ----------CCCCCCEEEEEeCCCeEEEE
Confidence 11346789999999987654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.62 E-value=5e-08 Score=97.24 Aligned_cols=85 Identities=19% Similarity=0.289 Sum_probs=63.6
Q ss_pred CcceEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCC
Q 005400 81 SGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (698)
Q Consensus 81 ~~~l~~~~~g~l~l-~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~ 159 (698)
.-.|.++.+|+|+| ++ +.++|++++.......+++|+++||||+++.+ +.++||||.+
T Consensus 151 ~~~l~l~~dG~LvL~~~-~~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~-~~~vw~s~~~------------------- 209 (236)
T 1dlp_A 151 PYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ-NIAVWTSGNS------------------- 209 (236)
T ss_dssp SCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-TEEEEECCCC-------------------
T ss_pred cEEEEECCCCcEEEEcC-CEeEEeCCCcCCCCceEEEECCCCcEEEEeCC-CcEEEEeCCC-------------------
Confidence 45688999999988 44 46899998754334567899999999999865 6899999943
Q ss_pred ceeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeC
Q 005400 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (698)
Q Consensus 160 ~~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g 202 (698)
| ++|.|++.+|++|.++++ .. .||.+|
T Consensus 210 ------~------~~~~~rl~Ld~dG~l~ly--~~--~~W~sg 236 (236)
T 1dlp_A 210 ------R------SAGRYVFVLQPDRNLAIY--GG--ALWTTG 236 (236)
T ss_dssp ------C------SSSCCEEEECSSSCEEEE--CC--CCCBC-
T ss_pred ------C------CCCCEEEEEcCCCcEEEe--CC--CCccCC
Confidence 1 236799999999987765 22 566553
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=6e-06 Score=85.59 Aligned_cols=135 Identities=21% Similarity=0.171 Sum_probs=91.9
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCC---eeeeEEEEEE-eCCeeEEEEEecCCC
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR---NLVKLLGCCI-QADESMLIYEYMPNK 554 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~---nIv~l~~~~~-~~~~~~lV~E~~~~g 554 (698)
+.++.|....||+. ++.+++|+-.. ......+..|.++|..+.+. .+.+++.+.. .....++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46788888899988 67788888532 23456789999999999642 3566666664 334578999999998
Q ss_pred ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 005400 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD------------------------------------------- 591 (698)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 591 (698)
.+...... .++..+...++.++++.|+.||+.
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88653211 123333444444444444444432
Q ss_pred --------------CCCceeecCCCCCCEEEcC---CCc-eEEeecCCCcc
Q 005400 592 --------------SRMRIIHRDLKASNVLLDN---DMN-PKISDFGMARI 624 (698)
Q Consensus 592 --------------~~~~ivH~Dlkp~NILl~~---~~~-~kl~DFgla~~ 624 (698)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999987 455 58999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=5.3e-06 Score=84.08 Aligned_cols=135 Identities=18% Similarity=0.184 Sum_probs=97.4
Q ss_pred ceeeecce-eEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 480 KLGEGGFG-PVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 480 ~LG~G~fG-~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
.+..|..+ .||+.... ++..+++|+-.. .....+.+|.+.|+.+. +--+.+++.++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987764 356788988643 23456788999998874 44577889999999999999999999888
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD--------------------------------------------- 591 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 591 (698)
........ .....+..++++.|+.||..
T Consensus 108 ~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 76543211 12234556666667777643
Q ss_pred ----------CCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 592 ----------SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 592 ----------~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112389999999999999887778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=4.8e-06 Score=88.15 Aligned_cols=80 Identities=6% Similarity=-0.014 Sum_probs=55.8
Q ss_pred cCce-eeecceeEEEEEec-------cccEEEEEEecCCC---CcchHHHHHHHHHHhhcC-C--CeeeeEEEEEEeC--
Q 005400 478 YNKL-GEGGFGPVYKGTLV-------EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQ-H--RNLVKLLGCCIQA-- 541 (698)
Q Consensus 478 ~~~L-G~G~fG~Vy~g~~~-------~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~-H--~nIv~l~~~~~~~-- 541 (698)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+++++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78889999998764 26788888764322 111246788999888884 2 3567788877654
Q ss_pred -CeeEEEEEecCCCChh
Q 005400 542 -DESMLIYEYMPNKSLD 557 (698)
Q Consensus 542 -~~~~lV~E~~~~gsL~ 557 (698)
...++|||++++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 2468999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=4.6e-05 Score=81.88 Aligned_cols=75 Identities=9% Similarity=0.190 Sum_probs=50.4
Q ss_pred cCceeeecceeEEEEEec-cccEEEEEEecCCCC-------cchHHHHHHHHHHhhcCC--Ce-eeeEEEEEEeCCeeEE
Q 005400 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-------QGMEEFKNEVTLIARLQH--RN-LVKLLGCCIQADESML 546 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-------~~~~~~~~Ei~il~~l~H--~n-Iv~l~~~~~~~~~~~l 546 (698)
.+.||.|..+.||++... +++.+++|....... ...+.+..|.++++.+.+ +. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999764 468899998653211 223456789999887742 33 3455543 4556789
Q ss_pred EEEecCCC
Q 005400 547 IYEYMPNK 554 (698)
Q Consensus 547 V~E~~~~g 554 (698)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00014 Score=74.33 Aligned_cols=79 Identities=18% Similarity=0.235 Sum_probs=58.7
Q ss_pred CccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-C--CeeeeEEEEEEeCCeeEEEEEe
Q 005400 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-H--RNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H--~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
....++.+|.|..+.||+.++.+|+.+++|+...........|..|.+.|+.+. . .-+.++++. . ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 455567899999999999999999999999876554444456888999988874 2 234455544 2 34789999
Q ss_pred cCCCCh
Q 005400 551 MPNKSL 556 (698)
Q Consensus 551 ~~~gsL 556 (698)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00016 Score=75.47 Aligned_cols=141 Identities=13% Similarity=0.169 Sum_probs=79.8
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-----CCeeeeEE-E--EEEeCCeeEEEEEe
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----HRNLVKLL-G--CCIQADESMLIYEY 550 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-----H~nIv~l~-~--~~~~~~~~~lV~E~ 550 (698)
+.|+.|....||+....+| .+++|+.... ...+..|.+++..+. .|.++... | +.......+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987544 5899988652 233445555555543 34444310 0 12346678899999
Q ss_pred cCCCChh-----------HH---Hhhccc-c----------CCCCHHHHH------------------------------
Q 005400 551 MPNKSLD-----------FF---IFDQAR-A----------TFLDWQKRI------------------------------ 575 (698)
Q Consensus 551 ~~~gsL~-----------~~---l~~~~~-~----------~~l~~~~~~------------------------------ 575 (698)
+++..+. .. ++.... . ....|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987542 01 111100 0 012232210
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 576 -HIVGGIARGILYLHQ----------DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 576 -~i~~~ia~gL~yLH~----------~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
.+...+.+++.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223345666653 1234599999999999998888999999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00039 Score=71.88 Aligned_cols=139 Identities=19% Similarity=0.135 Sum_probs=93.1
Q ss_pred ccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcC---CCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~---H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
..+.|+.|....+|+... +++.+++|+.... ....+..|.+.|+.+. ...+.+++.+.......++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999986 5778899987532 3566888999888873 36788889888878889999999998
Q ss_pred CChhH--------H---Hhhccc-c------------------CCCCHHHHH---HHHH----------------HHHHH
Q 005400 554 KSLDF--------F---IFDQAR-A------------------TFLDWQKRI---HIVG----------------GIARG 584 (698)
Q Consensus 554 gsL~~--------~---l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~g 584 (698)
..+.. . |+.... . -.-+|.+.. ++.. .++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 86521 1 111111 0 012454332 1111 11111
Q ss_pred -HHHHHh-CCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 585 -ILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 585 -L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
...|.. ..++.++|+|+.+.|++++.++ +.|+|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223422 2356799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00054 Score=74.10 Aligned_cols=80 Identities=11% Similarity=0.046 Sum_probs=46.5
Q ss_pred CCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCC---CCCcchhHHHHHHHHHH
Q 005400 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG---LFSVKSDVFSFGVLVLE 669 (698)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~k~DVwSlGvil~e 669 (698)
...++|+|++|.|||++.++ ++|+||+.+..-.. .......-..-...|.+|+..... ......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH-HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch-HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34599999999999998776 99999998865211 100000000012345666554311 11223455677777777
Q ss_pred HHhCC
Q 005400 670 IVSGK 674 (698)
Q Consensus 670 lltG~ 674 (698)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00086 Score=68.87 Aligned_cols=138 Identities=12% Similarity=0.128 Sum_probs=76.5
Q ss_pred cCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCee-eeEEEEEEeCCeeEEEEEec-CCCC
Q 005400 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEYM-PNKS 555 (698)
Q Consensus 478 ~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nI-v~l~~~~~~~~~~~lV~E~~-~~gs 555 (698)
++.|+.|....+|+. +.+++|+....... ......|+++++.+...++ .++++. .....++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 568999999999998 56888887653221 1233568877777643223 455544 344467899999 6655
Q ss_pred hhHHH------------------hhccc--cCCCC-HHHHHHHHH--------------HHHHHH----HHHHh-CCCCc
Q 005400 556 LDFFI------------------FDQAR--ATFLD-WQKRIHIVG--------------GIARGI----LYLHQ-DSRMR 595 (698)
Q Consensus 556 L~~~l------------------~~~~~--~~~l~-~~~~~~i~~--------------~ia~gL----~yLH~-~~~~~ 595 (698)
+.... +.... ..... +..+..+.. .+.+.+ ..|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 53210 00000 00001 111111100 011111 11111 22345
Q ss_pred eeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 596 IIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 596 ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 6667889999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0007 Score=73.37 Aligned_cols=72 Identities=19% Similarity=0.297 Sum_probs=49.3
Q ss_pred CceeeecceeEEEEEecc--------ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCee-eeEEEEEEeCCeeEEEEE
Q 005400 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYE 549 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nI-v~l~~~~~~~~~~~lV~E 549 (698)
+.|+.|....+|+....+ ++.+++|+.... ...+.+..|..++..+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 568888889999998753 478999988432 112556689999888853333 55666543 2 38999
Q ss_pred ecCCCCh
Q 005400 550 YMPNKSL 556 (698)
Q Consensus 550 ~~~~gsL 556 (698)
|+++..+
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0043 Score=64.56 Aligned_cols=141 Identities=16% Similarity=0.142 Sum_probs=72.3
Q ss_pred Cceeeeccee-EEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCC--CeeeeEEEEEEeCCeeEEEEEecCCCC
Q 005400 479 NKLGEGGFGP-VYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQADESMLIYEYMPNKS 555 (698)
Q Consensus 479 ~~LG~G~fG~-Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H--~nIv~l~~~~~~~~~~~lV~E~~~~gs 555 (698)
+.|+.|.... +|+....+++.+++|....... +.+..|++++..+.. -.+.+++.+. ....+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCcc
Confidence 4566555444 6677654467777776533211 334556776666632 2355666653 233378999998766
Q ss_pred hhHHHhhcc---------------------c--cCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 005400 556 LDFFIFDQA---------------------R--ATFLDWQKRI-------H-------------IVGGIARGILYLH--- 589 (698)
Q Consensus 556 L~~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 589 (698)
+...+.... . ....+..... . ....+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 644332100 0 0111111100 0 0011112222221
Q ss_pred hCCCCceeecCCCCCCEEEcCC----CceEEeecCCCcc
Q 005400 590 QDSRMRIIHRDLKASNVLLDND----MNPKISDFGMARI 624 (698)
Q Consensus 590 ~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFgla~~ 624 (698)
......++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1224569999999999999875 6899999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0035 Score=68.30 Aligned_cols=73 Identities=14% Similarity=0.129 Sum_probs=47.9
Q ss_pred CceeeecceeEEEEEecc-ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCee-eeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nI-v~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
+.|+.|-...+|+....+ ++.+++|+....... .-.-..|..++..+...++ .++++.+ .+ .+|+||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 578888889999998754 478889887543211 1122578999988865445 4567665 22 359999987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0015 Score=69.36 Aligned_cols=141 Identities=18% Similarity=0.220 Sum_probs=82.0
Q ss_pred CceeeecceeEEEEEec--------cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe-eeeEEEEEEeCCeeEEEEE
Q 005400 479 NKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-LVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~--------~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n-Iv~l~~~~~~~~~~~lV~E 549 (698)
+.|..|-...+|+.... +++.+++|+.... ........+|.++++.+...+ ..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888889998864 2478999986332 234566778999998874222 3556666532 29999
Q ss_pred ecCCCChhHH--------------H---hhc--cccCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 005400 550 YMPNKSLDFF--------------I---FDQ--ARATFLD--WQKRIHIVGGIAR-------------------GILY-- 587 (698)
Q Consensus 550 ~~~~gsL~~~--------------l---~~~--~~~~~l~--~~~~~~i~~~ia~-------------------gL~y-- 587 (698)
|+++..|..- | +.. ...+... +..+.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 0 000 0011122 3444444433321 2222
Q ss_pred --HHh-CCCCceeecCCCCCCEEEcCC----CceEEeecCCCcc
Q 005400 588 --LHQ-DSRMRIIHRDLKASNVLLDND----MNPKISDFGMARI 624 (698)
Q Consensus 588 --LH~-~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFgla~~ 624 (698)
|.. ..+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 322 123469999999999999876 7899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.012 Score=60.68 Aligned_cols=143 Identities=16% Similarity=0.134 Sum_probs=79.0
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe--eeeEEEE------EEeCCeeEEEEEe
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGC------CIQADESMLIYEY 550 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~~~------~~~~~~~~lV~E~ 550 (698)
+.|+.|....+|+....+| .+++|+.... ...+.+..|++++..+...+ +.+++.. .......+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788889999987544 6889988652 12234566777776663211 2233211 1234567899999
Q ss_pred cCCCChhH----H----------Hhhcc-c--c---CCC---CHHHHHH------------HHHHHHHHHHHHHhC----
Q 005400 551 MPNKSLDF----F----------IFDQA-R--A---TFL---DWQKRIH------------IVGGIARGILYLHQD---- 591 (698)
Q Consensus 551 ~~~gsL~~----~----------l~~~~-~--~---~~l---~~~~~~~------------i~~~ia~gL~yLH~~---- 591 (698)
+++..+.. . ++... . . ... .|..... +...+.+.++.+++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 0 11100 0 0 001 1322110 001134445555532
Q ss_pred CCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 592 ~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
.+..++|+|+++.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234699999999999999876668999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0082 Score=62.10 Aligned_cols=142 Identities=13% Similarity=0.129 Sum_probs=81.3
Q ss_pred CceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCC--eeeeEEEE-----EEeCCeeEEEEEec
Q 005400 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR--NLVKLLGC-----CIQADESMLIYEYM 551 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~--nIv~l~~~-----~~~~~~~~lV~E~~ 551 (698)
+.++ |....||+....+|+.+++|...... ...+.+..|.+++..+... .+++++.. .......++++|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77889999887677789999986331 2345677788888777421 23444432 12345567899999
Q ss_pred CCCChh----HH----------Hhhcc------ccCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 005400 552 PNKSLD----FF----------IFDQA------RATFLDWQKR----IHI---------------VGGIARGILYLHQ-- 590 (698)
Q Consensus 552 ~~gsL~----~~----------l~~~~------~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~-- 590 (698)
++..+. .. ++... .....++... ..+ ...+.+.++.+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 886542 00 11100 0111222211 001 0111122223321
Q ss_pred --CCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 591 --DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 591 --~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0031 Score=66.70 Aligned_cols=73 Identities=14% Similarity=0.149 Sum_probs=44.2
Q ss_pred CceeeecceeEEEEEeccc---------cEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe-eeeEEEEEEeCCeeEEEE
Q 005400 479 NKLGEGGFGPVYKGTLVEG---------QEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-LVKLLGCCIQADESMLIY 548 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g---------~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n-Iv~l~~~~~~~~~~~lV~ 548 (698)
+.|+.|....+|+....++ +.+++|+..... ........|.++++.+...+ ..++++.. . -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4677888889999986542 688888875432 22223467888888774333 34566543 2 37899
Q ss_pred EecCCCCh
Q 005400 549 EYMPNKSL 556 (698)
Q Consensus 549 E~~~~gsL 556 (698)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987644
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.58 E-value=0.076 Score=55.24 Aligned_cols=32 Identities=28% Similarity=0.446 Sum_probs=27.9
Q ss_pred CCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 593 ~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34699999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.79 E-value=0.21 Score=53.62 Aligned_cols=73 Identities=15% Similarity=0.170 Sum_probs=47.4
Q ss_pred CceeeecceeEEEEEecc--------ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe-eeeEEEEEEeCCeeEEEEE
Q 005400 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-LVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n-Iv~l~~~~~~~~~~~lV~E 549 (698)
+.+..|-...+|+....+ ++.+++|+..... .....-.+|.++++.+...+ ..++++.+ . -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 467778888999988753 5789998864432 22223457888888774222 34455432 2 378999
Q ss_pred ecCCCCh
Q 005400 550 YMPNKSL 556 (698)
Q Consensus 550 ~~~~gsL 556 (698)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.92 E-value=0.35 Score=51.45 Aligned_cols=29 Identities=24% Similarity=0.416 Sum_probs=24.6
Q ss_pred eeecCCCCCCEEE------cCCCceEEeecCCCcc
Q 005400 596 IIHRDLKASNVLL------DNDMNPKISDFGMARI 624 (698)
Q Consensus 596 ivH~Dlkp~NILl------~~~~~~kl~DFgla~~ 624 (698)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 3456799999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.58 E-value=0.74 Score=44.12 Aligned_cols=103 Identities=9% Similarity=0.006 Sum_probs=66.0
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccccc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 633 (698)
-+|.++|.. ...++++.+++.++.|.++.|.-+-.... -..+=+.|..|++..+|++.+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 467788753 45579999999999999999877632110 11333457999999999988764 1110
Q ss_pred cccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 005400 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKN 676 (698)
Q Consensus 634 ~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~p 676 (698)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223567888763 3456889999999999998864443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.85 E-value=2 Score=41.06 Aligned_cols=115 Identities=13% Similarity=0.122 Sum_probs=76.8
Q ss_pred CCCeeeeEEEEEEeCCeeEEEEEecCCC-ChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCC
Q 005400 527 QHRNLVKLLGCCIQADESMLIYEYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (698)
Q Consensus 527 ~H~nIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 605 (698)
.||+++.. .+-.+.+...+.++.-+.+ ++.. + ..++..++++++.+|+....+++. -+|--|+|.|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 68888876 4555666666656554322 2221 2 126788999999999988866654 4788899999
Q ss_pred EEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 606 VLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 606 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
|+++.++.+++.=.|+-.. ++|. ..+...=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999976655322 2232 12223334457788888888888774
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=83.88 E-value=13 Score=36.72 Aligned_cols=71 Identities=11% Similarity=0.249 Sum_probs=40.5
Q ss_pred EEEEEeeCCCCeEEEeeCCCCC--CC----CCCcceEEecCceE-EeCCCCceEEeeccCCCCCCcEEEEeccceEEEec
Q 005400 55 LGIWYKRVSPRTVAWVANRETP--LT----DQSGLLNVTSKGIV-LLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTD 127 (698)
Q Consensus 55 ~~iw~~~~~~~t~vW~anr~~p--~~----~~~~~l~~~~~g~l-~l~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~ 127 (698)
+.|| .....+++|...+..+ +. .+.+.+.++.++.+ .+|++|.++|.-.+........++.+.+||+++.+
T Consensus 17 v~~~--d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~ 94 (276)
T 3no2_A 17 IAII--NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAW 94 (276)
T ss_dssp EEEE--ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEE
T ss_pred EEEE--ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEe
Confidence 4454 2335678888776541 11 12344555555444 44889999999875321122345667777777754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.67 E-value=4.6 Score=38.60 Aligned_cols=115 Identities=10% Similarity=0.060 Sum_probs=73.7
Q ss_pred CCCeeeeEEEEEEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceeecCCCCCC
Q 005400 527 QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL-YLHQDSRMRIIHRDLKASN 605 (698)
Q Consensus 527 ~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivH~Dlkp~N 605 (698)
.||++ -..+-.+++...+.++.-+++.-...+. .++..++++++.+|+.... +++. -+|--|+|.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57887 4444466777777776654433222331 2678888988888877665 4443 5788999999
Q ss_pred EEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 606 VLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 606 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
|+++.++.++|.=.|+-. -++|.-+ +..-=.-++=+++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~-------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE-------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETT-------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCcc-------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999997666532 2333211 222223356677777777776664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 698 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-23 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-18 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 9e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-14 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 8e-11 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 5e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 4e-64
Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 16/220 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE ++G G FG VYKG + + ++ + Q ++ FKNEV
Sbjct: 3 WEIPD-------GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 55
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ + +H N++ +G + ++ ++ SL + T + K I I
Sbjct: 56 GVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQ 112
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
A+G+ YLH IIHRDLK++N+ L D+ KI DFG+A + ++ G+
Sbjct: 113 TAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 641 YGYMSPEYA---AEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+M+PE + +S +SDV++FG+++ E+++G+ +
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 5e-62
Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 11/222 (4%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQH 528
D+F ++LG G G V+K + G +A K + + + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
+V G E + E+M SLD + R + Q + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
+ +I+HRD+K SN+L+++ K+ DFG++ I + + VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG 690
+SV+SD++S G+ ++E+ G+ + G
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 4e-60
Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 17/233 (7%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+++ WE + +LG G FG V+ G ++AVK L +GS
Sbjct: 3 WWEDE---WEVPR-------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MS 51
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+ F E L+ +LQH+ LV+L Q + +I EYM N SL F+ L
Sbjct: 52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTIN 109
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
K + + IA G+ ++ + IHRDL+A+N+L+ + ++ KI+DFG+AR+ +E
Sbjct: 110 KLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+ +PE G F++KSDV+SFG+L+ EIV+ + + +
Sbjct: 167 REG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-58
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 7/213 (3%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
++G G FG V+ G + ++A+K + +G+ E+F E ++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+L G C++ L++E+M + L ++ Q + + + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEG---MAYLE 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+IHRDL A N L+ + K+SDFGM R D+ T++ + SPE +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+S KSDV+SFGVL+ E+ S K + + +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-57
Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 13/217 (5%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
D + +LG+G FG VYK E A K + S + +E++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKLL + ++ E+ ++D + + R L + + + YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+IIHRDLKA N+L D + K++DFG++ + ++ +GT +M+PE
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 651 -----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ + K+DV+S G+ ++E+ + +P
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 4e-57
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 20/226 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W + +G+G FG V G G ++AVK + + + F E
Sbjct: 2 WALNM-------KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEA 51
Query: 521 TLIARLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
+++ +L+H NLV+LLG ++ + ++ EYM SL ++ + R + L +
Sbjct: 52 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSL 110
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ + YL +HRDL A NVL+ D K+SDFG+ + E +
Sbjct: 111 DVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKL 162
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+ +PE E FS KSDV+SFG+L+ EI S + P D
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 5e-57
Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 14/225 (6%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE ++ KLG+G FG V+ GT +A+K L G+ E F E
Sbjct: 12 WEIPR-------ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEA 63
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ +L+H LV+L + + ++ EYM SL F+ + +L + + +
Sbjct: 64 QVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQ 121
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IA G+ Y+ + M +HRDL+A+N+L+ ++ K++DFG+AR+ +E
Sbjct: 122 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFP 177
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+ +PE A G F++KSDV+SFG+L+ E+ + + + +
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 1e-56
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 22/228 (9%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQ 527
F+ ++G G FG VY V + +A+K++S Q ++ EV + +L+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H N ++ GC ++ + L+ EY + D + L + + G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH +IHRD+KA N+LL K+ DFG A I + VGT +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 648 YAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
EG + K DV+S G+ +E+ K + + L H+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYHI 226
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (485), Expect = 4e-56
Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 14/218 (6%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNE 519
WE + + +KLG G +G VY+G + +AVK L + + + +EEF E
Sbjct: 12 WEMER-------TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 63
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R + +++
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMAT 122
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
I+ + YL + IHRDL A N L+ + K++DFG++R+ GD +
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKF 178
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ +PE A FS+KSDV++FGVL+ EI + +
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-56
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 9/213 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHRN 530
+++ LGEG +G V + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VK G + + L EY L I + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ I HRD+K N+LLD N KISDFG+A +F + + +K+ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 651 EGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
F + DV+S G+++ +++G+ W
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 9e-56
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 10/220 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHR 529
+++ +G G +G K G+ + K L GS + +EV L+ L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 530 NLVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARAT-FLDWQKRIHIVGGIARGIL 586
N+V+ I + L + EY L I + +LD + + ++ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 587 YLHQ--DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
H+ D ++HRDLK +NV LD N K+ DFG+ARI D VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684
SPE ++ KSD++S G L+ E+ + +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-55
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 7/203 (3%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
+ +LG G FG V G ++A+K + +GS +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+L G C + +I EYM N L ++ + Q+ + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+ +HRDL A N L+++ K+SDFG++R DE ++ + PE
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176
Query: 653 LFSVKSDVFSFGVLVLEIVSGKK 675
FS KSD+++FGVL+ EI S K
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 1e-54
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 22/230 (9%)
Query: 463 FDFASIAKATDNFASY---------NKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG- 508
F F +A FA +G G FG V G L +A+K L G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF 568
+ + +F +E +++ + H N++ L G ++ M+I E+M N SLD F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
+ + ++ GIA G+ YL M +HRDL A N+L+++++ K+SDFG++R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 629 EIQTNTHKVVG---TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
+G + +PE F+ SDV+S+G+++ E++S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-54
Identities = 54/217 (24%), Positives = 106/217 (48%), Gaps = 10/217 (4%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY V GQE+A+++++ E NE+ ++
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
++ N+V L + DE ++ EY+ SL + + D + + + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQAL 129
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH ++IHRD+K+ N+LL D + K++DFG + Q+ +VGT +M+
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMA 184
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
PE + K D++S G++ +E++ G+ + +P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-53
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLL 535
++G G F VYKG E E+A L + + FK E ++ LQH N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 536 GCCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ +L+ E M + +L ++ + + I +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTR 131
Query: 592 SRMRIIHRDLKASNVLL-DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ IIHRDLK N+ + + KI D G+A + + V+GT +M+PE
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEM-Y 185
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
E + DV++FG+ +LE+ + + +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 68/261 (26%), Positives = 108/261 (41%), Gaps = 39/261 (14%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSGQG-M 513
WEF +N LG G FG V T ++AVK L + +
Sbjct: 32 WEFPR-------ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 84
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--------- 563
E +E+ ++ +L H N+V LLG C + LI+EY L ++ +
Sbjct: 85 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 564 -----------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
L ++ + +A+G+ +L +HRDL A NVL+ +
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGK 201
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
KI DFG+AR D +M+PE EG++++KSDV+S+G+L+ EI S
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 673 GKKNWRFSHPDHDHNLLGHVR 693
N + D N ++
Sbjct: 262 LGVNP-YPGIPVDANFYKLIQ 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-53
Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 14/227 (6%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
++F LG+G FG VY + +A+K L K + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
N+++L G A LI EY P ++ + ++ D Q+ + +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H R+IHRD+K N+LL + KI+DFG + + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEM 175
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHVRVE 695
+ K D++S GVL E + GK + + + + V
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 222
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (466), Expect = 2e-53
Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 38/253 (15%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSGQGME 514
E+ +N +GEG FG V++ +AVK L + + M+
Sbjct: 8 LEY-------PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 515 -EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF----- 568
+F+ E L+A + N+VKLLG C L++EYM L+ F+ + T
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 569 ----------------LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
L +++ I +A G+ YL + + +HRDL N L+ +M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
KI+DFG++R + +M PE ++ +SDV+++GV++ EI S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 673 GKKNWRFSHPDHD 685
+ +
Sbjct: 238 YGLQPYYGMAHEE 250
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 3e-53
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 471 ATDNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQG-MEEFKNEVTLIAR 525
DN + +LG G FG V +G + ++A+K L +G+ + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L + +V+L+G C QA+ ML+ E L F+ + + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYGYM 644
YL + +HRDL A NVLL N KISDFG+++ G D+ T +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
+PE FS +SDV+S+GV + E +S +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-52
Identities = 63/258 (24%), Positives = 103/258 (39%), Gaps = 34/258 (13%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRL 505
+ + D + WEF + + LG G FG V + T +AVK L
Sbjct: 10 TQLPYDHK-WEFPR-------NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 506 SKGSGQG-MEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ 563
+ E +E+ +++ L H N+V LLG C +++I EY L F+ +
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 564 ---------------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608
LD + + +A+G+ +L IHRDL A N+LL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178
Query: 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVL 668
+ KI DFG+AR D +M+PE +++ +SDV+S+G+ +
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 669 EIVSGKKNWRFSHPDHDH 686
E+ S + P
Sbjct: 239 ELFSLGSSPYPGMPVDSK 256
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-52
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSGQG--MEEFKNEVTLIARLQHRNLVK 533
+LG G FG V KG + +AVK L + +E E ++ +L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
++G C +A+ ML+ E L+ ++ + + I +V ++ G+ YL +
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE--- 125
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYGYMSPEYAAEG 652
+HRDL A NVLL KISDFG+++ DE + +PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 653 LFSVKSDVFSFGVLVLEIVSGKK 675
FS KSDV+SFGVL+ E S +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-52
Identities = 50/224 (22%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+G+G FG V++G G+E+AVK S + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 540 QADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD---- 591
+ + + L+ +Y + SL ++ + + I + A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 592 -SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMSPEY 648
+ I HRDLK+ N+L+ + I+D G+A D I + VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 649 AAEGL------FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
+ + ++D+++ G++ EI
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-52
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
+G G FG VY GTL++ AVK L++ + G + +F E ++ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LLG C++++ S +++ YM + L FI ++ + + + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK--VVGTYGYMSPEYAA 650
+ +HRDL A N +LD K++DFG+AR E + +K +M+ E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
F+ KSDV+SFGVL+ E+++ P D N
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTF 241
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-51
Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 468 IAKATDNFASYNKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKG-SGQGMEEFKNEVT 521
I K T+ F LG G FG VYKG + E +A+K L + S + +E +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
++A + + ++ +LLG C+ LI + MP L ++ + + Q ++ I
Sbjct: 64 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQI 120
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
A+G+ YL R++HRDL A NVL+ + KI+DFG+A++ G +E + +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
+M+ E +++ +SDV+S+GV V E+++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-50
Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKGSGQGM-EEFKNEVTLIARL 526
+G G FG VYKG L +A+K L G + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 527 QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
H N+++L G + M+I EYM N +LD F+ ++ + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMK 124
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK-VVGTYGYMS 645
YL M +HRDL A N+L+++++ K+SDFG++R+ D T T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
PE + F+ SDV+SFG+++ E+++ + + +H+
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEG---QEIAVKRLSK-GSGQGMEEFKNEVTLIARL-Q 527
++ + +GEG FG V K + + + A+KR+ + S +F E+ ++ +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI-------------FDQARATFLDWQKR 574
H N++ LLG C L EY P+ +L F+ + A+ L Q+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+H +ARG+ YL Q + IHRDL A N+L+ + KI+DFG++R E+
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
+M+ E +++ SDV+S+GVL+ EIVS
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-50
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 10/213 (4%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIAR 525
K ++F LGEG F V L +E A+K L K + E +++R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L H VKL ++ Y N L +I D I +
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH IIHRDLK N+LL+ DM+ +I+DFG A++ + Q + VGT Y+S
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
PE E SD+++ G ++ ++V+G +R
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 211
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (445), Expect = 1e-49
Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 11/215 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
D++ + +LG G FG V++ T G A K + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V L +E ++IYE+M L + D+ + + + + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 592 SRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
+H DLK N++ + K+ DFG+ + + GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVA 197
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684
+D++S GVL ++SG + + D
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-48
Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 14/211 (6%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSK---GSGQGMEEFKNEVTLIAR 525
+ KLG+G FG V +G + +AVK L + M++F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L HRNL++L G + ++ E P SL + L R + +A G+
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG-GDEIQTNTHKVVGTYGYM 644
YL R IHRDL A N+LL KI DFG+ R D+ + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
+PE FS SD + FGV + E+ + +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-48
Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 24/239 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKG-SGQGM 513
WE + +LG+G FG VY+G +A+K +++ S +
Sbjct: 15 WEVAR-------EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 67
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF----- 568
EF NE +++ ++V+LLG Q +++I E M L ++ A
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 569 --LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
K I + G IA G+ YL+ + +HRDL A N ++ D KI DFGM R
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184
Query: 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+ K + +MSPE +G+F+ SDV+SFGV++ EI + + +
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (434), Expect = 3e-48
Identities = 49/213 (23%), Positives = 87/213 (40%), Gaps = 11/213 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
D + +LG G FG V++ G+ K ++ KNE++++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ L E +LI E++ L I A + + I+ + G+ ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 592 SRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
I+H D+K N++ + KI DFG+A DEI T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+D+++ GVL ++SG +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 8e-48
Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 19/230 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQGM-EE 515
+E + +GEG FG V++G + +A+K + + E+
Sbjct: 2 YEIQR-------ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 54
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E + + H ++VKL+G + + +I E L F+ + + LD I
Sbjct: 55 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLI 111
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ + YL R +HRD+ A NVL+ ++ K+ DFG++R D
Sbjct: 112 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKAS 167
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
K +M+PE F+ SDV+ FGV + EI+ ++D
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-46
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 7/221 (3%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHR 529
+ + + +GEG +G V V +A+K++S Q + E+ ++ R +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N++ + + Y+ + ++ + L + + I RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK-VVGTYGYMSPEY 648
++HRDLK SN+LL+ + KI DFG+AR+ D T V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 649 AAEGLFSVKS-DVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
KS D++S G ++ E++S + + H N
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 6e-46
Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 33/259 (12%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGT------LVEGQEIAVKRLSKGSG 510
D WEF D LG G FG V + + +AVK L +G+
Sbjct: 4 DASKWEFPR-------DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 56
Query: 511 QG-MEEFKNEVTLIAR-LQHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQ---- 563
+E+ ++ H N+V LLG C + M+I E+ +L ++ +
Sbjct: 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
Query: 564 ---------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
FL + I +A+G+ +L + IHRDL A N+LL
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVV 173
Query: 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
KI DFG+AR D +M+PE + +++++SDV+SFGVL+ EI S
Sbjct: 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233
Query: 675 KNWRFSHPDHDHNLLGHVR 693
+ + D ++
Sbjct: 234 ASP-YPGVKIDEEFCRRLK 251
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (415), Expect = 2e-45
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 18/225 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ- 527
++F+ + +G GGFG VY + G+ A+K L K QG NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 528 --HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+V + D+ I + M L + + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
++H +++RDLK +N+LLD + +ISD G+A F + H VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 646 PEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
PE +G+ + +D FS G ++ +++ G +R H +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 4e-45
Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKG-SGQ 511
WE D LGEG FG V + ++AVK L + +
Sbjct: 8 WELPR-------DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 60
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-- 568
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++ +
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 569 -----------LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
L + + +ARG+ YL + IHRDL A NVL+ D KI+
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIA 177
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
DFG+AR + T +M+PE + +++ +SDV+SFGVL+ EI + +
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 678 RFSHPDHD 685
P +
Sbjct: 238 YPGVPVEE 245
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (408), Expect = 6e-45
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
+F LG G FG V+ G+ A+K L K + +E +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
++++ G A + +I +Y+ L + R + V L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
II+RDLK N+LLD + + KI+DFG A+ + T+ + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ ++ D +SFG+L+ E+++G + S+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-44
Identities = 45/215 (20%), Positives = 88/215 (40%), Gaps = 12/215 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
+ + LG G FG V++ + K + G K E++++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ L +E ++I+E++ + I A L+ ++ + V + + +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 592 SRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
I H D++ N++ + KI +FG AR + N + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVH 175
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684
+ S +D++S G LV ++SG +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (397), Expect = 5e-44
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 15/220 (6%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQ 527
+D + LG GG V+ L +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 528 HRNLVKLLGCCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
H +V + + ++ EY+ +L + + + ++ I ++ +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG-GDEIQTNTHKVVGTYG 642
+ + H + IIHRD+K +N+++ K+ DFG+AR T T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
Y+SPE A +SDV+S G ++ E+++G+ + P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 2e-43
Identities = 45/214 (21%), Positives = 88/214 (41%), Gaps = 8/214 (3%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHR 529
D + + LG G F V + +A+K ++K + +G E +NE+ ++ +++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+V L LI + + L I ++ + ++ + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
+ + LD D ISDFG++++ + GT GY++PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683
A+ +S D +S GV+ ++ G + +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 215
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 16/229 (6%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIAR-LQ 527
++F + LG+G FG V+ + Q A+K L K +E E +++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H L + + + EY+ L + I + D + I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH I++RDLK N+LLD D + KI+DFGM + + +TNT GT Y++PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHVRVEN 696
++ D +SFGVL+ E++ G+ + H + L +R++N
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPF---HGQDEEELFHSIRMDN 219
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (385), Expect = 3e-42
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM---------EEFKNEVTL 522
+N+ LG G V + +E AVK + G E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 523 IARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
+ ++ H N+++L L+++ M L ++ ++ L ++ I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
I LH ++ I+HRDLK N+LLD+DMN K++DFG + E +V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 642 GYMSPEYAAEGL------FSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
Y++PE + + + D++S GV++ +++G +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 6e-41
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 9/213 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+NF K+GEG +G VYK G+ +A+K++ + E++L+ L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+VKLL ++ L++E++ F D + T + + + +G+ + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
R++HRDLK N+L++ + K++DFG+AR F G ++T TH+VV +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILL 175
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+S D++S G + E+V+ + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-----FKNEVTLIARLQHRNLV 532
+ LGEG F VYK Q +A+K++ G ++ E+ L+ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LL L++++M + L + +G+ YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQ-- 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE- 651
I+HRDLK +N+LLD + K++DFG+A+ FG V T Y +PE
Sbjct: 119 -HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175
Query: 652 GLFSVKSDVFSFGVLVLEIVSGK 674
++ V D+++ G ++ E++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (373), Expect = 2e-40
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 11/215 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ + K+GEG +G VYK G+ A+K RL K E++++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKL +L++E++ + L+ + + GI Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-YA 649
R++HRDLK N+L++ + KI+DFG+AR FG + T Y +P+
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLM 173
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684
+S D++S G + E+V+G +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 5e-40
Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 17/220 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
++ +G G FG VY+ L + G+ +A+K++ + E+ ++ +L H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 532 VKLLGCCIQADESM------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
V+L + E L+ +Y+P L + + R +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
Y+H I HRD+K N+LLD D K+ DFG A+ E + + Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRA 190
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684
++ DV+S G ++ E++ G+ +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-40
Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 16/223 (7%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGSGQGM--EEFKNEVTLIAR 525
+A + ++GEG +G V+K ++ G+ +A+KR+ +G+ EV ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 526 L---QHRNLVKLLGCCIQADESMLIYEYMPNKSLD---FFIFDQARATFLDWQKRIHIVG 579
L +H N+V+L C + + + +D D+ + + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ RG+ +LH R++HRDLK N+L+ + K++DFG+ARI+ Q VV
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 177
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
T Y +PE + ++ D++S G + E+ K +R S
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (364), Expect = 3e-39
Identities = 43/219 (19%), Positives = 78/219 (35%), Gaps = 16/219 (7%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
K+G G FG +Y GT + G+E+A+K + + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ ++ + SL+ +R + + + + I Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 599 RDLKASNVL---LDNDMNPKISDFGMARIFGGDEIQTN-----THKVVGTYGYMSPEYAA 650
RD+K N L I DFG+A+ + + + GT Y S
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
S + D+ S G +++ G W+
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-39
Identities = 53/234 (22%), Positives = 97/234 (41%), Gaps = 20/234 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS------GQGMEEFKNEVTLIAR 525
D + + +LG G F V K G + A K + K G E+ + EV+++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+QH N++ L + +LI E + L F+ ++ L ++ + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVGTY 641
++ ++I H DLK N++L + P KI DFG+A + GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTP 180
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHVRVE 695
+++PE +++D++S GV+ ++SG + + V E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (362), Expect = 6e-39
Identities = 38/225 (16%), Positives = 84/225 (37%), Gaps = 18/225 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
++GEG FG +++GT L+ Q++A+K + S + ++E L + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
Q ++ + SL+ + R + + + +H+ +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 599 RDLKASNVLLDNDMNP-----KISDFGMARIFGGDEIQTNTHK-----VVGTYGYMSPEY 648
RD+K N L+ + + DFGM + + + + + GT YMS
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHVR 693
S + D+ + G + + + G W+ + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-38
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 20/206 (9%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE------FKNEVTLIARLQ--HRN 530
LG GGFG VY G V +A+K + K E EV L+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+++LL + D +LI E F + A L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHN 128
Query: 591 DSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
++HRD+K N+L+D N K+ DFG + T GT Y PE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWI 181
Query: 650 A-EGLFSVKSDVFSFGVLVLEIVSGK 674
+ V+S G+L+ ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 47/211 (22%), Positives = 85/211 (40%), Gaps = 21/211 (9%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCC 538
LG G G V + ++ A+K L + + EV L R Q ++V+++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 74
Query: 539 IQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+++ E + L I D+ F ++ I+ I I YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---I 130
Query: 595 RIIHRDLKASNVLLDNDMNP---KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
I HRD+K N+L + K++DFG A+ + T Y++PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGP 187
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ D++S GV++ ++ G + +H
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 49/226 (21%), Positives = 99/226 (43%), Gaps = 20/226 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG--MEEFKNEVTLIARLQHR 529
+ K+G+G FG V+K + GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 530 NLVKLLGCCIQADESM--------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
N+V L+ C L++++ + + T + ++ + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG--GDEIQTNTHKVVG 639
+ L+ R +I+HRD+KA+NVL+ D K++DFG+AR F + V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 640 TYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684
T Y PE E + D++ G ++ E+ + + + H
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 12/215 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
++F LG+G FG V G+ A+K L K + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
L L D + EY L F + +R ++ I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
+++RD+K N++LD D + KI+DFG+ + D GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683
+ + D + GV++ E++ G+ + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-36
Identities = 48/219 (21%), Positives = 93/219 (42%), Gaps = 11/219 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+ K+GEG +G V+K E + +A+KR+ E+ L+ L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+V+L + L++E+ +F + + + + L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
++HRDLK N+L++ + K+++FG+AR F G ++ + +VV +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
L+S D++S G + E+ + + F D D L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQL 212
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (345), Expect = 4e-36
Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 16/233 (6%)
Query: 455 KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SG 510
++ ++ WE + A+ D F LG G FG V E G A+K L K
Sbjct: 24 EDFLKKWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 511 QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD 570
+ +E NE ++ + LVKL ++ EY+ + + R
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FS 139
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630
I YLH + +I+RDLK N+L+D +++DFG A+ +
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RV 191
Query: 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683
+ T + GT ++PE ++ D ++ GVL+ E+ +G + P
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 7e-34
Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536
+G G +G V G ++A+K+L + S + E+ L+ ++H N++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 537 CCIQADESMLIYE-YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ + Y+ + + + L + +V + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL-F 654
IIHRDLK N+ ++ D KI DFG+AR + + V T Y +PE + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRY 196
Query: 655 SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
+ D++S G ++ E+++GK ++ S
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (319), Expect = 8e-33
Identities = 44/241 (18%), Positives = 100/241 (41%), Gaps = 22/241 (9%)
Query: 453 HMKEDMELWEFDFASIA-KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG 510
+ E W+++ + D++ KLG G + V++ + +++ VK L
Sbjct: 14 NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK- 72
Query: 511 QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM--LIYEYMPNKSLDFFIFDQARAT 567
++ K E+ ++ L+ N++ L L++E++ N
Sbjct: 73 --KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------Q 124
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFG 626
L + I + + Y H M I+HRD+K NV++D++ ++ D+G+A +
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 627 GDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+ V + + PE + ++ D++S G ++ ++ K+ + H ++D
Sbjct: 182 PGQEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
Query: 686 H 686
Sbjct: 239 Q 239
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-32
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 18/228 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS----GQGMEEFKNEVTLIA 524
+NF LG G +G V+ + G+ A+K L K + + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 525 RLQHR-NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
++ LV L + LI +Y+ L + + R T + Q +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+L L ++ II+RD+K N+LLD++ + ++DFG+++ F DE + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEY 196
Query: 644 MSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
M+P+ G D +S GVL+ E+++G + + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536
+G G G V V + +A+K+LS+ + + E+ L+ + H+N++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 537 CCI------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+ + L+ E M + D ++ +++ + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLHS 137
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
IIHRDLK SN+++ +D KI DFG+AR G + T V T Y +PE
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRAPEVIL 191
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
+ D++S G ++ E+V K + N +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-29
Identities = 50/225 (22%), Positives = 95/225 (42%), Gaps = 11/225 (4%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQH 528
+ + + + +G G +G V + G +AVK+LS+ S + E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 529 RNLVKLLGCCIQADESMLI-YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
N++ LL A Y+ + + + + L ++ I RG+ Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
+H IIHRDLK SN+ ++ D KI DFG+AR T V +
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 189
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
++ D++S G ++ E+++G+ + + L+ +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (283), Expect = 6e-28
Identities = 40/228 (17%), Positives = 80/228 (35%), Gaps = 18/228 (7%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLG G F V+ +V +A+K + E ++E+ L+ R+ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 539 I-------------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+ ++ + + + + I + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 586 LYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
Y+H+ R IIH D+K NVL++ D + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHV 692
SPE + +D++S L+ E+++G + H+
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.2 bits (236), Expect = 3e-23
Identities = 32/155 (20%), Positives = 48/155 (30%), Gaps = 20/155 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS----------GQGMEEFKNEVTLIARLQH 528
+GEG V+ + E VK G G F AR +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R L KL G + +Y + N L I + ++ I +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ I+H DL NVL+ + I DF +
Sbjct: 120 YH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 78.5 bits (193), Expect = 3e-18
Identities = 23/115 (20%), Positives = 44/115 (38%), Gaps = 11/115 (9%)
Query: 27 IRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNV 86
+ +GE L + ++ + L ++ T W +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD----HSTSVWASNTGILGKKGCKA-VL 57
Query: 87 TSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140
S G V+ D R W+S++ N V+ L + GN+V+ Y S +W + +
Sbjct: 58 QSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI----YGSDIWSTGTY 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 68.5 bits (167), Expect = 9e-15
Identities = 23/123 (18%), Positives = 42/123 (34%), Gaps = 16/123 (13%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
++ + +++ GE L G+F L ++ W N
Sbjct: 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS 49
Query: 78 TDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137
L T +V+ + ++ W+SNT N V L N+V+ Y + W +
Sbjct: 50 RS-CFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVI----YGTDRWAT 104
Query: 138 FDH 140
H
Sbjct: 105 GTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 67.6 bits (165), Expect = 3e-14
Identities = 16/92 (17%), Positives = 30/92 (32%), Gaps = 3/92 (3%)
Query: 57 IWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQ 116
I Y + L L++ + ++L RD WS+NT+
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71
Query: 117 LMDSGNLVLTDGNYNSLLWQSFD--HPCDTLL 146
L +G + + N +W S + +
Sbjct: 72 LQPNGRMDVLTNQ-NIAVWTSGNSRSAGRYVF 102
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 66.4 bits (161), Expect = 5e-14
Identities = 20/125 (16%), Positives = 44/125 (35%), Gaps = 14/125 (11%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
D + + G +L G + + + Y W + +
Sbjct: 2 DRLNSGHQLDTGGSLA--EGGYLFIIQNDCNL------VLY---DNNRAVWASGTNGKAS 50
Query: 79 DQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSF 138
L + + G +++ R W+SNT+ N + L N+V+ D + N+ +W +
Sbjct: 51 GCV--LKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-NNAIWATH 107
Query: 139 DHPCD 143
+ +
Sbjct: 108 TNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 57.7 bits (139), Expect = 8e-11
Identities = 20/130 (15%), Positives = 41/130 (31%), Gaps = 20/130 (15%)
Query: 11 ILGASAANDNITPSQSIRDGETL--VSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVA 68
I+ + +DN Q + E+L + + + L ++
Sbjct: 3 IIFSKQPDDN--HPQILHATESLEILFGTHVYRFIMQTDCN-----LVLY----DNNNPI 51
Query: 69 WVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTD 127
W N + G +V++ + W S + + V+ L N+V+
Sbjct: 52 WATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI-- 107
Query: 128 GNYNSLLWQS 137
Y LW +
Sbjct: 108 --YGDALWAT 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.3 bits (125), Expect = 5e-09
Identities = 17/84 (20%), Positives = 28/84 (33%), Gaps = 2/84 (2%)
Query: 57 IWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQ 116
I + + + L S + S ++L D W+SNT+
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGA-TGCRAV 61
Query: 117 LMDSGNLVLTDGNYNSLLWQSFDH 140
L G LV+ N++ W S
Sbjct: 62 LQSDGLLVILTAQ-NTIRWSSGTK 84
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 698 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.82 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.8 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.79 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.71 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.56 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.52 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.31 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.03 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.99 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.98 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.84 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.41 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.32 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 86.61 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 83.88 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.06 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=363.15 Aligned_cols=203 Identities=29% Similarity=0.428 Sum_probs=176.2
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|++.++||+|+||+||+|+.. +|+.||||++.... .+..+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999875 58999999997652 33456799999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++|+|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||+++++++||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999998853 335899999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
........||+.|||||++.+..+ +.++|||||||+||||+||+.||....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 333344689999999999988776 578999999999999999999997543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=358.67 Aligned_cols=200 Identities=29% Similarity=0.438 Sum_probs=178.6
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56899999999999999999975 5889999998643 2345667899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|.+++.+. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++++||+|||++......
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999998653 34899999999999999999999998 999999999999999999999999999875433
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||....+
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH
Confidence 2 2236799999999999999999999999999999999999999976543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=360.02 Aligned_cols=200 Identities=26% Similarity=0.497 Sum_probs=179.8
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999864 58999999998765556678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++|+|.+++.+ ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+......
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999988743 24899999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.....||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 173 --~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp --BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 233679999999999999999999999999999999999999997543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-43 Score=357.11 Aligned_cols=203 Identities=31% Similarity=0.519 Sum_probs=169.7
Q ss_pred hcCccccCceeeecceeEEEEEeccccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.++||+|+||+||+|++. +.||||+++.. ..+..+.|.+|++++++++|||||++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 367888999999999999999874 36999998654 4456678999999999999999999999875 456899999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++++||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999998643 235899999999999999999999988 9999999999999999999999999998765443
Q ss_pred cccccccccccccccChhcccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~---~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.........||+.|||||++.. ..++.++|||||||+||||+||+.||....+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 3333444689999999999864 3589999999999999999999999975443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=361.83 Aligned_cols=203 Identities=30% Similarity=0.439 Sum_probs=177.0
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999874 5889999998653 2345577999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988643 34899999999999999999999998 999999999999999999999999999987544
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
..........||+.|||||++.+..++.++|||||||+||||+||+.||...+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 33333344679999999999999999999999999999999999999998544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=358.08 Aligned_cols=203 Identities=27% Similarity=0.431 Sum_probs=179.2
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
+.|++.++||+|+||+||+|+.. +++.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999875 58899999998777777789999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++|+|..++.+. ...+++.++..++.||++||.|||+++ |+||||||+|||++.++++||+|||++.......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 999999987543 345899999999999999999999998 9999999999999999999999999997643221
Q ss_pred cccccccccccccChhccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~-----~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.......||+.|||||++. ...|+.++|||||||++|||+||+.||....+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 1222367999999999984 45689999999999999999999999976544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=352.10 Aligned_cols=200 Identities=30% Similarity=0.513 Sum_probs=166.9
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|++.++||+|+||.||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++++|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 568888999999999999999988899999999764 3445789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++++||+|||+++.........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999988653 345889999999999999999999998 9999999999999999999999999998765433222
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG-KKNWRF 679 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG-~~pf~~ 679 (698)
.....||+.|+|||++....++.++|||||||++|||+|+ +.||..
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 2235789999999999999999999999999999999995 555543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=367.05 Aligned_cols=201 Identities=26% Similarity=0.374 Sum_probs=177.7
Q ss_pred hhcCccccCceeeecceeEEEEEec-cccEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
..++|+++++||+|+||+||+|+.. +|+.||+|+++.. .....+.+.+|++++++++|||||+++++|.+....++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999874 5889999999765 3344567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
||+++|+|.+++.+.. .+++..+..++.|++.||.|||+. + |+||||||+|||+++++++||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999996543 489999999999999999999974 6 99999999999999999999999999987532
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. ......||+.|||||++.+..|+.++||||+||++|||++|+.||....
T Consensus 158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2 1223689999999999999999999999999999999999999997544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=355.00 Aligned_cols=207 Identities=28% Similarity=0.435 Sum_probs=167.2
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEe--CCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~--~~~~~lV 547 (698)
++|++.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999874 58899999997653 3345678999999999999999999999865 4568999
Q ss_pred EEecCCCChhHHHhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 548 YEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
|||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++++||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 3456999999999999999999999864 23599999999999999999999999999988
Q ss_pred cCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
+...... .....||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 164 LNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 6543222 233689999999999999999999999999999999999999997544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=351.67 Aligned_cols=199 Identities=33% Similarity=0.544 Sum_probs=173.5
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|++.++||+|+||.||+|++++++.||||+++... ...++|.+|++++++++|||||++++++. .+..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 5688889999999999999999888899999997543 44678999999999999999999999875 456799999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+|+|.+++.... ...+++..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+.......
T Consensus 91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999998875433 234899999999999999999999988 9999999999999999999999999999875443322
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
.....||+.|||||++....++.++|||||||+||||+||+.|+.
T Consensus 167 -~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 167 -REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp -CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred -ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 223578999999999998999999999999999999999766553
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-42 Score=355.67 Aligned_cols=201 Identities=30% Similarity=0.476 Sum_probs=177.3
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|++.++||+|+||+||+|++. +++.||||+++... ...++|.+|++++++++|||||+++++|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 356888899999999999999986 48899999997543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+++|+|..++.... ...+++..++.++.||++||+|||+++ |+||||||+||||++++++||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999986543 346899999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
.. .....|++.|||||++.+..++.++|||||||++|||++|+.||.
T Consensus 171 ~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 171 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp EE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 22 223568999999999999999999999999999999999877764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-42 Score=354.20 Aligned_cols=205 Identities=28% Similarity=0.486 Sum_probs=165.2
Q ss_pred cCccccCceeeecceeEEEEEecc-c---cEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-G---QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|++.++||+|+||+||+|++.. + ..||||++... .....+.|.+|+++|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456777899999999999998753 3 25899988654 334556899999999999999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++|+|..++... ...+++.+++.++.||++||+|||+.+ |+||||||+||||+.++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988643 335899999999999999999999988 99999999999999999999999999987654
Q ss_pred Ccccc---ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 628 DEIQT---NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 628 ~~~~~---~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
..... ......||+.|||||.+....++.++|||||||+||||+| |+.||....+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 32211 1122457899999999999999999999999999999998 8999975443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=344.68 Aligned_cols=203 Identities=30% Similarity=0.481 Sum_probs=180.5
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|+..++||+|+||+||+|++++++.||||++++.. ...++|.+|++++++++|||||+++++|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6788999999999999999999888899999997643 446789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+|+|..++... ...+++..+.+++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.......
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999887543 335889999999999999999999988 9999999999999999999999999998765443322
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
.....||..|+|||++....++.++|||||||++|||+| |+.||+....
T Consensus 158 -~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~ 207 (258)
T d1k2pa_ 158 -SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207 (258)
T ss_dssp -CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred -ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence 223578999999999999999999999999999999998 8999986543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=343.42 Aligned_cols=196 Identities=27% Similarity=0.424 Sum_probs=167.9
Q ss_pred cccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe----CCeeEEEE
Q 005400 476 ASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESMLIY 548 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~----~~~~~lV~ 548 (698)
+..++||+|+||+||+|+.. +++.||+|++... .....+.|.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999875 5789999998654 33345678999999999999999999999875 34579999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc-CCCceEEeecCCCcccCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGG 627 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFgla~~~~~ 627 (698)
||+++|+|.+++.+. ..+++.++..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999998653 34899999999999999999999875 4599999999999996 578999999999986543
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.. .....||+.|||||++.+ .++.++|||||||++|||++|+.||...
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 32 233689999999998865 5999999999999999999999999743
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-41 Score=354.02 Aligned_cols=202 Identities=24% Similarity=0.361 Sum_probs=179.9
Q ss_pred cCccccCceeeecceeEEEEEe-ccccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++++.||+|+||.||+++. .+|+.||+|++++. .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6799999999999999999987 46899999999754 2345677899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|..++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998654 34889999999999999999999998 999999999999999999999999999875433
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.. ......||+.|||||++.+..|+.++|||||||++|||++|+.||...+.
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 22 22346899999999999999999999999999999999999999986543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=355.30 Aligned_cols=207 Identities=31% Similarity=0.481 Sum_probs=175.9
Q ss_pred cCccccCceeeecceeEEEEEecc------ccEEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~------g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
++|++.++||+|+||+||+|+... ...||+|++... .......+.+|++++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578889999999999999998643 236999998654 344556899999999998 899999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCC
Q 005400 545 MLIYEYMPNKSLDFFIFDQAR--------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKAS 604 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 604 (698)
++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999965421 235899999999999999999999998 999999999
Q ss_pred CEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 605 NVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 605 NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
|||++.++++||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987654443333334678999999999999999999999999999999998 8999975444
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-41 Score=351.83 Aligned_cols=199 Identities=26% Similarity=0.413 Sum_probs=177.8
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|++.++||+|+||+||+++.. +|+.||||++++. .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999974 5899999999653 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999998885433 4788888999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
. ....||+.|||||++.+..++.++|||||||+||||+||+.||...++
T Consensus 158 ~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 206 (316)
T d1fota_ 158 T-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206 (316)
T ss_dssp B-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred c-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH
Confidence 2 236899999999999999999999999999999999999999976543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-41 Score=353.36 Aligned_cols=201 Identities=25% Similarity=0.381 Sum_probs=161.8
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
.+.|++.+.||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466999999999999999999875 58899999997653 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc---CCCceEEeecCCCcccC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARIFG 626 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFgla~~~~ 626 (698)
|+++|+|.+++.+. ..+++.++..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999998543 45899999999999999999999998 99999999999994 57899999999998764
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... .....||+.|||||++.+..++.++|||||||+||||++|+.||....
T Consensus 162 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 162 PGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 3322 223679999999999999999999999999999999999999997543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-41 Score=351.27 Aligned_cols=197 Identities=29% Similarity=0.505 Sum_probs=172.9
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC---cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
+.|+.+++||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888999999999999999864 588999999976532 33457899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+++|+|..++... ..+++.++..++.||+.||.|||+++ |+||||||+|||+++++++||+|||++......
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999997766433 35899999999999999999999998 999999999999999999999999999865322
Q ss_pred ccccccccccccccccChhcccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~---~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||....
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 23579999999999853 468999999999999999999999997543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.4e-41 Score=353.89 Aligned_cols=202 Identities=24% Similarity=0.390 Sum_probs=179.8
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999874 5899999999876655667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc--CCCceEEeecCCCcccCCC
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFgla~~~~~~ 628 (698)
+++|+|.+++.+. ...+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999988543 235899999999999999999999998 99999999999996 4578999999999876544
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 32 223679999999999999999999999999999999999999997544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=347.98 Aligned_cols=197 Identities=31% Similarity=0.470 Sum_probs=167.0
Q ss_pred CceeeecceeEEEEEecc---ccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecCC
Q 005400 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~---g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 553 (698)
++||+|+||+||+|.+.. ++.||||+++.. .....++|.+|++++++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 568999999654 33345689999999999999999999999864 567899999999
Q ss_pred CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc-cc
Q 005400 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI-QT 632 (698)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~-~~ 632 (698)
|+|.+++.+. ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999998643 34899999999999999999999988 99999999999999999999999999987654322 22
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
......||+.|||||.+....++.++|||||||++|||+| |+.||.....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence 2233578999999999999999999999999999999998 8999986443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=347.28 Aligned_cols=204 Identities=30% Similarity=0.508 Sum_probs=173.7
Q ss_pred cCccccC-ceeeecceeEEEEEec---cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~-~LG~G~fG~Vy~g~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|++++++++|||||++++++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999764 35579999997653 3456789999999999999999999999864 568999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++|+|.+++... +..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999987543 345899999999999999999999988 99999999999999999999999999998754
Q ss_pred Ccc-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 628 DEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 628 ~~~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
... ........||+.|||||++....++.++|||||||++|||+| |+.||.....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence 332 222233568999999999999999999999999999999998 9999986543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-40 Score=352.27 Aligned_cols=201 Identities=24% Similarity=0.365 Sum_probs=179.0
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 551 (698)
++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999874 58999999998765555677899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc--CCCceEEeecCCCcccCCCc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFgla~~~~~~~ 629 (698)
++|+|.+.+... ...+++.++..++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+|..+....
T Consensus 109 ~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999998877432 335899999999999999999999998 99999999999998 67899999999999876543
Q ss_pred cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. .....||+.|||||++.+..++.++|||||||+||||+||+.||....
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 2 223579999999999999999999999999999999999999997543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=341.43 Aligned_cols=201 Identities=26% Similarity=0.401 Sum_probs=177.4
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC------CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCee
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~------~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~ 544 (698)
.++|++.++||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|++++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999974 58999999986542 12357799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC----ceEEeecC
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFG 620 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFg 620 (698)
+|||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999998654 34899999999999999999999998 99999999999998776 49999999
Q ss_pred CCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 9987654322 223578999999999999999999999999999999999999998544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-40 Score=351.46 Aligned_cols=198 Identities=25% Similarity=0.337 Sum_probs=178.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~ 548 (698)
++|+++++||+|+||.||+++.. +|+.||||++.+. .....+.+.+|++++++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999874 5899999998643 2345567899999999999999999999999999999999
Q ss_pred EecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCC
Q 005400 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (698)
Q Consensus 549 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~ 628 (698)
||+.+|+|..++.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999986543 4899999999999999999999998 999999999999999999999999999876533
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
. ....||+.|||||++.+..++.++|||||||+||||+||+.||....
T Consensus 195 ~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 195 T-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp B-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 2 23679999999999999999999999999999999999999997543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=342.08 Aligned_cols=202 Identities=29% Similarity=0.492 Sum_probs=166.4
Q ss_pred cCccccCceeeecceeEEEEEeccc-----cEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEG-----QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g-----~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
+.|++.++||+|+||.||+|++... ..||||++.... ....++|.+|++++++++|||||+++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577888999999999999987542 369999997553 3345679999999999999999999999999999999
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
||||+.++++..++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999998887543 345899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcc-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 627 GDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 627 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.... ........||+.|||||++....++.++|||||||++|||++|+.|+..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 4322 1222335689999999999999999999999999999999997666643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=342.03 Aligned_cols=200 Identities=30% Similarity=0.515 Sum_probs=169.0
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEecC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 552 (698)
++|++.++||+|+||+||+|+++++++||||+++.. ....+.|.+|+.++++++|||||++++++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 568899999999999999999988889999999654 345578999999999999999999999985 466899999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcccc
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 632 (698)
+|+|..++.... ...++|.+++.++.||++||+|||+.+ |+||||||+||||+.++++||+|||+++.........
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999998886543 335899999999999999999999998 9999999999999999999999999998765433222
Q ss_pred ccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 633 ~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
.....||+.|+|||++..+.++.++|||||||++|||+||+.|+..
T Consensus 171 -~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 171 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred -eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 2235789999999999999999999999999999999997766653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-40 Score=350.03 Aligned_cols=201 Identities=27% Similarity=0.427 Sum_probs=172.2
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC---CcchHHHHH---HHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKN---EVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~---Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+.+ |+++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999875 58999999986431 122233444 466777788999999999999999999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||+++|+|..++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999654 34789999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
.... .....||+.|||||++.. ..++.++|||||||+||||+||+.||......
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 5432 223679999999999865 46899999999999999999999999865443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-40 Score=342.18 Aligned_cols=202 Identities=27% Similarity=0.431 Sum_probs=176.4
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC---CCcchHHHHHHHHHHh-hcCCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIA-RLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~-~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 5889999999753 2344566777777765 68999999999999999999999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++|+|..++.... .+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999986543 4789999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....+
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 332 22336899999999999999999999999999999999999999985443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-40 Score=344.70 Aligned_cols=212 Identities=27% Similarity=0.454 Sum_probs=179.7
Q ss_pred HHHhhcCccccCceeeecceeEEEEEec------cccEEEEEEecCCCC-cchHHHHHHHHHHhhcCCCeeeeEEEEEEe
Q 005400 468 IAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (698)
Q Consensus 468 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~ 540 (698)
++...++|++.++||+|+||+||+|+.. +++.||||+++.... +..++|.+|++++++++||||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3445678999999999999999999864 357899999976533 345679999999999999999999999999
Q ss_pred CCeeEEEEEecCCCChhHHHhhccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeec
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQAR---------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 599 (698)
....++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+.+ |+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence 9999999999999999999864321 234889999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCC-CCCC
Q 005400 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK-KNWR 678 (698)
Q Consensus 600 Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~-~pf~ 678 (698)
||||+|||++.++++||+|||+++.+.............||+.|+|||.+....++.++|||||||++|||++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998765443333333467899999999999999999999999999999999996 5676
Q ss_pred CCCC
Q 005400 679 FSHP 682 (698)
Q Consensus 679 ~~~~ 682 (698)
...+
T Consensus 245 ~~~~ 248 (301)
T d1lufa_ 245 GMAH 248 (301)
T ss_dssp TSCH
T ss_pred CCCH
Confidence 5443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=345.05 Aligned_cols=205 Identities=30% Similarity=0.525 Sum_probs=170.8
Q ss_pred cCccccCceeeecceeEEEEEec-ccc----EEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~l 546 (698)
.+|+++++||+|+||+||+|++. +|+ +||+|+++.. ..+..++|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45899999999999999999864 343 6899998654 445677899999999999999999999999864 5678
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~ 626 (698)
++|++.+++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++++||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999998887653 345899999999999999999999988 9999999999999999999999999999876
Q ss_pred CCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPD 683 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~ 683 (698)
............||+.|||||++.++.++.++|||||||+||||+| |+.||......
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 5444433444578999999999999999999999999999999998 78998765443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-39 Score=335.14 Aligned_cols=204 Identities=25% Similarity=0.402 Sum_probs=169.4
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC---CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCe----
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE---- 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~---- 543 (698)
.++|++.+.||+|+||.||+|+. .+|+.||||++++.. ....+.|.+|++++++++|||||++++++.....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 468999999997653 2335578999999999999999999999986543
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.+|||||+++++|..++... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999888554 34899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCc-cccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDE-IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
...... .........||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 653322 1222334679999999999999999999999999999999999999997544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=333.11 Aligned_cols=204 Identities=26% Similarity=0.387 Sum_probs=164.3
Q ss_pred cCccccCceeeecceeEEEEEecc----ccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|++.+.||+|+||.||+|++.. +..||||+++... ....+.|.+|++++++++|||||++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 578889999999999999998743 3568999986543 334567999999999999999999999985 5678999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~ 627 (698)
|||+++|+|..++... ...+++..++.++.||++||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 86 ~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 9999999999887543 345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005400 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPD 683 (698)
Q Consensus 628 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~ 683 (698)
.... ......||+.|+|||++....++.++|||||||++|||+| |+.||....+.
T Consensus 161 ~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 161 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred Ccce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 3322 2233578999999999999999999999999999999998 89999865543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.4e-39 Score=328.53 Aligned_cols=201 Identities=26% Similarity=0.404 Sum_probs=175.6
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCc---------chHHHHHHHHHHhhcC-CCeeeeEEEEEEeC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ---------GMEEFKNEVTLIARLQ-HRNLVKLLGCCIQA 541 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~---------~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~ 541 (698)
++|++.+.||+|+||+||+++.. +++.||||++++.... ..+.+.+|++++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 67999999999999999999874 6889999999765221 2245889999999997 99999999999999
Q ss_pred CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 542 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
+..+|||||+++|+|.+++..+ ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999653 34899999999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCccccccccccccccccChhccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAA------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
++.+..... .....||+.|+|||++. ...++.++||||+||+||||++|+.||....+
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~ 220 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence 988654322 22367999999999885 33578899999999999999999999986543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=336.02 Aligned_cols=207 Identities=29% Similarity=0.456 Sum_probs=166.3
Q ss_pred hcCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeC-C
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA-D 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~-~ 542 (698)
.++|++.++||+|+||.||+|+.. .++.||||+++... ....+.+..|.+++.++ +|+||+++++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 367899999999999999999863 25689999997543 34456788888888777 689999999998765 4
Q ss_pred eeEEEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999975432 235889999999999999999999998 99999999999999
Q ss_pred CCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCC
Q 005400 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK-KNWRFSH 681 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~-~pf~~~~ 681 (698)
+++++||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+||. .||....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999998765444333444468999999999999999999999999999999999975 5776443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=334.07 Aligned_cols=202 Identities=21% Similarity=0.329 Sum_probs=177.0
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.++|++.++||+|+||+||+|+.. +++.||||+++... .....+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999875 58899999997643 3345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCC--CceEEeecCCCcccCCC
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND--MNPKISDFGMARIFGGD 628 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~DFgla~~~~~~ 628 (698)
+++|+|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999998543 235899999999999999999999998 9999999999999854 47999999999876443
Q ss_pred ccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 629 ~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
.. .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||....+
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 32 2235789999999999999999999999999999999999999976543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=329.58 Aligned_cols=199 Identities=30% Similarity=0.486 Sum_probs=165.7
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-CeeEEEEEec
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEYM 551 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-~~~~lV~E~~ 551 (698)
++|++.++||+|+||.||+|++ .|++||||+++.. ...+.|.+|++++++++||||++++++|.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4577788999999999999998 5789999999653 3457899999999999999999999998654 5689999999
Q ss_pred CCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc
Q 005400 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (698)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 631 (698)
++|+|.+++.+.. ...+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 9999999996543 234899999999999999999999988 9999999999999999999999999998654322
Q ss_pred cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005400 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPD 683 (698)
Q Consensus 632 ~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~~ 683 (698)
....+|..|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~ 207 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence 22468899999999999999999999999999999998 68887765443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-39 Score=329.96 Aligned_cols=203 Identities=29% Similarity=0.426 Sum_probs=164.4
Q ss_pred cCccccCceeeecceeEEEEEecc----ccEEEEEEecCC---CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~----g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
++|++.++||+|+||.||+|++.. ...||||++.+. ..+..+.|.+|++++++++|||||++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998642 237899998754 33445789999999999999999999999965 5678
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCccc
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~ 625 (698)
+||||++++++.+++.... ..+++..++.++.||++||.|||+++ |+||||||+|||++.++++||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999998876533 34899999999999999999999988 999999999999999999999999999986
Q ss_pred CCCcc-ccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 005400 626 GGDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (698)
Q Consensus 626 ~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~ 681 (698)
..... ........|+..|+|||.+.+..++.++|||||||++|||+| |+.||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 54322 222233567889999999999999999999999999999998 899997543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=330.23 Aligned_cols=201 Identities=27% Similarity=0.440 Sum_probs=170.6
Q ss_pred cCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|+++++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999987 458999999996542 2346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
|+.++.+...... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9986655433322 2345899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccChhcccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~-~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||...
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 2 223357999999999877665 578999999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=331.73 Aligned_cols=196 Identities=27% Similarity=0.379 Sum_probs=165.2
Q ss_pred ccCceeeecceeEEEEEec-cccEEEEEEecCCCC-----cchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 477 SYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-----QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 477 ~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~-----~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
.+++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++..++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 588999999865422 1235688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+.++++..+.. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99987766653 2345888899999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
. .....||+.|+|||++... .++.++|||||||++|||+||+.||...
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 2 2235799999999988654 6799999999999999999999999754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=335.56 Aligned_cols=199 Identities=24% Similarity=0.312 Sum_probs=170.3
Q ss_pred hcCccccC-ceeeecceeEEEEEe-ccccEEEEEEecCCCCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEe----CCee
Q 005400 472 TDNFASYN-KLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ----ADES 544 (698)
Q Consensus 472 ~~~f~~~~-~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~----~~~~ 544 (698)
.++|.+.+ .||+|+||.||+|+. .+++.||||+++. ...+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788875 599999999999987 4589999999864 24677899987655 89999999999876 3568
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC---CCceEEeecCC
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFgl 621 (698)
++|||||++|+|.+++.+.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999996532 235899999999999999999999998 999999999999985 45799999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~ 682 (698)
++....... .....||+.|||||++.+..|+.++|||||||+||||+||+.||.....
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 987654332 2236799999999999999999999999999999999999999975543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=332.25 Aligned_cols=207 Identities=29% Similarity=0.485 Sum_probs=178.5
Q ss_pred cCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~ 545 (698)
++|.+.++||+|+||.||+|.+. .++.||||+++... .+....|.+|++++++++|||||++++++......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56788899999999999999864 35789999997653 334456899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHHhhcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEee
Q 005400 546 LIYEYMPNKSLDFFIFDQA-------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 618 (698)
+||||+++|+|..++.... ....+++..+.+++.|+++||.|||+++ |+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999886432 2235789999999999999999999988 99999999999999999999999
Q ss_pred cCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK-KNWRFSHP 682 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~-~pf~~~~~ 682 (698)
||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||+ .||.....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~ 241 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH
Confidence 99998775544444444467899999999999999999999999999999999985 66765443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=329.56 Aligned_cols=207 Identities=30% Similarity=0.464 Sum_probs=174.7
Q ss_pred cCccccCceeeecceeEEEEEecc--------ccEEEEEEecCCCC-cchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCC
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~ 542 (698)
++|++.++||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 568888999999999999998632 34799999976543 4457889999999888 7999999999999999
Q ss_pred eeEEEEEecCCCChhHHHhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999965432 245899999999999999999999998 99999999999999
Q ss_pred CCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005400 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~ellt-G~~pf~~~~~ 682 (698)
.++.+||+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||++ |+.||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999987765444444445689999999999999999999999999999999998 6888875443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=330.74 Aligned_cols=207 Identities=28% Similarity=0.418 Sum_probs=177.4
Q ss_pred cCccccCceeeecceeEEEEEec------cccEEEEEEecCCC-CcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCee
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~ 544 (698)
++|++.++||+|+||.||+|++. .++.||||+++... .....+|.+|+++++++ +|||||+++++|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 56888899999999999999752 36789999997653 33455789999999999 699999999999999999
Q ss_pred EEEEEecCCCChhHHHhhcc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEc
Q 005400 545 MLIYEYMPNKSLDFFIFDQA---------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~ 609 (698)
++||||+++|+|..++.... ....+++..+++++.||++||+|||+++ ++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999987543 1235899999999999999999999998 99999999999999
Q ss_pred CCCceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCC
Q 005400 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG-KKNWRFSHP 682 (698)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG-~~pf~~~~~ 682 (698)
.++.+||+|||+++...............||+.|+|||.+....++.++|||||||++|||+|+ ++||.....
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999887654443444457899999999999999999999999999999999995 455544333
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.3e-38 Score=325.70 Aligned_cols=200 Identities=26% Similarity=0.410 Sum_probs=172.3
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 550 (698)
++|+++++||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.++++++|||||++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999889999999996642 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCcc
Q 005400 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (698)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~ 630 (698)
+.++.+..+... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 998877766532 345999999999999999999999988 99999999999999999999999999987654332
Q ss_pred ccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 631 ~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
. .....+++.|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 2 2235689999999998654 5689999999999999999999999754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-38 Score=326.05 Aligned_cols=197 Identities=30% Similarity=0.478 Sum_probs=168.1
Q ss_pred CceeeecceeEEEEEeccc----cEEEEEEecCC-CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-CeeEEEEEecC
Q 005400 479 NKLGEGGFGPVYKGTLVEG----QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEYMP 552 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~g----~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-~~~~lV~E~~~ 552 (698)
++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++|||||+++|++.+. ...++||||++
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 5899999999999987542 25899999754 444567899999999999999999999998764 57899999999
Q ss_pred CCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCccc-
Q 005400 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ- 631 (698)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~~~- 631 (698)
+++|.+++... ...+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 113 ~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 113 HGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred cCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999988643 335788899999999999999999998 999999999999999999999999999876543222
Q ss_pred -cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 632 -TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 632 -~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.......||..|+|||.+....++.++||||||+++|||+||+.||...
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 1222357899999999999999999999999999999999988887643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-38 Score=323.67 Aligned_cols=197 Identities=25% Similarity=0.389 Sum_probs=167.9
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCC------cchHHHHHHHHHHhhcC--CCeeeeEEEEEEeCCe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQADE 543 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~il~~l~--H~nIv~l~~~~~~~~~ 543 (698)
++|++.++||+|+||.||+|+.. +|+.||||++.+... .....+.+|++++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999874 589999999875421 12244778999999996 8999999999999999
Q ss_pred eEEEEEecCC-CChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-CCceEEeecCC
Q 005400 544 SMLIYEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGM 621 (698)
Q Consensus 544 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFgl 621 (698)
.++||||+.+ +++..++.+. ..+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5676776443 34899999999999999999999998 999999999999985 47999999999
Q ss_pred CcccCCCccccccccccccccccChhcccCCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
+....... .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||..
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 98754332 223679999999999987765 5678999999999999999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-38 Score=327.55 Aligned_cols=203 Identities=32% Similarity=0.489 Sum_probs=170.0
Q ss_pred cCccccCceeeecceeEEEEEecc-cc--EEEEEEecCC-CCcchHHHHHHHHHHhhc-CCCeeeeEEEEEEeCCeeEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~~~~~~~~~~~lV 547 (698)
++|++.++||+|+||.||+|++.+ +. .||||+++.. ..+..+.|.+|++++.++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567888999999999999998754 33 5788888654 344567899999999998 799999999999999999999
Q ss_pred EEecCCCChhHHHhhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCce
Q 005400 548 YEYMPNKSLDFFIFDQ-------------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 614 (698)
|||+++|+|.++|... .....+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 23456899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCC
Q 005400 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK-NWRFSH 681 (698)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~-pf~~~~ 681 (698)
||+|||+++...... ......||..|+|||.+....++.++|||||||++|||++|.. ||....
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 999999997643221 1223578999999999999999999999999999999999765 676443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-38 Score=326.30 Aligned_cols=199 Identities=24% Similarity=0.381 Sum_probs=162.2
Q ss_pred cCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHH--HHhhcCCCeeeeEEEEEEeCC----eeEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT--LIARLQHRNLVKLLGCCIQAD----ESML 546 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~--il~~l~H~nIv~l~~~~~~~~----~~~l 546 (698)
+.|...++||+|+||.||+|++ +|+.||||+++.. ..+.+..|.+ .+.+++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567778999999999999997 6899999999643 2334444444 456789999999999998754 5789
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceeecCCCCCCEEEcCCCceEEeecCC
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-----SRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NILl~~~~~~kl~DFgl 621 (698)
||||+++|+|..++.+. .++|..+++++.|++.||+|||+. ...+|+||||||+||||+.++++||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999643 389999999999999999999974 123599999999999999999999999999
Q ss_pred CcccCCCcc--ccccccccccccccChhcccCCC------CCcchhHHHHHHHHHHHHhCCCCCCC
Q 005400 622 ARIFGGDEI--QTNTHKVVGTYGYMSPEYAAEGL------FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (698)
Q Consensus 622 a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~------~~~k~DVwSlGvil~elltG~~pf~~ 679 (698)
++....... ........||+.|||||++.... ++.++|||||||+||||+||..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 987644321 12233467999999999986543 57789999999999999999988754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=323.50 Aligned_cols=203 Identities=26% Similarity=0.423 Sum_probs=168.8
Q ss_pred hhcCccccCceeeecceeEEEEEec-c-ccEEEEEEecCC--CCcchHHHHHHHHHHhhc---CCCeeeeEEEEEEeC--
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTLV-E-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQA-- 541 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l---~H~nIv~l~~~~~~~-- 541 (698)
..++|+++++||+|+||+||+|+.. + ++.||||+++.. .......+.+|+++++.+ +||||+++++++...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3478999999999999999999874 3 567999998654 222344567788877666 799999999998642
Q ss_pred ---CeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEee
Q 005400 542 ---DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (698)
Q Consensus 542 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 618 (698)
...+++|||++++.+...... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 467899999998877655432 3345889999999999999999999998 99999999999999999999999
Q ss_pred cCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 9998864322 22334689999999999999999999999999999999999999997543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-36 Score=311.88 Aligned_cols=204 Identities=18% Similarity=0.290 Sum_probs=173.4
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCC-CeeeeEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H-~nIv~l~~~~~~~~~~~lV~E 549 (698)
.++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 58899999986542 23457889999999975 899999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC-----CCceEEeecCCCcc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARI 624 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFgla~~ 624 (698)
|+ +++|.+++... ...++..++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 68888887543 335899999999999999999999998 999999999999974 56899999999987
Q ss_pred cCCCccc-----cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 625 FGGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 625 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
+...... .......||+.|||||.+.+..++.++|||||||++|||+||+.||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 6432111 1223367999999999999999999999999999999999999999865544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-36 Score=319.39 Aligned_cols=204 Identities=23% Similarity=0.387 Sum_probs=168.2
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEe--------
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-------- 540 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~-------- 540 (698)
.++|+++++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999974 6899999998654 33445678999999999999999999999865
Q ss_pred CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecC
Q 005400 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (698)
Q Consensus 541 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFg 620 (698)
....++||||++++.+..... ....++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 345789999998887765542 2345888999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCccc--cccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 621 MARIFGGDEIQ--TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 621 la~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
++..+...... .......||+.|+|||++... .++.++|||||||++|||++|+.||...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 99876532211 112235799999999998765 68999999999999999999999997544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-36 Score=319.44 Aligned_cols=197 Identities=24% Similarity=0.360 Sum_probs=164.6
Q ss_pred CccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC------CeeEE
Q 005400 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------DESML 546 (698)
Q Consensus 474 ~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~------~~~~l 546 (698)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4777889999999999999975 589999999976432 234799999999999999999998653 24789
Q ss_pred EEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-ceEEeecCCCccc
Q 005400 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIF 625 (698)
Q Consensus 547 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFgla~~~ 625 (698)
||||++++.+..+.........+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||++..+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755554433334556999999999999999999999988 99999999999999775 8999999999876
Q ss_pred CCCccccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 626 GGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
...... ....||..|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 543322 23579999999998765 57899999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=319.00 Aligned_cols=205 Identities=26% Similarity=0.410 Sum_probs=174.3
Q ss_pred cCccccCceeeecceeEEEEEec----cccEEEEEEecCC----CCcchHHHHHHHHHHhhcCC-CeeeeEEEEEEeCCe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG----SGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADE 543 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~il~~l~H-~nIv~l~~~~~~~~~ 543 (698)
++|++.++||+|+||+||+|+.. +|+.||||++++. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 3789999998653 22345678899999999976 899999999999999
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++||||+.+++|..++.... .+....+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986543 3678888999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccChhcccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEG--LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~k~DVwSlGvil~elltG~~pf~~~~~~~ 684 (698)
.+...... ......|++.|+|||.+... .++.++|||||||+||||++|+.||......+
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 76433322 22336799999999998755 46889999999999999999999998665443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-36 Score=318.08 Aligned_cols=204 Identities=24% Similarity=0.377 Sum_probs=168.3
Q ss_pred hhcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC-CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC----ee
Q 005400 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----ES 544 (698)
Q Consensus 471 ~~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~----~~ 544 (698)
.+++|+++++||+|+||+||+|+. .+|+.||||++.+.. ....+.+++|+++|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346799999999999999999986 468999999997543 334567899999999999999999999987643 23
Q ss_pred EEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 545 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
+++++++.+++|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 5566777899999998542 4899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-ccccccccccccccChhcccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 625 FGGDEI-QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 625 ~~~~~~-~~~~~~~~gt~~y~APE~l~~-~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
...... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 543221 112233679999999999854 467899999999999999999999997543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=306.94 Aligned_cols=198 Identities=24% Similarity=0.379 Sum_probs=172.8
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCC--CCcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCCeeEEEEE
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~~~~lV~E 549 (698)
++|+++++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999974 5888999998654 23456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCcccCCCc
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~~~~~~ 629 (698)
++.+++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++++||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999988877433 34789999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccChhcccCCC-CCcchhHHHHHHHHHHHHhCCCCCC
Q 005400 630 IQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWR 678 (698)
Q Consensus 630 ~~~~~~~~~gt~~y~APE~l~~~~-~~~k~DVwSlGvil~elltG~~pf~ 678 (698)
.. .....++..|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 22 22246788999999887665 6899999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-36 Score=318.36 Aligned_cols=196 Identities=26% Similarity=0.421 Sum_probs=163.1
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeCC------
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~~------ 542 (698)
.++|+++++||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999874 58999999997542 234567899999999999999999999997654
Q ss_pred eeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCC
Q 005400 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (698)
Q Consensus 543 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla 622 (698)
..++||||+ +.+|..+... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 5566666532 34899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
+...... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 169 RQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp EECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 8764332 236799999999998764 5789999999999999999999999754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-35 Score=307.89 Aligned_cols=204 Identities=22% Similarity=0.324 Sum_probs=166.0
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCeee-eEEEEEEeCCeeEEEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYE 549 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~~~~~~~~~~~lV~E 549 (698)
.++|++.++||+|+||.||+|+.. +|+.||||++.... ..+++..|++++++++|+|++ .+..+..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 367999999999999999999874 58899999987543 234688999999999877654 55566678888999999
Q ss_pred ecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcC---CCceEEeecCCCcccC
Q 005400 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFG 626 (698)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFgla~~~~ 626 (698)
|+.+ ++...+... ...+++..+..++.|+++||+|||+++ |+||||||+|||++. +..+||+|||+|+.+.
T Consensus 84 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLGP-SLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCCC-BHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcCC-chhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9954 555554332 335899999999999999999999998 999999999999863 5579999999999865
Q ss_pred CCccc-----cccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005400 627 GDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (698)
Q Consensus 627 ~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~~~ 683 (698)
..... .......||+.|||||.+.+..++.++|||||||++|||+||+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 43211 1223367999999999999999999999999999999999999999865544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.1e-35 Score=307.77 Aligned_cols=195 Identities=21% Similarity=0.391 Sum_probs=167.8
Q ss_pred hcCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeC--CeeEEE
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQA--DESMLI 547 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~--~~~~lV 547 (698)
.++|+++++||+|+||+||+|+.. +++.||||+++.. ..+.+.+|+++|++++ ||||+++++++... ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 367999999999999999999874 5889999999653 3567899999999995 99999999999854 468999
Q ss_pred EEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCC-ceEEeecCCCcccC
Q 005400 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFG 626 (698)
Q Consensus 548 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFgla~~~~ 626 (698)
|||+++++|..+. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999987653 24889999999999999999999998 99999999999998655 69999999998765
Q ss_pred CCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 627 GDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
.... .....+|+.|+|||.+... .++.++||||+||+++||++|+.||....
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 4322 2235789999999998765 57999999999999999999999997544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=308.39 Aligned_cols=197 Identities=26% Similarity=0.350 Sum_probs=160.1
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEe------CCe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ------ADE 543 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~------~~~ 543 (698)
++|+++++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999975 58999999997652 3344568899999999999999999999964 367
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++||||+.++.+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999876554331 23789999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~~ 681 (698)
...... ......+|+.|+|||++.+..+++++||||+||+++||++|+.||...+
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 654332 2233578999999999999999999999999999999999999997543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-35 Score=308.34 Aligned_cols=197 Identities=26% Similarity=0.400 Sum_probs=165.5
Q ss_pred hcCccccCceeeecceeEEEEEe-ccccEEEEEEecCCC--CcchHHHHHHHHHHhhcCCCeeeeEEEEEEeC-----Ce
Q 005400 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (698)
Q Consensus 472 ~~~f~~~~~LG~G~fG~Vy~g~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~~~~~~~-----~~ 543 (698)
.++|+++++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999986 469999999997653 23455788999999999999999999998643 34
Q ss_pred eEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEeecCCCc
Q 005400 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (698)
Q Consensus 544 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~ 623 (698)
.++++|++.+|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4677888899999998843 24899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCccccccccccccccccChhcccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 6432 12236789999999987665 4689999999999999999999999754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.8e-30 Score=276.56 Aligned_cols=199 Identities=21% Similarity=0.302 Sum_probs=162.2
Q ss_pred cCccccCceeeecceeEEEEEec-cccEEEEEEecCCCCcchHHHHHHHHHHhhcC-----------CCeeeeEEEEEEe
Q 005400 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----------HRNLVKLLGCCIQ 540 (698)
Q Consensus 473 ~~f~~~~~LG~G~fG~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-----------H~nIv~l~~~~~~ 540 (698)
++|+++++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999874 68999999997542 23467788999988875 5789999988764
Q ss_pred --CCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEEcCCC-----
Q 005400 541 --ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDM----- 612 (698)
Q Consensus 541 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~----- 612 (698)
....+++++++.................+++..+..++.||++||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 45667777777666554444444555668899999999999999999998 65 99999999999998665
Q ss_pred -ceEEeecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 005400 613 -NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (698)
Q Consensus 613 -~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil~elltG~~pf~~~ 680 (698)
.++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 3999999999764322 22367999999999999999999999999999999999999999743
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.5e-21 Score=187.39 Aligned_cols=169 Identities=19% Similarity=0.170 Sum_probs=119.7
Q ss_pred cccCceeeecceeEEEEEeccccEEEEEEecCCCC------------------cchHHHHHHHHHHhhcCCCeeeeEEEE
Q 005400 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG------------------QGMEEFKNEVTLIARLQHRNLVKLLGC 537 (698)
Q Consensus 476 ~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~il~~l~H~nIv~l~~~ 537 (698)
.+.++||+|+||.||+|+..+|++||||+++.... .....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34579999999999999988899999998753210 011234568889999999999998866
Q ss_pred EEeCCeeEEEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCCEEEcCCCceEEe
Q 005400 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (698)
Q Consensus 538 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 617 (698)
. ..+++|||+++..+.. ++......++.|++++|+|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 2479999998865532 233345678999999999999998 9999999999999965 59999
Q ss_pred ecCCCcccCCCccccccccccccccccChhcccCCCCCcchhHHHHHHHH
Q 005400 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLV 667 (698)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~k~DVwSlGvil 667 (698)
|||+|.....+....... ....- ..|.+ ...|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~l~---rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE---RDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHH---HHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH---HHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 999997654322111000 00000 01222 35577889999986433
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.82 E-value=2e-20 Score=162.40 Aligned_cols=112 Identities=18% Similarity=0.374 Sum_probs=94.2
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEeCCC
Q 005400 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGR 97 (698)
Q Consensus 18 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~ 97 (698)
+|+|.|||.|.+|+.|+| |.|+|.|...|+ |.|+. ..++||.||++.|.. .+.+.++.||+|+|...
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCC--CcEEEEeccccEEEEec
Confidence 589999999999999985 899999998876 56654 468999999988753 46799999999999334
Q ss_pred CceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCc
Q 005400 98 DRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCD 143 (698)
Q Consensus 98 ~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTD 143 (698)
+..+|++++....+..+|+|+|+|||||++.+ +.++|||+.+|++
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-NNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-SCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCC-CcEEecCCCccCC
Confidence 67788887665556678999999999999976 7899999999986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.80 E-value=9.2e-20 Score=156.64 Aligned_cols=106 Identities=21% Similarity=0.334 Sum_probs=90.8
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CC
Q 005400 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (698)
Q Consensus 18 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (698)
+|+|.+||.|.+|+.|. +|.|+|.|...|+ |.||. ..++||.||++.|- +.+.+.++.+|+|+| ++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCC--CccEEEEeccceEEEECC
Confidence 47899999999999995 6999999998886 67765 46889999998873 356799999999988 89
Q ss_pred CCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCC
Q 005400 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (698)
Q Consensus 97 ~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~ 140 (698)
+|.++|++++.......+|+|+|+|||||++ ..+||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~----~~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYG----TDRWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEE----CCCCCCCCC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeC----CCcccCCCC
Confidence 9999999998655556678999999999995 358999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.79 E-value=3.9e-19 Score=152.70 Aligned_cols=107 Identities=20% Similarity=0.305 Sum_probs=90.2
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CC
Q 005400 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (698)
Q Consensus 18 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (698)
.|+|.|||.|.+|+.|.+ |.|.|+|...++ |.++. ..++||+||++.|... .+.|.+++||+|+| ++
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~ 68 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDA 68 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECS
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeC
Confidence 478999999999999974 889999987765 55543 4689999999999865 56799999999988 89
Q ss_pred CCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCC
Q 005400 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (698)
Q Consensus 97 ~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~ 140 (698)
+|.++|+|+++...+..+|+|+|+|||||++ ..+|||+-|
T Consensus 69 ~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~----~~~W~S~t~ 108 (109)
T d1kj1a_ 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYG----SDIWSTGTY 108 (109)
T ss_dssp SSCEEEECCCCCCSSCCEEEECTTSCEEEEC----CEEEECCCC
T ss_pred CCcEEEEEeeECCCCCEEEEEeCCCcEEEEC----CCEecCCCc
Confidence 9999999998755566789999999999995 359999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.71 E-value=7.4e-18 Score=147.00 Aligned_cols=103 Identities=17% Similarity=0.205 Sum_probs=88.3
Q ss_pred EEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceee
Q 005400 56 GIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135 (698)
Q Consensus 56 ~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~W 135 (698)
.|||.++++++.+|++|++.|++...-+|.++.||+|+|...+.++|++++.......+|+|+++|||||++.+ +.++|
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~-~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ-NIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-TEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecCCcEEEEEccccCCCcEEEEEeCCeeEEEEcCC-CCEEE
Confidence 68999999999999999999998877899999999999955678999999876656778999999999999987 88999
Q ss_pred eccCCCCcccCCCCeecccccCCCceeEEeeccCCCCCCCceEEeecCCCCceEE
Q 005400 136 QSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLV 190 (698)
Q Consensus 136 qSFd~PTDTlLpg~~l~~~~~~g~~~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~ 190 (698)
|||. +.++|.|.|.+|+||++.+|
T Consensus 90 ~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9973 34568899999999987654
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.56 E-value=7.4e-16 Score=132.72 Aligned_cols=110 Identities=18% Similarity=0.195 Sum_probs=92.5
Q ss_pred EEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeee
Q 005400 57 IWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQ 136 (698)
Q Consensus 57 iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~Wq 136 (698)
|||.-.++.+..|+.+.+.|+.....+|.++.||+|+|...+.++|++++.. ..+..|.|+|+|||||++.+ +.++||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~-~~~vWs 80 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ-NTIRWS 80 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEESSSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT-TCCSCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcCCeeEEEcccCC-CCceEEEEeccCCEEEEccC-CCEEEE
Confidence 7888888889999999999998877899999999999955688999999864 35788999999999999887 789999
Q ss_pred ccCCCCcccCCCCeecccccCCCceeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCC
Q 005400 137 SFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (698)
Q Consensus 137 SFd~PTDTlLpg~~l~~~~~~g~~~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (698)
|+. +.++|.|.|.|++||...++ . ..+|.+|.
T Consensus 81 S~t-------------------------------~~~~g~y~l~Lq~DGNlvlY--~--~~~Wssgt 112 (115)
T d1dlpa1 81 SGT-------------------------------KGSIGNYVLVLQPDRTVTIY--G--PGLWDSGT 112 (115)
T ss_dssp CCC-------------------------------CCCSSCCEEEECSSSCEEEE--C--SEEEECSC
T ss_pred cCC-------------------------------CCCCCCEEEEECCCCcEEEe--C--CCeecCCC
Confidence 863 34679999999999987544 3 35788764
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.52 E-value=2.7e-14 Score=123.72 Aligned_cols=102 Identities=14% Similarity=0.260 Sum_probs=80.9
Q ss_pred cccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CCC
Q 005400 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGR 97 (698)
Q Consensus 19 ~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~~ 97 (698)
++|.++|+| .+.+..|.|.|.|...|+ |.+ |. ..++||.||+..|. ....|.+..||+|+| |++
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLG--NGCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCC--cceEEEEEeCCCEEEECCC
Confidence 455555555 246789999999998887 555 33 46899999997764 346899999999999 899
Q ss_pred CceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccC
Q 005400 98 DRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFD 139 (698)
Q Consensus 98 ~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd 139 (698)
|.++|++++.......+|+|+|+|||||++ ..+|||-.
T Consensus 80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg----~~~W~S~T 117 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIYG----DALWATQT 117 (119)
T ss_dssp CCEEEECSCCCCSSCEEEEECTTSCEEEEE----SEEEECCC
T ss_pred CcEEEECCCcCCCCceEEEEcCCCCEEEEC----CCEeccCC
Confidence 999999998755556678999999999984 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.31 E-value=7.5e-13 Score=113.60 Aligned_cols=101 Identities=20% Similarity=0.321 Sum_probs=76.6
Q ss_pred cccccccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe
Q 005400 15 SAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL 94 (698)
Q Consensus 15 ~~~~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l 94 (698)
..+.+||.++|+| .+|.|.|.|...|+ |.++. ..++||.+|... ...+.+.+.++|+|+|
T Consensus 11 ~~~~~tl~~~~~l--------~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~---~~~~~l~l~~dGNLvl 70 (115)
T d1dlpa1 11 GSHPQTLHAAQSL--------ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAG---ATGCRAVLQSDGLLVI 70 (115)
T ss_dssp SCSCSCCCTTCEE--------CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCS---CSCCBCCBCSSSCBCC
T ss_pred CCCcceecCCCcE--------EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCC---CCceEEEEeccCCEEE
Confidence 3344555555555 35679999988876 66654 357899998653 2357899999999999
Q ss_pred -CCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccC
Q 005400 95 -DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFD 139 (698)
Q Consensus 95 -~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd 139 (698)
|..+.+||++++....+..+++|+++|||||++ ..+|+|-.
T Consensus 71 ~d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~----~~~Wssgt 112 (115)
T d1dlpa1 71 LTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG----PGLWDSGT 112 (115)
T ss_dssp BCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC----SEEEECSC
T ss_pred EccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC----CCeecCCC
Confidence 889999999998765566689999999999993 47999853
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.03 E-value=4.3e-10 Score=95.36 Aligned_cols=76 Identities=17% Similarity=0.309 Sum_probs=61.5
Q ss_pred ceEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCcee
Q 005400 83 LLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRH 162 (698)
Q Consensus 83 ~l~~~~~g~l~l~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~~~ 162 (698)
.|.+..||+|+|-..+.+||++++......+.++|.++|||||++.+ +.++|+|
T Consensus 22 ~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-g~~vWsS------------------------- 75 (108)
T d1jpca_ 22 VFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-NKPIWAS------------------------- 75 (108)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-CCEEEEC-------------------------
T ss_pred EEEECCCCeEEEEeCCceeeEeCCCCCCCccEEEEeccceEEEECCC-ccceEEc-------------------------
Confidence 57799999999965778999999876555678999999999999987 7899986
Q ss_pred EEeeccCCCCCCCceEEeecCCCCceEE
Q 005400 163 LSSWKSINDPAPGEFSLWIDTHGFPQLV 190 (698)
Q Consensus 163 l~s~~~~~d~s~g~~~~~~~~~g~~~~~ 190 (698)
.+..+++.|.+.|+.+|++.++
T Consensus 76 ------~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 ------NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp ------CCCCSCSCEEEEECTTSCEEEE
T ss_pred ------cccCCCCcEEEEEcCCCCEEEe
Confidence 1112457789999999987654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.99 E-value=7.5e-10 Score=95.24 Aligned_cols=85 Identities=16% Similarity=0.200 Sum_probs=67.1
Q ss_pred ceEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCcee
Q 005400 83 LLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRH 162 (698)
Q Consensus 83 ~l~~~~~g~l~l~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~~~ 162 (698)
.|.+..||+|+|...+.++|++++.+....+.+.|.++|||||++.+ +.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-g~~vWsS~t----------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-NVTVWQSPV----------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-CCEEEECSC-----------------------
T ss_pred EEEECCCCcEEEEECCeEEEEecCCCCCcceEEEEEeCCCEEEECCC-CcEEEECCC-----------------------
Confidence 58899999999965678999999876556788999999999999987 788998621
Q ss_pred EEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCC
Q 005400 163 LSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (698)
Q Consensus 163 l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (698)
.-+.|.|.+.|+++|+..++ . ...|.++.
T Consensus 89 --------~~~~~~~~l~Lq~DGNlvlY--g--~~~W~S~T 117 (119)
T d1b2pa_ 89 --------AGKAGHYVLVLQPDRNVVIY--G--DALWATQT 117 (119)
T ss_dssp --------CCCSSCEEEEECTTSCEEEE--E--SEEEECCC
T ss_pred --------cCCCCceEEEEcCCCCEEEE--C--CCEeccCC
Confidence 11347789999999987654 3 35787764
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.98 E-value=6.2e-10 Score=96.06 Aligned_cols=96 Identities=17% Similarity=0.281 Sum_probs=68.1
Q ss_pred cccCCCCccCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEEeeCCCCeEEEeeCCCCCCCCCCcceEEecCceEEe-CCC
Q 005400 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGR 97 (698)
Q Consensus 19 ~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~~iw~~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l-~~~ 97 (698)
++|.++|+|..| .|.|.|-..|+ |.|+. ...++|.+|- +..+....+.+.++|+|+| |.+
T Consensus 24 ~~l~~~q~l~~g--------~y~L~~q~DGN-----LvL~~----~~~~vW~s~t--~~~~~~~~~~l~~~GnLvl~d~~ 84 (120)
T d1dlpa2 24 QTLHATQSLQLS--------PYRLSMETDCN-----LVLFD----RDDRVWSTNT--AGKGTGCRAVLQPNGRMDVLTNQ 84 (120)
T ss_dssp CEECSSCCCBCS--------SCEEEEETTTE-----EEEEB----TTBCCSCCCC--CSSCSSCEEEEETTTEEEEEETT
T ss_pred cEEcCCCeeEcC--------CEEEEEcCCCc-----EEEec----CCcEEEEEcc--ccCCCcEEEEEeCCeeEEEEcCC
Confidence 455566665544 45555554443 44432 3467898874 4444456799999999999 889
Q ss_pred CceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeec
Q 005400 98 DRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (698)
Q Consensus 98 ~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqS 137 (698)
+.++|++++.......+++|+++|||||++ ..+|.|
T Consensus 85 ~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~----~~~W~t 120 (120)
T d1dlpa2 85 NIAVWTSGNSRSAGRYVFVLQPDRNLAIYG----GALWTT 120 (120)
T ss_dssp TEEEEECCCCCSSSCCEEEECSSSCEEEEC----CCCCBC
T ss_pred CCEEEEeCCCCCCCcEEEEECCCCcEEEeC----CCcccC
Confidence 999999998655566678999999999993 468876
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.84 E-value=7.7e-09 Score=87.50 Aligned_cols=86 Identities=22% Similarity=0.319 Sum_probs=65.3
Q ss_pred cceEEecCceEEeCCCCceEEeeccCCC-CCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCc
Q 005400 82 GLLNVTSKGIVLLDGRDRIFWSSNTSIT-MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (698)
Q Consensus 82 ~~l~~~~~g~l~l~~~~~~~ws~~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~ 160 (698)
-.|.+..||+|++...+.+||++|+... ..+..+.|.++|||||++++ +.++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-g~~vW~s~---------------------- 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-GRSLWASH---------------------- 77 (109)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-SCEEEECC----------------------
T ss_pred EEEEecCCCeEEEEeCCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-CcEEEEEe----------------------
Confidence 3577899999999777889999997533 24567999999999999987 78899871
Q ss_pred eeEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCC
Q 005400 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (698)
Q Consensus 161 ~~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (698)
+..+.|.|.+.|+++|+..++ + ...|.|+.
T Consensus 78 ---------t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t 107 (109)
T d1kj1a_ 78 ---------SVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGT 107 (109)
T ss_dssp ---------CCCCSSCCEEEECTTSCEEEE--C--CEEEECCC
T ss_pred ---------eECCCCCEEEEEeCCCcEEEE--C--CCEecCCC
Confidence 111346789999999987654 3 24687764
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.60 E-value=1.1e-07 Score=80.68 Aligned_cols=88 Identities=18% Similarity=0.339 Sum_probs=66.0
Q ss_pred cceEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeccceEEEecCCCCceeeeccCCCCcccCCCCeecccccCCCce
Q 005400 82 GLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDR 161 (698)
Q Consensus 82 ~~l~~~~~g~l~l~~~~~~~ws~~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~WqSFd~PTDTlLpg~~l~~~~~~g~~~ 161 (698)
-.|.+..||+|+|-..+.+||++++.....++.++|..+|||||++.+ ..+|.|
T Consensus 21 ~~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~--~~~w~s------------------------ 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS--RAIWAS------------------------ 74 (112)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEETT--EEEEEC------------------------
T ss_pred EEEEEcCCCCEEEEcCCcEEEEccCccCCCCcEEEEeccccEEEEecC--CeEEEE------------------------
Confidence 468899999999966788999999765556678999999999999853 456654
Q ss_pred eEEeeccCCCCCCCceEEeecCCCCceEEEecCcEEEEeeCC
Q 005400 162 HLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (698)
Q Consensus 162 ~l~s~~~~~d~s~g~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (698)
.+.-..|.|.+.|+.+|+..++ .......|.|+.
T Consensus 75 -------~t~~~~~~~~l~L~ddGNlvly-~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------NTNRQNGNYYLILQRDRNVVIY-DNSNNAIWATHT 108 (112)
T ss_dssp -------CCCCSCCCCEEEECTTSCEEEE-CTTSCEEEECCC
T ss_pred -------eeccCCCceEEEEcCCCCEEEE-CCCCcEEecCCC
Confidence 1222346789999999987654 333456788764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=1.5e-07 Score=92.77 Aligned_cols=149 Identities=16% Similarity=0.109 Sum_probs=104.5
Q ss_pred hHHHhhcCccccCceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcC-CCeeeeEEEEEEeCCeeE
Q 005400 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM 545 (698)
Q Consensus 467 ~l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~~~~~~~~~~~ 545 (698)
++.+....|...+..+.++...||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4455556777666555555678998864 56778889886655445556788988887774 444677888888888999
Q ss_pred EEEEecCCCChhHHHhhccccCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 005400 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD---------------------------------- 591 (698)
Q Consensus 546 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------- 591 (698)
+||+++++..+....... .. ...++.++++.++.||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998875543211 11 223455566666666642
Q ss_pred ----------------------CCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 592 ----------------------SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 592 ----------------------~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112379999999999999877677999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=3e-05 Score=75.15 Aligned_cols=131 Identities=18% Similarity=0.204 Sum_probs=85.6
Q ss_pred ceeeecc-eeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcC--CCeeeeEEEEEEeCCeeEEEEEecCCCCh
Q 005400 480 KLGEGGF-GPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (698)
Q Consensus 480 ~LG~G~f-G~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~--H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 556 (698)
.+..|.. +.||+....++..+++|.-.... ...+..|.+.++.+. ...+.+++.+..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444443 67899988778888899765432 234677888777663 33466778888888889999999988765
Q ss_pred hHHHhhccccCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 005400 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLH----------------------------------------------- 589 (698)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH----------------------------------------------- 589 (698)
.... .... .++.++++.|+-||
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 0100 11122222333333
Q ss_pred ----hC----CCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 590 ----QD----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 590 ----~~----~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
+. ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 122389999999999999877778999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.51 E-value=0.00019 Score=74.41 Aligned_cols=76 Identities=12% Similarity=0.208 Sum_probs=49.4
Q ss_pred CceeeecceeEEEEEecc-ccEEEEEEecCC-------CCcchHHHHHHHHHHhhcC-C--CeeeeEEEEEEeCCeeEEE
Q 005400 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-------SGQGMEEFKNEVTLIARLQ-H--RNLVKLLGCCIQADESMLI 547 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~-g~~vavK~l~~~-------~~~~~~~~~~Ei~il~~l~-H--~nIv~l~~~~~~~~~~~lV 547 (698)
+.||.|....||+....+ ++.++||.-... .+........|.+.|+.+. + ..+.+++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998755 678999964321 1122344566888887662 2 345555544 56677899
Q ss_pred EEecCCCCh
Q 005400 548 YEYMPNKSL 556 (698)
Q Consensus 548 ~E~~~~gsL 556 (698)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.63 E-value=0.0033 Score=62.82 Aligned_cols=135 Identities=12% Similarity=0.137 Sum_probs=77.9
Q ss_pred eeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCee--eeEE-----EEEEeCCeeEEEEEecCCCChhH-
Q 005400 487 GPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL--VKLL-----GCCIQADESMLIYEYMPNKSLDF- 558 (698)
Q Consensus 487 G~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nI--v~l~-----~~~~~~~~~~lV~E~~~~gsL~~- 558 (698)
-.||+++..+|+.+++|+.... ....+++..|.+.+..+...++ +..+ .........+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999989999999998643 2345678888888877742222 1111 12244566788999988654320
Q ss_pred ---HH----------hhc------cccCCCCH----------------------HHHHHHHHHHHHHHHHH-HhCCCCce
Q 005400 559 ---FI----------FDQ------ARATFLDW----------------------QKRIHIVGGIARGILYL-HQDSRMRI 596 (698)
Q Consensus 559 ---~l----------~~~------~~~~~l~~----------------------~~~~~i~~~ia~gL~yL-H~~~~~~i 596 (698)
.+ +.. ......++ ......+..+...+.-+ .+..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 000 00011111 11122223333332222 12234468
Q ss_pred eecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 597 IHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 597 vH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 46899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.35 E-value=0.0031 Score=64.85 Aligned_cols=72 Identities=19% Similarity=0.292 Sum_probs=49.2
Q ss_pred CceeeecceeEEEEEecc--------ccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCee-eeEEEEEEeCCeeEEEEE
Q 005400 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYE 549 (698)
Q Consensus 479 ~~LG~G~fG~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nI-v~l~~~~~~~~~~~lV~E 549 (698)
+.|+.|-.-.+|+....+ .+.|.+++... ........+|.++++.+.-.++ .++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 578888889999998654 24577777653 2233456688999888853344 467777632 68999
Q ss_pred ecCCCCh
Q 005400 550 YMPNKSL 556 (698)
Q Consensus 550 ~~~~gsL 556 (698)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.41 E-value=0.14 Score=49.79 Aligned_cols=158 Identities=12% Similarity=0.025 Sum_probs=79.2
Q ss_pred chhhHHHhhcCccccC-----ceeeecceeEEEEEeccccEEEEEEecCCCCcchHHHHHHHHHHhhcCCCe--eeeEEE
Q 005400 464 DFASIAKATDNFASYN-----KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLG 536 (698)
Q Consensus 464 ~~~~l~~~~~~f~~~~-----~LG~G~fG~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~~ 536 (698)
+.++++....+|.+.+ .|..|---+.|+.+..+| ++++|+..... ..+++..|++++..+.+.+ +...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 4455666666675533 344566677899887554 58999886532 2234555666666663221 111110
Q ss_pred ------EEEeCCeeEEEEEecCCCChhHH-----------H---hhc------ccc-CC-----------------CCHH
Q 005400 537 ------CCIQADESMLIYEYMPNKSLDFF-----------I---FDQ------ARA-TF-----------------LDWQ 572 (698)
Q Consensus 537 ------~~~~~~~~~lV~E~~~~gsL~~~-----------l---~~~------~~~-~~-----------------l~~~ 572 (698)
+.........++.++.+...... + +.. ... .. ....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11224455666776665433110 0 000 000 00 0001
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCCEEEcCCCceEEeecCCCcc
Q 005400 573 KRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (698)
Q Consensus 573 ~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFgla~~ 624 (698)
.....+..+...+.-.+. .-+..+||+|+.+.||+++.+...-|+||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111222222222222222 1234599999999999999887778999998754
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.32 E-value=0.026 Score=34.72 Aligned_cols=31 Identities=39% Similarity=0.925 Sum_probs=25.1
Q ss_pred CCCccCCCCCCCcccCCC-CCCcccccCCCccC
Q 005400 276 DRCDLYSVCGANARCTTN-SSRRCDCLEGFVPK 307 (698)
Q Consensus 276 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~ 307 (698)
|.|.+-..|| ||.|+.- ..-.|.|-.||+|.
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCC
Confidence 6799999999 7889754 34469999999985
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.61 E-value=0.1 Score=34.25 Aligned_cols=30 Identities=33% Similarity=0.930 Sum_probs=24.0
Q ss_pred CCCcc-CCCCCCCcccCCC-CCCcccccCCCc
Q 005400 276 DRCDL-YSVCGANARCTTN-SSRRCDCLEGFV 305 (698)
Q Consensus 276 ~~C~~-~~~CG~~g~C~~~-~~~~C~C~~Gf~ 305 (698)
|+|.. ...|..+|.|... .+-+|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 67875 5789999999754 355899999996
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.88 E-value=0.25 Score=31.70 Aligned_cols=29 Identities=38% Similarity=0.987 Sum_probs=22.3
Q ss_pred CCCccCCCCCCCcccCCC-CCCcccccCCCc
Q 005400 276 DRCDLYSVCGANARCTTN-SSRRCDCLEGFV 305 (698)
Q Consensus 276 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~ 305 (698)
|.|. ...|...|.|... ..-.|.|++||.
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 4565 4778899999754 456899999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.06 E-value=0.39 Score=31.50 Aligned_cols=31 Identities=26% Similarity=0.660 Sum_probs=23.5
Q ss_pred CCCCccCCCCCCCcccCCCC-CCcccccCCCcc
Q 005400 275 LDRCDLYSVCGANARCTTNS-SRRCDCLEGFVP 306 (698)
Q Consensus 275 ~~~C~~~~~CG~~g~C~~~~-~~~C~C~~Gf~~ 306 (698)
.|+|... .|+.++.|.... +-.|.|++||..
T Consensus 5 idEC~~~-~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEP-DVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSST-TSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCc-CCCCCCEeECCCCCeEeECCCCccc
Confidence 4789755 456789997654 457999999986
|